Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.9116639149416264,1.8734968891935373,0.0,1.0,0.69,1/26,0.01%,CPA1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.7754563021457059,1.8563356610672328,0.0,1.0,0.79,4/39,2.77%,CPA1;DPEP1;MGLL;ABCC1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.8815899199484455,1.843115891926264,0.0,1.0,0.86,5/22,3.39%,CRTAM;AGER;CD274;HMGB1;SCRIB
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.7541305807602522,1.8376835827107965,0.0,1.0,0.87,7/41,3.21%,CD38;CXCR4;AMPD1;REN;EAF2;ZNF165;ITGAL
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.9615410443728524,1.8160677497330058,0.0,0.8858796878932796,0.91,1/7,0.22%,CXCR4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.9615410443728524,1.8160677497330058,0.0,0.8858796878932796,0.91,1/7,0.22%,CXCR4
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.8694973752191718,1.7908936842376983,0.0,0.9823019668476504,0.94,3/12,3.36%,RPP40;TSR1;RCL1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.9387088656073207,1.7867807830654074,0.0,0.9043355147243897,0.94,1/9,0.03%,CYP1A2
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.7260910000338416,-1.7714808774959379,0.0,0.14524748138414367,0.11,59/111,19.54%,STMN2;TCEAL6;PAK5;GAP43;HTR5A;CHST1;CLVS2;ASTN1;GABRG2;SYNPR;TCEAL5;ATP2B3;BRINP2;KCNIP1;VSTM2A;CDH22;CADM3;SNAP25;SULT4A1;TMEM179;SYN2;UBE2QL1;GRM5;HPCA;SNCB;SH3GL2;RGS7BP;ASIC2;KCNC2;BRINP1;GADD45B;ACTL6B;ST8SIA3;LRRTM3;GABBR2;OPCML;OLFM3;GAD2;CDK5R2;LRFN5;MAP2;TMEM196;AQP4;PHYHIP;PTPRT;CBLN4;LRRC3B;MAPK4;SPHKAP;ADCYAP1R1;LY6H;CAMK2B;SLC17A6;CA10;C11ORF87;PTPN5;GAD1;NDRG4;TMEM59L
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.7343980428336182,-1.762807251265603,0.0,0.11135640239451015,0.17,53/120,13.13%,NPY;LRRTM1;SHISA6;STMN2;TCEAL6;RIT2;PAK5;SYT4;GAP43;PDE10A;HTR5A;CCK;CLVS2;ASTN1;GABRG2;GABRA1;SYNPR;TCEAL5;ATP2B3;BRINP2;KCNIP1;VSTM2A;PRSS12;CDH22;CADM3;SNAP25;SCN2A;SULT4A1;TMEM179;GRM5;NRGN;HPCA;SNCB;CELF4;RAB3C;ARHGDIG;ELAVL4;SH3GL2;RGS7BP;MRTFB;ASIC2;KCNC2;BRINP1;ACTL6B;ST8SIA3;LRRTM3;TAGLN3;CXCL14;OPCML;OLFM3;GAD2;TMEM196;AQP4
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.9634110474697265,1.7588366796180377,0.0,1.0,1.0,1/7,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.9142972957327459,1.752196614893363,0.0,1.0,1.0,3/14,4.26%,PANK1;PPCDC;CROT
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.7085137719491974,-1.7512677488234898,0.0,0.1000593760646323,0.22,43/118,16.03%,BTBD17;PPP1R17;PROM1;RND2;IGFBP3;HOPX;ZCCHC12;ISG15;STMN2;NKAIN1;PAK5;NYAP1;GAP43;CLVS2;ASTN1;RIMS4;CNTFR;PLPPR5;KCNIP1;IFI44;SOX9;RHBDL3;DCLK1;DCX;SULT4A1;TMEM200C;PCDH8;KLHDC8A;SOX21;ACTL6B;TAGLN3;OPCML;CDK5R2;MAP2;PLEKHH2;INA;PTPRZ1;MAPK4;IFIT1;ADCYAP1R1;RBM3;SLC35F1;LY6H
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.71700013816492,-1.744374834293822,0.0,0.09925244561249819,0.28,57/119,17.18%,NPY;PCSK2;HOPX;LRRTM1;SHISA6;PCSK1;RIMS1;STMN2;PAK5;SYT4;CLVS2;ASTN1;FGF12;TCEAL5;KCNIP1;VSTM2A;ROBO2;CDH22;NPTX2;SNAP25;CNTN1;SULT4A1;TMEM179;UBE2QL1;CACNA1B;CELF4;RAB3C;JPH3;CHGA;ELAVL4;SH3GL2;PFKFB2;PAK3;ACTL6B;ST8SIA3;KCNB2;SCG3;GAD2;WSCD2;RAPGEF4;TMEM196;PAX6;PTPRT;SLC2A2;CHGB;SYT13;GABRB3;MAPK4;NOL4;CNTN4;UNC5D;EFNA5;LY6H;CAMK2B;SEZ6L;SLC17A6;NRXN1
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.7388064840624744,-1.7387811253871521,0.0,0.10070492042633962,0.33,49/114,15.29%,NPY;AKAP12;LRRTM1;SHISA6;PCSK1;STMN2;FAM171B;SYT4;GAP43;CLVS2;ASTN1;RGS4;SYNPR;TCEAL5;KCNIP1;KALRN;VSTM2A;CDH22;CADM3;SNAP25;DCLK1;CNTN1;SULT4A1;TMEM179;CACNA1B;RAB3C;CHGA;CPE;ELAVL4;RGS7BP;ASIC2;TMEM35A;BRINP1;ACTL6B;ST8SIA3;SLC26A4;TAGLN3;SLC18A2;OPCML;MAP2;RAPGEF4;TMEM196;PHYHIP;SCG2;CHGB;MAPK4;PCLO;ADCYAP1R1;UNC5D
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.970542979884641,-1.7235351914525192,0.0,0.13233659414999757,0.48,1/12,0.11%,NCEH1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.8819199331516553,-1.7165168349492061,0.0,0.13694762530504975,0.55,5/19,2.99%,PARP14;IRGM;PPARG;PARP9;IFNGR2
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.6724188425696042,-1.7108691987538844,0.0,0.1416162943495401,0.57,114/271,18.61%,PDE4A;PDE1A;NPY;SEMA3E;NEFM;PCSK2;LRRTM1;ZIC4;SHISA6;STMN2;TCEAL6;RIT2;PAK5;CACNG2;SYT4;GAP43;HTR5A;CCK;CHST1;CLVS2;ASTN1;TRIM9;SYT1;PLPPR5;GABRG2;FGF12;SYNPR;L1CAM;TCEAL5;ATP2B3;BRINP2;NOS1;VSTM2A;MAGEE1;TCEAL3;CDH22;SNAP25;CACNA1E;NTNG1;PCP4L1;SULT4A1;PIANP;TMEM179;GDAP1L1;GRM5;NRGN;HPCA;LMO3;CACNA1B;SNCB;CELF4;ETV1;KCNMA1;RAB3C;CACNB1;KCNQ5;ELAVL4;FCHSD2;SH3GL2;GABRA4;PCDH8;RGS7BP;ADGRL2;KCNC2;ADCY8;BRINP1;DLGAP1;ACTL6B;NAT14;ST8SIA3;PLCB4;LRRTM3;GABBR2;TAGLN3;CXCL14;CALB2;CHN1;PACSIN1;OPCML;OLFM3;GAD2;CDK5R2;MAP2;TMEM196;AQP4;NRSN2;PAX6;GRIN2D;SYT13;MAPK4;NOL4;POU2F2;OPRM1;ADCYAP1R1;DHRS3;SLC35F1;SRGAP1;LY6H;ABAT;RAB15;SLC17A6;NRIP3;SLC17A7;NRXN1;GNG4;KIF5A;CA10;C11ORF87;PRKCG;TACR1;GDA;PTPN5;NRN1;GAD1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.7079982183307568,-1.700958456660369,0.0,0.16784153404389934,0.64,53/111,17.52%,ANGPT1;KCNT2;MEST;ASB4;NEFM;PCSK2;PCSK1;STMN2;IGSF1;SYT4;GAP43;CLVS2;GNRHR;ASTN1;TRPM3;TCEAL5;TMEM130;ROBO2;COL11A1;RNF150;CELF4;RAB3C;CHGA;THY1;AMPH;TMEM35A;NREP;ZNF385D;SULF1;PAK3;PRKG1;ST8SIA3;RUNX1T1;GRIA1;OPCML;OLFM3;GAD2;FGF14;GRIA3;FGF7;TMEM196;SCG2;CHGB;PDZRN4;CNTN4;GNB3;UNC5D;NKTR;CACNA1C;SLC17A6;NRXN1;PTPRN;SCN3A
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.8925837697633707,1.6851284434134377,0.0,1.0,1.0,2/12,3.13%,CYP1A2;HSD17B7
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.7439020420807037,1.682666140764862,0.0,1.0,1.0,9/60,8.94%,ADAT1;RPP40;TRMT10C;POP5;TRMT1;ANKRD16;NSUN2;CPSF4;CSTF2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.8921469408961102,-1.6799245883609144,0.0,0.23336428675719084,0.79,1/11,0.40%,DPYS
prerank,PanglaoDB_Augmented_2021__Neurons,-0.6372336070050287,-1.6791985804717067,0.0,0.2130296393634107,0.79,98/264,18.61%,PDE1A;NPY;NEFM;PNMA8A;PCSK2;LRRTM1;ZCCHC12;VSNL1;STMN2;TCEAL6;RIT2;PAK5;CACNG2;SYT4;GAP43;HTR5A;CCK;CLVS2;ASTN1;GABRG2;NMT1;GABRA1;SYNPR;TCEAL5;ATP2B3;TMEM130;VSTM2A;MAGEE1;TCEAL3;CDH22;SNAP25;SLC1A1;SCN2A;SULT4A1;AQP1;TMEM179;GDAP1L1;GRM5;NRGN;HPCA;CACNA1B;CALY;SNCB;CELF4;KCNMA1;RAB3C;ARHGDIG;ELAVL4;SH3GL2;RGS7BP;OGFOD1;ATP1B2;BRINP1;DLGAP1;DGKB;ACTL6B;CLSTN3;ST8SIA3;LRRTM3;GABBR2;MATN2;TAGLN3;NEFH;CALB2;CHN1;DIPK1B;PACSIN1;OPCML;OLFM3;DLG4;GAD2;SRRM4;CDK5R2;GRIA3;TMEM196;NRSN2;MAP7D2;GNG2;NOL4;PCLO;ADCYAP1R1;LY6H;ABAT;SLC17A6;NAPG;B3GAT2;SLC17A7;KCNK1;NRXN1;RBFOX3;KIF5A;CA10;C11ORF87;SCN1A;PTPN5;NRN1;CDK5;GAD1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.6813412356611208,-1.6751200909707815,0.0,0.2122227089112766,0.8,56/105,19.09%,STMN2;TCEAL6;RIT2;PAK5;GAP43;HTR5A;CLVS2;ASTN1;TRPM3;GABRG2;GABRA1;SYNPR;ATP2B3;BRINP2;TMEM130;VSTM2A;CDH22;SNAP25;SLC1A1;SCN2A;GRM5;HPCA;CACNA1B;CELF4;GABRA2;ASIC2;GRIN2B;KCNC2;CACNG3;ACTL6B;ST8SIA3;LRRTM3;GRIA1;OPCML;OLFM3;GAD2;SRRM4;TMEM196;ATCAY;NOL4;SPHKAP;CNTNAP5;ADCYAP1R1;TMEM132B;TNR;SLC17A6;SLC17A7;NRXN1;SLC1A6;CA10;NTRK3;C11ORF87;SCN1A;PTPN5;SLC1A2;NDRG4
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.6683798221942411,-1.6723411975770652,0.0,0.21153992160562463,0.81,71/146,18.61%,PDE1A;LRRTM1;SHISA6;STMN2;TCEAL6;RIT2;PAK5;CACNG2;SYT4;GAP43;HTR5A;CLVS2;ASTN1;GABRG2;GABRA1;SYNPR;TCEAL5;ATP2B3;VSTM2A;ATP2B2;CDH22;SNAP25;PCP4L1;SULT4A1;TMEM179;GDAP1L1;GRM5;HPCA;CACNA1B;CALY;SNCB;CELF4;KCNMA1;RAB3C;ELAVL4;PCDH8;HCN1;ASIC2;PDE1B;ATP1B2;BRINP1;PDE5A;PRKG1;DLGAP1;ACTL6B;CLSTN3;ST8SIA3;LRRTM3;OPCML;OLFM3;DLG4;GAD2;SRRM4;GRIA3;TMEM196;ITPR3;LRRC3B;ADCYAP1R1;LY6H;ABAT;SEZ6L;SLC17A6;NRIP3;NRXN1;SLC1A6;GNG4;KIF5A;CA10;C11ORF87;PTPN5;GAD1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.8159377730232062,1.6719128108134722,0.02564102564102564,1.0,1.0,1/21,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.9539418270958855,1.6674601531865052,0.0,1.0,1.0,3/8,3.39%,CRTAM;CD274;SCRIB
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.6880688730679685,-1.6645879577482476,0.0,0.22686273282856725,0.84,45/97,19.13%,SPARCL1;P2RY12;SHISA6;RASSF4;C1QB;CHL1;TCEAL6;MAOB;SSTR1;SYNPR;SERPING1;CADM3;LYVE1;A2M;CSF1R;LRRK2;GRM5;PHF24;TMIGD3;CHI3L1;RGS7BP;SLC8A1;BAALC;SCN4B;OPCML;EDNRB;OPALIN;GRIA3;C1QC;AQP4;PTPRT;TMEM176B;CBLN4;TGFA;PID1;FCGR3A;SLC6A7;SEZ6L;MAF;VWF;NRXN1;SLCO2B1;CA10;SLC1A2;CDH1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.8936401829056863,1.6613023794515687,0.0,1.0,1.0,2/12,5.54%,BACE2;NCSTN
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9493139832952238,-1.6559798467057223,0.0,0.2595088334063367,0.88,1/14,0.03%,CD44
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.8692587021292673,1.6539700323339934,0.05555555555555555,1.0,1.0,1/15,0.23%,AMPD1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.8049184935501181,1.6427606049971848,0.0,1.0,1.0,5/28,4.39%,CYP1A2;DAO;CYB5A;GLYAT;ST3GAL1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.9404695117941879,-1.6364115139290987,0.0,0.35646152723025265,0.95,1/7,0.40%,DPYS
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.6800306604477346,-1.6350226299046622,0.0,0.3463155634570955,0.95,59/135,18.40%,CLGN;NEFM;LRRTM1;SHISA6;STMN2;TCEAL6;PAK5;SYT4;GAP43;CLVS2;ASTN1;VWA5A;SYNPR;TCEAL5;ATP2B3;VSTM2A;CADM3;SNAP25;DCLK1;SCN2A;SULT4A1;TMEM179;GDAP1L1;GRM5;SCN9A;CACNA1B;RAB3C;PHF24;ELAVL4;SH3GL2;RGS7BP;ADD2;ASIC2;TMEM35A;ADCY8;BRINP1;ACTL6B;ST8SIA3;LRRTM3;TAGLN3;NEFH;OPCML;OLFM3;LRFN5;MAP2;TMEM196;AQP4;MAPK4;SPHKAP;ADCYAP1R1;LY6H;FKBP1B;SLC17A6;NRXN1;FGF13;KIF5A;CA10;C11ORF87;PTPN5
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.6705714158000993,-1.6337001916939113,0.0,0.3351451144530426,0.95,33/152,11.98%,CD44;FSTL1;PCOLCE;MEST;FBLN1;IGFBP3;SFRP4;BASP1;CD59;MFAP5;ACTA2;LAMC1;IGFBP4;TIMP1;FAP;COL4A1;RGS4;ID2;VIM;ECM2;MAGEE1;GPX7;COL11A1;GJA1;THY1;CRLF1;CTHRC1;SNTB1;GADD45B;SLC6A8;MATN2;VEGFA;FZD8
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.8099962966116456,1.6334935331616416,0.02857142857142857,1.0,1.0,3/19,8.23%,AMPD1;HPRT1;AK3
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.6922272041762098,-1.6264493051427975,0.0,0.3608253221753464,0.96,44/100,14.99%,KCNT2;PCSK2;LOXL4;DEPP1;DNALI1;PCSK1;STMN2;CNTN3;SYT4;FAP;SSTR1;RGS4;KCNIP1;DDAH1;SNAP25;SORBS2;TMEM179;FNDC4;RAB3C;PTGER3;CHGA;PCDHB4;CPE;SH3GL2;RGS7BP;ACTL6B;ST8SIA3;GPC6;RUNX1T1;KCNB2;TSPAN7;FGF14;LDB2;GRIA3;RAPGEF4;TMEM196;PAX6;PTPRT;SCG2;CHGB;SYT13;NOL4;CNTN4;AGT
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.7098710777977306,-1.625429622479965,0.0,0.35198306322090817,0.96,30/76,14.24%,BTBD17;RND2;NEFM;ZCCHC12;STMN2;NKAIN1;NYAP1;SYT4;GAP43;CLVS2;ASTN1;RIMS4;CNTFR;PLPPR5;RHBDL3;OGDHL;PURG;SULT4A1;TMEM179;GDAP1L1;CACNA1B;JPH3;PCDH8;ACTL6B;KCNB2;MEX3A;CDK5R2;SCG2;INA;MYT1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.6617777977869282,-1.6245096030707775,0.0,0.33937189301184045,0.96,70/130,18.40%,LRTM1;ADAMTS5;NEFM;PCSK2;STMN2;TCEAL6;PAK5;SYT4;HTR5A;CLVS2;ASTN1;TRPM3;GABRG2;TRNP1;GABRA1;SYNPR;TCEAL5;ATP2B3;TMEM130;VSTM2A;SNAP25;GPR179;SCN2A;NTNG1;GDAP1L1;GRM5;CACNA1B;CELF4;KCNMA1;RAB3C;CHGA;LIN7A;STX3;AMPH;HCN1;ATP1B2;CACNA2D3;CACNG3;VWC2L;PAK3;ACTL6B;ST8SIA3;AP3B2;SCG3;GRIA1;OPCML;OLFM3;GAD2;SRRM4;TMEM196;ATCAY;CNTN4;SPHKAP;GNB3;CNTNAP5;ADCYAP1R1;TNR;GRM6;SEZ6L;QPCT;ROM1;CACNA2D4;SLC17A6;NRXN1;B3GALT2;CA10;NTRK3;C11ORF87;SCN1A;PTPN5
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.7463285099187241,1.62427852037529,0.06666666666666667,1.0,1.0,7/22,10.62%,TRMT10C;PUS7;NSUN2;METTL8;PUS1;VIRMA;DKC1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.6603201499254033,-1.6241540544729978,0.0,0.32526632952388534,0.96,59/149,16.03%,CARTPT;DMKN;NEFM;LRRTM1;SHISA6;STMN2;PAK5;SYT4;GAP43;CCK;CLVS2;ASTN1;CNTFR;TCEAL5;ATP2B3;KCNIP1;KALRN;CASZ1;VSTM2A;CADM3;SNAP25;SNX21;GPR22;CACNA1E;DCLK1;ATRNL1;CNTN1;SULT4A1;TMEM179;GDAP1L1;GFRA2;CACNA1B;JPH3;CPE;ELAVL4;RGS7BP;FSTL5;ASIC2;TMEM35A;TOX;BRINP1;VSTM2L;ACTL6B;ST8SIA3;TAGLN3;FBXO7;OPCML;OLFM3;CDK5R2;MAP2;TMEM196;SCG2;INA;MAPK4;PCLO;ADCYAP1R1;EFNA5;CYB561;LY6H
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8603105829812379,-1.6238972473944229,0.014705882352941176,0.31238733677401337,0.96,2/20,2.28%,CD44;CLU
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.8112754376149935,1.6228297419233881,0.0,1.0,1.0,5/16,9.85%,AMPD1;POLD3;HPRT1;GMPR;ADA
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.8003876391062321,1.6177063291049578,0.05,1.0,1.0,3/12,9.02%,PTH;EPM2AIP1;AKT2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.7410604437622679,-1.615779457234017,0.0,0.34980435100014606,0.98,25/87,13.33%,CD44;ANGPT1;PARP14;TNFRSF1A;IL12A;PARP9;PTPRC;IL6R;NOX4;EPHA4;HGF;CSF1R;EFNA1;GRM5;GATA1;BMP6;CTF1;CRLF1;IFNA2;LYN;VEGFA;TNK2;DLG4;FGF7;IL31RA
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.8279707219560174,-1.61495443938556,0.0,0.34123474959848155,0.98,5/25,4.42%,DPP10;KCNIP4;PDZK1;FGF12;KCNIP1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.9679847350338613,-1.6113831085185697,0.0,0.3497112436402844,0.98,1/7,0.99%,IRGM
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.6669218832933931,-1.6084176635538106,0.0,0.3550493989390179,0.98,53/155,15.62%,NEFL;DACT1;NEFM;ZCCHC12;STMN2;FAM171B;PAK5;SYT4;GAP43;CLVS2;ASTN1;RIMS4;SYT1;PLPPR5;SNAP25;DCLK1;ATRNL1;SLITRK5;INSYN2A;PURG;SULT4A1;TMEM179;GDAP1L1;ST3GAL5;CACNA1B;TMEM200C;SNCB;ELAVL2;KCNH7;LZTFL1;SH3GL2;PCDH8;PNMA2;TMEM35A;FAT3;BRINP1;ACTL6B;ST8SIA3;TAGLN3;CALB2;CHN1;DIPK1B;OPCML;OLFM3;MAP2;NRG1;INA;B3GALT1;MAPK4;NOL4;ADCYAP1R1;LINGO2;SLC35F1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.9392258577139235,-1.6055006354715697,0.0,0.35862294808418327,0.98,1/8,0.40%,DPYS
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.680340817612626,-1.5983740030452809,0.0,0.38966393281677164,0.98,58/111,18.10%,GFRA3;NPY;PCSK2;LRRTM1;PCSK1;STMN2;PAK5;SYT4;GAP43;CCK;CLVS2;ASTN1;TCEAL5;KCNIP1;VSTM2A;CDH22;SNAP25;SULT4A1;TMEM179;GDAP1L1;HPCA;CACNA1B;CALY;CELF4;RAB3C;CHGA;CPE;ELAVL4;SH3GL2;ASIC2;ACTL6B;ST8SIA3;AFP;KCNB2;TAGLN3;SCG3;VEGFA;OPCML;OLFM3;GAD2;CDK5R2;TMEM196;PAX6;PTPRT;SCG2;CHGB;INA;SYT13;NPSR1;NOL4;UNC5D;LY6H;SLC17A6;NRXN1;PTPRN;SCN3A;PLPPR1;CA10
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.7266057384174273,-1.5980942239339946,0.0,0.3776434515987735,0.98,8/68,7.35%,CD44;DPEP2;CR1;GMFG;CEACAM1;AQP1;VAMP5;GATA1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.8283501351532879,-1.5946004510954404,0.0,0.3863895364993241,0.98,4/20,4.97%,ZACN;MT1M;PAM;GLRA2
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.6721320554391021,-1.592700731141869,0.0,0.38974740838078553,0.98,41/108,14.99%,CARTPT;PLCXD3;SEMA3E;SPARCL1;SHISA6;STMN2;PAK5;CNTN3;SYT4;MAOB;FGF12;KALRN;CADPS2;SYBU;SNAP25;CNTN1;SORBS2;LMO3;ETV1;PCDHB4;CPE;RGS7BP;FAM149A;ADGRL2;ST8SIA3;THSD7A;ABCC9;FGF14;MAP2;RAPGEF4;TMEM196;AQP4;PAX6;PTPRT;PDZRN4;SYT13;MAPK4;NOL4;CNTN4;PCLO;AGT
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.7582827832033171,1.5924611434251885,0.023809523809523808,1.0,1.0,5/24,5.70%,NGF;VAV1;RAPGEF1;RASGRF1;MMD2
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.6844197717912744,-1.5915406297845145,0.0,0.3843923244711681,0.98,34/97,15.62%,RND2;NKAIN1;PAK5;GAP43;CLVS2;ASTN1;RIMS4;CNTFR;SOX9;RHBDL3;PURG;SULT4A1;TMEM179;HPCA;CACNA1B;TMEM200C;SNCB;CPE;PCDH8;ATP1B2;TAGLN3;NEFH;CALB2;OPCML;CDK5R2;PAX6;INA;PTPRZ1;MAPK4;NOL4;PCLO;ADCYAP1R1;UNC5D;SLC35F1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.8475106191196228,1.590449340481595,0.0,1.0,1.0,4/11,9.85%,AMPD1;HPRT1;GMPR;ADA
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.8156092408446962,1.5904018004238905,0.0,1.0,1.0,2/11,1.95%,AMPD1;NT5E
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.798826096537208,1.5893506356417972,0.0,1.0,1.0,1/21,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.8137460131214748,1.5881198551228854,0.08108108108108109,1.0,1.0,4/13,9.02%,PTH;PHKG2;EPM2AIP1;AKT2
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.8666952971480748,1.588114480894546,0.022727272727272728,1.0,1.0,3/8,9.89%,DICER1;HENMT1;PRKRA
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.6671747132022395,-1.5868187649554644,0.0,0.4015665661796913,0.99,33/108,16.03%,PDGFD;SHISA6;STMN2;TSPAN11;GAP43;CLVS2;ASTN1;CNTFR;KCNIP1;CADM3;DKK3;DCLK1;PURG;TMEM200C;GJA1;BOC;CPE;RGS7BP;TMEM35A;FAT3;BRINP1;GLI3;RUNX1T1;OPCML;MAP2;AQP4;PAX6;PTPRZ1;LRRC3B;MAPK4;ADCYAP1R1;SLC35F1;LY6H
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.9148028246652318,1.5860520273883303,0.023255813953488372,1.0,1.0,3/9,4.86%,CRTAM;LCK;IKZF3
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.670724087416355,1.5856664066839465,0.0,1.0,1.0,5/40,6.14%,SUN3;CEP55;USP36;NUMA1;CHMP5
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5602496042989824,1.585649334936694,0.047619047619047616,1.0,1.0,8/193,3.31%,CPA1;BACE2;ADAM33;PRSS57;VASH1;REN;MALT1;ENPEP
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9562126589096505,-1.5839153457937456,0.0,0.4083529190914211,0.99,2/10,1.29%,CD44;VIL1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.9211043269099561,-1.5835666206051247,0.01818181818181818,0.39889262017163896,0.99,2/9,2.17%,YBX3;BIRC3
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.6626308084609641,-1.5804830891605057,0.0,0.4059078263546069,0.99,43/113,15.62%,BTBD17;RND2;NEFM;ZCCHC12;STMN2;NKAIN1;PAK5;NYAP1;SYT4;GAP43;CLVS2;ASTN1;RIMS4;CNTFR;PLPPR5;RHBDL3;EPHA4;DCX;PURG;NTNG1;SULT4A1;TMEM179;GDAP1L1;GRM5;CACNA1B;TMEM200C;ELAVL2;JPH3;PCDH8;ACTL6B;TAGLN3;PROS1;TRIM32;EGFR;CDK5R2;DRAXIN;INA;MYT1;MAPK4;NOL4;ADCYAP1R1;UNC5D;SLC35F1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.8889787928270294,1.5803684223276915,0.0,1.0,1.0,1/11,0.11%,BACE2
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.7858640670693182,1.574459136958983,0.06818181818181818,1.0,1.0,2/13,2.46%,HDC;PYCR1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9600512689423557,-1.5724798389150716,0.0,0.43897016596096755,0.99,1/10,0.03%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9600512689423557,-1.5724798389150716,0.0,0.43897016596096755,0.99,1/10,0.03%,CD44
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.8803814855335806,1.572089906649493,0.02857142857142857,1.0,1.0,1/7,0.64%,RPP40
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.6364009371840695,-1.5698792922238458,0.0,0.44397313476419914,0.99,48/122,18.40%,RND2;STMN2;PAK5;EPHA3;SYT4;GAP43;CLVS2;ASTN1;SYNPR;ATP2B3;VSTM2A;ROBO2;SNAP25;SLC1A1;DCLK1;ATRNL1;PURG;SULT4A1;TMEM179;GDAP1L1;CACNA1B;CELF4;RAB3C;ELAVL4;PCDH8;ATP1B2;FAT3;PAK3;ACTL6B;ST8SIA3;LRRTM3;OPCML;OLFM3;GAD2;SRRM4;SLITRK3;PAX6;MAPK4;NOL4;PCLO;ADCYAP1R1;SLC35F1;SLC17A6;NRXN1;RBFOX3;KIF5A;NTRK3;PTPN5
prerank,PanglaoDB_Augmented_2021__MÃ¼ller Cells,-0.6595642655015646,-1.5678681866868944,0.0,0.4468426581769103,1.0,34/124,13.13%,CD44;FSTL1;TLR2;SPARCL1;CRYM;CLU;PPP1R3C;TSPAN11;COL4A1;PLSCR4;SPC25;SYNPR;CADM3;DKK3;DCLK1;COL11A1;FNDC4;GJA1;PCDHB4;BOC;CPE;THY1;RGS7BP;TEK;LMOD1;ADGRL2;BRINP1;SCN4B;VEGFA;OPCML;EDNRB;LDB2;CNR2;AQP4
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.859264317775559,-1.5660742578265676,0.0,0.4511893985218558,1.0,1/13,1.19%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8344439277304183,-1.5657316898262905,0.015151515151515152,0.4424981409609958,1.0,2/24,2.28%,CD44;CLU
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.7712325642154316,-1.564957762505186,0.01282051282051282,0.4379431635673423,1.0,5/32,10.39%,CD44;SOX9;CHI3L1;XBP1;SULF1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.8669686921152625,1.564885147464045,0.05714285714285714,1.0,1.0,1/8,1.57%,SPX
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.8460899395674873,1.5621842482680095,0.0,1.0,1.0,1/8,0.23%,AMPD1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9113759229991557,-1.56171771697743,0.014285714285714285,0.44628633539365037,1.0,1/11,0.03%,CD44
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.906886468844873,-1.560730020797143,0.0,0.44226805563490706,1.0,1/15,0.03%,CD44
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7861653700168545,-1.55644874563482,0.034482758620689655,0.46211361807749546,1.0,4/30,6.45%,CD44;VIL1;NTNG1;WTIP
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.8558407606217666,1.5558949169531717,0.058823529411764705,1.0,1.0,2/15,2.39%,ADAT1;POP5
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),0.8573341567662365,1.55471947889666,0.06060606060606061,1.0,1.0,1/12,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.61539882550304,1.5545170512185702,0.047619047619047616,1.0,1.0,2/64,2.49%,CYP1A2;MGLL
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.8155938082703031,1.55421850617283,0.07692307692307693,1.0,1.0,3/11,5.27%,RPP40;POP5;RPP25
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.927557958252501,1.551936008340998,0.0,1.0,1.0,2/11,3.18%,PANK1;PPCDC
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.927557958252501,1.551936008340998,0.0,1.0,1.0,2/11,3.18%,PANK1;PPCDC
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.927557958252501,1.551936008340998,0.0,1.0,1.0,2/11,3.18%,PANK1;PPCDC
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.8032192604515512,-1.5519335504814646,0.0,0.4859738647977807,1.0,2/19,2.06%,PKP2;TGFB2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.6856044542258672,1.5503566439874101,0.05555555555555555,1.0,1.0,13/53,9.02%,CYP1A2;VDR;RDH16;DHCR24;CYP3A43;HSD17B7;MSMO1;CYP2E1;HSD11B1;CYP2C8;LIPA;CYP7B1;CUBN
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.8636081523109985,-1.549448744717746,0.016129032258064516,0.49344620546422685,1.0,2/13,1.44%,NR4A3;PPARG
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.8845447213758653,1.5491405215746263,0.02631578947368421,1.0,1.0,3/9,7.23%,NUPR1;IFNLR1;PRELID1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.7570960582978725,-1.5466960745380658,0.0,0.50546123521682,1.0,8/37,5.87%,CD44;ADAMTS5;LAMC1;TIMP1;SCUBE3;CAPN1;TLL1;A2M
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.8358193577876731,1.546283599284273,0.027777777777777776,1.0,1.0,4/13,5.27%,RPP40;TRMT10C;POP5;RPP25
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.7624225663906145,1.5452594131976414,0.06896551724137931,1.0,1.0,3/22,9.69%,USP27X;OTUD3;USP37
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.8970625893338543,-1.5445028107628145,0.01639344262295082,0.5126381695910952,1.0,4/13,4.77%,CD44;VIL1;TWF2;CARMIL2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.6438360514221916,-1.543635300138835,0.0,0.5094834731628425,1.0,49/108,18.65%,LRRTM1;ZCCHC12;STMN2;PAK5;SYT4;GAP43;CLVS2;ASTN1;RIMS4;CNTFR;GABRG2;VSTM2A;CADPS2;CDH22;SNAP25;ATRNL1;KCNJ6;SCN2A;SULT4A1;TMEM179;GDAP1L1;HPCA;CACNA1B;CALY;SNCB;CELF4;JPH3;CHGA;PCDH8;ACTL6B;ST8SIA3;KCNB2;SLC18A2;OLFM3;GAD2;CDK5R2;TMEM196;SYT13;MYT1;MAPK4;NOL4;ADCYAP1R1;LY6H;SLC17A6;NRXN1;KIF5A;PRKCG;PTPN5;TENM1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.8179199529415593,-1.5435729995186656,0.0,0.5004186811461252,1.0,6/21,8.10%,PKP2;HEY1;TGFB2;MEF2C;TGFBR2;CPE
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.7504028512214567,-1.5424855060363778,0.0,0.5015521054709258,1.0,8/37,5.87%,CD44;ADAMTS5;LAMC1;TIMP1;SCUBE3;CAPN1;TLL1;A2M
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7839983618825156,-1.5413007333938327,0.014925373134328358,0.4998273935146471,1.0,2/21,2.17%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.8615247239323411,-1.5403082847817735,0.014925373134328358,0.49972050142878,1.0,2/15,2.69%,BIRC3;DDX60
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.832945290352554,1.5392181570351284,0.04878048780487805,1.0,1.0,1/13,0.18%,NGF
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.7032869814400871,-1.5380635618540728,0.014285714285714285,0.5091306452728405,1.0,7/47,2.93%,BTBD17;ISG15;PLSCR1;MX1;TRIM5;ISG20;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.7840810602027758,-1.5375160887389727,0.014084507042253521,0.5053610645400033,1.0,12/31,13.33%,PARP14;TNFRSF1A;IL12A;PARP9;IL6R;CSF1R;CTF1;CRLF1;IFNA2;LYN;VEGFA;IL31RA
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.806191577061822,-1.5329356136661518,0.028169014084507043,0.5332305842000935,1.0,1/22,0.03%,CD44
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.9202806194649725,1.5328716031722798,0.027777777777777776,1.0,1.0,1/5,0.70%,DHFR
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.9299548391470464,1.5324842351071808,0.05128205128205128,1.0,1.0,2/8,1.46%,RAB27A;CYBA
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.6457606460622887,-1.531723366350032,0.0,0.5333810288606609,1.0,32/112,12.85%,FSTL1;KCNT2;MEST;TGFB2;STMN2;CRYM;TSPAN11;GAP43;ASTN1;CNTFR;CADM3;DKK3;DCLK1;COL11A1;TMEM200C;FNDC4;GJA1;PCDHB4;BOC;CPE;THY1;RGS7BP;LMOD1;TMEM35A;ADGRL2;BRINP1;PRKG1;RUNX1T1;OPCML;LRFN5;LDB2;MAP2
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),0.9518890550138589,1.5311962558420318,0.0196078431372549,1.0,1.0,1/5,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.767966178729347,-1.5298273340466364,0.0,0.536225127995232,1.0,12/37,13.33%,PARP14;TNFRSF1A;IL12A;PARP9;IL6R;CSF1R;CTF1;CRLF1;IFNA2;LYN;VEGFA;IL31RA
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.9401703663041072,-1.5293540858425303,0.0,0.5308561174459187,1.0,3/8,4.50%,PKP2;NEFL;VIM
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.844669274870346,1.5292259145945795,0.05128205128205128,1.0,1.0,2/9,1.35%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.844669274870346,1.5292259145945795,0.05128205128205128,1.0,1.0,2/9,1.35%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.844669274870346,1.5292259145945795,0.05128205128205128,1.0,1.0,2/9,1.35%,CYP1A2;DPEP1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.8722538161868768,-1.5288404148593504,0.014705882352941176,0.5261186547914538,1.0,3/12,2.12%,HEY1;TGFB2;OLFM1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.9698942609056374,-1.528536850434726,0.0,0.5126118804541933,1.0,2/6,1.44%,PARP14;PPARG
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.9698942609056374,-1.528536850434726,0.0,0.5126118804541933,1.0,2/6,1.44%,PARP14;PPARG
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.8230302623724047,1.5272696025330723,0.027777777777777776,1.0,1.0,1/10,1.57%,SPX
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.8752684946610558,-1.526660898506234,0.0,0.5180493502701125,1.0,3/13,4.33%,MEF2C;EDN1;PIM1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.8233960815083962,1.5258834899193254,0.07692307692307693,1.0,1.0,6/9,9.30%,CCDC78;TNNC2;STAC3;MYH3;MYH14;TCAP
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.8178357108288387,-1.5249721294563172,0.03278688524590164,0.5237580821255091,1.0,4/12,13.07%,HEY1;TGFB2;TEK;NRG1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.7489300852316155,1.5236832415525374,0.029411764705882353,1.0,1.0,4/15,10.59%,TRMT10C;NSUN2;METTL8;VIRMA
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.7006464859533321,-1.5211978749210806,0.0,0.5425420628172426,1.0,5/39,2.12%,PARP14;H2BC11;PPARG;ISG15;PTPRC
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.9132548393697549,1.520943166278554,0.0,1.0,1.0,1/7,0.06%,MDGA2
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.8053885295072435,-1.5166351780507117,0.015873015873015872,0.5734117960730541,1.0,1/13,0.58%,MDFIC
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.8007034083870315,-1.5160501148779297,0.015873015873015872,0.5697851198297978,1.0,2/18,1.20%,ANGPT1;SFRP4
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),0.9385667749033448,1.515645234363925,0.020833333333333332,1.0,1.0,1/5,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.9269835649813853,-1.514332044431518,0.0,0.5753982384598142,1.0,2/9,2.69%,TLR2;DDX60
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),0.9407677312194423,1.5118048465305063,0.0,1.0,1.0,2/6,3.00%,MEIOSIN;OOEP
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.7307056478911871,-1.5111331073194367,0.05970149253731343,0.5965905809445012,1.0,6/40,12.95%,FSTL1;PPARG;VWC2L;CHRDL1;BMPR1B;BMPER
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.7853856424316309,1.5110660080806655,0.05714285714285714,1.0,1.0,1/18,0.11%,BACE2
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.827917088349534,1.5108823081727651,0.06451612903225806,1.0,1.0,5/15,6.44%,ENPP6;MGLL;ABHD2;PRDX6;PLA2G4C
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8621565515769577,-1.5108507540350822,0.0,0.5910710292673463,1.0,3/9,2.47%,SHMT2;ISG15;MX1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.8721383353171087,1.5106602342522535,0.0,1.0,1.0,3/11,2.92%,RPP40;LACTB2;DICER1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.8809317376219383,1.5106250103834584,0.021739130434782608,1.0,1.0,1/6,0.46%,PTH
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.9011226320985093,1.5100827764812867,0.025,1.0,1.0,2/9,2.68%,DHFR;AIFM2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.7576581593497583,-1.5076007574315737,0.0,0.6061138142084266,1.0,4/25,10.39%,SFRP4;PTPRC;GJA1;SULF1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.683468603494527,-1.507415885138044,0.029850746268656716,0.599581603153745,1.0,6/53,14.35%,CARTPT;LPL;LRRK2;XBP1;KCNB1;WRN
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.8126408490304515,-1.5070988985756,0.0,0.5943679830324827,1.0,2/16,2.46%,MMRN2;TMEM204
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.6926992394050995,1.5069863340305192,0.08333333333333333,1.0,1.0,3/39,3.18%,PANK1;AMPD1;PPCDC
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.7739336194190647,-1.5057967936547236,0.03333333333333333,0.595577551372558,1.0,6/18,12.03%,RIMS1;SYT4;OSTN;SYT1;RIMS2;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.7711572695227666,-1.505773022438987,0.03225806451612903,0.588314371179023,1.0,2/20,4.93%,TLR2;ROBO2
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6869359851048875,-1.5054936979328333,0.014492753623188406,0.5829510729645463,1.0,16/63,10.38%,CD44;HLA-F;TLR2;GBP2;HLA-E;GBP3;TRIM5;IFNGR2;IRF1;TRIM22;HLA-A;B2M;HLA-DPB1;PTAFR;HLA-DRB1;TRIM25
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.8207890825221446,-1.5045597176833678,0.016666666666666666,0.5831686377573368,1.0,3/19,3.07%,TLR2;BIRC3;IRF1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.8445779372266591,1.5035353140488161,0.06818181818181818,1.0,1.0,2/6,3.95%,EVI2B;RUNX1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8340932370129485,1.5031878146136932,0.0,1.0,1.0,3/15,2.77%,CPA1;DPEP1;ABCC1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.7882082404721127,1.502762416963156,0.05714285714285714,1.0,1.0,5/14,13.85%,CHRNA4;NQO1;CHRNA7;CHRNB3;CHRNB4
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.9435826548605691,1.5025111325369707,0.07142857142857142,1.0,1.0,1/6,0.11%,BACE2
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.9429641598205065,1.502119708521605,0.05,1.0,1.0,1/5,1.46%,CYBA
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.6808842796091288,-1.501932710734843,0.04477611940298507,0.5993998943704497,1.0,6/48,2.93%,BTBD17;ISG15;PLSCR1;MX1;ISG20;IFITM3
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.7316998087785669,-1.5012402614528864,0.014084507042253521,0.5974040718068153,1.0,4/33,6.13%,TRPM1;KDM4D;FIGNL1;RAD9A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.9404713851258939,-1.5002321801365681,0.015625,0.5977896342267889,1.0,3/6,3.52%,VSIR;IL12A;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.8853620184958257,-1.4993961749679938,0.015625,0.5966674314637521,1.0,2/10,4.33%,MEF2C;PIM1
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.866996275169905,1.4987117953013567,0.05,1.0,1.0,3/6,11.34%,DUSP1;PTPN22;DLG1
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.9751288038181916,-1.4986166922996225,0.0,0.5975082665567322,1.0,1/5,0.99%,IRGM
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.7734914635589553,1.4984262730562403,0.07317073170731707,1.0,1.0,2/18,4.41%,NGF;RAPGEF1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.8092157074310297,-1.4976917656596116,0.043478260869565216,0.5966406231430832,1.0,4/15,4.62%,NR4A3;FABP3;ACADL;SOX9
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.8712724422540736,-1.497601536251291,0.078125,0.5910069932182398,1.0,4/9,11.62%,SEMA3E;COL4A1;TGFBR2;VEGFA
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.8760584738623877,1.4959370506652627,0.10526315789473684,1.0,1.0,2/7,9.02%,VDR;CUBN
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.7091653458884051,1.495147363640521,0.0967741935483871,1.0,1.0,1/31,0.11%,BACE2
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.7876245251201246,1.494804322587369,0.0625,1.0,1.0,5/17,7.39%,ICAM1;NT5E;ITGAL;SELP;TNIP1
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8706979804465945,-1.4942014982065992,0.0,0.6110297455501135,1.0,3/16,5.78%,CD44;CEMIP;LYVE1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.6064543461913313,1.493666949250059,0.05714285714285714,1.0,1.0,7/38,4.88%,GPT;DPEP1;FOLH1B;PYCR1;AADAT;THAP4;RIMKLA
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.7295431773099498,-1.4931633432452005,0.04225352112676056,0.6128682117130198,1.0,6/34,2.93%,BTBD17;ISG15;PLSCR1;MX1;ISG20;IFITM3
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.8512424168544117,1.4928571114293308,0.06976744186046512,1.0,1.0,3/8,6.50%,PDE6A;CNGB1;PDE6B
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.7679248689480286,-1.4923918260118636,0.028169014084507043,0.6113305105368181,1.0,8/29,13.50%,RIMS1;MCTP1;MCTP2;RIMS4;MEF2C;LRRK2;RIMS2;SNCAIP
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7051906513362957,-1.4923784594056102,0.012987012987012988,0.6046125928386114,1.0,14/45,10.38%,CD44;HLA-F;GBP2;HLA-E;TRIM5;IFNGR2;IRF1;TRIM22;HLA-A;B2M;HLA-DPB1;PTAFR;HLA-DRB1;TRIM25
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6841271661068066,1.4920688559144821,0.10869565217391304,1.0,1.0,4/20,8.64%,RAB27A;CYBA;SPHK2;SLC25A33
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.694410102812788,-1.4905877822528495,0.014705882352941176,0.6124602131698058,1.0,13/33,18.60%,TLR2;GBP2;GBP3;IFITM3;DAPK1;AQP4;DAPK3;STAT1;CALCOCO2;CIITA;CX3CL1;KYNU;CXCL16
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.6962643586594165,-1.4900019240489222,0.046153846153846156,0.6114971026301619,1.0,10/38,10.51%,LPL;PPARG;CDS1;ID2;PIM1;VSTM2A;LMO3;FNDC5;XBP1;CEBPB
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.7445653768493004,-1.489349960057531,0.0,0.6111725581929961,1.0,2/26,2.05%,PARP14;PARP9
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.8093757274975288,-1.4883786588387464,0.014492753623188406,0.6133011196409772,1.0,5/16,6.69%,HEY1;TGFB2;OLFM1;TGFBR2;EFNA1
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.9290449321383345,1.4877988294149762,0.0,1.0,1.0,2/5,6.31%,PAX8;FSHR
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.648605445405881,-1.487283302887249,0.04477611940298507,0.6171000632695771,1.0,46/98,15.62%,NEFL;NEFM;LRRTM1;SHISA6;STMN2;GAP43;CLVS2;ASTN1;TRPM3;TCEAL5;KCNIP1;ROBO2;CADM3;SNAP25;DCLK1;DCX;PURG;CNTN1;SULT4A1;TMEM179;GDAP1L1;CACNA1B;TMEM200C;RAB3C;DENND2A;SH3GL2;PNMA2;TMEM35A;ATP1B2;FAT3;BRINP1;PAK3;ACTL6B;ST8SIA3;RUNX1T1;GRIA1;OPCML;SRRM4;INA;ATCAY;GABRB3;MAPK4;ADCYAP1R1;UNC5D;TMEM132B;SLC35F1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.8328601312469397,-1.4867170520225086,0.015625,0.6152303970931116,1.0,2/11,2.05%,PARP14;PARP9
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.5945933808306854,1.485426003164038,0.029411764705882353,1.0,1.0,8/44,7.95%,NGF;MAPRE2;VAV1;RAPGEF1;RASGRF1;MMD2;GPR174;P2RY10
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7372990134299141,-1.4853096607867766,0.027777777777777776,0.6194261638076167,1.0,16/26,16.17%,NPY;CHRM3;CHRM5;HTR5A;TSHR;SSTR1;HTR1E;HTR2C;HTR2A;HTR2B;NPY1R;CNR2;CHRM1;AGT;OPRM1;HRH2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.8103113080558596,-1.4841906615279448,0.017543859649122806,0.624417455324157,1.0,4/18,11.95%,RIMS1;RIMS4;LRRK2;RIMS2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.8601368881237835,-1.4826271545470004,0.030303030303030304,0.6310518907869762,1.0,3/10,4.62%,HEY1;TGFB2;SOX9
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.9048820973821085,-1.4825285424462227,0.03225806451612903,0.6254749627393751,1.0,1/8,0.30%,PARP14
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.8204059016094478,1.4813012126261864,0.17777777777777778,1.0,1.0,1/7,0.22%,CXCR4
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.9250256268324715,1.48076396022214,0.0,1.0,1.0,2/5,0.86%,ICAM1;AGER
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.9842355205715292,-1.479701360437539,0.018867924528301886,0.6429811708593497,1.0,1/5,0.11%,NCEH1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.7309381486887656,1.4794630595633367,0.10256410256410256,1.0,1.0,11/29,11.62%,SQLE;SC5D;DHCR24;HSD17B7;HMGCS1;MSMO1;ACAA2;HMGCR;PMVK;IDI1;ARV1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.8863128824451736,-1.476663853621252,0.0,0.665130052293085,1.0,3/14,5.78%,CD44;CEMIP;LYVE1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.7037140603007038,-1.4756987222758946,0.014084507042253521,0.6667418039691365,1.0,18/66,16.63%,CD44;ANGPT1;PTPRC;IL6R;HGF;EFNA1;GATA1;BMP6;BST1;VEGFA;TNK2;EGFR;FGF7;AGT;TGFB1;EFNA5;DMTN;PTPRJ
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.6240101075673657,1.4752346207754454,0.0,1.0,1.0,6/34,8.43%,CYP1A2;MGLL;CYP2E1;PLA2G4C;PTGIS;CYP2C8
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.7035138805331022,-1.4738818455661882,0.04411764705882353,0.6779138004157715,1.0,19/51,14.51%,HLA-F;TLR2;FGL2;PTPRC;ITGAM;NCKAP1L;AOAH;LAPTM5;CD53;CSF1R;HLA-DMA;HLA-DPB1;PTAFR;HLA-DRB1;IGSF6;LY86;WDFY4;FCGR3A;SPI1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6640161473604026,1.4732629268076753,0.0,1.0,1.0,3/29,5.92%,RPP40;TSR1;DCAF13
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8937616105999515,1.472174589349069,0.044444444444444446,1.0,1.0,1/6,0.35%,SPIRE2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.8214435063126241,1.472059822849302,0.03125,1.0,1.0,1/11,0.17%,CRTAM
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.8371252915216185,-1.4718612857996662,0.015873015873015872,0.6880528489216164,1.0,2/11,1.44%,LPL;PPARG
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.8619317458216873,-1.4715952415100046,0.046153846153846156,0.6844278515316378,1.0,3/10,4.62%,HEY1;TGFB2;SOX9
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.7392722192277301,-1.4714913946245407,0.06666666666666667,0.6725802333696341,1.0,3/17,8.66%,VIL1;TWF2;ADD2
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.7392722192277301,-1.4714913946245407,0.06666666666666667,0.6725802333696341,1.0,3/17,8.66%,VIL1;TWF2;ADD2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.7109794982757518,1.4700321708221762,0.06451612903225806,1.0,1.0,6/14,17.83%,NUTF2;BANF1;ANP32A;NXT2;NPM1;RBM15B
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8420129334707132,-1.4697277050209787,0.0,0.6823110473990894,1.0,5/18,9.54%,CD44;CARMIL2;CEACAM1;RHOC;PLET1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6660530775904161,-1.4695460282771522,0.013513513513513514,0.6780832869663356,1.0,25/78,11.42%,PARP14;EPSTI1;GBP2;ISG15;PARP9;PLSCR1;MX1;TRIM5;ISG20;DDX60;IFITM3;IRF1;SELL;IFI44;PSMB8;PROCR;LPAR6;IL7;B2M;TMEM140;MVB12A;SP110;IFI35;TRIM25;NMI
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.6152423294715088,-1.469333642675054,0.015151515151515152,0.6742768495922241,1.0,51/103,20.80%,PCSK2;TCEAL6;CACNG2;HTR5A;CCK;GABRA1;SYNPR;VSTM2A;ATP2B2;CDH22;UNC13C;CACNA1E;KCNJ6;CELF4;SLC4A10;HCN1;XKR4;PDE1B;ATP1B2;KCNC2;CACNG3;ACTL6B;ST8SIA3;KCNB1;AP3B2;UNC80;SCG3;CACNB2;GAD2;SRRM4;WSCD2;CNTNAP5;RPH3A;KCNH2;TNR;MYT1L;SEZ6L;NRXN1;SLC24A4;FGF13;RBFOX3;SCN1A;CACNA1A;SLC1A2;GRM4;ADCY2;TAS1R1;CADPS;SV2B;SCN3B;CYP46A1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.831084166730467,-1.4692743634739809,0.046153846153846156,0.6685668730142118,1.0,6/15,14.64%,CR1;PTPRC;LAPTM5;SFTPD;NAV3;ZFP36
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.8005382258760176,-1.468847804044486,0.09375,0.6666944335579787,1.0,2/13,1.44%,LPL;PPARG
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.9024189517808959,1.4679224794474308,0.023255813953488372,1.0,1.0,2/7,4.41%,NGF;RAPGEF1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.9201298282938433,-1.467801109491671,0.0,0.6700750474521827,1.0,1/7,2.16%,ARL13A
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.8391299800498051,-1.4649693664978944,0.03636363636363636,0.6865865140141274,1.0,2/14,2.17%,KIF19;STMN2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.8359919412753275,1.4649286177420315,0.11428571428571428,1.0,1.0,2/8,4.54%,NUPR1;PPP1R10
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.6392409017797909,-1.4625324026599982,0.013333333333333334,0.700084584061807,1.0,28/109,8.62%,CD44;ANGPT1;TLR2;PROM1;FGL2;MGST1;ROBO4;CD59;TGFB2;HLA-E;PTPRC;C1QB;KITLG;TRPC6;TGFBR2;ADGRG1;SERPING1;HGF;PROCR;LYVE1;CSF1R;IL3RA;P2RY13;FES;C3AR1;THY1;FLI1;TEK
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7230089228734132,1.4621829404912539,0.05555555555555555,1.0,1.0,1/19,0.46%,PTH
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.760119854874063,-1.4614484614381302,0.016666666666666666,0.7021936148045861,1.0,7/19,18.31%,LPL;PPARG;AGT;ITGAV;NFKBIA;MSR1;ABCA1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.8814707586757264,-1.4611411850820561,0.03225806451612903,0.6980829931622232,1.0,4/10,4.62%,HEY1;TGFB2;TGFBR2;SOX9
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6579302385429502,-1.4604742725772621,0.02702702702702703,0.6975913758699567,1.0,25/51,18.39%,TLR2;FGL2;ITGAM;NLRP3;AOAH;LAPTM5;CSF1R;KLHDC4;C3AR1;PTAFR;PLET1;IGSF6;TRIM25;SLAMF8;TNFRSF1B;LY86;WDFY4;ADGRE2;TYMP;FCGR3A;SPI1;NR1D1;CLEC5A;LILRB1;GDA
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.5726664248165236,-1.4598371298091102,0.0,0.6980681984098541,1.0,64/147,18.68%,DPP10;NEFL;NEFM;LRRTM1;ZCCHC12;STMN2;SYT16;PAK5;NYAP1;SYT4;GAP43;CLVS2;ASTN1;CNTFR;PLPPR5;FGF12;DTX1;TCEAL5;ATP2B3;SNAP25;PURG;SULT4A1;PIANP;TMEM179;GDAP1L1;LHFPL5;HPCA;CACNA1B;CALY;SNCB;JPH3;NELL1;NKAIN3;SH3GL2;PCDH8;KLHDC8A;GRIP1;ASIC2;BRINP1;ACTL6B;ST8SIA3;RBPMS;TAGLN3;OPCML;OLFM3;CCDC184;CDK5R2;TMEM196;INA;MAPK4;EFNA3;TOX2;ADCYAP1R1;SLC35F1;BBC3;LY6H;SLC17A6;MTUS2;SHD;KIF5A;CA10;C11ORF87;PTPN5;GALNTL6
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.6114325133068258,-1.458444587722456,0.02702702702702703,0.70472808044252,1.0,10/125,5.26%,CD44;VIL1;TWF2;STMN2;MEF2C;TGFBR2;SOX9;NOS1;VSTM2A;HGF
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.6800501942109679,1.4583777476981115,0.16216216216216217,1.0,1.0,2/15,2.92%,CXCR4;DICER1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.5959704216942926,1.4572921848399696,0.03125,1.0,1.0,14/67,11.06%,TEAD2;PYCR1;EPHB4;NOC2L;FKBP4;EIF3B;SLC52A2;TUBA1C;TEAD3;PTBP1;KRT8;MRPS2;TUBG1;HDGF
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.8339083063279138,-1.455250264693874,0.06666666666666667,0.7281268050525446,1.0,1/9,1.38%,MCM2
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.8285629215041852,1.453948325623319,0.058823529411764705,1.0,1.0,1/8,0.55%,TNNC2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.7516981144896016,1.4538656924282336,0.09375,1.0,1.0,6/9,20.87%,WNT4;DGKQ;STAR;BMP5;SIRT1;EGR1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.7807102720273972,1.4538542206226202,0.02702702702702703,1.0,1.0,3/17,5.46%,ABCA13;ABCA8;YJEFN3
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.8780415770720997,1.452604209991006,0.045454545454545456,1.0,1.0,1/6,0.23%,AMPD1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.6776545559003522,1.4517282179076847,0.07894736842105263,1.0,1.0,10/44,11.62%,SQLE;SC5D;SOAT2;MSMO1;HMGCR;LIPA;CYP7B1;PMVK;LCAT;ARV1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.74339613712912,-1.4515107461832173,0.03508771929824561,0.7518509412723308,1.0,5/20,15.07%,IRGM;CEMIP;CHI3L1;CALM3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.9143179575467926,1.4513483773094416,0.1,1.0,1.0,1/8,0.11%,BACE2
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.6980237188057563,1.451013246514915,0.08823529411764706,1.0,1.0,3/15,6.44%,ENPP6;PRDX6;PLA2G4C
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.9212929695749905,1.4509947970076473,0.025,1.0,1.0,1/7,0.84%,ORC1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.6858567161363317,-1.4504930482833418,0.05714285714285714,0.7542023886698789,1.0,6/34,11.62%,ANGPT1;SFRP4;CLU;B2M;DGKD;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.917400284849622,-1.4497530437146937,0.03773584905660377,0.7494160076245397,1.0,2/5,5.39%,NCKAP1L;ANO6
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.917400284849622,-1.4497530437146937,0.03773584905660377,0.7494160076245397,1.0,2/5,5.39%,NCKAP1L;ANO6
prerank,PanglaoDB_Augmented_2021__Microglia,-0.63006780169423,-1.4496835711463631,0.013888888888888888,0.7439394437144109,1.0,27/81,14.87%,FGL2;P2RY12;SLA;PTPRC;C1QB;IL6R;ALDH1A2;ITGAM;FOS;AOAH;LAPTM5;CD53;GPR34;CSF1R;P2RY13;CX3CR1;C3AR1;PTAFR;CYFIP1;IGSF6;GPR183;TNFRSF1B;LY86;WDFY4;FCGR3A;SPI1;OTULINL
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.8906897146645483,-1.4491143058525469,0.015873015873015872,0.7433518388357493,1.0,2/9,0.85%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.777186980782441,1.4489324190303907,0.041666666666666664,1.0,1.0,3/10,10.67%,PIH1D1;PRR7;ST18
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.8329713873402189,1.4488321110947278,0.058823529411764705,1.0,1.0,4/10,11.45%,PTH;PTH1R;AKT2;SLC45A3
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.819617390028846,-1.4483131275978747,0.08928571428571429,0.7398381888925669,1.0,4/8,12.35%,CACNG2;CACNG3;CACNG8;DLG4
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.819617390028846,-1.4483131275978747,0.08928571428571429,0.7398381888925669,1.0,4/8,12.35%,CACNG2;CACNG3;CACNG8;DLG4
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6366355050378124,-1.4482611812190334,0.02857142857142857,0.7351869992080242,1.0,21/100,8.33%,NCEH1;PARP14;TLR2;NR4A3;PPARG;FGL2;SLA;PTPRC;ITGAM;LGALS3;AOAH;LAPTM5;SLC7A7;CD53;GPR34;LYVE1;CSF1R;CX3CR1;C3AR1;RGS1;PTAFR
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.8958548801089327,1.4475138441396702,0.021739130434782608,1.0,1.0,3/5,6.50%,PDE6A;CNGB1;PDE6B
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.7518287958751669,-1.4453634147284964,0.03508771929824561,0.7561605722585044,1.0,5/17,12.03%,RIMS1;SYT4;SYT1;RIMS2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.7101498632112972,-1.4449853551064884,0.014925373134328358,0.7536248673409126,1.0,8/33,6.19%,IGFBP3;NR4A3;PPARG;IL12A;IL6R;EDN1;ID2;OGN
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.7360700720455465,1.4449238581633999,0.1,1.0,1.0,11/27,11.62%,SQLE;SC5D;DHCR24;HSD17B7;HMGCS1;MSMO1;ACAA2;HMGCR;PMVK;IDI1;ARV1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.748151164425097,-1.4448009933898154,0.04285714285714286,0.749979094001287,1.0,5/22,4.93%,HEY1;TGFB2;TGFBR2;CITED2;ROBO2
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.7337300792588931,-1.443973756352072,0.10344827586206896,0.751584516417167,1.0,3/24,2.17%,VIL1;TWF2;STMN2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.9486800602029293,1.4438673309742616,0.047619047619047616,1.0,1.0,2/5,3.96%,MGLL;ABHD2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8646252022696399,-1.4435417257380236,0.015151515151515152,0.749067059712484,1.0,4/14,7.28%,CD44;CARMIL2;CEACAM1;RHOC
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7696070188519799,1.442642453052627,0.08333333333333333,1.0,1.0,3/12,17.25%,B4GALNT2;GFPT2;GFPT1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.7825475146648977,-1.4423882785146769,0.0,0.7557780782553679,1.0,3/16,3.07%,PPARG;SLC22A9;FABP3
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.6220568929241437,-1.441728710011869,0.027777777777777776,0.7554262293187789,1.0,34/100,15.56%,GFRA3;SPARCL1;SHISA6;STMN2;CHL1;TSPAN11;MAOB;CHST1;ASTN1;CNTFR;L1CAM;TCEAL5;KCNIP1;CADM3;DKK3;DCLK1;CNTN1;AQP1;THY1;RGS7BP;SORCS1;SCN4B;CXCL14;SLC18A2;EDNRB;TSPAN7;RAPGEF4;AQP4;PHYHIP;PTPRT;PTPRZ1;MAPK4;ADCYAP1R1;DHRS3
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.9702750906195552,-1.4414991175211644,0.0,0.7513444715599775,1.0,1/5,0.99%,IRGM
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.926456552622,-1.4405868706901293,0.016666666666666666,0.7495588335091583,1.0,1/7,0.58%,MDFIC
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.926456552622,-1.4405868706901293,0.016666666666666666,0.7495588335091583,1.0,1/7,0.58%,MDFIC
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8104447889962794,-1.4384662685896064,0.016129032258064516,0.7655117841714426,1.0,2/20,1.19%,CD44;NR4A3
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.8989903580488248,1.4370450582018799,0.05128205128205128,1.0,1.0,1/8,0.18%,NGF
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.8770299311294969,-1.436705854972674,0.06896551724137931,0.7747877224574552,1.0,1/7,0.38%,PEX11A
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6937558127775041,-1.436465685166171,0.04477611940298507,0.7715145528418444,1.0,11/40,14.07%,SLC28A2;FMO5;VIL1;TPH1;SLC5A9;ABCG5;CYP3A5;SLC18A2;ACSM3;SLC2A2;SLC22A3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.9480250788392134,-1.436316967027592,0.0,0.7670924062506875,1.0,1/5,1.74%,CHRM3
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.65313300680729,-1.4360888364316566,0.0,0.7636526311502846,1.0,18/51,14.51%,DPEP2;DOCK8;TLR2;CR1;ITGAM;SELL;NLRP3;AOAH;CEACAM1;P2RY13;ARG2;PTAFR;BST1;IGSF6;ADGRE3;LY86;FCGR3A;SPI1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.8242391471535886,-1.4348622810067775,0.08196721311475409,0.7700079317162103,1.0,2/13,2.74%,SHMT2;COX7A1
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.8103373418020725,1.434397753850308,0.06976744186046512,1.0,1.0,1/9,1.07%,RFWD3
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.7731093713597947,-1.4338933785013308,0.05357142857142857,0.7727036034261603,1.0,2/14,4.62%,LPL;SOX9
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.7584742718081087,-1.4332937122242724,0.06349206349206349,0.7722647199104491,1.0,6/18,10.58%,BEGAIN;NPTX2;NPTX1;HTR2C;SLC8A3;DLGAP1
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.8597643506266601,-1.4319823865082308,0.05660377358490566,0.7810017994602585,1.0,3/8,9.75%,PTPRC;AXL;TOX
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.8078640731459318,-1.431686046857186,0.03333333333333333,0.7782844210833699,1.0,4/13,5.63%,VSIR;IL12A;NCKAP1L;RFTN1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.6776551715745966,-1.431187050805812,0.031746031746031744,0.7778809558573029,1.0,10/48,13.54%,CLDN5;DACT1;DTX3L;LRRK2;B2M;ADD2;CAV1;NMD3;LRP1;FLOT1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.8200366998239956,-1.4304208582609177,0.07142857142857142,0.7798092052494155,1.0,4/12,9.59%,ACTA2;MYH11;TPCN2;SLC8A1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.6061110374411796,-1.429895286350947,0.0,0.7791512205690495,1.0,34/95,19.54%,STMN2;NYAP1;GAP43;CLVS2;ASTN1;RIMS4;CTXN1;SULT4A1;PIANP;TMEM179;GRM5;HPCA;SNCB;JPH3;PCDH8;ASIC2;GNG3;BRINP1;ACTL6B;TAGLN3;OPCML;CDK5R2;PHYHIP;INA;MAPK8IP1;LY6H;SCAMP5;CAMK2N2;KIF5A;C11ORF87;PRKCG;GAD1;NDRG4;TMEM59L
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.8695607922598612,1.4294962264125486,0.06666666666666667,1.0,1.0,2/8,2.79%,CXCR4;HMGB1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.7021798446474246,-1.429310762922138,0.109375,0.7789361726024013,1.0,6/22,6.52%,LPL;TLR2;IL6R;C5;CSF1R;IL7
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7771896244270515,1.4291078045410248,0.10256410256410256,1.0,1.0,4/9,16.50%,HDAC1;HDAC9;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.7118925708741418,1.428959630482606,0.1282051282051282,1.0,1.0,10/26,11.62%,SQLE;DHCR24;HSD17B7;HMGCS1;MSMO1;ACAA2;HMGCR;PMVK;IDI1;ARV1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.8463509449210588,1.4288123585406185,0.11904761904761904,1.0,1.0,1/7,0.98%,TRMT10C
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.9045758472603675,-1.428457857863731,0.03225806451612903,0.781931027171199,1.0,4/7,5.87%,F8;SERPING1;F3;A2M
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.7581066472300174,1.4284063697670588,0.07894736842105263,1.0,1.0,5/14,12.46%,OOEP;ESPL1;LLGL2;LLGL1;KIF25
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.7714349676974481,-1.4280222448578372,0.07575757575757576,0.781149534903922,1.0,3/16,11.84%,WNT8B;AMER1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.8961959350761652,-1.4273528478196842,0.0,0.7812913789002849,1.0,3/6,5.39%,PDZK1;TRPC6;ANO6
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.6881016432289749,-1.4273505138801101,0.046153846153846156,0.7764083077821581,1.0,7/31,11.40%,MYO7A;CLVS2;GNPTAB;LRRK2;TPCN2;TPP1;HOOK1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.8120644943061786,-1.4268673737606015,0.03125,0.7758561117413886,1.0,4/16,10.38%,TRIM5;TRIM22;AXL;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.8596302032074994,-1.426773355592965,0.04411764705882353,0.7721427837532379,1.0,5/9,7.20%,HLA-F;HLA-E;PTPRC;CEACAM1;CX3CR1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.7062951122140815,-1.4259932173069905,0.03225806451612903,0.7742967985116272,1.0,7/29,11.40%,MYO7A;CLVS2;GNPTAB;LRRK2;TPCN2;TPP1;HOOK1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.8204766187804877,-1.4250275011751836,0.0,0.7768378506386904,1.0,2/11,1.44%,LPL;PPARG
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7984911857685748,-1.4235583692440157,0.08620689655172414,0.7849819438360831,1.0,1/18,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.7818779465939547,-1.4221838195618883,0.10606060606060606,0.7913362780952984,1.0,1/12,0.30%,PARP14
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-0.9229061498919171,-1.4219495748489488,0.0,0.7882792452764205,1.0,1/5,0.99%,IRGM
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.8774689981596171,-1.4213899004664041,0.0,0.7883134138456084,1.0,3/10,6.32%,ASB4;HEY1;CEACAM1
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.8528728138755965,-1.421303567495059,0.03125,0.7845655868217276,1.0,1/8,0.57%,LPL
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.9269518932839743,1.420719203589501,0.0,1.0,1.0,2/6,1.57%,NMU;SPX
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.7140067528136276,1.4205334084923764,0.12195121951219512,1.0,1.0,7/17,16.82%,RASL11A;ATF4;FLNA;POLR2K;DHX33;POLR2L;UBTF
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.8718246897421226,1.4204793260100823,0.05,1.0,1.0,2/6,2.79%,CXCR4;HMGB1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.5863596660324406,-1.4200163159932198,0.014492753623188406,0.7913994142554087,1.0,50/128,18.40%,BTBD17;SPARCL1;HOPX;SHISA6;CHL1;TCEAL6;GAP43;HTR5A;CLVS2;ASTN1;TRPM3;SYNPR;TCEAL5;KCNIP1;VIM;VSTM2A;ATP2B2;CADM3;A2M;SCN2A;GRM5;GJA1;ALDH1L1;RGS7BP;GRIN2B;ATP1B2;ADCY8;BAALC;ST8SIA3;LRRTM3;GRIA1;OPCML;EGFR;OPALIN;GRIA3;RAPGEF4;AQP4;PTPRZ1;LRRC3B;SPHKAP;GPR37L1;ADCYAP1R1;TNR;GRIN3A;NRXN1;CA10;NTRK3;C11ORF87;SCN1A;PTPN5
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.7337355294675156,1.418579163293737,0.11904761904761904,1.0,1.0,3/14,6.38%,HSPA1A;ACAA2;BAK1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.9093084391766894,-1.4183936553575223,0.0,0.7986629541684064,1.0,1/5,0.81%,SRGN
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.9182981351855821,-1.416104327700392,0.0196078431372549,0.8083484108477083,1.0,1/6,1.38%,MCM2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.9182981351855821,-1.416104327700392,0.0196078431372549,0.8083484108477083,1.0,1/6,1.38%,MCM2
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9744967405160485,-1.415961873446218,0.0,0.8049270385977985,1.0,1/5,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.8389813098617289,1.4157838586577902,0.15217391304347827,1.0,1.0,2/5,9.61%,PRPF39;SNRPC
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.8348417206711591,1.4155279761794428,0.08,1.0,1.0,3/6,15.03%,UXT;UBB;LRPPRC
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.7408892703830438,-1.4155246480191572,0.0547945205479452,0.8040900569426193,1.0,6/19,17.70%,PTPRC;DDX60;XBP1;HLA-DRB1;PTPRJ;LILRB1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.9010202399471464,-1.4150002373030446,0.06349206349206349,0.8040878562232044,1.0,2/5,5.54%,ALOX12;PTGR1
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.881039546673807,1.4147307532620441,0.08163265306122448,1.0,1.0,2/5,5.55%,MST1;HMGA2
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.7849164244619029,1.414619801619502,0.046511627906976744,1.0,1.0,1/11,0.22%,CXCR4
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.7714383905301749,-1.4145136024450153,0.017543859649122806,0.80419509466927,1.0,3/14,4.72%,LPL;MEST;VSTM2A
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.7949019985278712,-1.4132018539762081,0.05263157894736842,0.8115363023553016,1.0,1/13,0.50%,CARTPT
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.610745583684825,-1.4130698989705017,0.045454545454545456,0.8080304020241914,1.0,22/108,11.15%,GFRA3;FBLN1;LRRTM1;TSPAN11;COL4A1;CNTFR;FIGN;TUSC3;DKK3;DCLK1;PTPRG;GFRA2;GJA1;TENM3;BOC;CPE;DENND2A;THY1;LMOD1;ADGRL2;GPC6;RUNX1T1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.822064062338688,1.412676495197988,0.1111111111111111,1.0,1.0,3/7,13.67%,F2;TMEM98;HES5
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.8336031057290741,-1.4123872767794396,0.03278688524590164,0.8099429924887657,1.0,1/7,2.17%,BIRC3
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.7213456824347092,-1.4119514127930695,0.08928571428571429,0.8084640658111157,1.0,4/17,7.12%,HEY1;DTX1;SOX9;B2M
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.7167847380619994,-1.4114189504196957,0.10294117647058823,0.809342376122928,1.0,5/25,8.69%,BIRC3;TRIM5;IRF1;SAMHD1;ERAP1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.6268563934178754,-1.411253978768528,0.10526315789473684,0.8067187982450472,1.0,15/60,15.41%,LPL;PPARG;CDS1;ID2;LMO3;WWTR1;XBP1;E2F1;CEBPB;RUNX1T1;ZFP36;GNB3;ZFPM1;TGFB1;NR1D1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6436546112051862,-1.410945533630363,0.05333333333333334,0.8043342411142217,1.0,8/70,8.25%,CD44;ITGB4;L1CAM;ECM2;ACTN1;LYVE1;SGCE;THY1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.6935308780642608,-1.4107264141560913,0.06756756756756757,0.8022371701530703,1.0,3/39,4.62%,CD44;MEF2C;SOX9
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.8046510324995123,1.4103664214518166,0.13953488372093023,1.0,1.0,3/5,15.77%,STMP1;DHX33;DDX3X
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.7429238359162339,1.4103633551404657,0.06976744186046512,1.0,1.0,5/15,19.04%,DICER1;HENMT1;PRKRA;DHX9;CELF1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.843417161506901,-1.4101469366551704,0.08196721311475409,0.8026615297421962,1.0,2/9,2.05%,PARP14;PARP9
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.9181834932778346,-1.4093428901647898,0.016666666666666666,0.8044276731916834,1.0,1/5,1.44%,PPARG
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.9112551418028411,-1.4085252147760066,0.06557377049180328,0.8065355712745765,1.0,2/6,1.59%,DACT1;PLEKHA4
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.7810839557469081,1.4084137104698222,0.06666666666666667,1.0,1.0,2/13,5.45%,ABCA13;PLEKHA3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.7372756407784764,-1.4083226965777818,0.03508771929824561,0.8036002629665938,1.0,5/16,12.42%,RHBDF2;CEACAM1;MVB12A;CDH13;EGFR
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.6645167355229699,1.4080033190915338,0.09090909090909091,1.0,1.0,13/30,26.00%,BICDL1;UXT;UBB;LRPPRC;TRAK1;BICD2;CDC42;CLN3;TRAK2;TMEM201;NDEL1;HAP1;BORCS5
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7725138154512554,-1.4079000596253608,0.10714285714285714,0.798937193414562,1.0,4/11,11.94%,ALOX12;MET;TMEM79;CLDN4
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7725138154512554,-1.4079000596253608,0.10714285714285714,0.798937193414562,1.0,4/11,11.94%,ALOX12;MET;TMEM79;CLDN4
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.6257315270195885,-1.407489225570741,0.06666666666666667,0.7977516182411059,1.0,13/54,16.87%,ZACN;TTN;PLSCR1;PAM;ANXA11;SNCB;KCNMA1;CALM3;CAV1;NEDD4L;ITPR3;SLC11A2;PPP3CA
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.871233391070772,-1.406511920966408,0.058823529411764705,0.8006422479890034,1.0,1/6,2.04%,ISG15
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.8093252913867295,1.405911411557865,0.1,1.0,1.0,3/10,4.90%,ICAM1;AGER;XG
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.8699582520791639,-1.405482765873898,0.029850746268656716,0.8050503873693654,1.0,2/6,2.99%,TIMP4;TIMP1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.7733150146827181,-1.4054008171838717,0.11428571428571428,0.8019647262748445,1.0,3/14,2.46%,FSTL1;SFRP4;TMEM204
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.8839168485030602,-1.4053348553031555,0.1,0.7984659163709286,1.0,1/5,4.04%,PIK3AP1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.7910761528951245,-1.4051742484073646,0.04477611940298507,0.795641617991585,1.0,6/12,14.01%,PLSCR1;IL6R;F3;ANO6;CEBPB;MYLK3
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.8727292673984559,1.4044349304459471,0.075,1.0,1.0,2/6,4.41%,PTH;PTH1R
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.8833435826847309,-1.4039083205596232,0.03125,0.8027246328078566,1.0,2/6,5.34%,CPS1;DDAH1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.7357334447029543,-1.4032731431513066,0.14925373134328357,0.8039946850620455,1.0,7/18,17.57%,PTPRC;MEF2C;CR2;IFNA2;IFNA6;IFNK;RASGRP1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.8040010325261047,-1.4028011131576728,0.05357142857142857,0.8045742152138997,1.0,2/11,1.72%,VIL1;TWF2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.9033008790217867,1.402380650627352,0.04878048780487805,1.0,1.0,1/7,2.92%,DICER1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.7279168673679206,-1.4022867096549565,0.06557377049180328,0.8051961538489476,1.0,6/24,10.38%,TRIM5;IFITM3;TRIM22;IFNA2;HLA-DRB1;TRIM25
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.7851355181732979,-1.4022424528507518,0.1016949152542373,0.8015455895129592,1.0,3/13,3.07%,LPL;CPS1;FABP3
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.628378952771475,1.4019463215790586,0.05714285714285714,1.0,1.0,7/44,7.25%,NGF;GPR143;PIK3C2G;FGFR1;IGF1R;PLCE1;PLCD3
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.9256974404053577,-1.4014970277834176,0.0,0.8043228345154123,1.0,2/5,6.70%,YBX3;AQP1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.8508046875007503,-1.400899816879663,0.05970149253731343,0.8052691247326789,1.0,1/8,4.18%,EDN1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.9292695390224999,-1.4005801657593402,0.06779661016949153,0.8044584895783254,1.0,1/5,0.91%,DOCK8
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.8296326563011546,-1.4001002691728284,0.08196721311475409,0.8046428434737123,1.0,5/9,16.20%,SYT4;SYT1;KCNB1;CACNA1G;SCAMP5
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8695867636757886,1.3996940765111279,0.1111111111111111,1.0,1.0,2/5,8.23%,CMPK1;AK3
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.6974226081632595,1.399340847151021,0.06896551724137931,1.0,1.0,4/20,8.20%,RPP40;ERI1;EXOSC8;URB1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.7211313359949557,-1.3988583664293572,0.0625,0.8118422027123392,1.0,7/24,7.65%,TLR2;H2BC11;GBP2;IL12A;HLA-E;HLA-A;CHGA
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.69070040874628,-1.397858780304517,0.04,0.8130152482707985,1.0,19/41,16.37%,HLA-F;GBP2;ISG15;HLA-E;MX1;ISG20;IFITM3;IRF1;PSMB8;HLA-A;SAMHD1;IFNA2;IFI35;XAF1;IFNA6;IFIT1;STAT1;IRF4;HLA-C
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.69070040874628,-1.397858780304517,0.04,0.8130152482707985,1.0,19/41,16.37%,HLA-F;GBP2;ISG15;HLA-E;MX1;ISG20;IFITM3;IRF1;PSMB8;HLA-A;SAMHD1;IFNA2;IFI35;XAF1;IFNA6;IFIT1;STAT1;IRF4;HLA-C
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8534736248707364,-1.3977432681375086,0.047619047619047616,0.810065953319567,1.0,6/12,10.00%,HLA-F;HLA-E;HLA-A;B2M;ERAP1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.6343020405873024,1.3969436364545853,0.1,1.0,1.0,3/27,9.02%,PTH;ENPP1;AKT2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7937963204363283,-1.396280107450981,0.07692307692307693,0.8195353941731557,1.0,2/14,2.20%,PKP2;TTN
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.8772711524460951,-1.3953710101833119,0.047619047619047616,0.8235258142629278,1.0,2/8,6.32%,ASB4;CEACAM1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7256647000019572,-1.3947056117628174,0.06060606060606061,0.8248420351279822,1.0,2/18,5.35%,ENC1;PSMB8
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.6770228798512935,-1.3944647912701034,0.03225806451612903,0.8228880674305411,1.0,7/28,8.05%,BASP1;TGFB2;KITLG;SOX9;ADAM21;GATA1;AR
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.571120244273046,-1.3940437000019479,0.013333333333333334,0.8225736434108528,1.0,48/140,18.40%,SPARCL1;SHISA6;STMN2;TCEAL6;GAP43;ASTN1;CNTFR;SYNPR;TCEAL5;KCNIP1;VIM;SOX9;ATP2B2;CADM3;SNAP25;DKK3;GRM5;PHF24;GJA1;ALDH1L1;RGS7BP;ATP1B2;ADCY8;BRINP1;BAALC;SCN4B;LRRTM3;OPCML;EDNRB;OPALIN;GRIA3;RAPGEF4;AQP4;PHYHIP;PTPRZ1;LRRC3B;MAPK4;SPHKAP;GPR37L1;AGT;ADCYAP1R1;LY6H;DIO2;NRXN1;SLC1A6;CA10;C11ORF87;PTPN5
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.7211256402626965,1.3936553576146684,0.09375,1.0,1.0,1/19,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.8348915509873562,1.3936128489084778,0.08823529411764706,1.0,1.0,1/7,3.67%,ACADS
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.7141498893931301,-1.393544476673,0.058823529411764705,0.8227552548898731,1.0,5/26,4.93%,HEY1;TGFB2;TGFBR2;CITED2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.6763725286759827,1.3931959933601215,0.08571428571428572,1.0,1.0,1/27,0.32%,ICAM1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.7362406366487768,-1.393123787984547,0.07352941176470588,0.8223550950624835,1.0,4/25,9.92%,FSTL1;SFRP4;DKK3;NREP
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.8531083891293181,-1.3924238043291555,0.034482758620689655,0.8247125342077662,1.0,2/9,5.96%,PPP1R3C;PPP1R3D
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.7540280492915811,-1.3917453008576934,0.04838709677419355,0.8259872754146691,1.0,6/14,15.17%,CHRM3;CHRM5;PLCB1;CDK5R1;CHRM1;OPRM1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.8489561802509422,1.3917018132892895,0.11627906976744186,1.0,1.0,3/7,8.23%,CMPK1;AK8;AK3
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.8382080904013306,1.3911649823641703,0.09090909090909091,1.0,1.0,2/7,8.81%,NUMA1;SMC6
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.6856295302975942,-1.3908492256485483,0.09375,0.8287469172672852,1.0,3/21,7.32%,MDFIC;LRRK2;SIAH3
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.595979513569259,-1.3907125170471082,0.04285714285714286,0.8263990185177477,1.0,10/73,11.66%,SRGN;PCSK2;PCSK4;PCSK1;F3;CPE;TASP1;MMP16;FURIN;MAGEF1
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.7512639899261404,1.3894201084075306,0.14814814814814814,1.0,1.0,2/7,5.60%,ACTN2;EHD2
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.7653127455046334,1.3890423082236587,0.05,1.0,1.0,3/14,6.57%,NUPR1;MST1;FBP1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.7591509279386468,-1.3889642080621893,0.057971014492753624,0.8368523056565106,1.0,4/15,14.92%,IL26;TGFB2;LYN;SCIMP
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.7606670253185741,-1.3880459064855255,0.05454545454545454,0.8410458795005916,1.0,2/12,7.35%,KLF9;GATA1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.8636112269334767,-1.3878621771123172,0.034482758620689655,0.8385880629080366,1.0,1/9,0.43%,MMRN2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7580812837081266,1.387811451081434,0.1388888888888889,1.0,1.0,2/11,14.45%,RAP2B;MAP4K4
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7580812837081266,1.387811451081434,0.1388888888888889,1.0,1.0,2/11,14.45%,RAP2B;MAP4K4
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7596148518651091,1.3875944305883716,0.17391304347826086,1.0,1.0,4/9,18.97%,SCRIB;ANXA2;INPP5F;SNCA
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.8625381239131975,-1.3870690733133542,0.03389830508474576,0.8419189565386674,1.0,2/6,2.12%,HEY1;OLFM1
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.6310083386728319,-1.3858431048167446,0.0958904109589041,0.8484338130881454,1.0,23/54,14.27%,SRGN;TLR2;FGL2;GBP2;HLA-E;PTPRC;BIRC3;IL6R;IRF1;ITGAM;NLRP3;LAPTM5;CSF1R;C3AR1;PTAFR;IGSF6;GPR183;SLAMF8;TNFRSF1B;LY86;WDFY4;ADGRE2;TYMP
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.9291727333576933,1.3856991932670457,0.044444444444444446,1.0,1.0,1/5,2.72%,ZNF598
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6773773974228,1.3856773831143412,0.029411764705882353,1.0,1.0,7/22,13.58%,GNL3L;PINX1;NAT10;CTC1;TNKS2;TENT4B;HNRNPU
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.9354433804993314,-1.3847904475596648,0.0,0.853270299596777,1.0,1/5,2.12%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.7883176367361456,-1.3845657746770668,0.06349206349206349,0.8518637373108636,1.0,5/11,15.07%,BMP6;RBPMS;TGFB3;KIAA0319;TGFB1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.7223627756580553,-1.3844366063593183,0.0847457627118644,0.8489894996305201,1.0,12/32,14.05%,HEY1;NRCAM;CNTFR;L1CAM;ADGRG1;THY1;CDK5R1;ETS2;VEGFA;SCG2;RASA1;OPHN1
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.8453129857473798,-1.3842389579898884,0.06153846153846154,0.8469822697061455,1.0,3/6,12.32%,SOX9;SULF1;BMPR1B
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8465452229620989,-1.3822673037896493,0.030303030303030304,0.8607537612531042,1.0,3/5,15.02%,TIMP1;LRP1;TIMP3
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.8531174978821989,-1.3801621507366861,0.12280701754385964,0.8749491242114378,1.0,4/6,12.39%,EDN1;PTGER3;HTR2B;EDNRB
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.6908794390244566,-1.3798404929693697,0.03333333333333333,0.8740615245983718,1.0,15/40,15.17%,AKAP12;P2RY12;CHRM3;CHRM5;HTR5A;HTR1E;ADCY7;GRM7;RGS1;ADCY8;GNAL;NPY1R;CHRM1;GPR37L1;OPRM1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.718023618705924,1.3797711715086187,0.15151515151515152,1.0,1.0,6/17,11.47%,PPP1R36;SH3RF2;MFHAS1;PTPA;PPP1R26;ENSA
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.7840479926290298,-1.3796400429595979,0.1,0.8715262693536894,1.0,2/14,3.27%,LPL;GPIHBP1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.7621711171639487,1.3791890563468248,0.13513513513513514,1.0,1.0,2/11,6.32%,POLD3;ACTR5
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7066509187768532,-1.3789013247215984,0.04918032786885246,0.8732567015529523,1.0,8/24,17.93%,EPN1;CEACAM1;VEGFA;BMPER;ADAMTS9;RHOJ;PIK3CB;CREB3L1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.8984858388134407,-1.3786988387103838,0.05,0.8711566454090786,1.0,1/6,3.52%,NCKAP1L
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6653295691930975,1.3785691620769105,0.05555555555555555,1.0,1.0,7/29,10.56%,CRTAM;ICAM1;ITGAL;SELP;GRID2;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.7650495914679478,-1.3784453669722083,0.08064516129032258,0.869278597448394,1.0,3/10,4.93%,HEY1;TGFB2;ROBO2
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.8718904191211126,-1.3781455704989474,0.07142857142857142,0.8683520994906941,1.0,2/5,8.48%,LPL;XBP1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.6979402692071859,-1.3778362664194823,0.06153846153846154,0.8668661399428558,1.0,4/25,4.64%,DPP10;KCNIP4;KCNIP1;NOS1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.7595635493799372,1.37769603329262,0.08,1.0,1.0,1/25,0.09%,TEAD2
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.9068470990608164,-1.376749374209825,0.018518518518518517,0.8722514722343894,1.0,2/5,8.62%,MFAP5;TEK
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.8040903782131097,-1.3764098159303393,0.06779661016949153,0.8714447091952122,1.0,2/11,1.19%,WNT8B;NR4A3
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.7062573097550415,-1.3762184545040739,0.0547945205479452,0.8696442866123908,1.0,3/25,2.30%,IRGM;IL12A;LGALS8
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.5863532752478084,-1.3761327159295802,0.0,0.8667030782181412,1.0,26/123,17.79%,IRGM;TGFB2;PTPRC;CLU;CENPE;PAK5;IL6R;SPDYA;NOX4;TGFBR2;EPHA4;CSF1R;EFNA1;GRM5;PAK3;CAMK1;CALM3;VEGFA;DLG4;MTCP1;DDR2;AGT;CDKN1A;TOM1L1;BORA;EZH2
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.8377165149745861,1.3756536183803447,0.05,1.0,1.0,1/6,2.60%,NUTF2
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.5844841283583814,1.3756366811126877,0.1724137931034483,1.0,1.0,4/57,4.36%,VWA3A;BPIFB1;TTC29;CFAP43
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.8091386343228149,1.3755870269840484,0.1,1.0,1.0,1/6,5.30%,NPL
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.7915016327095836,-1.3754437388419156,0.05555555555555555,0.8693815777820861,1.0,1/10,0.57%,LPL
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.851014988778938,-1.3753234505153638,0.09615384615384616,0.8671373446443842,1.0,2/6,3.97%,CARTPT;FGF12
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.761951305671331,1.3752403281594112,0.0975609756097561,1.0,1.0,6/13,16.62%,TFB1M;SLC25A33;TFB2M;FASTKD1;PNPT1;EARS2
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.7489724213834968,1.3747898657557753,0.1,1.0,1.0,3/9,12.18%,CA6;TAS2R40;RTP5
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),0.7489724213834968,1.3747898657557753,0.1,1.0,1.0,3/9,12.18%,CA6;TAS2R40;RTP5
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7876719446978314,-1.3747846763242617,0.07042253521126761,0.8682178040352457,1.0,5/16,10.00%,HLA-F;IL12A;HLA-E;HLA-A;HLA-DRB1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5803278869318146,-1.374691955384079,0.02702702702702703,0.8652907986803829,1.0,18/149,8.60%,CD44;PEX11A;OLFM1;PDZK1;IGFBP4;MPPED2;PRSS23;FOS;BCL11B;CCN5;FKBP5;SYBU;SLC1A1;CCND1;GJA1;AR;XBP1;BHLHE40
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.8313584271675517,-1.3733830536656466,0.08620689655172414,0.8726562389611857,1.0,2/7,13.07%,TGFB2;NRG1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.6835031121829716,-1.3732498292544058,0.12162162162162163,0.8703960182971631,1.0,14/33,20.44%,PTPRC;NOX4;EPHA4;CSF1R;EFNA1;GRM5;THY1;CAV1;DLG4;AGT;SH3BP5;NEDD9;IL34;GAS6
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.808277032525537,1.373135497698531,0.13043478260869565,1.0,1.0,1/5,0.47%,SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.9040393421941174,-1.3730894585563096,0.0625,0.8686186713388817,1.0,2/7,3.86%,NR4A3;MEF2C
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.6356296129575041,-1.372379798547353,0.058823529411764705,0.870674742990369,1.0,11/57,6.99%,CD44;TLR2;IL13RA1;TNFRSF1A;IFNGR2;IRF1;CNTFR;PIM1;A2M;IL7;IL3RA
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.890963005960898,-1.3714460913732387,0.046875,0.8756348163444091,1.0,2/5,3.27%,LPL;GPIHBP1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),-0.9042378998126117,-1.370807213129181,0.0196078431372549,0.8781444566212893,1.0,3/6,5.39%,PLSCR1;PLSCR4;ANO6
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.8379488071320736,1.3704622636341157,0.11363636363636363,1.0,1.0,2/7,5.88%,CMPK1;AK8
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.7641231779920351,-1.3704072173732542,0.13114754098360656,0.878270728642494,1.0,8/15,19.17%,ADAMTS5;ERVW-1;MEF2C;NOS1;ERVFRD-1;ADAMTS15;MYEF2;KCNH1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8260693884994321,-1.3703978929303144,0.05970149253731343,0.874902476102136,1.0,4/10,6.32%,HLA-F;HLA-E;HLA-A;CEACAM1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.7252788932779805,-1.3703238395319033,0.16666666666666666,0.8720900861439628,1.0,8/18,20.58%,PTPRC;IFNA2;AXL;TOX;IFNA6;IFNK;RASGRP1;IL21R
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.8426464046050378,-1.3697416139701002,0.10909090909090909,0.8730673511370629,1.0,3/9,6.32%,HLA-F;PTPRC;CEACAM1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.8442029234637907,-1.3693067578923832,0.12698412698412698,0.8728735593155116,1.0,5/10,13.33%,PPARG;CSF1R;PDE1B;VEGFA;IL31RA
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.9324398319056738,1.3690018430566822,0.0,1.0,1.0,2/5,5.86%,PASK;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.9324398319056738,1.3690018430566822,0.0,1.0,1.0,2/5,5.86%,PASK;ENPP1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.63459751427304,-1.3684821580779187,0.07352941176470588,0.8769807389518297,1.0,4/67,6.95%,CD44;FGF22;KIF16B;ANOS1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.7636323131125922,1.3680120574327517,0.16666666666666666,1.0,1.0,2/10,11.70%,MGMT;ASCC2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.7636323131125922,1.3680120574327517,0.16666666666666666,1.0,1.0,2/10,11.70%,MGMT;ASCC2
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.8346221965276243,-1.367933074731024,0.1111111111111111,0.8784493188225121,1.0,1/7,2.28%,CLU
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.7843491387869469,-1.3677508700060603,0.11666666666666667,0.8763079208923304,1.0,2/11,4.97%,MT1M;GLRA2
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.8321185875840732,-1.3674833423376846,0.08064516129032258,0.874811166504499,1.0,2/6,8.31%,SHMT2;PRPS1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.7577980724403061,-1.3672532267582937,0.0847457627118644,0.8732153399208455,1.0,5/12,14.06%,ADAMTS5;ERVW-1;NOS1;ERVFRD-1;ADAMTS15
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5806530895013737,-1.3662602178621508,0.07462686567164178,0.8781604038634263,1.0,21/83,8.33%,CD44;DPEP2;TLR2;FGL2;PTPRC;PLSCR1;MX1;IFITM3;ITGAM;SELL;AOAH;LAPTM5;CD53;CSF1R;P2RY13;CX3CR1;RHOC;C3AR1;AR;RGS1;PTAFR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.8422233765554654,-1.3659710062188202,0.06349206349206349,0.8705056918011487,1.0,1/8,5.26%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.8422233765554654,-1.3659710062188202,0.06349206349206349,0.8705056918011487,1.0,1/8,5.26%,DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.8422233765554654,-1.3659710062188202,0.06349206349206349,0.8705056918011487,1.0,1/8,5.26%,DTX3L
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.7023047860942104,1.3658856949596307,0.13157894736842105,1.0,1.0,5/20,12.27%,HMGA2;HDAC1;ZNFX1;BEND3;HELLS
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7822963271767512,-1.365581813333692,0.08928571428571429,0.8702925582337981,1.0,2/11,2.73%,IGFBP3;IGFBP4
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.6024773805086514,-1.3654582762638672,0.07246376811594203,0.867741210965593,1.0,8/65,11.84%,ANGPT1;BIRC3;FANCI;PRICKLE1;LAPTM5;LRRK2;AMER1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.7819858874610262,-1.3650658355503689,0.109375,0.8670378049242118,1.0,3/12,7.65%,TGFB2;EDN1;CHGA
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.7727985460047273,-1.364575230769412,0.13333333333333333,0.8681261519579717,1.0,4/12,15.10%,PKP2;CAV3;NEDD4L;KCNH2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.8336746860111008,1.3644340663737464,0.1111111111111111,1.0,1.0,1/5,7.67%,PIH1D1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.7654010261783034,-1.3642649198240762,0.06666666666666667,0.8674265027955992,1.0,4/13,4.93%,HEY1;TNFRSF1A;TGFB2;ROBO2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.783686226190152,-1.3640718031561696,0.11428571428571428,0.865774303566682,1.0,6/12,15.07%,FAP;CARMIL2;CST3;LRP1;DDR2;TGFB1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.8755784694497757,-1.363737513453853,0.078125,0.8653710648792033,1.0,3/8,7.49%,CPS1;NOS1;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.8238834984129034,-1.363423164694288,0.05357142857142857,0.8642313171133146,1.0,1/7,0.50%,CARTPT
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.8920347362767418,-1.3631861707738406,0.06896551724137931,0.8629945765911029,1.0,1/6,1.54%,TNFRSF1A
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.8889110583011777,-1.362970810881298,0.05357142857142857,0.8618017228792525,1.0,2/6,5.39%,NCKAP1L;ANO6
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.7057098368866114,1.3629417600746854,0.125,1.0,1.0,2/13,11.53%,SMARCD3;SMARCA4
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.7057098368866114,1.3629417600746854,0.125,1.0,1.0,2/13,11.53%,SMARCD3;SMARCA4
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.8234482433682295,1.3628434481532348,0.15789473684210525,1.0,1.0,1/5,14.42%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.68344821318719,1.3625703011656034,0.16279069767441862,1.0,1.0,3/12,13.58%,RNF168;RNF8;HNRNPU
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.5572440075015169,-1.3625331664161868,0.0,0.8618017228792525,1.0,26/143,11.62%,CD44;FOSL2;TLR2;NR4A3;CEBPD;BIRC3;KLF9;IFNGR2;IRF1;TUBB2A;EDN1;ID2;NFKBIE;FOS;F3;SNN;STAT5A;CCND1;EFNA1;NINJ1;BHLHE40;GPR183;CEBPB;GADD45B;ETS2;VEGFA
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.8184980848895034,1.3612808256283502,0.10256410256410256,1.0,1.0,2/6,9.99%,DUSP1;ANAPC15
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.8184980848895034,1.3612808256283502,0.10256410256410256,1.0,1.0,2/6,9.99%,DUSP1;ANAPC15
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.75125069131248,-1.3610065997901957,0.10294117647058823,0.8696107272547441,1.0,1/14,0.03%,CD44
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.8389477645224642,1.360614291183553,0.1276595744680851,1.0,1.0,1/6,6.68%,ATG9A
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6913201732190376,1.3605103571336905,0.03225806451612903,1.0,1.0,6/17,13.58%,GNL3L;PINX1;NAT10;CTC1;TENT4B;HNRNPU
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.9100349128788203,-1.3603473184134054,0.0425531914893617,0.8705857372296267,1.0,2/5,6.32%,PCSK2;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of protein sumoylation (GO:0033234),0.886559270988913,1.3599460594211548,0.10416666666666667,1.0,1.0,1/5,3.44%,GNL3L
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.8996927435181286,1.3598889327542922,0.12121212121212122,1.0,1.0,2/5,4.54%,NUPR1;PPP1R10
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.5758589606531366,1.3596284722637815,0.08571428571428572,1.0,1.0,7/59,8.23%,AMPD1;PTH;GLYAT;CROT;ENPP1;HPRT1;AK3
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.7113983999398026,-1.3594716811790395,0.07462686567164178,0.8746207176775683,1.0,8/27,17.05%,NDST3;XYLT2;CHST9;CSGALNACT1;BMPR1B;CHST8;CHST10;B3GAT2
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.8361051506552688,1.3592502923215357,0.1388888888888889,1.0,1.0,2/6,5.89%,RNF113A;SLIT2
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.824228198991886,-1.3588508374963617,0.08333333333333333,0.8761204462213772,1.0,1/8,2.28%,CLU
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.7615876930796215,-1.3586929435899988,0.04838709677419355,0.8741879627522937,1.0,5/15,11.25%,CLU;GSAP;EPHA4;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.7016446188706724,1.3584660450466073,0.1935483870967742,1.0,1.0,2/14,11.53%,SMARCD3;SMARCA4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.595503187068357,-1.3584065002925534,0.06493506493506493,0.873291957908937,1.0,21/79,17.81%,TLR2;ISG15;PTPRC;PLSCR1;MX1;TRIM5;ISG20;IFITM3;IRF1;SAMHD1;DDIT4;IFNA2;AGBL4;ABCC9;IFIT1;NLRC5;STAT1;MOV10;IFIT2;LILRB1;AGBL5
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.8218572400838909,-1.358157918364861,0.10714285714285714,0.8724362168379043,1.0,4/7,6.13%,VSIR;HLA-E;IRF1;HLA-A
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.8550297117969337,1.3576205592063122,0.1111111111111111,1.0,1.0,1/5,5.11%,JMJD6
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.726781370902897,-1.3572876961486613,0.1111111111111111,0.876021756021756,1.0,5/17,15.76%,PKP2;RNASE10;NINJ1;CD200;ITGAV
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.8471099454889945,-1.357252074679647,0.09523809523809523,0.8734080256890423,1.0,3/6,15.07%,TIE1;AGT;TGFB1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.6679087212517314,-1.3572318040624098,0.125,0.8704762252396943,1.0,3/22,8.60%,HEY1;BASP1;BHLHE40
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.8903426027402351,1.3571930704535995,0.046511627906976744,1.0,1.0,3/5,4.58%,SLC22A2;SLC25A29;SLC47A1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.8422264301109466,1.3570919234887582,0.0625,1.0,1.0,1/7,0.98%,TRMT10C
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.8483042731730808,-1.3570794089601024,0.10526315789473684,0.868603392711082,1.0,3/6,13.58%,IL16;VEGFA;SCG2
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7344926722080567,-1.3567667687559648,0.0625,0.8681124755187014,1.0,3/19,10.51%,CARTPT;UBASH3B;CEBPB
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.6576286911983923,1.3567583921976132,0.16216216216216217,1.0,1.0,5/21,9.02%,PASK;PTH;ENPP1;EPM2AIP1;AKT2
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.8012920327109874,-1.356277633856401,0.045454545454545456,0.8691556045255057,1.0,3/9,11.78%,TGFB2;TGFBR2;TGFB3
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.7772350549088033,-1.3555213284640304,0.1044776119402985,0.8725460571186274,1.0,5/13,11.84%,TRIM5;TRIM22;FUCA2;TRIM25;CAV1
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.8506615947034153,-1.355372528811593,0.10204081632653061,0.8704273412276624,1.0,1/6,0.57%,LPL
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.6160448188425479,1.355015894132651,0.19047619047619047,1.0,1.0,9/87,4.36%,VWA3A;CFAP61;TTLL9;DNAH6;HDC;BPIFB1;TTC29;NWD1;CFAP43
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.6877789623809764,1.3545443894089435,0.1,1.0,1.0,1/17,0.75%,SUN3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.6400434930120689,-1.354485791600772,0.10294117647058823,0.8740209554401406,1.0,5/29,10.43%,VIL1;TWF2;CARMIL2;CYFIP1;CARMIL1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.6668750665750254,-1.3543862640075197,0.08196721311475409,0.8716490097527537,1.0,21/55,16.28%,BEGAIN;NEFL;SHISA6;CACNG2;MEF2C;CAPN1;NPTX2;NPTX1;GRIN2B;CACNG3;DLGAP1;DAPK1;GRIA1;CACNG8;DLG4;GRIA3;NETO1;LRRC7;GSG1L;OPRM1;CAMK2B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.8985739381717003,-1.3543138084849484,0.03225806451612903,0.869162237138584,1.0,3/7,8.39%,PPARG;IL12A;E2F3
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.8188469882974665,-1.3542699252011785,0.06557377049180328,0.8664965909643964,1.0,2/6,11.81%,SULT4A1;UST
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.739197157563889,1.353985698752764,0.0975609756097561,1.0,1.0,7/18,20.45%,SPRED1;PLA2R1;SPRED2;UBB;ATR;DDX5;CHD5
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.8664762047710624,-1.3535869184978637,0.09836065573770492,0.8652669359245374,1.0,2/5,1.44%,DND1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.8664762047710624,-1.3535869184978637,0.09836065573770492,0.8652669359245374,1.0,2/5,1.44%,DND1;PPARG
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.6692040933395204,1.3535515618814322,0.18421052631578946,1.0,1.0,1/16,0.22%,CXCR4
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.5994454221445942,1.3532225615948779,0.09090909090909091,1.0,1.0,8/51,6.95%,TRMT1;HENMT1;JMJD6;ANKRD16;PUS7;NAT10;NSUN2;TFB1M
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.8795814524915725,-1.3518948237880237,0.07272727272727272,0.874583501241057,1.0,2/7,5.96%,PPP1R3C;PPP1R3D
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),-0.8802799163944044,-1.3514832060157551,0.10344827586206896,0.8751200965875658,1.0,2/5,9.42%,PKD1L3;ASIC2
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.8380603757114976,1.35130260867704,0.12195121951219512,1.0,1.0,1/6,0.98%,TRMT10C
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.8053479843752867,-1.3510949530699068,0.11290322580645161,0.8754928210141375,1.0,4/10,11.95%,RIMS1;SYT1;UNC13C;RIMS2
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.837273776709671,-1.3510667611698188,0.0784313725490196,0.8727631939716092,1.0,5/8,12.39%,ACTA2;EDN1;SLC8A1;HTR2B;EDNRB
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.7838242883834767,1.350955815007515,0.13157894736842105,1.0,1.0,4/6,14.42%,SNAI1;WNT4;NFKB1;BMP5
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.8368677388128525,-1.3509374547817043,0.015873015873015872,0.8709433955014564,1.0,3/11,4.32%,PKP2;HOPX;ID2
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.9292110502188017,1.350677053881412,0.05555555555555555,1.0,1.0,1/5,0.35%,SPIRE2
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.7779071342934445,-1.350657615050992,0.12727272727272726,0.8699609803034547,1.0,7/11,17.57%,PTPRC;MEF2C;CR2;IFNA2;IFNA6;IFNK;RASGRP1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.8567405650355904,-1.3503890176596158,0.09375,0.8699976047264187,1.0,2/5,4.93%,GAP43;ROBO2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.7276694529518282,1.350313846907899,0.11428571428571428,1.0,1.0,1/20,0.14%,ABCA13
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.887971858409115,-1.3500430712646145,0.015625,0.8698762842765034,1.0,2/8,4.18%,TLR2;EDN1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6001672235037426,-1.3499520132347074,0.0945945945945946,0.8679008595434351,1.0,21/72,17.81%,TLR2;ISG15;PTPRC;PLSCR1;MX1;TRIM5;ISG20;IFITM3;IRF1;SAMHD1;DDIT4;IFNA2;AGBL4;ABCC9;IFIT1;NLRC5;STAT1;MOV10;IFIT2;LILRB1;AGBL5
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.7325668366213027,1.3497339885635933,0.07894736842105263,1.0,1.0,2/13,2.79%,AGER;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.7539811573065601,-1.3496414042805707,0.14285714285714285,0.8673797275580826,1.0,2/14,4.18%,NR4A3;EDN1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.6345405708411987,-1.3496352461150398,0.09375,0.8646129644544295,1.0,6/39,5.26%,HEY1;TGFB2;OLFM1;LOXL3;SOX9;HGF
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.7970816160007073,-1.349512203851662,0.14705882352941177,0.8601878619749842,1.0,3/7,18.50%,MX1;DNM1;DNM1L
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.7970816160007073,-1.349512203851662,0.14705882352941177,0.8601878619749842,1.0,3/7,18.50%,MX1;DNM1;DNM1L
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.6490150965021341,1.349137084752406,0.125,1.0,1.0,5/21,11.52%,LACTB2;DICER1;PCF11;ZC3H12D;TRIR
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.8621022161871398,1.34877044923114,0.058823529411764705,1.0,1.0,3/6,2.77%,SLC22A2;ABCC2;ABCC1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.5687371979598723,1.3485575565626797,0.0967741935483871,1.0,1.0,22/79,19.08%,MRPL58;MRPL32;MRPS10;MRPL3;MRPS7;MRPL15;MRPL50;MRPS2;PTCD3;MRPS5;MRPS26;MRPL52;MRPL24;MRPL47;MRPL39;MRPS27;MRPL13;MRPL43;MRPS9;MRPS16;MRPL22;MRPS30
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.7090531823829143,-1.3484760069701218,0.12121212121212122,0.8655759918310875,1.0,5/18,11.55%,TTN;LHFPL5;PKD2L2;PKD1L3;CAV3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.7737967316846525,-1.3483722029030147,0.04838709677419355,0.8634053044147038,1.0,6/14,13.54%,RIMS1;MCTP1;MCTP2;MEF2C;SNCAIP;FLOT1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.6404177853375814,-1.34822296022316,0.11267605633802817,0.8616480218407508,1.0,8/35,11.84%,GPAT3;LPL;CPS1;FABP3;DGAT1;PNPLA1;CAV3;CAV1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.7125384177828716,-1.3480367330646352,0.12857142857142856,0.8600857188797775,1.0,1/16,0.58%,MDFIC
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.8290562213920982,-1.3473071628933408,0.1724137931034483,0.8633290360378659,1.0,4/6,15.17%,CHRM3;CHRM5;CHRM1;OPRM1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),-0.8815448497676187,-1.3462806003590615,0.018518518518518517,0.868439867730771,1.0,2/6,4.33%,CHRM3;PIM1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.6823563552082336,1.3462243034242416,0.08333333333333333,1.0,1.0,11/32,13.58%,HSPA1A;RAE1;TPX2;NUMA1;CHMP5;PARP3;FSD1;HSPA1B;PSRC1;TPR;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.6676025818144607,-1.3456349401792893,0.12121212121212122,0.8706653100399986,1.0,2/23,4.62%,PPARG;SOX9
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7498056572220811,-1.345264260896709,0.11940298507462686,0.8710612498174917,1.0,6/14,17.33%,TRIM5;BMP6;LY86;SCIMP;LY96;CX3CL1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6286549044842665,-1.3444329105768875,0.1,0.8751650944790812,1.0,10/49,13.32%,PARP9;HLA-E;BIRC3;PLSCR1;IRF1;SAMHD1;ERAP1;IFI35;NMI;IFNK
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.7597775384235173,1.3443564729715436,0.14285714285714285,1.0,1.0,2/8,15.51%,HMGA2;RESF1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.7137360594168078,1.3441987092326217,0.10810810810810811,1.0,1.0,1/6,7.23%,PRELID1
prerank,GO_Biological_Process_2021__negative regulation of meiotic cell cycle (GO:0051447),0.847209075762728,1.3441845633485434,0.13636363636363635,1.0,1.0,2/5,7.20%,DUSP1;DMRT1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.7125851903937988,1.3436777552365513,0.15,1.0,1.0,7/13,17.28%,CDK11A;PTCD2;SRPK3;IWS1;SAFB2;SLTM;DHX9
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.5917903407903865,-1.3436272972372456,0.043478260869565216,0.8774090609410269,1.0,21/65,16.25%,ANGPT1;NR4A3;IL26;TGFB2;LAMC1;SOX9;B2M;BMP6;LAMB1;SGPP2;VEGFA;AQP11;EGFR;FGF7;TIE1;TGFA;ZFP36;TGFB1;NR1D1;UHRF1;HPN
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.8671727421566311,-1.34317655309628,0.04838709677419355,0.8784699581010448,1.0,4/6,11.88%,FABP3;HTR2C;HTR2A;HTR2B
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.8229526814420596,1.3428938147454443,0.16666666666666666,1.0,1.0,2/5,6.33%,CCL28;SELP
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.6975906510742805,-1.3427390364494862,0.21311475409836064,0.8788668076262373,1.0,2/21,2.47%,PEX11A;MX1
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),-0.8953762291019627,-1.3421956455068413,0.1206896551724138,0.8800954569448656,1.0,2/5,10.07%,ANGPT1;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.8204350716314168,-1.3421955648435289,0.08771929824561403,0.8773957776290838,1.0,2/10,1.54%,CLDN5;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.7882069629354458,-1.3421621877995686,0.10526315789473684,0.8749198950001852,1.0,4/11,10.61%,LPL;GPIHBP1;RHOC;FURIN
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.572639459130926,-1.341774319002983,0.0410958904109589,0.8758836433305202,1.0,52/106,15.31%,BCHE;KCNT2;SPARCL1;PCSK2;LRRTM1;SHISA6;PCSK1;STMN2;SYT4;MAOB;ASTN1;SSTR1;GABRG2;TCEAL5;KCNIP1;KALRN;VSTM2A;CDH22;NPTX2;SNAP25;PPP1R1A;CNTN1;SORBS2;DACT2;TMEM179;ETV1;RAB3C;CHGA;CPE;ELAVL4;RGS7BP;FAM149A;ASIC2;ACTL6B;ST8SIA3;KCNB2;TSPAN7;GAD2;GRIA3;RAPGEF4;TMEM196;PTPRT;SCG2;CHGB;SYT13;GABRB3;MAPK4;NOL4;CNTN4;AGT;UNC5D;RBP1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.7993771716954675,-1.341406086467229,0.09230769230769231,0.8755465200031421,1.0,1/8,1.23%,CPS1
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.6938164570880845,1.3408298977006634,0.11904761904761904,1.0,1.0,1/12,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.8629338289410945,-1.3407137319420541,0.07407407407407407,0.8782924470283209,1.0,2/5,11.62%,RIN3;VEGFA
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.7543099945423803,1.3400588310846564,0.18181818181818182,1.0,1.0,1/8,3.35%,GRAMD2A
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.7660033052817105,-1.3389367708542075,0.0821917808219178,0.8883938599544159,1.0,3/16,4.93%,TGFB2;TGFBR2;ROBO2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.6706183672698397,1.3387833229602013,0.14705882352941177,1.0,1.0,5/29,9.16%,TBPL2;PRIM1;TAF13;TAF12;TAF5
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.5531661992951149,-1.3387161920238317,0.05333333333333334,0.8874679444893019,1.0,13/99,7.00%,SLC28A2;CPS1;VIL1;PPARG;PDZK1;ASPN;L1CAM;TREH;TMC4;SLC23A1;CEACAM1;AQP1;GFRA2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.7642014229916212,1.3384893130845734,0.10810810810810811,1.0,1.0,4/10,14.95%,NLGN3;PTPRD;IL1RAPL1;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.8254382506094666,-1.3383823979674108,0.06153846153846154,0.8873617901738796,1.0,1/7,4.32%,ID2
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.8560321628336744,-1.3382168569281045,0.046153846153846156,0.8858646788770248,1.0,1/7,2.69%,DDX60
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.8343530242619621,1.338205099840213,0.14634146341463414,1.0,1.0,1/6,3.20%,SOD3
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7181804986555796,-1.338198636826605,0.11428571428571428,0.8833359265869514,1.0,5/17,15.02%,TIMP4;TIMP1;FURIN;TNFRSF1B;TIMP3
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.830836045317229,1.3381847230451782,0.14583333333333334,1.0,1.0,2/6,7.20%,OOEP;DMRT1
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.8501344854150994,-1.3380062561714745,0.11320754716981132,0.882061441016763,1.0,2/5,7.58%,TIMP1;GJA1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.8684649354790326,-1.3379406743132713,0.11290322580645161,0.8799899831594034,1.0,2/6,2.11%,HLA-F;HLA-E
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.8737364827921436,-1.337768733012101,0.10526315789473684,0.8787902350016977,1.0,2/5,12.39%,EDN1;EDNRB
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.5184705898546397,-1.3376393995490239,0.0,0.876940595078583,1.0,61/312,15.76%,CLDN5;PDGFD;NR4A3;IL13RA1;CR1;TGFB2;PTPRC;KITLG;LAMC1;IL6R;SPDYA;TIMP1;TSHR;FGF22;MEF2C;TGFBR2;EDN1;CAPN1;ID2;PIM1;SOX9;CSF1R;IL7;PRAME;AQP1;BMP6;COX17;WWTR1;GJA1;LAMB1;AR;CTF1;CRLF1;STX3;XBP1;E2F1;BST1;IL12RB2;TOX;CDH13;COPS9;LYN;VEGFA;TGFB3;HTR2B;ROMO1;AQP11;EGFR;FGF7;NRG1;IL31RA;DDR2;TGFA;PID1;SERTAD1;EFNB2;AGT;STAT1;TGFB1;CDKN1A;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8508642042034656,1.3376153639357307,0.10256410256410256,1.0,1.0,3/5,6.59%,DSCAM;SEMA5A;MEGF8
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.6725800973002616,1.337125400005214,0.10256410256410256,1.0,1.0,4/22,5.29%,NGF;HMGB1;PYHIN1;PINX1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.660698436213048,-1.3369909144685588,0.07692307692307693,0.8790035814588647,1.0,6/24,8.05%,TGFB2;KITLG;SOX9;ADAM21;GATA1;AR
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.8428860029979487,1.336772213878884,0.1276595744680851,1.0,1.0,1/5,2.92%,DICER1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.7783949353280066,-1.3367229920371502,0.09230769230769231,0.8786975687098615,1.0,2/12,2.45%,DACT1;IGSF1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.8424095899623769,-1.3367133728599334,0.08620689655172414,0.876213217620876,1.0,3/9,4.94%,MSMP;IL6R;LGALS3
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.8703188714622088,-1.3362408187088028,0.1,0.8773004337208258,1.0,4/6,12.39%,ACTA2;EDN1;SLC8A1;EDNRB
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7301629274524495,-1.3356991171885573,0.16393442622950818,0.8788880060575809,1.0,5/16,8.80%,AKAP12;PRKAR1B;ADGRV1;LRRK2;TCIM
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.7104961470311318,1.335652507571771,0.11363636363636363,1.0,1.0,4/14,7.41%,CRTAM;IKZF3;PRELID1;ABL1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7387350254884087,-1.3352761208751882,0.1016949152542373,0.8794278906684779,1.0,6/21,13.95%,RIMS1;SYT4;SYT1;RIMS2;SYT12;SYT13
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.7729003750332131,1.3352308175031058,0.1590909090909091,1.0,1.0,1/7,10.66%,PJVK
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.777009035779626,1.3346983710340432,0.1111111111111111,1.0,1.0,4/10,19.18%,HDAC1;SMARCA4;ZBTB7A;SIRT1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.5910277474905362,-1.3345879230717619,0.04411764705882353,0.8823154808473791,1.0,33/104,18.53%,MMRN2;FSTL1;ADAMTS5;SPARCL1;ROBO4;ENC1;MAOB;CLDN16;COL4A1;PLSCR4;SERPING1;DKK3;SORBS2;AQP1;NRGN;TEK;LMOD1;ADGRF5;EDNRB;LDB2;DRAM1;LRP1;CYYR1;TIMP3;PLXNA2;SLC14A2;SYNPO;SLC11A2;VWF;CX3CL1;EPAS1;PRICKLE2;LAMB2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7769586317594779,-1.334295768195463,0.08064516129032258,0.8821726472616588,1.0,2/12,2.99%,PARP9;IFNGR2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.5500406516064215,-1.33388996610791,0.02666666666666667,0.8825871383187075,1.0,40/191,18.21%,MMRN2;DLK2;KANK2;DACT1;IGFBP3;SFRP4;HEY1;IL12A;PTPRC;GLIS2;TMEM25;NLRP12;DKK3;LRRK2;PRAME;CX3CR1;APCDD1;DDIT4;TCIM;LRPAP1;UBASH3B;SULF1;GLI3;LYN;EGFR;GPC3;LRP1;PTPRT;PID1;AGT;CNMD;TULP3;SIAH1;PIK3CB;PTPRJ;PRKCQ;CX3CL1;EZH2;CREB3L1;NEURL1
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.7632629337561301,1.333546571596509,0.18421052631578946,1.0,1.0,4/12,8.23%,CMPK1;ENPP1;AK8;AK3
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.8765969548015909,1.33322693945944,0.08888888888888889,1.0,1.0,1/5,1.20%,NMU
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.7975730591082106,1.3331587039436927,0.11363636363636363,1.0,1.0,2/6,5.48%,MOGAT1;PLCE1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6295601002172376,-1.332721726744513,0.07352941176470588,0.8882431459468911,1.0,8/44,12.95%,VIL1;TGFB2;SOX9;PTPRG;CEACAM1;RAB11A;PTPRR;BMPER
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.7091866430750912,1.3326772936463849,0.1,1.0,1.0,3/17,9.89%,DICER1;HENMT1;PRKRA
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.821398556864692,-1.3325774956907859,0.09722222222222222,0.8867289573034645,1.0,3/11,2.11%,HLA-F;IL12A;HLA-E
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.8385788347008545,-1.3325702851095174,0.1346153846153846,0.8842026639778136,1.0,2/5,9.25%,MET;PBXIP1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.5834700412450926,1.3324214149965001,0.16216216216216217,1.0,1.0,18/46,24.92%,GNL3L;PINX1;NAT10;CTC1;TNKS2;PKIB;TENT4B;HNRNPU;MAP2K7;ATR;SMG5;NAF1;HNRNPC;CCT8;CCT2;CCT3;CCT6A;ACD
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.7195881277565209,-1.3323937385442859,0.1206896551724138,0.8829836472477733,1.0,2/10,6.70%,MT1M;AQP1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.8262914329379666,-1.3323057915738215,0.08928571428571429,0.8812229158575289,1.0,4/10,10.58%,BEGAIN;NPTX2;NPTX1;DLGAP1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.5329233380831947,1.3320811989595351,0.11538461538461539,1.0,1.0,1/59,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.7029953826485017,-1.3319685458210369,0.08196721311475409,0.8813595287530118,1.0,5/22,14.99%,NR4A3;MLIP;EDN1;CAV3;AGT
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.8955512157186922,-1.3318590696009824,0.07142857142857142,0.8794223563016293,1.0,4/5,10.46%,P2RY12;CX3CR1;ATP1B2;GPR183
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),-0.8211712999617038,-1.3310790604021308,0.10869565217391304,0.8825824486802797,1.0,4/7,13.42%,ANGPT1;SH3GL2;VEGFA;TJP3
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.8301981754120906,-1.3302963527179987,0.0625,0.8869182808179483,1.0,2/8,1.44%,DND1;PPARG
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.6824698629385331,1.3302948715642444,0.175,1.0,1.0,3/13,13.58%,RNF168;RNF8;HNRNPU
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6316371866327529,-1.3302111772023,0.125,0.8849818144148597,1.0,6/44,6.19%,CD44;NAGLU;CEMIP;LYVE1;PRELP;OGN
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.8867555197344577,-1.3300520321844538,0.08928571428571429,0.8836495334495693,1.0,1/5,2.28%,CLU
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.8316805332269286,-1.3293772885612032,0.03125,0.8860903294884899,1.0,6/11,11.01%,CR1;CD59;SERPING1;A2M;CR2;C4BPA
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7796469591370982,-1.3291535066179656,0.09230769230769231,0.8851647064961665,1.0,6/11,16.34%,P2RY12;TGFB2;NCKAP1L;RAC3;SKAP1;SYK
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7725281046615422,1.3290819683108719,0.22727272727272727,1.0,1.0,1/9,2.92%,DICER1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.7030184002771552,-1.3290336220653363,0.06349206349206349,0.8834684742459479,1.0,11/25,23.45%,PARP14;PTPRC;THY1;CAV1;DMTN;SH3BP5;CADM4;PRKCZ;SOCS3;PRKCD;PPP2R1A
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.8244964678445735,-1.3289530379332106,0.07936507936507936,0.8813014306647088,1.0,1/7,2.12%,PTPRC
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.8635994719584392,-1.3288903910482388,0.09433962264150944,0.8794655191501447,1.0,4/5,11.94%,PTPRG;CEACAM1;TENM3;PTPRR
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.7556959846410032,-1.3288795182017237,0.14035087719298245,0.8771356122381629,1.0,6/15,17.74%,ACTA2;DACT2;LRTOMT;TMEM79;WNT5B;PDZD7
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.7101588034667761,-1.3285118203016029,0.11428571428571428,0.8775170241437664,1.0,2/24,0.85%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.8635566511083733,-1.328493172351423,0.06557377049180328,0.8751523542290031,1.0,2/6,3.84%,COX7A1;HIGD1C
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.7984407046202381,-1.3282057154042122,0.171875,0.8745635033994172,1.0,1/7,1.52%,SHMT2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.7160356843114353,1.3280244057500246,0.12195121951219512,1.0,1.0,2/11,1.25%,SLC22A2;SLC38A1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.7740657390799806,-1.327845439705471,0.11475409836065574,0.8747913350355581,1.0,6/10,17.33%,PTPRC;LRFN5;IL31RA;NR1D1;CD200;CX3CL1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.709529816671003,1.3270358800870685,0.13157894736842105,1.0,1.0,6/13,25.57%,DUT;NT5C;NT5M;MBD4;SMUG1;UPP2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.625135876103349,-1.326552813787387,0.04477611940298507,0.8823457360119646,1.0,18/53,17.99%,P2RY12;IL12A;TGFB2;NCKAP1L;ADGRG1;ECM2;CITED2;EPHA4;RNASE10;STX3;VEGFA;RAC3;PRKD2;ITGAV;SYK;PTPRJ;PPP3CA;TPM1
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.8780173117060791,-1.326520045977716,0.13846153846153847,0.8778101818490103,1.0,2/5,9.75%,STPG4;TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.8780173117060791,-1.326520045977716,0.13846153846153847,0.8778101818490103,1.0,2/5,9.75%,STPG4;TOX
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.8517829286094323,-1.3265096422499785,0.08333333333333333,0.8754827635744167,1.0,2/5,6.13%,HLA-E;HLA-A
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.5955508156465699,-1.3262535715754098,0.05970149253731343,0.87487658528549,1.0,16/52,19.11%,MCTP1;RIT2;EPHA3;LGALS3;CALY;LRPAP1;CDH13;PACSIN1;NEDD4L;GPC3;LRP1;FLOT1;OPHN1;SCAMP5;LILRB1;SNX33
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.8203253628909927,1.3260030662777234,0.13513513513513514,1.0,1.0,4/6,14.77%,MSRB1;MSRB2;MSRB3;MSRA
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.834348228806093,-1.3256706950062984,0.1,0.8771398569134181,1.0,3/6,12.69%,TIMP1;CLDN4;LRP1
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.7091785481351355,1.3253623528646694,0.14285714285714285,1.0,1.0,1/11,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.6685479865603254,1.3249306311228712,0.17647058823529413,1.0,1.0,5/15,6.50%,GUCA1C;PDE6A;CNGB1;GUCA1B;PDE6B
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.7141385068963796,-1.324842822856617,0.14285714285714285,0.8799319049527343,1.0,3/20,5.38%,CLU;GNPTAB;LAPTM5
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.8382459814764256,-1.3247611331320286,0.07017543859649122,0.8784968356820276,1.0,5/7,11.88%,HTR5A;HTR1E;HTR2C;HTR2A;HTR2B
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.7339804022152807,-1.3243259088368755,0.11267605633802817,0.879707893864705,1.0,4/15,10.31%,CYSLTR2;PRKAR1B;ADCY7;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.7782391296322814,1.324008028791684,0.21052631578947367,1.0,1.0,1/8,2.74%,PIWIL2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6216152261714378,-1.3239898575366154,0.1076923076923077,0.8796606480309703,1.0,12/43,19.86%,NR4A3;PDHX;ENO4;ME3;SLC16A8;PFKFB2;SDS;LDHA;PGK1;PFKM;SLC16A3;GPI
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7335289941307143,-1.3239874496263664,0.11428571428571428,0.8773457515887836,1.0,8/17,16.95%,HLA-E;NLRP3;HLA-DRB1;CEBPB;ZFPM1;IRF4;SYK;PRKCQ
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5878176215331836,-1.3239050520386664,0.09090909090909091,0.8756275548780231,1.0,14/71,14.35%,CD44;GMFG;PIM1;DOK3;STAT5A;ADCY7;GATA1;MFSD2B;FAM117A;NMI;FBXO7;FERMT3;ADGRE2;WRN
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.853636426364001,-1.3234438731340072,0.10638297872340426,0.8765799570235728,1.0,2/5,10.43%,CARMIL2;CARMIL1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.7103079828699745,-1.3233654275247253,0.109375,0.8749232969155224,1.0,3/14,14.14%,IRF1;ADCY7;SKAP1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.7361460935610411,1.3232038711456202,0.075,1.0,1.0,5/10,24.12%,METAP1D;NAA50;NAA40;NAA11;NTMT1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.7763652885614716,-1.3231273515126354,0.1896551724137931,0.8741578454275564,1.0,2/8,3.91%,LOXL4;LOXL3
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.8256740170824828,1.323066283864765,0.16666666666666666,1.0,1.0,3/6,14.92%,NSUN2;TPR;IWS1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.8256740170824828,1.323066283864765,0.16666666666666666,1.0,1.0,3/6,14.92%,NSUN2;TPR;IWS1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.5558081389371933,1.3228597957102601,0.16666666666666666,1.0,1.0,22/79,19.08%,MRPL58;MRPL32;MRPS10;MRPL3;MRPS7;MRPL15;MRPL50;MRPS2;PTCD3;MRPS5;MRPS26;MRPL52;MRPL24;MRPL47;MRPL39;MRPS27;MRPL13;MRPL43;MRPS9;MRPS16;MRPL22;MRPS30
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.8441432926678407,-1.3225819431480985,0.09090909090909091,0.8753581544751059,1.0,2/6,4.27%,GUCY1A1;NPR2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.8044843820511406,-1.322376683699869,0.14545454545454545,0.8746206284038288,1.0,6/10,18.12%,F3;IL16;CDH13;VEGFA;SCG2;NTRK3
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.7909731357669043,-1.3223000175475865,0.07936507936507936,0.87271092217012,1.0,4/13,10.70%,SHISA6;GRIK2;SLC4A10;RAB3A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.6797923214320976,-1.322182211374615,0.11594202898550725,0.871260278797567,1.0,6/19,17.47%,PKP2;PLN;CAV3;CAV1;CACNA1C;FGF13
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.7905372226982584,1.3219184151512129,0.15789473684210525,1.0,1.0,1/5,0.47%,SLC22A2
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.7905372226982584,1.3219184151512129,0.15789473684210525,1.0,1.0,1/5,0.47%,SLC22A2
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.900762960907087,-1.3217710628127706,0.03636363636363636,0.8697220556248151,1.0,1/5,1.24%,HEY1
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.900762960907087,-1.3217710628127706,0.03636363636363636,0.8697220556248151,1.0,1/5,1.24%,HEY1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7848047242013636,1.3217024124956158,0.17073170731707318,1.0,1.0,1/6,2.48%,DCXR
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.6284776178895707,-1.3215324857620852,0.13333333333333333,0.8689093148924237,1.0,4/36,8.79%,DND1;YBX3;ELAVL4;E2F1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.7840511008363991,-1.3214433509909669,0.1323529411764706,0.8672361524548496,1.0,4/9,20.73%,TENM3;VEGFA;SHROOM2;IFT122
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.6180210709413574,1.3213887527878052,0.13513513513513514,1.0,1.0,14/54,14.74%,SQLE;SOAT2;DHCR24;HSD17B7;HMGCS1;MSMO1;ACAA2;HMGCR;PMVK;LCAT;IDI1;ARV1;CLN6;ACAT2
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.8692523289899646,-1.3203301117081898,0.12244897959183673,0.8725197304114157,1.0,2/6,5.37%,UNC13C;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.7831176513817675,-1.3201202161652987,0.125,0.8712636992469166,1.0,5/12,10.71%,IL12A;HLA-E;HLA-A;HLA-DRB1;GLI3
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.7099076768461492,1.320054124010982,0.14705882352941177,1.0,1.0,2/13,13.14%,RNF128;LAMTOR4
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.7278074774511007,-1.3192368394675043,0.11764705882352941,0.875211068418008,1.0,4/17,10.31%,CYSLTR2;PRKAR1B;ADCY7;ADCY8
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.5908789691240184,-1.3190505867285602,0.08333333333333333,0.8742235613545294,1.0,25/78,19.32%,BTBD17;LRRTM1;STMN2;SYT4;CNTFR;SYT1;ENHO;OGDHL;DACT2;TMEM179;CALY;CHGA;ACTL6B;ST8SIA3;SLC18A2;FTCD;SYT13;KCNH2;SCAMP5;SEMA4G;GRIK5;SHD;PLPPR1;CAMSAP3;CARMIL3
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.7523199373046581,1.3188753182660493,0.25,1.0,1.0,5/6,24.79%,DRD4;RAB3B;SNCA;TOR1A;GDNF
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.6438020150882674,-1.318685795722596,0.08196721311475409,0.8741190995541462,1.0,8/34,13.79%,IL6R;MEF2C;HGF;BMP6;WWTR1;NELL1;BMPR1B;DDR2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.8129108712424827,-1.3185725945808076,0.12280701754385964,0.8727500254961477,1.0,2/5,10.97%,PLSCR1;LYN
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.7474663556647205,1.3184854481902326,0.13043478260869565,1.0,1.0,5/13,16.57%,SYNE2;PCM1;SYNE3;SUN2;CEP120
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.6596757536578566,-1.3184226362518443,0.12307692307692308,0.8714120825497822,1.0,15/37,14.51%,IL13RA1;FGL2;PTPRC;ITGAM;SOX9;AOAH;KLF3;DCLK1;P2RY13;PTAFR;NREP;ADGRE3;TMEM176B;FCGR3A;SPI1
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.7737697034545663,1.3183806339953048,0.15789473684210525,1.0,1.0,3/10,11.80%,TFB1M;SLC25A33;TFB2M
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.7576363107463101,-1.3182965150978134,0.136986301369863,0.8698871660096364,1.0,2/13,2.12%,P2RY12;PTPRC
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.8168211475480712,1.3182220185626934,0.18604651162790697,1.0,1.0,1/5,14.42%,BMP5
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.7260927306724988,-1.317315649103432,0.14285714285714285,0.8736581673280661,1.0,5/13,22.67%,KLF9;GATA1;HPN;BRD8;CTSS
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.870257073710586,-1.3171472440195762,0.05,0.8726410871616512,1.0,1/7,0.54%,FSTL1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.6726123394540764,-1.3169520158398704,0.1111111111111111,0.8721336363606721,1.0,10/32,12.03%,CHRM3;UTRN;PDZK1;TRPC6;FGF12;SCN4B;SCN1B;CAV3;NEDD4L;YWHAH
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.6679058611098522,-1.3168544054915057,0.15873015873015872,0.8705740955173046,1.0,5/24,9.63%,PYGL;PPP1R3C;AGL;PHKG1;GYG1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.7396755430916235,-1.3165598658088067,0.15,0.8704089810353498,1.0,4/10,13.33%,CSF1R;HLA-DRB1;VEGFA;IL31RA
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.8972838776622918,-1.3164833388771349,0.1346153846153846,0.868813670256418,1.0,1/5,1.32%,PDHX
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.543535718267206,-1.316364475139638,0.058823529411764705,0.867464114454916,1.0,22/113,10.81%,DLK2;NUDT11;TGFB2;MX1;FGF22;PLAG1;CLDN16;CNTFR;TEX15;EDN1;C5;NOS1;SNN;HSD11B2;CAMK1D;SNCB;ARHGDIG;CHST2;KLHDC8A;ZC2HC1C;CLSTN3;STAG3
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.817820979540377,1.315934010784909,0.15384615384615385,1.0,1.0,2/6,9.74%,PTPRU;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.7468195774323325,1.3156800419414758,0.16666666666666666,1.0,1.0,2/8,1.92%,EPB41L4B;MAPRE2
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.7208167416981421,1.3154088034352145,0.1111111111111111,1.0,1.0,2/13,9.89%,DICER1;PRKRA
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.5539157781610029,-1.3150704283880006,0.03278688524590164,0.874119278898594,1.0,22/83,19.66%,PKP2;HEY1;TGFB2;MEF2C;FGF12;TGFBR2;ID2;SOX9;CITED2;TEK;SMYD4;ZFPM1;TGFB1;CDKN1A;CACNA1C;MTHFD1;CRB2;POU6F1;NTRK3;KDM6A;MICAL2;KAT2B
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.8254797471158744,-1.3148804983010713,0.078125,0.8733078803287542,1.0,2/6,12.30%,AQP1;AQP11
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.5199152466634938,-1.3146680317602872,0.06097560975609756,0.8725712922306621,1.0,41/147,19.62%,ROR1;TWF2;STMN2;RIT2;EPHA3;PLPPR5;EPHA4;NTNG1;CAMK1D;LRRK2;KNDC1;ZDHHC15;FES;TENM3;CDK5R1;TOX;ATP1B2;SIPA1L1;PAK3;LYN;CAMK1;SCN1B;CHN1;FBXO7;ITM2C;LRRC7;EFNB2;RTN4RL2;PRAG1;PTK7;DISC1;NTNG2;CAMK2B;CX3CL1;TRPV4;NTRK3;CDK5;NDRG4;SERPINI1;RTN4IP1;EPHB3
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7154524066549037,1.3144012591106256,0.1724137931034483,1.0,1.0,2/9,7.18%,HDAC1;GLI2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.7079050138885199,-1.3143689967601488,0.07575757575757576,0.8723801688064998,1.0,4/18,14.73%,CARTPT;CEACAM1;C1QC;ZFPM1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.7494603669572717,-1.3138223674689808,0.12307692307692308,0.8738351711751556,1.0,11/19,20.44%,PPARG;CSF1R;AXL;PDE1B;LYN;IKZF1;VEGFA;IL31RA;TRPM2;LILRB1;GAS6
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.7027048280914757,-1.3138137129483007,0.13636363636363635,0.8717427934372632,1.0,4/14,16.47%,PPARG;FABP3;CAV1;PRKAB2
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.8083002270543558,1.313232986884547,0.15555555555555556,1.0,1.0,4/6,17.28%,DCP1A;DDX3X;YBX1;DHX9
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.8247406981782307,-1.3130562529859258,0.0625,0.8752739530366223,1.0,2/10,4.99%,KDM4D;KDM3A
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.8007124236136787,-1.3130331978988659,0.13793103448275862,0.8733981884612475,1.0,2/11,3.45%,PDZK1;TRPC6
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.8779780540382589,1.3129827325325873,0.14583333333333334,1.0,1.0,3/5,8.49%,SPRY2;SPRED1;SPRED2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5738314215562763,-1.3129787051166129,0.09722222222222222,0.8717409335444816,1.0,16/67,12.07%,TLR2;IRGM;H2BC11;GBP2;IL12A;ISG15;HLA-E;IL6R;SFTPD;HLA-A;AQP1;CHGA;NOD1;CEBPB;SLAMF8;ROMO1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.7864522727391142,-1.312739432013196,0.15,0.8713455621836301,1.0,2/10,5.29%,NEFL;SYBU
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.8145872664878314,-1.3127293382454144,0.08196721311475409,0.8693304998250015,1.0,3/8,10.97%,IL12A;CSF1R;LYN
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),-0.8327342708530923,-1.3126961268630462,0.125,0.8674174966225057,1.0,1/6,0.26%,ANGPT1
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),-0.8549340459181434,-1.312265583639732,0.06557377049180328,0.8684416077425277,1.0,1/5,9.59%,SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.9063897751992692,-1.3110236478175261,0.06451612903225806,0.8748199452804282,1.0,1/5,0.92%,TLR2
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.8519462811985515,1.310834582463044,0.10638297872340426,1.0,1.0,1/5,2.34%,GPAT2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7919171223264112,1.3108142489515686,0.10344827586206896,1.0,1.0,1/7,5.30%,NPL
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.7558953299912133,1.3104372183812776,0.23684210526315788,1.0,1.0,2/8,6.57%,NUPR1;FBP1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.7558953299912133,1.3104372183812776,0.23684210526315788,1.0,1.0,2/8,6.57%,NUPR1;FBP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.8441876545825566,-1.3103585407336011,0.05263157894736842,0.8767853888103497,1.0,1/7,1.54%,TNFRSF1A
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.7862361472505257,-1.310208599258075,0.1,0.8754909260104924,1.0,5/11,14.99%,GUCY1A1;NOS1;DDAH1;KCNC2;AGT
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.7363177512069736,-1.3097819986679846,0.11290322580645161,0.8759839062030816,1.0,4/14,10.31%,GUCY1A1;NPR2;ADCY7;ADCY8
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.8108401068030402,-1.309463499102941,0.15254237288135594,0.8756087775802393,1.0,2/8,3.29%,OLFM1;NRCAM
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.5433847478977726,1.3091279654813455,0.11538461538461539,1.0,1.0,2/29,1.52%,CRTAM;LCK
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.6176198353759378,-1.308854532529665,0.043478260869565216,0.8776902971339499,1.0,10/58,16.34%,ITGB4;FBLN1;ISG15;CEACAM1;THY1;FERMT3;ITGBL1;FYB1;ITGAV;SYK
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.6368047805187175,-1.3087141298771132,0.17142857142857143,0.876700644857298,1.0,7/29,13.54%,ANGPT1;SFRP4;RIN3;LRPAP1;VEGFA;DLG4;FLOT1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.6359581695076699,-1.3082777514443857,0.10294117647058823,0.8771861913124639,1.0,7/54,12.95%,FSTL1;SFRP4;PPARG;SULF1;VWC2L;BMPR1B;BMPER
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.7013936832272017,-1.308225907901022,0.1643835616438356,0.8755703263981844,1.0,3/17,10.89%,DACT1;NELL1;AMER1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.778828291269198,-1.3081069150528333,0.1864406779661017,0.8744123569219068,1.0,3/7,17.33%,PTPRC;NR1D1;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.8369031682284694,-1.3081029067543022,0.15254237288135594,0.8724060246910569,1.0,5/5,16.34%,NCKAP1L;XBP1;CD27;PPP2R3C;SYK
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.6730577249593098,1.3079897545612342,0.15384615384615385,1.0,1.0,5/17,13.58%,HSPA1A;CHMP5;HSPA1B;TPR;HNRNPU
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.8417110851903487,-1.3079690648006188,0.11864406779661017,0.8717538651222401,1.0,3/6,14.21%,GABRG2;GABRB2;GABRB3
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.7570536866272939,1.3078537664877168,0.1282051282051282,1.0,1.0,1/7,0.47%,SLC22A2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.801220116159993,-1.3078348597686782,0.07272727272727272,0.8705009176842458,1.0,1/9,0.25%,PKP2
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.6729746796448483,1.307632552777658,0.07692307692307693,1.0,1.0,5/13,16.83%,SNAPC3;CAVIN1;GTF3A;MARS1;NIFK
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.5119055889516769,-1.3076128622793044,0.025974025974025976,0.8702131361637105,1.0,24/217,6.64%,CD44;ITGB4;ADAMTS5;ADAMTS17;ADAMTS6;LOXL4;TGFB2;MFAP5;MMP24;LAMC1;TIMP1;ITGAM;COL4A1;LOXL3;SCUBE3;CAPN1;ECM2;TLL1;P3H2;ST7;PAPLN;MMP21;A2M;COL11A1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.6207696958850294,-1.30756593626029,0.13636363636363635,0.8685688086019773,1.0,10/37,12.64%,TRPM1;GRIK2;GRM5;GRM7;PLCB1;GRIK1;GRIN2B;CDK5R1;KCNB1;GRIA3
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.6792023950682404,-1.3073569601237558,0.1111111111111111,0.8681091058629063,1.0,8/22,15.07%,HEY1;TNFRSF1A;SOX9;ROBO2;EFNA1;TNFRSF1B;TIE1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.7706514730976557,-1.3072089676305287,0.14035087719298245,0.8670753919211175,1.0,2/7,4.72%,LPL;VSTM2A
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.8528492150508361,-1.307121506320846,0.0967741935483871,0.8657368905636326,1.0,3/6,10.51%,PLSCR1;IL6R;CEBPB
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.6515644044495175,1.3069242360989108,0.06060606060606061,1.0,1.0,5/18,4.58%,SLC22A2;ABCC2;ABCC1;ABCA8;SLC47A1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8559009547520049,-1.3068433401092632,0.109375,0.8653529521127903,1.0,4/7,7.12%,HLA-F;HLA-E;HLA-A;B2M
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.7918858818114347,-1.3065716445871756,0.1694915254237288,0.8651908307782158,1.0,3/10,4.88%,BAIAP2;GAS2L3;BAIAP2L2
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.6383652489500735,-1.3062807626043416,0.1,0.8651611884350761,1.0,7/32,14.21%,TRPM1;TRPM3;SLC25A19;ASIC2;ABCC9;SLC25A20;SLC7A8
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.8602892793429356,-1.3062435010411746,0.12857142857142856,0.8635105167778894,1.0,2/6,10.70%,CBLN2;RAB3A
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.6818725137624866,-1.3062415253069917,0.15517241379310345,0.8616049994281679,1.0,4/17,11.55%,NOS1;SLC8A3;CALM3;CAV3
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.8006013025433802,-1.3061781562822314,0.1016949152542373,0.8601006262504292,1.0,1/8,2.06%,TGFB2
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.8473218112428164,-1.3059634542705985,0.13114754098360656,0.8598215699495212,1.0,3/6,11.98%,TPH1;TYRP1;TYR
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.8039865862148615,-1.305912267717371,0.12280701754385964,0.8582628081609243,1.0,2/6,13.72%,VIL1;PLEKHH2
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.5844282192645261,-1.3058812910840103,0.0684931506849315,0.8565377201982165,1.0,17/75,12.48%,VIL1;BAIAP2;STMN2;CLU;NCKAP1L;EDN1;SYNPO2;BAIAP2L2;MET;FES;FCHSD2;LMOD1;NAV3;CDK5R1;CARMIL1;CAV3;SYNPO2L
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.7296162313498487,1.3056811803558848,0.16666666666666666,1.0,1.0,3/11,8.23%,CMPK1;AK8;AK3
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.7814145012772633,1.3052307611271758,0.23076923076923078,1.0,1.0,4/7,17.12%,PUS7;PUS1;DKC1;RPUSD2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.6761792165899849,1.3046345479632706,0.16666666666666666,1.0,1.0,9/22,16.86%,RASL11A;ATF4;PIH1D1;DHX33;SMARCA4;NCL;MARS1;UBTF;NOL11
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.8188703194942675,-1.303673907126249,0.16666666666666666,0.8699718937071105,1.0,1/5,0.92%,TLR2
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.5539296028619008,-1.30341011672169,0.11688311688311688,0.8700183955455271,1.0,23/108,15.17%,CD44;ANGPT1;ROR1;PDGFD;IL26;PTPRC;CSF1R;HTR2C;PRXL2C;CHI3L1;TEK;HLA-DRB1;GPR183;HTR2A;HTR2B;EGFR;BMPER;PRKD2;DENND2B;NOTCH2;SCIMP;TGFB1;OPRM1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.6247219506308082,1.303166021839182,0.13513513513513514,1.0,1.0,3/23,3.39%,CRTAM;CD274;SCRIB
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.8128702488100044,1.3029749996134912,0.21739130434782608,1.0,1.0,2/6,7.06%,GRAMD2A;VAPB
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.5993949772273067,1.3027425614249761,0.07407407407407407,1.0,1.0,3/27,3.03%,DHFR;ORC1;KLF11
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.861638941735808,1.3023203896643,0.1111111111111111,1.0,1.0,2/6,10.18%,PRDM5;BEND3
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.6066998807249936,1.3022472161244374,0.175,1.0,1.0,14/44,13.83%,SPIRE2;HMGB1;OOEP;EYA4;HDAC10;MGMT;RNF168;H2AX;TMEM161A;BRCC3;SLF2;UBE2N;RNF8;UIMC1
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.8483142658433798,-1.302172831058833,0.10606060606060606,0.8755948540743985,1.0,1/6,4.62%,SOX9
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7208910813985188,1.3020302166235727,0.16216216216216217,1.0,1.0,4/11,14.95%,NLGN3;PTPRD;IL1RAPL1;NLGN2
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.546134899808136,-1.3015562690060742,0.056338028169014086,0.8779045478664081,1.0,25/101,15.02%,FBLN1;IGFBP3;SPARCL1;PPP1R3C;MAOB;COL4A1;PLSCR4;SERPING1;NOS1;HSD11B2;AQP1;ADAM21;KIAA1217;GJA1;CPE;TEK;LMOD1;MATN2;ADGRF5;CXCL14;CALB2;EGFR;COL21A1;SLC22A3;TIMP3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.7770087965534294,1.3011316171676375,0.2,1.0,1.0,3/8,12.67%,SNAPC3;ELL;ZC3H8
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6661310604632926,-1.300850328757911,0.09523809523809523,0.8798398319243039,1.0,11/24,25.18%,RIMS1;SNAP25;RAB3A;SLC18A2;PCLO;SLC17A6;SLC17A7;CDK5;SYT7;CPLX2;CPLX1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.5960543515500701,-1.300817430549407,0.07142857142857142,0.8781327126919803,1.0,10/52,16.51%,DACT1;VSIR;APC2;HECW1;C4BPA;NEDD4L;TRIM32;GPC3;OAZ3;PLK2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.7515198686454712,-1.3006700448441166,0.11666666666666667,0.8769449992056463,1.0,3/14,4.33%,TP73;MEF2C;PIM1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7923401655977851,-1.3005263503774351,0.1016949152542373,0.8761668584007613,1.0,2/8,9.28%,CARTPT;UBASH3B
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.8009447524151234,1.300260980485274,0.1836734693877551,1.0,1.0,1/5,2.48%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.8009447524151234,1.300260980485274,0.1836734693877551,1.0,1.0,1/5,2.48%,DCXR
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.8009447524151234,1.300260980485274,0.1836734693877551,1.0,1.0,1/5,2.48%,DCXR
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8158031599608957,1.2999850885264086,0.15555555555555556,1.0,1.0,1/6,1.07%,RFWD3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.819817656654621,1.299672447599862,0.20454545454545456,1.0,1.0,3/5,9.16%,CYBA;MFHAS1;TLR1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.6603688356508088,-1.2996683085187462,0.1267605633802817,0.8797240729213894,1.0,7/24,11.78%,IGFBP3;PPARG;IL12A;MEF2C;OGN;PRKG1;TGFB3
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.6493442092807048,1.299480969292928,0.20588235294117646,1.0,1.0,6/22,13.58%,HSPA1A;NUMA1;CHMP5;HSPA1B;TPR;HNRNPU
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.65015608862724,1.2994449954909661,0.16279069767441862,1.0,1.0,7/19,23.73%,DICER1;PRKRA;TENT4B;RAN;TUT4;XPO5;LIN28B
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.8373044619679364,-1.2992471669125207,0.16363636363636364,0.8807866599062683,1.0,1/5,2.17%,BIRC3
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.7867355170520165,1.298588686368205,0.2222222222222222,1.0,1.0,3/7,18.71%,RNF168;RNF8;LIG4
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.7708977220328176,-1.2984064740065018,0.1206896551724138,0.884127973292885,1.0,1/11,1.28%,H2BC11
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.7514748930749862,-1.2983273529444874,0.09722222222222222,0.8827502703032837,1.0,3/15,5.34%,CLU;EDN1;DDAH1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.5305374139177931,-1.2982820905409094,0.06172839506172839,0.8809575501342627,1.0,32/158,15.17%,CD44;ANGPT1;ROR1;FBLN1;PDGFD;IL26;PTPRC;APIP;RPS6KA6;CSF1R;CEACAM1;LMO3;HTR2C;PRXL2C;CHI3L1;TEK;HLA-DRB1;GPR183;HTR2A;LYN;HTR2B;PTPRR;EPHB1;EGFR;BMPER;PRKD2;DENND2B;NOTCH2;SCIMP;TIMP3;TGFB1;OPRM1
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.7864969430823125,1.2979465610842162,0.16216216216216217,1.0,1.0,1/5,5.69%,IDH2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.6905377302230237,1.2978095869042157,0.17777777777777778,1.0,1.0,2/8,10.67%,PRR7;ST18
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.849471088210191,-1.2977958264578737,0.12280701754385964,0.8824283355646074,1.0,2/5,8.48%,AQP1;XBP1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.5297061171260473,-1.2977519135119546,0.0547945205479452,0.8808536652426271,1.0,58/125,14.57%,LRRTM1;STMN2;TCEAL6;RIT2;PAK5;SYT4;GAP43;HTR5A;CCK;KCND2;KCNQ3;CLVS2;ASTN1;GABRG2;GABRA1;SYNPR;TCEAL5;ATP2B3;BRINP2;VSTM2A;CDH22;SNAP25;GRM5;NRGN;HPCA;CACNA1B;CALY;SNCB;CELF4;RAB3C;PHF24;EMX1;ELAVL4;ASIC2;GRIN2B;KCNC2;CACNG3;ADCY8;BRINP1;ACTL6B;ST8SIA3;KCNB2;LRRTM3;KCNB1;TAGLN3;GRIA1;OPCML;OLFM3;DLG4;GAD2;SRRM4;GRIA3;MAP2;TMEM196;GRIN2D;SORCS3;LRRC3B;SPHKAP
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.8097425919015084,-1.2975604976355546,0.12903225806451613,0.8802687532697778,1.0,2/7,4.00%,TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.7716965442518917,1.2975560697356483,0.1388888888888889,1.0,1.0,1/8,0.03%,CYP1A2
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.8764120455309836,-1.2972879141169127,0.1016949152542373,0.8799159202702634,1.0,1/5,1.44%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.8247965775709759,1.2972388341830423,0.25,1.0,1.0,1/6,5.20%,MST1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.7691604996397228,-1.2970660145875545,0.11290322580645161,0.8793771887270256,1.0,2/15,3.00%,DACT1;ALDH1A2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.8251448330053426,-1.2968992434306597,0.1276595744680851,0.8784459621623282,1.0,2/8,10.37%,GATA1;NECAB1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.6910508007984532,1.296436151788227,0.1794871794871795,1.0,1.0,1/16,0.80%,CRYAB
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.539722827558945,1.2962819924495252,0.07407407407407407,1.0,1.0,25/93,19.08%,MRPL58;ZNF598;MRPL32;MRPS10;EEF1D;EEF1A1;MRPL3;MRPS7;MRPL15;MRPL50;MRPS2;PTCD3;MRPS5;MRPS26;MRPL52;MRPL24;MRPL47;MRPL39;MRPS27;MRPL13;MRPL43;MRPS9;MRPS16;MRPL22;MRPS30
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.8446367678654978,-1.296026439755089,0.08196721311475409,0.8823914086771761,1.0,3/6,15.07%,TGFB2;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.7871093632810608,1.2958462781167432,0.15217391304347827,1.0,1.0,4/5,19.78%,CORO1B;MARS1;MTSS2;HYAL1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.5854970100340561,1.2958380663817368,0.16666666666666666,1.0,1.0,17/47,19.18%,EYA4;HMGA2;SPRED1;PLA2R1;RNF168;H2AX;TMEM161A;BRCC3;SPRED2;UBE2N;RNF8;UIMC1;ATR;DHX9;DDX5;RPS3;SIRT1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.668219479061137,-1.2957117842208443,0.07936507936507936,0.8823887946708796,1.0,13/31,23.79%,RIMS1;SYT1;UNC13C;SNAP25;STX3;RAB3A;RIMS2;PCLO;CDK5;STX19;SYT7;CPLX2;SYT2
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.6196389267220573,1.2956675686381631,0.17142857142857143,1.0,1.0,3/21,4.41%,DSCAM;PTH;PTH1R
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.7622225764726168,1.2955136445753008,0.20512820512820512,1.0,1.0,2/8,9.69%,OTUD3;USP37
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7858955142715832,1.2952861866646754,0.1702127659574468,1.0,1.0,4/10,16.32%,SYNE2;SYNE3;KIF25;SUN2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.7635161759633093,1.2952166253619628,0.14285714285714285,1.0,1.0,2/6,2.79%,AGER;HMGB1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8240897463256465,1.2947218195997756,0.08108108108108109,1.0,1.0,4/5,16.47%,DHFR;QDPR;GCH1;MTHFS
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.7274904179776682,-1.2947062089455363,0.13559322033898305,0.8880020148304221,1.0,3/18,8.48%,LPL;GPIHBP1;XBP1
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.7911656052133493,-1.2946223130131176,0.10909090909090909,0.8866689157914028,1.0,2/7,7.81%,CPS1;ARG2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.5199694197904664,1.2944775592497257,0.11627906976744186,1.0,1.0,4/50,3.55%,CYP1A2;GPC4;GPC2;AWAT2
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.8122809037930597,-1.2943021639782417,0.1791044776119403,0.887006735218525,1.0,5/7,15.07%,TNFRSF1A;FAP;CST3;TNFRSF1B;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.8935020294598113,-1.294229389177874,0.14516129032258066,0.8856403631855201,1.0,2/5,8.39%,PPARG;E2F3
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.5449382763005346,-1.2938788604523193,0.09333333333333334,0.8863883649007264,1.0,20/115,17.47%,PKP2;DPP10;TNFRSF1A;KCNIP4;PDZK1;ANK1;RAB11A;RAB3C;RAB3A;KCNB2;KCNB1;CAV3;PACSIN1;CACNB2;FLOT1;FYB1;RAMP1;RAB15;MRAP;FGF13
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.7233386597268276,1.2937187037236033,0.2619047619047619,1.0,1.0,1/8,2.29%,OAS3
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6699599613902139,1.29369149495604,0.1282051282051282,1.0,1.0,3/18,5.29%,VDR;DHFR;NOS1AP
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.8223087008030288,1.2935111809011806,0.1951219512195122,1.0,1.0,3/5,2.49%,SCN11A;SPX;MGLL
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.6520764549162061,1.2930356471115345,0.21621621621621623,1.0,1.0,3/21,5.84%,NUPR1;CDSN;PLA2R1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.5578158484235215,-1.2928960283995385,0.07936507936507936,0.8908716477751226,1.0,1/58,0.14%,GPAT3
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.7907675633476952,-1.2927858546127227,0.18333333333333332,0.8895057688022071,1.0,3/6,16.12%,CPS1;SDS;MTHFD1
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.8247780523956507,1.292656058739177,0.13333333333333333,1.0,1.0,1/5,9.61%,VPS25
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.8247780523956507,1.292656058739177,0.13333333333333333,1.0,1.0,1/5,9.61%,VPS25
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7210190361884292,-1.2924506790050236,0.2033898305084746,0.8899357938532398,1.0,2/16,4.18%,NR4A3;EDN1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.5384460698838793,1.2921374856774568,0.12121212121212122,1.0,1.0,22/85,19.08%,MRPL58;MRPL32;MRPS10;MRPL3;MRPS7;MRPL15;MRPL50;MRPS2;PTCD3;MRPS5;MRPS26;MRPL52;MRPL24;MRPL47;MRPL39;MRPS27;MRPL13;MRPL43;MRPS9;MRPS16;MRPL22;MRPS30
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.5501795949250331,-1.2921266571764891,0.057971014492753624,0.8906279176473145,1.0,19/149,8.55%,CD44;MEST;OLFM1;IGSF1;ISG20;PDZK1;IGFBP4;IMPA2;PRSS23;ID2;FOS;CCN5;FKBP5;CCND1;PTGER3;TOP2A;CPE;XBP1;COX6C
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.5806115785723751,-1.29183050168553,0.1323529411764706,0.890749930814809,1.0,10/64,13.79%,PPARG;IL6R;MEF2C;SOX9;HGF;BMP6;WWTR1;NELL1;BMPR1B;DDR2
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.8030162228987991,-1.2915617539886908,0.08064516129032258,0.8906288500126955,1.0,1/9,2.83%,TSPYL2
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.614286562396184,-1.291542191845718,0.13432835820895522,0.8888540662870491,1.0,16/58,16.54%,EPN1;CLDN5;PTPRM;SEMA3E;PPARG;TGFB2;TEK;PDE3B;SULF1;CD160;PGK1;EFNA3;STAT1;CNMD;ADAMTS9;PIK3CB
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.7082193923617386,-1.291453752691261,0.12121212121212122,0.8875899451457926,1.0,7/22,14.83%,BASP1;LOXL3;SPEF2;CHI3L1;VEGFA;FGF7;CCDC39
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6401125018164497,1.291391950709994,0.21951219512195122,1.0,1.0,3/16,12.62%,DUSP1;DUSP7;PPM1F
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.8045196684752836,-1.2912995599359633,0.1694915254237288,0.8870743828489969,1.0,2/7,8.10%,TGFBR2;CPE
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.8019702344987572,-1.2909773206074282,0.09615384615384616,0.887262634039758,1.0,2/10,4.62%,TGFB2;SOX9
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.848568892260751,-1.2909699879219074,0.1206896551724138,0.8854494533194808,1.0,1/7,0.20%,ITGB4
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.692381499587703,-1.2908857743904796,0.15492957746478872,0.8842626736087592,1.0,6/21,13.13%,PRKAR1B;ADCY7;RAB11A;AQP1;ADCY8;AQP4
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.6929121384905873,-1.2908341719188525,0.13559322033898305,0.8827420662173504,1.0,9/23,12.35%,CARTPT;RIMS1;SYT1;EDN1;GRIK2;LGI1;CLSTN3;RIMS2;DLG4
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7566816290362975,1.2907041852090833,0.16666666666666666,1.0,1.0,1/6,1.92%,MAPRE2
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7566816290362975,1.2907041852090833,0.16666666666666666,1.0,1.0,1/6,1.92%,MAPRE2
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.8978151752669304,-1.29036486426055,0.05555555555555555,0.883315449759149,1.0,1/6,2.69%,DDX60
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.6853185618182581,1.2902396272788506,0.21052631578947367,1.0,1.0,5/16,20.19%,HSD17B7;STAR;TSPOAP1;FDX1;SRD5A1
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.8066109966090711,-1.2899657927448398,0.13333333333333333,0.8841444365457203,1.0,1/7,8.09%,CHI3L1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.6938501342599708,1.2897625371431096,0.23529411764705882,1.0,1.0,3/8,15.77%,STMP1;DHX33;DDX3X
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.6240584335922497,-1.2895941830996727,0.1935483870967742,0.8849106268704312,1.0,12/30,23.23%,HEY1;TTN;GJA1;NRG1;CACNA1G;ZFPM1;NOTCH2;ADAMTS9;CBY1;MYOCD;MESP1;HEY2
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.7256456349002087,1.2889525491346463,0.2857142857142857,1.0,1.0,2/6,7.68%,EYS;AKIRIN1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.6112571636814932,1.2888570165012303,0.16666666666666666,1.0,1.0,3/23,12.49%,AUP1;TMEM129;LMAN1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.7213236737539702,1.2885954775971538,0.3055555555555556,1.0,1.0,1/9,0.47%,SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.7590531366470257,1.2885715758099874,0.21951219512195122,1.0,1.0,5/6,23.73%,NFKB1;PNPT1;RELA;ZSWIM8;LIN28B
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.5745912232866923,-1.2885494936291562,0.14925373134328357,0.8898829026135201,1.0,9/67,11.84%,ANGPT1;BIRC3;FANCI;PRICKLE1;LAPTM5;LRRK2;FANCM;AMER1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.8481243001529523,-1.2883578631146224,0.10344827586206896,0.8890960221644738,1.0,2/6,9.28%,CARTPT;UBASH3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.6937164700941209,-1.288167092065801,0.1864406779661017,0.888528833952378,1.0,1/16,1.23%,CPS1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.5915902902501436,-1.2877202749852195,0.18055555555555555,0.8893584796584212,1.0,7/43,14.16%,NR4A3;PPARG;PSMB8;ERAP1;STEAP4;TRIM32;PID1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.7870616873571784,1.287505612111246,0.1794871794871795,1.0,1.0,3/6,18.71%,RNF168;RNF8;LIG4
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.8167901326679692,-1.287433370763425,0.15789473684210525,0.8895967199916297,1.0,2/7,8.67%,SAMHD1;POLQ
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.7695329445784278,1.287110620342761,0.20454545454545456,1.0,1.0,2/5,10.10%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.7695329445784278,1.287110620342761,0.20454545454545456,1.0,1.0,2/5,10.10%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.5844818761606643,1.2870845867636411,0.15151515151515152,1.0,1.0,10/34,17.28%,CDK11A;PTCD2;JMJD6;CPSF4;SRPK3;RBM23;IWS1;SAFB2;SLTM;DHX9
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.6988965970098854,-1.2870536869099412,0.16981132075471697,0.8898731216383429,1.0,2/14,4.72%,LPL;VSTM2A
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5987908915355012,1.2870032768757123,0.20588235294117646,1.0,1.0,3/20,5.86%,DAO;THAP4;ENPP1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.736819525778533,1.2864470019523646,0.20454545454545456,1.0,1.0,3/7,18.02%,NUMA1;SAPCD2;GNAI1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.7452944889468827,-1.2861064443607544,0.15789473684210525,0.8948533338985205,1.0,4/14,3.07%,IRGM;PLSCR1;IFITM3;IRF1
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.8196031075626224,1.285926993896641,0.1276595744680851,1.0,1.0,2/5,6.31%,LHFPL2;FSHR
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.8414811744529873,-1.285538673224125,0.125,0.8966767049956331,1.0,2/6,7.95%,CR1;C3AR1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6330571196637241,1.2854951525468095,0.17073170731707318,1.0,1.0,5/16,18.48%,PINX1;TNKS2;HNRNPA2B1;SMG5;NAF1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.7394132387198281,-1.285273193044115,0.234375,0.8967233395547441,1.0,2/12,2.24%,TLR2;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8422175475121727,-1.2850300911653356,0.1746031746031746,0.8965369255081926,1.0,2/5,4.00%,TGFB2;TGFBR2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6361482244943647,1.2845940678171492,0.1891891891891892,1.0,1.0,7/15,22.00%,CPSF4;CSTF2;TSEN15;ZBTB8OS;RTRAF;TSEN34;FAM98B
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.8447673510228365,-1.2845457003173604,0.10294117647058823,0.8977843656008178,1.0,1/6,1.71%,GBP2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6384905581729268,-1.2843975091319266,0.15151515151515152,0.8969587646141503,1.0,14/39,19.34%,RIMS1;SYT1;SYN3;SNAP25;SYN2;LIN7A;RAB3A;RIMS2;GAD2;PCLO;NRXN1;CDK5;GAD1;GRM4
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.5781108639348981,-1.2843950706331329,0.1111111111111111,0.8951719941667118,1.0,19/52,16.46%,DPEP2;SLA;PTPRC;ITGAM;NCKAP1L;GMFG;AOAH;LAPTM5;CD53;SIGLEC10;C3AR1;IKZF2;ADGRE3;TNFRSF1B;ARHGAP25;LY86;SPI1;NR1D1;TRAF3IP3
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.7708012515344347,1.2842318781976672,0.2,1.0,1.0,2/5,21.45%,GLA;NAGA
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.7593306296494884,-1.2839311562558946,0.125,0.8965879652730426,1.0,4/13,17.10%,CEACAM1;SLC18A2;ABCD2;CIITA
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.6475322712126133,-1.2838926857199944,0.15625,0.8950011471956283,1.0,15/26,21.63%,PTPRM;PPARG;IL12A;MEF2C;SULF1;CAV1;CAV2;SCG2;STAT1;CNMD;NGFR;NR2F2;COL4A3;ATP5IF1;FLT1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.5332772927585728,-1.2835622517401497,0.11538461538461539,0.8950888024413479,1.0,55/187,12.64%,ZACN;NPY;CHRM3;CHRM5;RIT2;HTR5A;GLRA3;KCND2;KCNQ3;SYT1;GABRG2;GABRA1;HTR1E;GRIK2;PRKAR1B;GLRA2;NPTX2;UNC13C;SNAP25;SLC1A1;NPTX1;CACNA1E;PTCHD1;SYN2;PCDHB11;GRM5;NRGN;CACNA1B;SNCB;GRM7;CACNB1;HTR2C;HTR3B;PCDHB4;GABRB2;GABRA6;GABRA4;AMPH;GABRA2;GRIK1;ASIC2;GRIN2B;DLGAP1;GPR176;HTR2A;GABBR2;CAMK1;SLC18A2;GRIA1;HTR2B;PCDHB9;CACNB2;DLG4;GAD2;GRIA3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.6073886600221426,-1.283407486703844,0.16666666666666666,0.8942575500765525,1.0,4/45,5.38%,H2BC11;TNFRSF1A;BIRC3;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5304310725111674,-1.2832796024580637,0.0759493670886076,0.8931621915752109,1.0,33/175,15.17%,CD44;ANGPT1;ROR1;PDGFD;IL26;TGFB2;PTPRC;RIT2;TRIM5;EDN1;LAPTM5;CSF1R;LRRK2;HTR2C;PRXL2C;CHI3L1;TEK;DIRAS1;HLA-DRB1;GPR183;HTR2A;VEGFA;HTR2B;EGFR;BMPER;CAV2;PRKD2;DENND2B;NOTCH2;GPR37L1;SCIMP;TGFB1;OPRM1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.8143251660752007,-1.2831804803466615,0.14754098360655737,0.8919186547148098,1.0,2/9,9.27%,PPARG;RARB
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.8226424569902278,-1.2829494379293804,0.1206896551724138,0.8915931512810297,1.0,3/7,15.07%,CENPF;MRTFB;TGFB1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.776233479432838,1.2828763044617622,0.25,1.0,1.0,4/7,7.65%,SCN11A;SPX;MGLL;ATPSCKMT
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.764660136600654,-1.282410252599183,0.2028985507246377,0.8929967048288143,1.0,3/8,15.61%,IL12A;VEGFA;NGFR
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.7960554204311908,-1.282333925260738,0.16393442622950818,0.8915902474370963,1.0,5/7,17.33%,C1QB;ITGAM;CX3CR1;C1QC;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8312371273035428,-1.2822063270561121,0.09433962264150944,0.8906810072638343,1.0,1/7,0.24%,EPN1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.6571502987245506,1.2815709443409282,0.3225806451612903,1.0,1.0,10/22,21.90%,LYRM4;CIAO3;CIAPIN1;ISCA2;CIAO2B;NFU1;GLRX3;ISCA1;CIAO1;NFS1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.7674648275534011,-1.281139892824527,0.19696969696969696,0.8958721197471381,1.0,2/8,12.03%,HECW1;NEDD4L
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.7424134231899979,-1.280228730859857,0.18181818181818182,0.8994794093602236,1.0,6/13,19.81%,ITGAM;PIK3AP1;NMI;SCIMP;LY96;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.7521420422286487,1.2802051728601516,0.2391304347826087,1.0,1.0,2/8,7.30%,PINX1;PARP3
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.7169548194902224,-1.279687636164597,0.11594202898550725,0.9010044411557494,1.0,2/15,1.19%,PDGFD;NR4A3
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.7376668018457977,-1.2796300748048504,0.15517241379310345,0.8996336250072154,1.0,2/12,5.29%,NEFL;SYBU
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.6647818441197726,-1.2793703660971822,0.1232876712328767,0.8994106129655658,1.0,6/30,11.88%,TGFB2;PTPRC;MEF2C;GPM6A;SOX21;HTR2B
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.7263092424745434,-1.279236323467095,0.17647058823529413,0.8984220338228223,1.0,6/10,15.04%,LRMDA;MEF2C;TYRP1;SLC24A5;HPS6;MREG
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.5767958015882448,-1.2789857309044075,0.16,0.898164900941898,1.0,19/61,16.38%,TGFB2;NPR2;ATP2B3;NOS1;ATP2B2;RYR3;TMIGD3;SLC8A3;CELF2;SLC8A1;ATP1B2;PLN;CALM3;CAV3;ABCC9;ATP1A1;ITPR3;AGT;FKBP1B
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.8021075573829723,-1.278825995995719,0.13333333333333333,0.8973314914024508,1.0,1/7,2.87%,SYT4
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.712006305159398,-1.2787316157906434,0.1267605633802817,0.8961295665281984,1.0,6/27,8.69%,HLA-F;HLA-E;TAPBPL;HLA-A;B2M;ERAP1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.5479716758814653,-1.2787014444457334,0.12857142857142856,0.8946539948500467,1.0,23/116,11.73%,TNFRSF1A;PPP1R3C;GAP43;CHST1;COL4A1;CNTFR;VIM;NOS1;FIGN;DKK3;DCLK1;GFRA2;FNDC4;GJA1;PCDHB4;TENM3;BOC;CPE;THY1;LMOD1;ADGRL2;GPC6;NR2F1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.850565281429197,-1.2786456354871023,0.16981132075471697,0.893350697803227,1.0,3/6,13.56%,TPCN2;CAV1;CAV2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.6208561398755474,-1.2784423926854014,0.09859154929577464,0.8930502586325078,1.0,8/33,17.79%,TGFB2;OLFM1;TGFBR2;WWTR1;TGFB3;TGFB1;CRB2;EZH2
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.7052785175781072,1.2779640243352413,0.1891891891891892,1.0,1.0,2/14,2.57%,LOC400499;CRHBP
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7796229455131117,1.2778290383104718,0.175,1.0,1.0,4/8,19.18%,HDAC10;HDAC9;HDAC4;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.708933946631728,-1.2777854639512773,0.17142857142857143,0.8951118119433494,1.0,6/14,21.77%,PPARG;ITGAV;NFKBIA;PNPLA2;ABCA1;TTC39B
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.7015254118977371,-1.277532082044104,0.19117647058823528,0.8950484847778284,1.0,2/13,2.55%,TGFB2;MMP24
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7730553321123427,1.277347896396554,0.25,1.0,1.0,2/7,11.95%,SOD3;ADPRS
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.821326734220589,-1.2772740793074455,0.12698412698412698,0.8950221461989908,1.0,3/7,13.13%,AQP1;AQP11;AQP4
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.6441354453613426,-1.2772338306497233,0.208955223880597,0.8936021184247203,1.0,11/29,20.44%,NOX4;EPHA4;CSF1R;EFNA1;GRM5;DLG4;TGFA;AGT;NEDD9;IL34;GAS6
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.5963078889403937,-1.2771586285996246,0.16666666666666666,0.8922789826781938,1.0,9/43,12.30%,IGFBP3;MCTP1;CLU;NLRP12;DDAH1;THY1;UBASH3B;LYN;AQP11
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.5229259008251849,1.2769476280290815,0.21875,1.0,1.0,17/62,24.42%,EAF2;CCNT1;ELL;POLR2K;ELOC;MLLT3;POLR2L;IWS1;GTF2H5;ERCC2;CTDP1;CCNK;POLR2E;POLR2D;ELP4;TCEA1;CCNH
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.7540683892778155,-1.2767998701753718,0.2,0.8928609327349813,1.0,4/7,15.07%,TGFB2;TGFBR2;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.7495769840956784,-1.2764144155682762,0.15625,0.8933130408744565,1.0,3/12,7.58%,FBLN1;PTPRC;GJA1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.8131573091272468,-1.2764017163224253,0.15942028985507245,0.8917248882170385,1.0,3/7,13.13%,AQP1;AQP11;AQP4
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.8731927701910478,-1.2758655366502705,0.10606060606060606,0.8933764724284259,1.0,3/5,6.32%,HLA-F;NCKAP1L;CEACAM1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.5729581750016152,-1.275778505241615,0.1111111111111111,0.8921930810315402,1.0,11/60,10.54%,ARHGAP18;VIL1;BAIAP2;TWF2;NCKAP1L;BAIAP2L2;ARHGAP28;FCHSD2;LMOD1;CARMIL1;PAK3
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.7147067256003012,1.2753768035469728,0.2894736842105263,1.0,1.0,2/6,11.98%,KDM1B;DNMT3A
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.8344633489627806,-1.2751978123364829,0.16981132075471697,0.8926758454769517,1.0,1/6,0.92%,TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.8344633489627806,-1.2751978123364829,0.16981132075471697,0.8926758454769517,1.0,1/6,0.92%,TLR2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.7932217431472202,-1.2747910316316928,0.15254237288135594,0.8933576623481848,1.0,2/8,2.64%,ITGB4;LAMC1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.7528077080626743,-1.274741174453202,0.14754098360655737,0.8920931121195887,1.0,2/12,4.62%,PPARG;SOX9
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.6566336748020845,-1.2743382446198042,0.15384615384615385,0.8926836549138031,1.0,4/27,8.25%,ITGB4;LAMC1;ACTN1;THY1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6255759746042998,1.2740734416494082,0.14285714285714285,1.0,1.0,12/22,27.10%,HDAC10;HDAC1;ABHD17A;HDAC4;ABHD10;HDAC3;SIRT1;LYPLAL1;SIRT7;SIRT6;SIN3A;LYPLA1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4960640405980934,-1.2739293603476418,0.04878048780487805,0.8935230555420365,1.0,54/391,10.38%,CD44;HLA-F;IL13RA1;TNFRSF1A;GBP2;IL26;IL12A;ISG15;SLA;HLA-E;CEBPD;BIRC3;MX1;TRIM5;ISG20;IL6R;IFITM3;IFNGR2;TIMP1;IRF1;DUOX1;ITGAM;CNTFR;PIM1;TRIM22;VIM;FOS;F3;HGF;PSMB8;ZEB1;STAT5A;CCND1;CSF1R;HLA-A;CEACAM1;IL7;SAMHD1;IL3RA;B2M;CTF1;HLA-DPB1;PTAFR;CRLF1;STX3;IL16;PLCB1;IL12RB2;IFNA2;IFI35;HLA-DRB1;NOD1;XAF1;TRIM25
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.7326298065132588,-1.2738746521128492,0.1774193548387097,0.8922831105314023,1.0,2/11,4.93%,BASP1;ROBO2
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.7367918184208591,-1.2738613425146244,0.18867924528301888,0.890761891061749,1.0,3/9,15.46%,DOCK8;LRCH1;CD200
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.7127770848719754,-1.2737901595610184,0.18181818181818182,0.8878074300241341,1.0,1/15,1.51%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.7127770848719754,-1.2737901595610184,0.18181818181818182,0.8878074300241341,1.0,1/15,1.51%,MGST1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.7444730763666209,-1.2737447155039296,0.17307692307692307,0.8863027964974463,1.0,4/12,14.82%,HEY1;GJA1;CACNA1G;NOTCH2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.6419861779409453,1.2737359652323974,0.1282051282051282,1.0,1.0,5/15,21.72%,PRPF39;SNRPC;DCPS;RBM22;WBP4
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.6178299594513383,-1.2729960283163522,0.16417910447761194,0.8893615013982951,1.0,10/40,19.22%,SRGN;SAR1A;HOOK1;CAV1;DNM1;CAV2;SNX10;PI4K2A;SNX33;FNBP1L
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.7606353767316397,1.2718736140473863,0.2631578947368421,1.0,1.0,2/6,17.47%,PSPH;PSAT1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.544570188743445,-1.2716927845971282,0.15942028985507245,0.8950997743702425,1.0,34/96,19.58%,FSTL1;IGFBP3;GBP2;LURAP1L;LRIG3;PPP1R3C;COL4A1;PLSCR4;MUC16;F3;NTN4;CDON;KIAA1217;WWTR1;PALLD;AR;COBLL1;SULF1;MATN2;ADGRF5;CALB2;CAV1;EGFR;CAV2;AOX1;TIMP3;GNG12;NNMT;EPAS1;PRICKLE2;LAMB2;CDH1;CCDC80;OSMR
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8384353387405116,-1.2715490627975317,0.13513513513513514,0.8925797259169368,1.0,3/6,6.13%,HLA-F;HLA-E;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8384353387405116,-1.2715490627975317,0.13513513513513514,0.8925797259169368,1.0,3/6,6.13%,HLA-F;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.675392977373571,-1.2714250046217157,0.1774193548387097,0.8916434781454492,1.0,5/17,17.16%,HEY1;GATA1;H1-0;TGFB1;MAD2L2
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.7665520525441664,-1.2712084451327352,0.2727272727272727,0.8910621047914846,1.0,5/8,19.18%,NCKAP1L;MEF2C;LYN;PPP2R3C;CAMLG
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.704561238221934,1.2708826062578564,0.21951219512195122,1.0,1.0,2/11,5.69%,AADAT;IDH2
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.5818997227000535,-1.2708623174191427,0.08571428571428572,0.891605523709163,1.0,15/59,15.08%,ITGB4;CHRM3;CDS1;C1ORF115;TMC4;HSD11B2;SLC5A9;EFNA1;SLC44A3;CBLC;CLDN4;EGFR;TJP3;OVOL2;PPL
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.7779963562878867,-1.2707152503436636,0.14754098360655737,0.8910088113601147,1.0,4/9,13.52%,SLC23A1;AQP1;AQP11;SLC2A2
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.5323773258650802,1.2704324176255242,0.1724137931034483,1.0,1.0,5/33,13.54%,NUPR1;TBC1D12;FEZ1;UBQLN2;SEC22B
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),-0.8701552734702848,-1.2701212850097865,0.1276595744680851,0.8934205789350786,1.0,1/5,0.26%,ANGPT1
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.844617243802011,-1.2698905174513857,0.17857142857142858,0.8917916704743958,1.0,3/5,14.64%,NPR2;PDE1B;ZFP36
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.844617243802011,-1.2698905174513857,0.17857142857142858,0.8917916704743958,1.0,3/5,14.64%,NPR2;PDE1B;ZFP36
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.634747834163223,-1.2698886509812128,0.09230769230769231,0.8902079927274501,1.0,12/29,15.83%,CDH9;CDH12;SELL;CDH22;PCDHB11;CDH10;PCDHB4;CDH18;CDH13;PCDHB9;CDH23;PCDHB13
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.7779250290715765,1.2697137198654376,0.12121212121212122,1.0,1.0,2/6,13.19%,CROT;CPT1C
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.7324903803680556,-1.2696698039260732,0.208955223880597,0.8898447252587955,1.0,2/10,4.00%,TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6312026695843134,-1.2695475807386398,0.16417910447761194,0.8889977331086033,1.0,13/38,19.34%,RIMS1;SYT1;SYN3;SNAP25;SYN2;LIN7A;RAB3A;GAD2;PCLO;NRXN1;CDK5;GAD1;GRM4
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5663591337673202,-1.269228434627216,0.14084507042253522,0.8892431220407567,1.0,12/73,12.95%,SRGN;VSIR;PCSK2;PCSK4;PCSK1;F3;PRSS12;CPE;MMP16;FURIN;HJV;ATP23
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.7270464124795146,-1.2688163381202548,0.25,0.8900227130234089,1.0,3/10,15.07%,EDN1;AR;TGFB1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.7500186957099155,1.268585049273185,0.13157894736842105,1.0,1.0,1/6,2.29%,OAS3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),-0.7933030195566784,-1.2682810840917544,0.16129032258064516,0.8918505493957348,1.0,1/6,0.99%,IRGM
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.768281002541803,-1.2682102870169538,0.171875,0.8906792268749869,1.0,1/8,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5309471927226769,-1.267966409255446,0.10126582278481013,0.8907482067579364,1.0,34/137,15.07%,F8;SRGN;ABCC4;TGFB2;RIMS1;TTN;CLU;SYT4;TIMP1;SYT1;TPH1;SERPING1;HGF;SNAP25;TUBA4A;ACTN1;A2M;RAB27B;MANF;TMEM79;RAB3A;LYN;SCG3;VEGFA;TGFB3;RIMS2;PROS1;FERMT3;PHACTR2;SYT12;SYT13;PCLO;TIMP3;TGFB1
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.8185099856291468,-1.2679497980446421,0.13559322033898305,0.8892744913345662,1.0,2/6,7.65%,NR4A3;CHGA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6645975430049198,-1.2678983572423996,0.1527777777777778,0.8878573075845588,1.0,6/25,10.00%,HLA-F;IL12A;HLA-E;HLA-A;B2M;HLA-DRB1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.7190031204430769,-1.267884041855649,0.11864406779661017,0.8864109669326977,1.0,6/15,16.03%,CHRM3;CHRM5;PLCB1;CDK5R1;CHRM1;LY6H
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5278409645579315,-1.2677266870333588,0.07246376811594203,0.885805062525834,1.0,31/110,13.24%,ANGPT1;DPEP2;SRGN;ABCC4;FGL2;P2RY12;HLA-E;LGALS8;ITGAM;GMFG;SELL;ALOX12;AOAH;LAPTM5;HLA-A;NRGN;P2RY13;PALLD;C3AR1;MAP3K7CL;MFSD2B;SLC26A4;SMOX;CXCL14;VEGFA;ADGRE3;TNFRSF1B;FERMT3;CYP2U1;LY86;MPL
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6883978145485707,1.2674159135140832,0.1891891891891892,1.0,1.0,2/16,7.49%,SPIRE2;ARPC5
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.5429484403077769,-1.2673885694249802,0.10810810810810811,0.8859670917797193,1.0,22/119,17.47%,PKP2;DPP10;TNFRSF1A;KCNIP4;PDZK1;ANK1;RAB11A;RAB3C;LIN7A;RAB3A;KCNB2;KCNB1;CAV3;CAV1;PACSIN1;CACNB2;FLOT1;FYB1;RAMP1;RAB15;MRAP;FGF13
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.6736713939990675,-1.2673291086718232,0.16417910447761194,0.8847355357293804,1.0,7/22,15.60%,CHST9;CSGALNACT1;SULF1;BMPR1B;CHST8;CNMD;CHST10
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.6117809396746551,-1.267282765496718,0.10606060606060606,0.8834574185859134,1.0,15/46,18.59%,CCK;NRCAM;ASTN1;TUBB2A;MEF2C;GPM6A;DCX;DDIT4;CDK5R1;VEGFA;KIAA0319;CEP85L;DISC1;FGF13;CDK5
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.7233280200167516,1.267188773845837,0.2647058823529412,1.0,1.0,3/7,14.75%,CA2;NFKB1;RELA
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6498766263599896,1.266996045374548,0.13333333333333333,1.0,1.0,4/21,5.89%,CDK10;TESK1;EVI5L;SLIT2
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.7324307148893997,1.2666965813015494,0.2608695652173913,1.0,1.0,3/5,21.45%,GLA;GALC;NAGA
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.8555663906592771,-1.2666180917471326,0.125,0.8861281367194639,1.0,2/5,6.70%,YBX3;AQP1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6876896438883812,-1.2659155168850855,0.12698412698412698,0.8884515516335043,1.0,9/21,16.34%,P2RY12;TGFB2;NCKAP1L;EFNA1;PDE3B;LYN;FERMT3;RAC3;SYK
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.679836390397929,-1.2657988638405826,0.16923076923076924,0.8875953813039164,1.0,5/19,18.50%,CIDEB;HRK;MLLT11;BBC3;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5808460579829362,1.2655800913649529,0.15,1.0,1.0,2/24,4.33%,ABCA13;ABCA8
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.8051332239752299,-1.2654460010468662,0.2222222222222222,0.8882072939876974,1.0,5/8,12.39%,HEY1;TMEM204;MEF2C;MRTFB;EDNRB
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.7306701962077325,-1.2651948223674225,0.1864406779661017,0.8881950730844729,1.0,1/8,4.62%,SOX9
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.5611551587203949,-1.2650751059611147,0.06666666666666667,0.8873605806664334,1.0,17/87,15.85%,MDFIC;TLR2;DACT1;SFRP4;RSPO4;LRRK2;APCDD1;KREMEN1;ATP6V1C2;SULF1;AMER1;GPC3;LRP1;DEPDC1B;ATP6AP2;PTK7;DISC1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.6199815741220703,1.2650020774050672,0.23076923076923078,1.0,1.0,4/29,10.36%,SQLE;SOAT2;IDH2;LCAT
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.7231981445469424,-1.2646274379207154,0.16666666666666666,0.8881540052572522,1.0,3/16,5.34%,CLU;EDN1;DDAH1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.595256644387711,1.264316911843172,0.13333333333333333,1.0,1.0,12/46,7.95%,CD38;CXCR4;ZAP70;CCR3;ITGAL;IL4R;IL2RA;PYHIN1;CD247;GPR174;GNLY;P2RY10
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.7225786869668127,1.2642605718283213,0.24324324324324326,1.0,1.0,4/11,16.00%,M1AP;NOC2L;RBBP4;CHAF1B
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.7637707539997676,-1.2640611801257258,0.19298245614035087,0.8897307146940504,1.0,2/8,12.69%,PPARG;LRP1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.7416753083488501,-1.2639374806670594,0.21875,0.8891650127630009,1.0,4/10,16.95%,NCKAP1L;TGFBR2;HLA-DRB1;PRKCQ
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.572286282504163,1.2638435596876914,0.1875,1.0,1.0,4/42,7.51%,CXCR4;KLK6;BCAS1;ZNF24
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7213919762944134,-1.2637864796059468,0.23076923076923078,0.8884179280164272,1.0,2/7,11.84%,CALM3;CAV1
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),0.8061483375314884,1.2636564457121198,0.3023255813953488,1.0,1.0,2/5,15.94%,TRPV1;RYR1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.7277865764851836,-1.2636415953905558,0.23076923076923078,0.8878564257254802,1.0,4/11,10.71%,TGFB2;ID2;RARB;GLI3
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.7117424955689629,1.2631747944847433,0.10526315789473684,1.0,1.0,3/9,5.98%,ABCC2;ABCC1;HMOX2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.7117424955689629,1.2631747944847433,0.10526315789473684,1.0,1.0,3/9,5.98%,ABCC2;ABCC1;HMOX2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.8072896252113971,-1.2631740631285293,0.1694915254237288,0.8892401264523349,1.0,2/7,10.07%,NDST3;CSGALNACT1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.593916369769526,1.2631610815244998,0.16,1.0,1.0,5/43,3.79%,CXCR4;CCL28;CCR3;ABCC1;SEMA5A
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.6863647692578744,1.2631088948999374,0.2972972972972973,1.0,1.0,1/12,0.17%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.8336997724428921,1.263093264648098,0.26666666666666666,1.0,1.0,2/5,7.30%,HMGB1;PARP3
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6475894338789302,1.262840012507338,0.16666666666666666,1.0,1.0,2/13,9.61%,CHMP5;VPS25
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.8186704503514083,1.2625287167702461,0.17073170731707318,1.0,1.0,3/5,10.82%,SLC38A1;SLC38A2;SLC38A3
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.65684881228919,-1.2624344900475992,0.19047619047619047,0.8913486420375337,1.0,7/18,14.54%,TXNDC8;TP73;CAPN1;TTC6;SLC25A31;SYCP2;SYCP3
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.5058379437474063,-1.262315803951065,0.1388888888888889,0.8904043038287454,1.0,47/188,17.35%,FAM131C;ACBD7;CARTPT;PDE4A;CLGN;CFAP126;NYAP1;FGF12;TTC9;MACROD1;SPEF2;SYBU;CTXN1;KLHDC9;HPCA;SCN9A;CPE;FSTL5;FLRT1;MEIG1;VSTM2L;SCN4B;LRRC73;NAT14;ABHD3;CALB2;GNAL;CCDC184;CDK5R2;MAP2;NRG1;NRSN2;ANO2;EFNA3;CNTN4;PCLO;MAPK8IP1;SMIM10L2B;EFNA5;CYB561;LRRC49;CERS5;SCAMP5;TMEM9;GRAMD1C;EBF2;DBNDD1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.7718269186607514,-1.2622486844754446,0.16417910447761194,0.8890996568094692,1.0,3/9,10.00%,VSIR;CR1;HLA-DRB1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7843922181746115,-1.2620241878901284,0.12698412698412698,0.8886902401599059,1.0,1/10,0.54%,FSTL1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.8163433882720946,-1.2619701785145736,0.1724137931034483,0.8873929457897921,1.0,2/7,6.07%,CAPN1;ADGRV1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.7171748387372201,-1.261957304041816,0.1935483870967742,0.8859849764294592,1.0,6/13,18.18%,ADGRV1;COL11A1;LHFPL5;HPN;PDZD7;SCN1A
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.7375607757111245,1.261936671353962,0.18181818181818182,1.0,1.0,3/8,13.23%,EPHB2;PAX8;USH1C
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.8201681398008096,-1.2618937973270579,0.15714285714285714,0.8847951377288779,1.0,1/5,1.09%,YBX3
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.6079512536088254,-1.2617671317090215,0.13636363636363635,0.8840189349217678,1.0,10/48,14.56%,CLU;CIDEB;ITGAM;FOS;MAP3K5;LRRK2;DDIT4;GRIN2B;LRP1;EFNB2
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6333923091635212,-1.261278390992781,0.2028985507246377,0.8854698653975921,1.0,8/32,18.50%,CLU;CIDEB;HGF;NOL3;HRK;MLLT11;BBC3;DNM1L
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.75423369207015,1.261276881842792,0.16666666666666666,1.0,1.0,4/8,18.97%,SPHK2;SLC25A33;MID1IP1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.49434350291271567,-1.2611568578932748,0.0684931506849315,0.8847931173468043,1.0,43/273,13.79%,CD44;ANGPT1;IRGM;PDGFD;TGFB2;PTPRC;CENPE;IL6R;SPDYA;MUSK;FGF22;SOX9;NOS1;HGF;CEMIP;INHBC;CCND1;CSF1R;LRRK2;EFNA1;CX3CR1;TERF2IP;KNDC1;GATA1;BMP6;CHI3L1;SH2D3C;TEK;HLA-DRB1;LYN;RBPMS;CAMK1;CALM3;VEGFA;TGFB3;CAV1;TNK2;EGFR;FGF7;MTCP1;FLOT1;PRKD2;DDR2
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.8378061830308494,-1.2610656331072916,0.16981132075471697,0.8840045365319128,1.0,2/5,9.75%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.8469707394192225,-1.261065119265512,0.11666666666666667,0.8810380783556312,1.0,1/7,5.26%,HGF
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.8469707394192225,-1.261065119265512,0.11666666666666667,0.8810380783556312,1.0,1/7,5.26%,HGF
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.6061840001750165,-1.2610502072363319,0.11666666666666667,0.8796109618027355,1.0,9/31,12.35%,CARTPT;RIMS1;SYT1;EDN1;GRIK2;LGI1;CLSTN3;RIMS2;DLG4
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.7193320477349758,1.2608940936319806,0.2894736842105263,1.0,1.0,2/9,5.23%,F2;PDGFA
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.6279004071136274,1.2608854049170848,0.15384615384615385,1.0,1.0,7/36,8.86%,KIF3B;MAP10;TPX2;ZNF207;FLNA;KIFC2;BCCIP
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.8131926571995886,-1.260764849922861,0.24561403508771928,0.879840261815923,1.0,3/5,6.32%,PTPRC;NCKAP1L;CEACAM1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.5167538547653101,-1.260763362031154,0.11688311688311688,0.8783714132987012,1.0,35/133,18.59%,WNT8B;HEY1;TGFB2;CCK;NRCAM;ASTN1;TUBB2A;MEF2C;ATP2B2;GPM6A;MET;DCX;ANOS1;CX3CR1;CTF1;DDIT4;EMX1;BHLHE40;CDK5R1;FZD8;KIAA0319;ITM2C;OPHN1;CEP85L;MYT1L;DISC1;LHX4;WNT5B;MYEF2;CX3CL1;FGF13;PRUNE1;CIT;TAFA1;CDK5
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5332554162837492,-1.2606059625714015,0.16216216216216217,0.8778112230495936,1.0,18/93,11.15%,FSTL1;FBLN1;PPP1R3C;TSPAN11;ALDH1A2;COL4A1;DKK3;FNDC4;GJA1;LAMB1;BOC;CPE;THY1;LMOD1;ADGRL2;SULF1;PRKG1;RUNX1T1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.4883193671636938,1.2604687798022867,0.13157894736842105,1.0,1.0,4/94,1.72%,NGF;CXCR4;LCK;FGF6
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.8130143178649603,-1.2603967152489155,0.17647058823529413,0.8774784615799482,1.0,4/7,13.13%,AQP1;NEDD4L;AQP11;AQP4
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.6891794201765404,1.2602710462609996,0.2,1.0,1.0,2/10,7.09%,IGF1R;MTMR2
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5392675153112915,-1.259835309319541,0.11842105263157894,0.879044834733494,1.0,22/90,13.23%,F8;SRGN;ABCC4;TGFB2;TTN;CLU;TIMP1;TPH1;SERPING1;HGF;TUBA4A;ACTN1;A2M;RAB27B;MANF;LYN;SCG3;VEGFA;TGFB3;PROS1;FERMT3;PHACTR2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.5572978045322979,-1.2598046977151467,0.11764705882352941,0.8776833988426486,1.0,23/79,19.19%,ROR1;TWF2;STMN2;RIT2;EPHA3;PLPPR5;CAMK1D;ZDHHC15;FES;TENM3;TOX;ATP1B2;LYN;CAMK1;SCN1B;PACSIN1;LRRC7;PTK7;CAMK2B;CX3CL1;NTRK3;NDRG4;SERPINI1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5499629857278459,-1.259715290815686,0.13043478260869565,0.8767753594811056,1.0,24/75,13.55%,LAMP5;DPEP2;DOCK8;SLA;PTPRC;MCTP2;ITGAM;NCKAP1L;GMFG;BLNK;SELL;AOAH;LAPTM5;CD53;CCR9;IL3RA;IL16;GPR183;IKZF1;PACSIN1;ARHGAP25;LY86;WDFY4;ITM2C
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.6198899036698828,1.2593793651828147,0.2894736842105263,1.0,1.0,8/16,24.21%,CPSF4;CSTF2;TSEN15;ZBTB8OS;RTRAF;TSEN34;FAM98B;ERN1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.7079999293566968,-1.2592047269223465,0.19047619047619047,0.8780790439335416,1.0,4/14,7.67%,PYGL;AGL;AOAH;PHKG1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.5389154860420402,1.2590063916282195,0.07692307692307693,1.0,1.0,3/61,3.31%,BACE2;DPEP1;ENPEP
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.6755487409586136,-1.258943657450204,0.19047619047619047,0.8783078448011248,1.0,5/24,9.04%,OLFM1;MUSK;NRCAM;STAT5A;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.6007769801283773,-1.2587450025498055,0.20588235294117646,0.8780573168968738,1.0,3/26,3.07%,TLR2;ISG15;IRF1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.5776235513863875,-1.2586897394512981,0.19117647058823528,0.8768838900799963,1.0,9/38,17.70%,MX1;CEACAM1;CAV3;CAV1;LRP1;DNM1;RAMP1;SYK;LILRB1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.636224081246959,1.258350768676748,0.19444444444444445,1.0,1.0,6/23,9.91%,VDR;ERRFI1;RUNX1;NUMA1;CTSK;TRIM16
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7468038624390341,1.2583264361968718,0.2,1.0,1.0,2/9,1.92%,EPB41L4B;MAPRE2
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.6946153448375748,1.258050679313754,0.2222222222222222,1.0,1.0,7/11,25.72%,DKC1;CCT8;CCT2;CCT3;LARP7;CCT6A;MEPCE
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.6946153448375748,1.258050679313754,0.2222222222222222,1.0,1.0,7/11,25.72%,DKC1;CCT8;CCT2;CCT3;LARP7;CCT6A;MEPCE
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.8686373552618134,-1.258021345748798,0.2,0.8788307379380831,1.0,1/5,2.16%,ARL13A
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.684353755404707,1.2579866642744288,0.2765957446808511,1.0,1.0,2/11,3.21%,ICAM1;ITGAL
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.5999166759926543,1.2579653482896673,0.2,1.0,1.0,4/23,4.58%,SLC22A2;SLC38A1;SLC25A29;SLC47A1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8691171263517812,-1.2577833064317907,0.10714285714285714,0.8788821917283606,1.0,1/5,1.56%,P2RY12
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.5658698677158291,-1.2577830993266583,0.14492753623188406,0.8774437593360064,1.0,22/77,17.41%,TRPM1;TRPC4;TRPC6;TRPM3;ATP2B3;ANO6;RYR3;SLC8A3;SLC24A5;TRPC7;GRIN2B;SLC8A1;SLC24A1;GRIN2D;CACNA1G;CACNA1C;ITGAV;CACNA2D4;TRPV3;TRPM2;SLC24A4;TRPV4
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.8141192921112648,-1.2577329943924886,0.17543859649122806,0.8762473601890263,1.0,2/7,2.56%,CRYM;SLC22A9
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.7802575129949495,-1.2576518994792922,0.22388059701492538,0.8752128280119483,1.0,4/6,15.47%,BMP6;LY86;SCIMP;LY96
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.6519039280155365,1.2574829903110085,0.3225806451612903,1.0,1.0,9/21,21.90%,LYRM4;CIAO3;CIAPIN1;ISCA2;CIAO2B;NFU1;ISCA1;CIAO1;NFS1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.6244772766000253,1.257416163330795,0.20512820512820512,1.0,1.0,7/33,15.47%,UBC;CDC26;KNTC1;ANAPC15;UBB;ANLN;ANAPC1
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.7314450485835969,-1.2571180458809292,0.1111111111111111,0.8768942136159111,1.0,4/11,15.17%,IGFBP3;NLRP12;UBASH3B;OPRM1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.7536871846046739,-1.2567036957150495,0.13793103448275862,0.8776726671865931,1.0,3/12,10.61%,LPL;GPIHBP1;FURIN
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.7815993354556932,-1.256199015986884,0.15151515151515152,0.8792660033790126,1.0,5/10,17.70%,HLA-F;TGFB2;TGFB3;TGFB1;LILRB1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.6680341838162346,1.2561446047381837,0.19444444444444445,1.0,1.0,6/15,7.95%,ZAP70;LCK;PYHIN1;CD247;GNLY;P2RY10
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.7312201637674919,-1.2554212768362485,0.2033898305084746,0.8822509360876306,1.0,4/13,17.70%,CR1;LGALS3;SLAMF8;LILRB1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.755453391099684,-1.2553812820745138,0.14285714285714285,0.8810583738631913,1.0,3/11,6.13%,HLA-E;TGFBR2;HLA-A
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.7503994786353264,-1.2552442008485043,0.19402985074626866,0.8803389620219783,1.0,2/9,4.00%,TGFB2;TGFBR2
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.7997279711317913,1.2551832974872568,0.1951219512195122,1.0,1.0,2/5,10.43%,RAB32;AP3D1
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.7997279711317913,1.2551832974872568,0.1951219512195122,1.0,1.0,2/5,10.43%,RAB32;AP3D1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.6932556435893897,1.2550819334624623,0.2222222222222222,1.0,1.0,5/10,22.37%,PSMG2;PSMD13;PSMD11;PSMD4;PSMG1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.610581739309948,-1.2547829899800753,0.14285714285714285,0.8813398518267325,1.0,14/42,14.51%,TLR2;FGL2;ITGAM;AOAH;SLC7A7;CSF1R;P2RY13;C3AR1;IGSF6;ADGRE3;LY86;WDFY4;FCGR3A;SPI1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.7608874767291415,1.2547272928906918,0.2558139534883721,1.0,1.0,2/8,9.56%,TRMT10C;PUS1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5417109708746053,1.2543872046152273,0.16666666666666666,1.0,1.0,15/86,8.99%,ABCA13;SLC22A2;VDR;SLC22A6;WNK4;PIK3C2G;LARP1B;PLD1;FRK;PLA2R1;MUC4;CNKSR3;ATP1B1;TMEM52B;MYH14
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.6937934138317037,-1.2543471317887165,0.20967741935483872,0.8823687038718112,1.0,4/16,4.62%,SRGN;HEY1;ASPN;SOX9
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.7734901494276469,-1.2542093901928437,0.19117647058823528,0.8816662230128182,1.0,1/8,1.44%,PPARG
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.6633656106040129,-1.253676213980814,0.19696969696969696,0.8837015303988093,1.0,2/26,0.85%,ZNF366;KANK2
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.6281709066053712,-1.2536704312324158,0.15942028985507245,0.8823163778354318,1.0,8/35,14.03%,TWF2;OLFM1;NRCAM;L1CAM;GOLGA4;MAP2;KIAA0319;TRIM46
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.7003750673180567,1.253662928810608,0.225,1.0,1.0,2/9,6.76%,ERI1;EXOSC8
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.7229928585127983,-1.2536571679597204,0.1780821917808219,0.880935657760257,1.0,6/14,16.63%,LGALS3;LAPTM5;CEACAM1;THY1;CD160;PTPRJ
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.786189241542299,-1.2534711966830605,0.21818181818181817,0.8804874478539112,1.0,2/6,4.22%,ABCC4;NMUR2
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.674866844179281,1.2527868336708359,0.21212121212121213,1.0,1.0,4/12,17.28%,NSUN2;TPR;IWS1;DHX9
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5185593835608556,-1.2517421813362146,0.10810810810810811,0.8884111232434077,1.0,37/152,13.16%,NOSTRIN;F8;MMRN2;CLDN5;SRGN;HEY1;SPARCL1;ROBO4;COX7A1;ELK3;GPIHBP1;CHST1;COL4A1;PLSCR4;TGFBR2;CASZ1;PLAC8;GPM6A;PROCR;LYVE1;A2M;BMX;SEMA3D;AQP1;FLI1;TEK;LMOD1;FGD5;WFDC1;PTPRB;ADGRF5;GGT5;CAV1;EDNRB;LDB2;C1QC;TIE1
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.789920776788963,-1.251424913173871,0.21212121212121213,0.8886000373851592,1.0,3/8,13.03%,SHMT2;MTG1;TSFM
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.8311342676756184,-1.2509920946161137,0.1864406779661017,0.8897274177632838,1.0,1/5,3.86%,MEF2C
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.8214765307744119,-1.2506235724677897,0.17857142857142858,0.8891478414029232,1.0,1/5,8.05%,AR
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.8214765307744119,-1.2506235724677897,0.17857142857142858,0.8891478414029232,1.0,1/5,8.05%,AR
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.800570146516248,1.2505669830921422,0.2608695652173913,1.0,1.0,1/5,0.34%,GJC1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.8325589571637939,-1.2505074133122027,0.14545454545454545,0.8882925346211497,1.0,4/5,13.56%,CAV3;CAV1;FLOT1;CAV2
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.8027164645245347,-1.2504862922130835,0.22950819672131148,0.8870116069573007,1.0,3/5,13.13%,AQP1;AQP11;AQP4
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.5917395425859363,-1.2504783163009128,0.17857142857142858,0.8856583544167954,1.0,13/30,15.17%,NPY;CYSLTR2;GLRA3;SSTR1;NMUR2;GLRA2;CPE;SORCS1;SORCS3;GPR149;HCRTR2;LTB4R;OPRM1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.6367600646719892,-1.2504671386179818,0.14492753623188406,0.8843551113272471,1.0,9/29,18.59%,EPHA4;LRRK2;EFNA1;ZDHHC15;CDK5R1;SIPA1L1;NGEF;CAMK2B;CDK5
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),-0.8226943651600093,-1.2503419522804018,0.16,0.8836040701897444,1.0,2/5,13.60%,VEGFA;PRKD2
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.7233146022085419,-1.2503336285271527,0.23333333333333334,0.8823385462544463,1.0,1/11,1.38%,MCM2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.6353945416325549,-1.249978753578529,0.21739130434782608,0.8826857912579966,1.0,9/31,12.76%,PKP2;NKAIN1;FGF12;NOS1;NKAIN3;SCN4B;SCN1B;YWHAH;ATP1A1
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.8361519429863449,-1.2498162570039653,0.2,0.8822894218705266,1.0,5/7,16.36%,P2RY12;LGALS3;SFTPD;EDNRB;CXCL17
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.784302551838517,1.2495847708189174,0.2682926829268293,1.0,1.0,2/6,1.43%,CRTAM;ZAP70
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.7639537591387159,-1.2495318000155589,0.15,0.8822120200029202,1.0,1/10,1.24%,HEY1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.5559295909051819,-1.249505458757592,0.13513513513513514,0.8810320966496128,1.0,15/86,12.69%,DPP10;EPHA3;PDZK1;TP73;ITGAM;NMT1;LGALS3;CEMIP;STAC2;STX3;E2F1;KCNB1;YWHAH;EGFR;LRP1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7354233997732192,-1.2493753598663906,0.14814814814814814,0.8803535818722427,1.0,6/12,23.53%,HEY1;GATA1;MAD2L2;ZNF593;HEY2;ZNF675
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.7024046600766731,-1.2492928099015248,0.1875,0.879345871745248,1.0,4/14,8.48%,CR1;HLA-E;PTPRC;XBP1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5646160360670293,-1.2492640013932967,0.1388888888888889,0.8781608594989159,1.0,14/49,15.08%,ITGB4;SMIM22;SOX9;TMC4;EFNA1;AQP1;SLC44A3;LGALS2;CBLC;CLDN4;AQP4;TJP3;OVOL2;PPL
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.5372885362782813,-1.248712654705709,0.058823529411764705,0.8799520283049299,1.0,23/93,16.07%,FSTL1;FBLN1;AKAP12;PDE10A;COL4A1;PAPPA;FIGN;PTPRG;RNF150;WWTR1;GPR161;GJA1;LAMB1;TENM3;DENND2A;THY1;ADGRL2;RUNX1T1;DZIP1;FLRT2;MYH10;LRRC49;ADAMTS9
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.8552789951623201,-1.2484792042072534,0.18,0.8801487731593548,1.0,3/5,10.00%,TAPBPL;HLA-DMA;HLA-DRB1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.677241343826415,1.2483494698185167,0.2,1.0,1.0,3/21,4.75%,CDSN;TXNIP;TGM1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.7577708858102072,-1.248260383087026,0.15492957746478872,0.8799857197758763,1.0,3/6,22.74%,ROBO2;LHX6;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7315968591464663,1.2481164929378767,0.25,1.0,1.0,2/9,4.41%,PTH;PTH1R
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.8357344319107584,1.2479222711425186,0.09090909090909091,1.0,1.0,1/5,0.13%,GABRE
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7023795269138149,-1.2473952861943216,0.26865671641791045,0.883708390339042,1.0,2/13,1.20%,DACT1;SFRP4
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.8088514492414509,1.24709131996945,0.21428571428571427,1.0,1.0,2/6,6.15%,PIWIL4;MUC4
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.742496137909799,1.2469523319394502,0.30952380952380953,1.0,1.0,1/5,0.47%,SLC22A2
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.7389598757154117,1.2468517740070462,0.19047619047619047,1.0,1.0,6/11,17.37%,PYHIN1;SPRED1;PLA2R1;SPRED2;ATR;DDX5
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.7918016564896172,-1.2460955408895942,0.15625,0.8895531677045742,1.0,2/7,15.95%,ALG10B;RAMP1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.570361089791098,1.2459793614434667,0.20588235294117646,1.0,1.0,7/39,8.92%,SQLE;SC5D;MSMO1;OSBPL7;HMGCR;CYP7B1;PMVK
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.7906325462513558,-1.2458382471984957,0.2727272727272727,0.8897041364825858,1.0,2/5,7.49%,ANO6;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.8234935365328726,-1.2457132500610895,0.171875,0.8889770581059632,1.0,3/5,15.07%,TGFB2;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6536786510760303,-1.2453344788030978,0.1643835616438356,0.8898116155060924,1.0,1/25,0.58%,MDFIC
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.7835043827306072,1.2453343758832838,0.22727272727272727,1.0,1.0,3/5,20.47%,COLGALT1;CHADL;RB1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.5599432977343395,-1.2452534653031797,0.08695652173913043,0.8889976269995709,1.0,30/87,17.41%,TRPM1;TRPC4;TRPC6;TRPM3;NMUR2;ATP2B2;ANO6;CACNA1E;RYR3;CACNA1B;SLC8A3;SLC24A5;TRPC7;SLC8A1;CACNG3;SLC24A1;CAV1;CACNG8;CACNB2;CACNA1G;CDH23;CACNA1C;ITGAV;RAMP1;CACNA2D4;GRIN3A;TRPV3;TRPM2;SLC24A4;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7517128306682378,-1.2451602627382543,0.1791044776119403,0.888245352007905,1.0,3/7,16.13%,STK17B;STK17A;BTG1
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.7003857702566914,1.2448593564497377,0.23809523809523808,1.0,1.0,2/8,6.76%,ERI1;EXOSC8
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.7003857702566914,1.2448593564497377,0.23809523809523808,1.0,1.0,2/8,6.76%,ERI1;EXOSC8
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.7719647378399435,-1.244693582862867,0.15254237288135594,0.8894467905829011,1.0,2/8,4.62%,HEY1;SOX9
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),-0.8291930948668338,-1.2444514915794094,0.140625,0.8894046487114017,1.0,1/5,1.44%,PPARG
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.7454812663765398,-1.2442518893657588,0.2112676056338028,0.8890383890992318,1.0,2/10,1.88%,PROM1;BASP1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.5386162013470137,1.2439921068511541,0.24,1.0,1.0,5/26,8.68%,DAO;F2;F11;CYP2C8;CREB3L3
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.7090699474550368,-1.2439475906922102,0.2542372881355932,0.889585638264588,1.0,3/11,11.62%,TIMP1;GJA1;VEGFA
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.6956671607864066,1.243464641766594,0.3076923076923077,1.0,1.0,3/8,13.55%,CAT;PXDNL;PRDX3
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.765638809066797,1.2434642803528588,0.20588235294117646,1.0,1.0,1/5,7.26%,NCK1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7210293681096694,-1.243426554522657,0.18867924528301888,0.8909099940600302,1.0,3/11,9.20%,TRIM5;IFITM3;IFNA2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5356075277746339,-1.2432167466720194,0.17647058823529413,0.8907338474539527,1.0,14/102,11.01%,CD44;TGFB2;SOX9;TLL1;SPEF2;PRELP;KIAA1217;BMP6;GJA1;MEPE;CHI3L1;MMP16;SULF1;ETS2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.7793503848610308,-1.243200446540428,0.18181818181818182,0.8894888373337185,1.0,3/6,17.33%,PTPRC;NR1D1;CX3CL1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.7295225463051689,-1.2431321893443135,0.15517241379310345,0.8886864027165189,1.0,3/10,11.62%,MYO7A;DCX;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6844086373639393,1.2428829157407144,0.21621621621621623,1.0,1.0,4/10,27.48%,MTMR2;VPS11;PTPN23;PRKN
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.7971819620118615,-1.242836349455251,0.1864406779661017,0.8887042729757423,1.0,2/7,14.05%,P2RY12;OPHN1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.7891983128261626,1.2427965290826581,0.2608695652173913,1.0,1.0,1/6,3.91%,ASAP1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5422660426875133,-1.2422665826239028,0.1388888888888889,0.8903408113399722,1.0,20/112,10.39%,CD44;FSTL1;OLFML1;IGFBP3;SFRP4;ACTA2;OLFML2B;FAP;COL4A1;CCN5;NLRP3;DKK3;COL11A1;GJA1;PALLD;THY1;TEK;LMOD1;NOD1;SULF1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.5058415572239964,-1.2422532967562163,0.057971014492753624,0.8890601975811189,1.0,18/170,8.63%,CD44;PKP2;PYGL;IGFBP3;IL13RA1;NDST3;ISG20;CHST1;GLRX;AGL;SOX9;PAM;CITED2;MET;XYLT2;DDIT4;PRPS1;CHST2
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.7816467398275042,-1.2417344848449237,0.2,0.8905604334075643,1.0,2/6,6.92%,TTN;MYH11
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.7222681983712851,1.2417227058045668,0.21428571428571427,1.0,1.0,1/9,0.70%,DHFR
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6662755364855102,-1.2415709364498886,0.208955223880597,0.8901108271970016,1.0,8/27,16.28%,SHISA6;MCTP1;GRIK2;SLC4A10;RAB3A;DLG4;NETO1;CAMK2B
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.7299262008851958,-1.2412588309930888,0.2459016393442623,0.8902568931344494,1.0,4/10,21.10%,ALG10B;PLCB1;RAMP1;IL33
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.5975000595312328,-1.240260330770017,0.16393442622950818,0.8942092077640654,1.0,5/31,11.25%,CLU;GSAP;EPHA4;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.606837131198103,1.240228084542963,0.20689655172413793,1.0,1.0,8/34,11.15%,GPAT2;MBOAT1;ABCA8;SPHK2;AGPAT5;CPNE1;HDHD5;IDI1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6109860616733775,1.2401815433188252,0.17391304347826086,1.0,1.0,5/14,16.13%,DHFR;SPHK2;QDPR;GCH1;ACER3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.7824572497645761,-1.2400881065433913,0.19642857142857142,0.8936694538695049,1.0,4/10,11.47%,PKP2;NOS1;SCN4B;SCN1B
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7186672026393327,1.2399723938522218,0.3157894736842105,1.0,1.0,2/7,7.09%,IGF1R;MTMR2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.5024341573527185,-1.239948829680411,0.11594202898550725,0.8930158612035349,1.0,20/155,14.87%,GPAT3;PLEKHA2;PLEKHA4;PLSCR1;CDS1;INPP4B;BMX;CHKB;SLC44A3;DGKD;PIP5K1B;DGKB;ABHD3;ETNPPL;PLA2G12A;DDHD2;INPP5D;LIPI;PTPN13;PI4K2A
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.6748453500094335,-1.2398293196533408,0.22033898305084745,0.8909375475254032,1.0,3/12,15.41%,PPP1R3C;GYG1;NR1D1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.6748453500094335,-1.2398293196533408,0.22033898305084745,0.8909375475254032,1.0,3/12,15.41%,PPP1R3C;GYG1;NR1D1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.8396628064792809,-1.239674569890711,0.19672131147540983,0.8905495181561736,1.0,3/5,15.06%,COL4A1;MEF2C;STAT1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.7741196980004217,-1.239474199819168,0.21875,0.8902630565154145,1.0,1/8,0.03%,CD44
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.6520486867553474,1.2394480521144693,0.24390243902439024,1.0,1.0,5/15,20.87%,GNL3L;ZMIZ1;HDAC4;UBA2;EGR1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.7775602367087386,-1.2383456398180481,0.22,0.8948906461531551,1.0,1/6,2.36%,CENPE
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.8054406909922074,-1.2381940404137493,0.25806451612903225,0.8942124361058866,1.0,1/5,0.70%,NPY
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.5300725937032347,-1.2380243497513672,0.10294117647058823,0.8936362003625619,1.0,36/120,16.03%,LRRTM1;STMN2;TCEAL6;NYAP1;GAP43;CHST1;CLVS2;ASTN1;CNTFR;TCEAL5;BRINP2;KCNIP1;ATP2B2;CADM3;SNAP25;DCLK1;TMEM179;HPCA;SNCB;ATP1B2;ADCY8;BRINP1;ST8SIA3;LRRTM3;TAGLN3;OPCML;MAP2;AQP4;PHYHIP;LRRC3B;MAPK4;GPR37L1;ADCYAP1R1;TNR;SLC35F1;LY6H
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.7540529129585041,1.2379660917913067,0.2647058823529412,1.0,1.0,2/11,2.83%,HMGB1;FGFR1
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.8430976050999612,-1.2379364875556744,0.11666666666666667,0.8927907044254227,1.0,4/5,15.70%,SCN4B;CACNB2;CACNA1G;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.701309478155088,1.2377400554275948,0.25,1.0,1.0,1/7,7.23%,PRELID1
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.8037764524982509,1.237323508750655,0.2,1.0,1.0,2/5,12.11%,CDK6;DLL1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.588917571297039,-1.2372065972723205,0.18181818181818182,0.8958921611570603,1.0,9/34,17.59%,CERS6;ST3GAL5;SGMS2;ST8SIA3;PNPLA1;B4GALT6;CERS5;ST6GALNAC5;DEGS2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.5577145587447676,-1.2371367854493203,0.13513513513513514,0.8949178642540611,1.0,17/68,15.36%,ANGPT1;PTPRM;F3;STAT5A;TEK;CDH13;SULF1;VEGFA;CAV1;HTR2B;TIE1;CAV2;SCG2;PRKD2;STAT1;ZNF580;CNMD
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5296106366809177,-1.2371287150770232,0.11428571428571428,0.8936482625414844,1.0,12/119,6.00%,CD44;TGFB2;BIRC3;CLU;ISG20;IFITM3;TIMP1;IRF1;BCL2L2;LGALS3;HGF;CCND1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5061150217936115,-1.2366527917451322,0.09859154929577464,0.8946082306316105,1.0,15/156,6.64%,CD44;ITGB4;ADAMTS5;ADAMTS17;ADAMTS6;MFAP5;MMP24;LAMC1;ITGAM;COL4A1;ECM2;ST7;PAPLN;MMP21;COL11A1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.6426887187854128,1.2365987221051093,0.20689655172413793,1.0,1.0,3/19,6.44%,ENPP6;PRDX6;PLA2G4C
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.7893897573129244,1.2362854156114025,0.2,1.0,1.0,1/5,0.98%,TRMT10C
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.7216315349228009,-1.2360761126843953,0.1864406779661017,0.8966412990670085,1.0,3/10,14.22%,SHMT2;SDS;CBS
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.6264019551063235,-1.2357219995992204,0.1527777777777778,0.8973679188074768,1.0,3/21,6.61%,ATAD5;CCND1;RAB11A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6614771381531002,-1.2354145730937451,0.22950819672131148,0.8979936123125803,1.0,6/19,17.47%,PKP2;CALM3;CAV3;CAV1;CACNA1C;FGF13
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.760431245675213,-1.2351165490829739,0.26785714285714285,0.8983214923374102,1.0,1/8,1.19%,NR4A3
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.651901113117404,1.2347832269410053,0.22857142857142856,1.0,1.0,2/13,6.14%,CEP55;CHMP5
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.7254726445006923,-1.2347399104630192,0.19047619047619047,0.8990706502731683,1.0,1/11,0.91%,DOCK8
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.7151783711885829,-1.2346340714913466,0.25806451612903225,0.898173322475011,1.0,2/9,16.03%,SPEF2;SPAG17
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.680514900002694,1.2346116222630446,0.1794871794871795,1.0,1.0,3/11,20.47%,ESPL1;CDC23;RB1
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.680514900002694,1.2346116222630446,0.1794871794871795,1.0,1.0,3/11,20.47%,ESPL1;CDC23;RB1
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.680514900002694,1.2346116222630446,0.1794871794871795,1.0,1.0,3/11,20.47%,ESPL1;CDC23;RB1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.721601662153817,1.234490673592358,0.19444444444444445,1.0,1.0,6/13,13.62%,FHDC1;OPTN;STX6;TMED5;VAMP4;TRIP11
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5890891907071876,-1.2339689616020268,0.208955223880597,0.9004361495701266,1.0,11/48,13.50%,RHBDF2;RIMS1;MCTP1;MCTP2;SYT1;MEF2C;STXBP5L;RAB3C;RAB3A;RIMS2;SNCAIP
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.7295952758260913,1.2338745129585709,0.20930232558139536,1.0,1.0,1/5,2.26%,KIF3B
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.7295952758260913,1.2338745129585709,0.20930232558139536,1.0,1.0,1/5,2.26%,KIF3B
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.6169229366346498,-1.2337270706704853,0.2,0.9004783315256815,1.0,8/32,15.03%,CR1;ISG15;SERPING1;A2M;SAMHD1;NMI;SLAMF8;NLRC5
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.6045293227175963,1.2336044397316066,0.15,1.0,1.0,1/24,0.18%,NGF
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.7708848898851322,1.233464154567925,0.18,1.0,1.0,3/5,20.76%,ERRFI1;ASCL1;PKD1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.48906181016143657,-1.2327824458556882,0.125,0.9039067008643091,1.0,45/196,21.12%,TLR2;DACT1;TGFB2;RIMS1;PTPRC;LOXL3;ENHO;CITED2;F3;RSPO4;IL7;LRRK2;LMO3;BMP6;XBP1;TEK;AXL;ATP6V1C2;SULF1;RIMS2;DLG4;CDH3;LY86;CAV2;PRKD2;TXNDC15;DEPDC1B;SCIMP;ATP6AP2;LY96;ITGAV;DISC1;DMTN;VWF;NRXN1;TM2D3;NTRK3;STAT3;KAT2B;JAG2;FGFBP3;GAS6;WLS;GPS2;VPS35
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5796202274911443,-1.2327502738625176,0.13432835820895522,0.9027979816941709,1.0,11/57,11.55%,BAIAP2;NCKAP1L;BAIAP2L2;MET;FES;FCHSD2;LMOD1;NAV3;CDK5R1;CARMIL1;CAV3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.8194621047350267,-1.2326422785211506,0.21428571428571427,0.9017901264956747,1.0,3/6,18.03%,TNFRSF1A;TNFRSF1B;RIC1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.7152464545403892,1.232515210702505,0.1951219512195122,1.0,1.0,2/7,21.88%,MIA3;AKT1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5795509900093189,-1.2324400473953798,0.2318840579710145,0.9017186566121611,1.0,8/26,18.31%,PLSCR1;PLSCR4;ANO6;ABCB1;ABCB4;ATP8B1;ATP8B4;ABCA1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6014883332413656,-1.2322676659009622,0.16417910447761194,0.9012717520638133,1.0,9/34,18.31%,PPARG;TGFB2;SOX9;FOS;SPI1;TGFB1;NGFR;POU5F1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6749261203774465,1.2320966847579504,0.3142857142857143,1.0,1.0,2/14,8.20%,SAP18;PTBP1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.7542921797314424,-1.232072207488783,0.19642857142857142,0.9009789488480028,1.0,3/7,16.86%,EFNA1;NGEF;GRIN3A
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.7759591915130302,-1.2320377848792166,0.13114754098360656,0.8997991299003765,1.0,4/9,18.31%,PPARG;ITGAV;NFKBIA;ABCA1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.5899223114661011,-1.2319009510550476,0.15492957746478872,0.8991213904852499,1.0,11/31,16.92%,WNT8B;TWF2;EPHA3;BRINP2;SOX9;AQP1;BRINP1;LYN;BRINP3;PTK7;WNT5B
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.561173965553682,-1.231318996051951,0.18421052631578946,0.9008110464509939,1.0,12/64,12.50%,SLC28A2;RIMS1;SYT1;SYN3;SNAP25;SLC1A1;SYN2;LIN7A;GABRA2;RAB3A;SLC18A2;GAD2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.7419424892217973,-1.231224786594703,0.16071428571428573,0.9000785436986022,1.0,4/10,16.54%,TGFB2;NCKAP1L;VEGFA;PIK3CB
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.6745172324194308,-1.231030451372299,0.16393442622950818,0.8997757320198552,1.0,1/23,0.38%,PEX11A
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6419034163984101,1.230942037526638,0.23255813953488372,1.0,1.0,2/12,15.51%,DNMT1;RESF1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5033097695481531,-1.2309389568662015,0.1267605633802817,0.8989365934161563,1.0,15/155,6.64%,CD44;ITGB4;ADAMTS5;ADAMTS17;ADAMTS6;MFAP5;MMP24;LAMC1;ITGAM;COL4A1;ECM2;ST7;PAPLN;MMP21;COL11A1
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.8019031716867792,-1.2306918638049682,0.26785714285714285,0.8986087550936434,1.0,1/5,1.20%,SFRP4
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.5415955473745985,-1.2302709220841201,0.15492957746478872,0.8992845008175341,1.0,18/74,15.99%,RND2;ARHGAP18;SEMA3E;BAIAP2;TWF2;EPHA3;SMIM22;PEAK3;CSF1R;RHOC;BST1;PAK3;LRP1;RAC3;DAPK3;NOTCH2;EFNA5;DMTN
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.6712025799562928,-1.2301854803912156,0.17567567567567569,0.8983398994993995,1.0,5/15,19.46%,SPEF2;AQP4;CCDC39;SPAG17;ODAD4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.5617092916185294,1.2290550544160688,0.21951219512195122,1.0,1.0,9/28,15.91%,SNAPC3;ELL;POLR2K;GTF3C6;GTF3C5;GTF3A;ZC3H8;POLR2L;POLR3GL
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8237863717933342,-1.2287359656604038,0.15254237288135594,0.9048760584712497,1.0,3/7,8.69%,HLA-A;B2M;ERAP1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6806294981097855,1.2286705387322208,0.23076923076923078,1.0,1.0,6/17,10.77%,RAE1;TPX2;NUMA1;PARP3;FSD1;PSRC1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5702931241906164,1.2284240098597479,0.2,1.0,1.0,6/25,7.41%,CRTAM;ZAP70;IL2RA;RUNX1;PRELID1;ABL1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.6230673231882106,-1.2283233969140084,0.23809523809523808,0.905622149466333,1.0,3/32,4.64%,TWF2;TGFBR2;NOS1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.564524814308152,1.2283088912426967,0.16666666666666666,1.0,1.0,13/51,16.25%,TCOF1;RCL1;BYSL;RRP12;PUS1;NOLC1;TFB2M;MPHOSPH10;PLK4;TMEM97;WDR74;SLC29A2;NPM1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6803955239251567,1.2282726545476406,0.3333333333333333,1.0,1.0,2/13,8.20%,SAP18;PTBP1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),-0.7346891334611025,-1.2282216406142865,0.25396825396825395,0.9048228386629904,1.0,1/13,0.99%,IRGM
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.7563451776649746,1.228197216683626,0.2,1.0,1.0,6/6,24.39%,NPHS1;MAGI2;JAG1;PODXL;MYO1E;IQGAP1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.7563451776649746,1.228197216683626,0.2,1.0,1.0,6/6,24.39%,NPHS1;MAGI2;JAG1;PODXL;MYO1E;IQGAP1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.5259980848054041,-1.228160084454902,0.136986301369863,0.903725737693793,1.0,23/85,18.33%,NR4A3;LAMC1;SOX9;F3;STAT5A;BMP6;LAMB1;XBP1;TEK;CDH13;VEGFA;HTR2B;CDH3;EGFR;FGF7;SCG2;PRKD2;TGFA;NOTCH2;ZNF580;HPN;PTPRN;EMC10
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.7522545821502782,-1.2280522754227243,0.18461538461538463,0.9029585807079333,1.0,4/13,6.13%,H2BC11;HLA-E;SFTPD;HLA-A
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.6236504476571998,1.227894708503608,0.21951219512195122,1.0,1.0,3/13,2.74%,PIWIL4;SPOCD1;PIWIL2
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.8305197413017431,-1.2272344495802594,0.2222222222222222,0.9060559648665186,1.0,1/5,6.91%,SAMHD1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.7268875506917145,-1.2270943386445572,0.23809523809523808,0.9055728900135297,1.0,2/10,14.78%,MX1;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.6279038552425881,-1.226991906351503,0.21875,0.9048199311846216,1.0,6/27,7.65%,RHBDF2;TNFRSF1A;IL12A;SYT4;GRM7;CHGA
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.5202053790411961,1.2266832647273813,0.125,1.0,1.0,25/94,19.08%,MRPL58;MRPL32;MRPS10;MRPL3;MRPS7;MRPL15;MRPL50;MRPS2;PTCD3;HARS1;MRPS5;MRPS26;MRPL52;MRPL24;MRPL47;MRPL39;MRPS27;MRPL13;EARS2;MRPL43;MRPS9;MRPS16;MRPL22;NOA1;MRPS30
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.7474113810951374,-1.2265755330100192,0.20967741935483872,0.9056265107355777,1.0,1/10,0.54%,FSTL1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.5417803944029788,-1.2262850057440304,0.12857142857142856,0.9057411145940646,1.0,16/63,15.19%,PKP2;CLDN5;TGFB2;CDH9;CDH12;CDH22;CADM3;CSF1R;CDH10;CDH18;CDH13;TGFB3;CDH3;TJP3;TGFB1;PARD6A
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.7804263536305615,-1.2260613399162976,0.19642857142857142,0.9058148834400078,1.0,2/9,2.54%,PYGL;PPP1R3C
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),0.8187304553777683,1.2260112546619217,0.18604651162790697,1.0,1.0,2/5,13.48%,CGAS;GPR62
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.6395021063408569,-1.2260042746021955,0.2318840579710145,0.9048230288788269,1.0,6/22,22.08%,MEF2C;TGFBR2;CCDC39;MICAL2;NDRG4;MESP1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.7867996270401879,-1.225742869653429,0.16129032258064516,0.9048439992356477,1.0,2/6,5.38%,DTX3L;LAPTM5
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.8054827628962207,-1.2257107729649601,0.17142857142857143,0.9037621063902274,1.0,1/6,0.92%,TLR2
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6726484194441515,-1.2256850180453631,0.2413793103448276,0.9026160636953794,1.0,3/15,4.62%,SRGN;MEF2C;SOX9
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.7820475267214748,1.2253797368696169,0.3333333333333333,1.0,1.0,2/6,9.56%,PUS7;PUS1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6292310326093848,1.2253417678082184,0.3142857142857143,1.0,1.0,3/10,18.50%,PPM1F;SNX3;CORO2B
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5635883637203661,1.225224693624336,0.14285714285714285,1.0,1.0,7/36,13.22%,RFWD3;KMT5A;HMGA2;ABL1;CASP9;UBE2N;POLH
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4922746089705794,-1.2245156703748818,0.11842105263157894,0.9072804125721086,1.0,21/161,9.28%,MDFIC;IGFBP3;RGS20;PLSCR1;CLU;GPHB5;TMEM204;TRIM5;MFNG;IGFBP4;TSPYL2;TIMP1;RGS4;NLRP12;DTX1;LRRK2;WWTR1;SLC8A3;BST1;PLCB1;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.6484482736538131,-1.2244178350992445,0.1896551724137931,0.906427320663666,1.0,4/22,12.42%,DLK2;HEY1;TCIM;EGFR
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.769344413863555,1.2243781842381196,0.3111111111111111,1.0,1.0,1/5,0.17%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.769344413863555,1.2243781842381196,0.3111111111111111,1.0,1.0,1/5,0.17%,CRTAM
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.670556514218009,1.2242291754999517,0.3,1.0,1.0,5/8,29.77%,STAR;TSPOAP1;FDX1;FDXR;STARD3
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5853733398531243,1.2240945876273035,0.1891891891891892,1.0,1.0,6/26,14.14%,EAF2;RNF168;ELL;RNF8;HNRNPU;ZMYND11
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.7359905151474413,-1.2239641486984032,0.15942028985507245,0.9073955225144777,1.0,2/10,2.61%,FBLN1;SPINT2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6139008592854873,1.2239049204881811,0.26666666666666666,1.0,1.0,1/17,0.18%,NGF
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.6324496854531525,-1.2238290616673695,0.25,0.9068384591760186,1.0,3/23,2.99%,FSTL1;LPL;TIMP1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4720617830260718,1.2237908578998822,0.13793103448275862,1.0,1.0,28/85,25.58%,U2AF1;RIDA;HSPA1A;SF3A3;SF3B2;PCF11;PTBP1;KIN;HSPA1B;ZC3H12D;NUDT16L1;PNPT1;SF3A2;DDX5;HNRNPA2B1;CELF1;SNRPB;SF3A1;SRSF9;HNRNPR;HSF1;PRPF18;ERN1;SF3B4;HNRNPA0;RNH1;DXO;SRSF7
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.4609546780848241,1.2235001372957426,0.125,1.0,1.0,8/165,2.19%,CPA1;CXCR4;CD274;HDC;CFH;RNF128;CCR3;DUSP1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.6254831482260286,-1.2228872431789577,0.18055555555555555,0.9105109792626219,1.0,10/32,14.73%,HEY1;TGFB2;OLFM1;TTN;SOX9;VEGFA;HTR2B;SYNPO2L;FLRT2;ZFPM1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.8223149522379061,-1.2228744820270505,0.1724137931034483,0.9080494786276653,1.0,2/5,7.65%,NR4A3;CHGA
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.8223149522379061,-1.2228744820270505,0.1724137931034483,0.9080494786276653,1.0,2/5,7.65%,NR4A3;CHGA
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.6741794710886451,1.2228701638845634,0.2682926829268293,1.0,1.0,1/10,2.92%,DICER1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5641527505546244,1.2222794205000111,0.2,1.0,1.0,5/21,15.03%,HDC;PYCR1;PRLR;STAR;GCH1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.6663957461934864,1.2221003606845389,0.21875,1.0,1.0,2/15,10.16%,AUP1;TMEM129
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.7208835448228035,1.2217986567730994,0.23404255319148937,1.0,1.0,3/7,14.62%,GTF3C6;GTF3C5;POLR2L
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.713307224893869,-1.2216777199260522,0.25925925925925924,0.9120215369907017,1.0,3/11,15.99%,FBLN1;EFNA5;DMTN
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.713307224893869,-1.2216777199260522,0.25925925925925924,0.9120215369907017,1.0,3/11,15.99%,FBLN1;EFNA5;DMTN
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5122007476642172,-1.2216224025568967,0.11538461538461539,0.910999091402801,1.0,62/240,12.64%,ZACN;NPY;CHRM3;SHISA6;CBLN2;CHRM5;RIMS1;RIT2;HTR5A;GLRA3;KCND2;KCNQ3;SYT1;GABRG2;GABRA1;HTR1E;GRIK2;PRKAR1B;GLRA2;NPTX2;SYN3;UNC13C;SNAP25;SLC1A1;NPTX1;CACNA1E;PTCHD1;SYN2;PCDHB11;GRM5;NRGN;CACNA1B;SNCB;GRM7;CACNB1;HTR2C;HTR3B;PCDHB4;GABRB2;LIN7A;GABRA6;FCHSD2;GABRA4;AMPH;GABRA2;GRIK1;ASIC2;GRIN2B;DLGAP1;GPR176;HTR2A;RAB3A;GABBR2;CAMK1;SLC18A2;GRIA1;HTR2B;PCDHB9;CACNB2;DLG4;GAD2;GRIA3
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.6912489041424354,-1.220965096146891,0.16393442622950818,0.9131145626141426,1.0,9/19,18.24%,TGFB2;NCKAP1L;EDN1;LGALS3;SCG2;ADGRE2;SYK;CX3CL1;SRP54
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.7299687642470003,-1.2207339399807235,0.22807017543859648,0.9131370309882821,1.0,3/11,15.99%,NCKAP1L;GATA1;DMTN
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.67145081479016,-1.2204679223669963,0.16666666666666666,0.913357322992716,1.0,11/23,26.19%,TMEM204;MEF2C;NINJ1;MRTFB;WNT5B;NEB;MYOCD;HEY2;NEBL;SYNE1;DMD
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.7081181857927692,1.220344982190718,0.25,1.0,1.0,2/6,13.67%,TMEM98;HES5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.5631677486746247,-1.2196546834557769,0.15492957746478872,0.9160537980121236,1.0,14/62,13.60%,CD44;IRGM;NOS1;TERF2IP;SH2D3C;IFNA2;CAMK1;IFNA6;VEGFA;CAV1;EGFR;IFNK;MTCP1;PRKD2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.8452362664223917,-1.2196111669293601,0.2711864406779661,0.915019663295816,1.0,3/5,15.07%,MEF2C;FLOT1;TGFB1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.5511021224134084,-1.2192346446961257,0.14925373134328357,0.9160905146548546,1.0,15/55,17.60%,PLEKHA2;SEMA3E;EPHA3;UTRN;THY1;BST1;PLET1;CDH13;RASA1;SKAP1;DAPK3;EFNA5;PIK3CB;CX3CL1;VCL
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.7304854327900046,1.2191391292623779,0.16666666666666666,1.0,1.0,2/7,7.65%,SPHK2;ATPSCKMT
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.5849063657278032,-1.2186993408931583,0.19117647058823528,0.9179457131992842,1.0,13/52,15.36%,CLDN5;PTPRM;SEMA3E;PPARG;TGFB2;TEK;PDE3B;SULF1;CD160;PGK1;EFNA3;STAT1;CNMD
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6749180216970372,-1.2184048227925794,0.21212121212121213,0.9183152445039534,1.0,1/18,0.57%,LPL
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.7343708174094574,-1.2183101233030724,0.25396825396825395,0.9174930094351909,1.0,1/10,3.19%,NOX4
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.7575469741130807,1.21811621784153,0.35,1.0,1.0,4/5,21.52%,RAB7B;SNX3;SGSM2;GCC2
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6835515313290296,-1.2181049293489492,0.2714285714285714,0.9174178525032665,1.0,4/15,8.62%,BAIAP2;BAIAP2L2;FES;TEK
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.5098979102797128,-1.2177624778442286,0.1,0.918165053705678,1.0,25/131,11.84%,PTPRM;PPARG;GCNT1;LAMC1;RGS4;TGFBR2;KALRN;CITED2;INPP4B;F3;MET;DDAH1;CDON;COL11A1;KCNMA1;GJA1;BHLHE40;AMPH;CELF2;ADGRL2;MMP16;SIPA1L1;PLCB4;RBPMS;CAV1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.7787332257025714,-1.2176537044262392,0.18518518518518517,0.9174896984696019,1.0,4/7,20.44%,AXL;LYN;LILRB1;GAS6
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.6894646035806945,-1.2167956309638388,0.25806451612903225,0.9204083007173168,1.0,2/10,16.03%,SPEF2;SPAG17
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.7537651868903239,1.2167527947372108,0.25,1.0,1.0,1/6,2.46%,PYCR1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5904232157220011,-1.2163666301655218,0.23529411764705882,0.9215903953058351,1.0,3/30,8.43%,PEX11A;VAV3;RIN3
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.7329076556284697,-1.2162442085062366,0.2909090909090909,0.9209001842502986,1.0,3/13,13.39%,NPY;MAP2;B4GALT6
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.5180894897452687,-1.2161377763239836,0.16666666666666666,0.9201210819820871,1.0,18/82,16.34%,PTPRC;RIT2;SYT1;STXBP5L;LRRK2;RAB11A;RAB3C;FES;USP6;CDH13;RAB3A;RIMS2;PACSIN1;OPHN1;SCARB1;ITGAV;RAB15;SYK
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.6512626736706915,1.2161127531855167,0.20512820512820512,1.0,1.0,1/13,1.34%,RAB27A
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.5418152839705084,-1.2158629853437184,0.10144927536231885,0.9205738766657063,1.0,8/75,4.94%,KANK2;DACT1;VIL1;PPARG;ALDH1A2;LOXL3;SOX9;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6516848261520302,1.2157985733401002,0.21951219512195122,1.0,1.0,1/11,5.74%,ANXA2
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.6564383207321609,1.2157763518300237,0.21212121212121213,1.0,1.0,2/10,5.30%,ST3GAL1;NPL
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),0.8141613880974936,1.2156790516738971,0.19047619047619047,1.0,1.0,2/5,9.06%,GPAT2;GK5
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.8362929884357795,-1.21537258465406,0.22950819672131148,0.9220338560139855,1.0,4/5,16.36%,LGALS3;SFTPD;EDNRB;CXCL17
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),-0.7945781149185871,-1.215248468397604,0.22580645161290322,0.92148875456271,1.0,3/5,17.06%,SLC18A2;SLC17A6;SLC17A7
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.6305533132619819,1.2146888146709602,0.1388888888888889,1.0,1.0,6/17,27.25%,MTMR2;SNX3;DNAJC13;VPS11;MAP2K2;PTPN23
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.6887573182502167,-1.2145652566714622,0.2153846153846154,0.9238719736900174,1.0,7/13,16.34%,NCKAP1L;ID2;XBP1;SLAMF8;CD27;PPP2R3C;SYK
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.6552331243998837,-1.214541930376773,0.2602739726027397,0.9227335563818915,1.0,6/18,19.43%,STAT5A;NMI;IL31RA;STAT1;STAT3;STAT4
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.7908226590894829,1.214454256403458,0.225,1.0,1.0,3/7,12.67%,CD274;PRELID1;ZC3H8
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.8114253013125293,-1.2140723392714674,0.19230769230769232,0.9239257231065032,1.0,5/6,18.12%,F3;ANGPT2;CDH13;VEGFA;NTRK3
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.8287008835095344,-1.2139484124589575,0.13793103448275862,0.923470901093811,1.0,1/5,2.12%,PTPRC
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.7283347500208747,-1.2139001432478633,0.27692307692307694,0.9224273162128371,1.0,1/14,0.20%,ITGB4
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.6822846872579175,-1.2135186803184705,0.27586206896551724,0.9232180961805724,1.0,8/15,27.33%,MEF2C;NRG1;MYEF2;CBY1;MYOCD;MESP1;KDM6B;AKAP13
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.6222528038185849,-1.2134602164958999,0.1875,0.9222543514148283,1.0,6/26,13.16%,SEMA3E;COL4A1;TGFBR2;MET;VEGFA;TIE1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.7313766422931218,-1.213416828238151,0.20967741935483872,0.9213186987604068,1.0,4/13,8.66%,GCNT1;SELL;CX3CR1;ADD2
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.6045573706827111,1.2131682935383412,0.25,1.0,1.0,5/31,3.95%,F2;RAB27A;CYBA;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.7606958045488064,-1.2130135063253011,0.18461538461538463,0.9220440247761278,1.0,2/9,12.32%,SFRP4;BMPR1B
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.5100723646542314,-1.2129659916179036,0.13043478260869565,0.9210983701039721,1.0,28/121,14.57%,FRY;NPY;PTPRM;TGFB2;STMN2;GPRIN3;MEF2C;L1CAM;GPM6A;DCX;RAB11A;LGI1;ETV1;LAMB1;TENM3;STX3;SH3GL2;XBP1;MANF;CDK5R1;ACTL6B;LYN;SRRM4;MAP2;B4GALT6;ATCAY;OPHN1;CNTN4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.750857705148237,-1.2129453833253843,0.26865671641791045,0.9199770610210224,1.0,3/8,19.76%,ANO6;CD160;PLCG1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.7542941019289858,-1.2127577900705016,0.24285714285714285,0.9195321960138251,1.0,4/6,15.65%,PLSCR1;ITGAM;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.7819115695461897,1.212617019710061,0.26666666666666666,1.0,1.0,2/6,11.01%,ATF4;ZBTB1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.711279683562229,-1.2125784360088894,0.18333333333333332,0.9191138789238826,1.0,3/12,14.64%,KLF9;AQP1;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.8267535186082076,-1.212408277182902,0.19148936170212766,0.9186586340039704,1.0,1/5,0.57%,LPL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.7238582091269331,-1.2121656709799296,0.20588235294117646,0.9185336803140002,1.0,6/13,16.95%,HLA-E;NLRP3;CEBPB;IRF4;SYK;PRKCQ
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5455158344550931,1.2119758063961918,0.3076923076923077,1.0,1.0,7/26,6.84%,CA6;SLC39A8;CA2;CYB5R1;CA5A;CA3;SLC26A7
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7211601921206502,-1.2119248681368644,0.2,0.9184722589145107,1.0,3/10,9.20%,TRIM5;IFITM3;IFNA2
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.4775605772510082,1.211855336285166,0.14285714285714285,1.0,1.0,12/73,14.52%,U2AF1;NUTF2;MALT1;RAE1;NUP42;RANBP17;RBM8A;WASHC4;TPR;EIF4E;SARNP;NXF1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5484239774409461,1.2116459536447985,0.21052631578947367,1.0,1.0,1/33,0.32%,ICAM1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.6082252223154172,-1.2115769607548643,0.2535211267605634,0.9190548587399296,1.0,7/29,15.06%,FSTL1;LGALS8;FAP;CDH13;VEGFA;SCG2;STAT1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5203978618212916,-1.2113541292174321,0.14084507042253522,0.9189803103859444,1.0,26/129,12.68%,SLC28A2;TLR2;IFNGR2;TIMP1;IRF1;EDN1;SELL;F3;NLRP3;MET;CXCR6;RNF144B;C3AR1;RGS1;PTAFR;CHST2;SGMS2;BEST1;AXL;GPR183;NDP;LYN;NMI;SCN1B;TNFRSF1B;GPC3
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.6901029436367413,1.211199923378524,0.21052631578947367,1.0,1.0,5/10,27.65%,HSD17B7;HSD17B10;SRD5A1;HSD17B4;AKR1D1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.536915496561161,1.211174437317604,0.17142857142857143,1.0,1.0,3/44,3.23%,GPC4;TRIM67;GPC2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.5810900090858041,1.21091919506999,0.21052631578947367,1.0,1.0,6/24,13.58%,GNL3L;PINX1;NAT10;CTC1;TENT4B;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.6057980132823624,-1.210776337081785,0.25757575757575757,0.9208702911647328,1.0,10/29,12.23%,CR1;NCKAP1L;LGALS3;LAPTM5;SFTPD;CEACAM1;IFNA2;HLA-DRB1;CEBPB;FGL1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.522806128150248,-1.2106263488819669,0.16,0.9206049456456815,1.0,12/78,13.60%,CD44;IRGM;NOS1;TERF2IP;DDIT4;SH2D3C;CAMK1;VEGFA;CAV1;EGFR;MTCP1;PRKD2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5654758190729533,1.210431021194334,0.25806451612903225,1.0,1.0,10/33,18.21%,ACTN2;EHD2;NUMA1;PCM1;CEP290;PRR5L;TPR;STX18;CAPN10;ZFAND1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.778033849796197,1.2102393770124065,0.3181818181818182,1.0,1.0,2/6,16.00%,ACAA2;THEM4
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.6109350599712011,-1.2101208204861091,0.15384615384615385,0.9221613766217681,1.0,7/25,18.31%,PPARG;TGFB2;FOS;SPI1;TGFB1;NGFR;STAT3
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.5571476774730094,-1.2101146709768984,0.2222222222222222,0.9209919529873504,1.0,15/43,21.35%,ABCC4;SLC6A12;CEACAM1;SLC16A14;SLC16A8;SLC6A8;SLC51A;ABCB4;ATP8B1;SLC16A9;SLCO2B1;SLC10A6;SLC16A3;SLC6A11;RXRA
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.7908797219569236,-1.2098897214289834,0.19642857142857142,0.9208402204871411,1.0,2/7,12.17%,ASIC2;ABCC9
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.7971174850649126,-1.2097518768647286,0.2786885245901639,0.9203385846705021,1.0,2/5,10.00%,NCKAP1L;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.606257600506922,-1.20934401368359,0.1774193548387097,0.9212875946099973,1.0,3/32,5.33%,CD44;CITED2;RNASE10
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7645624775446647,-1.2093306541496587,0.25862068965517243,0.9201877164700092,1.0,1/8,1.38%,MCM2
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.5029814751250886,-1.2090081885077524,0.16216216216216217,0.9207855349248254,1.0,22/121,10.39%,NOSTRIN;FSTL1;ADAMTS5;AKAP12;HOPX;ROBO4;ACTA2;FAP;COL4A1;PLSCR4;MEF2C;ACTN1;DKK3;ANGPT2;FILIP1L;GJA1;PALLD;THY1;TEK;LMOD1;SH3BGRL;SULF1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.6934995789565822,1.2089171344306004,0.24324324324324326,1.0,1.0,6/8,29.74%,POLG;POLG2;PRIMPOL;SSBP1;DNA2;TEFM
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.7195524204059814,-1.20860567716559,0.2753623188405797,0.9215934024481836,1.0,3/7,15.99%,DDR2;TGFB1;DMTN
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7076904030424341,-1.2084162667072333,0.30434782608695654,0.9213923455369833,1.0,4/10,18.31%,MX1;CRLF1;STAT1;STAT3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.4478311054486538,1.2075991022674275,0.047619047619047616,1.0,1.0,15/148,9.16%,TEAD2;TBPL2;VDR;HDAC10;NR2C2AP;MAML2;CAVIN1;TAF13;HDAC1;TAF12;TFB1M;TEAD3;HDAC9;POLR2K;TAF5
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.49799708894941896,-1.2069775221442143,0.13513513513513514,0.9274237901097296,1.0,28/156,9.11%,CD44;FSTL1;FOSL2;ADAMTS5;IGFBP3;FBLN7;MFAP5;ACTA2;KLF9;OLFML2B;LAMC1;COX7A1;FAP;NOX4;ASPN;COL4A1;PLSCR4;SYNPO2;VIM;HGF;DKK3;LAMB1;PALLD;THY1;FLI1;TEK;LMOD1;CTHRC1
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.7340992680519123,-1.2068617953759118,0.22580645161290322,0.9268314317874756,1.0,3/8,20.19%,PKD1L3;ASIC2;TAS1R1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.8230089516778629,-1.2067503134344673,0.2727272727272727,0.9263025012705571,1.0,1/5,3.72%,BCAT2
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4638539092551439,-1.206420355008409,0.05,0.9266900613060385,1.0,73/305,16.63%,DOCK8;TLR2;IRGM;YBX3;IL13RA1;TNFRSF1A;GBP2;IL26;IL12A;SLA;CEBPD;GBP3;IL6R;IFNGR2;TIMP1;IRF1;DUOX1;ITGAM;CNTFR;NLRP12;NPR2;PIM1;VIM;SOX9;FOS;F3;HGF;ZEB1;STAT5A;CCND1;CSF1R;IL7;IL3RA;CTF1;CHI3L1;PTAFR;CRLF1;STX3;XBP1;LRCH1;IL16;IL12RB2;IFNA2;AXL;PDE1B;IFNA6;VEGFA;DAPK1;TNFRSF1B;INPP5D;AQP4;IFNK;IL31RA;ADAMTS7;PTPRT;MYLK3;PLP2;PTPRZ1;PID1;DAPK3;ZFP36;IFIT1;PTPN13;STAT1;TGFB1;OPRM1;NR1D1;CDKN1A;BRCA1;IRF4;SYK;PIK3CB;PTPRJ
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.8077826320447162,-1.2062327183096164,0.20967741935483872,0.9264343818999348,1.0,2/7,8.39%,PPARG;E2F3
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6852040137678754,-1.206210641653668,0.27419354838709675,0.9253528926534442,1.0,3/9,19.99%,ID2;TGFB1;IL34
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.7436078721594812,1.2061919471000373,0.2765957446808511,1.0,1.0,1/5,10.60%,ACVR1B
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6688312817216326,1.206126328498615,0.2972972972972973,1.0,1.0,5/13,20.94%,TPR;AHCTF1;NDC1;RTN4;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.6792631966262994,-1.2060834158349725,0.2033898305084746,0.9248408545368151,1.0,8/17,20.44%,NLRP12;NLRP3;CEACAM1;CX3CR1;CARD18;GIT1;CX3CL1;GAS6
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.6172639122026288,-1.20584548799607,0.20967741935483872,0.9249453124144855,1.0,4/25,7.58%,CLDN5;LAMC1;SLC1A1;GJA1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.7073299088194701,-1.2058050615749476,0.17391304347826086,0.9239312715999148,1.0,6/12,20.44%,TGFBR2;AXL;LYN;TRPM2;LILRB1;GAS6
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.7076794931374291,-1.2056902717443772,0.203125,0.9231775280674319,1.0,3/13,5.46%,FBLN1;SPINT2;ACTN1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.692560177963896,-1.205636990535246,0.2413793103448276,0.9223398925464495,1.0,7/13,18.62%,SLC2A12;SLC5A9;SLC23A1;SLC5A2;SLC2A2;SLC2A9;SLC5A10
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7704174294261353,1.2056179597518313,0.25,1.0,1.0,1/5,5.89%,SLIT2
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.561535275040228,1.2052316082463645,0.14285714285714285,1.0,1.0,7/22,18.85%,UBC;UBB;ITCH;UBE2N;MAP3K7;IRAK2;TAB3
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.6719133080991704,-1.2051202867327122,0.24242424242424243,0.9240139184455582,1.0,1/14,0.84%,PPP1R17
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.8156715646022583,-1.2049915171208818,0.14035087719298245,0.92350745002957,1.0,2/6,14.69%,RAB3A;PCLO
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.7674607158576445,-1.2046727335017235,0.23333333333333334,0.9238570150519484,1.0,3/6,10.71%,IRF1;IFNA2;GLI3
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.4829916001633668,1.2043936097800962,0.1,1.0,1.0,18/112,10.38%,CRYAB;NUPR1;VASH1;CRHBP;AIFM2;HSPA1A;RAE1;SLC38A2;NUP42;RSL1D1;FKBP4;ATF4;ABL1;NUP210;BAG2;CASP9;HSPA1B;MLST8
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.7847175828273785,-1.2043766423740527,0.2,0.924217894980348,1.0,3/5,19.65%,ALDH1A2;RBP1;RBP2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5957629785262953,-1.2041323873297822,0.23214285714285715,0.9244073458825647,1.0,2/25,8.79%,DND1;E2F1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.586161326856774,-1.204092546083532,0.23809523809523808,0.9235379848578562,1.0,17/40,19.78%,CACNG2;SYT1;MEF2C;TPRG1L;LRRK2;GRM5;GRM7;GRIK1;CACNG3;CACNG8;OPHN1;GRM6;NRXN1;CDK5;GRM4;TSHZ3;GRIK3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5577249735887843,-1.2039148085755533,0.21621621621621623,0.9233268793601646,1.0,12/56,14.99%,EPN1;RHBDF2;CEACAM1;SH3GL2;MVB12A;DGKD;CDH13;DOK1;CBLC;EGFR;TGFA;AGT
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.5550215151640827,1.2039110763665348,0.23333333333333334,1.0,1.0,4/32,6.28%,SLC22A2;SLC38A1;SLC47A1;LRRC8A
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5924881177524246,1.2037625598722708,0.2,1.0,1.0,5/12,21.52%,PCM1;BCCIP;SAXO1;BICD2;GCC2
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.6970215796649516,-1.203539657918358,0.16923076923076924,0.9239050319622973,1.0,6/11,28.37%,EDN1;TPM1;SCN3B;ADRA1B;ADRA1A;KCNQ1
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5417498355898,-1.203298948540051,0.2375,0.9240212113587012,1.0,13/80,8.33%,CD44;TLR2;FGL2;ITGAM;L1CAM;AOAH;HGF;CSF1R;FAR2;IL3RA;P2RY13;C3AR1;PTAFR
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.6043479795499573,1.2027070268459412,0.2,1.0,1.0,4/14,17.28%,IFNLR1;ITCH;TRAF3;DHX9
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.783625239411371,-1.202538916154972,0.22641509433962265,0.9267031391444006,1.0,4/6,16.38%,PRPS1;CARMIL1;SLC16A9;SLC2A9
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.5252847767829428,-1.202524723625234,0.17142857142857143,0.9255945617693171,1.0,13/95,14.87%,PLEKHA2;PLEKHA4;CDS1;PLCB3;INPP4B;BMX;CSF1R;PLCB1;PIP5K1B;PLA2G12A;INPP5D;PTPN13;PI4K2A
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5737159456777451,1.2024672883794212,0.1951219512195122,1.0,1.0,2/16,5.29%,FEM1A;PINX1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.6189958796604806,-1.2024230749951086,0.25806451612903225,0.9249716998203863,1.0,10/24,23.79%,SYT4;SYT1;KCNB1;SYT12;CACNA1G;SYT13;SCAMP5;SYT7;SYT17;SYT2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5598266359113648,-1.202148305170853,0.22388059701492538,0.9253633230764978,1.0,6/60,9.55%,TNFRSF1A;PTPRC;BIRC3;IFNGR2;IL7;AXL
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6792627459405619,-1.2021408939172655,0.27586206896551724,0.9242485048839609,1.0,2/11,12.85%,STMN2;MAP2
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.740401471762338,-1.2020849671084897,0.24615384615384617,0.9233650031876622,1.0,5/7,23.48%,SLC24A1;PLK2;ARF1;SHANK2;PICK1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.7694137002056534,1.2020378152609836,0.30952380952380953,1.0,1.0,2/7,2.63%,PTPRU;SERPINF2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.6150063370713188,-1.2020112981461395,0.2222222222222222,0.9224596660974941,1.0,3/27,5.60%,KANK2;DACT1;MYO16
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.6764795530556589,-1.202001050743425,0.18461538461538463,0.9213525902984598,1.0,3/16,8.48%,CITED2;MET;XBP1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7621981090551515,-1.2019048366038227,0.26666666666666666,0.9206197623704551,1.0,3/5,22.75%,FES;ALPL;CDKN2D
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5427717420036386,-1.2016769155591085,0.18840579710144928,0.92065478146729,1.0,17/64,19.86%,ANGPT1;PTPRM;EDN1;CEACAM1;TEK;VEGFA;BMPER;PRKD2;AGT;ZNF580;SCARB1;ADAMTS9;RHOJ;PIK3CB;EMC10;NR2F2;GPI
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.674080658851936,-1.201393655242742,0.2318840579710145,0.9208929410259045,1.0,1/13,1.09%,YBX3
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.7622072188914727,-1.20112849616665,0.19117647058823528,0.9210111154138985,1.0,2/6,13.12%,MX1;DNM1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.7828940511714875,1.2008664370129665,0.28846153846153844,1.0,1.0,3/6,10.69%,LEPR;SUCO;GREM1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7099250017737981,-1.2006801426411728,0.3220338983050847,0.9222380312252985,1.0,5/10,19.43%,IL12A;IL12RB2;STAT1;STAT3;STAT4
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.7270233233731273,-1.2006011035357749,0.21875,0.9215443523686222,1.0,7/8,27.33%,TGFB2;NRG1;CBY1;MYOCD;MESP1;KDM6B;AKAP13
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.7726455639062886,-1.2004381825619153,0.29850746268656714,0.9211497723981298,1.0,1/6,12.69%,LRP1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5815793495043654,1.2002565608275826,0.17647058823529413,1.0,1.0,3/17,3.39%,MTCL1;OOEP;SCRIB
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.72421068040802,1.2001706798439462,0.2972972972972973,1.0,1.0,1/10,0.22%,CXCR4
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.5693945749898848,-1.20005787137131,0.18461538461538463,0.9218729920717458,1.0,2/49,1.36%,IRGM;ATG16L2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.677036474886747,-1.19999174178109,0.2,0.9209212451223736,1.0,4/13,15.17%,IGFBP3;NLRP12;UBASH3B;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.6887159280679713,-1.199979906106383,0.25806451612903225,0.9198533070342533,1.0,2/9,14.16%,NOS1;PID1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7137178929776791,1.1997860201032393,0.36363636363636365,1.0,1.0,2/6,3.84%,MALT1;NFKBIZ
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5779420850154786,-1.1997292091609981,0.22058823529411764,0.920090117201626,1.0,11/34,21.05%,PTPRC;BLNK;CR2;IFNA2;IFNA6;IFNK;NHEJ1;PTPRJ;KLF6;TPD52;GPS2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.5681093932005428,1.19952936384261,0.2647058823529412,1.0,1.0,4/37,5.55%,NGF;HMGB1;PYHIN1;HMGA2
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.7458116130762366,-1.1994220902186385,0.28,0.9205391659005325,1.0,2/8,13.22%,TWF2;TMSB10
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.5510846797085939,1.199369320247454,0.24324324324324326,1.0,1.0,4/25,13.54%,NUPR1;USP36;FEZ1;SEC22B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7058556886138623,-1.1991558862645162,0.26785714285714285,0.9206210484706687,1.0,3/11,10.57%,NR4A3;MEF2C;PRKG1
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.771630665016565,-1.1991166543019225,0.140625,0.9175240454256521,1.0,3/8,11.01%,CR1;CR2;C4BPA
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.771630665016565,-1.1991166543019225,0.140625,0.9175240454256521,1.0,3/8,11.01%,CR1;CR2;C4BPA
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.771630665016565,-1.1991166543019225,0.140625,0.9175240454256521,1.0,3/8,11.01%,CR1;CR2;C4BPA
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.6059095556593301,-1.1986178625444315,0.140625,0.9189018452130352,1.0,3/30,5.60%,KANK2;DACT1;MYO16
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.7189001635823214,1.1985736075211193,0.28125,1.0,1.0,2/6,5.85%,CYBA;COX10
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6133841917738021,1.1980627672269326,0.2972972972972973,1.0,1.0,5/19,10.10%,FGFR1;HSPA1A;EYA4;UNC5B;HSPA1B
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.7551472201310571,1.1978006312844378,0.2857142857142857,1.0,1.0,3/5,10.10%,HSPA1A;PTPN22;HSPA1B
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.6966952205217425,-1.197722046650375,0.24561403508771928,0.9222950981563334,1.0,3/14,17.41%,EDN1;RIMS2;PTPRN
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.6881964573519466,-1.1975764884115159,0.28125,0.9219053416893012,1.0,3/13,7.67%,PYGL;AGL;PHKG1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.789916107478072,-1.1975079351052618,0.29310344827586204,0.9209779236785641,1.0,3/6,7.81%,NOS1;DDAH1;ARG2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.7544874254514916,-1.197332182742281,0.25396825396825395,0.9206491726638748,1.0,2/8,3.30%,HLA-F;ITGAM
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6086442946669774,1.1972871713515703,0.1875,1.0,1.0,2/19,4.41%,NGF;RAPGEF1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7039598676489386,-1.196985152185354,0.18333333333333332,0.9211038107752957,1.0,3/15,5.26%,KDM4D;PARP9;DTX3L
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6725778836360058,-1.1969518571087352,0.23636363636363636,0.9200407130053283,1.0,2/13,6.70%,MT1M;AQP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.7508845399976503,-1.1968249398316724,0.23636363636363636,0.9195860999497675,1.0,2/6,24.49%,MACROH2A1;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.49144458556490567,1.1967800634945795,0.15789473684210525,1.0,1.0,8/56,12.31%,CDK10;CDKL1;TESK1;EVI5L;USP6NL;TBC1D19;CROCC;ARHGAP35
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7076938218513821,-1.196491987922862,0.2459016393442623,0.9202498680323911,1.0,4/11,18.50%,PGAM5;LY96;ITPK1;DNM1L
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.7882294521075848,-1.1964507259213901,0.25925925925925924,0.9192729952252474,1.0,1/6,0.54%,FSTL1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.49780735464371156,-1.1962648917420982,0.15492957746478872,0.9191228112560323,1.0,27/127,11.07%,ANGPT1;FSTL1;ADAMTS5;PDGFD;MFAP5;ACTA2;PPP1R3C;COX7A1;NOX4;COL4A1;PLSCR4;SYNPO2;IRAG1;DKK3;OGN;PCP4L1;AQP1;MYH11;PRXL2C;THY1;TEK;LMOD1;MAP3K7CL;SULF1;PRKG1;PLN;WFDC1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.7086466267634195,1.1962579463866772,0.29310344827586204,1.0,1.0,2/5,2.79%,AGER;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),-0.8072078897199271,-1.1960257938462113,0.2777777777777778,0.9192049191149021,1.0,1/6,1.95%,IL12A
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.7163492944520421,1.1953321308524056,0.2608695652173913,1.0,1.0,2/6,11.33%,GTF3C6;GTF3C5
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.6444810798758795,1.1944557461239378,0.34285714285714286,1.0,1.0,3/10,9.91%,VDR;NUMA1;TRIM16
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4943911829745173,1.1942705948734276,0.13333333333333333,1.0,1.0,3/42,2.55%,NGF;PLXNA1;CHODL
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6357457078215001,1.1934048614401966,0.21951219512195122,1.0,1.0,1/10,2.92%,DICER1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.7043566176435472,-1.1929146724295516,0.26666666666666666,0.9324332333641414,1.0,2/11,8.49%,LAPTM5;CCDC91
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.690109177918348,-1.1927400616169466,0.2727272727272727,0.9320249177818213,1.0,3/15,7.40%,TRPM1;GRM5;GRM7
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.7128195054766578,-1.1926683917084528,0.2037037037037037,0.9312478138194833,1.0,2/11,10.71%,PTPRC;GLI3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.833422027091508,-1.192465635224618,0.2033898305084746,0.9312458305859187,1.0,1/5,3.80%,MLIP
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.7434813809087335,-1.1921884361073076,0.2033898305084746,0.9315205139436414,1.0,4/9,17.74%,ADGRV1;COL11A1;HPN;PDZD7
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6480641157082465,-1.1919291147691657,0.2028985507246377,0.9315412389112586,1.0,9/23,20.10%,IHO1;RNF212B;STAG3;SYCE2;SYCP2;MEIOB;KASH5;SYCP1;FANCD2
prerank,MSigDB_Hallmark_2020__Complement,-0.4744611075292792,-1.191638603452949,0.14666666666666667,0.9317229174014688,1.0,29/151,14.88%,F8;CR1;CTSO;CD59;PLSCR1;CLU;TIMP1;IRF1;ITGAM;PIM1;SERPING1;LGALS3;F3;ZEB1;PPP4C;CR2;CDK5R1;CDH13;CEBPB;LYN;CALM3;SCG3;L3MBTL4;LRP1;C1QC;CP;GNG2;PCLO;PREP
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.7300246947594897,-1.1916249708358286,0.2711864406779661,0.9306865900884823,1.0,3/10,16.63%,MCM2;MCM7;DONSON
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.668376019845476,-1.1915707872671364,0.359375,0.9298592315341293,1.0,3/15,11.84%,BASP1;MEF2C;CAV1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.6407172522829547,-1.191529840736728,0.2698412698412698,0.9289536156533023,1.0,3/17,15.76%,SOX9;HTR2B;ITGAV
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.5639401352666354,-1.191529360922529,0.2222222222222222,0.9278555617340902,1.0,12/50,15.68%,PPARG;TGFBR2;CSF1R;E2F1;PDE1B;HLA-DRB1;GPR183;VEGFA;IL31RA;SNX10;SPI1;CDKN1A
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.709766317835044,-1.1913071048836796,0.36363636363636365,0.9277318468573994,1.0,5/12,13.16%,MEST;BMX;IKZF1;VEGFA;TIE1
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.816619585657476,1.191287254326493,0.2,1.0,1.0,1/6,0.46%,TBXA2R
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.5847936243092726,-1.1912766303046736,0.23880597014925373,0.9267976870332263,1.0,5/36,12.23%,LPL;XBP1;ADCY8;KCNB1;EIF2B4
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.4797737294624395,-1.1911273140469665,0.13414634146341464,0.9262763214080757,1.0,62/196,20.92%,TRPM1;KCNK10;TRPC4;KCND2;KCNV1;KCNQ3;TRPC6;TRPM3;KCNS1;ANO6;SLC6A12;KCNJ4;SCN2A;RYR3;SCN9A;KCNH7;KCNQ5;SLC8A3;SLC24A5;TRPC7;HCN1;ASIC2;SLC8A1;KCNK6;KCNC2;SLC9C1;SLC24A1;SCN4B;KCNB2;SLC6A8;KCNB1;SCN1B;SLC9C2;ABCC9;KCNH5;ATP1A1;CACNA1G;KCNH2;CACNA1C;ITGAV;SLC6A7;HPN;CACNA2D4;SLC11A2;TRPV3;TRPM2;KCNK1;SLC24A4;KCNC3;TRPV4;SCN3A;SCN1A;CACNA1A;KCNG3;KCNH1;SLC9A7;KCNC4;SLC6A4;GAS6;SLC6A11;SCN3B;KCNE1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.6834658360880247,-1.1910793638707953,0.2631578947368421,0.9253916398271966,1.0,1/11,1.19%,NR4A3
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.7456878433487182,1.1906135451239899,0.3170731707317073,1.0,1.0,3/7,9.23%,F2;SERPINF2;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.4736039762728261,-1.1902607255120559,0.13513513513513514,0.9279908806709927,1.0,24/136,17.16%,PKP2;HEY1;PPARG;HOPX;DTX1;ID2;SOX9;ADGRV1;PRAME;EFNA1;WWTR1;E2F1;RUNX1T1;CAV1;EGFR;ADAMTS7;OVOL2;CNTN4;ZFPM1;TGFB1;ITGAV;HPN;NFKBIA;MAD2L2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.6634025651397695,-1.1902558127650613,0.21212121212121213,0.9269244199317676,1.0,2/19,8.15%,TP73;DDIT4
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.6800636847238384,1.190001194165816,0.32075471698113206,1.0,1.0,4/6,15.13%,REN;ENPEP;AOPEP;MME
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.6800636847238384,1.190001194165816,0.32075471698113206,1.0,1.0,4/6,15.13%,REN;ENPEP;AOPEP;MME
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.6568097729672104,-1.1899829575202998,0.22807017543859648,0.9273475577766378,1.0,7/20,19.11%,MCTP1;EPHA3;LGALS3;CAV1;SCAMP5;LILRB1;SNX33
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.7899919157088352,-1.1899181489783814,0.25862068965517243,0.9265337971354644,1.0,1/5,2.24%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.5097031772334873,-1.1896526285986395,0.21052631578947367,0.9268204979768252,1.0,17/88,17.83%,DACT1;CLU;APC2;HECW1;C4BPA;NEDD4L;TRIM32;GPC3;RAB1B;AGT;TGFB1;UHRF1;OAZ3;PLK2;NFKBIA;RASGRP1;MAP2K5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.7878648078040744,-1.1896436568971307,0.22033898305084745,0.9257830121867849,1.0,1/6,1.95%,IL12A
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.5646983534274195,-1.1894771769261459,0.25757575757575757,0.9253693876219357,1.0,9/41,16.09%,DACT1;ALDH1A2;KIAA1217;SULF1;VEGFA;TGFB3;PTPRR;TGFB1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.6829931649212928,-1.1892694088586706,0.22033898305084745,0.9252050135098755,1.0,4/12,6.54%,NR4A3;HGF;MET;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.7553636424949405,-1.189148342550211,0.26666666666666666,0.9245563002068061,1.0,3/6,17.70%,FURIN;CDH3;LILRB1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.732437647959624,-1.1890914254609106,0.2857142857142857,0.9237514626137919,1.0,4/9,13.40%,GAP43;DGKD;HTR2B;CHRM1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.5480937335794984,-1.188917275701267,0.23529411764705882,0.9235895403569517,1.0,13/53,17.41%,STMN2;EPHA4;EFNA1;THY1;NGEF;KIAA0319;ITM2C;EFNB2;RTN4RL2;PRAG1;NGFR;OMG;TRPV4
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.7585609034304711,-1.18891609468009,0.2835820895522388,0.9225293241447343,1.0,3/7,14.82%,TGFB2;ZFPM1;NOTCH2
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.7070201302889187,-1.1887987191857192,0.24528301886792453,0.922133565861295,1.0,2/9,12.69%,PPARG;LRP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6797654619449539,-1.1886327599349362,0.2727272727272727,0.9217723457871655,1.0,5/13,19.99%,P2RY12;CSF1R;CXCL17;CX3CL1;IL34
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.8083087705449574,-1.188428327802215,0.3508771929824561,0.9216694323545819,1.0,2/5,8.34%,MAOB;LRTOMT
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.7448898292853939,-1.188370746725499,0.28846153846153844,0.9209294119908268,1.0,2/5,4.62%,GPIHBP1;SOX9
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.7846097590962973,1.1882648394701476,0.3684210526315789,1.0,1.0,1/5,9.46%,KDM1B
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.6253356516285973,-1.1882527415809339,0.18571428571428572,0.9205038191618407,1.0,5/21,12.24%,MUSK;UNC13C;LRRK2;CACNB1;CACNB2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.48992453974218897,-1.1882473770294781,0.17105263157894737,0.9194656423319897,1.0,31/166,17.47%,PKP2;DPP10;TNFRSF1A;KCNIP4;PDZK1;ANK1;LRRC4;RFTN1;RAB11A;ZDHHC15;RAB3C;LIN7A;CPE;THY1;HPS6;RAB3A;KCNB2;KCNB1;CAV3;CAV1;PACSIN1;CACNB2;DLG4;FLOT1;LRRC7;FYB1;RAMP1;RAB15;MRAP;NRXN1;FGF13
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.580997088783703,1.1882180849130288,0.21428571428571427,1.0,1.0,1/18,2.05%,RIDA
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.6701248447479162,1.1881702925754556,0.3333333333333333,1.0,1.0,3/10,9.69%,MYRFL;KLK6;PIDD1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.6719234173711041,-1.187868044237845,0.24193548387096775,0.9202907163418814,1.0,4/11,27.33%,ADRA1B;ADRB2;ADRA1A;AKAP13
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.4756275463226971,1.1876411902391533,0.2631578947368421,1.0,1.0,15/102,7.30%,CYP1A2;VDR;C6;F2;EPB41L4B;LEPR;F11;HMGCS1;MSMO1;MTTP;CYP2E1;GJB1;RND3;SDC2;HSD11B1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.6948373903352025,-1.187469697613015,0.21311475409836064,0.9210693733291041,1.0,4/17,4.94%,TGFB2;NCKAP1L;EDN1;LGALS3
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.5804479967069847,-1.1866636157334816,0.208955223880597,0.9238251211679733,1.0,5/45,19.74%,WNT8B;AMER1;CAV1;LIX1;PPP1CA
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.510794316856017,-1.1865074025241864,0.19444444444444445,0.9234763797299813,1.0,29/99,23.35%,CLDN5;DACT1;DTX3L;LRRK2;B2M;ADD2;LRPAP1;CAMK1;PRMT8;CAV1;NMD3;LRP1;FLOT1;CARD18;ZFPM1;IFIT1;CDKN1A;DISC1;IFIT2;PPP1CA;ADD1;PIN1;AURKA;CTSZ;RALB;EFHB;ITGB1BP1;DDX11;PRKCD
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5929897924650901,-1.1864159853764402,0.25,0.9228289578983864,1.0,6/21,14.99%,CPS1;EDN1;NOS1;HTR2B;EDNRB;AGT
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.6931422398798296,1.1863352423521412,0.3170731707317073,1.0,1.0,1/9,6.98%,CCNT1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.6693527217286507,1.1862586001903075,0.32558139534883723,1.0,1.0,1/15,6.68%,ATG9A
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.6264811842542652,-1.1861144793483653,0.20689655172413793,0.9229031614630473,1.0,6/18,15.07%,HEY1;SOX9;ROBO2;EFNA1;TIE1;TGFB1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.7170228844302386,1.185496949912661,0.22448979591836735,1.0,1.0,2/10,4.47%,VASH1;RSL1D1
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.7575499963595356,-1.185486186829114,0.2711864406779661,0.9247367649083287,1.0,3/5,14.16%,E2F3;E2F1;PID1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.719710459615214,-1.185446889189267,0.234375,0.9238911523263403,1.0,4/8,20.44%,STK17B;STK17A;BTG1;GAS6
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.5386590717542322,1.1848355101991563,0.2,1.0,1.0,2/41,3.55%,CFAP61;TTC29
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.6894826912408896,1.184705439785895,0.3170731707317073,1.0,1.0,1/6,0.70%,DHFR
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.7436721552295291,-1.1846135193556646,0.2542372881355932,0.9270996023855865,1.0,4/11,17.70%,NOS1;PLN;CAV3;LILRB1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5535819021981017,-1.1845523933434243,0.24242424242424243,0.926429683464756,1.0,15/42,12.73%,DPEP2;SLA;PTPRC;IL6R;NCKAP1L;GMFG;SELL;AOAH;LAPTM5;CD53;IL16;GPR183;IKZF1;TNFRSF1B;ARHGAP25
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.7207842429024023,-1.1844942111688121,0.29850746268656714,0.9256180793190207,1.0,3/7,12.42%,TIMP1;CCND1;EGFR
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.7016808917065361,1.1844507124221655,0.2894736842105263,1.0,1.0,3/9,6.45%,HMGA2;ZNF639;HDAC1
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.7204012850942096,-1.184326196113298,0.24528301886792453,0.9252594672082188,1.0,5/10,17.33%,PTPRC;TNFRSF1B;NR1D1;CD200;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.7592085967385054,-1.1842797284956497,0.30303030303030304,0.9244180604839036,1.0,2/7,8.25%,EPHA4;THY1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.6405149691043691,-1.1841600860950434,0.26153846153846155,0.9240067288900278,1.0,4/13,13.32%,TLR2;ROBO2;B2M;PAX6
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.5034613482119444,-1.1840522287592186,0.17105263157894737,0.9235743965400213,1.0,32/88,19.95%,KCNK10;KCND2;KCNV1;KCNQ3;KCNS1;KCNJ4;KCNJ6;KCNJ3;AQP1;KCNMA1;KCNH7;KCNQ5;HCN1;KCNK6;KCNC2;SLC9C1;SLC24A1;KCNB2;KCNB1;SLC9C2;ABCC9;KCNH5;KCNH2;HPN;KCNK1;SLC24A4;KCNC3;KCNJ13;KCNG3;KCNH1;SLC9A7;KCNC4
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.75672147974624,-1.1839553100450084,0.3275862068965517,0.9230882732822904,1.0,1/5,6.24%,CAMK1D
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.6877371231294837,1.183916001043336,0.3333333333333333,1.0,1.0,4/9,20.07%,TPR;AHCTF1;NDC1;RTN4
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.49672147537055217,1.1836700940254223,0.16216216216216217,1.0,1.0,14/40,23.79%,NASP;ACTR5;HDAC1;SMARCA4;GATAD2B;RNF8;RBBP4;CHD4;DMAP1;HNRNPC;SPTY2D1;ARID1B;PBRM1;SMARCA5
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.48733527543997823,-1.1836009739421807,0.2077922077922078,0.9235879772955431,1.0,37/135,23.68%,TLR2;DACT1;SFRP4;PLEKHA4;RSPO4;PSMB8;LRRK2;ATP6V1C2;SULF1;AMER1;GPC5;CAV1;CDH3;EGFR;GPC3;DEPDC1B;DAPK3;TGFB1;ATP6AP2;PTK7;DISC1;TMEM9;WNT5B;PSMC3;WLS;PRDM15;PIN1;PSME1;LRRK1;SCEL;ZBED3;FZD9;UBE2B;PSMC5;RSPO2;PSMA3;LYPD6
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.562824646836814,1.1835767608409455,0.19444444444444445,1.0,1.0,11/35,19.86%,NUTF2;MALT1;GEMIN6;SNUPN;ANP32A;NXT2;NPM1;GEMIN5;RBM15B;SMN1;SNRPB
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.6507544311412543,-1.1835427282886293,0.2459016393442623,0.922807850876716,1.0,2/27,2.16%,TTC8;ARL13A
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.6836108377666411,-1.1832472157720113,0.16923076923076924,0.9230338253282312,1.0,5/13,17.70%,TGFB2;LAPTM5;TGFB3;TGFB1;LILRB1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.5564658869698047,-1.1829174111015368,0.23076923076923078,0.9235209980019442,1.0,2/51,1.36%,IRGM;ATG16L2
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.6877116819873236,1.182619762358324,0.2978723404255319,1.0,1.0,3/8,14.62%,GTF3C6;GTF3C5;POLR2L
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.55785621122603,-1.1818553182574343,0.2,0.9277213147305339,1.0,6/43,6.10%,ITGB4;SMIM22;DUOX1;MUC16;TMC4;SFTPD
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.8212191625631334,-1.1817741114175642,0.25806451612903225,0.9271250096380839,1.0,1/5,4.18%,EDN1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.5048688009266392,-1.1817733118688196,0.14285714285714285,0.9260844652950557,1.0,34/139,16.92%,LPL;IRGM;WNT8B;MGST1;TWF2;EPHA3;SSTR1;MEF2C;BRINP2;VIM;SOX9;NLRP3;AQP1;CX3CR1;FES;AR;XBP1;LDOC1;AXL;ADCY8;BRINP1;LYN;ABCB4;TNFRSF1B;EGFR;ATP1A1;PID1;ZFP36;BRINP3;NR1D1;LY96;PTK7;GIT1;WNT5B
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.49879348858661393,-1.181766713433725,0.12162162162162163,0.9250462540110925,1.0,27/108,19.13%,CLDN5;IGFBP3;MCTP1;TIMP1;ARHGAP4;ADGRG1;CITED2;EPHA4;PTPRG;TMIGD3;GJA1;THY1;NAV3;ATP1B2;SULF1;PTPRR;LRP1;PTPRT;TP53INP1;NGFR;SRGAP1;PTPRJ;CX3CL1;VCL;TPM1;NDRG4;CDH1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.7618585508778313,-1.1813748488721363,0.18181818181818182,0.9256910965496797,1.0,3/8,16.54%,MEF2C;LYN;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.7229978006551271,1.1808580509449582,0.38461538461538464,1.0,1.0,2/5,18.02%,NUMA1;GNAI1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6055592187614347,1.1808080457369423,0.22857142857142856,1.0,1.0,4/29,6.45%,CDSN;TXNIP;TGM1;HDAC1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.5526083119901394,-1.1807962915326493,0.15789473684210525,0.9275475999860201,1.0,13/67,15.15%,SEMA3E;CBLN2;TGFB2;L1CAM;GRM5;SNCB;SLC8A3;PAK3;TGFB3;TJP3;OPHN1;TGFB1;MYOT
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6286136052377032,1.1807707938140986,0.37037037037037035,1.0,1.0,3/11,18.50%,HNRNPU;HES5;JAG1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.7364331825984549,-1.1806500251241403,0.3114754098360656,0.927192842245045,1.0,2/7,15.07%,ACMSD;TGFB1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.6570522202343424,1.1804408840629532,0.3181818181818182,1.0,1.0,2/9,17.65%,SRPK3;POGLUT1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.5433154349365641,-1.180375607278466,0.28378378378378377,0.9272171250234654,1.0,6/53,16.58%,SOX9;CCND1;CSF1R;CEBPB;CDKN1A;MOV10
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.5308901622151448,-1.180105873944285,0.16176470588235295,0.9275436152337253,1.0,19/63,19.62%,LAMC1;MEF2C;NTN4;ACTN1;ATRNL1;NTNG1;DACT2;EFNA1;LAMB1;TEK;FERMT3;OPHN1;SPI1;ITGAV;NTNG2;LAMB4;ANTXR1;LAMB2;EPHB3
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.6673212525351466,1.1800346822433174,0.27906976744186046,1.0,1.0,5/11,19.18%,HMGA2;CDK6;YBX1;ZKSCAN3;SIRT1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.5009711035229348,-1.1800125872125626,0.1780821917808219,0.9269312542497223,1.0,19/76,13.79%,FSTL1;ADAMTS5;ACTA2;PPP1R3C;FAP;COL4A1;PLSCR4;DKK3;AQP1;GJA1;PALLD;THY1;TEK;LMOD1;SULF1;PRKG1;LDB2;LRP1;DDR2
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.6557035091735371,-1.179871014792481,0.2857142857142857,0.926567989513502,1.0,10/17,20.92%,PKP2;FGF12;SCN4B;SCN1B;ATP1A1;CACNA1G;CACNA1C;SCN1A;SCN3B;KCNE1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.49301794607034793,1.1796377585226385,0.18518518518518517,1.0,1.0,8/64,10.56%,NGF;PLXNA1;CHODL;ZNF335;SLIT2;SMARCD3;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.7929705424830801,-1.1796171494958174,0.24074074074074073,0.926883353612044,1.0,1/5,6.87%,GRM5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7634836423691373,1.1790960679583407,0.2857142857142857,1.0,1.0,2/9,9.89%,SSC5D;PTPN22
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7158032363833301,1.179038871316343,0.28125,1.0,1.0,1/8,6.28%,LRRC8A
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.587734101143653,-1.1789153344572119,0.2714285714285714,0.9289820414979932,1.0,9/22,18.56%,TRPC4;CACNA1E;CACNA1B;SLC8A1;CACNB2;CACNA1G;CACNA1C;TRPV4;CACNA1A
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.7279461225039991,1.1789098088191463,0.3,1.0,1.0,1/5,3.02%,SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.7279461225039991,1.1789098088191463,0.3,1.0,1.0,1/5,3.02%,SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5397047960810953,1.178871099106915,0.20930232558139536,1.0,1.0,6/33,13.50%,NUPR1;LCK;NCK1;UBB;STYXL1;BECN1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.5721218100940112,-1.1781501938598893,0.1875,0.9312907803071582,1.0,4/34,4.48%,TIMP4;CR1;TIMP1;SERPING1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.6969755542913506,-1.1780164211904074,0.30303030303030304,0.9308170636092893,1.0,4/8,28.48%,ALOX12;GPX4;GPX1;HPGD
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.7760666281240429,-1.1779884499613993,0.234375,0.9298623789791676,1.0,1/5,0.91%,ABCC4
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),-0.7853613437499374,-1.1779008965810795,0.30612244897959184,0.9293484889918194,1.0,2/5,8.80%,ADGRV1;TCIM
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.5297926807226442,-1.177752256227102,0.16216216216216217,0.9289105481633614,1.0,18/73,22.90%,DACT1;APC2;HECW1;FURIN;AMER1;C4BPA;NEDD4L;TNFRSF1B;TRIM32;GPC3;OAZ3;PLK2;SNX33;DTL;VPS35;C4BPB;WNT5A;ADAM9
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4495485814241393,-1.1777508246285682,0.15,0.9278970670357563,1.0,41/353,12.38%,CD44;PYGL;GGH;TLR2;FGL2;MGST1;CR1;CD59;PTPRC;FRMPD3;ITGAM;NCKAP1L;GMFG;NBEAL2;CAPN1;AGL;SELL;PLAC8;DOK3;LGALS3;SNAP25;ANO6;CD53;CEACAM1;B2M;C3AR1;FUCA2;CHI3L1;PTAFR;BST1;GYG1;CYFIP1;DYNC1LI1;RAB3A;PTPRB;CST3;DGAT1;DSN1;ADGRE3;TNFRSF1B;APAF1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.5852362848588231,1.1777346651538265,0.18181818181818182,1.0,1.0,5/18,24.74%,EIF5;EIF3D;EIF2S2;EIF3M;EIF4B
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.7061697489937454,-1.177558121916764,0.2727272727272727,0.9276856391781687,1.0,4/8,27.33%,ADRA1B;ADRB2;ADRA1A;AKAP13
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6379907887084048,1.1774385183936737,0.2903225806451613,1.0,1.0,2/17,10.16%,AUP1;TMEM129
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.8404013043453619,-1.177363324129455,0.24193548387096775,0.9274320663194952,1.0,2/5,7.20%,P2RY12;CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6073529995999238,-1.1768634505434172,0.2361111111111111,0.9286474868393397,1.0,6/23,10.80%,HLA-F;HLA-E;LAPTM5;HLA-A;B2M;CD160
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.6845776173320284,-1.176685652652472,0.3888888888888889,0.9283827856959576,1.0,2/9,11.83%,H1-0;LIN54
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.6238372676032863,-1.1762815223342475,0.21052631578947367,0.9291697981265032,1.0,5/21,12.37%,DUOX1;CSF1R;LYN;VEGFA;TRIM32
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.5252695455573135,-1.176253227615174,0.27692307692307694,0.9282687521479218,1.0,20/65,20.53%,PPP1R17;EPHA3;ARHGAP15;VAV3;NOS1;EPHA4;SIPA1L1;FGD5;PRKG1;CHN1;CAV1;NGEF;WRN;PLXNA2;EFNA5;PLXNA4;PLXNC1;PLXND1;EPHB3;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),-0.7496212192586758,-1.1760696067801195,0.3090909090909091,0.9282066253822293,1.0,2/5,6.54%,TMEM25;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.5834258207371287,-1.1757634635102499,0.2537313432835821,0.9286526037465483,1.0,11/35,18.35%,TIMP4;TIMP1;NELL1;CST3;EGFR;AZIN1;TIMP3;MAD2L1;MAD2L2;RIC1;PRKCG
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4497744749871271,-1.1754336048784269,0.15,0.9292033197719235,1.0,41/350,12.38%,CD44;PYGL;GGH;TLR2;FGL2;MGST1;CR1;CD59;PTPRC;FRMPD3;ITGAM;NCKAP1L;GMFG;NBEAL2;CAPN1;AGL;SELL;PLAC8;DOK3;LGALS3;SNAP25;ANO6;CD53;CEACAM1;B2M;C3AR1;FUCA2;CHI3L1;PTAFR;BST1;GYG1;CYFIP1;DYNC1LI1;RAB3A;PTPRB;CST3;DGAT1;DSN1;ADGRE3;TNFRSF1B;APAF1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.7866787532551017,1.175402133812712,0.2894736842105263,1.0,1.0,1/5,5.29%,NOS1AP
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.4709060640985574,-1.1752662946256724,0.14814814814814814,0.928802469471938,1.0,13/133,11.30%,CERS6;CPS1;MGST1;GCNT1;PCSK1;PAM;CHKB;ARG2;SLC44A3;SGPP2;SGMS2;FURIN;ABHD3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.7013814670143014,-1.175260952254081,0.2542372881355932,0.9278328945179409,1.0,3/12,10.80%,SFRP4;ANO6;CD160
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.6958424361934308,-1.1747098074495401,0.22413793103448276,0.9293520749397346,1.0,1/12,1.19%,NR4A3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.4557996115728844,1.174563318100431,0.09090909090909091,1.0,1.0,15/106,11.93%,ABCA13;SLC22A2;TXNIP;SLC22A6;ABCA8;SLC47A1;ARRDC4;ARRDC5;ARRDC3;CEP290;CUBN;SCAMP2;CMTM6;ABCA6;RILP
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5459989602835997,1.1745375254949268,0.1891891891891892,1.0,1.0,8/35,10.82%,SLC22A2;SLC38A1;SLC38A2;SLC47A1;SLC7A11;SLC38A7;SLC6A13;SLC38A3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.6466930351330594,-1.174502774324955,0.24615384615384617,0.9293102261834478,1.0,3/18,6.70%,YBX3;SCN2A;AQP1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.6769266235333098,-1.1744242879101805,0.25396825396825395,0.928732266961153,1.0,3/13,7.67%,PYGL;AGL;PHKG1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.7304863720677287,1.1741103666710413,0.29545454545454547,1.0,1.0,1/7,2.23%,PIK3C2G
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.4915676833919447,-1.1740089131514868,0.16176470588235295,0.9298149325281112,1.0,20/120,17.08%,IRGM;DACT1;TRIM5;TRIM22;DTX3L;LAPTM5;LRRK2;PRXL2C;PFKFB2;FURIN;AMER1;DAPK1;TNFRSF1B;TP53INP1;GTPBP1;ABCD2;PLK2;PIK3CB;MOV10;PNPLA2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6840583389824493,-1.173922160278679,0.27692307692307694,0.9290803142925074,1.0,3/12,14.64%,YBX3;ELAVL4;ZFP36
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.5900385140709217,-1.173901475308553,0.27419354838709675,0.928116734581912,1.0,6/23,11.55%,NOS1;CHGA;SLC8A1;PLN;CALM3;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.5903707988985135,-1.1737643616028401,0.23880597014925373,0.9277205257820237,1.0,7/32,17.33%,FBLN1;SEMA3E;PLET1;RASA1;EFNA5;DMTN;CX3CL1
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.7473504763964035,-1.173701487946757,0.36363636363636365,0.92709511911846,1.0,3/5,22.50%,CAV1;FLOT1;COLEC12
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.668043532318955,-1.1732571673508976,0.23809523809523808,0.9281632654346976,1.0,2/11,4.62%,SFRP4;SOX9
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.5396078129033302,-1.1729896982951056,0.23529411764705882,0.9284360918533285,1.0,6/66,4.17%,DLK2;HEY1;TGFB2;MFNG;DTX1;ENHO
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.5967594876927937,1.1726492240180038,0.21052631578947367,1.0,1.0,1/25,0.06%,MDGA2
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.6825883244035857,-1.1724060105773613,0.2413793103448276,0.9298340379846923,1.0,3/12,15.07%,H1-0;PAX6;TGFB1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.5154740244080995,-1.172381374459174,0.17647058823529413,0.9289799845201482,1.0,35/116,20.21%,TRPM1;FSTL1;PPARG;LAMC1;FAP;COL4A1;SOX9;CCN5;DKK3;CCND1;TYRP1;FILIP1L;WWTR1;LAMB1;PALLD;SYNC;GLI3;SLC45A2;CAV1;TYR;EGFR;DDR2;TIMP3;ITGAV;GNG12;ANTXR1;EPAS1;PRICKLE2;LAMB2;CCDC80;OSMR;MLANA;PLAT;ANGPTL2;COL12A1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.6527664635421202,-1.1719029450718388,0.25757575757575757,0.9300207153889981,1.0,5/17,17.98%,FAP;FURIN;NEDD4L;TMEM9;FAM83D
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.5438729861661736,-1.1717603194971633,0.21739130434782608,0.9297605051205746,1.0,14/57,15.99%,RND2;ARHGAP18;BAIAP2;TWF2;EPHA3;SMIM22;PEAK3;RHOC;BST1;PAK3;LRP1;RAC3;EFNA5;DMTN
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.7941814200850067,-1.1716202613130955,0.3275862068965517,0.9295838808585194,1.0,1/6,2.06%,TGFB2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5839139056669558,-1.171565880243675,0.18840579710144928,0.9287648550891157,1.0,2/38,2.93%,MDFIC;IFITM3
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.6117523872614092,1.1713937273641537,0.2903225806451613,1.0,1.0,4/19,5.75%,CASQ2;EPHB2;DRD4;CLIC2
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.6680583870297909,1.1712091147373136,0.29411764705882354,1.0,1.0,3/11,5.32%,CDK10;TESK1;EVI5L
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.613021228383604,-1.1711719868442378,0.2923076923076923,0.9295942371851779,1.0,8/23,17.60%,P2RY12;CYFIP1;CDH13;CARMIL1;ABLIM2;ABLIM1;DMTN;VCL
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6017575547426897,-1.1709876608697853,0.18181818181818182,0.9295942261207263,1.0,5/18,14.51%,NLRP12;NLRP3;IFI35;NMI;SPI1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.6141449991512291,-1.1704414617662409,0.28,0.9308963269727695,1.0,6/21,19.43%,STAT5A;NMI;IL31RA;STAT1;STAT3;STAT4
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.49462691161789923,-1.1704105448777147,0.23076923076923078,0.9300277786338939,1.0,33/97,19.95%,KCNT2;KCNK10;KCND2;KCNV1;KCNQ3;KCNS1;KCNJ4;KCNJ6;KCNJ3;KCNH7;KCNQ5;HCN1;KCNK6;ATP1B2;KCNC2;SLC9C1;SLC24A1;KCNB2;KCNB1;SLC9C2;ABCC9;KCNH5;ATP1A1;KCNH2;HPN;KCNK1;SLC24A4;KCNC3;KCNJ13;KCNG3;KCNH1;SLC9A7;KCNC4
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),0.7491763683806707,1.1703061336338407,0.39473684210526316,1.0,1.0,1/6,2.29%,OAS3
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.685703960148986,-1.1702960517715562,0.18032786885245902,0.9296354419097741,1.0,4/19,4.94%,TGFB2;NCKAP1L;EDN1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.46225916800943645,-1.170258059496015,0.16455696202531644,0.9288215891122481,1.0,46/199,20.39%,PDGFD;SEMA3E;VSIR;VIL1;TGFB2;PTPRC;SMIM22;NCKAP1L;EDN1;SOX9;CARMIL2;F3;HGF;CEMIP;CSF1R;SEMA3D;RAB11A;RHOC;LAMB1;XBP1;PLET1;CDH13;CARMIL1;VEGFA;CAV1;CLDN4;TRIM32;EGFR;FERMT3;DDR2;SEMA4B;GTSE1;TGFB1;DMTN;SEMA4G;PPP3CA;WNT5B;NTRK3;STAT3;CXCL16;KIF20B;NEDD9;PLCG1;SEMA6B;RREB1;PDGFRB
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6435864585494546,1.1700378258881543,0.2619047619047619,1.0,1.0,2/9,5.60%,ACTN2;EHD2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6599710579820662,1.1699565050941516,0.2972972972972973,1.0,1.0,1/11,1.34%,RAB27A
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.5943923712316829,1.169877645636496,0.24324324324324326,1.0,1.0,4/18,21.20%,SAP18;PTBP1;TMBIM6;SRSF9
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.6726795796553945,-1.1693864950059636,0.2571428571428571,0.9316007782266593,1.0,11/17,24.09%,TTN;SORBS2;MYH11;SLC8A1;VEGFA;FHOD3;MYLK3;ALPK2;PDGFRB;HEY2;MYH6
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.6126768533452338,-1.1693065179888877,0.25,0.9308790813294608,1.0,4/30,10.70%,NR4A3;CHGA;HPS6;RAB3A
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.44755077490868994,-1.169175787031307,0.15,0.9304669691157862,1.0,41/352,12.38%,CD44;PYGL;GGH;TLR2;FGL2;MGST1;CR1;CD59;PTPRC;FRMPD3;ITGAM;NCKAP1L;GMFG;NBEAL2;CAPN1;AGL;SELL;PLAC8;DOK3;LGALS3;SNAP25;ANO6;CD53;CEACAM1;B2M;C3AR1;FUCA2;CHI3L1;PTAFR;BST1;GYG1;CYFIP1;DYNC1LI1;RAB3A;PTPRB;CST3;DGAT1;DSN1;ADGRE3;TNFRSF1B;APAF1
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),-0.7894008602828262,-1.1687244555309686,0.2857142857142857,0.9315943685951926,1.0,4/5,17.33%,C1QB;CX3CR1;C1QC;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.5983215722642476,1.1685627394618208,0.2564102564102564,1.0,1.0,2/13,5.29%,DHFR;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.6410972176921694,1.1683992876785958,0.3023255813953488,1.0,1.0,6/10,22.27%,PIH1D1;SMARCA4;NCL;MARS1;NOL11;MTOR
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.7470741786612924,-1.1682619876692688,0.2727272727272727,0.9325861744772536,1.0,4/8,13.32%,IFNA2;GPR183;IFNA6;IFNK
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.6901875369512587,-1.1679241068747999,0.29850746268656714,0.933217626869187,1.0,1/12,1.44%,PPARG
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.6377665679007634,-1.167859727597924,0.29508196721311475,0.9325593836450584,1.0,1/15,0.86%,NEFL
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6835789914391113,-1.1678266779492412,0.26785714285714285,0.9316778143102599,1.0,3/11,19.99%,ID2;C1QC;IL34
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5923998412280389,1.1674116902304177,0.2682926829268293,1.0,1.0,3/11,10.29%,B4GALNT2;GALT;GFPT2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.5405909182925994,-1.1673598966235872,0.22727272727272727,0.9326959624758125,1.0,13/47,15.10%,DPP10;KCNIP4;KCNIP1;KCNJ4;KCNJ6;KCNJ3;KCNMA1;GABBR2;CAV3;CAV1;NEDD4L;GNG2;KCNH2
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.6222151869167163,1.1672770445443192,0.21875,1.0,1.0,2/15,6.14%,CEP55;CHMP5
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.5908492569491418,-1.1668298196225926,0.3,0.9342725714856568,1.0,8/39,15.99%,NCKAP1L;ID2;GATA1;LYN;IKZF1;VEGFA;ZFPM1;DMTN
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.5518964709380703,1.1668032672949085,0.25925925925925924,1.0,1.0,4/25,4.56%,ICAM1;AGER;ABCC1;IGF1R
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.5390002897504818,-1.1667827703012095,0.16176470588235295,0.9335345308954663,1.0,27/74,16.38%,NEFL;SHISA6;CACNG2;KCNS1;MEF2C;FGF12;CAPN1;NOS1;HPCA;JPH4;CACNB1;JPH3;GRIN2B;CACNG3;DAPK1;GRIA1;CACNG8;CACNB2;DLG4;FGF14;GRIA3;NETO1;LRRC7;GSG1L;OPRM1;CAMK2B;FKBP1B
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.4787792570173608,1.166521045045654,0.21621621621621623,1.0,1.0,15/61,21.20%,U2AF1;CPSF4;PCF11;TENT4A;CSTF2;RBM8A;SYMPK;TENT4B;SARNP;PNPT1;THOC2;MAGOH;ALYREF;CSTF1;SRSF9
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.533785118855349,-1.1665153191925217,0.29411764705882354,0.933652437760036,1.0,5/45,13.25%,TRPM1;SLC24A1;TYR;TRIM32;UVSSA
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.7868213600834079,-1.1664160735949531,0.2909090909090909,0.9331299718695769,1.0,2/5,16.60%,SIGLEC10;GIT1
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6394706578220923,1.166353942065091,0.2682926829268293,1.0,1.0,3/13,15.51%,TPR;DNMT1;RESF1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.587029747218396,-1.1662591076853368,0.2878787878787879,0.9328319028042167,1.0,5/22,14.78%,PARP9;TIMP1;NOS1;PLN;IFIT1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.616791785091262,-1.1661486009390312,0.31746031746031744,0.9323823663637218,1.0,11/30,18.59%,SEMA3E;BAIAP2;BAIAP2L2;CSF1R;FES;TEK;DAPK3;NOTCH2;TRPM2;NTRK3;CDK5
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.4967513653881274,-1.1657928960571609,0.1643835616438356,0.9327035617696992,1.0,32/127,15.61%,BCHE;ITGB4;GFRA3;NPY;SPARCL1;SHISA6;TCEAL6;LAMC1;GAP43;CHST1;ASTN1;CNTFR;CADM3;DCLK1;AQP1;PCDHB4;CPE;THY1;LMOD1;CTHRC1;SCN4B;MATN2;OPCML;EDNRB;AQP4;TST;PHYHIP;MAPK4;GPR37L1;AGT;ADCYAP1R1;NGFR
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.6110079566371623,1.1657739554406645,0.2702702702702703,1.0,1.0,3/9,15.09%,SLC12A9;SLC12A4;SLC12A2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.6110079566371623,1.1657739554406645,0.2702702702702703,1.0,1.0,3/9,15.09%,SLC12A9;SLC12A4;SLC12A2
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.5019431266229344,-1.1657226451245317,0.1794871794871795,0.9321134434043946,1.0,31/97,14.56%,TLR2;IL13RA1;RASSF4;CEBPD;C1QB;OLFML2B;SERPING1;SLC7A7;CSF1R;LRRK2;KCTD12;CX3CR1;TCN2;KCNMA1;TMIGD3;C3AR1;CHI3L1;MMP19;CST3;SLAMF8;EPHB1;LRP1;HNMT;C1QC;ITPR3;TMEM176B;PID1;SNX10;LTB4R;FCGR3A;EFNB2
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.7298895083997977,-1.165720329323659,0.2545454545454545,0.9311404648622188,1.0,2/6,18.85%,AQP11;USP14
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.7228159871086164,-1.1656045961214183,0.288135593220339,0.9306440814525643,1.0,1/6,11.62%,VEGFA
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.603823417194297,-1.1653068016124868,0.28125,0.9307841899060689,1.0,9/22,24.83%,ENO4;PFKFB2;LDHA;PGK1;PFKM;GPI;GAPDHS;PFKL;ALDOB
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.6861194127342031,-1.1652272742209733,0.31746031746031744,0.9300675353230661,1.0,4/11,11.62%,TTN;MYH11;SLC8A1;VEGFA
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.7127294078862944,-1.1651601292059826,0.3235294117647059,0.9293423050059055,1.0,6/11,24.09%,TGFB2;ZFPM1;NOTCH2;MESP1;HEY2;MYH6
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6954339663757259,-1.1646270698712577,0.3275862068965517,0.9311524933262194,1.0,2/10,3.07%,IRGM;IRF1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.7368844910538317,1.1645722353245314,0.3617021276595745,1.0,1.0,1/5,2.26%,KIF3B
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.6408064456427275,-1.164517162724456,0.2903225806451613,0.9307892541480143,1.0,3/19,12.37%,TRIM5;TRIM25;TRIM32
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.4581174836578577,1.1644885758396526,0.25,1.0,1.0,8/75,4.23%,GPC4;PTH;VDR;SLC22A6;SOWAHA;FGFR1;LGI2;DUSP15
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.5179056091464955,1.1637768841654663,0.2702702702702703,1.0,1.0,9/35,13.55%,PYCR1;OPRD1;BAK1;PRELID1;ABL1;SLC25A33;AKT2;UBB;PRDX3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5997069188183838,1.163698634444606,0.275,1.0,1.0,3/14,8.53%,F2;CHID1;NLRP7
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.48300434333064624,-1.1635470770601406,0.2125,0.9337381093416308,1.0,24/125,9.08%,OLFML1;ADAMTS5;TLR2;MEST;PPARG;EPSTI1;ROBO4;TMEM26;ACTA2;OLFML2B;COX7A1;TIMP1;MAOB;FAP;ASPN;PLSCR4;BCAT2;SERPING1;ECM2;AQP1;MPZL1;AR;LMOD1;PDE3B
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.4861817005182414,-1.1635220999235558,0.17105263157894737,0.9329218664555464,1.0,31/104,13.79%,ANGPT1;FSTL1;ADAMTS5;SPARCL1;ROBO4;ACTA2;COX7A1;FAP;ASPN;GPIHBP1;COL4A1;PLSCR4;SYNPO2;SERPING1;VIM;ECM2;INPP4B;ANGPT2;AQP1;THY1;P2RY14;TEK;LMOD1;PDE5A;ADGRF5;VEGFA;STEAP4;ABCC9;LDB2;SLC38A11;DDR2
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.6283980559196646,-1.1634667946916,0.27941176470588236,0.9321573798392657,1.0,6/19,15.44%,TEKT3;DNAH2;DNAH7;CCDC39;RSPH9;CFAP44
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.7474877201995138,-1.1634249677312978,0.34545454545454546,0.931364462930584,1.0,3/6,12.34%,PTPRM;ROBO2;EPHB1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.5872705189123024,-1.1630843936370656,0.2714285714285714,0.9319222304040228,1.0,8/29,10.71%,VSIR;CR1;NCKAP1L;TESPA1;IL7;XBP1;HLA-DRB1;GLI3
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.5001192663540857,-1.1630727295330503,0.28125,0.9310113990604393,1.0,28/104,19.66%,PKP2;TGFB2;MEF2C;FGF12;TGFBR2;ID2;SOX9;CITED2;MMP21;TEK;VEGFA;HTR2B;SYNPO2L;SMYD4;GPC3;FLRT2;ZFPM1;TGFB1;CDKN1A;CACNA1C;MTHFD1;POU6F1;NTRK3;KDM6A;ALPK2;MICAL2;NDRG4;KAT2B
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.6399651443790811,-1.1629125263311388,0.3088235294117647,0.9307905369002278,1.0,3/17,10.07%,NDST3;XYLT2;CSGALNACT1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.6006030550400588,-1.1626678894787168,0.18461538461538463,0.9309686133627989,1.0,3/22,3.07%,LPL;CPS1;FABP3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.7723206470369783,-1.1625125946199277,0.3137254901960784,0.9306785860967693,1.0,1/7,1.29%,VIL1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7097520190944628,1.1624624822953011,0.3225806451612903,1.0,1.0,4/11,12.55%,TCOF1;KBTBD8;NOLC1;CDH2
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.49069985525865534,-1.1623303809893855,0.21333333333333335,0.9304189793141162,1.0,30/122,12.17%,TRPM1;SLC5A4;KCNV1;TRPC6;TRPM3;KCNS1;ANO6;SLC1A1;KCNJ4;KCNJ6;SLC5A9;SCN2A;SLC23A1;SLC5A2;KCNJ3;AQP1;SCN9A;SLC5A12;KCNMA1;CNGB3;PKD1L3;SLC8A3;SLC8A1;KCNK6;SLC22A4;SCN4B;KCNB2;SLC18A2;NEDD4L;ABCC9
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5408352172713106,-1.1616436904732907,0.2463768115942029,0.9325732478258102,1.0,6/47,12.03%,ARIH2;TP73;NMT1;TOMM7;E2F1;YWHAH
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.6853183002573802,1.1613550212625894,0.28888888888888886,1.0,1.0,3/7,9.16%,CYBA;MFHAS1;TLR1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.6055192245067209,1.1612303617179383,0.3333333333333333,1.0,1.0,2/11,6.89%,GAB1;MYO1C
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.6762099740022527,-1.1612063902159404,0.2463768115942029,0.9334035721380887,1.0,2/15,11.62%,ROBO2;VEGFA
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.5342622401299327,1.1610966165608188,0.1875,1.0,1.0,6/47,11.19%,NUPR1;PSME2;OSBPL7;BAG2;UBB;COMMD1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.6989847414080841,-1.1610341415570098,0.3235294117647059,0.9331617956166005,1.0,1/8,2.23%,MFAP5
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.6494790193259318,-1.1609288112102807,0.3492063492063492,0.9326630878599148,1.0,7/13,18.03%,FAP;ANGPTL7;LRP1;TIE1;DDR2;AGT;RIC1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.6021836562851096,-1.160786429616454,0.2878787878787879,0.932293980272837,1.0,6/25,11.55%,STMN2;MET;FES;NAV3;CDK5R1;CAV3
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.7710286955682542,1.1602929025011666,0.29545454545454547,1.0,1.0,1/6,3.50%,RAE1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.7020267195655888,1.1602835148311057,0.2708333333333333,1.0,1.0,1/7,6.39%,ATF4
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5274982217276524,-1.1601044244876961,0.22058823529411764,0.9343266557608587,1.0,16/84,13.46%,IRGM;PDGFD;SPDYA;EDN1;CEMIP;CCND1;CSF1R;LRRK2;TCIM;DIRAS1;CAMK1;CALM3;VEGFA;HTR2B;EGFR;MTCP1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.6493735758819391,-1.1597674353880185,0.2537313432835821,0.9348647101171343,1.0,3/12,11.55%,TTN;SLC8A1;CAV3
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.5153023338020047,-1.159498473039885,0.28169014084507044,0.9352044554945658,1.0,14/70,15.54%,ARIH2;TGFB2;PTPRC;MFAP5;KITLG;TGFBR2;CSF1R;TPO;TEK;TOX;ZFPM1;NOTCH2;TGFB1;ETV6
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.4905533215725561,-1.1593763598908289,0.22058823529411764,0.9347456089185595,1.0,11/89,13.07%,ANGPT1;TGFB2;PAK5;TGFBR2;PRKAR1B;ADCY7;CHI3L1;ADCY8;PAK3;VEGFA;NRG1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.6345910840471773,-1.1593424890031543,0.2638888888888889,0.9339924764994473,1.0,5/17,10.80%,LGALS3;LAPTM5;CEACAM1;THY1;CD160
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.7557412760078837,-1.159033380570665,0.3389830508474576,0.9345385157564964,1.0,3/7,11.83%,CENPE;CENPF;CENPA
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.7279895346172205,-1.159030067108593,0.2727272727272727,0.9336103492403652,1.0,2/10,15.65%,ISG20;SETMAR
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.7407327733109257,-1.1589844963597187,0.29508196721311475,0.9328312240762265,1.0,4/8,20.87%,AXL;LILRB1;GAS6;MERTK
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),-0.7192474925852619,-1.1588066148349414,0.375,0.9325633163740916,1.0,1/6,4.32%,ID2
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.7154280986148671,-1.158144443684118,0.34545454545454546,0.9345870128428335,1.0,5/7,28.29%,KYNU;HAAO;NMNAT2;NMNAT3;QPRT
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.616255376337396,1.158034406029497,0.28888888888888886,1.0,1.0,2/7,16.75%,ANXA2;KIT
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.6844925680194713,-1.1579645374912406,0.32727272727272727,0.9342494060181313,1.0,2/11,12.30%,RNFT1;AQP11
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.6251527999414809,-1.1577833281327612,0.328125,0.9340101915929303,1.0,10/18,22.08%,TTN;MEF2C;MYH11;SLC8A1;VEGFA;NRG1;ALPK2;CBY1;MYOCD;MESP1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.6045472359528461,1.157666525906014,0.2972972972972973,1.0,1.0,7/17,16.83%,TCOF1;CAVIN1;GTF3C6;GTF3C5;GTF3A;MARS1;NIFK
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7210809672292245,-1.1576553290189948,0.3333333333333333,0.9335371893236121,1.0,1/8,1.59%,PLEKHA4
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.6571866256753368,1.1575248014157238,0.3333333333333333,1.0,1.0,2/8,11.94%,CYP2C8;LTA4H
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.7009956619000117,-1.1575179341772746,0.3225806451612903,0.9331821568323865,1.0,3/6,13.66%,SHISA6;GRIN2B;GRIN2D
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.7132222111751892,-1.1572425945367382,0.3333333333333333,0.9335487182108566,1.0,2/7,22.60%,MVB12A;VPS4B
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.5206338100226807,-1.157238854566631,0.23529411764705882,0.9326104782930567,1.0,6/38,14.63%,GPAT3;DGKD;DGKB;PLA2G12A;DDHD2;LIPI
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.4328953398032576,1.1572112251749884,0.15384615384615385,1.0,1.0,12/119,9.16%,TEAD2;VDR;HDAC10;NR2C2AP;MAML2;TAF13;HDAC1;TAF12;TEAD3;HDAC9;POLR2K;TAF5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.571930094793569,-1.1565493821327824,0.2535211267605634,0.9343087989276424,1.0,7/45,12.69%,DPP10;EPHA3;LGALS3;STAC2;STX3;EGFR;LRP1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.5529901247595663,1.1565107620450528,0.2647058823529412,1.0,1.0,9/20,26.49%,MDN1;NLE1;BRIX1;RPL23A;RPL3;RPL11;RPL5;RSL24D1;RPL10
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.7116011094285013,-1.1563087286079778,0.26666666666666666,0.9343429090014971,1.0,4/8,19.38%,NCKAP1L;BST1;SLAMF8;RHOH
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.7886023633235433,1.1558000839987153,0.21428571428571427,1.0,1.0,2/5,4.63%,HSPA1A;ACAA2
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.7074783302058405,-1.1551961401587425,0.35,0.9380736301044196,1.0,2/7,11.55%,MLIP;CAV3
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6849880190709743,-1.1551901387034669,0.2923076923076923,0.9371830817530921,1.0,2/11,6.25%,SLC22A9;SLCO4A1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5807164439300203,-1.1551426512053797,0.24561403508771928,0.9364105124835744,1.0,7/32,20.36%,FIGNL1;TERF2IP;PPP4C;H1-0;RAD50;RPA2;MRE11
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.574421706957981,-1.1549692994370127,0.25,0.9362005493411538,1.0,3/32,3.11%,FSTL1;KANK2;FAP
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.5180059903084316,-1.154754744791386,0.2608695652173913,0.936068315988843,1.0,17/69,15.08%,ITGB4;SMIM22;CDS1;L1CAM;ADGRG1;LGALS3;TMC4;HSD11B2;EFNA1;KIAA1217;SLC44A3;CBLC;CLDN4;AQP4;OVOL2;NR3C2;PPL
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.6477838150346685,-1.1547350399157281,0.31343283582089554,0.9352219353037399,1.0,6/11,11.62%,ANGPT1;CLDN5;DDAH1;CEACAM1;SH3GL2;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6330721955780063,-1.154389355028559,0.32142857142857145,0.9357178382396827,1.0,3/9,17.16%,BMP6;VEGFA;MAD2L2
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),0.7162302813507531,1.1543748649325443,0.3,1.0,1.0,2/6,10.06%,SELP;RPS6KA1
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.7369208962589204,1.1541687293182032,0.325,1.0,1.0,3/5,20.00%,SF3A3;SF3A2;SF3A1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.7436043790720139,1.1539556751009454,0.38095238095238093,1.0,1.0,2/5,9.23%,F2;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.7436043790720139,1.1539556751009454,0.38095238095238093,1.0,1.0,2/5,9.23%,F2;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.5220503402481771,-1.1537921481408793,0.2463768115942029,0.9372533332752212,1.0,8/60,15.36%,MMRN2;PPARG;SULF1;VWC2L;BMPR1B;BMPER;AGT;CNMD
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.6270901632586579,1.1536719344981299,0.24324324324324326,1.0,1.0,1/6,1.57%,SPX
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.7749837385427926,1.1536565632010873,0.2777777777777778,1.0,1.0,1/5,3.52%,RNF6
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.5234899225091162,-1.1534076302921408,0.2857142857142857,0.9379194884714199,1.0,14/79,17.95%,HLA-F;HLA-E;CENPE;HLA-A;HLA-DMA;HLA-DPB1;SH3GL2;DYNC1LI1;HLA-DRB1;AP1S2;KIF2C;KIF3C;ACTR10;KIF5A
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6028520054574467,1.1532422799341566,0.29545454545454547,1.0,1.0,9/14,26.78%,HDAC1;HDAC9;ELK4;HDAC4;HDAC3;SIRT1;SIRT7;SIRT6;SFPQ
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.7128330315105269,-1.1532363841748325,0.26153846153846155,0.9378246681174544,1.0,2/10,6.18%,P2RY12;RYR3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.7722800195683921,-1.1531435998304715,0.32727272727272727,0.937307358043232,1.0,4/5,22.68%,NLRP3;DENND1B;RSAD2;PRKCZ
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.6780235940958266,-1.1531266738220793,0.3076923076923077,0.9363976047952716,1.0,4/12,20.69%,IFITM3;TRIM32;ZFP36;TRIM13
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.49079757928696455,-1.1530637313103762,0.20512820512820512,0.9357293353514063,1.0,37/127,16.60%,RHBDF2;PPARG;TNFRSF1A;GPHB5;CYSLTR2;TSHR;NLRP12;PRKAR1B;NLRP3;AOAH;ADCY7;SIGLEC10;RXFP1;FNDC4;TEK;HLA-DRB1;ADCY8;FURIN;GPR176;LYN;GGT5;SLAMF8;TNFRSF1B;LRFN5;PTH2R;NPSR1;GNG2;FCGR3A;ADCYAP1R1;NR1D1;CD200;RAMP1;HRH2;SYK;CXCL17;PLK2;GIT1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.6559191534095281,-1.1530053361663546,0.30434782608695654,0.9350144988568583,1.0,8/14,17.33%,ANGPT1;LGALS3;MET;VEGFA;FGF7;SCG2;PTPRJ;CX3CL1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5185680544500203,1.1529156396195142,0.275,1.0,1.0,1/23,0.22%,CXCR4
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7450693578354919,-1.1522267703030793,0.288135593220339,0.9372385570842978,1.0,2/5,12.69%,LRPAP1;LRP1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.5117550644766418,1.1521765487996825,0.25,1.0,1.0,10/47,12.65%,SPIRE2;MSRB1;CASQ2;ZNF207;MSRB2;MAP7D3;WASF3;PSTPIP1;WASHC5;CORO7
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.7606653434472548,-1.1521237457494984,0.35714285714285715,0.9367626145550969,1.0,4/5,23.52%,MMP24;EPHB1;SCN1A;TMEM120A
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.46284402985793743,-1.15207209114326,0.2054794520547945,0.9360202255299799,1.0,35/187,12.37%,LPL;ASB4;IGFBP3;PPARG;TGFB2;OLFM1;KITLG;IL6R;NRCAM;MEF2C;TGFBR2;CDS1;ID2;BRINP2;SOX9;HGF;ZEB1;CDON;CEACAM1;LMO3;BMP6;WWTR1;GJA1;FES;AR;BOC;NELL1;XBP1;PLCB1;BRINP1;CEBPB;CAMK1;TGFB3;BMPR1B;TRIM32
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.6263706088577987,-1.152014032969827,0.265625,0.9353365397271328,1.0,7/18,15.07%,BMP6;WWTR1;RBPMS;TGFB3;KIAA0319;OVOL2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5710096774654783,-1.1518692336114582,0.22950819672131148,0.9350354267477407,1.0,12/39,14.83%,TLR2;NLRP12;C1QTNF4;LAPTM5;TERF2IP;TCIM;IFI35;NOD1;NMI;EGFR;CD27;NR3C2
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.5382198067515217,-1.1517587958339557,0.3611111111111111,0.9344968733458495,1.0,3/30,8.48%,GLRA3;GLRA2;XBP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6584454785237466,-1.1514136314762786,0.25862068965517243,0.9351008120440338,1.0,2/14,5.38%,NR4A3;LAPTM5
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.5757304663343269,1.1514078171936957,0.24390243902439024,1.0,1.0,1/21,0.80%,CRYAB
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.7268581203323259,-1.1512242095965035,0.3125,0.934886340434074,1.0,4/9,22.31%,CR1;SLC25A41;SLC25A42;ABCC6
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.6314366189527365,1.1512160898515373,0.3,1.0,1.0,2/12,3.44%,F2;KLK6
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.6328859981193338,1.1505902761876223,0.35294117647058826,1.0,1.0,3/11,6.50%,EYS;CNGB1;PDE6B
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.677608857816574,-1.1505532725095722,0.3389830508474576,0.9370930807130854,1.0,2/11,4.77%,P2RY12;CARMIL2
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.7555347640798373,-1.1504795212564085,0.31746031746031744,0.9365735898875833,1.0,2/5,23.23%,EGFR;HEY2
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.7672394554070354,-1.1504037059207928,0.25,0.9359414190195606,1.0,3/5,22.98%,DMTN;KCNE1;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.6869479968778537,-1.1502182093984044,0.3442622950819672,0.9357080333808746,1.0,3/11,11.62%,NCKAP1L;BST1;VEGFA
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.7726305892176795,-1.150137104456009,0.36538461538461536,0.9350779424916046,1.0,5/6,22.68%,NLRP3;IFNA2;DENND1B;RSAD2;PRKCZ
prerank,MSigDB_Hallmark_2020__DNA Repair,0.43982258424179765,1.1500189986683667,0.18181818181818182,1.0,1.0,19/134,9.95%,BCAM;POLD3;PRIM1;SF3A3;RAE1;ZNF707;PDE4B;TAF13;TAF12;RALA;DAD1;DUT;HPRT1;POLE4;ELL;AK3;POLR2K;ADA;RAD52
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5615470667952124,1.1495615140485338,0.23809523809523808,1.0,1.0,6/25,12.49%,FEM1A;ARRDC4;ABL1;ARRDC3;LIMK1;UBE2N
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6000359285077772,-1.1494598546023287,0.2692307692307692,0.9366974648248454,1.0,5/26,11.84%,CLU;EDN1;DDAH1;CX3CR1;CAV1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.5878946418471895,-1.1493697358156925,0.3088235294117647,0.9362563934861081,1.0,9/26,15.70%,PKP2;KCNJ3;SCN4B;SCN1B;CAV1;CACNB2;CACNA1G;KCNH2;CACNA1C
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.7553969781580324,-1.1493254922737395,0.2978723404255319,0.9355144661094525,1.0,3/5,20.12%,BMP6;VEGFA;ADD1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.4380056541379036,-1.1492986202266233,0.1724137931034483,0.9347080462199315,1.0,69/303,19.52%,IGSF10;CLDN5;PDGFD;SEMA3E;VSIR;VIL1;ROBO4;MCTP1;SMIM22;ARHGAP4;FGF22;EDN1;CARMIL2;CITED2;F3;EPHA4;HGF;CEMIP;CSF1R;NTNG1;CEACAM1;SEMA3D;RHOC;TMIGD3;LAMB1;THY1;XBP1;PLET1;NAV3;CDH13;SULF1;CARMIL1;VEGFA;CAV1;CLDN4;TRIM32;EGFR;FERMT3;LDB2;FGF7;TMSB10;PTPRT;SEMA4B;TP53INP1;GTSE1;TGFB1;PLXNA2;NGFR;SRGAP1;NTNG2;CAMK2B;PLXNA4;SEMA4G;PTPRJ;PPP3CA;WNT5B;CX3CL1;VCL;TPM1;PLXNC1;NTRK3;STAT3;CXCL16;CDH1;PLXND1;CAMSAP3;AMOT;NEDD9;OSGIN1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6472386748503643,-1.1491116169540398,0.35384615384615387,0.9344678097758095,1.0,7/18,10.00%,HLA-F;IL12A;HLA-E;PTPRC;HLA-A;CEACAM1;HLA-DRB1
prerank,"GO_Biological_Process_2021__complement activation, classical pathway (GO:0006958)",-0.7510597947344935,-1.1487537775654613,0.3728813559322034,0.9349237235398266,1.0,5/5,24.92%,C1QB;C1QC;C1S;C1R;C1QA
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.6653265806451022,1.1484350456376935,0.25,1.0,1.0,6/12,20.10%,OOEP;CEP290;PTP4A3;CEP120;CORO2B;KIAA0586
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.4945762389377029,1.1484157787097338,0.24390243902439024,1.0,1.0,15/42,25.83%,RIDA;HSPA1A;HSPA1B;ZC3H12D;NUDT16L1;PNPT1;DHX34;DDX5;PDE12;TUT4;ERN1;RC3H1;RNH1;DXO;NBDY
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6309321889392386,-1.1482614760531007,0.3114754098360656,0.9361582899738702,1.0,6/18,15.07%,P2RY12;DUOX1;CSF1R;STX3;TRIM32;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.48122806367521737,-1.1481867703115183,0.208955223880597,0.9356358592495254,1.0,17/129,11.84%,BICC1;DACT1;SFRP4;SHISA6;ANKRD6;IGFBP4;PRICKLE1;APC2;SOX9;PSMB8;DKK3;WWTR1;HECW1;KREMEN1;GLI3;AMER1;CAV1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.5936809483651369,-1.1480598233168058,0.30303030303030304,0.9352550474437024,1.0,5/24,14.94%,MGST1;SLC25A19;SLC35F3;SLC26A4;SLC26A8
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.5853867647572646,-1.1480149383024416,0.3142857142857143,0.9344910169155982,1.0,7/24,22.08%,MEF2C;TGFBR2;MMP21;CCDC39;MICAL2;NDRG4;MESP1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.6376974794932013,1.1479952138988925,0.20588235294117646,1.0,1.0,4/13,22.47%,HDAC1;HELLS;SIRT1;SIRT7
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.6470758852581241,-1.1479640026994657,0.28125,0.9337658856365363,1.0,6/19,23.23%,TGFB2;VEGFA;LRP1;ADAMTS9;PDGFRB;HEY2
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.563438195982914,-1.1478624085969158,0.3064516129032258,0.933331901452795,1.0,6/29,6.52%,LPL;TLR2;IL6R;C5;CSF1R;IL7
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.47693130964798575,-1.1478616579560021,0.19480519480519481,0.9324318706895811,1.0,23/118,16.56%,LPL;TLR2;PPARG;TNFRSF1A;BIRC3;PIK3AP1;NLRP12;NLRP3;AOAH;FNDC4;NINJ1;TEK;BST1;IL16;IFI35;NMI;TNFRSF1B;LRFN5;AGT;NR1D1;CD200;CXCL17;NFKBIA
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6623253461052452,-1.1476696698229711,0.3103448275862069,0.9323731549069368,1.0,4/11,18.21%,DLG4;NETO1;CAMK2B;NEURL1
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.7697588465288472,-1.1476018867158178,0.36538461538461536,0.9317926491028596,1.0,1/5,6.24%,CAMK1D
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.7533771055270614,1.147374166944506,0.43902439024390244,1.0,1.0,1/5,3.02%,SLC39A8
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.707568512228712,1.1472480097207967,0.275,1.0,1.0,1/8,6.98%,CCNT1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5402983646744606,-1.146760686959045,0.28169014084507044,0.934183384435684,1.0,4/50,6.40%,TLR2;TNFRSF1A;BIRC3;CARD11
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5880548240879455,-1.1467464545013972,0.31343283582089554,0.9333511066004713,1.0,7/37,13.40%,PKP2;TRPC6;ANO6;SCN4B;SCN1B;CACNB2;CHRM1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.6348141373706588,-1.1462705015648995,0.288135593220339,0.9344812207618749,1.0,4/16,15.87%,MCM2;RECQL4;WRN;MCM7
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.7117270819947066,-1.1462151813495385,0.4126984126984127,0.9337709447194494,1.0,1/8,3.29%,NRCAM
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.7940614849837709,-1.1458347760040535,0.2727272727272727,0.934675890263366,1.0,2/6,12.36%,TGFB2;CDH3
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.6678876146022839,-1.1452441820273631,0.3220338983050847,0.9361721398227382,1.0,2/9,14.82%,NOS1;GPR37L1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.5406269378979708,1.1451518928527111,0.21875,1.0,1.0,3/38,3.00%,RFWD3;TONSL;OOEP
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5279751801457533,-1.145075008277717,0.26666666666666666,0.9361195546543898,1.0,11/51,16.13%,ITGB4;PROM1;CEBPD;TMC4;AR;SLC44A3;CBLC;CLDN4;OVOL2;PPL;BTG1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.6991536761634805,-1.1447674884918932,0.30158730158730157,0.9366219791287094,1.0,3/7,16.69%,DUOX1;TPO;DIO2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.7914349220348298,-1.144719301929008,0.3508771929824561,0.9358945697761639,1.0,4/5,19.73%,GAD2;ABAT;GAD1;ALDH5A1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.461747895881419,-1.1446221067139473,0.1388888888888889,0.9354270111868425,1.0,35/206,15.89%,ANGPT1;IRGM;FBLN1;IGFBP3;KDM4D;TTN;TSPYL2;MUSK;FGF22;SOX9;HGF;CCND1;CSF1R;LRRK2;EFNA1;GRM5;TERF2IP;KNDC1;WWTR1;SH3GL2;TEK;BST1;HLA-DRB1;CEBPB;LYN;VEGFA;EGFR;FGF7;BMPER;FLOT1;PID1;PTPN13;TGFB1;EFNA5;WARS1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.6587757069464678,1.1444848559361993,0.2926829268292683,1.0,1.0,4/10,15.17%,CYBA;NOX1;MAPK8;NOS2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.5643983749078866,-1.144023148216177,0.2753623188405797,0.9369615307066029,1.0,6/35,15.61%,CARTPT;XBP1;ADCY8;KCNB1;NR1D1;NGFR
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5384767043553815,-1.1438445517763067,0.27692307692307694,0.9368992313322912,1.0,1/42,0.03%,CD44
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.5177806732142775,-1.1438133089685831,0.27941176470588236,0.9361375061275633,1.0,6/39,14.63%,GPAT3;DGKD;DGKB;PLA2G12A;DDHD2;LIPI
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.634420932079498,1.1436626742122633,0.34285714285714286,1.0,1.0,2/11,17.25%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.6421806815869973,1.1432953465441629,0.4318181818181818,1.0,1.0,4/8,26.33%,PAX8;SALL1;GDNF;FGF2
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.6714975755346774,1.1430330789644458,0.3023255813953488,1.0,1.0,2/7,22.56%,MLLT3;MEOX1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.6394030030133144,1.142960236076486,0.35555555555555557,1.0,1.0,2/9,1.31%,CRTAM;CD274
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.5344651052039333,-1.1428582971105596,0.29850746268656714,0.9392578504955007,1.0,6/30,14.91%,PAM;ALOX12;FAR2;ACSS3;GGT5;AWAT1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.5942054872917529,-1.1424901323411454,0.27941176470588236,0.9396804641628315,1.0,4/18,17.14%,MT1M;FOS;EGFR;MT1E
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.44216021235652225,1.1423673509633492,0.16129032258064516,1.0,1.0,6/89,5.45%,ABCA13;ABCC2;PRELID2;ABCA8;MTTP;PLEKHA3
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6547602948808326,1.1423413281176373,0.35555555555555557,1.0,1.0,4/7,26.33%,PAX8;SALL1;GDNF;FGF2
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.4560544723734458,1.1423003837772743,0.13333333333333333,1.0,1.0,14/133,6.03%,CA6;RDH16;DHCR24;MGLL;HSD17B7;CA2;HMGCS1;AADAT;ACADS;KMT5A;ACAA2;ACADVL;PRDX6;ERP29
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.6021371870357304,-1.141984764600107,0.31666666666666665,0.9405795511712024,1.0,6/24,15.12%,SHISA6;CACNG2;MEF2C;CACNG3;CACNG8;GSG1L
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.6918500899327514,-1.1418859567397683,0.3076923076923077,0.9400281284151193,1.0,4/10,27.85%,LRRK2;MLLT11;FZD9;BCL2
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.7824871124630425,1.141724252697693,0.3404255319148936,1.0,1.0,3/5,12.55%,CCDC78;E2F4;PLK4
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.6651838342281916,1.141356991527422,0.36585365853658536,1.0,1.0,3/11,10.92%,SLC22A2;GUCA1B;PRLR
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.596145888150408,1.141219186038909,0.35714285714285715,1.0,1.0,2/22,2.26%,BICDL1;KIF3B
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.7176526033372393,-1.1409501464007081,0.2833333333333333,0.9430963397069341,1.0,4/10,16.34%,CX3CR1;IFI35;NMI;SYK
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.5468578337684091,-1.1407060708369556,0.3064516129032258,0.9432208529607484,1.0,8/41,12.36%,CDH9;CDH12;CDH22;CADM3;CDH10;CDH18;CDH13;CDH3
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.4768055802703583,-1.1406233596500526,0.27941176470588236,0.9427233602887376,1.0,25/91,16.04%,FSTL1;ADAMTS5;IGFBP3;PPARG;ACTA2;PPP1R3C;TIMP1;FAP;COL4A1;PLSCR4;HGF;DKK3;GJA1;THY1;TEK;LMOD1;SLC8A1;SULF1;VEGFA;LDB2;DDR2;TIMP3;RBP1;NGFR;NNMT
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.7921596310766199,-1.1404219849658255,0.34545454545454546,0.9427383697385929,1.0,4/5,20.80%,RFTN1;CAV1;FLOT1;CYP46A1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.6368307876440336,-1.140171656350699,0.34375,0.9429085005770774,1.0,2/15,7.30%,CALY;NSG2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.7062011886427401,1.139791054941273,0.3333333333333333,1.0,1.0,1/6,0.17%,CRTAM
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.7348717647729262,-1.1397550387928068,0.375,0.943807739675799,1.0,3/6,21.12%,LRRK2;CAV2;VPS35
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.4985596972434791,-1.1396663925324089,0.22058823529411764,0.943311566932267,1.0,6/73,4.64%,WNT8B;CPS1;PPARG;IL12A;SOX9;NOS1
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.7340254014159416,-1.139309114472935,0.296875,0.9439175138898495,1.0,3/8,18.24%,MET;CCDC39;SRP54
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.55725634786867,1.1392036833215946,0.23333333333333334,1.0,1.0,4/26,11.91%,NUTF2;NUP42;RANBP17;TPR
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.7131744138060117,-1.1389323094420511,0.3793103448275862,0.944522322918873,1.0,1/5,0.57%,LPL
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.6124700380627158,-1.1388586429506813,0.3235294117647059,0.943945123389372,1.0,8/20,23.48%,TMEM25;LRRK2;SLC24A1;PLK2;GRIK3;ARF1;SHANK2;PICK1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.5577408717436473,-1.138487690347184,0.27692307692307694,0.9446667495908186,1.0,4/25,14.64%,VIL1;SOX9;EGFR;ZFP36
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.7849564814251538,-1.13844988723725,0.3673469387755102,0.9439635628482357,1.0,1/5,10.89%,AMER1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.6402073825852174,1.1382320668258257,0.3142857142857143,1.0,1.0,1/10,0.94%,F2
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.45233701822884315,1.1379180386002123,0.1875,1.0,1.0,23/84,15.91%,ETV5;CYBA;PYCR1;HSPA1A;SOD3;NOX1;PRDX6;ATF4;CAT;TMEM161A;ABL1;KEAP1;RAD52;HSPA1B;VKORC1L1;PRR5L;PRDX3;PNPT1;PRKAA2;MSRA;CPEB2;DDX3X;SERPINB6
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.6072504822695974,-1.1377176663324617,0.38333333333333336,0.9461421843178407,1.0,3/26,6.22%,IGSF10;ADGRG1;NTNG1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.6922745006387376,1.1376597245413702,0.3488372093023256,1.0,1.0,2/8,5.25%,SOAT2;MTTP
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.7195148901325045,-1.1372464228707568,0.3559322033898305,0.9473393673679081,1.0,3/6,6.13%,HLA-E;NCKAP1L;HLA-A
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.5564472539607299,-1.1372300061293381,0.2465753424657534,0.9464909950937108,1.0,9/33,16.23%,CR1;PTPRC;LAPTM5;SFTPD;CARD11;NAV3;PRKD2;ZFP36;IRF4
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.7126288030732988,-1.137196530910378,0.38333333333333336,0.9457435664428623,1.0,4/9,13.32%,RFTN1;IFNA2;IFNA6;IFNK
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.7364645916218937,-1.1369511799802192,0.3620689655172414,0.9457465549286656,1.0,4/5,20.16%,CDH3;TRPV3;CLOCK;PER1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.6792557984435817,-1.1369370987222263,0.3709677419354839,0.9449561313712422,1.0,3/12,6.32%,ACADL;SOX9;CEACAM1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6297465692235188,1.1366243300247039,0.32608695652173914,1.0,1.0,6/12,24.88%,GNL3L;DKC1;CCT8;CCT2;CCT3;CCT6A
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.7203222026458533,-1.1365398988834672,0.3064516129032258,0.9456534316671591,1.0,4/8,15.07%,TGFB2;MEF2C;EFNB2;TGFB1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.523267523628399,-1.1364156228368754,0.26229508196721313,0.9452425312679625,1.0,9/42,12.83%,NUDT11;IMPA2;PLCB3;INPP4B;NUDT4;PLCB1;PLCB4;ITPKA;INPP5D
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6353358686182866,1.136336723462487,0.2978723404255319,1.0,1.0,2/12,1.34%,GPR143;RAB27A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6353358686182866,1.136336723462487,0.2978723404255319,1.0,1.0,2/12,1.34%,GPR143;RAB27A
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7443482005456169,-1.1361321910297797,0.2833333333333333,0.9456505629528223,1.0,5/7,24.92%,C1QB;C1QC;C1S;C1R;C1QA
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.7398755328510388,-1.135886333530687,0.36923076923076925,0.9432083902131468,1.0,3/5,18.39%,RNASE10;TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.7398755328510388,-1.135886333530687,0.36923076923076925,0.9432083902131468,1.0,3/5,18.39%,RNASE10;TAC4;TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.7398755328510388,-1.135886333530687,0.36923076923076925,0.9432083902131468,1.0,3/5,18.39%,RNASE10;TAC4;TACR1
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),-0.7398755328510388,-1.135886333530687,0.36923076923076925,0.9432083902131468,1.0,3/5,18.39%,RNASE10;TAC4;TACR1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5881301393685602,-1.135538197376838,0.3142857142857143,0.9437775041163907,1.0,10/20,29.54%,LZTFL1;PID1;TGFB1;DMTN;MRAP;KCNE1;ITGB1BP1;RHOQ;MRAP2;CLTC
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.7559891746472565,-1.1352396714649424,0.3728813559322034,0.9440326300069822,1.0,3/5,22.48%,NINJ1;SLAMF8;PTN
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.7027896232020179,-1.1352128523503289,0.3064516129032258,0.9432689449102113,1.0,2/10,13.38%,PTPRC;PTPRT
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.7504604198610326,-1.1351866028022637,0.3728813559322034,0.9425066675279044,1.0,2/6,14.21%,UNC80;SLC7A8
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.6812788928354199,1.1351198091145,0.3488372093023256,1.0,1.0,2/8,9.42%,NEU4;GLA
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.5536017556907437,1.1349587563062553,0.20588235294117646,1.0,1.0,11/26,23.34%,RNF6;HDAC1;SMARCA4;PRMT2;KDM5D;ZBTB7A;SAFB2;DDX5;SIRT1;PKN1;KDM4C
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.6222358967223712,1.1349428335869411,0.2777777777777778,1.0,1.0,2/18,8.75%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5857493023758932,-1.1344215221098717,0.3333333333333333,0.9447684395323804,1.0,8/24,17.85%,HLA-E;PLSCR1;IFI35;NMI;IFNK;SPI1;NLRC5;SLC15A4
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.6419460030873532,1.1339076210388956,0.3333333333333333,1.0,1.0,2/11,15.51%,DNMT1;RESF1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.5449490715368989,-1.1338694670453722,0.2571428571428571,0.9457432755982214,1.0,28/65,20.79%,SLC5A4;ANO6;SLC6A12;SLC5A9;SCN2A;SLC23A1;SLC5A2;SCN9A;SLC5A12;SLC8A3;HCN1;ASIC2;SLC8A1;SLC24A1;SCN4B;SLC6A8;SCN1B;NEDD4L;SLC6A7;KCNK1;SLC24A4;FGF13;SCN3A;SCN1A;SLC5A10;SLC6A4;SLC6A11;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.5980836600177883,-1.1337758436369312,0.3684210526315789,0.9453457245798013,1.0,3/21,9.69%,TWF2;CARMIL2;CYFIP1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.6171508265919268,-1.1336556417922223,0.2876712328767123,0.9450644970256326,1.0,8/21,12.03%,UTRN;FGF12;NOS1;SCN4B;SCN1B;CAV3;NEDD4L;YWHAH
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.5245708738643229,1.1336148806061122,0.23529411764705882,1.0,1.0,1/34,0.22%,CXCR4
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.5260387175096919,-1.133466725095542,0.22950819672131148,0.9448992727793919,1.0,9/41,12.83%,NUDT11;IMPA2;PLCB3;INPP4B;NUDT4;PLCB1;PLCB4;ITPKA;INPP5D
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6667617793242947,1.1330962345018227,0.3333333333333333,1.0,1.0,2/8,19.18%,BEND3;SIRT1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6452124914583864,1.1329578009209562,0.35,1.0,1.0,1/9,2.71%,KDM8
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.666389297248199,1.1327526656489384,0.2972972972972973,1.0,1.0,1/8,6.52%,TAF12
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.710053982503545,-1.1327415083804866,0.36666666666666664,0.9471484861539196,1.0,3/5,27.25%,VEGFA;CCBE1;PROX1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.5961823147542905,-1.1323242701276692,0.3684210526315789,0.9479925360083047,1.0,3/14,20.36%,RAD9A;FANCD2;MRE11
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.7645422976062088,1.1321388364374718,0.32558139534883723,1.0,1.0,2/6,10.32%,PRR5;PRR5L
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7011439538225747,-1.1320667948996754,0.3050847457627119,0.9481440195288324,1.0,3/11,7.09%,KITLG;TGFBR2;TPO
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.6769246189529017,-1.1320348756380525,0.3384615384615385,0.9474189616013012,1.0,3/9,17.05%,XYLT2;CHST9;B3GAT2
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.6410807107480314,1.1319652309053017,0.375,1.0,1.0,1/8,10.68%,MAN2A1
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.7960493466318116,-1.1318976977104693,0.29310344827586204,0.9471373816528893,1.0,1/6,3.89%,APIP
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.7351070835198906,-1.1317931224661522,0.3064516129032258,0.9467502954770957,1.0,4/9,16.24%,P3H2;OGFOD1;P4HTM;P4HA3
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.751454615323657,-1.1317417423833183,0.38461538461538464,0.9460637986794976,1.0,1/5,1.19%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.6181858574026844,-1.1314217494349024,0.3783783783783784,0.9465779243695847,1.0,3/14,12.23%,LGALS3;LAPTM5;FGL1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6596603587863566,-1.1312947839830616,0.34285714285714286,0.9462012147918222,1.0,4/9,10.61%,EPHA4;EFNA1;NELL1;FURIN
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.6181190480318214,-1.131130134062387,0.3225806451612903,0.9461685023692908,1.0,6/16,22.68%,IL6R;SPI1;STAT1;STAT3;PTPN11;SOCS3
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.6211019504480826,1.1309917178534865,0.3333333333333333,1.0,1.0,1/7,0.37%,DAO
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.4735270519719865,-1.1308903515903987,0.1935483870967742,0.9463557214276725,1.0,9/75,16.54%,IRGM;TRIM5;TRIM22;LRRK2;DAPK1;FBXO7;TP53INP1;PLK2;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.6344864104930451,-1.1308299530757655,0.3492063492063492,0.9456814843609848,1.0,3/14,17.98%,ATAD5;EZH2;FAM83D
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6930014124261942,1.1308119660801903,0.36585365853658536,1.0,1.0,1/7,7.09%,MTMR2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.5620550470686301,-1.1305523254575927,0.3333333333333333,0.9457810161352644,1.0,3/22,8.48%,HLA-E;PTPRC;XBP1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.5609640268081948,-1.1304764746415863,0.2676056338028169,0.9452576277929076,1.0,7/33,14.05%,MX1;SYT1;SNCB;AMPH;PACSIN1;DNM1;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.7252562838975364,-1.1304023478053637,0.3442622950819672,0.9446738454403292,1.0,2/6,14.51%,ITGAM;SPI1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.7938111485000257,-1.1300628606697483,0.3333333333333333,0.9452555500373995,1.0,4/5,19.86%,P2RY12;FLI1;VWF;GPI
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.6305890819317804,-1.1300304847279707,0.34285714285714286,0.944515374428091,1.0,5/22,14.83%,CITED2;MET;XBP1;CEBPB;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7524221457016121,1.1300083137079098,0.3953488372093023,1.0,1.0,2/6,11.64%,TXNIP;ZFYVE19
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.548843971450905,-1.1299055298718266,0.3088235294117647,0.9443008940144098,1.0,4/33,7.50%,ARIH2;LRRK2;SIAH3;TOMM7
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4483976784463301,1.129841861997757,0.28,1.0,1.0,13/92,10.67%,NGF;SLC22A2;LCK;MALT1;HMGB1;ATP2A3;ANP32B;NLRP2;CRADD;PIDD1;CASP9;PRR7;ST18
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.6978025690658165,-1.129205348384861,0.3728813559322034,0.9460513740890872,1.0,6/9,29.54%,NLRP3;DENND1B;RSAD2;PRKCZ;TNFSF4;CD74
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.720202414078945,-1.1289273138920206,0.41509433962264153,0.9462546278209879,1.0,4/6,22.48%,CEACAM1;XBP1;HPN;PTN
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.5172994686805056,-1.1286344762536527,0.2916666666666667,0.946657977230049,1.0,8/45,17.33%,GBP2;GBP3;SOX9;CHI3L1;ADAMTS7;MYLK3;NR1D1;CX3CL1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.704692413047773,1.1285475173676756,0.375,1.0,1.0,2/6,4.97%,CA2;ACTN2
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.4648904849026671,1.128501565776896,0.26666666666666666,1.0,1.0,13/104,9.21%,BCAM;PTPRU;EPB41L4B;GPRC5C;RNF128;SEC23B;COL18A1;UNC5B;MYO1D;ARHGEF10L;ATP1B1;MYH14;PPP1R26
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.6253902671918492,1.1282931206361384,0.34615384615384615,1.0,1.0,3/8,11.06%,LYRM7;SLC25A33;UQCRFS1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.6253902671918492,1.1282931206361384,0.34615384615384615,1.0,1.0,3/8,11.06%,LYRM7;SLC25A33;UQCRFS1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.7324636003568532,1.128280300718795,0.3870967741935484,1.0,1.0,1/5,10.92%,PRLR
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.6092284613454163,1.1282556977384304,0.32608695652173914,1.0,1.0,4/9,20.13%,RIPPLY2;COBL;CXXC4;STIL
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.5259510673079559,1.1278187525525942,0.3333333333333333,1.0,1.0,9/24,23.73%,EXOSC8;TRIR;TENT4B;NUDT16L1;EXOSC7;DIS3;EXOSC5;TUT4;LIN28B
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.6732620638305401,1.1277532179777643,0.42857142857142855,1.0,1.0,1/8,2.30%,LEPR
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.6678661987710397,-1.1274055760989652,0.3384615384615385,0.9507614512857518,1.0,1/8,1.95%,IL12A
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5223662065593027,-1.1273963501687705,0.25,0.9499072181758814,1.0,3/37,3.07%,TLR2;ISG15;IRF1
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.724327532459129,-1.1266388704350638,0.37735849056603776,0.9520446523663968,1.0,2/5,12.17%,SLC51A;ABCB4
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.6365046041752951,1.1260032842394698,0.37142857142857144,1.0,1.0,2/10,12.79%,NPL;BCKDK
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.6664986375548517,1.1259174300295538,0.36363636363636365,1.0,1.0,3/7,17.75%,JMJD6;P3H3;PLOD3
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.6579623937348429,1.1252909072894364,0.38095238095238093,1.0,1.0,1/6,5.30%,SMYD1
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.48686615319810206,-1.1252779333748364,0.2571428571428571,0.9566359528771506,1.0,24/90,20.21%,FSTL1;LRIG3;KITLG;LAMC1;COL4A1;FIGN;DDAH1;CCND1;PTPRG;WWTR1;LAMB1;TENM3;ADGRL2;EGFR;PCGF2;ADAMTS15;FAT1;GNG12;ANTXR1;MYO1B;LAMB2;NR2F2;LARP6;COL12A1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.5847506180592299,1.125271839392702,0.27906976744186046,1.0,1.0,6/16,13.84%,GPC4;PTPRD;MDGA1;IL1RAPL1;SLITRK2;LRFN4
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.5847506180592299,1.125271839392702,0.27906976744186046,1.0,1.0,6/16,13.84%,GPC4;PTPRD;MDGA1;IL1RAPL1;SLITRK2;LRFN4
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5919974492518305,-1.1252397658089413,0.2727272727272727,0.9558568422462844,1.0,6/25,19.27%,STMN2;APC2;NAV3;TRPV4;FGF13;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.5136135026466302,-1.1250939847637595,0.27692307692307694,0.9555732541315521,1.0,14/57,14.83%,TLR2;NLRP12;C1QTNF4;NLRP3;LAPTM5;TERF2IP;TCIM;IFI35;NOD1;NMI;EGFR;SPI1;CD27;NR3C2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.7058124274955693,1.1244410104561127,0.37142857142857144,1.0,1.0,2/7,5.29%,BYSL;PINX1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),-0.7281862720931126,-1.1242404079791886,0.36666666666666664,0.958053080101792,1.0,1/5,0.85%,KANK2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.5150733122229734,1.124132334834193,0.3157894736842105,1.0,1.0,8/33,18.08%,TCOF1;CAVIN1;POLR2K;POLR2L;UBTF;GTF2H5;ERCC2;TAF1C
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.5005435799588062,-1.1236787964667971,0.2222222222222222,0.9592218089932049,1.0,15/91,17.72%,PTPRC;TTN;CENPE;TSPYL2;SPDYA;CEACAM1;WWTR1;THY1;UBASH3B;CAV3;DDR2;CDKN1A;WARS1;DBNDD1;CAMK2N2
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.6803171083057225,-1.1235323255130438,0.3448275862068966,0.9590829526729657,1.0,4/9,24.49%,FES;HLA-DRB1;IL34;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.497357301695487,1.1235241189633443,0.2631578947368421,1.0,1.0,8/30,17.37%,RNF6;RUNX1;CARM1;PRMT2;KDM5D;KCTD6;SAFB2;DDX5
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5492142983628664,1.123500715491942,0.3170731707317073,1.0,1.0,7/27,23.73%,DICER1;PRKRA;SNIP1;HNRNPA2B1;TUT4;PUS10;LIN28B
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.5044683970639602,1.1233520563302928,0.25925925925925924,1.0,1.0,4/29,4.56%,ICAM1;AGER;ABCC1;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5823786948361731,1.1232880320926892,0.2682926829268293,1.0,1.0,3/12,13.54%,NUPR1;FEZ1;SEC22B
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.5224500632233846,1.1231678167405477,0.30303030303030304,1.0,1.0,7/23,17.19%,PRELID2;MTTP;PRELID1;PITPNM1;ABCA3;NPC2;PLTP
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.49983621144480017,-1.1231600022897439,0.29333333333333333,0.9596958475611732,1.0,17/69,12.76%,CLDN16;EDN1;ATP2B3;ATP2B2;TPCN2;KCNMA1;HTR2C;SLC8A3;SLC24A5;SLC8A1;ATP1B2;SLC24A1;HTR2A;CAV1;HTR2B;NEDD4L;ATP1A1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),0.6875128669664562,1.123058047718944,0.43902439024390244,1.0,1.0,1/7,0.60%,PM20D1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6766673160933678,-1.1230508939345019,0.28125,0.9593324291847908,1.0,1/12,5.60%,STAT5A
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.5166186164170439,-1.1229654813806822,0.2833333333333333,0.9589437902745486,1.0,10/47,15.46%,ARHGAP18;ACTN1;FES;NRG4;LYN;VEGFA;EGFR;NRG1;DAPK3;PRAG1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.638974948982949,-1.1228239694196376,0.3684210526315789,0.9586506069670663,1.0,2/11,12.37%,TRIM5;TRIM32
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.4481363374494538,-1.1225556548267368,0.2716049382716049,0.958788307782158,1.0,41/226,15.99%,LPL;TLR2;IRGM;WNT8B;NR4A3;P2RY12;TWF2;EPHA3;TSHR;SSTR1;MEF2C;BRINP2;VIM;SOX9;FOS;GLRA2;NLRP3;RYR3;AQP1;CX3CR1;FES;XBP1;LDOC1;HCN1;AXL;KCNC2;BRINP1;LYN;DAPK1;ROMO1;ABCB4;TNFRSF1B;EGFR;PID1;GNG2;ZFP36;BRINP3;NR1D1;LY96;PTK7;DMTN
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5150158463456195,-1.1225435758457922,0.2647058823529412,0.9579798064671898,1.0,11/52,9.11%,CD44;DPEP2;SLA;PTPRC;GMFG;SELL;AOAH;CD53;STYK1;IL16;IL12RB2
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.7071336298036635,1.122507127589943,0.3,1.0,1.0,1/6,2.26%,KIF3B
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.5677882740695608,-1.12201972064688,0.29411764705882354,0.9592605919322157,1.0,3/28,6.59%,LRTM1;SEMA3E;SEMA3D
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.6607854699068534,1.121965664606901,0.425531914893617,1.0,1.0,3/7,17.85%,USH1C;USH2A;ERCC2
prerank,GO_Biological_Process_2021__detection of molecule of bacterial origin (GO:0032490),0.7544309606045705,1.1216231940275434,0.391304347826087,1.0,1.0,1/5,0.66%,SSC5D
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5233475635039282,-1.1216009202693014,0.2898550724637681,0.9601613943744958,1.0,22/55,15.33%,GUCY1A1;P2RY12;CHRM3;MCTP1;MCTP2;EDN1;NMUR2;NOS1;DDAH1;NUDT4;LRRK2;CCR9;TPCN2;CX3CR1;CXCR6;DGKD;HTR2B;EDNRB;KSR2;ACKR4;AGT;LAT2
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.7647407099677928,-1.121145216297095,0.42,0.9611292151679898,1.0,2/5,17.70%,LGALS3;LILRB1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.7247641508138225,-1.1211420460879682,0.3469387755102041,0.9602957966862936,1.0,5/10,21.52%,SLC1A1;SLC25A22;SLC1A6;SLC1A2;SLC25A12
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.5910401821095072,-1.1207748130833703,0.26153846153846155,0.9608850769646455,1.0,6/24,19.27%,STMN2;APC2;NAV3;PLEKHH2;FGF13;CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),-0.7338910149477125,-1.1207700420853886,0.3709677419354839,0.9600447925904945,1.0,3/5,26.07%,TPM1;ADRA1B;ADRA1A
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.48492196994141773,1.1206850259631271,0.2894736842105263,1.0,1.0,11/70,7.73%,NGF;VAV1;EPHB2;SPRY2;RAPGEF1;RASGRF1;PLCE1;MMD2;FBP1;EPS8L2;SPRY3
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.4715414303890255,1.1206511186570747,0.2857142857142857,1.0,1.0,13/95,11.38%,ORC1;RFWD3;TSR1;DDX12P;NAT10;EIF3B;NSUN2;BRPF1;PTBP1;EIF3D;HDGF;UGGT1;POLG
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.5802286955694711,-1.1205845201695446,0.23880597014925373,0.9599409890595478,1.0,6/19,22.25%,MT1M;FOS;EGFR;MT1E;MT2A;HAAO
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.7118494170388162,-1.120218153175866,0.3103448275862069,0.960674185368788,1.0,2/10,14.14%,P2RY12;SKAP1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5056502324953983,-1.1202117204663236,0.2711864406779661,0.9598533706647422,1.0,9/52,9.47%,PKP2;CLDN5;CDH9;CDH12;CDH22;CDH10;RHOC;GJA1;CDH18
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.7026726604519853,-1.1201493025160834,0.36231884057971014,0.9593323380199432,1.0,3/9,16.34%,ITGAM;TGFB1;SYK
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5209736860618521,1.1200486344593918,0.3125,1.0,1.0,10/43,12.91%,SQLE;SC5D;MSMO1;OSBPL7;HSD11B1;HMGCR;CYP7B1;PMVK;PRLR;STAR
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.7067545690667507,1.120047165842277,0.35135135135135137,1.0,1.0,1/7,0.32%,ICAM1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.5827667845761931,-1.120042713192998,0.31343283582089554,0.9579781893165681,1.0,5/22,15.78%,TP73;NMT1;E2F1;YWHAH;BBC3
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.5827667845761931,-1.120042713192998,0.31343283582089554,0.9579781893165681,1.0,5/22,15.78%,TP73;NMT1;E2F1;YWHAH;BBC3
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6351162509148773,1.1199982010979892,0.358974358974359,1.0,1.0,2/11,11.30%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7178948573944013,1.1199901040241296,0.30952380952380953,1.0,1.0,1/5,13.80%,ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.5051727121963809,-1.1199377780922328,0.2112676056338028,0.9575536914381996,1.0,18/72,17.33%,VIL1;CLU;SLF1;SYNPO2;LGALS3;RHOC;CHGA;VEGFA;SYNPO2L;NRG1;FLOT1;SMPD3;HRK;TGFB1;WARS1;SYK;SYNPO;CX3CL1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.688057270133805,1.1198512868351365,0.358974358974359,1.0,1.0,2/7,13.31%,CARM1;PRDM4
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.743706615315078,1.1194993654634275,0.375,1.0,1.0,3/5,24.69%,NFKB1;RELA;RC3H1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.6552295038231557,-1.1194542260960307,0.4,0.9588881972781274,1.0,4/13,8.74%,CPS1;NOS1;ARG2;MTARC2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.6569364281681588,-1.1194470382010222,0.4098360655737705,0.9580647775880073,1.0,3/11,8.23%,PIM1;VSTM2A;FNDC5
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5850650682926913,1.119320148898042,0.2857142857142857,1.0,1.0,5/13,18.02%,SARNP;NXF1;IWS1;ENY2;THOC2
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.6625050162836472,1.119161648424983,0.34146341463414637,1.0,1.0,4/12,18.35%,SNX1;STX10;LMAN1;TRAPPC10
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.5115731046148819,-1.1190401932197351,0.2727272727272727,0.9587860014590445,1.0,10/57,15.07%,VIL1;SOX9;KIF16B;DGKD;NRG4;PTPRR;EGFR;NRG1;TGFA;TGFB1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.5865686774330312,-1.1187355498267453,0.27692307692307694,0.9592094534686304,1.0,5/41,5.72%,ANGPT1;PPARG;MEF2C;STAT5A;ANGPT2
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.7027393612616566,-1.1185866669915325,0.3582089552238806,0.9589042349094912,1.0,3/8,16.34%,ITGAM;TGFB1;SYK
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.518403065618015,1.1184558660284856,0.3870967741935484,1.0,1.0,7/25,13.38%,STAC3;EPHB2;NLGN3;ACTN2;ATPSCKMT;RELN;P2RY6
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.7274716645610919,-1.1178798854282903,0.3103448275862069,0.9608321745245696,1.0,3/6,24.18%,TST;CBS;MPST
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5104234433806627,-1.117602537729475,0.2857142857142857,0.96123583346265,1.0,13/50,23.86%,LPL;ALDH1A2;ACMSD;XBP1;SDS;ACSM3;LIPI;OXSM;ACOX2;CYP46A1;OSBPL3;ACOT8;OSBPL2
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.7382368045000641,-1.1175883791937047,0.32727272727272727,0.960482211684789,1.0,2/7,11.80%,IL12A;SLAMF8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.6455392181521793,1.1175279153894773,0.4318181818181818,1.0,1.0,3/7,19.66%,EXOSC8;EXOSC7;EXOSC5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.6455392181521793,1.1175279153894773,0.4318181818181818,1.0,1.0,3/7,19.66%,EXOSC8;EXOSC7;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),-0.670941696260073,-1.1173370528683657,0.37735849056603776,0.9606492974635021,1.0,1/7,3.11%,FAP
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.6740671792553892,-1.1173115290929094,0.36923076923076925,0.9599227803643459,1.0,5/10,24.34%,ROBO2;LRP1;ADAMTS9;PDGFRB;PDE2A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.5392832792962436,-1.11726402136051,0.2916666666666667,0.9592817282116717,1.0,7/45,12.69%,DPP10;EPHA3;LGALS3;STAC2;STX3;EGFR;LRP1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.5266247450068582,-1.1172268298555001,0.3050847457627119,0.9585744873369301,1.0,10/47,20.49%,PPARG;FABP3;XBP1;PNPLA1;ABCB4;RBP1;PNPLA2;ABCA1;ACOX2;USF2
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7752402101538289,-1.1170421520525693,0.37735849056603776,0.9585072942522023,1.0,3/5,17.10%,NLRP12;NLRC5;CIITA
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.7432232979551556,-1.116997057965973,0.36538461538461536,0.95789433241943,1.0,2/5,16.54%,MEF2C;PIK3CB
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.677080023248848,1.1168959188160306,0.35714285714285715,1.0,1.0,1/5,7.09%,MTMR2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5838809585500645,-1.116811844782916,0.3188405797101449,0.9578781909236456,1.0,1/17,0.40%,DPYS
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.7513306585446116,-1.1165890032672963,0.32786885245901637,0.9579123795365583,1.0,3/6,21.10%,CSF1R;IL34;IL33
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.47427150060082524,-1.1165236525999365,0.30303030303030304,0.9572680173045744,1.0,15/134,12.37%,ROR1;TNFRSF1A;BIRC3;TRIM5;TRIM22;CARD11;APOL3;TERF2IP;RHOC;GJA1;HLA-DRB1;NOD1;TRIM25;HTR2B;TRIM32
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.6240763444821628,-1.1164004266868834,0.3548387096774194,0.9568842141500824,1.0,1/10,5.26%,DTX3L
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.4301464693007227,1.1161884548362209,0.25806451612903225,1.0,1.0,26/94,23.00%,U2AF1;RAE1;NUP42;NUP210;CPSF4;RBM8A;SYMPK;TPR;EIF4E;SARNP;NXF1;IWS1;NUP37;ENY2;HNRNPA2B1;SMG5;RBM15B;THOC2;MAGOH;NDC1;ALYREF;SEH1L;SRSF9;POLR2D;FYTTD1;NUP214
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.6256235933343273,1.116027239983081,0.43902439024390244,1.0,1.0,3/10,11.05%,TTLL9;TTLL1;TTLL11
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.7055240581499831,-1.1160073418234229,0.4,0.9578055417492211,1.0,3/7,15.19%,CBLN2;CSF1R;PARD6A
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5312993523322272,-1.1159021311795483,0.34328358208955223,0.9573718085596217,1.0,10/62,14.11%,FSTL1;VIL1;PPARG;BASP1;LGALS3;TPP1;VEGFA;TST;OVOL2;PGK1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.712451540154918,-1.1158926871624977,0.34545454545454546,0.9565715307042054,1.0,1/5,11.62%,VEGFA
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.5420571194773164,1.1158859097017837,0.2857142857142857,1.0,1.0,7/26,12.65%,SPIRE2;MSRB1;MSRB2;WASF3;PSTPIP1;WASHC5;CORO7
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.5680753150762643,-1.1157731585399038,0.28378378378378377,0.9561396075726805,1.0,9/25,23.09%,EPHA4;LRRK2;ZDHHC15;CDK5R1;SIPA1L1;CDK5;VPS35;WNT5A;KIF1A
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.664039149682067,-1.1155619372399765,0.3620689655172414,0.9561250872961843,1.0,3/11,5.26%,KDM4D;PARP9;DTX3L
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5107496691584518,-1.1155344894380683,0.3157894736842105,0.9554195320327813,1.0,13/62,18.60%,YBX3;GBP2;GBP3;CHI3L1;GGT5;TRIM32;ADAMTS7;PID1;ZFP36;NR1D1;BRCA1;CX3CL1;CXCL16
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.620445882427847,-1.115498316708303,0.32786885245901637,0.9546735947104426,1.0,2/8,11.84%,PRKAR1B;PKIA
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.6347977760034985,1.1154685776523652,0.44680851063829785,1.0,1.0,2/8,8.49%,SPRED1;SPRED2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.5436472091885888,-1.1154425444293852,0.24285714285714285,0.9541533546766328,1.0,13/40,16.38%,NPR2;ATP2B3;NOS1;ATP2B2;RYR3;SLC8A3;SLC8A1;ATP1B2;ABCC9;ATP1A1;ITPR3;AGT;FKBP1B
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.5518910569493957,1.1153373804659492,0.3225806451612903,1.0,1.0,1/16,3.02%,SLC39A8
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5179776231803583,-1.1153075283479317,0.28205128205128205,0.9539080588444634,1.0,5/53,5.80%,KANK2;RIT2;ADGRG1;MET;LPAR6
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.6557472629145964,-1.1152089021976348,0.3709677419354839,0.9534474487797304,1.0,4/9,23.39%,GATA1;ZFPM1;ZNF385A;UBA5
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5753859240366895,1.1151009574435475,0.34210526315789475,1.0,1.0,10/16,31.09%,DDX3X;YTHDF1;POLR2D;MTOR;LARP1;KHDRBS1;RPS6KB1;CDC123;BOLL;UHMK1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4970653705685045,1.1147993176606097,0.32,1.0,1.0,8/64,9.82%,NGF;SLC22A2;LCK;ATP2A3;ANP32B;CRADD;PIDD1;CASP9
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.7715837721901182,-1.1147646745181368,0.3787878787878788,0.9540819577700573,1.0,2/5,15.95%,ALG10B;RAMP1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.6306326999430271,-1.114731368275778,0.3582089552238806,0.9533569217237885,1.0,4/13,13.91%,NR4A3;ANO6;AZIN1;ACSL5
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.5775573695218631,1.1145996903042321,0.3939393939393939,1.0,1.0,5/13,19.66%,EXOSC8;TRIR;EXOSC7;DIS3;EXOSC5
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.6234621754428707,-1.1145550439485126,0.375,0.953195907319429,1.0,3/18,11.84%,P2RY12;CARMIL2;CAV1
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6648872617447057,-1.1142116991506619,0.36507936507936506,0.9537380449987464,1.0,2/10,8.41%,SNAP25;STX3
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.7260385080381705,-1.1138141373370598,0.41509433962264153,0.954436237172712,1.0,1/5,5.39%,ANO6
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.5232357837364076,-1.1137468896979479,0.29850746268656714,0.9538454522019693,1.0,8/43,10.97%,WNT8B;TWF2;EPHA3;BRINP2;SOX9;AQP1;BRINP1;LYN
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.6510849939686695,1.1136815273178793,0.39473684210526316,1.0,1.0,2/8,6.93%,SLC39A8;SLC25A28
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.7046367480159461,-1.1136271064315166,0.3384615384615385,0.9534206339079332,1.0,2/7,13.79%,CARMIL2;DDR2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.4358683918689357,1.113164445582006,0.24324324324324326,1.0,1.0,16/70,22.17%,U2AF1;CPSF4;PCF11;CSTF2;RBM8A;SYMPK;TENT4B;SARNP;PAPOLG;THOC2;MAGOH;ALYREF;CSTF1;SRSF9;APP;POLR2D
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.5538733414334172,-1.1130925942675471,0.3125,0.9546282550954791,1.0,10/31,16.33%,RIMS1;SYT4;RIMS4;SYT1;LRRK2;RAB3A;RIMS2;SYT12;SYT13;RAB15
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.6372402026967775,1.112168775858741,0.375,1.0,1.0,2/14,8.92%,HMGCS1;PMVK
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.7194474261495915,-1.1121047888024649,0.3709677419354839,0.9576864689517214,1.0,2/10,11.21%,MGST1;SLC6A8
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.6743843060552837,1.1120229617864748,0.38461538461538464,1.0,1.0,2/10,10.42%,KLRF2;CLEC2A
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.5093359089547712,-1.1119794429832797,0.3188405797101449,0.9572512430728993,1.0,10/43,24.12%,CERS6;ASAH2B;SGMS2;PNPLA1;CERS5;DEGS2;CERS3;PPP2R1A;AGK;ABCA12
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.731684415339231,-1.11178330671361,0.39622641509433965,0.9571455563017021,1.0,2/5,13.54%,MEF2C;FLOT1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6591867665869182,-1.1117337933166043,0.36666666666666664,0.9564897756289156,1.0,2/10,11.82%,NDUFAF5;PRMT8
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.6704123545655832,1.1116204799871046,0.45454545454545453,1.0,1.0,1/5,6.59%,SNAI1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6981053456324687,-1.111616534971311,0.33962264150943394,0.9560977007654216,1.0,3/7,23.39%,PSMC3;ESR1;PSMC5
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.7474227774607476,-1.1115612646114494,0.45,0.9555751038891566,1.0,1/5,10.18%,CDH13
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.43015078376547594,-1.1115006812467263,0.2,0.9549550850235895,1.0,68/401,17.39%,ANGPT1;ROR1;TLR2;PDGFD;TNFRSF1A;P2RY12;IL26;TGFB2;PTPRC;BIRC3;KITLG;RIT2;TRIM5;DDX60;FGF22;PIK3AP1;NLRP12;C1QTNF4;TRIM22;SOX9;F3;HGF;MET;LAPTM5;ADGRV1;CARD11;APOL3;CX3CR1;TERF2IP;RHOC;GJA1;CHI3L1;TEK;TCIM;IFI35;AXL;HLA-DRB1;NOD1;CDH13;NRG4;TRIM25;LYN;NMI;VEGFA;CAV1;HTR2B;TRIM32;EGFR;FGF7;NRG1;CAV2;PRKD2;TGFA;CD27;ALPK1;GPR37L1;NR3C2;AGT;TGFB1;ITGAV;BBC3;SIAH1;PLK2;PIK3CB;PTPRJ;VWF;CX3CL1;BCAP31
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.4985709477539614,-1.1114852754929423,0.3472222222222222,0.9542215206988278,1.0,16/69,16.93%,BAIAP2;CCK;NRCAM;MEF2C;SLITRK5;NTNG1;SLITRK4;PAK3;RAB3A;NEFH;MAP2;SLITRK3;OPHN1;CNTN4;NTNG2;ABITRAM
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.5364370115389145,-1.1114563466446434,0.2916666666666667,0.9535137305505242,1.0,11/28,24.03%,SYT1;SNCB;AMPH;RAB3A;PACSIN1;OPHN1;CDK5;SYT7;CANX;SYT2;SNCG
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.617735488715629,-1.1114526189767187,0.3275862068965517,0.9527172490609674,1.0,8/18,21.11%,GRIK2;UNC13C;GRIK1;GRIK5;SLC17A6;SLC17A7;GRIK3;SLC1A4
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.5473392337298912,-1.1114434145939736,0.30303030303030304,0.9519629334989883,1.0,8/35,9.70%,TGFB2;CLU;ITGAM;FOS;MAP3K5;DDIT4;GRIN2B;CDK5R1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.5671935552052868,1.1113778966747414,0.3333333333333333,1.0,1.0,7/24,19.92%,EAF2;CCNT1;ELL;ZMYND11;ALYREF;HMGN1;CCNK
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.7137804405254132,-1.1105307437623066,0.42105263157894735,0.9547503217498468,1.0,3/6,14.51%,LAPTM5;DAPK1;SPI1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.7314428143373907,-1.1105125198244514,0.3829787234042553,0.9540118663640345,1.0,1/5,6.54%,LRRK2
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.47286388578223815,-1.110418233319818,0.2631578947368421,0.9535108278900091,1.0,12/91,13.51%,RND2;ARHGAP18;BAIAP2;TWF2;EPHA3;SMIM22;PEAK3;RHOC;BST1;PAK3;LRP1;RAC3
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.564790248572751,-1.1099654321449717,0.3448275862068966,0.9545973686890438,1.0,8/28,18.81%,ABCC4;CEACAM1;SLC16A8;ABCG5;SLC51A;ATP8B1;SLCO2B1;SLC10A6
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.68299027791506,-1.10993132700821,0.36666666666666664,0.9539096835062305,1.0,1/7,0.64%,KCNT2
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.5025793895653641,-1.109848564836513,0.2857142857142857,0.953369374454312,1.0,9/58,13.10%,KANK2;DACT1;ID2;MYO16;CCND1;E2F1;PLCB1;EGFR;RBL2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.4997782265793118,-1.1098349504259735,0.32,0.9526189382582513,1.0,13/80,14.99%,ROR1;PDGFD;TGFB2;PIK3AP1;SOX9;HGF;CEACAM1;TEK;PIP5K1B;LYN;EGFR;PTPN13;AGT
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.6328835570791362,1.1098348825789008,0.43333333333333335,1.0,1.0,1/9,0.47%,SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6319393977380563,-1.109574411083939,0.4262295081967213,0.9528348316752889,1.0,2/9,16.05%,SLC18A2;ABCD2
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.4343059377753223,-1.109311610618436,0.24358974358974358,0.9530260545625266,1.0,41/247,17.57%,ANGPT1;GFRA3;NEFL;KITLG;RIT2;FGF22;MEF2C;SOX9;HGF;MET;PSMB8;MAP3K5;LRRK2;IL3RA;GFRA2;SPTB;TEK;GRIN2B;NRG4;HTR2B;WDR83;DLG4;EGFR;FGF7;NRG1;IL31RA;SCG2;LRRC7;RASA1;TGFA;ZFP36;RASA3;TGFB1;RASGRF2;ITGAV;CAMK2B;PIK3CB;PRKCQ;PSMC3;FGF13;RASGRP1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.5385225366317694,-1.109150817182849,0.25862068965517243,0.9528850097004127,1.0,3/42,4.64%,CPS1;IL12A;NOS1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.6717849293655929,-1.1090302162168029,0.3870967741935484,0.9526147680487539,1.0,2/6,17.67%,ATCAY;PRUNE1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.62795774126636,-1.1088746689960776,0.30985915492957744,0.952344977551772,1.0,3/16,3.07%,VSIR;CR1;IRF1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.49818482071161097,-1.1088438287722422,0.2857142857142857,0.9516718353531334,1.0,20/72,13.42%,DPEP2;DOCK8;CR1;PTPRC;BIRC3;ADAM28;NCKAP1L;GMFG;SELL;CD53;SIGLEC10;CR2;P2RY14;IL16;STAG3;IKZF1;ABCB4;ARHGAP25;LY86;WDFY4
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.7196113960667467,-1.1087131933912198,0.4,0.9513548644570984,1.0,1/8,1.44%,PPARG
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.7608625746824935,-1.10852485712424,0.3770491803278688,0.951264173805617,1.0,1/5,10.70%,RAB3A
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.7515118566163994,-1.1084629231902434,0.3728813559322034,0.9506580578580158,1.0,3/7,15.35%,SLC6A8;CKMT2;CKMT1A
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.4409546577915407,1.1081717040806445,0.2857142857142857,1.0,1.0,5/71,7.69%,NGF;NUPR1;UNC5B;ATF4;GRID2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.4778809171819748,1.1077897697289893,0.1891891891891892,1.0,1.0,23/86,20.48%,RFWD3;UBC;NDC80;RAE1;HDAC10;HMGA2;HDAC1;ABL1;PHF1;CENPT;UBB;SMARCA4;ZBTB7A;HDAC3;BRWD1;AXIN2;PADI2;LIG4;SIRT1;EHMT1;TCF7L1;HMGN1;COPS6
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.6549186647536804,-1.107208347749057,0.42857142857142855,0.954745622438283,1.0,1/7,4.60%,DBF4
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.6954432578348447,-1.1071428373910959,0.43548387096774194,0.9541858767363762,1.0,2/6,7.32%,LRRK2;SIAH3
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),-0.7192615308023251,-1.106803262330187,0.35185185185185186,0.9546556452800148,1.0,3/5,25.33%,NOL3;CARD18;BCL2L12
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.523729652968173,-1.1067922289427141,0.29411764705882354,0.9539042026447312,1.0,12/64,14.64%,HLA-F;RHBDF2;HLA-E;ISG20;IRF1;NBEAL2;IFI35;TBC1D10A;CEBPB;PRKD2;TYMP;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.7355398163242008,-1.1066161412926703,0.4482758620689655,0.9530463189386181,1.0,1/5,5.06%,NLRP3
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7355398163242008,-1.1066161412926703,0.4482758620689655,0.9530463189386181,1.0,1/5,5.06%,NLRP3
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.5635429705705327,-1.1066044537601951,0.39285714285714285,0.9523461274586704,1.0,2/23,1.72%,VIL1;TWF2
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.4760600190126965,-1.106371586716127,0.30985915492957744,0.9523753313809461,1.0,22/90,18.56%,RHBDF2;IL12A;TGFB2;TTN;STXBP5L;SNAP25;FRMD4A;CACNA1E;BMP6;KCNC2;KCNB1;TGFB3;RAPGEF4;ITPR3;SLC2A2;MYH10;TGFB1;CACNA1C;TMED10;CLOCK;DNM1L;CACNA1A
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.7159670735659591,1.106123644063575,0.35714285714285715,1.0,1.0,2/7,5.88%,CMPK1;AK8
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.5717513743021908,1.1060989305514184,0.3888888888888889,1.0,1.0,1/9,1.57%,SPX
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.6495080545822915,-1.1058116644441425,0.41379310344827586,0.9538117844420017,1.0,2/9,17.83%,MEF2C;MAP2K5
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.609169765728148,-1.105713258842627,0.4,0.953256503924593,1.0,5/15,21.13%,PRKAR1B;ADCY7;ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.6703868662813983,1.1054407701856295,0.4318181818181818,1.0,1.0,2/7,10.10%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.611251372862327,1.1048747365630818,0.30612244897959184,1.0,1.0,2/13,1.34%,GPR143;RAB27A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.611251372862327,1.1048747365630818,0.30612244897959184,1.0,1.0,2/13,1.34%,GPR143;RAB27A
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.5072823555346193,1.1047980404227569,0.2857142857142857,1.0,1.0,22/57,22.63%,BYSL;NOC2L;LTV1;NOM1;DDX31;SDAD1;RIOK1;RIOK2;RRP36;LTO1;GTF3A;WDR74;URB2;NPM1;METTL17;NAF1;RPL11;TGS1;RPL5;RPL7;RPS16;SURF6
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.7313315911489572,1.1046446022052017,0.375,1.0,1.0,2/5,18.36%,CRACR2A;ORAI2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.6058033390649668,-1.1046124494199248,0.2631578947368421,0.9563902036113613,1.0,2/17,7.58%,NR4A3;GJA1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.6332195904445288,-1.1039862646301895,0.4032258064516129,0.9581468259895805,1.0,5/14,17.33%,NLRP3;CX3CR1;CARD18;GIT1;CX3CL1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.39499172692589746,1.1039827086691174,0.23076923076923078,1.0,1.0,56/190,24.44%,ADAT1;POP5;DICER1;RCL1;BYSL;DCAF13;MDN1;EXOSC8;PIH1D1;NOL8;RRP12;PELP1;PRKRA;DKC1;INTS8;ESF1;RRP1B;RPL18A;NOLC1;MPHOSPH10;RRP36;UTP3;WDR74;KRR1;RPL23A;NOL11;EXOSC7;UTP6;HNRNPA2B1;RPL3;RPL11;DIS3;DDX10;WDR36;RPL13;EXOSC5;RPL8;RPL21;KARS1;RPL5;NOP56;POP4;RPL32;RPL7;RPS16;UTP15;TUT4;WDR18;PUS10;LIN28B;INTS11;RPS6;RPS2;RPL41;RPL29;C1D
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.5242858213806386,-1.1039304797010232,0.2318840579710145,0.9575335608154024,1.0,9/49,15.07%,TGFB2;SOX9;VSTM2A;BMP6;HJV;TGFB3;BMPR1B;ADAMTS7;TGFB1
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.7303995451411723,1.1035401093463448,0.38461538461538464,1.0,1.0,2/5,14.08%,BEND3;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.7303995451411723,1.1035401093463448,0.38461538461538464,1.0,1.0,2/5,14.08%,BEND3;KMT5B
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.7501787410243346,-1.1034423169128476,0.35714285714285715,0.958593561488039,1.0,2/6,14.21%,CRYM;SLC7A8
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6484632042616996,-1.1034140405308743,0.39344262295081966,0.9579252409620703,1.0,3/11,8.83%,TIMP1;LOXL3;BST1
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.775578131560741,-1.1033220816302869,0.3684210526315789,0.9574885694003009,1.0,3/5,14.01%,EDN1;CAV3;MYLK3
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.5543020277807782,-1.103313511425349,0.3492063492063492,0.9567507600673667,1.0,6/26,15.07%,TGFB2;INHBC;BMP6;RBPMS;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.6818858178129867,-1.1030035258210806,0.3275862068965517,0.9571888393423476,1.0,2/10,11.55%,MLIP;CAV3
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.5679618752560245,1.1027934017782857,0.325,1.0,1.0,5/15,16.00%,M1AP;NOC2L;BANF1;RBBP4;CHAF1B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.46004567198144514,1.1025748833115707,0.2972972972972973,1.0,1.0,15/63,17.00%,ICAM1;HSPA1A;EYA4;UNC5B;ACVR1;SERPINE1;HSPA1B;ITGA6;ZMYND11;BMP5;RELA;SH3RF1;DDX3X;FAIM;PEA15
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5466266539534314,-1.102524378544155,0.328125,0.9580941017471899,1.0,1/38,0.03%,CD44
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5140841978942383,-1.1023678168936677,0.2777777777777778,0.9579756825933469,1.0,8/42,11.43%,CERS6;CPS1;PCSK1;PAM;ARG2;SGMS2;FURIN;PNPLA1
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.7069047679228213,-1.1023353467249464,0.38333333333333336,0.957342816248697,1.0,1/7,1.95%,IL12A
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.6539941839999236,-1.1023346040177016,0.46296296296296297,0.9565606734249644,1.0,3/7,30.98%,DNM1L;CHMP4B;CORO1C
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.6763071974226011,1.102332328141748,0.3142857142857143,1.0,1.0,2/5,12.14%,TNIP1;ITCH
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.6524402618387707,1.1022546606529868,0.4117647058823529,1.0,1.0,1/7,2.19%,SOAT2
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),-0.7153827216311923,-1.102090878009276,0.4444444444444444,0.956546556178319,1.0,1/7,1.74%,CHRM3
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.6866660671967932,1.1019595426345503,0.4,1.0,1.0,2/7,13.04%,EVI2B;MLLT3
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.5474071479417083,-1.1015789938750735,0.3188405797101449,0.9573459742280281,1.0,8/26,17.60%,P2RY12;CYFIP1;CDH13;CARMIL1;ABLIM2;ABLIM1;DMTN;VCL
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.5754808394781068,-1.1015603160113863,0.359375,0.9566209833427398,1.0,8/18,22.68%,SLC8A3;GRIN2B;SLC24A1;GRIN2D;PLK2;TSHZ3;SHANK2;PRKCZ
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.5164951266621636,-1.1014201002374775,0.3283582089552239,0.9563150948591844,1.0,14/42,19.62%,LAMC1;NTN4;ATRNL1;NTNG1;EFNA1;LAMB1;TEK;FERMT3;ITGAV;NTNG2;LAMB4;ANTXR1;LAMB2;EPHB3
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6242852512820989,-1.1014002456726402,0.4098360655737705,0.9556472748600789,1.0,4/16,12.26%,CARTPT;RIMS1;RIMS2;TNFRSF1B
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.4526622975495944,1.1009105496565168,0.20833333333333334,1.0,1.0,5/41,8.21%,GPC4;B3GNT6;GPC2;SDC2;HS6ST1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.6750894258710944,1.1008964356536741,0.3888888888888889,1.0,1.0,2/9,10.79%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.7052071352280673,-1.1007984389470207,0.3559322033898305,0.956273548030813,1.0,1/5,3.21%,DPY19L2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.7052071352280673,-1.1007984389470207,0.3559322033898305,0.956273548030813,1.0,1/5,3.21%,DPY19L2
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.6146385555380983,1.1007689450576634,0.325,1.0,1.0,2/14,6.57%,NUPR1;FBP1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5806164297861418,-1.1001843362286277,0.3333333333333333,0.9575251577156965,1.0,6/19,20.73%,MFAP5;TENM3;VEGFA;STAT3;SHROOM2;IFT122
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.6362256834858584,-1.1000673551872064,0.3793103448275862,0.9571883629923539,1.0,2/11,11.36%,TERF2IP;CAMK1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.6482955987058777,-1.0999760032130963,0.38095238095238093,0.9566794807083007,1.0,3/8,14.21%,GABRG2;GABRB2;GABRB3
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.5206992751093997,1.099933450009653,0.34285714285714286,1.0,1.0,5/26,12.35%,HSPA1A;BAK1;OPTN;HSPA1B;DAXX
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.6758925065653617,1.0997238142893984,0.35714285714285715,1.0,1.0,2/5,24.25%,SALL1;ERBB3
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.3988276378845547,1.0995839444713411,0.21739130434782608,1.0,1.0,18/153,7.82%,CYP1A2;CYB5A;ABCC2;PYCR1;DCXR;F11;CA2;ENPEP;CROT;NQO1;CSAD;ATOH8;CYP2E1;CAT;FBP1;HSD11B1;HPRT1;AP4B1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.6351301458398979,-1.0995571742024168,0.3484848484848485,0.9573867185906746,1.0,2/17,5.82%,EDN1;MAP3K5
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.5647799754634144,-1.0994685738210719,0.3584905660377358,0.9569333391925026,1.0,2/19,3.65%,FMO5;ACADL
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.6066374693434956,-1.0994376295143742,0.3870967741935484,0.9562223707076297,1.0,1/10,1.29%,VIL1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.7099257404255314,-1.099221029219443,0.4057971014492754,0.9555072543183637,1.0,3/5,15.65%,PLSCR1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.7099257404255314,-1.099221029219443,0.4057971014492754,0.9555072543183637,1.0,3/5,15.65%,PLSCR1;UHRF1;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.6686506578729224,-1.0990132042023577,0.375,0.9554785393676496,1.0,3/8,22.74%,GRIP1;DLG4;WNT5A
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5399384916419842,1.0983327347324827,0.2894736842105263,1.0,1.0,4/16,9.32%,DAO;GLYAT;THNSL2;SEPHS2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4494665880094758,-1.098175975496427,0.3,0.9578687113724879,1.0,25/157,12.52%,PDGFD;SEMA3E;VSIR;VIL1;SMIM22;DUOX1;EDN1;CARMIL2;F3;HGF;CEMIP;CSF1R;SEMA3D;RHOC;LAMB1;XBP1;PLET1;CDH13;CARMIL1;VEGFA;CAV1;CLDN4;TRIM32;EGFR;FERMT3
prerank,PanglaoDB_Augmented_2021__Myocytes,0.4709286632158002,1.0980697060990048,0.25,1.0,1.0,15/83,6.70%,CXCR4;TNNC2;CRYAB;MYH4;CHODL;CASQ2;IL4R;ASB5;PLD1;TPM2;ACTN2;NPHS1;SMYD1;PAX3;SRL
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.7179346540285428,-1.0979246599733823,0.3709677419354839,0.9579862734877431,1.0,2/5,14.73%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.42117052874064304,1.0979021317195756,0.25,1.0,1.0,21/89,21.20%,U2AF1;RAE1;NUP42;NUP210;CPSF4;RBM8A;SYMPK;TPR;EIF4E;SARNP;NXF1;NUP37;HNRNPA2B1;SMG5;RBM15B;THOC2;MAGOH;NDC1;ALYREF;SEH1L;SRSF9
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.6236588419602865,1.0975769265033808,0.46153846153846156,1.0,1.0,3/10,24.74%,EIF5;EIF2S2;EIF4B
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.5201812798414516,-1.0975532779786237,0.36619718309859156,0.9585632657203599,1.0,5/42,5.26%,TGFB2;MEF2C;LOXL3;SOX9;HGF
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.6090706617502372,1.0972566123716991,0.425,1.0,1.0,3/10,5.91%,SLC22A2;SLC22A6;GUCA1B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.7019728454185337,-1.097215981235809,0.3968253968253968,0.9591860336829514,1.0,2/6,25.60%,PLN;EHD3
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7312616290175309,1.0967520578382548,0.3888888888888889,1.0,1.0,3/6,19.40%,PTPN22;DDX3X;MARCHF7
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.6298578109465102,-1.096739758780692,0.39655172413793105,0.9603211256472818,1.0,3/13,8.23%,PIM1;VSTM2A;FNDC5
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.6373138956448978,-1.0962218325209259,0.3492063492063492,0.9612445678119171,1.0,3/9,26.77%,CX3CR1;LRRC19;LPCAT3
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5981452458252754,1.0962039617818526,0.3684210526315789,1.0,1.0,7/13,22.69%,DAXX;GSTO2;ATF3;CPEB2;DDX3X;ZFAND1;HSF1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6392752198285617,-1.0960535623982017,0.4057971014492754,0.9611182311339007,1.0,3/9,19.09%,F3;PTPRJ;NDRG4
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.591149147452637,-1.095947613962688,0.3333333333333333,0.960844676932062,1.0,6/17,18.62%,SLC2A12;SLC5A9;SLC5A2;SLC2A2;SLC2A9;SLC5A10
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.48020612612827757,-1.0954936684923888,0.25333333333333335,0.9617267182120642,1.0,26/101,19.52%,FBLN1;ARHGAP18;ROBO4;SPINT2;DUOX1;FGF22;CSF1R;CEACAM1;FES;NRG4;TRIM32;EGFR;LDB2;FGF7;NRG1;TMSB10;DAPK3;TGFB1;PLXNA2;PRAG1;PLXNA4;PLXNC1;PLXND1;CAMSAP3;AMOT;OSGIN1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.5048789813474573,-1.0954818969815499,0.3670886075949367,0.9610270556285588,1.0,6/56,5.26%,ROR1;PDGFD;TGFB2;PIK3AP1;SOX9;HGF
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.507113580720236,1.0953057591990247,0.40625,1.0,1.0,9/30,19.66%,LSM7;EXOSC8;DCP1A;DCP1B;PATL1;EXOSC7;DIS3;DCPS;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.633907220689491,-1.0950470194186022,0.3787878787878788,0.9621010494860062,1.0,2/11,10.31%,HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.5690520243698751,1.0947823698798522,0.4146341463414634,1.0,1.0,3/18,2.74%,PIWIL4;SPOCD1;PIWIL2
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),-0.7569604352154987,-1.094625030236618,0.3968253968253968,0.9629181004946037,1.0,2/5,20.44%,BCL11B;GAS6
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.6739814601333205,-1.0946118900502348,0.35714285714285715,0.9622191622570425,1.0,5/12,23.23%,HEY1;LRP1;ADAMTS9;PDGFRB;HEY2
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.7030676136475462,-1.0945238169623384,0.3958333333333333,0.9617684370737832,1.0,3/6,24.70%,PLCB1;POMZP3;GLRA1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6365748127181609,-1.094492889840814,0.359375,0.9611255384361226,1.0,4/14,12.26%,HLA-F;HLA-A;B2M;TNFRSF1B
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.7115306590745486,1.0942914431960145,0.3333333333333333,1.0,1.0,1/5,2.79%,HMGB1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.6648695630157089,1.093961778982345,0.38095238095238093,1.0,1.0,2/8,9.06%,COQ2;GK5
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.613122645666973,-1.0938889100621694,0.3728813559322034,0.9624341737554323,1.0,7/10,17.47%,GABRG2;GABRA1;GABRB2;GABRA2;CBLN4;GABRB3;FGF13
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.581534502066867,-1.0937916521253754,0.35384615384615387,0.9621923448574099,1.0,5/21,19.27%,STMN2;APC2;NAV3;FGF13;CAMSAP3
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.6621153774710525,-1.0937818315218615,0.4153846153846154,0.9614659724267824,1.0,2/8,8.31%,SHMT2;PRPS1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5598958001773411,-1.0937213126241334,0.3582089552238806,0.9608638123803258,1.0,2/26,7.50%,ARIH2;TOMM7
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.4684941046677179,1.0936061078177637,0.32142857142857145,1.0,1.0,1/53,0.18%,NGF
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.7357638643239122,-1.093507083553463,0.4166666666666667,0.9609235226090241,1.0,3/5,24.70%,PLCB1;POMZP3;GLRA1
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.6896257892990086,-1.0932246165564603,0.36363636363636365,0.9611751120726019,1.0,1/7,0.50%,CARTPT
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.6887784165607715,1.0931540095500378,0.42424242424242425,1.0,1.0,1/10,0.84%,ORC1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5684116827562385,1.0931517232512873,0.3235294117647059,1.0,1.0,3/18,9.82%,BCL2A1;BAK1;CASP9
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.670141038543202,-1.0930765096272839,0.34545454545454546,0.9594837184029452,1.0,1/8,10.82%,H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.670141038543202,-1.0930765096272839,0.34545454545454546,0.9594837184029452,1.0,1/8,10.82%,H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.670141038543202,-1.0930765096272839,0.34545454545454546,0.9594837184029452,1.0,1/8,10.82%,H1-0
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.41924337771785547,-1.0929668942260309,0.3076923076923077,0.9591309310900239,1.0,36/280,13.92%,FSTL1;ASB4;IGFBP3;SPARCL1;FBXL16;LAMC1;IGFBP4;TIMP1;ASB18;PRSS23;PSMB8;FBXW9;FBXO41;RAB11A;MEPE;LAMB1;FUCA2;FBXL13;HIF3A;FBXL18;FBXO17;RAB3A;AFP;CST3;SCG3;FBXO7;CHRDL1;FBXO10;ASB14;GPC3;SCG2;FBXL5;CP;CCNF;CHGB;RAB1B
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6528241869500488,-1.0927644672850625,0.4117647058823529,0.9591228894475432,1.0,2/8,16.38%,PLN;FKBP1B
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.4865920831805139,1.0923034696776537,0.3235294117647059,1.0,1.0,6/44,13.50%,NUPR1;LCK;CRADD;STYXL1;BCL10;BECN1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.5187089519158282,1.0922974308883537,0.3076923076923077,1.0,1.0,3/22,4.56%,ICAM1;RAPGEF1;COL18A1
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.7560992593330303,-1.0922047576495986,0.40350877192982454,0.9602612494602534,1.0,2/5,19.99%,CSF1R;IL34
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6131121935104085,-1.0917629164104592,0.38461538461538464,0.9612909020313357,1.0,1/15,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.6053942602929184,1.0915187213515827,0.42857142857142855,1.0,1.0,1/11,1.68%,WNK4
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5657022330253114,1.0915102988606593,0.39473684210526316,1.0,1.0,1/18,1.28%,FBF1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5549437656130376,-1.0914618383772725,0.4166666666666667,0.9616627046956059,1.0,9/37,12.26%,CR1;PTPRC;NCKAP1L;LGALS3;SFTPD;HLA-DPB1;HLA-DRB1;CEBPB;TNFRSF1B
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5584143907628896,-1.0913700571330653,0.2857142857142857,0.9612257206351177,1.0,11/25,24.69%,DCX;RSPH6A;SPAG16;CCDC39;RSPH9;SPAG17;CFAP74;CFAP46;RSPH1;HOATZ;SPEF1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),-0.7199352967425257,-1.0913265173770843,0.45454545454545453,0.9605837235940076,1.0,5/5,28.03%,SAMHD1;NT5C1A;NUDT18;NUDT16;NUDT15
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.5541664687827396,1.0912007658302134,0.25,1.0,1.0,4/16,11.53%,ZNF639;CCNT1;RRP1B;SMARCA4
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.4675809289733339,1.091136270867888,0.2,1.0,1.0,3/22,9.43%,ATP6V0A4;ATP12A;UCP2
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6126256953529224,-1.0910824774349879,0.4262295081967213,0.9607039911257301,1.0,5/13,17.45%,DUOX1;RFC3;ABCC9;STAT1;TYMS
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.4891976594451214,-1.0909720046025158,0.32857142857142857,0.9603144294205483,1.0,11/63,15.61%,FAM131C;NKAIN1;RIMS4;TENM3;NR2F1;MEX3A;CDK5R2;FHOD3;RAC3;PCGF2;NGFR
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.6251923902793048,-1.090373127440724,0.38571428571428573,0.9617648246670211,1.0,3/16,12.42%,SPDYA;CCND1;EGFR
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),-0.7371720290364161,-1.0899303932484892,0.48,0.9626205628988346,1.0,1/5,3.63%,HORMAD2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.5372963802922179,-1.0897989588460715,0.3387096774193548,0.9623290680148716,1.0,11/31,23.23%,HEY1;CX3CR1;BHLHE40;TNFRSF1B;PTPRZ1;TYMP;CX3CL1;PRUNE1;TENM4;PTN;HEY2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5377073661368138,1.0897628917242608,0.2903225806451613,1.0,1.0,1/11,2.49%,MBOAT1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.6134285088534661,-1.0893822620972935,0.4084507042253521,0.9630162037727815,1.0,1/13,0.91%,ABCC4
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.46569520001625636,-1.0892669189185666,0.36231884057971014,0.9626642409901404,1.0,29/102,21.44%,MT1M;SYT4;SYT1;MEF2C;FOS;GLRA2;ADGRV1;RYR3;ADCY7;LRRK2;AQP1;HPCA;B2M;BMP6;ADCY8;DLG4;EGFR;SYT12;SYT13;DMTN;TRPM2;MT1E;CPNE8;CDH1;KCNH1;ADD1;ADCY1;SYT7;MT2A
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.5353024974555752,-1.0889951437356133,0.34285714285714286,0.9628049362827374,1.0,6/24,8.05%,TGFB2;KITLG;SOX9;ADAM21;GATA1;AR
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.563256740444319,-1.0889232769625365,0.3333333333333333,0.9624763834136371,1.0,6/24,14.83%,NPY;TGFB2;RARB;GLI3;EDNRB;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6714026386780303,-1.088660428950541,0.4166666666666667,0.962700155432755,1.0,2/10,11.87%,NR4A3;FBXO7
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6121282720340208,1.088570824180215,0.43902439024390244,1.0,1.0,2/8,22.70%,METAP1D;NAA20
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.625906626040552,1.0885337982836527,0.3157894736842105,1.0,1.0,2/8,4.90%,ZAP70;XG
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.6263146042064047,-1.088335892043226,0.3,0.9630670886055767,1.0,3/12,10.97%,ID2;LAPTM5;LYN
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.5844718020223445,-1.0882793344620247,0.3793103448275862,0.9624900392807002,1.0,4/15,13.66%,MEF2C;LRRK2;GRIN2B;GRIN2D
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.5486249431025075,-1.0882576725640938,0.3787878787878788,0.9618460161316954,1.0,10/21,29.14%,MEF2C;CAMK1;CAMK2B;GRIN3A;NEURL1;KIF1A;SHANK1;ARF6;FMR1;APOE
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.6684821556570576,-1.088224676928562,0.390625,0.9612482085771277,1.0,4/9,20.53%,PRICKLE1;SOX9;TGFB1;SRA1
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.7017512752658979,-1.087936274864123,0.49122807017543857,0.961472065599932,1.0,3/7,24.18%,STAT3;STAT4;IL12RB1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.5823672257258014,-1.0877808068185677,0.4098360655737705,0.9612968119144204,1.0,4/28,7.75%,KDM4D;PARP9;DTX3L;CYREN
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.5104772868547451,1.0877741925320021,0.3142857142857143,1.0,1.0,9/40,16.57%,ASAP1;NUMA1;G3BP2;CROCC;ARHGAP35;PLK4;STX18;SAXO1;CEP120
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.5608639824922707,-1.0876531859119678,0.38333333333333336,0.9610165785638562,1.0,9/26,15.70%,PKP2;FGF12;SLC8A1;SCN4B;SCN1B;ATP1A1;CACNA1G;KCNH2;CACNA1C
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.5284635680913602,-1.0874788129221387,0.3508771929824561,0.9609546324623562,1.0,7/33,15.99%,IRGM;CEMIP;CHI3L1;DDIT4;CALM3;TGFB1;DMTN
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.6439685723737995,-1.0874488649264036,0.40384615384615385,0.9596084441418,1.0,3/9,18.31%,STAT5A;PLCB1;STAT3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.6439685723737995,-1.0874488649264036,0.40384615384615385,0.9596084441418,1.0,3/9,18.31%,STAT5A;PLCB1;STAT3
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.5922907403043087,1.0872991669596177,0.3611111111111111,1.0,1.0,2/12,17.25%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.5575584957610172,1.087259575533177,0.2926829268292683,1.0,1.0,5/17,16.32%,MORC3;SP100;HNRNPU;TAF3;SUN2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.6592704562387706,-1.0871851495672589,0.423728813559322,0.9598400254585086,1.0,1/8,15.07%,TGFB1
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.503320807710989,-1.0868855504905526,0.36923076923076925,0.9602809381513066,1.0,19/78,17.99%,ROR1;FSTL1;COL4A1;P3H2;WWTR1;GPR161;GJA1;TENM3;AXL;ADGRL2;GLI3;CXCL14;ADAMTS7;ADAMTS15;EFNB2;EFNA5;GNG12;ANTXR1;TPM1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.6104768735773496,-1.0866469514417674,0.40298507462686567,0.9601898674046889,1.0,3/19,12.42%,SPDYA;CCND1;EGFR
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.6105578849388714,1.0851956360388808,0.4375,1.0,1.0,3/13,6.33%,F2;PDGFA;SELP
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.6279604841651238,-1.0850908947895503,0.36619718309859156,0.9648993946076733,1.0,2/12,7.58%,PTPRC;GJA1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5397037870500547,-1.0849366504309543,0.3870967741935484,0.9646554692133122,1.0,3/24,15.68%,TERF2IP;H1-0;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.7323761670791258,1.0844853722581729,0.4528301886792453,1.0,1.0,2/5,13.58%,BECN1;HNRNPU
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.707251201638778,1.0844728729977273,0.45652173913043476,1.0,1.0,2/5,9.90%,RYK;WNT3
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.49549079651407785,-1.0844459546216663,0.2702702702702703,0.9656587114957943,1.0,6/46,5.35%,TIMP4;VSIR;BIRC3;TIMP1;SERPING1;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.6852982488113497,-1.0842576752749449,0.3684210526315789,0.9655264779467991,1.0,3/7,19.44%,TGFB1;STAT3;ESR1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.5005122876463273,1.084145676670149,0.32432432432432434,1.0,1.0,5/37,13.83%,ORC1;HMGA2;BRCC3;NABP1;UIMC1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5171016652512369,-1.0840212471023953,0.35526315789473684,0.9656255320000301,1.0,15/51,21.63%,PDGFD;EDN1;MAP3K5;LRRK2;DIRAS1;VEGFA;HTR2B;EGFR;TGFB1;RASGRP1;EZH2;TENM1;IL34;PDGFRB;FLT1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.43071435476844366,-1.0837213897660523,0.2625,0.9660298258027561,1.0,54/212,17.18%,LRTM1;GFRA3;SEMA3E;BAIAP2;ROBO4;EPHA3;CCK;NRCAM;DOK6;L1CAM;EMB;ROBO2;EPHA4;NTN4;SLITRK5;NTNG1;SLITRK4;SEMA3D;EFNA1;ANOS1;LGI1;GFRA2;PALLD;SPTB;CYFIP1;CDK5R1;PAK3;DOK1;RAB3A;VSTM2L;EPHA6;EPHB6;NEFH;SCN1B;EPHB1;SLITRK3;B4GALT6;DRAXIN;OPHN1;EFNA3;EFNB2;CNTN4;SEMA4B;NOTCH2;UNC5D;TNR;EFNA5;NTNG2;SEMA4G;SIAH1;PIK3CB;DAB1;PRKCQ;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.4810599908438395,-1.0836427788701346,0.3561643835616438,0.9655403544719858,1.0,26/104,16.51%,RHBDF2;CR1;GPHB5;CYSLTR2;TSHR;PRKAR1B;LGALS3;ADCY7;RXFP1;HLA-DRB1;ADCY8;FURIN;GPR176;LYN;NMI;GGT5;PTH2R;NPSR1;GNG2;FCGR3A;SPI1;ADCYAP1R1;RAMP1;HRH2;SYK;PLK2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.6046210945998711,-1.0835935606224418,0.4461538461538462,0.9650218864292028,1.0,3/14,12.17%,P2RY12;RYR3;ABCC9
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.6400678838531486,-1.0833736977675061,0.41509433962264153,0.9650169835057233,1.0,1/11,0.99%,IRGM
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.5115734949904837,1.0833253111189887,0.2727272727272727,1.0,1.0,1/16,3.02%,SLC39A8
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.6567589782352322,-1.0833135469252588,0.4117647058823529,0.9645145634981417,1.0,2/7,13.12%,MX1;DNM1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5469173911088538,-1.0833122416178431,0.4264705882352941,0.9637754718786029,1.0,4/21,11.55%,VAV3;EDN1;PRR16;CAV3
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.6674403948715207,1.0831652373581935,0.4523809523809524,1.0,1.0,4/9,12.73%,SERPINF2;RUNX1;SERPINE1;MELTF
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.6602891089763709,-1.0830969019008552,0.4166666666666667,0.9638011920676988,1.0,4/12,14.09%,ISG15;LRRK2;MTCH2;COX18
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.47424142396751195,-1.0830074567456158,0.3055555555555556,0.963374942454698,1.0,22/79,15.52%,ROR1;TTN;EPHA3;TSPYL2;MUSK;EPHA4;MET;CSF1R;TEK;AXL;HLA-DRB1;EPHA6;EPHB6;SLAMF8;EPHB1;EGFR;LDB2;RBL2;TIE1;DDR2;NLRC5;RAD50
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5422462924209792,1.0828949647541875,0.2916666666666667,1.0,1.0,3/16,4.75%,VDR;EPB41L4B;TGM1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6871684452009219,-1.082762034891988,0.46774193548387094,0.9634379446897983,1.0,4/6,20.99%,ADGRG1;HTR2B;FLOT1;PLVAP
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.40933232792903435,-1.0827351537749235,0.2692307692307692,0.9628128946796335,1.0,69/421,16.87%,CLDN5;TLR2;PDGFD;IL13RA1;CR1;IL12A;TGFB2;KITLG;IL6R;SPDYA;CIDEB;TIMP1;TSHR;FGF22;TGFBR2;EDN1;ADGRG1;CAPN1;SOX9;CITED2;EPHA4;CCND1;SFTPD;CSF1R;CAMK1D;IL7;PRAME;LGI1;BMP6;COX17;WWTR1;AR;CTF1;CRLF1;STX3;XBP1;BST1;IL12RB2;COPS9;LYN;VEGFA;TGFB3;CAV1;HTR2B;ROMO1;TNFRSF1B;AQP11;BMPR1B;CDH3;TRIM32;EGFR;LRP1;FGF7;NRG1;IL31RA;FLOT1;PRKD2;TGFA;SERTAD1;EFNB2;ZFP36;TGFB1;ITGAV;HPN;FKBP1B;PTPRJ;DOCK2;NCBP1;PPP3CA
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.5387775163186141,1.082689322061662,0.3225806451612903,1.0,1.0,4/16,21.31%,SPHK2;EPC1;DMAP1;NAA40
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.626465793311301,-1.0825640705389648,0.453125,0.9625953440575824,1.0,1/12,5.11%,ALOX12
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.7174588498807697,-1.0823142003816748,0.4727272727272727,0.9626366385088649,1.0,1/5,3.07%,FABP3
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5289872548398665,-1.0821804214919435,0.3484848484848485,0.9624047929375483,1.0,11/44,14.14%,TGFB2;PTPRC;PLSCR1;ITGAM;NLRP3;XBP1;IFI35;HLA-DRB1;NMI;IFNK;SKAP1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.5259181569401584,-1.0821778068594166,0.3484848484848485,0.961671811374001,1.0,9/40,13.07%,SOX9;CITED2;MET;DKK3;XBP1;TGFB3;CAV1;IGSF3;NRG1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.5848843540433126,-1.0820460548428066,0.38461538461538464,0.961411576043609,1.0,2/20,5.15%,ACADL;AOAH
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),-0.7458192082338673,-1.0819424618287994,0.46551724137931033,0.9610339185260317,1.0,2/5,24.49%,ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7024260546830056,-1.0818596729662617,0.4423076923076923,0.9605758966432213,1.0,2/6,28.41%,PRKD2;HIF1A
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.48028469627679704,-1.0817985798310237,0.3181818181818182,0.9600818081063771,1.0,13/87,14.22%,ANGPT1;MGST1;CHST1;PRELP;OGN;CHST9;CHST2;CSGALNACT1;GGT5;CHST15;UST;B4GALT6;CBS
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.6193684820930105,-1.0816686494283418,0.3684210526315789,0.9598456095292978,1.0,1/12,2.36%,CENPE
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.4598119518683228,-1.0815025881823779,0.26865671641791045,0.9596831820298609,1.0,12/112,14.87%,PLEKHA2;PLEKHA4;CDS1;INPP4B;BMX;PIGH;PIGC;PIP5K1B;ITPKA;INPP5D;PTPN13;PI4K2A
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.518731180893527,-1.081219369457436,0.3611111111111111,0.9599318015901458,1.0,9/34,17.33%,PLEKHA2;UTRN;THY1;TEK;CDH13;VEGFA;SKAP1;PTPRJ;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.6871356510600714,-1.0809953039287608,0.4827586206896552,0.9599454790363202,1.0,3/7,16.95%,RFTN1;TGFB1;PRKCQ
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.667212773339078,-1.0809931474045014,0.4307692307692308,0.9592193478116331,1.0,2/7,10.51%,UBASH3B;CEBPB
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5769530967632582,-1.0809235066326714,0.421875,0.9587285253972778,1.0,7/27,17.60%,P2RY12;ACTN1;GATA1;UBASH3B;FERMT3;PIK3CB;VCL
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.5482728388663696,-1.0809057982817232,0.3728813559322034,0.9580702323182999,1.0,17/28,35.42%,SNX10;TULP3;FSIP2;ODAD4;WDR35;ATP6V1D;IFT122;FAM149B1;EHD1;CSNK1D;TMEM107;RAB29;TCTN1;BBS4;TTC21B;RABEP1;BBS9
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.4820654526984087,1.0807461896642327,0.28888888888888886,1.0,1.0,3/22,3.79%,ICAM1;NUPR1;SEMA5A
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.39636634898024703,1.0804248604780262,0.2608695652173913,1.0,1.0,57/233,22.17%,U2AF1;SF3A3;LSM7;RNF113A;PRPF4;SF3B2;CRNKL1;RALY;CPSF4;PCF11;PTBP1;CSTF2;RBM8A;POLR2K;SYMPK;SNRPC;PPIL1;PDCD7;GEMIN6;CCAR1;DNAJC8;SNRNP25;HNRNPU;RBM17;POLR2L;YBX1;SF3A2;SNIP1;SRSF8;HNRNPH1;CWC27;GEMIN5;DHX9;SNRNP35;DDX5;HNRNPA2B1;RBM15B;GPATCH1;CDC5L;BCAS2;MAGOH;RBM22;RBM5;ALYREF;SNRPB;SF3A1;CSTF1;SRSF9;HNRNPC;HNRNPM;POLR2E;HNRNPR;WBP4;DDX46;ZMAT2;RBM19;POLR2D
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.7276488838248738,-1.080345870450756,0.359375,0.9591084003449064,1.0,2/5,21.40%,OLFM2;MYOCD
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.4842110352656399,-1.0802577980036216,0.31666666666666665,0.9587429152057736,1.0,18/59,16.58%,TRPM1;MYO7A;RDH12;RPGR;GPR179;ADGRV1;COL11A1;SLC4A10;BEST1;SLC24A1;TYR;PAX6;CDH23;ABLIM1;DHRS3;RP2;CRYBG3;ROM1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.5885914435285878,-1.0802308660020823,0.2857142857142857,0.9580933965464296,1.0,3/17,15.99%,DUOX1;CLDN4;DMTN
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.456151126088091,-1.0801059869710439,0.2916666666666667,0.9578823484916451,1.0,43/163,20.32%,FSTL1;SEMA3E;LRIG3;KITLG;LAMC1;COL4A1;PLSCR4;CADPS2;NLRP3;NTN4;MET;DDAH1;PTPRG;KIAA1217;WWTR1;GJA1;LAMB1;PALLD;CPE;ADGRL2;CDH13;SULF1;THSD7A;VEGFA;PROS1;EGFR;PLEKHH2;FAT1;SRGAP1;LRRC49;GNG12;SYNPO;CRB2;ANTXR1;MYO1B;TPM1;PRICKLE2;LAMB2;NR2F2;FAT4;ANGPTL2;COL12A1;COL4A3
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.5286139885959973,-1.0798028063017233,0.3787878787878788,0.9581452115345085,1.0,1/31,0.58%,MDFIC
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.5861113773919011,1.0797485556362203,0.4,1.0,1.0,4/13,12.62%,DUSP1;NCK1;PPP2R2C;PPM1F
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.4838456290459965,-1.0793980191953203,0.410958904109589,0.9588445138250796,1.0,29/68,17.39%,IRGM;P2RY12;CHRM3;PTPRC;MCTP1;MCTP2;EDN1;NMUR2;NUDT4;LRRK2;CCR9;GRM5;TPCN2;CX3CR1;CXCR6;SLC8A1;HTR2B;EDNRB;EGFR;KSR2;ACKR4;LAT2;CACNA1C;DMTN;FKBP1B;PTPRJ;PPP3CA;TRPM2;BCAP31
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.5533307184321675,-1.0792735548856118,0.38095238095238093,0.9585315256582945,1.0,7/20,21.35%,ABCC4;CEACAM1;SLC51A;ATP8B1;SLCO2B1;SLC10A6;RXRA
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.49771344292160763,-1.0790535855375878,0.35135135135135137,0.9586988039287645,1.0,10/66,15.07%,DPP10;EPHA3;LGALS3;STAC2;AR;STX3;EGFR;LRP1;PID1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.5068815650452766,1.078754711806791,0.3548387096774194,1.0,1.0,5/26,15.97%,LRRC8A;UCN;ACSL4;NLGN2;CAPN10
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.49507087437379965,-1.0783891756666006,0.29850746268656714,0.9602460273412637,1.0,10/48,17.70%,MX1;KIF16B;MVB12A;CAV1;LRP1;DNM1;TGFB1;RAMP1;SYK;LILRB1
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),-0.7107518816299205,-1.0778384454135133,0.39622641509433965,0.9615150987800012,1.0,3/5,28.03%,CBS;NUDT1;NUDT15
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.4130325073361391,1.077835233868285,0.2692307692307692,1.0,1.0,15/72,8.29%,DAO;C6;SLC22A6;ABCC2;SERPINF2;F11;SOD3;ENPEP;GLYAT;SLC47A1;CYP2E1;GJB1;FBP1;HSD11B1;CLDN2
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.39005114082787884,1.0776742897655311,0.25925925925925924,1.0,1.0,65/256,22.17%,U2AF1;SF3A3;LSM7;RNF113A;PRPF4;SF3B2;CRNKL1;RALY;CPSF4;PCF11;PTBP1;SRPK3;CSTF2;RBM8A;POLR2K;SYMPK;SNRPC;PPIL1;PDCD7;GEMIN6;CCAR1;SNUPN;DNAJC8;SNRNP25;HNRNPU;RBM17;POLR2L;STRAP;COIL;YBX1;SF3A2;SNIP1;SRSF8;HNRNPH1;CWC27;GEMIN5;DHX9;SNRNP35;DDX5;HNRNPA2B1;RBM15B;GPATCH1;CDC5L;SMN1;BCAS2;MAGOH;DCPS;RBM22;RBM5;WDR77;ALYREF;SNRPB;SF3A1;CSTF1;TGS1;SRSF9;HNRNPC;HNRNPM;POLR2E;HNRNPR;WBP4;DDX46;ZMAT2;RBM19;POLR2D
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.6197768200613252,-1.0776369123944818,0.41379310344827586,0.9615927265687929,1.0,3/11,14.99%,EDN1;RFK;AGT
prerank,GO_Biological_Process_2021__cellular response to salt stress (GO:0071472),-0.7092974093952823,-1.0775355718793496,0.3793103448275862,0.9612571090845028,1.0,1/5,6.70%,AQP1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5388248748926656,-1.0774078948631447,0.37681159420289856,0.960885781359256,1.0,6/33,16.63%,EPN1;SH3GL2;CBLC;EGFR;TGFA;PTPRJ
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.6794316563785772,-1.0771857103189468,0.4,0.9602532644059505,1.0,3/6,18.31%,STAT5A;STAT1;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.6794316563785772,-1.0771857103189468,0.4,0.9602532644059505,1.0,3/6,18.31%,STAT5A;STAT1;STAT3
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.6154337967733623,-1.077147306257691,0.417910447761194,0.9596739561064586,1.0,2/11,9.76%,KCNK10;KCNK6
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.5115232251318443,-1.0770184890905392,0.4057971014492754,0.9594060085302327,1.0,10/45,13.92%,GGH;SMIM22;MUC16;TMC4;CEACAM1;CBLC;CLDN4;GALNT6;TJP3;OVOL2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.5124791313245332,-1.076705697434719,0.3442622950819672,0.9597662064735157,1.0,10/32,12.32%,ISG15;TGFB2;MEF2C;ANO6;ADGRV1;BMP6;NELL1;SLC8A1;TGFB3;BMPR1B
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.4514889314528761,-1.076639491092482,0.3287671232876712,0.95928228621078,1.0,13/137,9.65%,ANGPT1;HOPX;CLU;CENPE;COX7A1;HIGD1C;CENPF;TESPA1;CALY;NSG2;TBCA;RPL38;TMEM35A
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.6824335012742724,1.0761751093714584,0.4418604651162791,1.0,1.0,2/6,11.05%,TMEM98;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.5926083384877098,1.076085238822683,0.375,1.0,1.0,4/13,5.68%,ICAM1;CYBA;CFH;NOX1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.5731239132395249,-1.0758546426458253,0.38461538461538464,0.9610613732279304,1.0,5/21,13.39%,CHST1;PRELP;OGN;CHST2;B4GALT6
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.5927898740110522,-1.075828231537902,0.4375,0.9604620195279912,1.0,3/19,10.39%,NDST3;XYLT2;SULF1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.5359182790033908,-1.075700160659643,0.39436619718309857,0.9601081534445979,1.0,8/33,17.60%,P2RY12;MEGF11;ACTN1;GATA1;UBASH3B;FERMT3;PIK3CB;VCL
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.530337474062838,-1.075619656450146,0.3380281690140845,0.9596685484948789,1.0,11/39,19.22%,GAP43;PLPPR5;GPM6A;TGFB3;DMTN;ABITRAM;TRPM2;TENM2;NEURL1;TENM1;FNBP1L
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5066394168369767,1.0756063655468526,0.3404255319148936,1.0,1.0,2/25,4.41%,ICAM1;RAPGEF1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.7344124561683005,-1.075467998465971,0.38333333333333336,0.9581599779367629,1.0,1/5,6.54%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.7344124561683005,-1.075467998465971,0.38333333333333336,0.9581599779367629,1.0,1/5,6.54%,MAN1A1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.7344124561683005,-1.075467998465971,0.38333333333333336,0.9581599779367629,1.0,1/5,6.54%,MAN1A1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6541786867752653,-1.0752628281695455,0.38095238095238093,0.9583036764620855,1.0,2/7,19.79%,ALOX12;SCD
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.4237269866424688,-1.0751409806305405,0.3116883116883117,0.9580460845577595,1.0,48/177,17.18%,LRTM1;GFRA3;PTPRM;SEMA3E;ROBO4;EPHA3;GAP43;DOK6;L1CAM;EMB;ROBO2;EPHA4;NTN4;SEMA3D;EFNA1;ANOS1;LGI1;GFRA2;PALLD;SPTB;CYFIP1;CDK5R1;DOK1;VSTM2L;EPHA6;EPHB6;SCN1B;CHN1;VEGFA;EPHB1;DRAXIN;OPHN1;EFNA3;EFNB2;CNTN4;SEMA4B;NOTCH2;PLXNA2;UNC5D;TNR;EFNA5;PLXNA4;SEMA4G;SIAH1;PIK3CB;DAB1;PRKCQ;NRXN1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.6485489306540317,1.0750464019725146,0.4423076923076923,1.0,1.0,7/8,30.93%,KIF25;NSFL1C;KIF11;CEP85;UBXN2B;RANBP1;CHEK1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.5579117586752522,-1.074895332296714,0.3220338983050847,0.9581681844134969,1.0,5/23,7.65%,IRGM;H2BC11;IL6R;AQP1;CHGA
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.5681579276012432,-1.0745899545032616,0.410958904109589,0.9585904679827976,1.0,4/20,11.78%,TGFB2;AQP1;LAMB1;TGFB3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5564454851801846,1.074533114203403,0.41379310344827586,1.0,1.0,6/28,11.34%,AGER;DUSP1;MFHAS1;RELL1;PTPN22;DLG1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.5064945187731649,-1.0745086202537018,0.3333333333333333,0.9581760172923675,1.0,18/62,18.65%,VIL1;BAIAP2;NCKAP1L;EDN1;SYNPO2;BAIAP2L2;FES;FCHSD2;TEK;LMOD1;CARMIL1;SYNPO2L;MYLK3;SYNPO;CX3CL1;NTRK3;CDK5;TENM1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.6575989431891374,-1.0744624986672047,0.41818181818181815,0.9575693714949236,1.0,5/12,21.52%,SLC1A1;SLC25A22;SLC1A6;SLC1A2;SLC25A12
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.4518341436273768,-1.0742911731584175,0.3333333333333333,0.9574631198547292,1.0,22/115,16.09%,NR4A3;P2RY12;SSTR1;GABRG2;MEF2C;SLC1A1;RYR3;LRRK2;AQP1;FES;GABRB2;AR;HCN1;ADCY8;ABCB4;EGFR;ATP1A1;GABRB3;GNG2;TGFB1;DMTN;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.7077527578689776,-1.0742882364421296,0.42105263157894735,0.9567651964714972,1.0,3/7,15.46%,LRFN5;IL31RA;CD200
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5239370657643465,-1.07346577400648,0.36764705882352944,0.9588756344013312,1.0,10/36,12.73%,DPEP2;SLA;PTPRC;GMFG;SELL;AOAH;CD53;IL16;IKZF1;ARHGAP25
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5192654865695056,-1.0732942354070747,0.4057971014492754,0.9587472967285906,1.0,12/54,13.60%,RHBDF2;PRICKLE3;NBEAL2;CAPN1;TMC4;TMCO4;ANXA11;SLC14A1;TMEM79;TRIM25;TJP3;PRKD2
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.6114625195854887,-1.0731600279020683,0.375,0.9585693444470084,1.0,1/10,4.04%,PIK3AP1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.6233054582229662,-1.072941500178545,0.4107142857142857,0.9585765009801317,1.0,5/11,26.78%,CLU;B4GALT6;TENM4;MYRF;CNTNAP1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.6615931578575256,1.0729394722399412,0.3829787234042553,1.0,1.0,1/6,2.19%,SOAT2
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.6833697349859079,1.0726997514446275,0.45,1.0,1.0,1/7,0.46%,PTH
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.6803555951791179,-1.072694263284987,0.43548387096774194,0.957966062215988,1.0,2/8,8.41%,RFC3;RFC4
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.6803555951791179,-1.072694263284987,0.43548387096774194,0.957966062215988,1.0,2/8,8.41%,RFC3;RFC4
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4808246984571696,1.0723829311545725,0.3611111111111111,1.0,1.0,14/41,19.18%,EYA4;RNF168;H2AX;TMEM161A;BRCC3;RAD52;UBE2N;RNF8;POLH;UIMC1;AXIN2;DHX9;RPS3;SIRT1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.43664510471197204,1.072250114693099,0.30303030303030304,1.0,1.0,17/64,24.42%,EAF2;CCNT1;ELL;POLR2K;ELOC;MLLT3;POLR2L;IWS1;GTF2H5;ERCC2;CTDP1;CCNK;POLR2E;POLR2D;ELP4;TCEA1;CCNH
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.5928651123361619,1.0722268107133446,0.4166666666666667,1.0,1.0,3/13,8.52%,ZNF335;PIH1D1;FAM47E
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.7054534973197768,-1.0721735145898323,0.4074074074074074,0.9591725130857851,1.0,1/7,3.86%,MEF2C
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6669015695249072,1.072146649019138,0.43902439024390244,1.0,1.0,4/8,23.16%,PTBP1;CAMTA1;CIB1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6669015695249072,1.072146649019138,0.43902439024390244,1.0,1.0,4/8,23.16%,PTBP1;CAMTA1;CIB1;AKAP6
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.48813891452912805,1.0721152101806144,0.32,1.0,1.0,3/51,2.55%,NGF;PLXNA1;CHODL
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.5960048751272872,-1.0720280858462086,0.4090909090909091,0.9589169251712373,1.0,4/12,27.85%,CAV1;PTRH2;TLE1;BCL2
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5845601165573913,-1.0717219190266078,0.41935483870967744,0.9592354759365017,1.0,4/20,20.43%,DKK3;NREP;TGFB1;BCL9
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.5424735919473107,-1.0715798642131933,0.4090909090909091,0.9589802156630198,1.0,7/25,16.11%,P2RY12;NCKAP1L;CYFIP1;ATP1B2;NEFH;RAC3;RHOJ
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.7181665138222593,1.0714392055978061,0.4888888888888889,1.0,1.0,1/5,3.91%,SLC38A2
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.6155264548200442,-1.071398128591905,0.39655172413793105,0.9589233769764366,1.0,2/9,4.62%,TGFBR2;SOX9
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.5164114549879428,-1.0712798416617682,0.38235294117647056,0.9585768331036658,1.0,8/42,14.56%,ANGPT1;SEMA3E;TEK;CDH13;VEGFA;BMPER;RNF213;EFNB2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6464356444787273,1.0712632471677814,0.38461538461538464,1.0,1.0,2/7,11.12%,SLIT2;NRP2
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6464356444787273,1.0712632471677814,0.38461538461538464,1.0,1.0,2/7,11.12%,SLIT2;NRP2
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.6134437394723359,1.0712234528946962,0.42105263157894735,1.0,1.0,1/11,0.13%,GABRE
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.6820262524251786,-1.0710266584270007,0.4339622641509434,0.957977010965828,1.0,1/5,15.28%,SCARB1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.6820262524251786,-1.0710266584270007,0.4339622641509434,0.957977010965828,1.0,1/5,15.28%,SCARB1
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.7395475315092577,1.0709392273852774,0.4,1.0,1.0,1/5,3.59%,NEU4
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.6895970172833231,-1.0709183742565378,0.5,0.9577447545252776,1.0,2/6,23.54%,TBCA;TBCC
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5282730637899846,-1.0708542150263012,0.3333333333333333,0.9572661761946144,1.0,11/31,22.53%,CENPK;CENPE;CENPF;CENPA;MIS18BP1;CENPL;CENPQ;OIP5;ITGB3BP;CENPI;CENPP
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.6649963191607682,1.070682952173204,0.3548387096774194,1.0,1.0,1/5,19.48%,CLN3
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.6742322399046585,1.0704869973460418,0.5238095238095238,1.0,1.0,2/5,10.27%,SLC39A8;CYBRD1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.4296558804605679,-1.0698896056144822,0.29333333333333333,0.959753103173655,1.0,52/206,24.13%,BICC1;DACT1;SFRP4;PLEKHA4;SHISA6;ANKRD6;IGFBP4;PRICKLE1;APC2;SOX9;PSMB8;DKK3;LRRK2;WWTR1;HECW1;KREMEN1;GLI3;AMER1;GPC5;CAV1;CDH3;EGFR;GPC3;DRAXIN;DAPK3;TGFB1;ATP6AP2;PTK7;TMEM9;MAD2L2;PSMC3;PPP1CA;RBX1;WLS;PRDM15;PIN1;PSME1;LRRK1;SCEL;TLE1;ZBED3;CTNND2;FZD9;WNT5A;UBE2B;TMEM170B;PSMC5;PSMA3;LYPD6;TMEM64;IGFBP2;RBMS3
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.6092743072573354,-1.0697306048744384,0.43333333333333335,0.9596537688408086,1.0,4/12,16.91%,MYO7A;THY1;VEGFA;CRB2
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.6268631505250969,1.0696970332153752,0.41025641025641024,1.0,1.0,1/12,0.84%,ORC1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.7170905022594899,-1.0696456017913758,0.3770491803278688,0.9592311033961882,1.0,2/7,13.38%,PTPRB;PTPRT
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.5414664097412525,-1.0695759789998516,0.373134328358209,0.9588090513992381,1.0,6/32,14.43%,KLF9;AQP1;AR;ADCY8;TRERF1;GNG2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.6248403067655215,-1.0695662928460856,0.35714285714285715,0.9581207802709033,1.0,5/10,28.64%,LYN;SYK;PRKCQ;ANK3;JAK1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.44617835644778575,-1.06955153511909,0.3492063492063492,0.957517708075441,1.0,21/152,14.10%,BICC1;DACT1;SFRP4;SHISA6;ANKRD6;IGFBP4;PRICKLE1;APC2;SOX9;PSMB8;DKK3;APCDD1;WWTR1;HECW1;KREMEN1;GLI3;AMER1;CAV1;LRP1;DRAXIN;RNF213
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5448657763328991,1.0695127271071236,0.358974358974359,1.0,1.0,1/19,0.18%,NGF
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.7075673514572302,-1.0686499376208909,0.4603174603174603,0.9592709806474542,1.0,2/6,11.62%,SFTPD;VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.7075673514572302,-1.0686499376208909,0.4603174603174603,0.9592709806474542,1.0,2/6,11.62%,SFTPD;VEGFA
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.6294694486831038,-1.0684996920655088,0.3939393939393939,0.9591024820402766,1.0,2/8,18.66%,FAM83D;KIF20B
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.5800351401058585,1.0683360369445958,0.3333333333333333,1.0,1.0,5/14,19.18%,HMGA2;SNAI1;HP1BP3;LOXL2;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.4482654180044859,1.0682341585939514,0.375,1.0,1.0,1/38,0.14%,ABCA13
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.6759275121380292,-1.0681789236327357,0.4603174603174603,0.9594589649389769,1.0,4/9,21.13%,ADCY7;ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.4822683689664915,-1.0678584186181153,0.373134328358209,0.9597380270539376,1.0,21/70,16.60%,EPHA3;VAV3;KALRN;EPHA4;EFNA1;GRIN2B;CDK5R1;SIPA1L1;PAK3;EPHA6;LYN;EPHB6;CHN1;NGEF;EPHB1;DNM1;RASA1;EFNA3;EFNB2;EFNA5;GIT1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.6681427938797698,-1.0678132131250633,0.4,0.9592342084676733,1.0,1/8,5.54%,PTGR1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.5478193804197417,1.0678118109714716,0.3684210526315789,1.0,1.0,4/16,10.10%,HSPA1A;EYA4;UNC5B;HSPA1B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5478193804197417,1.0678118109714716,0.3684210526315789,1.0,1.0,4/16,10.10%,HSPA1A;EYA4;UNC5B;HSPA1B
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.6026423752024755,-1.0677817548173765,0.4626865671641791,0.9586543212566726,1.0,1/12,0.40%,DPYS
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6462211325646299,1.0676019394307328,0.5,1.0,1.0,3/6,32.36%,PLA2G6;GPAM;SLC27A1
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.6134629680940688,-1.0675655125085637,0.3880597014925373,0.958668258855181,1.0,1/12,0.91%,ABCC4
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),-0.6798738313907288,-1.0669460941381406,0.4482758620689655,0.9597627312022661,1.0,3/7,17.74%,ADGRV1;LRTOMT;PDZD7
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.5233316629833841,-1.0668725249357314,0.4084507042253521,0.9592882099051376,1.0,5/42,4.94%,TLR2;MCTP1;PLSCR1;EPHA3;LGALS3
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.48567832090918994,-1.0668321506560259,0.35384615384615387,0.9587795643919533,1.0,8/34,18.52%,PIGH;ST3GAL5;PIGC;ST8SIA3;B4GALT6;ST6GALNAC5;MPPE1;PIGB
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.6639366150680703,-1.0667453104023783,0.3968253968253968,0.9584455571163171,1.0,1/7,2.87%,SYT4
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.658530250401207,-1.0666855337033023,0.391304347826087,0.9579730033267102,1.0,4/9,17.18%,MYO7A;TPP1;CDH23;NRXN1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.6054504072186103,-1.0666528234893977,0.3728813559322034,0.957403879086329,1.0,5/14,19.99%,CSF1R;CAMK1D;BST1;CXCL17;IL34
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.5605320924139137,-1.0666046531370308,0.4307692307692308,0.9568494534691248,1.0,6/29,16.54%,CLU;B2M;LRPAP1;TNK2;FLOT1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.5188712329807198,-1.0663983325935975,0.3888888888888889,0.9568923495409155,1.0,10/51,18.50%,TLR2;TGFB2;TTN;FRMD4A;BMP6;TGFB3;MYH10;TGFB1;TMED10;DNM1L
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.49031964211281265,-1.0660864803438392,0.38028169014084506,0.9572886855873396,1.0,2/52,2.12%,CD44;PTPRC
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5141685991275412,-1.0660373594413959,0.3939393939393939,0.9568255758649018,1.0,8/41,17.70%,TRPC6;NOS1;IL16;PLN;CAV3;CACNB2;CAMK2B;LILRB1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.5659460851256183,1.0659722697767415,0.36363636363636365,1.0,1.0,2/21,8.75%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__nose development (GO:0043584),-0.7166146509489028,-1.065691977866829,0.4482758620689655,0.9572421575137989,1.0,1/5,10.71%,GLI3
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.5725672400695194,-1.0654409342332463,0.36363636363636365,0.957256984335565,1.0,9/20,22.08%,MEF2C;EDN1;NRG1;MYLK3;EFNB2;TGFB1;RBM24;MYOCD;MESP1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.5255425794094295,-1.0652126457039763,0.36065573770491804,0.9574722266774593,1.0,9/26,21.71%,BAIAP2;BAIAP2L2;ADD2;DMTN;MYO1B;NEDD9;SHROOM2;ADD1;LCP1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.48560017551876594,-1.0648753354499096,0.39436619718309857,0.9579841492109493,1.0,18/75,20.24%,ANGPT1;VIL1;TGFB2;EDN1;SOX9;RAB11A;TEK;VEGFA;FGF7;PRKD2;AGT;ZNF580;SCARB1;PIK3CB;EMC10;PLCG1;GPI;RREB1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.515727757644786,-1.0648540089844076,0.40625,0.957363453800842,1.0,7/38,10.78%,TTC8;TUSC3;PTCHD1;GPR155;GRM5;CYFIP1;DOP1B
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.5857242685802138,-1.0647667546612043,0.3870967741935484,0.956991928865195,1.0,3/17,7.35%,TLR2;NCKAP1L;GATA1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.4938480768014182,1.0647532260659671,0.38235294117647056,1.0,1.0,7/35,14.07%,ZDHHC16;NAT9;NAT10;ZDHHC12;ZDHHC14;KAT2A;ZDHHC3
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.6234976308932184,-1.0641644291998165,0.4117647058823529,0.9581716176453013,1.0,3/14,13.49%,CLU;HGF;NOL3
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5460775850245462,1.0640037244802079,0.47619047619047616,1.0,1.0,1/20,0.35%,SPIRE2
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5154745947721951,1.0638642450431974,0.4482758620689655,1.0,1.0,9/28,19.66%,LSM7;EXOSC8;DCP1A;DCP1B;PATL1;EXOSC7;DIS3;DCPS;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5577089354350574,-1.063549076746367,0.3939393939393939,0.9594253856872296,1.0,4/19,8.48%,HLA-E;PTPRC;LAPTM5;XBP1
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.6598286197028853,1.0633428214130294,0.4878048780487805,1.0,1.0,2/6,8.69%,CFAP43;ODAD2
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6881240172658163,-1.0631066366909279,0.4444444444444444,0.9603057361960612,1.0,1/5,11.39%,CALM3
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7059713444252285,1.0628879923351053,0.40476190476190477,1.0,1.0,1/6,13.00%,JADE3
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.7090150233555699,-1.0624884416365818,0.47619047619047616,0.9617831567979399,1.0,1/6,5.14%,EPHA4
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.5979479347231293,-1.0617977771557476,0.5245901639344263,0.9633753105233331,1.0,6/17,20.10%,IHO1;RNF212B;MEIOB;KASH5;SYCP1;FANCD2
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.529695086467564,-1.061780567145995,0.3384615384615385,0.9627195355950914,1.0,6/25,12.35%,RIMS1;TMEM25;LRRK2;SLC8A3;RIMS2;DLG4
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.564021174882019,-1.0617443221295655,0.4153846153846154,0.9621744922024033,1.0,10/19,22.50%,RFTN1;IFNA2;IFNA6;CAV1;IFNK;FLOT1;IFIT1;PQBP1;RALB;COLEC12
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.6542887707408741,-1.0616144647412973,0.43548387096774194,0.9619251047587849,1.0,3/8,18.25%,TGFBR2;MTHFD1;EIF4A3
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.612059413472326,-1.0614596870881423,0.3968253968253968,0.9618953635066082,1.0,2/15,7.16%,PDXDC1;ASAH2B
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5583166806537307,-1.0613572553633002,0.36363636363636365,0.9615575013480323,1.0,5/15,16.92%,SOX9;GJA1;VEGFA;AGT;WNT5B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.6208549336853464,-1.0613458932729363,0.423728813559322,0.960884798637133,1.0,3/11,19.11%,STX3;TMEM35A;SNX33
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5367326743292037,-1.0610893300498858,0.36507936507936506,0.9612251283333044,1.0,6/31,10.18%,NR4A3;IL6R;EDN1;ID2;GJA1;CDH13
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.6941978329513502,-1.0610453992553115,0.4727272727272727,0.9606492796057469,1.0,4/5,28.37%,CHGA;RGS2;ADRA1A;KCNQ1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.5158597068358767,-1.0608993547774725,0.4057971014492754,0.9604156805035317,1.0,7/38,15.07%,VIL1;SOX9;KIF16B;DGKD;EGFR;TGFA;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.6961921445116717,-1.060891585892357,0.4067796610169492,0.959752502667272,1.0,3/5,28.64%,DMTN;ANK3;JAK1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.5002407238379855,-1.0608359083820038,0.4520547945205479,0.95917208845128,1.0,26/65,20.79%,ANO6;SLC6A12;SCN2A;SLC5A2;SCN9A;SLC8A3;HCN1;ASIC2;SLC8A1;ATP1B2;SLC9C1;SLC24A1;SCN4B;SLC6A8;SCN1B;SLC9C2;ATP1A1;SLC6A7;KCNK1;SLC24A4;SCN3A;SCN1A;SLC9A7;SLC6A4;SLC6A11;SCN3B
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.5802900585285252,-1.0607817649926332,0.4098360655737705,0.9586742631258857,1.0,2/17,3.65%,FMO5;ACADL
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.48401652191222816,-1.0605035210411988,0.38571428571428573,0.9589670445796906,1.0,11/58,16.36%,PPARG;TNFRSF1A;NLRP12;NLRP3;AOAH;FNDC4;TEK;NMI;LRFN5;NR1D1;CXCL17
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.6616592510613513,-1.0604845718328055,0.45,0.9583407726987346,1.0,4/8,21.40%,MEF2C;EFNB2;TGFB1;MYOCD
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.6360907426349506,1.0602730488880332,0.42424242424242425,1.0,1.0,1/7,7.19%,BRPF1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.4712539394771127,1.0602648116691322,0.30303030303030304,1.0,1.0,3/49,4.56%,BACE2;LEPR;IGF1R
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.5897557931305547,1.0599736260882897,0.375,1.0,1.0,2/8,2.79%,AGER;HMGB1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.46459319283290706,1.0598016539198847,0.43333333333333335,1.0,1.0,4/32,7.69%,NGF;NLGN3;PXK;GRID2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5657211518753866,-1.059619120590456,0.4444444444444444,0.9603877708711679,1.0,5/21,21.63%,P2RY12;TEK;TGFB1;PDGFRB;FLT1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.4846224730150912,-1.0595296427372745,0.36231884057971014,0.9599992131006447,1.0,6/54,8.83%,BIRC3;IRF1;PIK3AP1;SAMHD1;ERAP1;BST1
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.4884423232836876,-1.05952007227246,0.3972602739726027,0.9593531636256108,1.0,6/56,16.58%,SOX9;CCND1;CSF1R;CEBPB;CDKN1A;MOV10
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.4646073895901073,1.059446770830481,0.28125,1.0,1.0,7/75,5.84%,CFAP61;SLC22A6;BPIFB1;NWD1;FRK;ATP6V0A4;PLA2R1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6275877940315463,1.0591377949406175,0.4791666666666667,1.0,1.0,1/12,3.39%,SCRIB
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.507801586811725,-1.058925426168174,0.4098360655737705,0.9606894381892793,1.0,7/33,15.07%,TGFB2;INHBC;BMP6;RBPMS;TGFB3;BMPER;TGFB1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.49650741597096326,-1.0589251676453597,0.37681159420289856,0.9600166864818638,1.0,7/50,12.36%,WNT8B;SFRP4;LRRK2;AMER1;CAV1;FZD8;CDH3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.6823823089437877,1.0589059551845985,0.4897959183673469,1.0,1.0,3/5,23.33%,TRIR;PDE12;TOE1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5568284230804126,-1.0582881686843806,0.4576271186440678,0.9613370741296228,1.0,6/23,17.33%,VIL1;SYNPO2;SYNPO2L;FHOD1;SYNPO;CX3CL1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.4454731614578369,-1.058275727581304,0.3815789473684211,0.9607392963293094,1.0,20/148,7.92%,TLR2;IRGM;H2BC11;PPARG;SHMT2;CR1;ISG15;SLA;HLA-E;MX1;TRIM5;IFITM3;TRIM22;SFTPD;B2M;CX3CR1;CR2;CHGA;STYK1;FES
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.4261459441063004,1.0581330021216717,0.3611111111111111,1.0,1.0,12/91,12.93%,U2AF1;SF3A3;YJU2;RNF113A;PRPF4;SF3B2;PTBP1;RBM8A;RP9;PDCD7;MPHOSPH10;SNRNP25
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.6764251935151641,1.0578772615109193,0.4166666666666667,1.0,1.0,3/7,2.87%,F2;SERPINF2;F11
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.6826356258350301,-1.0574284720320664,0.44642857142857145,0.9627204714170171,1.0,2/5,17.67%,ATCAY;PRUNE1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.5048561356732457,-1.0571440627106763,0.3448275862068966,0.963015144730177,1.0,7/38,12.85%,STMN2;MET;FES;NAV3;CDK5R1;CAV3;MAP2
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.6726821943025428,-1.0570958456088466,0.4791666666666667,0.9624715055106073,1.0,2/5,7.01%,CITED2;LMO3
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.4612200691613592,1.0569668211357768,0.2692307692307692,1.0,1.0,10/49,17.72%,TRARG1;EHD2;RAB35;STX6;CMTM6;MICALL1;SNX3;SNX27;VPS29;DENND1A
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.6855062358897908,-1.0569537796970434,0.5084745762711864,0.9622932625333123,1.0,2/5,16.56%,ITGAV;NFKBIA
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.6566854436564045,-1.0568486776275132,0.41935483870967744,0.9620005545202813,1.0,3/6,29.88%,BDNF;NTRK2;FYN
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.51978059202656,-1.056735451430906,0.47058823529411764,0.9617284836328097,1.0,3/35,4.93%,TGFB2;ENHO;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.6987545319901389,1.056729290943508,0.4722222222222222,1.0,1.0,2/5,3.84%,MALT1;NFKBIZ
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.7067725826001541,-1.056662480037205,0.4375,0.961322022232647,1.0,3/6,27.23%,VEGFA;HEY2;HES1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6764836335634429,1.056652044451023,0.3902439024390244,1.0,1.0,2/6,11.39%,AKIRIN1;THBS4
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.44541526445173535,-1.056480239495348,0.3333333333333333,0.9612595485651033,1.0,27/137,16.13%,CLDN5;PTPRM;SEMA3E;PPARG;TGFB2;F3;CEACAM1;AQP1;CHI3L1;XBP1;NINJ1;TEK;PDE3B;SULF1;CD160;VEGFA;BMPER;TIE1;PRKD2;PGK1;EFNA3;STAT1;CNMD;WARS1;BRCA1;RHOJ;BTG1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.6112915577637698,1.0564278491434134,0.5208333333333334,1.0,1.0,1/5,6.89%,MYO1C
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.6164993094106976,1.0564151811238989,0.3684210526315789,1.0,1.0,5/7,21.88%,HMGB1;NPM1;RPS3;SIRT1;AKT1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.44360116589512527,-1.0563241046142482,0.4090909090909091,0.9610827671387685,1.0,32/146,14.57%,FRY;NPY;PTPRM;STMN2;NYAP1;NCKAP1L;GPRIN3;L1CAM;GPM6A;EPHA4;MYO16;DCLK1;ADGRV1;LRRK2;RAB11A;LGI1;GRM7;LAMB1;STX3;SH3GL2;MANF;CDK5R1;PAK3;LYN;NEFH;PACSIN1;EPHB1;DLG4;MAP2;ATCAY;OPHN1;CNTN4
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5968003457429844,1.0562574525593773,0.4117647058823529,1.0,1.0,2/10,10.10%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.49134054124509946,1.0561699560668028,0.36585365853658536,1.0,1.0,12/29,24.79%,FBP1;AKT2;SLC45A3;DGKQ;BCKDK;ADIPOR1;SIRT1;FOXK1;AKT1;SIRT7;KHK;SDHAF3
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.5372675301175704,1.0560905071325692,0.38235294117647056,1.0,1.0,3/21,10.43%,GPR143;RAB32;AP3D1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.6780579941153955,-1.0560781756389956,0.43333333333333335,0.961222279002612,1.0,3/6,27.19%,CACNA1C;AKAP5;CACNA1D
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.7422849657663741,-1.056023107849887,0.4117647058823529,0.960676182332701,1.0,3/5,25.66%,PRAME;EZH2;CALR
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6140782244351004,-1.0556940250265219,0.45901639344262296,0.9610575260387082,1.0,9/14,18.53%,COL4A1;NTN4;NTNG1;LAMB1;FLRT2;NTNG2;HPN;LAMB4;LAMB2
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.6400937215280273,-1.0555326089284753,0.42028985507246375,0.96026959068372,1.0,4/11,19.47%,STAG3;SYCE2;SYCP2;SYCP1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.6400937215280273,-1.0555326089284753,0.42028985507246375,0.96026959068372,1.0,4/11,19.47%,STAG3;SYCE2;SYCP2;SYCP1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.4952903954318216,-1.0553156824611278,0.3492063492063492,0.960161239915306,1.0,13/57,17.79%,TGFB2;OLFM1;EPHA3;TGFBR2;EFNA1;WWTR1;TGFB3;OVOL2;TGFB1;HPN;CRB2;MAD2L2;EZH2
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.5335136589638426,-1.0545627883466755,0.43478260869565216,0.9621490492297085,1.0,9/30,19.27%,ARHGAP18;ARHGAP28;FCHSD2;PAK3;MAP2;RASA1;ABITRAM;PRUNE1;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.624553028334823,1.0544442070692568,0.4473684210526316,1.0,1.0,3/7,11.88%,CD274;TARM1;TWSG1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.45634696425777677,-1.0543064352006373,0.4117647058823529,0.9621867709439167,1.0,21/88,21.65%,DACT1;APC2;HECW1;FURIN;C4BPA;NEDD4L;TRIM32;EGFR;GPC3;AZIN1;EEF1A2;OAZ3;PLK2;TMEM9;MAD2L1;MAD2L2;FAM83D;PRKCG;DTL;PIN1;C4BPB
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.6837530671967686,-1.0542598120119373,0.49122807017543857,0.9603095664607468,1.0,1/5,3.77%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.6837530671967686,-1.0542598120119373,0.49122807017543857,0.9603095664607468,1.0,1/5,3.77%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.6837530671967686,-1.0542598120119373,0.49122807017543857,0.9603095664607468,1.0,1/5,3.77%,SLF1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.5955357734897081,-1.0538816774097726,0.4918032786885246,0.9608356132417928,1.0,1/11,6.54%,LRRK2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.46179130534629154,-1.0535997131810206,0.4246575342465753,0.9611675388858522,1.0,25/99,12.35%,BEGAIN;RIMS1;MCTP1;MCTP2;SYT1;MEF2C;GRIK2;NPTX2;SYN3;NPTX1;LRRC4;TPRG1L;LRRK2;GRM5;LGI1;CACNA1B;CX3CR1;GRM7;NRG3;SLC8A3;GRIK1;DLGAP1;CLSTN3;RIMS2;DLG4
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.7012616889110189,-1.0535674246885312,0.43859649122807015,0.9606326542363,1.0,1/5,7.01%,LMO3
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.6659621625147751,-1.0535041669252134,0.4727272727272727,0.9601850810859445,1.0,3/8,5.26%,KDM4D;PARP9;DTX3L
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.5916429682598842,1.053367287335636,0.40625,1.0,1.0,1/9,5.55%,HMGA2
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.4469875567789595,1.0532033332218436,0.39473684210526316,1.0,1.0,7/43,7.61%,TEAD2;NES;ALDH1A3;PDGFA;ATF4;GLI2;TEAD3
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.639641437932006,-1.0530779409170172,0.4067796610169492,0.9609759711077294,1.0,2/11,8.05%,KDM3A;AR
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.45796954277553237,-1.0530262612534294,0.3194444444444444,0.9604622717040588,1.0,27/102,23.20%,RND2;PAK5;ANK1;ARHGAP4;WTIP;RHOC;PALLD;THY1;FGD5;PACSIN1;RAC3;PCLO;PPP2R3C;ARHGAP10;DIAPH3;DMTN;TPM1;MICAL2;NEDD9;RHOH;ZMYM6;FMNL3;SEMA6A;CSPG5;FGD1;STRIP2;RHOF
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.5706048539128251,-1.0527141894135954,0.42105263157894735,0.9609328797003867,1.0,4/24,5.72%,PTPRM;PPARG;MEF2C;ANGPT2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5109305258222843,-1.0526617307245836,0.38028169014084506,0.9604464801265632,1.0,5/35,13.96%,EPN1;SH3GL2;CBLC;EGFR;TGFA
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.5152165657965607,1.0526471485689652,0.36363636363636365,1.0,1.0,5/26,14.08%,VCPKMT;ZNF335;ATPSCKMT;BEND3;KMT5B
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.4522483808938693,-1.0526106042791952,0.3835616438356164,0.9599474736084603,1.0,13/73,11.88%,MT1M;EDN1;ATP2B3;ATP2B2;TPCN2;HTR2C;SLC8A3;SLC24A5;SLC8A1;SLC24A1;HTR2A;CAV1;HTR2B
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.5796253391831521,1.0526062883655052,0.45652173913043476,1.0,1.0,1/9,3.82%,ERRFI1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.46735430896382624,-1.0524948070512314,0.4,0.9596547521185975,1.0,12/62,11.88%,EDN1;ATP2B3;ATP2B2;TPCN2;HTR2C;SLC8A3;SLC24A5;SLC8A1;SLC24A1;HTR2A;CAV1;HTR2B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.5457547527072282,-1.0524414828589284,0.42105263157894735,0.9591635983769969,1.0,6/31,11.78%,NR4A3;PPARG;MEF2C;GJA1;PRKG1;TGFB3
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.6632974167347758,-1.052151045221555,0.5,0.9593818023700226,1.0,2/7,19.13%,MET;CDH1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5299814940271136,-1.0517963315295193,0.44,0.9598446001516753,1.0,7/42,8.86%,SHMT2;ALDH1A2;APIP;RYR3;SAMHD1;B2M;HCN1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6074520373923946,-1.0516776432790023,0.43859649122807015,0.959466764323618,1.0,2/10,2.17%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.6477329867036747,1.051620867058382,0.5384615384615384,1.0,1.0,2/5,7.67%,SPHK2;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4982642785140993,1.051458137131184,0.3870967741935484,1.0,1.0,4/32,2.48%,F2;RAB27A;CYBA;DCXR
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.6749970459980107,1.0511451036336896,0.475,1.0,1.0,3/5,17.28%,HNRNPU;YBX1;DHX9
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.6284979331769389,-1.0510946476177536,0.46774193548387094,0.9607022036051202,1.0,1/9,10.61%,FURIN
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.5190837265476752,-1.0509492479092688,0.40625,0.9605422685459902,1.0,10/36,15.41%,SPINT2;CITED2;RNASE10;PTPRG;CEACAM1;TENM3;PTPRR;FERMT3;TGFB1;EFNA5
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.48614283219073084,-1.0509353636029402,0.4,0.9599205054639056,1.0,2/31,8.79%,DND1;E2F1
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.6312288634785912,1.0509141568118714,0.45,1.0,1.0,2/5,11.15%,PMVK;IDI1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.6502397059802475,1.0503911737346157,0.4883720930232558,1.0,1.0,2/6,7.42%,NT5E;HPRT1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5616756966850176,-1.0501008439250794,0.42857142857142855,0.9619314580023816,1.0,5/13,9.78%,PKP2;GJC3;GJA1;SLC8A1;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.5685666516278269,-1.0500459341306159,0.45161290322580644,0.9614348375205655,1.0,2/19,1.95%,RHBDF2;IL12A
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.6109285969464637,-1.0499117097836748,0.3898305084745763,0.9612353161442705,1.0,1/14,1.02%,DND1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.5408191231559631,1.0497707441191941,0.4,1.0,1.0,5/23,10.57%,DAO;AADAT;THNSL2;MTRR;ALDH4A1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.457921344009523,-1.049480312419209,0.4383561643835616,0.9617799121954714,1.0,21/119,16.11%,ARHGAP18;ARHGAP4;ARHGAP15;VAV3;KALRN;A2M;ARHGAP31;RHOC;ARHGDIG;ARHGAP28;CHN1;NGEF;ARHGAP25;RAC3;DEPDC1B;OPHN1;RASGRF2;ARHGAP10;ITGAV;SRGAP1;RHOJ
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.6651879101235013,1.0493596445962443,0.45454545454545453,1.0,1.0,3/5,23.84%,ENPP1;SMPDL3A;ITPA
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.7099406699888895,-1.0493564557604826,0.4918032786885246,0.9615212233458392,1.0,4/5,23.48%,SLC18A2;SLC22A3;SLC6A4;PICK1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.5310866594898076,-1.0488977343979284,0.47761194029850745,0.9624330170647456,1.0,2/20,3.86%,CLDN5;MEF2C
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.7257129407717754,-1.0487982045377484,0.5079365079365079,0.9621216816407747,1.0,3/5,20.16%,LMO3;CLOCK;PER1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.7002340053599857,1.0487739057270802,0.5217391304347826,1.0,1.0,1/5,8.00%,ATP6V1G1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.6892792579242574,-1.0487724942444714,0.49122807017543857,0.9615284794761576,1.0,2/7,14.35%,RECQL4;WRN
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.4558605107957002,-1.048748232876626,0.3424657534246575,0.9609295206983316,1.0,2/72,0.91%,SLC28A2;ABCC4
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.4790329647058071,1.0486646221590343,0.36666666666666664,1.0,1.0,8/32,13.54%,NUPR1;CDK10;TESK1;EVI5L;FEZ1;STYXL1;KAT2A;SEC22B
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.6223443521630395,-1.047991358368749,0.45588235294117646,0.9627111895217593,1.0,1/15,0.14%,GPAT3
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.45404526361071357,-1.0479640665366332,0.3939393939393939,0.9621843078935893,1.0,27/108,18.65%,WNT8B;TGFB2;MYO7A;MEF2C;ID2;ATP2B2;MET;ANOS1;TENM3;CTF1;DDIT4;EMX1;XBP1;MANF;CDK5R1;VEGFA;FZD8;PAX6;ITM2C;OPHN1;MYT1L;LHX4;WNT5B;MYEF2;TENM2;CDK5;TENM1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.45757274509725765,-1.0476658999932749,0.3287671232876712,0.9623259432611384,1.0,2/70,0.91%,SLC28A2;ABCC4
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.4848939359901049,-1.0476365564887025,0.4583333333333333,0.9618131192953795,1.0,9/67,11.66%,ARIH2;CLU;PRICKLE1;RNF217;LAPTM5;LRRK2;RNF144B;CAV3;MAGEF1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.6586394051303619,-1.0474550293137896,0.4406779661016949,0.9616409774701089,1.0,1/6,2.38%,RIT2
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.48039800041781544,-1.0472919811151302,0.39473684210526316,0.961501737204068,1.0,11/84,11.84%,NR4A3;PPARG;CYSLTR2;TSHR;PRKAR1B;CEACAM1;ADCY7;XBP1;PDE3B;ADCY8;CAV1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5596342856408514,-1.0470333328131927,0.4520547945205479,0.9616695685870734,1.0,7/20,23.23%,TGFBR2;VEGFA;CAV1;RASA1;TGFB1;PDGFRB;HEY2
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.6092521855196144,-1.0467334852835635,0.42105263157894735,0.9618632739585806,1.0,1/10,10.82%,H1-0
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.5244794008277587,1.0466831550882878,0.4666666666666667,1.0,1.0,6/20,15.49%,MFHAS1;PPP1R1B;PTPA;ENSA;STYXL1;PPP1R8
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.6038602084639779,-1.0464601682698467,0.4423076923076923,0.9620501977973142,1.0,4/12,16.86%,GLRA2;ADCY7;GRIN2B;GRIN3A
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.666720778019628,-1.0463843413097593,0.48484848484848486,0.9616438902084516,1.0,2/6,26.10%,MLLT11;ANK3
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.7010181000880242,1.046307431764857,0.5217391304347826,1.0,1.0,2/5,21.41%,PDCL3;DNAJB2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.4845927071203226,-1.0459389165549215,0.42857142857142855,0.9622344467253697,1.0,10/49,19.27%,EPHA3;THY1;TEK;VEGFA;DAPK3;EFNA5;DMTN;PTPRJ;VCL;CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.597771935152126,-1.0459208903699007,0.3770491803278688,0.9616268288126201,1.0,3/11,31.50%,CAV2;VPS4A;TSG101
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.6904209968749971,-1.0458330380031131,0.5,0.961247636706265,1.0,2/6,16.63%,FAP;PTPRJ
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.6167992643524984,-1.0456796387970235,0.42857142857142855,0.9611094080260578,1.0,6/11,19.09%,IGFBP3;MEF2C;PRKG1;LRP1;TPM1;NDRG4
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.426877963738265,1.045534864642722,0.38461538461538464,1.0,1.0,11/48,9.81%,ONECUT1;GPRC5C;RNF128;LAMB3;ALDH1A3;GJB1;S100A16;EPS8L2;CLDN2;MYH14;KRT8
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.4682991235502374,-1.0454040195616197,0.36666666666666664,0.9614584455190773,1.0,13/65,11.68%,ROR1;CRYM;MYO7A;ATP2B2;MYO3B;CEMIP;ADGRV1;COL11A1;LHFPL5;GRM7;LRTOMT;SLC26A4;NDUFB9
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.5471511074213704,-1.0453425382772514,0.45161290322580644,0.9610866187780295,1.0,6/25,14.11%,VSIR;CIDEB;PRSS12;TBC1D10A;FURIN;PGK1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5677794993061268,1.0452480070553036,0.38235294117647056,1.0,1.0,4/13,11.91%,DUSP1;NDC80;ANAPC15;TPR
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.5523802109671531,-1.0451731015887775,0.4411764705882353,0.9609228328588848,1.0,6/22,16.93%,ARHGAP18;ARHGAP28;FCHSD2;PAK3;RASA1;ABITRAM
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5270127723077982,1.0449860573393857,0.42424242424242425,1.0,1.0,1/12,3.74%,OSBPL7
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.5251028034509256,1.0446880746280813,0.30303030303030304,1.0,1.0,5/18,14.29%,EPHB4;SLIT2;ID1;GREM1;MIA3
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.711828872848701,1.0445965617708566,0.575,1.0,1.0,1/5,2.01%,RNF128
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.6551525559413361,-1.0444842434017902,0.45614035087719296,0.9626064563896312,1.0,1/6,4.60%,DBF4
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.606133614246188,-1.044107841397905,0.3870967741935484,0.9626270356029961,1.0,3/13,28.66%,ZFP36;ZFP36L1;DHX36
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.606133614246188,-1.044107841397905,0.3870967741935484,0.9626270356029961,1.0,3/13,28.66%,ZFP36;ZFP36L1;DHX36
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.5180178420671614,1.0439721724608784,0.38461538461538464,1.0,1.0,4/23,11.12%,SEMA5A;NLGN3;SLIT2;NRP2
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.6885889340695563,-1.0439458368378836,0.5,0.9625144053620455,1.0,3/5,22.75%,KYNU;ALPL;CDKN2D
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6554232408764373,1.043709413129433,0.4883720930232558,1.0,1.0,2/6,13.12%,NOC2L;BCL10
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.6356134016561975,1.0436902384736189,0.40540540540540543,1.0,1.0,4/6,19.48%,RFT1;NPC2;PLTP;CLN3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.513968218740498,1.0436760922937864,0.4166666666666667,1.0,1.0,24/39,28.78%,PARS2;FARSB;TARS1;DARS1;HARS1;TARS2;IARS1;MARS1;VARS1;HARS2;EARS2;NARS2;CARS1;FARSA;RARS2;KARS1;RARS1;AARS1;EPRS1;FARS2;SARS1;LARS2;WARS2;IARS2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.49364765544562406,-1.0436684174875852,0.3888888888888889,0.9628220895490965,1.0,6/62,6.70%,CD44;NLRP12;NLRP3;HGF;MAP3K5;AQP1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6076931196944889,1.0434644405402067,0.38461538461538464,1.0,1.0,6/13,22.90%,HMGA2;CDK6;YBX1;ZKSCAN3;SIRT1;MARCHF5
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.62983692839044,1.0430791914206579,0.4594594594594595,1.0,1.0,2/7,8.69%,CFAP43;ODAD2
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.5920019774627637,1.0430304102256684,0.3888888888888889,1.0,1.0,1/10,0.87%,CHRNA4
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.5435915293250185,-1.04282572600775,0.3939393939393939,0.964640944744299,1.0,3/18,19.79%,FAR2;DGAT1;SCD
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.5757302521655453,1.0426593122433732,0.36363636363636365,1.0,1.0,3/16,7.83%,AGER;MFHAS1;RELL1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3877699149440511,1.042482637660367,0.3333333333333333,1.0,1.0,21/93,21.20%,U2AF1;RAE1;NUP42;NUP210;CPSF4;RBM8A;SYMPK;TPR;EIF4E;SARNP;NXF1;NUP37;HNRNPA2B1;SMG5;RBM15B;THOC2;MAGOH;NDC1;ALYREF;SEH1L;SRSF9
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),-0.7082936237218723,-1.0424549062003032,0.46153846153846156,0.9645619774192491,1.0,3/5,12.42%,CEMIP;TCIM;EGFR
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),-0.7082936237218723,-1.0424549062003032,0.46153846153846156,0.9645619774192491,1.0,3/5,12.42%,CEMIP;TCIM;EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.5217368424657848,-1.0424237532495473,0.4262295081967213,0.9640100482172114,1.0,6/20,20.36%,PDGFD;CALM3;VEGFA;RAD50;TOM1L1;MRE11
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6541606741791202,-1.042382002945953,0.5151515151515151,0.9635039513614034,1.0,4/9,19.97%,CEBPB;VEGFA;EIF2B4;EIF2B2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.4697150690690092,-1.0420745030177823,0.39436619718309857,0.9637131760188629,1.0,6/67,7.94%,ARIH2;CLU;PRICKLE1;RNF217;LRRK2;RNF144B
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.5127069972448084,-1.0420735719118475,0.43283582089552236,0.9630728350381195,1.0,6/41,11.62%,KANK2;TGFB2;CENPF;ROBO2;SULF1;VEGFA
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.5456676299001938,-1.0419917363142541,0.421875,0.962606947011196,1.0,2/28,2.47%,RIMS1;MX1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.638914377195963,-1.0413651251303093,0.4745762711864407,0.9641142929336528,1.0,2/7,11.88%,TTN;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.5302225669623791,-1.0412113060005177,0.48484848484848486,0.9638602316820631,1.0,4/26,6.59%,SEMA3E;ROBO2;ANGPT2;SEMA3D
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.4638896780855624,-1.041191450939846,0.3466666666666667,0.9632856600601771,1.0,13/70,12.34%,HLA-F;CLU;ITGAM;MEF2C;FOS;MAP3K5;LRRK2;SNCB;CHGA;DDIT4;GRIN2B;TNFRSF1B;EPHB1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.5171400475409492,-1.0409897871213305,0.3898305084745763,0.9632825790781078,1.0,9/26,21.71%,BAIAP2;BAIAP2L2;ADD2;DMTN;MYO1B;NEDD9;SHROOM2;ADD1;LCP1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.6162134410205884,-1.0409337762894302,0.5079365079365079,0.961666966303715,1.0,2/8,17.95%,RAB27B;KIF5A
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.6162134410205884,-1.0409337762894302,0.5079365079365079,0.961666966303715,1.0,2/8,17.95%,RAB27B;KIF5A
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.6162134410205884,-1.0409337762894302,0.5079365079365079,0.961666966303715,1.0,2/8,17.95%,RAB27B;KIF5A
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6099207346412788,-1.0407664928505713,0.4032258064516129,0.9616457753622056,1.0,4/14,8.66%,GCNT1;SELL;CX3CR1;ADD2
prerank,PanglaoDB_Augmented_2021__T Cells,0.43029680077756866,1.0406978509624596,0.3103448275862069,1.0,1.0,12/70,7.95%,CXCR4;ZAP70;LCK;EEF1B2P3;EVI2B;ITGAL;IL2RA;PYHIN1;CD247;GPR174;GNLY;P2RY10
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.6011370784061923,1.0405338509276347,0.4418604651162791,1.0,1.0,5/11,24.88%,DKC1;CCT8;CCT2;CCT3;CCT6A
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.6051951080428829,1.0405122155589388,0.45,1.0,1.0,1/5,10.54%,SLC6A13
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6326011982885151,-1.0403315476052837,0.43333333333333335,0.9622318075872415,1.0,3/9,18.31%,CLU;SCARB1;ABCA1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.5514775675076234,1.0401155184975677,0.42857142857142855,1.0,1.0,6/19,16.90%,MRM1;TFB1M;MTERF4;TFB2M;FTSJ3;METTL5
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6613892226264996,-1.0400838007947575,0.5396825396825397,0.9622613705138089,1.0,3/7,14.82%,TGFB2;ZFPM1;NOTCH2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.5589966656457092,-1.0398786198888124,0.4,0.9623228099738468,1.0,1/13,5.71%,RFK
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.6995062046529344,-1.0398357432248129,0.4666666666666667,0.9618292044596107,1.0,1/5,14.99%,AGT
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6195138573451241,-1.0397653701569682,0.4067796610169492,0.9614191199207277,1.0,2/9,7.20%,P2RY12;CX3CR1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.3679432792860751,1.039736677438415,0.14285714285714285,1.0,1.0,41/280,15.06%,TEAD2;VDR;EAF2;SNAPC3;HDAC10;NR2C2AP;MAML2;INTS14;ATF4;TAF13;HDAC1;TAF12;CCNT1;TEAD3;CPSF4;HDAC9;PCF11;ELL;CSTF2;POLR2K;TAF5;SYMPK;GMEB2;MNT;INTS8;ZBTB1;NR6A1;ELOC;ESRRG;NFKB1;ZC3H8;MLLT3;NABP1;MED18;TRIP11;HNF4A;TAF3;NR5A2;POLR2L;IWS1;TFDP1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.6463939361419863,1.0397186892799297,0.475,1.0,1.0,1/7,1.22%,CDSN
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.5085846884747866,-1.0393351294121622,0.47058823529411764,0.9623091576949382,1.0,9/37,16.34%,COL4A1;TGFBR2;SLC1A1;VEGFA;CAV1;RASA1;EFNB2;TGFB1;SYK
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.6817562448829487,1.0392629429524949,0.4117647058823529,1.0,1.0,4/8,14.93%,KDM1B;KDM5A;KDM5B;KDM5D
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.6364178914188305,-1.0389938533952368,0.4461538461538462,0.9628096799093125,1.0,1/7,2.20%,TTN
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6281419710605467,1.0387443624815955,0.42857142857142855,1.0,1.0,4/8,19.48%,CPNE1;HDHD5;CPNE7;CLN3
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.6840427773513684,1.037918094357365,0.46808510638297873,1.0,1.0,1/5,5.54%,NCSTN
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6046364414179222,-1.03785756766676,0.38333333333333336,0.9655744635212484,1.0,1/13,1.54%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.5988347602538703,1.037825115712882,0.39473684210526316,1.0,1.0,1/6,10.54%,SLC6A13
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.4635230174864819,-1.0377112482166775,0.38235294117647056,0.9654300310027,1.0,17/91,15.47%,IRGM;CPS1;IL12A;MEF2C;VIM;NOS1;NLRP3;CX3CR1;XBP1;LDOC1;AXL;GGT5;TNFRSF1B;ZFP36;SCARB1;NR1D1;LY96
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.5642449192428763,1.03756346577071,0.5294117647058824,1.0,1.0,1/10,0.37%,DAO
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5504583739395048,1.037442301133657,0.4,1.0,1.0,9/26,26.64%,ARRDC4;ARRDC3;UBE2N;BTRC;BMI1;UBE2L3;FBXW7;RPS2;AXIN1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.5687518955375817,-1.0373923348332081,0.4426229508196721,0.9652179296247627,1.0,2/14,6.24%,NCKAP1L;CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.5687518955375817,-1.0373923348332081,0.4426229508196721,0.9652179296247627,1.0,2/14,6.24%,NCKAP1L;CAMK1D
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.4933417600258138,1.037167181531191,0.3902439024390244,1.0,1.0,7/27,13.71%,NDC80;LLGL2;DYNLT1;NUMA1;LLGL1;KIF25;SAPCD2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.5324236870633428,-1.0368819320529457,0.4714285714285714,0.9660892876039532,1.0,11/31,13.33%,UTRN;GLRX;FGF12;HECW1;SCN4B;SCN1B;CAV3;NEDD4L;YWHAH;FGF14;NETO1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.5252942846622246,-1.0368163961694707,0.3783783783783784,0.9656595377716125,1.0,7/33,17.99%,PLSCR1;DNAJC9;ATP1B2;DNAJB1;UHRF1;SETMAR;TPM1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.6428375034150104,1.0365319388444056,0.4666666666666667,1.0,1.0,1/8,7.41%,ABL1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6298382682689996,1.036425880931461,0.4418604651162791,1.0,1.0,2/8,18.97%,PDE4B;SNCA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6298382682689996,1.036425880931461,0.4418604651162791,1.0,1.0,2/8,18.97%,PDE4B;SNCA
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.5264596130942151,-1.0362882621210308,0.47619047619047616,0.9665674891202063,1.0,4/24,12.30%,CLU;LRRK2;XBP1;AQP11
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),-0.5495670320427204,-1.0361649831117425,0.4153846153846154,0.9662583157700336,1.0,2/14,12.32%,SOX9;BMPR1B
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.5300915587751374,-1.0360143514493296,0.4444444444444444,0.9660444795623997,1.0,9/23,24.03%,SYT1;SNCB;AMPH;PACSIN1;OPHN1;CDK5;CANX;SYT2;SNCG
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.6188496328030774,1.0359386460168598,0.4583333333333333,1.0,1.0,2/5,16.97%,EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.6188496328030774,1.0359386460168598,0.4583333333333333,1.0,1.0,2/5,16.97%,EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.6188496328030774,1.0359386460168598,0.4583333333333333,1.0,1.0,2/5,16.97%,EXOSC8;EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.6188496328030774,1.0359386460168598,0.4583333333333333,1.0,1.0,2/5,16.97%,EXOSC8;EXOSC7
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.4444097060683387,-1.0359185857730684,0.40540540540540543,0.9656348559897896,1.0,17/77,12.42%,FSTL1;PCOLCE;KANK2;FBLN1;PPARG;LRIG3;LAMC1;COL4A1;CCN5;WWTR1;LAMB1;BOC;LMOD1;NRG4;GLI3;CAV1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.5260061971649108,-1.0358442848223732,0.35714285714285715,0.9651688817372284,1.0,4/21,11.26%,PDZK1;ITGAM;CEMIP;KCNB1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5712193538923639,-1.0355725063253605,0.42424242424242425,0.9652530492593135,1.0,2/18,16.09%,NOS1;BRCA1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.4195935580588282,1.0355313700560413,0.3125,1.0,1.0,14/70,20.09%,HSPA1A;SLC38A2;JMJD6;PTBP1;RBM23;RRP1B;AHNAK2;AFF2;RBM12B;HNRNPH1;TMBIM6;CELF1;RBM22;FASTK
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.5255087123685754,1.0354428775392128,0.3684210526315789,1.0,1.0,8/23,7.95%,ZAP70;LCK;ITGAL;PYHIN1;CD247;GPR174;GNLY;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.5869825341636331,-1.0352045505672118,0.4262295081967213,0.9657726601186365,1.0,3/13,17.39%,RNFT1;CAV1;BCAP31
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.6819360279332448,-1.035109553264059,0.4576271186440678,0.9654084388077292,1.0,3/5,22.25%,AOX1;NNMT;HAAO
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.6010131035815619,-1.0351023121495775,0.5084745762711864,0.9647799176887137,1.0,8/16,26.09%,SLC1A1;GJA1;SLC25A22;SLC1A6;SLC1A2;SLC25A12;GIPC1;SLC6A6
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.5766871675750979,1.0349723134280195,0.39473684210526316,1.0,1.0,1/9,6.44%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.5180210332358911,-1.0348359559140752,0.4142857142857143,0.9649082195321648,1.0,11/29,16.28%,NEFL;MEF2C;CAPN1;GRIN2B;DAPK1;GRIA1;DLG4;GRIA3;LRRC7;OPRM1;CAMK2B
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.6536540180090963,-1.03479245522899,0.39344262295081966,0.9644067599021129,1.0,1/7,6.97%,ME3
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.637566840769605,1.034670413125282,0.45652173913043476,1.0,1.0,3/6,10.69%,DUSP1;SLIT2;GREM1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.6988604701717134,-1.0345883774497031,0.484375,0.964270879553377,1.0,3/6,18.61%,BCAT2;GAD2;GAD1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.5041781787867787,1.0342312792350046,0.38235294117647056,1.0,1.0,6/31,7.77%,GABRE;CHRNA4;NLGN3;DRD4;GRID2;GRIN2A
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.716033391702585,-1.034230747795277,0.5084745762711864,0.9646759238717189,1.0,2/5,10.76%,GRM5;ABCB1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.6099915630685994,1.0342262093223684,0.45714285714285713,1.0,1.0,1/9,0.34%,GJC1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.43952149410447094,-1.034175093530298,0.4473684210526316,0.9642509954938783,1.0,29/115,23.68%,DACT1;SFRP4;PLEKHA4;PSMB8;LRRK2;AMER1;GPC5;CAV1;CDH3;EGFR;GPC3;DAPK3;TGFB1;ATP6AP2;PTK7;TMEM9;PSMC3;WLS;PRDM15;PIN1;PSME1;LRRK1;SCEL;ZBED3;FZD9;UBE2B;PSMC5;PSMA3;LYPD6
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5982044457906702,-1.0340862859850575,0.453125,0.9639333717003382,1.0,2/9,11.84%,AXL;CAV1
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.6933995747187321,-1.0340153064884339,0.48,0.9635345775225168,1.0,4/5,29.54%,CD27;CD70;SLA2;CD74
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.4763412958418194,-1.0338207869800582,0.46153846153846156,0.9635000457689447,1.0,13/54,20.23%,NR4A3;MEF2C;LGALS3;GATA1;FES;LYN;SPI1;ZFPM1;MOV10;PRKCQ;KAT2B;RBBP5;SETD1A
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.7024161192431263,-1.0336586276451702,0.5416666666666666,0.9633464777179103,1.0,4/5,29.74%,ABCA1;ABCA12;APOE;ABCA7
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.5365855852808092,-1.0334004104338999,0.4126984126984127,0.9635313301514069,1.0,8/30,17.72%,HEY1;CX3CR1;BHLHE40;SLAMF8;NOTCH2;CX3CL1;PRUNE1;CLOCK
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.5925529909917111,-1.0333592211705132,0.3770491803278688,0.9631025304087065,1.0,5/8,27.66%,CARMIL1;DOCK2;SNX33;RAB34;MAPKAPK3
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5237937942740281,1.0331046055181545,0.37142857142857144,1.0,1.0,2/20,1.07%,PDE3A;LHFPL2
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.5157510981040461,1.0328707064183091,0.4,1.0,1.0,2/11,8.41%,RFWD3;SDE2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.5813956541941501,-1.0325799172059635,0.417910447761194,0.9648135886602205,1.0,4/14,17.99%,CSF1R;CYFIP1;CARMIL1;TPM1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.38317393128126603,-1.0325029773444567,0.3698630136986301,0.964378263530529,1.0,83/535,15.89%,CLDN5;KANK2;PDGFD;IGFBP3;NR4A3;SFRP4;IL13RA1;CR1;TP53I11;TGFB2;CLU;KITLG;IL6R;WDR6;SPDYA;SMIM22;TIMP1;ALDH1A2;FABP3;IRF1;TSHR;NOX4;FGF22;SSTR1;TRNP1;TGFBR2;EDN1;ADGRG1;CAPN1;ID2;SOX9;P3H2;DDAH1;STAT5A;MYO16;CSF1R;IL7;PRAME;BMP6;COX17;WWTR1;TMIGD3;FES;AR;CTF1;CDKN3;CRLF1;STX3;XBP1;LDOC1;BST1;IL12RB2;RERG;IFI35;CDH13;INCA1;COPS9;LYN;NMI;VEGFA;TGFB3;HTR2B;ROMO1;AQP11;EGFR;FGF7;NRG1;IFNK;IL31RA;CHRM1;TGFA;SERTAD1;EFNB2;TP53INP1;AGT;STAT1;TGFB1;OPRM1;CD200;UHRF1;CDKN1A;ITGAV;WARS1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.5274657124316956,1.0324664666379066,0.4838709677419355,1.0,1.0,1/22,0.23%,AMPD1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.669707193268952,-1.0323585255502807,0.5161290322580645,0.9642183770646999,1.0,2/5,28.03%,PLBD2;NUDT15
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.5908706407669448,-1.032088717034767,0.4461538461538462,0.9643333964993597,1.0,5/16,20.44%,NCKAP1L;NLRP12;CD200;CX3CL1;GAS6
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.6457034791773772,-1.0320603974190894,0.5223880597014925,0.9637744391912132,1.0,3/8,18.08%,ARG2;AZIN1;ASL
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.6615333456896824,-1.0319854432824471,0.5,0.9633346692994883,1.0,3/6,27.25%,TIE1;NR2F2;PROX1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.4729749861547801,-1.031854791599114,0.3870967741935484,0.9630948613340203,1.0,19/59,16.70%,TRPM1;MYO7A;RDH12;RPGR;GPR179;ADGRV1;COL11A1;SLC4A10;BEST1;SLC24A1;TYR;PAX6;ABLIM1;DHRS3;RP2;GRM6;CRYBG3;ROM1;CACNA2D4
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.5573550833957778,-1.0317614373978392,0.5,0.9627993177589705,1.0,3/15,16.28%,IL16;PLN;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.6987414082803227,-1.0316726508534835,0.4444444444444444,0.9624543691477675,1.0,3/5,21.04%,DDAH1;NOL3;HYOU1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.4677915706909017,-1.0316669078516976,0.4411764705882353,0.9618486607095551,1.0,6/66,8.39%,LAMP5;PRICKLE1;RAB11A;NUP62CL;ZDHHC15;E2F3
prerank,GO_Biological_Process_2021__natural killer cell activation involved in immune response (GO:0002323),-0.6739393495081232,-1.0316590173627431,0.5272727272727272,0.9612685903192112,1.0,3/5,13.32%,IFNA2;IFNA6;IFNK
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.5945852922223385,1.0314993002697357,0.43243243243243246,1.0,1.0,2/9,26.19%,BECN1;NPRL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.5945852922223385,1.0314993002697357,0.43243243243243246,1.0,1.0,2/9,26.19%,BECN1;NPRL2
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.5972745516025176,-1.0310979766976511,0.45454545454545453,0.9622606822081872,1.0,1/8,1.29%,VIL1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.5571035342376509,-1.031062291833348,0.4411764705882353,0.961755577269375,1.0,5/25,10.31%,TSHR;ADCY7;RXFP1;TMIGD3;ADCY8
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.6431854527308586,1.0305061954951689,0.5238095238095238,1.0,1.0,1/5,2.49%,MGLL
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.6042105802878825,-1.03010157650434,0.46153846153846156,0.9640425509028892,1.0,2/12,11.36%,TERF2IP;CAMK1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.5046527367021842,-1.0299896505579076,0.4027777777777778,0.9637105298136929,1.0,14/36,17.41%,PTPRC;RYR3;HTR2C;SLC8A3;GRIN2B;SLC8A1;SLC24A1;HTR2A;HTR2B;ITPR3;GRIN2D;TRPV3;TRPM2;TRPV4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.6026987694629276,-1.0296488224195017,0.49230769230769234,0.9639984579149886,1.0,1/11,0.40%,DPYS
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.7103678750358354,-1.0295118202030222,0.5,0.9637659501135006,1.0,3/6,16.34%,IRF1;MAPK8IP1;SYK
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.6165660473337903,1.0294358985943712,0.38461538461538464,1.0,1.0,1/8,0.89%,NUPR1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5176049375048085,-1.0294117693676335,0.4838709677419355,0.9634409295543249,1.0,2/37,6.97%,NR4A3;ME3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.5666828061945209,1.0293946859971148,0.38095238095238093,1.0,1.0,2/8,9.25%,AKT2;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.6374753652371716,-1.0291165438646614,0.47619047619047616,0.9636109941006201,1.0,2/8,9.69%,FCHSD2;CYFIP1
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),-0.6878239768068874,-1.0288117767456753,0.5142857142857142,0.9638179181641207,1.0,1/5,10.71%,GLI3
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.4374231599123566,-1.0279232610594322,0.44155844155844154,0.965864873763785,1.0,18/108,10.51%,CD44;TLR2;TNFRSF1A;NOX4;LOXL3;BLNK;FOS;NLRP3;CSF1R;APOL3;TMIGD3;PTGER3;C3AR1;CHI3L1;IFNA2;NOD1;ADCY8;CEBPB
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7019914261705336,1.0277060390345683,0.54,1.0,1.0,1/6,7.67%,PIH1D1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.6940883024150427,-1.027683509594961,0.6140350877192983,0.9660454113457733,1.0,1/5,16.58%,MOV10
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.5479387819447261,-1.0276079315677271,0.4727272727272727,0.9656829682700437,1.0,4/14,15.88%,RMI1;TOP2A;FANCM;MEIOB
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.42561525781893844,1.0273686312518224,0.46153846153846156,1.0,1.0,11/68,14.62%,SNAPC3;INTS14;TAF13;CCNT1;ELL;POLR2K;TAF5;INTS8;ZC3H8;NABP1;POLR2L
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.5944007723565592,-1.0272900697948342,0.4878048780487805,0.9658695554992348,1.0,3/8,15.53%,ID2;PAX6;MYT1L
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6150472935818313,-1.027185526130235,0.4909090909090909,0.9656000820312544,1.0,3/13,22.18%,PRPF19;USP4;DDX20
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.5630041861740046,-1.0271467775736034,0.423728813559322,0.9651401195732816,1.0,5/15,16.58%,NTNG1;GRIP1;DLG4;NTNG2;MOV10
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.7233747297405573,-1.026893147615248,0.5084745762711864,0.965295936319551,1.0,2/5,18.89%,GRM7;SLC43A1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.3756702875235239,1.026458967189155,0.2857142857142857,1.0,1.0,64/276,22.17%,U2AF1;SF3A3;LSM7;RNF113A;PRPF4;SF3B2;CRNKL1;RALY;CPSF4;PCF11;PTBP1;KIN;CSTF2;RBM8A;POLR2K;SYMPK;SNRPC;PPIL1;PDCD7;GEMIN6;CCAR1;DNAJC8;SNRNP25;HNRNPU;SARNP;RBM17;POLR2L;YBX1;SF3A2;SNIP1;SRSF8;HNRNPH1;CWC27;GEMIN5;DHX9;SNRNP35;DDX5;CMTR2;GTF2H5;HNRNPA2B1;RBM15B;ERCC2;GPATCH1;THOC2;CDC5L;BCAS2;MAGOH;CELF1;RBM22;RBM5;ALYREF;SNRPB;SF3A1;CSTF1;SRSF9;HNRNPC;HNRNPM;POLR2E;HNRNPR;WBP4;DDX46;ZMAT2;RBM19;POLR2D
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.6657447924133986,1.0263700906365902,0.46153846153846156,1.0,1.0,4/7,15.06%,AGER;TARM1;TWSG1;SH3RF1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.5237688504233357,-1.026083852959889,0.5,0.9670500460037035,1.0,3/23,6.98%,TTN;SMC4;NCAPH
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.631371686065699,-1.0260471968157683,0.4074074074074074,0.9665470300973946,1.0,5/6,27.66%,CARMIL1;DOCK2;SNX33;RAB34;MAPKAPK3
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.5098095871125016,-1.0260403929494128,0.4915254237288136,0.965946408220891,1.0,2/21,7.92%,MET;ARHGAP28
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.5488606973811865,-1.0259817614594844,0.47619047619047616,0.9654631383005595,1.0,10/19,17.41%,TRPM1;JPH4;JPH3;GRIN2B;SLC8A1;ITPR3;GRIN2D;CACNA1C;TRPM2;TRPV4
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.5911094797252402,-1.0259493758132268,0.4307692307692308,0.9649436856995992,1.0,2/7,31.68%,MTIF3;MCTS1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.5249056923982582,1.0259386694382333,0.42857142857142855,1.0,1.0,9/17,31.17%,GFI1B;KAT2A;EHMT1;NIPBL;INSR;SCX;CCSAP;DUSP6;TRIP12
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4388236999626585,-1.0256862905030397,0.44,0.965129677990504,1.0,17/119,10.38%,SRGN;VSIR;CR1;IL12A;ISG15;PTPRC;NCKAP1L;NLRP12;LAPTM5;SFTPD;CEACAM1;ADCY7;IFNA2;AXL;NAV3;HLA-DRB1;TRIM25
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.40112503643312286,-1.0256288699684113,0.4189189189189189,0.9647029640656323,1.0,71/325,16.82%,ANGPT1;ROR1;PDGFD;NR4A3;BAIAP2;SLA;EPHA3;MUSK;FGF22;NCKAP1L;VAV3;BLNK;KALRN;EPHA4;HGF;MET;ANGPT2;KIF16B;CSF1R;PTPRG;EFNA1;MPZL1;ANOS1;GFRA2;STYK1;FES;DDIT4;TEK;PLCB1;UBASH3B;AXL;GRIN2B;FLRT1;CYFIP1;CDK5R1;ATP6V1C2;SIPA1L1;SULF1;PAK3;EPHA6;LYN;EPHB6;CHN1;VEGFA;TNK2;NGEF;EPHB1;EGFR;FGF7;NRG1;DNM1;FLRT2;TIE1;IL31RA;PTPRT;CAV2;PRKD2;RASA1;DDR2;EFNA3;EFNB2;EFNA5;NGFR;ITGAV;SH2D6;HPN;SYK;PIK3CB;GIT1;PTPRJ;NCBP1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.5628117866929819,1.0254125472564335,0.36585365853658536,1.0,1.0,1/11,2.79%,HMGB1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.5897998800049966,1.025391362648063,0.47058823529411764,1.0,1.0,3/10,8.62%,KCND3;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.4670286581054856,-1.0252699480163967,0.4266666666666667,0.9653173320309018,1.0,15/68,19.86%,ANGPT1;EDN1;MET;STAT5A;TEK;VEGFA;PRKD2;AGT;TGFB1;ZNF580;SCARB1;PIK3CB;EMC10;PLCG1;GPI
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.6163503963266572,1.0252637986488256,0.4772727272727273,1.0,1.0,1/7,4.09%,CMPK1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.467836601769289,-1.0252470148472408,0.43243243243243246,0.9647503483454617,1.0,14/86,10.76%,PROM1;SPARCL1;HOPX;SHISA6;TSPAN11;MAOB;CDS1;KALRN;DACT2;APCDD1;CHGA;SLC44A3;SPON1;SCN4B
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.6296262147381819,-1.025185596681397,0.5147058823529411,0.9643369082856599,1.0,2/8,5.65%,EDN1;PROCR
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.39917442244287027,1.02512658348492,0.43333333333333335,1.0,1.0,9/85,6.50%,CXCR4;F2;GUCA1C;PDE6A;MGLL;EPHB2;CNGB1;GUCA1B;PDE6B
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.5652423277712818,1.0249394742385776,0.3611111111111111,1.0,1.0,3/16,11.69%,KLK6;NCSTN;ADAM19
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.49220897475999775,1.0248802050361645,0.42857142857142855,1.0,1.0,4/26,10.40%,F2;CHID1;NLRP7;IL17D
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.44462697315179933,-1.0247900096207325,0.4266666666666667,0.9649075795909324,1.0,26/75,23.93%,DACT1;LRRK2;ARHGAP28;E2F1;LRPAP1;PLN;CAMK1;CAV1;CARD18;ZFPM1;IFIT1;CDKN1A;DISC1;NFKBIA;IFIT2;PPP1CA;MDFI;PIN1;AURKA;CTSZ;RALB;EFHB;ITGB1BP1;DDX11;PRKCD;TFAP4
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.4484616758712646,-1.0247417710526265,0.4027777777777778,0.9644518239516193,1.0,7/98,6.54%,ANGPT1;ISG15;BIRC3;FANCI;PRICKLE1;LAPTM5;LRRK2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.543055098112081,1.0246953915246009,0.34615384615384615,1.0,1.0,5/11,22.29%,OXSR1;ACKR3;GPR35;WNK1;CIB1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4558566853847766,-1.0245564920015184,0.4507042253521127,0.9645152747221709,1.0,23/61,24.24%,DACT1;LRRK2;B2M;LRPAP1;CAMK1;CAV1;MAP2;CARD18;ZFPM1;IFIT1;CDKN1A;DISC1;IFIT2;PPP1CA;PIN1;AURKA;CTSZ;RALB;EFHB;ITGB1BP1;DDX11;PRKCD;ADRB2
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5906438781153742,-1.0245389163675502,0.44642857142857145,0.9639505813237181,1.0,3/10,10.57%,ALOX12;CEACAM1;PRKG1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6066826910393824,-1.0241880198613007,0.4642857142857143,0.9644652143362974,1.0,3/8,12.24%,NOS1;CACNB1;CACNB2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.40017674139451065,1.0240214544221995,0.3333333333333333,1.0,1.0,2/75,0.60%,NGF;PM20D1
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6489529095132209,-1.0240036055541737,0.5,0.9644067361438249,1.0,2/7,4.62%,TGFBR2;SOX9
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.44582377768173814,-1.023932452770306,0.47297297297297297,0.9640744518622464,1.0,12/59,19.79%,LPL;OLAH;PAM;XBP1;LSS;ACSM3;ACSL5;LIPI;OXSM;SREBF1;PDSS1;SCD
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.6373917152488401,-1.023869491697382,0.5471698113207547,0.9636878435101481,1.0,1/8,1.24%,HEY1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.482196051539294,1.0237807313498801,0.3225806451612903,1.0,1.0,2/26,3.23%,GPC4;GPC2
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.5156614143231028,-1.0235261719787243,0.42424242424242425,0.963879184895738,1.0,8/29,11.95%,PDE7A;IRAG1;SOX9;NUDT4;AQP1;HTR2C;HTR2B;RIMS2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.4365114194225514,1.023480729301362,0.375,1.0,1.0,3/28,9.61%,RAB27A;CHMP5;VPS25
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.5802619766995449,-1.0229515440944426,0.515625,0.9648539300812857,1.0,5/15,15.07%,TGFB2;TGFB3;CAV1;TRERF1;TGFB1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5821451383404628,-1.0229053994591095,0.43548387096774194,0.9643461411889523,1.0,4/13,18.50%,PGAM5;LY96;ITPK1;DNM1L
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5669602745740286,1.0226054395528974,0.4897959183673469,1.0,1.0,2/9,12.63%,RAPGEF1;RAP2B
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.4543937846115544,-1.0224968813467956,0.4931506849315068,0.9648340006096421,1.0,21/73,16.11%,PCSK1;CNTN3;SSTR1;TPH1;KALRN;TREH;A2M;SORBS2;DENND2A;THY1;SMLR1;GABRA2;AFP;EDNRB;FGF14;GRIA3;SLC2A2;SLC38A11;CNTN4;AGT;RHOJ
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.5034913049014801,-1.022330789880811,0.5076923076923077,0.964714914343793,1.0,5/34,10.82%,TTN;SMC4;NCAPH;TOP2A;H1-0
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5001263700749419,1.022293527388667,0.39473684210526316,1.0,1.0,11/29,26.94%,TNKS2;PKIB;MAP2K7;ATR;NAF1;CCT8;CCT2;CCT3;CCT6A;ACD;MAP3K4
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),-0.6560635268367885,-1.0221741485210476,0.5423728813559322,0.9644869051711048,1.0,2/6,18.31%,DCX;STAT3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5542876394516987,1.0220140604298462,0.39473684210526316,1.0,1.0,3/9,10.29%,B4GALNT2;ST3GAL1;GFPT2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5605844984574322,1.0218735958417544,0.40625,1.0,1.0,5/19,13.66%,HSPA1A;HSPA1B;ITCH;DAXX;ZMIZ1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.5157723928808404,1.0218022813578904,0.39473684210526316,1.0,1.0,5/14,15.74%,PAX8;CHRNA7;MAPK8;NFKB1;TMEM106A
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.6510539859365305,1.0217519930548524,0.46153846153846156,1.0,1.0,1/8,3.59%,NEU4
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.5362285677551417,-1.021690500212347,0.5151515151515151,0.9652644378864692,1.0,4/16,27.85%,CAV1;PTRH2;TLE1;BCL2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.44706010798673357,-1.0216065720150587,0.38028169014084506,0.9648790188348665,1.0,6/87,7.94%,ARIH2;CLU;PRICKLE1;RNF217;LRRK2;RNF144B
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.576723589836569,-1.0214715543788782,0.515625,0.9645787560318967,1.0,2/15,2.54%,PYGL;PPP1R3C
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5027016916922049,-1.0208125837928015,0.45454545454545453,0.9659048178388491,1.0,8/28,20.32%,GUCY1A1;SERPING1;C3AR1;PLN;STAT1;ELN;GCLM;COL4A3
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.598791311268116,-1.020775376062887,0.4444444444444444,0.9653989075637217,1.0,7/15,16.95%,ALOX12;CEACAM1;PRKG1;LYN;DMTN;SYK;PRKCQ
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4873115599113305,-1.0203555376265172,0.4594594594594595,0.9661311897654025,1.0,14/50,15.15%,PTPRM;ROBO4;L1CAM;EMB;ROBO2;CADM3;CEACAM1;PALLD;TENM3;CDH13;VSTM2L;PTPRT;CNTN4;MYOT
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.6408664133758479,1.0199748201735852,0.4634146341463415,1.0,1.0,2/5,15.77%,NCK1;DDX3X
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5418769328971192,-1.01967853739778,0.48333333333333334,0.9671528744867719,1.0,5/18,23.88%,RPA3;RPA2;RBX1;RPA1;XPA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5418769328971192,-1.01967853739778,0.48333333333333334,0.9671528744867719,1.0,5/18,23.88%,RPA3;RPA2;RBX1;RPA1;XPA
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6197843143181978,-1.0195682293868824,0.5172413793103449,0.9669246251911284,1.0,2/8,15.07%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.5690355133379159,-1.0194062535680517,0.49122807017543857,0.9668291409066507,1.0,1/14,0.76%,CLDN5
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.5292612058398031,1.0193925511814061,0.43243243243243246,1.0,1.0,4/15,13.53%,RUNX1;CD22;PTPN22;NFAM1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.6320585249661866,-1.0191951150154863,0.5535714285714286,0.9667999747006386,1.0,3/6,24.37%,GMPPB;PMM2;GMDS
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.5672953196587947,-1.0191886605163158,0.5106382978723404,0.9662175209873319,1.0,1/9,6.02%,RPS6KA6
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.44236345187884696,-1.0189198378341102,0.4098360655737705,0.9664352075030958,1.0,25/92,18.21%,TGFB2;CLU;SLF1;LGALS3;CALY;RHOC;FRMPD4;AR;CAMK1;VEGFA;TGFB3;NEDD4L;ABCB4;GPC3;LRP1;NRG1;FLOT1;HRK;TGFB1;PPP1R15A;WARS1;CAMK2B;SYK;NRXN1;NEURL1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.5495419247954525,-1.0188926138963696,0.4482758620689655,0.9658897442781127,1.0,5/21,19.27%,EPHA3;DAPK3;EFNA5;VCL;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.6379866735822648,1.0188703758540656,0.3939393939393939,1.0,1.0,4/10,23.13%,SPHK2;ZBTB7B;ING2;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.6273142287957568,-1.0188529812098897,0.45901639344262296,0.9653989862082943,1.0,2/8,2.17%,VIL1;STMN2
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.6976305041271744,-1.0187630926820566,0.5081967213114754,0.9644372806226486,1.0,3/6,26.34%,HLA-DRB1;IL12RB1;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.6976305041271744,-1.0187630926820566,0.5081967213114754,0.9644372806226486,1.0,3/6,26.34%,HLA-DRB1;IL12RB1;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.42288659180956056,-1.0185657623521989,0.3888888888888889,0.9643977367513361,1.0,25/144,17.16%,SRGN;ADAMTS5;HEY1;TIMP1;MEF2C;NLRP12;SOX9;PROCR;RPS6KA6;PTPRG;EFNA1;GJA1;PGAM5;LRPAP1;SLAMF8;PTPRR;EGFR;OVOL2;SPI1;ACOT11;TGFB1;NR1D1;HPN;TRPV3;MAD2L2
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.5728047611168581,1.0183931987587846,0.5,1.0,1.0,4/7,39.74%,CLN3;PKDCC;RACK1;ATP2C1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5360501013406334,-1.0183925760564876,0.4666666666666667,0.9643163233251463,1.0,6/15,25.96%,CAV2;DAPK3;BORA;KIF20B;PIN1;FBXO43
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6422327247884587,1.018135996697656,0.4888888888888889,1.0,1.0,3/6,27.28%,CNOT2;NBDY;CNOT6
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.4946116823790867,1.0175683716859947,0.3235294117647059,1.0,1.0,8/32,9.30%,CCDC78;TNNC2;STAC3;CASQ2;MYH3;ATP1B1;MYH14;TCAP
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.49491657426318464,-1.0173686741097452,0.39655172413793105,0.9667485639815329,1.0,4/37,15.41%,ADAMTS5;PGAM5;ACOT11;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.4624291778138372,-1.017367536429561,0.4342105263157895,0.9661514370118098,1.0,22/75,16.51%,RHBDF2;GPHB5;CYSLTR2;TSHR;PRKAR1B;ADCY7;RXFP1;HLA-DRB1;ADCY8;FURIN;GPR176;LYN;GGT5;PTH2R;NPSR1;GNG2;FCGR3A;ADCYAP1R1;RAMP1;HRH2;SYK;PLK2
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6068718957398995,-1.0172796111512328,0.5166666666666667,0.9658479331036882,1.0,2/7,19.66%,WARS1;KAT2B
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6220422276289882,-1.0171162934955051,0.5081967213114754,0.9656344072888426,1.0,4/13,12.03%,LRRK2;SCN1B;CAV3;NEDD4L
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.43892654518171803,-1.0169689039399328,0.44,0.9654629340076648,1.0,17/149,10.76%,CD44;FGL2;HOPX;PLSCR1;IFITM3;PIM1;SELL;SCN9A;IL3RA;GATA1;XBP1;BHLHE40;CYFIP1;IKZF2;FURIN;GADD45B;ABCB1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.4218728422473286,1.0165586883345483,0.32,1.0,1.0,22/61,24.83%,ATF4;EIF3B;EIF5;NCK1;EIF3E;EIF4EBP1;EIF1;TPR;EIF4G2;ATF3;DDX3X;NPM1;EIF4G3;PAIP2B;EIF3H;KLHL25;YTHDF1;POLR2D;PAIP2;LARP1;EIF4B;EIF4EBP2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.5678600326058703,-1.0165430258290056,0.4426229508196721,0.9661269419995291,1.0,1/15,0.40%,DPYS
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.6867487667133253,1.0163078976839106,0.5128205128205128,1.0,1.0,3/6,5.45%,CHRNA4;NLGN3;DRD4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5469820468708015,1.0162680120447924,0.4444444444444444,1.0,1.0,2/16,2.63%,PTPRU;SERPINF2
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5981751642299008,1.0161734082510094,0.48936170212765956,1.0,1.0,2/7,7.41%,AGER;ABL1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.4646744499509975,-1.0160761659792414,0.4166666666666667,0.9669511208353023,1.0,9/56,9.53%,LPL;TLR2;TNFRSF1A;PLSCR1;MEF2C;NLRP12;NINJ1;IL16;IFI35
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.624352153315716,-1.015837955127061,0.5,0.9669400433527635,1.0,4/6,36.44%,NRL;BBS4;RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.6248075546720915,1.0153843691851043,0.475,1.0,1.0,2/8,22.94%,MBD4;SMUG1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.6202713063063199,1.0151739769422399,0.5,1.0,1.0,2/7,3.84%,MALT1;NFKBIZ
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.5985112363060452,1.0151722217986725,0.42105263157894735,1.0,1.0,2/8,4.43%,AADAT;AFMID
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.46107783393415214,-1.0149805545659092,0.41333333333333333,0.9689716152527272,1.0,22/76,16.51%,RHBDF2;GPHB5;CYSLTR2;TSHR;PRKAR1B;ADCY7;RXFP1;HLA-DRB1;ADCY8;FURIN;GPR176;LYN;GGT5;PTH2R;NPSR1;GNG2;FCGR3A;ADCYAP1R1;RAMP1;HRH2;SYK;PLK2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.5692653246892669,-1.0144193762229168,0.49206349206349204,0.9699294115408842,1.0,2/17,5.54%,EDN1;PTGR1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.45782939050124283,-1.0141856747465403,0.45901639344262296,0.9698867856029485,1.0,13/68,11.68%,ROR1;CRYM;MYO7A;ATP2B2;MYO3B;CEMIP;ADGRV1;COL11A1;LHFPL5;GRM7;LRTOMT;SLC26A4;NDUFB9
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.6102374194073118,1.01387083787038,0.46511627906976744,1.0,1.0,2/7,7.69%,AGER;GRID2
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.6392318560478101,-1.0137056608641444,0.5245901639344263,0.9707893460091185,1.0,3/5,31.50%,SDC4;SDCBP;TSG101
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.368365812572119,1.013500530742633,0.23076923076923078,1.0,1.0,40/196,18.61%,TBPL2;MLF1;EAF2;SNAPC3;PAX8;ATF4;TAF13;TAF12;CCNT1;EPC1;ELL;SLC25A33;POLR2K;TAF5;THAP1;GMEB2;MNT;GTF3C6;GTF3C5;TFB2M;ELOC;GTF3A;NFKB1;MLLT3;TRIP11;HOXD3;TAF3;POLR2L;IWS1;TFDP1;POLR3GL;UBTF;BTF3;DDX5;GTF2H5;ERCC2;TAF1C;TAF4;CTDP1;SMN1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5777514213574378,1.0134476380325588,0.46511627906976744,1.0,1.0,2/5,18.78%,OTUB1;RPS3
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.6559629045634443,-1.0126728767738857,0.5833333333333334,0.9730393134280496,1.0,4/6,16.34%,FES;LYN;ADGRE2;SYK
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),-0.6647125124873581,-1.012576885129507,0.4827586206896552,0.9727692550497421,1.0,3/5,31.48%,CAV1;MLC1;PACSIN2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.6251263305070603,1.0123437982223225,0.4878048780487805,1.0,1.0,3/7,9.76%,BPIFB1;MFHAS1;RAB7B
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.5930067403205556,-1.0118871968084617,0.42105263157894735,0.9741133885295978,1.0,6/16,21.35%,GATA1;E2F1;SPI1;CDKN1A;SRP54;RXRA
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.5164441276189844,-1.0118565445959318,0.43636363636363634,0.9736236050569288,1.0,2/23,3.27%,ANGPT1;GPIHBP1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.42539391804320026,-1.0114543239338616,0.4117647058823529,0.9742129621438718,1.0,28/87,22.90%,TTN;SYT4;SYT1;MEF2C;ADGRV1;RYR3;HPCA;ANXA11;KCNMA1;ADCY8;CALM3;CAV1;SYT12;ITPR3;SYT13;DMTN;PPP3CA;TRPM2;CPNE8;KCNH1;ADD1;ADCY1;SYT7;SLC25A12;SYT17;KCNMB3;WNT5A;ADAM9
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.6525165556753706,-1.011417096312647,0.5714285714285714,0.9737059496174133,1.0,1/7,5.11%,ALOX12
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4232253632152182,1.0113237183157386,0.40540540540540543,1.0,1.0,4/46,6.90%,NGF;DICER1;ZNF335;SNX1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.4057227313453336,-1.011224055518172,0.4411764705882353,0.9736079544744632,1.0,29/127,19.38%,RND2;VIL1;BAIAP2;TTN;MYO7A;GAS2L3;CARMIL2;BAIAP2L2;ACTN1;RHOC;MYO5C;LMOD1;CARMIL1;TMOD1;ARHGAP25;FHOD3;RAC3;FAT1;MYO1H;FHOD1;DMTN;KASH5;MAD2L2;TRPV4;MYO1B;TPM1;NEDD9;SHROOM2;RHOH
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.6567021223870302,-1.0107912100559044,0.45614035087719296,0.974196241053967,1.0,3/5,29.88%,BDNF;NTRK2;FYN
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.49825878840213206,1.0106899382236563,0.36363636363636365,1.0,1.0,7/17,15.09%,AJAP1;CRK;SERPINE1;TFPI;KNG1;CASK;SLC12A2
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.6718426470400802,-1.0105896304249007,0.5737704918032787,0.9741276241320044,1.0,2/5,17.18%,LRRC4;NRXN1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.6463734021565601,1.0103037311516903,0.5675675675675675,1.0,1.0,3/6,14.95%,ZDHHC12;ZDHHC3;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.6588033599218799,-1.0102739749824199,0.5087719298245614,0.9745376366385459,1.0,1/6,13.59%,NFATC2
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.6086312722353434,1.01021203750798,0.5476190476190477,1.0,1.0,3/8,11.34%,WNK4;ATP1B1;DLG1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.4436232182655252,1.0101607560231451,0.4444444444444444,1.0,1.0,3/35,6.18%,CRTAM;SCRIB;PDE4B
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5003087066961216,-1.0101388397074966,0.45454545454545453,0.97432719036783,1.0,12/21,35.09%,PGK1;PFKM;GPI;GAPDHS;PFKL;ALDOB;TPI1;PGAM2;PFKP;PKM;ADPGK;ENO2
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.4878339422883874,1.010057809035012,0.45454545454545453,1.0,1.0,2/22,5.51%,PDE3A;ZNF335
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.4910094961284064,-1.0099058303598505,0.423728813559322,0.9744179399101841,1.0,10/31,12.32%,ISG15;MEF2C;ANO6;ADGRV1;BMP6;NELL1;SLC8A1;CEBPB;TGFB3;BMPR1B
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.6152301809962089,1.0097935680758867,0.5135135135135135,1.0,1.0,1/12,0.46%,PTH
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.6012405709066502,1.0097526366029805,0.4186046511627907,1.0,1.0,5/10,24.88%,DKC1;CCT8;CCT2;CCT3;CCT6A
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.6645199021542946,-1.0095438700067096,0.5076923076923077,0.9749803531157317,1.0,2/6,11.55%,TTN;CAV3
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.5273747926876808,-1.0094661485506087,0.43661971830985913,0.9745814268259748,1.0,5/25,9.04%,IGFBP3;MEF2C;SOX9;BOC;PLCB1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.5212846230193361,-1.0094071470999257,0.47692307692307695,0.9741535358315047,1.0,6/19,19.97%,SOX9;SLC8A3;EIF2B4;PTPRZ1;CDK5;EIF2B2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.5192360729651136,-1.009377980519283,0.45,0.9736437551507309,1.0,8/24,23.70%,ITGAM;XKR4;ARHGAP25;MSR1;RHOH;GULP1;BIN2;ARHGAP12
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.6280355472620578,-1.0093309311273968,0.47368421052631576,0.9725966545402194,1.0,1/9,1.54%,TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6280355472620578,-1.0093309311273968,0.47368421052631576,0.9725966545402194,1.0,1/9,1.54%,TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.6917273544802294,-1.0093047569895015,0.4915254237288136,0.9721181251036576,1.0,2/6,20.53%,TOMM7;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.45449053130499817,1.009222787220234,0.4864864864864865,1.0,1.0,1/17,0.17%,CRTAM
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.4763454492225857,-1.0087835103190534,0.4067796610169492,0.9732021663536244,1.0,3/36,4.62%,H2BC11;NAP1L2;SOX9
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5594983417712566,1.0087182283825968,0.47619047619047616,1.0,1.0,1/10,2.79%,HMGB1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.511327831994209,-1.008345148485133,0.5,0.9738740926567471,1.0,6/34,17.33%,ECM2;THY1;BST1;DMTN;PIK3CB;CX3CL1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6018383971363601,1.008083915261409,0.45,1.0,1.0,1/6,4.59%,GALT
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5580229650656922,-1.008006338131967,0.5223880597014925,0.9742812786226446,1.0,7/17,22.95%,POLQ;RADX;MAGEF1;KLHL15;MAD2L2;FANCB;SHLD2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.5078833806068347,-1.0078474174604044,0.4827586206896552,0.9741956072836493,1.0,2/26,2.17%,TWF2;STMN2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.6404713275399423,-1.0076486079944227,0.49122807017543857,0.9742564879581557,1.0,2/8,4.62%,ACADL;SOX9
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.45324184296760356,-1.007368234771647,0.45714285714285713,0.9745631795072246,1.0,5/50,6.45%,HEY1;DTX1;DTX3L;SUSD5;SORBS2
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.6598715634572648,-1.007356170845813,0.5409836065573771,0.9740035738562403,1.0,1/6,4.32%,ID2
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.454222449842018,-1.0072107230510097,0.4864864864864865,0.9738422619614415,1.0,19/85,17.99%,CLDN5;FBLN1;MCTP1;SPINT2;ARHGAP4;CITED2;EPHA4;TMIGD3;THY1;NAV3;SULF1;PTPRT;TP53INP1;NGFR;SRGAP1;PTPRJ;CX3CL1;VCL;TPM1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.43314319373376226,-1.007118160634664,0.4594594594594595,0.9734882995927409,1.0,18/112,13.96%,ANGPT1;P2RY12;IL26;KITLG;FGF22;PIK3AP1;F3;HGF;MET;CX3CR1;CHI3L1;TEK;AXL;NRG4;EGFR;FGF7;NRG1;TGFA
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.4765674572425648,-1.0070235679997548,0.4444444444444444,0.9731522850051102,1.0,14/48,15.17%,P2RY12;NMUR2;LPAR6;GRM5;CX3CR1;PTGER3;HTR2C;C3AR1;HTR2A;HTR2B;CHRM1;LTB4R;AGT;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.6187282156556971,1.0069181337218596,0.5111111111111111,1.0,1.0,2/6,9.11%,EIF3E;EIF3D
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6136818012355351,-1.0067953393965001,0.5094339622641509,0.9732019008859942,1.0,4/9,15.26%,RSPH6A;BBOF1;CCDC39;RSPH9
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.6248615187081815,1.006792124763397,0.5106382978723404,1.0,1.0,1/6,3.66%,HDAC10
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.6112989702770406,-1.0065911297093493,0.5263157894736842,0.9731697917381308,1.0,3/6,19.75%,LRTOMT;PDZD7;JAG2
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.4715460185561951,-1.0065644044853401,0.4918032786885246,0.9726946625095628,1.0,10/50,15.41%,LPL;FABP3;GPIHBP1;XBP1;ABCG5;CAV3;CAV1;ACSM3;SCARB1;NR1D1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5565074283378231,1.0064523758773907,0.40625,1.0,1.0,4/18,12.59%,UBC;UBB;UGGT1;AMFR
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.5016582953351882,-1.0064492990358396,0.48333333333333334,0.9724531535430173,1.0,5/38,13.83%,BASP1;MAOB;CALM3;YWHAH;INA
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5840452784078607,-1.0063809169143105,0.546875,0.9720197856221049,1.0,5/10,27.13%,RFTN1;SCIMP;COLEC12;SCARA3;TNIP2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.5960916617082485,1.0061055998027222,0.5116279069767442,1.0,1.0,1/8,2.29%,OAS3
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.4541069126187977,-1.0059902653621315,0.4657534246575342,0.9725063737547311,1.0,12/75,15.89%,FBLN1;IGFBP3;LRRK2;TERF2IP;WWTR1;SH3GL2;LYN;PID1;PTPN13;TGFB1;PPP1R15A;WARS1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4715136031585977,-1.0059582318938507,0.4666666666666667,0.9720095215671212,1.0,10/51,15.41%,LPL;FABP3;GPIHBP1;XBP1;ABCG5;CAV3;CAV1;ACSM3;SCARB1;NR1D1
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.6620967637137944,-1.0055418342442701,0.5384615384615384,0.9726292128765655,1.0,2/5,17.70%,NOTCH2;LILRB1
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.6789571690282945,-1.0051515416281218,0.5357142857142857,0.9732133082800873,1.0,2/5,5.38%,DTX3L;LAPTM5
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.38697636561350834,1.004689101093965,0.5,1.0,1.0,22/104,14.77%,ETV5;CYBA;PYCR1;HSPA1A;SOD3;PRDX6;PLA2R1;ATF4;CAT;TMEM161A;ABL1;KEAP1;RAD52;HSPA1B;VKORC1L1;PRR5L;CHUK;MAPK8;PRDX3;PNPT1;PRKAA2;MSRA
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.62690561055198,1.0046403588051516,0.5609756097560976,1.0,1.0,4/8,22.27%,MAP3K7;DAPK2;AKT1;MTOR
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.6537076434224869,-1.0041150327767276,0.5306122448979592,0.9755150588246003,1.0,1/5,0.20%,ITGB4
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.4704254969579376,-1.0041006849441418,0.46774193548387094,0.9749827840672642,1.0,13/41,15.07%,SRGN;ISG15;MEF2C;ANO6;ADGRV1;BMP6;NELL1;SGMS2;SLC8A1;TGFB3;BMPR1B;DDR2;TGFB1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.5443732888197164,-1.003905021990529,0.5238095238095238,0.9750309770297338,1.0,3/14,8.82%,TRPC4;TRPC6;TRPC7
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.41949678483857045,-1.0036802434615588,0.37333333333333335,0.9751718296336664,1.0,25/114,18.60%,TIMP4;SHMT2;ISG15;PLSCR1;MX1;IL6R;IFITM3;TIMP1;ALDH1A2;NLRP12;CSF1R;CHI3L1;XAF1;GGT5;TRIM32;PID1;PTPN13;TIMP3;STAT1;CALCOCO2;CIITA;KYNU;STAT3;PTPN5;CXCL16
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.6663704597913032,1.0034657334047152,0.5277777777777778,1.0,1.0,2/6,19.18%,HMGA2;SIRT1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.5169844748542689,1.0032180548832912,0.4666666666666667,1.0,1.0,8/27,13.74%,UBC;CCDC88C;CHUK;UBB;MAPK8;NFKB1;MAP3K7;MAP2K7
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.6284799395403002,1.003212001149658,0.53125,1.0,1.0,2/7,4.44%,EYS;CNGB1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.6284799395403002,1.003212001149658,0.53125,1.0,1.0,2/7,4.44%,EYS;CNGB1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4449258712207732,-1.0029033359325268,0.4057971014492754,0.9767082331720274,1.0,16/55,16.25%,PTPRM;IL26;TGFB2;KLF9;SOX9;CEACAM1;B2M;SULF1;CAV1;AQP11;CAV2;SCG2;STAT1;TGFB1;CNMD;HPN
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.608642725281879,-1.0028633142343488,0.5538461538461539,0.9762575485166878,1.0,1/5,11.84%,CAV1
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.6203002857478002,1.0028354077019277,0.4878048780487805,1.0,1.0,2/5,18.41%,XG;ADAM8
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.6203002857478002,1.0028354077019277,0.4878048780487805,1.0,1.0,2/5,18.41%,XG;ADAM8
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.6053559919578388,-1.0024325894713972,0.4262295081967213,0.9762885336785194,1.0,4/6,20.58%,STAT1;STAT3;STAT4;IL21R
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.6053559919578388,-1.0024325894713972,0.4262295081967213,0.9762885336785194,1.0,4/6,20.58%,STAT1;STAT3;STAT4;IL21R
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.5635810974548666,-1.002244491081215,0.5416666666666666,0.9762491118505532,1.0,6/16,24.92%,ACTL6B;SRRM4;B4GALT6;CX3CL1;PICK1;C1QA
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.46920812238354676,-1.0022153375204315,0.4788732394366197,0.9757535831502155,1.0,15/62,17.70%,TLR2;IRGM;MEF2C;VIM;NLRP3;CX3CR1;XBP1;LDOC1;AXL;TNFRSF1B;ZFP36;NR1D1;LY96;GIT1;LILRB1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),-0.6128996015852718,-1.0019650913872225,0.47619047619047616,0.975899188192216,1.0,2/8,12.32%,SOX9;BMPR1B
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.45428168757312676,1.0019631130108488,0.35555555555555557,1.0,1.0,3/41,4.09%,NUPR1;LCK;NOC2L
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.5209558348240698,-1.0019599410486342,0.45901639344262296,0.9753410187303398,1.0,9/30,20.44%,IL12A;IL6R;ANO6;CSF1R;VEGFA;ZNF580;CXCL17;IL34;GAS6
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.5943215559821406,-1.0016363376013961,0.5230769230769231,0.9756192631527718,1.0,2/8,17.18%,LRRC4;NRXN1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.37755093672352846,1.001618560233899,0.4117647058823529,1.0,1.0,25/92,23.11%,U2AF1;RAE1;NUP42;NUP210;CPSF4;RBM8A;SYMPK;TPR;EIF4E;SARNP;NXF1;NUP37;HNRNPA2B1;SMG5;RBM15B;THOC2;MAGOH;NDC1;ALYREF;RAN;SEH1L;SRSF9;FYTTD1;NUP214;XPO5
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.6802625670222461,-1.0016095746494487,0.5740740740740741,0.9751368089880379,1.0,2/5,7.41%,B2M;BMP6
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.41462309978745426,1.0015732447118373,0.3333333333333333,1.0,1.0,12/91,7.61%,TEAD2;PTPRU;MTCL1;NES;RAI14;EHD2;FJX1;FSHR;RND3;ADAMTS1;GLI2;TEAD3
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5116099568150744,-1.0015138896411842,0.4915254237288136,0.9747412825223016,1.0,1/19,2.28%,CLU
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.37480336950047,1.0015010867765144,0.37037037037037035,1.0,1.0,54/182,21.95%,POP5;RCL1;BYSL;NOC2L;DCAF13;MDN1;EXOSC8;LTV1;PIH1D1;NOL8;NOM1;DDX31;RRP12;PELP1;SDAD1;RIOK1;DKC1;ESF1;RRP1B;RPL18A;NOLC1;RIOK2;MPHOSPH10;RRP36;LTO1;GTF3A;UTP3;WDR74;KRR1;URB2;NPM1;METTL17;RPL23A;NOL11;EXOSC7;UTP6;RPL3;MRPL22;NAF1;RPL11;DIS3;DDX10;WDR36;RPL13;EXOSC5;RAN;RPL8;RPL21;RPL5;NOP56;POP4;RPL32;RPL7;RPS16
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),-0.6753904526623684,-1.0013067974359244,0.55,0.9748985635038558,1.0,2/7,7.41%,DKK3;BMP6
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),0.6372888531741326,1.0011269390508373,0.5227272727272727,1.0,1.0,1/5,1.61%,FOLH1B
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.4737016788888203,-1.0010900703965544,0.35,0.9749406557262204,1.0,4/41,15.41%,ADAMTS5;PGAM5;ACOT11;NR1D1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.5898139534902693,-1.000959650543837,0.5081967213114754,0.974729843816139,1.0,3/9,12.88%,LRTOMT;SMOX;HNMT
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.4933048070352526,-1.0008072277483868,0.4126984126984127,0.9745020521477796,1.0,4/36,14.99%,IRGM;TIE1;SNCAIP;AGT
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.44073347776917765,-1.0006838741941626,0.42857142857142855,0.97426879066194,1.0,5/78,5.60%,KANK2;DACT1;AVEN;PSMB8;MYO16
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.5159696449551318,-1.0006307264752765,0.46296296296296297,0.9738579749076041,1.0,2/24,3.65%,FMO5;ACADL
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.6029438389536822,1.0004475314086498,0.5365853658536586,1.0,1.0,1/6,4.59%,GALT
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.5252728279937191,-1.0003923162426562,0.4745762711864407,0.9740266862932888,1.0,1/17,2.28%,CLU
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.5875684777174355,-1.0003714075317132,0.5614035087719298,0.9734961766111063,1.0,3/9,18.85%,CAV1;BCAP31;USP14
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.4373809374758123,-1.0001247623410205,0.4647887323943662,0.9736362709349327,1.0,14/78,16.56%,ANGPT1;SFRP4;PPARG;TGFBR2;VEGFA;ROMO1;RAB1B;PID1;AGT;TGFB1;UHRF1;CDKN1A;HPN;NFKBIA
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.5164751290179879,1.0000226592739123,0.4117647058823529,1.0,1.0,3/13,10.61%,HMGB1;ABL1;TOP3B
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.4105392894764275,0.9999767493252111,0.5384615384615384,1.0,1.0,11/69,14.62%,SNAPC3;INTS14;TAF13;CCNT1;ELL;POLR2K;TAF5;INTS8;ZC3H8;NABP1;POLR2L
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.5619737106715545,0.9998523544213497,0.48717948717948717,1.0,1.0,4/11,21.90%,ZNF335;BEND3;KMT2D;TET3
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.6298676645578509,-0.9998203446139441,0.46551724137931033,0.9733554490819041,1.0,2/7,7.12%,TLR2;B2M
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.6298676645578509,-0.9998203446139441,0.46551724137931033,0.9733554490819041,1.0,2/7,7.12%,TLR2;B2M
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.45662157270441195,-0.9997589543547688,0.48484848484848486,0.9729409114094338,1.0,12/58,18.25%,TGFB2;CITED2;INHBC;BMP6;SULF1;RBPMS;TGFB3;BMPR1B;KIAA0319;TGFB1;CRB2;RNF111
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.4612872347677271,-0.9994562234440332,0.4696969696969697,0.9720996531544635,1.0,6/57,14.07%,F8;CD59;GRIA1;RAB1B;TGFA;MCFD2
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.4612872347677271,-0.9994562234440332,0.4696969696969697,0.9720996531544635,1.0,6/57,14.07%,F8;CD59;GRIA1;RAB1B;TGFA;MCFD2
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.4612872347677271,-0.9994562234440332,0.4696969696969697,0.9720996531544635,1.0,6/57,14.07%,F8;CD59;GRIA1;RAB1B;TGFA;MCFD2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.40697876849544645,-0.9991586352399873,0.43661971830985913,0.972393964986936,1.0,32/94,28.47%,MCM2;DBF4;RMI1;RPA3;RFC3;RAD9A;RFC4;RECQL4;ORC2;WRN;RAD50;MCM7;BRCA1;DONSON;RPA2;MRE11;RBMS1;PTMS;MCM5;RPA1;CDC7;ORC6;TIMELESS;RFC2;TOP3A;ORC3;PCLAF;FAM111A;WDHD1;NBN;RFC5;RBBP8
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.44625801190004005,-0.9989405088047476,0.45588235294117646,0.9723516697659794,1.0,22/95,23.42%,PEX11A;HSD11B2;CACNA1B;TOP2A;SLC25A19;ABCB1;YWHAH;ABCB4;DLG4;ACSL5;DHRS3;ABCD2;SIAH1;EHHADH;RETSAT;GSTK1;ABCC5;CRABP1;VPS4B;ITGB1BP1;LONP2;ACOT8
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5071417226311006,-0.9989339605480821,0.46875,0.9717910901548529,1.0,5/28,21.63%,P2RY12;TEK;TGFB1;PDGFRB;FLT1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.4307246795413882,-0.9989175537858328,0.4189189189189189,0.9712653254477689,1.0,25/106,19.62%,MEF2C;EPHA4;CEACAM1;WTIP;LRRK2;KNDC1;ZDHHC15;HECW1;CDK5R1;SIPA1L1;PAK3;CHN1;CLDN4;NEDD4L;BMPER;PID1;TGFB1;EFNA5;WARS1;CRB2;CDK5;PLXND1;ZMYM6;BCL6;EPHB3
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.5926616596699403,-0.9986562826588861,0.5223880597014925,0.9715139215087796,1.0,3/10,28.27%,ZWILCH;MTBP;SPDL1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.512240965308213,0.9981915117502438,0.4444444444444444,1.0,1.0,3/17,4.58%,SLC22A2;SLC25A29;SLC47A1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.42855425684603526,-0.9978568983974218,0.38666666666666666,0.9731325385183808,1.0,21/93,20.11%,CLGN;PCSK4;HTR5A;DBF4;NOS1;NCAPH;CDKN3;RFC4;ZC2HC1C;IL12RB2;NEFH;SCG3;KIF2C;OAZ3;CCT6B;EZH2;GAD1;STRBP;SYCP1;MEP1B;PHF7
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.40169267078007215,0.9975107297242478,0.3103448275862069,1.0,1.0,2/59,0.43%,NGF;BCL2A1
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.5703496360456937,0.997458158790584,0.48717948717948717,1.0,1.0,1/8,19.48%,CLN3
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.6067350883832046,-0.997250423063148,0.5573770491803278,0.9742775992108783,1.0,5/10,37.54%,ATG10;APOE;PORCN;PIK3C3;UGCG
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.5503781462173639,-0.9970743222405006,0.5,0.9740639697813195,1.0,9/18,28.29%,PARP9;NNMT;KYNU;HAAO;PARP10;NMNAT2;NAPRT;NMNAT3;QPRT
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.59902029063152,-0.9969762570703361,0.5166666666666667,0.9737824794336788,1.0,4/8,24.84%,LAPTM5;LILRB1;WNT5A;SEMA7A
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5390448666176688,0.9967479183796175,0.43333333333333335,1.0,1.0,4/10,22.92%,SMDT1;MCUR1;MAIP1;MCUB
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5135876601584353,-0.9967273574125732,0.5277777777777778,0.973887057176042,1.0,5/22,5.87%,F8;EDN1;SERPING1;F3;A2M
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5766738926873506,-0.9966154259360901,0.47619047619047616,0.973617338622401,1.0,1/11,2.05%,PARP9
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.45180937931109266,0.996475095268353,0.42857142857142855,1.0,1.0,7/62,7.25%,NGF;GPR143;PIK3C2G;FGFR1;IGF1R;PLCE1;PLCD3
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.5162137403358331,-0.9964742576578475,0.5423728813559322,0.973540579145166,1.0,6/24,15.07%,TGFB2;AR;TGFB3;CAV1;ATP1A1;TGFB1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.62065494251028,-0.9961092099080795,0.5087719298245614,0.9739282483719397,1.0,1/7,8.43%,RIN3
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.5955362558597699,0.9960591120264756,0.5208333333333334,1.0,1.0,4/5,39.49%,WDR70;CTR9;CDK9;RNF20
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.43960018271911433,-0.9959982678080469,0.410958904109589,0.9737042535400228,1.0,12/69,9.07%,ANGPT1;FSTL1;PCOLCE;ADAMTS5;ACTA2;FAP;COL4A1;SERPING1;AQP1;THY1;TEK;LMOD1
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),0.6678995271905113,0.9956375814929597,0.5476190476190477,1.0,1.0,3/5,29.21%,ADCY6;NPR3;TRPV5
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.46714412779116543,0.9953470767826293,0.39473684210526316,1.0,1.0,2/15,5.48%,TNNC2;PLCE1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5101479781873922,0.9953196001899604,0.43243243243243246,1.0,1.0,3/18,19.46%,RGPD4;IPO5;CBLB
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.6256612055735106,-0.9951973623193593,0.45614035087719296,0.975233897301332,1.0,2/7,22.74%,PTN;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6087880227208657,0.9951841376418945,0.47619047619047616,1.0,1.0,1/7,5.14%,EIF4E2
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6087880227208657,0.9951841376418945,0.47619047619047616,1.0,1.0,1/7,5.14%,EIF4E2
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.6422301118659468,-0.9951062085837646,0.5084745762711864,0.974879388479891,1.0,1/6,11.40%,HOOK1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.5597671561815295,0.994966098572761,0.6111111111111112,1.0,1.0,3/10,11.79%,WASHC2A;RAB35;MICALL1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.3868799619432385,0.9946748321185389,0.45161290322580644,1.0,1.0,7/106,6.15%,CYP1A2;GPAT2;GLYAT;MSMO1;CROT;ALDH1A3;PDZD11
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.44690939999493345,-0.9945730707077232,0.45161290322580644,0.975756874454498,1.0,6/66,6.10%,TLR2;BIRC3;ITGAM;PIK3AP1;RFTN1;SFTPD
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.42745791331808525,-0.9945154923006315,0.4084507042253521,0.9753403663448985,1.0,14/88,11.34%,FSTL1;ADAMTS5;ACTA2;COX7A1;ASPN;COL4A1;PLSCR4;SYNPO2;AQP1;MYH11;TEK;LMOD1;MATN2;ADGRF5
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.6114751761012417,-0.9943493638003729,0.5,0.9752121300610129,1.0,6/11,23.33%,TTN;FHOD3;MYLK3;PDGFRB;NEB;NEBL
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.5556599261163344,0.9941874783009274,0.5,1.0,1.0,1/9,3.74%,OSBPL7
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.536167266282828,0.9941278279243889,0.4186046511627907,1.0,1.0,4/7,22.10%,H6PD;DGKQ;EGR1;PPTC7
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.5901599095006083,-0.9939274113006554,0.5441176470588235,0.9757607932084852,1.0,2/7,4.00%,VSIR;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.592172214383708,-0.9939232263401463,0.5178571428571429,0.9752153752041163,1.0,1/8,0.81%,SRGN
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.5936001140391309,0.9938872277258534,0.4634146341463415,1.0,1.0,3/9,20.47%,ESPL1;AXIN2;RB1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.6321513811396187,-0.9937947159261614,0.5789473684210527,0.974991674049816,1.0,3/7,24.76%,ADH4;ADH5;ACSS2
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.43312523365490097,-0.9936330209743738,0.4492753623188406,0.9749258659386705,1.0,29/99,15.54%,NR4A3;FGL2;SLA;PTPRC;ITGAM;PLAC8;LGALS3;AOAH;LAPTM5;CD53;HLA-A;CX3CR1;CR2;HLA-DMA;HLA-DPB1;PTAFR;SEPTIN6;AXL;HLA-DRB1;IGSF6;SLAMF8;TNFRSF1B;LY86;WDFY4;FCGR3A;SPI1;SCIMP;PPL;ETV6
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.6348232900002106,-0.9936113466959714,0.5151515151515151,0.9744100162134478,1.0,2/8,6.66%,IGSF1;DACT2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.46145727851836704,-0.9935380644626388,0.4714285714285714,0.9740578386698703,1.0,7/41,11.79%,UTRN;MEF2C;VAMP5;SGCE;CTF1;CAV3;SGCA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5295015787488297,0.9934722178886001,0.5,1.0,1.0,4/20,17.85%,UBC;UBB;GTF2H5;ERCC2
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.6296785465370818,-0.993469943791746,0.5689655172413793,0.9737060699220487,1.0,2/5,30.58%,TPRKB;OSGEP
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4999680531846301,-0.9934590596462932,0.45454545454545453,0.9731525085884808,1.0,9/24,22.68%,IL6R;PTPRT;PID1;SPI1;STAT1;STAT3;SELPLG;PTPN11;SOCS3
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.57380843394456,-0.9933382744092222,0.5,0.972350259792136,1.0,3/7,14.99%,SOX9;VEGFA;AGT
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.57380843394456,-0.9933382744092222,0.5,0.972350259792136,1.0,3/7,14.99%,SOX9;VEGFA;AGT
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.6250942322659528,-0.9933366472072003,0.4444444444444444,0.9717928381972507,1.0,2/5,15.46%,LRCH1;CD200
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.3933517268369359,-0.9933300763805787,0.46153846153846156,0.9712584765010303,1.0,10/180,8.74%,ANGPT1;LPL;SPARCL1;PPARG;COL4A1;ACADL;NMT1;STAT5A;PTGER3;MTARC2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.49960247374628414,-0.9932823934167314,0.421875,0.9707975386763686,1.0,12/32,13.10%,CR1;CD59;C1QB;CLU;C5;SERPING1;CR2;C3AR1;HLA-DRB1;C4BPA;PROS1;C1QC
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.505984010760576,-0.9932645724730016,0.5507246376811594,0.9703035504951147,1.0,6/37,16.11%,ANGPT1;STAT5A;VEGFA;PRKD2;TGFB1;RHOJ
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.6273161979794883,0.9931547330631497,0.5405405405405406,1.0,1.0,2/6,9.70%,NOX1;SLC26A3
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.5956755255869222,-0.9931434028714154,0.5172413793103449,0.9700674557777204,1.0,1/10,3.11%,FAP
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.6319873814975319,-0.9930668300401223,0.5079365079365079,0.9697589540389064,1.0,1/6,2.55%,MMP24
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.5149675900212313,-0.9928711911250425,0.515625,0.9697022465572367,1.0,5/30,6.24%,TLR2;PTPRC;PLSCR1;SFTPD;CAMK1D
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.421792610673409,-0.9928661771343298,0.45569620253164556,0.9691430180413444,1.0,29/126,16.65%,ITGB4;MMRN2;FSTL1;ROBO4;COX7A1;COL4A1;PLSCR4;NTN4;PROCR;BMX;AQP1;BMP6;WWTR1;PALLD;TEK;LMOD1;GASK1B;FGD5;SULF1;ADGRF5;CAV1;ITGBL1;EFNB2;TIMP3;NR1D1;GNG12;NNMT;PTPRJ;SYNPO
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.39120709047502095,-0.9928454172054706,0.4788732394366197,0.9686067584699675,1.0,41/280,12.37%,KANK2;FBLN1;IGFBP3;SFRP4;PPARG;IL26;IL12A;TP53I11;TGFB2;WDR6;ALDH1A2;FABP3;IRF1;FAP;TP73;NOX4;SSTR1;ADGRG1;SOX9;P3H2;DDAH1;MYO16;OGN;B2M;TMIGD3;AR;NELL1;CDKN3;E2F3;LDOC1;E2F1;RERG;IFI35;CDH13;INCA1;LYN;NMI;TGFB3;AQP11;BMPR1B;TRIM32
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.45884610338080556,-0.9927842008514158,0.46835443037974683,0.9682328746569346,1.0,9/69,12.26%,HLA-F;KANK2;CLU;CCN5;LRRK2;CHGA;LRPAP1;HTR2B;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.4781530028977399,-0.9926762053263517,0.4098360655737705,0.9679095931792252,1.0,9/28,12.32%,ISG15;MEF2C;ANO6;ADGRV1;BMP6;NELL1;SLC8A1;TGFB3;BMPR1B
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6666026515328636,-0.9925823334270661,0.5423728813559322,0.9675866837170253,1.0,1/5,8.54%,POLR3H
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.5870678439981996,-0.9925739119342869,0.5,0.967074825545483,1.0,4/14,12.16%,SLC5A2;SLC8A1;SLC9C1;SLC9C2
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.4610998975929784,0.992021534610886,0.41025641025641024,1.0,1.0,1/19,0.89%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.36696724180106927,0.9919896616777855,0.3181818181818182,1.0,1.0,42/251,13.41%,NGF;TNFRSF8;USP27X;NUPR1;AIFM2;HMGB1;UBC;VAV1;KLF11;SCRIB;TNFAIP8;SAP18;FANK1;MCF2L;NCSTN;HMGA2;SPHK2;SLIT2;IP6K2;BAK1;ATF4;C3ORF38;ABL1;PTGIS;TCTN3;CRADD;PTPA;PIDD1;CASP9;RYBP;ITGA6;PRR7;UBB;RRP1B;MAPK8;CCAR1;KNG1;LATS2;EPHA7;PRMT2;BCL10;TRIM35
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.43732288928121726,0.9919810334708815,0.43902439024390244,1.0,1.0,9/39,13.67%,ZDHHC16;FREM2;ADAMTS18;MEIS1;CEP290;ABCB5;PBX4;PBX3;HES5
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.5431796375138742,-0.9917991054149419,0.559322033898305,0.9686003594786049,1.0,2/13,8.98%,P3H2;OGFOD1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4317340861108378,-0.9915505018008977,0.5342465753424658,0.9687169951230739,1.0,26/114,13.10%,SEMA3E;CBLN2;C1QB;MUSK;NRCAM;L1CAM;GPM6A;UNC13C;LRRC4;NTNG1;LRRK2;PCDHB11;GRM5;CX3CR1;SNCB;CACNB1;PCDHB4;SLC8A3;CYFIP1;PAK3;GPC6;PCDHB9;CACNB2;LRFN5;SLITRK3;C1QC
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5562222277337763,-0.9914170440773136,0.5384615384615384,0.9685388884949558,1.0,6/14,17.99%,PPARG;MEF2C;PRKG1;TGFB3;CDKN1A;TPM1
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.6245915572212927,-0.9913150578890707,0.5961538461538461,0.9681665451619379,1.0,2/5,13.52%,SLC23A1;SLC2A2
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.4433821008966878,-0.9909622437721956,0.5342465753424658,0.9686108130698783,1.0,5/56,5.53%,FSTL1;PCOLCE;ACTA2;COL4A1;DKK3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.3920420797378285,-0.9909204311852827,0.49382716049382713,0.968205560722269,1.0,50/217,20.23%,PPP1R17;ZIC4;GLIS2;NRCAM;ITGAM;COL4A1;LOXL3;TGFBR2;NMUR2;ADGRG1;SOX9;ROBO2;NPTX1;DCLK1;RPS6KA6;DCX;SLC23A1;ZFHX2;CX3CR1;BTD;DDIT4;EMX1;SH3GL2;SLC8A3;GRIK1;ASIC2;GRIN2B;CDK5R1;ADGRL2;TPP1;TAGLN3;CHST8;PAX6;GRIN2D;PTPRZ1;CNTN4;ATP6AP2;NHEJ1;POU6F1;MACROH2A2;CA10;STAT3;CDK5;NDRG4;SERPINI1;SHROOM2;ALDH5A1;SEMA6B;EIF2B2;SETD1A
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.6455550041532947,-0.9907490886831056,0.6290322580645161,0.9681002519243032,1.0,1/9,22.07%,RALB
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.44844944981946233,-0.9906503233323846,0.44776119402985076,0.9677955250738329,1.0,17/71,14.65%,BAIAP2;GAP43;CCK;NRCAM;L1CAM;SLITRK5;NTNG1;SLITRK4;GRM7;CDK5R1;NREP;PAK3;RAB3A;NEFH;SLITRK3;CNTN4;RTN4RL2
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.5912070652744346,-0.9905039401028866,0.5423728813559322,0.967624096520797,1.0,3/9,10.43%,VIL1;CARMIL2;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.41133083466449116,-0.9904351038872087,0.47761194029850745,0.967248017159504,1.0,24/130,18.12%,FBLN1;IGFBP3;PTPRC;NLRP12;CEACAM1;LRRK2;TERF2IP;WWTR1;DDIT4;THY1;SH3GL2;UBASH3B;LYN;CALM3;CAV3;CAV1;PID1;PTPN13;TGFB1;WARS1;DMTN;DBNDD1;CAMK2N2;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.6223867342362476,-0.9902590562206968,0.5084745762711864,0.9671324297603405,1.0,1/7,14.16%,PID1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.4705687450550381,-0.9898816769652594,0.45,0.9675368016557545,1.0,7/31,11.84%,LPL;DGKD;DGAT2L6;DGKB;DGAT1;CAV3;CAV1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.599592368383043,0.9898179339767369,0.4864864864864865,1.0,1.0,3/9,10.10%,HSPA1A;SACS;HSPA1B
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5865789055743613,-0.9895862404303364,0.5094339622641509,0.9678578081258404,1.0,1/7,4.64%,NOS1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.4669379125322431,-0.9894861082091149,0.4507042253521127,0.9675874051758008,1.0,7/54,13.49%,YBX3;CLU;BCL2L2;LRRK2;XBP1;TRIM32;NOL3
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.6624099437017812,-0.9891937546325756,0.609375,0.9679356198617748,1.0,2/6,24.24%,GPR37L1;ADRB2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.4550052826137581,-0.9888839381576484,0.5,0.968233780463303,1.0,14/58,14.59%,DPEP2;EPSTI1;SLA;PTPRC;GMFG;ARHGAP15;SELL;CD53;CXCR6;IL16;IKZF1;ARHGAP25;SKAP1;CD27
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5583480019953737,0.9888504657842583,0.4418604651162791,1.0,1.0,2/8,4.75%,CD247;TGM1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6278883968274697,-0.9888257963632501,0.5254237288135594,0.9677706237812678,1.0,3/7,17.47%,CAV3;CAV1;FGF13
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.48728000128454635,0.9886596968858952,0.40540540540540543,1.0,1.0,12/31,26.94%,TNKS2;PKIB;MAP2K7;ATR;HNRNPA2B1;NAF1;CCT8;CCT2;CCT3;CCT6A;ACD;MAP3K4
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.575787348667677,0.9886027967224171,0.4722222222222222,1.0,1.0,1/10,6.68%,ATG9A
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.3976740870776506,0.9884966408751887,0.41379310344827586,1.0,1.0,2/57,1.76%,GABRE;GABRR1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5547444497016388,0.9884910554835321,0.5263157894736842,1.0,1.0,2/9,5.75%,CASQ2;CLIC2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5547444497016388,0.9884910554835321,0.5263157894736842,1.0,1.0,2/9,5.75%,CASQ2;CLIC2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.4813627878358116,-0.988296821583649,0.5,0.9686361917326627,1.0,9/59,10.00%,SHMT2;ALDH1A2;APIP;RYR3;SAMHD1;B2M;HCN1;GRIN2B;HLA-DRB1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.4681844892485625,-0.987667705481904,0.5,0.9697431295036386,1.0,10/32,21.31%,SEMA3E;MET;SEMA3D;SEMA4B;PLXNA2;PLXNA4;SEMA4G;PLXND1;SEMA6B;SEMA6A
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5700312726432498,0.9876464380499407,0.5,1.0,1.0,3/11,12.18%,CA6;TAS2R40;RTP5
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.5686993018722369,0.9874579436842332,0.5,1.0,1.0,2/6,25.34%,NFAM1;SLC39A10
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.4715271207340754,0.9874419681599262,0.4444444444444444,1.0,1.0,3/35,3.00%,RFWD3;TONSL;OOEP
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.43855957412488933,-0.9872715770964293,0.417910447761194,0.9702983160420375,1.0,8/75,6.64%,ITGB4;LOXL4;TGFB2;COL4A1;LOXL3;TLL1;P3H2;COL11A1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5161257793404559,-0.9872477195218368,0.4714285714285714,0.9697800209718738,1.0,9/26,23.93%,HEY1;GATA1;E2F1;NFKBIA;MAD2L2;MDFI;HEY2;ZNF675;TFAP4
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5428065016045303,-0.9872255443726888,0.515625,0.9692733118875086,1.0,3/11,19.44%,EGFR;TGFB1;ESR1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.4341778934929565,-0.9871229922425679,0.4852941176470588,0.9690254689740699,1.0,9/57,12.76%,NR4A3;KLF9;MEF2C;ROBO2;GATA1;AR;XBP1;CAV1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.44360284896806595,-0.9870876178586951,0.48333333333333334,0.9686021492553035,1.0,11/66,11.62%,MCTP1;CLU;EPHA3;FAP;CARMIL2;LGALS3;BMP6;AR;CARMIL1;DNAJB1;VEGFA
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.619142947923669,-0.9867084928886003,0.5172413793103449,0.9690795584306628,1.0,2/8,12.85%,NEFH;MAP2
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.4828441331975565,-0.9866587441779548,0.5147058823529411,0.9687389809392989,1.0,12/59,15.07%,TGFB2;TTN;EDN1;CADPS2;FRMD4A;BMP6;RAB27B;RAB3A;KCNB1;TGFB3;MYH10;TGFB1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.4027004687901408,-0.9864322108873527,0.44285714285714284,0.9688922687046096,1.0,32/176,22.77%,ROR1;TNFRSF1A;BIRC3;TRIM5;NLRP12;TRIM22;CARD11;APOL3;TERF2IP;RHOC;GJA1;HLA-DRB1;NOD1;TRIM25;HTR2B;TRIM32;ALPK1;STAT1;NR1D1;PLK2;CX3CL1;RHOH;ESR1;TIRAP;PER1;TRIM13;WLS;ZDHHC13;TRAF5;TLE1;WNT5A;TNFRSF10B
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.519032602570369,-0.9864149718738403,0.4852941176470588,0.9683768225947335,1.0,1/22,0.92%,TLR2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.5402777562981723,0.9863843686006983,0.5121951219512195,1.0,1.0,3/12,14.06%,FOLH1B;ICMT;AGTPBP1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.43521425512329465,-0.9862892610197982,0.547945205479452,0.9681577123588408,1.0,19/77,11.15%,FSTL1;ADAMTS5;SFRP4;ACTA2;FAP;ASPN;COL4A1;SYNPO2;ECM2;SEMA3D;AQP1;MYH11;GJA1;THY1;TEK;LMOD1;SULF1;PRKG1;RUNX1T1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.6285966995355127,-0.9859192073757377,0.5370370370370371,0.9685026520151527,1.0,4/6,29.88%,GRIN2B;VPS35;APOE;FYN
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.36859528524408286,0.9856150434814909,0.42857142857142855,1.0,1.0,23/182,12.12%,CXCR4;DHFR;NUPR1;SQLE;SC5D;MTHFD2L;DHCR24;HMGCS1;SLC7A11;CYB5B;HPRT1;HMGCR;PSMD13;GGA2;GLA;TUBG1;SERPINH1;CCNG1;IDI1;PGM1;LTA4H;MTHFD2;NIBAN1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.5226792568127501,-0.985502055386452,0.5538461538461539,0.9690441476466108,1.0,3/12,10.39%,TIMP1;GJA1;SULF1
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.5811098536564719,0.9853049601631446,0.48717948717948717,1.0,1.0,1/7,16.63%,STAMBP
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6182679443650801,-0.9852271243737731,0.5538461538461539,0.9693225857220601,1.0,3/8,10.08%,VIM;LDOC1;NOD1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.49741715018728505,-0.9851129607461752,0.5,0.9691143654459122,1.0,11/32,13.10%,CR1;CD59;C1QB;CLU;C5;SERPING1;CR2;C3AR1;C4BPA;PROS1;C1QC
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.40853065129471117,-0.9850851993298142,0.5405405405405406,0.9686551529706521,1.0,36/161,20.34%,LPL;NUDT11;PTPRC;HDHD2;PLPPR5;IMPA2;PLCB3;INPP4B;NUDT4;LRRK2;PLPPR3;PLAAT4;PFKFB2;PLCB1;PLCB4;PTPRB;HTR2B;ITPKA;TNK2;INPP5D;PGK1;TGFB1;PIK3CB;PFKM;ITPK1;PPP3CA;PLB1;PLPPR1;STAT3;PRKCG;CDK5;PPP1CA;PLCG1;GPI;GPX4;ALPL
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.4046129030326244,0.9850564572951646,0.40625,1.0,1.0,2/43,1.76%,GABRE;GABRR1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.642699385649542,-0.9850276188259434,0.5,0.9682783339036978,1.0,2/7,6.19%,PRELP;OGN
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.5307829534637882,0.9849368106776568,0.5121951219512195,1.0,1.0,1/9,1.95%,TRARG1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5046787724351538,0.9848848721736191,0.45161290322580644,1.0,1.0,4/18,6.57%,DPEP1;CRHBP;PDE4B;FBP1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.5778685139248507,0.9848131843590768,0.4666666666666667,1.0,1.0,2/8,11.19%,WNK4;COMMD1
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.6293905319135387,0.9846365813136545,0.5384615384615384,1.0,1.0,3/6,26.85%,AXIN2;RMI2;MSH3
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.48271527134310294,-0.9846017834709622,0.5,0.9688838942253314,1.0,3/31,11.29%,NEFL;SYBU;AP3B2
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5751270662359477,0.9845497306289119,0.5208333333333334,1.0,1.0,1/8,4.39%,ST3GAL1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.6145148389952229,-0.984402322654561,0.5362318840579711,0.9687254600198095,1.0,2/10,14.73%,TTN;ZFPM1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4836238581104041,0.9842131276258922,0.34210526315789475,1.0,1.0,7/23,18.85%,UBC;UBB;ITCH;UBE2N;MAP3K7;IRAK2;TAB3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.6621927767834493,-0.9841266877656656,0.5614035087719298,0.9688451115234137,1.0,2/5,32.80%,TMEM33;ATL3
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.5070174854496747,-0.9839101146310288,0.49295774647887325,0.9689047213382163,1.0,2/18,6.61%,CCND1;RAB11A
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.6025222996885532,-0.983891640997359,0.543859649122807,0.9683981881379022,1.0,4/8,28.37%,SLC2A2;SLC2A5;TJP2;KCNQ1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.42384514224400405,-0.9838534338399498,0.4861111111111111,0.9679466238817772,1.0,27/123,19.34%,ROR1;PTPRC;RIT2;PAK5;TRIM5;APIP;LAPTM5;CEACAM1;TEK;HLA-DRB1;PAK3;LYN;CAV3;CAV1;EPHB1;EGFR;CAV2;GPR37L1;ATP6AP2;SYK;PTPRJ;CX3CL1;RASGRP1;FAM83D;NTRK3;GFRAL;GRM4
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.42955842788688353,-0.9838481396988911,0.4794520547945205,0.9674140128244888,1.0,13/66,16.68%,RND2;FBN3;NKAIN1;RIMS4;CACNA1B;TMEM200C;MEX3A;GPC3;ZNF663P;INA;GABRB3;UNC5D;POU5F1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4447404233606562,0.9836817924779503,0.42857142857142855,1.0,1.0,1/37,0.11%,BACE2
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6590744062170028,0.9835957143200805,0.5531914893617021,1.0,1.0,3/5,28.88%,PRIMPOL;SIRT7;DDX21
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.6965111634555039,0.9835578762046252,0.5,1.0,1.0,2/5,3.95%,HMGB1;RUNX1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6356557817781724,-0.9834209934021838,0.5,0.9679687745546509,1.0,1/6,5.72%,DENND3
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.46414859492344457,-0.9832826926746183,0.47297297297297297,0.9678386297412978,1.0,12/48,10.46%,HLA-F;GBP2;SLA;HLA-E;PTPRC;SELL;AOAH;CD53;HLA-DPB1;IL16;IKZF2;GPR183
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.46457036477840974,0.983262490672263,0.4166666666666667,1.0,1.0,7/39,18.48%,PINX1;DKC1;GREM1;PKIB;MAP2K7;MEN1;NAF1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.5721106955031324,-0.983205199769802,0.5072463768115942,0.9674589527979273,1.0,2/10,6.32%,ACADL;CEACAM1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.6392352165097663,0.9829298964850647,0.5348837209302325,1.0,1.0,3/6,23.73%,TENT4B;TUT4;LIN28B
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.5545071868779899,-0.9827804496146366,0.4857142857142857,0.9681592250274327,1.0,5/16,20.39%,LGALS3;PLN;CAV3;GRM6;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),-0.6610340999211903,-0.9824181276943618,0.5849056603773585,0.9685984712295646,1.0,1/5,7.49%,KCNMA1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.4816874373185387,-0.9824075520041294,0.4383561643835616,0.9680943770419594,1.0,4/25,11.26%,PDZK1;ITGAM;CEMIP;KCNB1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6386865992456486,-0.982256605752351,0.6111111111111112,0.9680186823269485,1.0,1/6,12.38%,APAF1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.490044854583203,0.9820810288986451,0.4857142857142857,1.0,1.0,4/26,6.02%,NDC80;ESPL1;DYNLT1;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.5252026039350985,0.9820686259149675,0.5,1.0,1.0,3/13,5.23%,F2;ADAMTS18;PDGFA
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.6372441986237387,-0.9819505666714538,0.5686274509803921,0.9682299407460836,1.0,3/7,17.41%,MEF2C;BMPR1B;TRPV4
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.5199803514273147,-0.9819237571597745,0.46875,0.9677485356505171,1.0,5/25,13.39%,CHST1;PRELP;OGN;CHST2;B4GALT6
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.5369365806816503,-0.9818427087850409,0.5522388059701493,0.9674298652132192,1.0,3/17,19.38%,CYFIP1;CDH13;RHOH
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4990229782164023,-0.9815683580935086,0.5303030303030303,0.9675654488142168,1.0,5/29,15.78%,TP73;NMT1;E2F1;YWHAH;BBC3
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.6722411840262842,-0.9813339603201483,0.6,0.9676738784864194,1.0,1/5,8.42%,SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.4407925733989484,-0.9811124303471678,0.5588235294117647,0.9677713922220578,1.0,21/93,15.68%,ROR1;PTPRC;CENPE;EPHA3;SPDYA;MUSK;EPHA4;MET;CSF1R;TEK;AXL;HLA-DRB1;EPHA6;EPHB6;EPHB1;EGFR;TIE1;DDR2;EEF1A2;RAD50;CDKN1A
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4880817512120659,-0.9810628774338159,0.49230769230769234,0.9673563178000896,1.0,5/33,19.44%,KDM3A;AR;TRERF1;NR3C2;ESR1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.6242844733552702,0.9808381941267273,0.4864864864864865,1.0,1.0,3/8,9.89%,HMGB1;RAB7B;PTPN22
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.5533486721726515,0.9806928941865118,0.4166666666666667,1.0,1.0,3/10,26.25%,CYP2C8;CARNS1;FADS1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.4867833768717961,0.9806481671584036,0.4864864864864865,1.0,1.0,11/19,31.59%,CROCC;ARHGAP35;ZMYND10;SAXO1;CEP120;HAP1;MARK4;CCDC88A;HTT;SEPTIN9;ENTR1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.4485400404821973,0.9805268899934714,0.4838709677419355,1.0,1.0,10/35,17.33%,TSR1;DCAF13;NAT10;SRFBP1;RIOK1;RIOK2;RRP36;UTP3;NOL11;UTP6
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.4547539842120819,-0.9803700307176243,0.47692307692307695,0.9687209063732745,1.0,16/78,18.94%,PTPRC;CEACAM1;WWTR1;THY1;SLC8A3;UBASH3B;SLC8A1;PTPRB;CAV3;CAV1;PTPRT;CDKN1A;WARS1;DBNDD1;CAMK2N2;SH3BP5
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.5900176042667745,0.9803680321487022,0.53125,1.0,1.0,1/9,1.52%,LCK
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.3885991529016354,-0.9803118046063014,0.5454545454545454,0.9683542621814247,1.0,56/377,16.71%,GPAT3;ARHGAP18;AKAP12;BIRC3;RIT2;PAK5;ARHGAP4;TP73;ARHGAP15;VAV3;NLRP12;PRKAR1B;KALRN;RMI1;RPA3;RFC3;A2M;RAD9A;CEACAM1;LRRK2;ARHGAP31;RHOC;ARHGDIG;ARHGAP28;DDIT4;RFC4;TEK;BST1;TAF10;CDK5R1;PIP5K1B;PAK3;LYN;CHN1;VEGFA;NGEF;EGFR;ARHGAP25;RAC3;PRKD2;DEPDC1B;OPHN1;WRN;TP53INP1;PTPN13;ATP6AP2;RASGRF2;RAD50;ARHGAP10;ITGAV;SRGAP1;BRCA1;RHOJ;PRKAB2;NFKBIA;PRDM1
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.6650419023854072,-0.9801682535399983,0.5873015873015873,0.9682519163178502,1.0,3/5,32.49%,CHRM1;HES1;PRKCH
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.5916769992450892,0.9799523009094431,0.5333333333333333,1.0,1.0,1/9,0.85%,PDE3A
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.44728459450443386,0.9798149127843752,0.41935483870967744,1.0,1.0,8/29,20.57%,PRDM5;SMYD1;DPY30;ASH2L;KMT2B;WDR5B;MEN1;KMT2D
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.44881957703199826,0.979720992917807,0.44,1.0,1.0,3/33,5.70%,NGF;FGFR1;MMD2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.4118113462900637,-0.9796187264146314,0.4714285714285714,0.9691615992434596,1.0,16/92,15.68%,IRGM;CCND1;CSF1R;CCNJL;CDKN3;THY1;SLC8A3;SLC8A1;CDK5R1;CAMK1;CALM3;CDK5R2;MTCP1;CCNF;SERTAD1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.4863192056700423,-0.9793383425888458,0.4696969696969697,0.969257961421781,1.0,4/27,15.99%,SEMA3E;PLET1;RASA1;DMTN
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.5583657928102175,0.9791960386248785,0.43243243243243246,1.0,1.0,5/10,26.39%,ATF4;ZBTB1;DDX5;HSF1;TFCP2
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.5527605834937832,-0.9790369469388243,0.532258064516129,0.9695746551148683,1.0,5/18,10.00%,VSIR;CR1;LAPTM5;AXL;HLA-DRB1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.5310099242562718,0.9785957086397189,0.4594594594594595,1.0,1.0,3/25,12.06%,SF3A3;PRPF4;MPHOSPH10
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.5435053943302881,0.9781493815018443,0.5357142857142857,1.0,1.0,2/18,4.58%,SLC22A2;SLC47A1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.5401406224731218,0.9780594540722443,0.55,1.0,1.0,4/8,27.10%,ABHD17A;ABHD10;LYPLAL1;LYPLA1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.5401406224731218,0.9780594540722443,0.55,1.0,1.0,4/8,27.10%,ABHD17A;ABHD10;LYPLAL1;LYPLA1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.5184634831486221,-0.9777912490379291,0.5211267605633803,0.9725240445189223,1.0,2/25,5.10%,RHBDF2;STXBP5L
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5020068238952997,-0.9775576374113576,0.49230769230769234,0.9722134262078495,1.0,9/20,30.39%,PGK1;PFKM;GPI;GAPDHS;PFKL;ALDOB;TPI1;PGAM2;PFKP
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5020068238952997,-0.9775576374113576,0.49230769230769234,0.9722134262078495,1.0,9/20,30.39%,PGK1;PFKM;GPI;GAPDHS;PFKL;ALDOB;TPI1;PGAM2;PFKP
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.5406237557422389,0.9772120410284783,0.5116279069767442,1.0,1.0,2/13,5.88%,CMPK1;AK8
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.5858371634900734,-0.9770705453916434,0.5272727272727272,0.9730266917264343,1.0,3/7,21.27%,SULF1;TBC1D8B;TMEM63C
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.47440859618895603,-0.9769209753367724,0.5,0.9728578720822709,1.0,15/42,24.85%,FIGNL1;TERF2IP;PPP4C;POLQ;RADX;MAGEF1;KLHL15;MAD2L2;RPA2;FANCB;WDR48;SHLD2;WAS;MMS19;TIMELESS
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.592236740760145,-0.9767526874945459,0.5555555555555556,0.9722744293140139,1.0,1/9,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.592236740760145,-0.9767526874945459,0.5555555555555556,0.9722744293140139,1.0,1/9,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.5747278450232955,-0.9766653428111196,0.5454545454545454,0.9719189584434538,1.0,6/11,33.99%,NCBP1;ZFP36L1;LEO1;DHX36;NCBP2;PAF1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.4529215586935285,-0.9766157757593253,0.5138888888888888,0.9715371312826246,1.0,9/55,17.72%,PTPRC;CEACAM1;WWTR1;THY1;UBASH3B;CAV3;WARS1;DBNDD1;CAMK2N2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.5782592798377553,-0.9765952779755528,0.515625,0.9705502970575941,1.0,2/11,6.52%,STAT5A;IL7
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.5782592798377553,-0.9765952779755528,0.515625,0.9705502970575941,1.0,2/11,6.52%,STAT5A;IL7
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.5743934820157338,0.9763739173273547,0.47619047619047616,1.0,1.0,3/7,16.00%,NASP;RBBP4;CHAF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.5743934820157338,0.9763739173273547,0.47619047619047616,1.0,1.0,3/7,16.00%,NASP;RBBP4;CHAF1B
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.40355826182365456,-0.9762445529218802,0.4264705882352941,0.9709442962230647,1.0,27/162,16.04%,ANGPT1;IRGM;ALG10B;MUSK;FGF22;SOX9;HGF;CCND1;CSF1R;LRRK2;EFNA1;TERF2IP;KNDC1;TEK;HLA-DRB1;LYN;CAMK1;CALM3;VEGFA;EGFR;FGF7;FLOT1;ATG10;TGFB1;EFNA5;RAMP1;NNMT
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.6147781139085771,-0.9761618226016999,0.5409836065573771,0.9705905384106325,1.0,4/9,9.84%,RAB11A;STX3;GRIP1;GRIP2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.38394447133327086,-0.9760088375088997,0.5454545454545454,0.9704719138182284,1.0,32/248,16.09%,FIGNL1;IL12A;TGFB2;PTPRC;BIRC3;WDR6;TSPYL2;SMIM22;IRF1;FAP;TP73;TRNP1;CENPF;ID2;SOX9;CITED2;CCND1;CRLF3;CDKN3;CKS2;BRINP1;GADD45B;LIN54;TRIM32;DAPK3;TP53INP1;NOTCH2;TGFB1;PPP1R15A;SETMAR;CDKN1A;BRCA1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.5378035104340219,-0.9757928886081767,0.515625,0.9705880340099168,1.0,6/20,18.59%,MMP24;SOX9;SLC8A3;PTPRZ1;STAT3;CDK5
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.5149731368899968,-0.9757010912373892,0.5245901639344263,0.9702617023740275,1.0,2/22,5.23%,SFRP4;SPEF2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.4983321711194353,0.9756987785646534,0.5,1.0,1.0,1/14,0.31%,GPC4
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.45810254145831597,0.9756163450969414,0.53125,1.0,1.0,5/30,16.58%,ZDHHC16;ZDHHC12;ZDHHC14;ZDHHC3;ZDHHC7
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.5721368478169897,0.9756161653495709,0.5,1.0,1.0,1/5,4.29%,PLD1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.6451398842217801,-0.9753708331511426,0.5192307692307693,0.9706281453083255,1.0,1/6,6.54%,LRRK2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.6076436792017094,0.9752711707400037,0.5909090909090909,1.0,1.0,2/7,8.62%,WNK4;ATP1B1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.6517906560360204,-0.9751301142851304,0.6101694915254238,0.9706321978441576,1.0,2/6,20.39%,PLAT;PDGFRB
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.37549225278139287,0.9750936447457847,0.5357142857142857,1.0,1.0,47/164,21.95%,POP5;RCL1;BYSL;ERI1;RSL1D1;DCAF13;NAT10;MDN1;EXOSC8;SRFBP1;TFB1M;PIH1D1;NOL8;RRP12;PELP1;RIOK1;DKC1;ESF1;RRP1B;RPL18A;NOLC1;RIOK2;MPHOSPH10;RRP36;UTP3;WDR74;KRR1;RPL23A;NOL11;EXOSC7;UTP6;RPL3;NSA2;RPL11;DIS3;DDX10;WDR36;RPL13;EXOSC5;RPL8;RPL21;RPL5;NOP56;POP4;RPL32;RPL7;RPS16
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.5952786184461891,0.9748327084230396,0.5714285714285714,1.0,1.0,2/8,6.37%,AADAT;CYP2E1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.5256248391441907,0.9748139941620061,0.6060606060606061,1.0,1.0,2/13,7.65%,SPHK2;ATPSCKMT
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4361360091636998,-0.9747965910754695,0.527027027027027,0.9709448303193376,1.0,18/94,14.10%,SHMT2;ALDH1A2;GLRA3;APIP;RYR3;CARD11;SAMHD1;B2M;NINJ1;POLQ;HCN1;KCNC2;ADCY8;STEAP4;PRMT8;AQP11;AQP4;RNF213
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.449426153058564,0.9744215720064296,0.4782608695652174,1.0,1.0,9/24,29.41%,MTMR2;MTMR11;INPP5F;MTMR12;SYNJ2;INPP5J;MTMR10;MTMR9;MTMR3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6018589979672079,-0.9742237594436087,0.5671641791044776,0.971868631800006,1.0,1/10,5.82%,MAP3K5
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.5858111631594587,-0.9741041692089955,0.5535714285714286,0.9716966156733002,1.0,3/8,21.27%,SULF1;TBC1D8B;TMEM63C
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4696433843611275,0.9740815376741856,0.40625,1.0,1.0,3/23,2.12%,CD38;LCK;SH2B2
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6031419157301581,-0.9739006494005106,0.5483870967741935,0.9716150865704494,1.0,3/10,18.31%,WTIP;ZFP36;STAT3
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.6347827682566127,0.973664931042181,0.5882352941176471,1.0,1.0,1/5,9.67%,ALDH7A1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.5345082967254398,-0.9736565093537451,0.5,0.9717194532176551,1.0,6/13,31.50%,SMPD3;SDC4;VPS4B;SDCBP;VPS4A;TSG101
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.44555593094369966,-0.9736008862141727,0.48214285714285715,0.9713037327717076,1.0,10/61,16.54%,NR4A3;BAIAP2;NCKAP1L;VAV3;WIPF3;CYFIP1;LYN;FCGR3A;SYK;PIK3CB
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.4723126860190878,0.973478605309613,0.5483870967741935,1.0,1.0,4/18,9.50%,SMIM20;COX19;COX10;FASTKD3
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.6615193716074396,-0.9734087860852005,0.603448275862069,0.9712861880365007,1.0,1/5,3.49%,CLDN16
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.6061305701656688,-0.9733778127573433,0.5573770491803278,0.9708128594276584,1.0,2/8,12.03%,HECW1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.4393849327385268,-0.9728229702896846,0.5671641791044776,0.9717914640703671,1.0,19/79,15.47%,LPL;TLR2;TNFRSF1A;P2RY12;PLSCR1;DDX60;NLRP12;BMP6;STX3;NINJ1;IL16;IFI35;NMI;LY86;IFNK;SCIMP;AGT;TGFB1;LY96
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.47847985599517956,0.9727605753066003,0.5428571428571428,1.0,1.0,5/30,12.35%,HSPA1A;BAK1;OPTN;HSPA1B;DAXX
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.6514609733772475,-0.9725769497409983,0.6382978723404256,0.971937802895084,1.0,3/8,15.46%,SOX9;LYN;CD200
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.5955865883576054,0.9725245760279181,0.5581395348837209,1.0,1.0,1/7,5.54%,NCSTN
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6511920249971302,0.9724042843513147,0.6341463414634146,1.0,1.0,1/5,16.32%,PIGT
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.47193382920707716,0.972084158505875,0.5121951219512195,1.0,1.0,2/19,3.31%,DPEP1;ENPEP
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3780872264296367,-0.9719885343418934,0.5205479452054794,0.9729940935097222,1.0,50/275,19.41%,ITGB4;NEFL;RND2;LOXL4;FIGNL1;TGFB2;STMN2;MYO7A;COL4A1;LOXL3;VIM;TLL1;P3H2;FIGN;ACTN1;COL11A1;MYH11;B2M;RHOC;MYO5C;LMOD1;CARMIL1;FURIN;CST3;HOOK1;TMOD1;ARHGAP25;COL21A1;SNCAIP;RAC3;DDR2;FAT1;MYO1H;KIF2C;P4HA3;KASH5;COL10A1;SIAH1;MAD2L2;TRPV4;FGF13;COL15A1;MYO1B;TPM1;ADAMTS14;COL19A1;CAMSAP3;SHROOM2;RHOH;CEP126
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.6630049248946008,-0.9719304483935347,0.576271186440678,0.972642500681192,1.0,1/5,5.60%,STAT5A
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.43126581102219963,-0.9718579845481999,0.5,0.9722860061169801,1.0,21/71,18.56%,TRPC4;NMUR2;ATP2B2;TUSC3;CACNA1E;RYR3;CACNA1B;SLC8A3;SLC8A1;CACNG3;SLC24A1;NIPAL2;CAV1;CACNG8;CDH23;CACNA1C;RAMP1;GRIN3A;TRPM2;TRPV4;CACNA1A
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.693060217553668,-0.9718425353389889,0.5645161290322581,0.9718242467849648,1.0,3/5,27.23%,MESP1;HEY2;HES1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.5305436936627298,-0.9715011913724855,0.59375,0.9722869571738577,1.0,4/19,17.18%,MUSK;LRRC4;DLG4;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.45089641800001146,0.971471869863805,0.5405405405405406,1.0,1.0,3/20,4.72%,CD38;EPHB2;TNFSF13B
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.5260421741674743,-0.9714556220956884,0.5,0.971862639109192,1.0,4/15,17.04%,DUOX1;ABCC9;STAT1;TRPM2
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.3947038097841219,-0.9706170079875842,0.5142857142857142,0.9733427172072575,1.0,16/118,17.16%,IRGM;RIT2;PAK5;ANGPTL7;CEACAM1;SLITRK4;NRG3;CDH13;WFDC1;PACSIN1;SNCAIP;OPHN1;AGT;OGFR;PRKCQ;MAD2L2
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.44376788789468635,0.969744510355644,0.3870967741935484,1.0,1.0,3/21,6.59%,DSCAM;SEMA5A;MEGF8
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.5703700161973914,-0.9694570848597499,0.5932203389830508,0.975838522453361,1.0,1/8,14.35%,ATG10
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.5723560692155396,-0.9693809260196741,0.5333333333333333,0.9755183309923007,1.0,2/10,7.12%,TLR2;B2M
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.5607601673391479,-0.9693585197291167,0.5076923076923077,0.9750247278530877,1.0,4/14,9.04%,IGFBP3;MEF2C;BOC;PLCB1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.41492314195744273,0.9693490050758289,0.44,1.0,1.0,6/43,7.77%,ICAM1;AGER;ABCC1;IGF1R;CHMP5;GRIN2A
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.4673563836549884,0.9692251847057831,0.4864864864864865,1.0,1.0,3/21,12.02%,MST1;FBP1;DGKQ
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.6309499423154117,-0.9690106313378698,0.6190476190476191,0.9749385443376241,1.0,2/5,19.13%,BRCA1;CDH1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.6309499423154117,-0.9690106313378698,0.6190476190476191,0.9749385443376241,1.0,2/5,19.13%,BRCA1;CDH1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5282307379289615,-0.9688568862055489,0.5606060606060606,0.9748350686889469,1.0,4/20,11.84%,PTPRC;THY1;CBLC;CAV1
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.612499354877499,-0.9687531457152162,0.56,0.974505782317533,1.0,1/6,17.16%,MAD2L2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.46799164909977814,0.9686365515864174,0.48717948717948717,1.0,1.0,9/27,20.57%,HDAC1;TLE2;ASH2L;SMARCA4;AXIN2;MEN1;TCF7L1;BCL9L;KMT2D
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.5919563321612027,-0.9686293712385163,0.5384615384615384,0.9743501418418827,1.0,3/10,10.08%,VIM;LDOC1;NOD1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.4844340376536986,0.9682713434538779,0.4166666666666667,1.0,1.0,4/14,25.40%,FHDC1;FAM171A1;RHOA;PDCD10
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.4844340376536986,0.9682713434538779,0.4166666666666667,1.0,1.0,4/14,25.40%,FHDC1;FAM171A1;RHOA;PDCD10
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.5280544956423487,0.96805469006134,0.5128205128205128,1.0,1.0,4/13,17.12%,PUS7;PUS1;DKC1;RPUSD2
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.4072128398583442,-0.9678838893006088,0.5333333333333333,0.9757324302283759,1.0,24/136,18.11%,RGS7;DOCK8;EPHA3;ARHGAP15;VAV3;EPHA4;LRRK2;RGS1;THY1;LRCH1;SIPA1L1;FGD5;PRKG1;CHN1;NGEF;CAV2;PLXNA2;EFNA5;PLXNA4;CX3CL1;RASGRP1;EZH2;RIC1;PLXNC1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.4970700482085197,0.9676865861256149,0.4878048780487805,1.0,1.0,1/10,1.95%,NT5E
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5112476475118362,-0.9676601485023338,0.5555555555555556,0.9757966042602642,1.0,6/18,21.31%,SEMA3E;SEMA3D;SEMA4B;SEMA4G;SEMA6B;SEMA6A
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.4915675539488854,0.9676156080054051,0.43243243243243246,1.0,1.0,3/20,8.73%,CMPK1;AK8;DCTD
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.62748392698149,-0.9668605355630288,0.5737704918032787,0.9775016567058783,1.0,4/6,36.73%,ATP23;TMEM70;OXA1L;ATPAF1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.613303615966547,0.9667765728284786,0.5581395348837209,1.0,1.0,2/5,9.89%,HMGB1;PTPN22
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4150287596117954,0.9665469860308835,0.41935483870967744,1.0,1.0,2/23,2.49%,CTNNA2;MBOAT1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.509854010790663,-0.9663771382475286,0.5606060606060606,0.9782250197361891,1.0,7/17,31.50%,SMPD3;SDC4;ATP9A;VPS4B;SDCBP;VPS4A;TSG101
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.5577820696391148,-0.9663422703982085,0.5666666666666667,0.9778007029642996,1.0,3/11,12.69%,CLU;LRPAP1;LRP1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.36624623773938725,0.9663006078128938,0.47619047619047616,1.0,1.0,35/233,11.99%,NGF;TNFRSF8;USP27X;AIFM2;HMGB1;UBC;VAV1;KLF11;SCRIB;TNFAIP8;SAP18;FANK1;MCF2L;NCSTN;HMGA2;SPHK2;SLIT2;IP6K2;BAK1;ATF4;C3ORF38;ABL1;TCTN3;CRADD;PTPA;PIDD1;CASP9;RYBP;ITGA6;PRR7;UBB;RRP1B;MAPK8;CCAR1;KNG1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.4637089325565681,0.9661991025632379,0.4482758620689655,1.0,1.0,2/27,4.56%,AGER;IGF1R
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.5030457145411532,-0.9660546328125378,0.4918032786885246,0.9780154104169873,1.0,1/15,2.05%,PARP9
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5806023024973168,-0.9660354413818908,0.515625,0.9775236582546762,1.0,1/9,4.60%,DBF4
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.5435228972949867,0.9651609374078334,0.5277777777777778,1.0,1.0,5/13,10.78%,F2;SERPINF2;RUNX1;SUCO;WNT4
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.5250920335021786,-0.9647899449493512,0.5645161290322581,0.9802322736651503,1.0,4/19,15.10%,KCNT2;ATP1B2;ATP1A1;KCNH2
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.6084495697632414,-0.9645347544145869,0.6142857142857143,0.9797702544155219,1.0,3/8,16.91%,ANK1;LIN7A;CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.6084495697632414,-0.9645347544145869,0.6142857142857143,0.9797702544155219,1.0,3/8,16.91%,ANK1;LIN7A;CRB2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.3918246417008899,-0.964406872336052,0.5,0.979544838426449,1.0,33/194,13.79%,ANGPT1;ROR1;IRGM;EPHA3;MUSK;FGF22;NCKAP1L;SOX9;EPHA4;HGF;MET;CCND1;CSF1R;LRRK2;EFNA1;KNDC1;PRXL2C;AR;TEK;PFKFB2;IFNA2;AXL;HLA-DRB1;EPHA6;LYN;EPHB6;VEGFA;EPHB1;EGFR;FGF7;TIE1;FLOT1;DDR2
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.490816275193644,0.9643468365828647,0.48717948717948717,1.0,1.0,4/16,14.92%,FOLH1B;ASPA;MSRA;SMS
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6209573739120069,0.9640638260742138,0.5675675675675675,1.0,1.0,2/6,18.71%,ANAPC1;CDC23
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6209573739120069,0.9640638260742138,0.5675675675675675,1.0,1.0,2/6,18.71%,ANAPC1;CDC23
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.42908161010343876,0.9639096798565507,0.47058823529411764,1.0,1.0,10/45,18.37%,HSPA1A;BAK1;DNAJB4;OPTN;HSPA1B;SERPINH1;DAXX;DNAJC4;ERP44;TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.5811022077361405,-0.9638474551357015,0.6153846153846154,0.9803161548879523,1.0,4/11,22.90%,FURIN;TNFRSF1B;SNX33;ADAM9
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.640165993110799,-0.9636284980648957,0.5689655172413793,0.9803931236733497,1.0,3/5,12.36%,TCN2;AMN;CBLIF
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3614293305962999,0.9635491341929548,0.4827586206896552,1.0,1.0,34/162,21.72%,U2AF1;PIWIL2;DICER1;M1AP;SF3A3;YJU2;PRPF4;SF3B2;PTBP1;TENT4A;KIN;RBM8A;RP9;DKC1;PDCD7;TENT4B;MPHOSPH10;SNRNP25;HNRNPU;SF3A2;HNRNPH1;SNRNP35;HNRNPA2B1;BCAS2;MAGOH;CELF1;RBM5;SNRPB;SF3A1;TSEN34;SRSF9;HNRNPC;HNRNPR;WBP4
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.6826472432131188,-0.9633298032680678,0.6140350877192983,0.9796291868995867,1.0,1/5,23.39%,UBA5
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.6826472432131188,-0.9633298032680678,0.6140350877192983,0.9796291868995867,1.0,1/5,23.39%,UBA5
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.6826472432131188,-0.9633298032680678,0.6140350877192983,0.9796291868995867,1.0,1/5,23.39%,UBA5
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.48068446974761647,-0.9632367320869522,0.578125,0.9793733542371643,1.0,2/37,2.51%,ARIH2;TRIM5
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.528140696226369,0.9630611582363611,0.48,1.0,1.0,5/19,4.97%,TNNC2;MYH4;MYH3;TPM2;ACTN2
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.528140696226369,0.9630611582363611,0.48,1.0,1.0,5/19,4.97%,TNNC2;MYH4;MYH3;TPM2;ACTN2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6044264393150842,0.9623952027105329,0.6046511627906976,1.0,1.0,3/6,30.91%,BAP1;USP15;USP7
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.47775263847205873,0.9623158361701083,0.4583333333333333,1.0,1.0,3/21,9.95%,TUBA1A;TUBA1C;CCDC88C
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.3996236551246159,0.9623048569000313,0.5161290322580645,1.0,1.0,13/68,8.36%,BACE2;LAMB3;MYOF;SH3RF2;ACADVL;ALDH1A3;ANXA2;PPP1R13L;TAX1BP3;MYO1C;S100A16;EPS8L2;CDC42EP5
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.5363199452353467,-0.962012743827917,0.5846153846153846,0.981926018349798,1.0,4/15,17.18%,ASTN1;CDK5R1;CNTN4;NRXN1
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.402628297665274,-0.9619782053022925,0.5324675324675324,0.9814821131584185,1.0,28/144,10.38%,PARP14;FGL2;EPSTI1;ISG15;PLSCR1;MX1;ISG20;DDX60;IFITM3;IRF1;PIM1;SERPING1;IFI44;PSMB8;HLA-A;IL7;SAMHD1;VAMP5;ST3GAL5;B2M;HLA-DMA;P2RY14;SP110;IFI35;HLA-DRB1;NOD1;XAF1;TRIM25
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.5165861212396867,-0.9619733162202805,0.5,0.9809659566228458,1.0,1/14,1.03%,WNT8B
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.492861371229299,0.961941932287425,0.5945945945945946,1.0,1.0,3/11,10.40%,GFI1B;RUNX1;IL17D
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.5796420314308928,-0.9618821350048636,0.5555555555555556,0.9807307240797957,1.0,4/12,16.74%,IFI35;NMI;SYK;DOCK2
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.6320546152582595,0.9617550076228014,0.6666666666666666,1.0,1.0,2/6,7.12%,HMGB1;TMEM98
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5312075995545062,-0.9615959925310061,0.5918367346938775,0.9808849384134907,1.0,3/10,23.93%,RPS6KA6;MAD2L2;TFAP4
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.5541432893815752,-0.9615919181594254,0.5441176470588235,0.9798502915288279,1.0,6/13,17.41%,SLC8A3;SLC8A1;SLC24A1;TRPV3;TRPM2;TRPV4
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.5541432893815752,-0.9615919181594254,0.5441176470588235,0.9798502915288279,1.0,6/13,17.41%,SLC8A3;SLC8A1;SLC24A1;TRPV3;TRPM2;TRPV4
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.4225298156354511,-0.961493713719313,0.5714285714285714,0.9795902546883661,1.0,13/74,10.39%,FSTL1;PCOLCE;ADAMTS5;ACTA2;OLFML2B;TIMP1;FAP;COL4A1;DKK3;GJA1;THY1;LMOD1;SULF1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.510291671898436,-0.9614186042041009,0.5151515151515151,0.9792528235122344,1.0,5/19,10.97%,CR1;SFTPD;HLA-DRB1;CEBPB;LYN
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.5252034942352927,-0.9614077295284349,0.5217391304347826,0.9787708419515144,1.0,5/19,14.83%,LOXL3;CHI3L1;VEGFA;FGF7;CCDC39
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.5971215402810581,0.9610327265888281,0.6097560975609756,1.0,1.0,3/7,29.74%,LIG4;MSH3;PRKDC
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.5268579572869083,0.9608405691004615,0.5555555555555556,1.0,1.0,3/14,10.63%,ERI1;INTS14;INTS8
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.5760528544632517,-0.9606652959783987,0.6140350877192983,0.980167040418902,1.0,4/7,27.13%,IL33;WNT5A;LBP;TNIP2
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.394790770175526,-0.9603572848892098,0.53125,0.9804450562227197,1.0,37/166,16.13%,FOSL2;IGFBP3;AKAP12;PPP1R3C;ISG20;GLRX;PIM1;PLAC8;FOS;CCN5;PAM;CITED2;F3;KDM3A;HS3ST1;EFNA1;PHKG1;LXN;DDIT4;BHLHE40;CHST2;VEGFA;TGFB3;CAV1;NEDD4L;EGFR;GPC3;LDHA;CP;PGK1;EFNA3;ZFP36;SCARB1;PPP1R15A;CDKN1A;MAFF;BTG1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.42755370017879046,-0.9603285837356831,0.546875,0.9799425416045124,1.0,3/63,3.11%,CTSO;ISG15;FAP
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.589215223918439,0.960312965089542,0.6304347826086957,1.0,1.0,2/7,16.95%,NCSTN;GALNT11
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.6289474716426269,-0.9594983351560438,0.5283018867924528,0.9814959762495741,1.0,2/5,18.50%,LRRK2;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.6643847069654986,-0.9593994509019776,0.5925925925925926,0.9812721636794439,1.0,4/5,21.40%,MEF2C;EFNB2;TGFB1;MYOCD
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.4238769774601857,-0.9589895235215593,0.5205479452054794,0.9819255944484154,1.0,17/54,22.37%,ITGB4;KDM3A;SLC44A3;SGMS2;CBLC;CLDN4;OVOL2;PPL;NNMT;WNT5B;STAT3;CDH1;NEDD9;TMEM184A;SDC4;SCEL;KLF5
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.44721134552485503,0.9588950572639432,0.4722222222222222,1.0,1.0,11/35,22.20%,SLC25A33;MRPS7;MRPS2;TFB2M;PTCD3;HARS1;MRPL47;MRPS16;NOA1;RARS2;MRPL57
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.5368527116340736,0.9588716988085471,0.4791666666666667,1.0,1.0,2/8,2.79%,AGER;HMGB1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.5247386139743058,-0.9586315778547968,0.5714285714285714,0.9822998996611992,1.0,2/16,12.32%,SOX9;BMPR1B
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.5596219921352416,-0.9582477108664631,0.5901639344262295,0.982720186714539,1.0,3/8,16.77%,LRRK2;ATP6AP2;TMEM9
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.4453090508051619,0.9582350944964787,0.5,1.0,1.0,9/25,17.23%,EPHB2;NLGN3;GRID2;PTPRD;IL1RAPL1;SEMA4A;SLITRK2;NLGN2;SEMA4D
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.40494641860458575,-0.9581731183436992,0.5714285714285714,0.9824189398669785,1.0,16/114,17.05%,ERCC6L;CENPK;CENPE;SPC25;CENPF;DYNC1LI1;NUP43;ZWILCH;DSN1;CENPA;NUF2;CENPL;CENPQ;KIF2C;PLK2;MAD2L1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.4562457224365314,0.9581073722910863,0.48484848484848486,1.0,1.0,3/21,4.21%,SLC38A1;SLC38A2;LLGL2
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.4968182353096079,-0.9578204782432641,0.5254237288135594,0.9827512027701069,1.0,3/18,8.83%,NCKAP1L;CAMK1D;BST1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.46285388490675455,0.9578090380307749,0.42857142857142855,1.0,1.0,1/24,0.46%,PTH
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.41218536407131817,-0.9575013235894884,0.5657894736842105,0.9829390484799708,1.0,22/114,18.31%,ROR1;TLR2;CLU;TRIM5;TRIM22;NLRP3;CARD11;CX3CR1;TERF2IP;AR;NOD1;TRIM25;CAV1;TRIM32;FLOT1;PRKD2;AGT;NFKBIA;PRKCQ;CX3CL1;CLOCK;STAT3
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.44742473253834625,-0.9573475027443502,0.5,0.9828695739759739,1.0,9/44,17.41%,STMN2;EPHA4;GRIN2B;YWHAH;ITM2C;EFNB2;RTN4RL2;PRAG1;TRPV4
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.42639235118249363,-0.9566770903646341,0.5194805194805194,0.9840285577977351,1.0,15/82,9.07%,MMRN2;FSTL1;ADAMTS5;TLR2;ROBO4;ACTA2;OLFML2B;FAP;COL4A1;SERPING1;DKK3;AQP1;THY1;TEK;LMOD1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.4230916583792529,-0.9566436056949866,0.5671641791044776,0.9836195398038706,1.0,21/76,25.14%,SNAP25;CACNA1E;CHGA;KCNC2;KCNB1;RAPGEF4;ITPR3;SLC2A2;EFNA5;NR1D1;CACNA1C;CLOCK;CACNA1A;SYT7;NNAT;PICK1;TM7SF3;ABCA12;EPHA5;ITPR1;CACNA2D2
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.45774709787355455,-0.9562046121947244,0.5571428571428572,0.984340487043104,1.0,16/57,13.95%,NKAIN1;PDZK1;SYT4;SYT1;NOS1;KCNJ4;KCNJ6;KCNJ3;B2M;NKAIN3;NEDD4L;YWHAH;ATP1A1;SYT12;CHRM1;SYT13
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.554720097841627,-0.9558809377281754,0.49206349206349204,0.9846604121320053,1.0,3/12,10.97%,CR1;C3AR1;LYN
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5169923251837848,-0.9558579774933698,0.5882352941176471,0.9841850350539854,1.0,6/22,10.76%,PDZK1;TRPC6;GLRX;COX17;ATP1B2;ABCB1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.5059319177259112,0.9554828747774743,0.39473684210526316,1.0,1.0,1/11,6.65%,IFI27
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.521744210276408,-0.9552024462011518,0.582089552238806,0.9852838678964622,1.0,3/14,14.54%,BTBD18;SLC25A31;SYCP3
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.4648251358328105,0.9551683134323246,0.47058823529411764,1.0,1.0,7/17,25.40%,USP6NL;PDE4DIP;STX18;AKAP9;ARMH3;MAP2K2;PDCD10
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.6328554011866716,-0.9549093047063305,0.6190476190476191,0.9854900719295522,1.0,4/5,36.73%,ATP23;TMEM70;OXA1L;ATPAF1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.45413376828174784,0.9548990097528729,0.5555555555555556,1.0,1.0,6/24,21.55%,PCF11;SYMPK;TENT4B;PNPT1;PAPOLG;APP
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.45413376828174784,0.9548990097528729,0.5555555555555556,1.0,1.0,6/24,21.55%,PCF11;SYMPK;TENT4B;PNPT1;PAPOLG;APP
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5417966851327678,-0.9548440318039166,0.6129032258064516,0.9851327854259507,1.0,3/12,15.07%,HEY1;NOTCH2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.48693801160937544,-0.9547910695537382,0.5522388059701493,0.9847298150344937,1.0,1/28,0.99%,IRGM
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5618753731452526,-0.9547730689247164,0.5714285714285714,0.984250541663321,1.0,3/10,24.80%,SAR1A;BCAP31;EDEM1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.49916855970551766,-0.9545929990032546,0.5161290322580645,0.984129652730657,1.0,11/29,13.10%,CR1;CD59;C1QB;CLU;C5;SERPING1;CR2;C3AR1;C4BPA;PROS1;C1QC
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5063015994014675,-0.9543776223804316,0.49230769230769234,0.9841621868801217,1.0,7/26,6.52%,PARP14;IRGM;PARP9;EDN1;C1QTNF4;LAPTM5;IL7
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.3740244039944417,0.9543270712807884,0.5,1.0,1.0,14/72,10.08%,C6;F2;RNF128;F11;EYA4;ENPEP;GRAMD2A;ABCA8;MTTP;GJB1;CLDN2;C2ORF72;KRT8;ANXA13
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.43198271472273836,0.9542272740848681,0.55,1.0,1.0,6/23,21.85%,NAT9;NAT10;NAA50;SIRT1;NAA40;NAA11
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.45128269156869594,0.9541772845299566,0.4444444444444444,1.0,1.0,4/21,6.31%,PIWIL2;MEIOSIN;M1AP;FSHR
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4892241950585894,0.9540036333660887,0.5151515151515151,1.0,1.0,3/19,5.75%,JPH1;CASQ2;CLIC2
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.39973930840269256,-0.9538785409893679,0.5555555555555556,0.9847820095083023,1.0,28/142,16.72%,ITGB4;IGFBP3;CLU;PPP1R3C;COX7A1;FABP3;MEF2C;AGL;NOS1;MYH11;WWTR1;CTF1;BHLHE40;CDH13;GADD45B;SLC6A8;CAV3;SGCA;PKIA;CKMT2;DENND2B;ABLIM1;TGFB1;KCNH2;CDKN1A;CAMK2B;FKBP1B;PFKM
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.48698062272447795,-0.9537376434447338,0.5079365079365079,0.9845487334167504,1.0,5/25,6.24%,PTPRC;NCKAP1L;ANO6;SFTPD;CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5520196379192749,0.9535218547091313,0.38235294117647056,1.0,1.0,5/11,24.10%,SELP;RELA;ST3GAL4;RHOA;NFAT5
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.595134709792406,-0.9534211921512311,0.5857142857142857,0.9848003715863238,1.0,2/8,15.55%,NCKAP1L;PPP2R3C
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.5937452536590901,-0.9534093820875291,0.6271186440677966,0.9843123771792501,1.0,3/8,10.57%,ALOX12;CEACAM1;PRKG1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4683694936423668,-0.9532843308327617,0.5151515151515151,0.9841459698304018,1.0,6/31,19.27%,STMN2;APC2;NAV3;MAP2;FGF13;CAMSAP3
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.511501152380968,-0.9531792285246385,0.59375,0.9838269258965606,1.0,1/20,0.14%,GPAT3
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.4967146938831294,0.952956835275749,0.5,1.0,1.0,2/13,12.95%,RASGRF1;KAT2A
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.5933221857230044,-0.9526075708777281,0.631578947368421,0.9846740664897083,1.0,2/6,12.60%,EPHA4;OPALIN
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.6300135058425504,-0.9525728996286602,0.6206896551724138,0.984212606034213,1.0,2/8,14.35%,RECQL4;WRN
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.4124785456366202,0.9521336560093016,0.4864864864864865,1.0,1.0,12/42,20.00%,HDAC10;PRDM5;HDAC1;FLNA;ZNF541;HDAC9;HDAC4;MIER3;HDAC3;TBL1X;SIRT1;SUDS3
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5137734260581911,-0.9515998370121523,0.6,0.9861520788779813,1.0,7/19,14.44%,CLU;GSAP;EPHA4;EFNA1;LYN;LRRTM3;EFNA3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.6516869774407517,-0.9513308593078914,0.559322033898305,0.9863206223181805,1.0,2/6,16.24%,P4HTM;P4HA3
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3344626871033184,0.9511233221601647,0.45454545454545453,1.0,1.0,18/228,9.91%,CRTAM;CXCR4;TBXA2R;VDR;LEPR;IL4R;IGF1R;MST1;PLA2R1;NUMA1;PAX8;SNAI1;UCN;ACVR1;SERPINE1;KLRF2;UCP2;TRIM16
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.42585108523524057,0.95091752020164,0.5588235294117647,1.0,1.0,17/51,22.63%,NOC2L;RSL1D1;MDN1;SDAD1;LTO1;GTF3A;NLE1;WDR74;BRIX1;NPM1;RPL23A;RPL3;NSA2;RPL11;RPL5;RPL7;SURF6
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.6245122421084429,-0.9506839071390947,0.5636363636363636,0.98746949830836,1.0,3/8,10.71%,NCKAP1L;TGFBR2;GLI3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.5744512888955977,0.9504460737445527,0.5348837209302325,1.0,1.0,3/6,24.22%,AKT2;AKT1;BAD
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.4753084705935633,-0.9503489102377285,0.5797101449275363,0.9877082618899579,1.0,8/29,16.54%,NOSTRIN;DDAH1;CAV3;CAV1;HTR2B;EGFR;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5496074583935584,0.9502614680043673,0.5277777777777778,1.0,1.0,3/8,13.87%,EPHB2;RYK;NFIB
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.5880696250265592,0.9498983403351061,0.5581395348837209,1.0,1.0,1/6,0.62%,VDR
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.5067065133343687,0.9496388360033614,0.5121951219512195,1.0,1.0,7/10,31.32%,EXOSC8;EXOSC7;EXOSC5;DXO;EXOSC9;PCID2;XRN1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.6111606524978161,-0.949488319899032,0.6140350877192983,0.9894337602422794,1.0,4/7,16.34%,FES;LYN;ADGRE2;SYK
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.5007550169113291,-0.9494831220825563,0.53125,0.9889256054861812,1.0,3/19,11.94%,VEGFA;TGFB3;PTPRR
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.5186792419498595,0.9493715956516133,0.5384615384615384,1.0,1.0,5/14,10.78%,F2;SERPINF2;RUNX1;SUCO;WNT4
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.6574736144965603,-0.94932901072805,0.5806451612903226,0.9887525843571002,1.0,1/5,15.47%,LY96
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.6054233663134715,0.9489477630752198,0.5909090909090909,1.0,1.0,1/7,7.63%,GBF1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.4945950347555523,-0.9489414168597058,0.5396825396825397,0.9891979265059799,1.0,10/27,24.09%,TTN;MYH11;SLC8A1;CAV3;VEGFA;ALPK2;NEB;HEY2;NEBL;MYH6
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.5393850207570019,-0.9489210689024168,0.5333333333333333,0.9887362721614064,1.0,4/12,24.49%,FES;HLA-DRB1;IL34;ZFP36L1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.49327650656038957,-0.9486336706685204,0.625,0.9889533776055005,1.0,2/19,4.32%,MFAP5;ID2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.6914151524198475,-0.9483251060808711,0.6129032258064516,0.9892714386909865,1.0,2/5,17.33%,CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.542011467033104,-0.9483236857372346,0.5737704918032787,0.9887750737943866,1.0,4/13,16.20%,ST3GAL5;ST8SIA3;B4GALT6;ST6GALNAC5
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.5169552015740685,0.9482341495059373,0.5681818181818182,1.0,1.0,1/9,1.35%,DPEP1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.4852675954604595,-0.9477122572913909,0.5588235294117647,0.9898054879626759,1.0,10/29,17.85%,PLSCR1;DDX60;BMP6;IFI35;NMI;LY86;IFNK;SCIMP;LY96;SLC15A4
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.4663038625069571,-0.9476245379179992,0.5833333333333334,0.9894558473633449,1.0,2/33,2.48%,STMN2;EPHA3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.45055043212740387,-0.9474897124401213,0.5942028985507246,0.9892580285804722,1.0,4/39,11.66%,CLU;LAPTM5;CAV3;MAGEF1
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.5437745467362093,-0.9473911822146752,0.5538461538461539,0.9890099565319974,1.0,1/8,1.72%,TWF2
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.4924834372736038,-0.9472486658725348,0.5588235294117647,0.9887520562612546,1.0,7/28,15.17%,TTC8;MYO7A;ADGRV1;SCN9A;GNAL;CDH23;OPRM1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.44732047932743235,-0.9468515285279838,0.48484848484848486,0.9892051617820541,1.0,4/30,22.38%,RPS6KA6;PLCB1;CRB2;ZBED3
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.40687022670874695,-0.9468194414778044,0.5571428571428572,0.9887862101594239,1.0,22/123,15.52%,ROR1;EPHA3;MUSK;RFC3;EPHA4;DTX3L;MET;CSF1R;PLAAT4;RFC4;TEK;AXL;HLA-DRB1;EPHA6;EPHB6;EPHB1;EGFR;TIE1;DDR2;TGFB1;CD200;RAD50
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.43278299370082945,0.9468027190754065,0.59375,1.0,1.0,9/33,16.58%,NUPR1;ALK;FBP1;FLNA;HMGCR;RILP;SNX3;HDAC4;ZDHHC7
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.45957550263350455,0.9466267661142467,0.5,1.0,1.0,6/31,10.22%,ZAP70;LCK;LEPR;LFNG;PTPN22;SOX13
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.49774836611107615,-0.9465409766640026,0.5384615384615384,0.98888130990271,1.0,5/17,16.36%,C5;SULF1;TGFB1;BRCA1;CXCL17
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4221429744680203,-0.9465168195292287,0.5526315789473685,0.9884327651213327,1.0,5/62,7.12%,HLA-F;HLA-E;PSMB8;HLA-A;B2M
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5548748138553955,-0.9460372079198462,0.5833333333333334,0.9890712129744981,1.0,1/7,1.95%,IL12A
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.51626337496141,-0.9456979334086743,0.5901639344262295,0.9892967343164453,1.0,6/18,25.11%,MEF2C;CAV1;CAV2;MYL6B;ZBTB18;SVIL
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5727645293088344,-0.9456283416869212,0.6212121212121212,0.9889190221899143,1.0,5/11,20.44%,MSMP;GPR183;CX3CL1;CXCL16;GAS6
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.5811529153980148,-0.9455695201521841,0.5254237288135594,0.9885165899374109,1.0,6/8,18.53%,NTN4;NTNG1;LAMB1;NTNG2;LAMB4;LAMB2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.3590949825816482,0.9453851631061958,0.5,1.0,1.0,23/164,13.62%,PASK;DHFR;TCOF1;RIDA;ZNF598;PIWIL2;PLD1;EIF4E2;PUS7;NAT10;EIF3B;EIF5;EIF3E;EIF1;EIF3D;SAMD4A;RPS6KA1;NOLC1;NCL;NIBAN1;EIF4G2;CNOT9;EIF4E
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.4077118166153269,-0.9452274703602903,0.6103896103896104,0.98885750312166,1.0,23/94,15.95%,AKAP12;P2RY12;GPHB5;TSHR;HTR1E;ADGRG1;ADCY7;ADGRG2;RXFP1;GPR161;PTGER3;RGS1;ADGRL2;ADCY8;ADGRE3;GNAL;NPY1R;CNR2;PTH2R;ADGRE2;GPR37L1;ADCYAP1R1;RAMP1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.4267600515473443,-0.9451497523905321,0.5789473684210527,0.988550846271571,1.0,5/60,7.12%,HLA-F;HLA-E;PSMB8;HLA-A;B2M
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.34887509012614976,0.9448109641095795,0.4642857142857143,1.0,1.0,24/338,6.39%,POU3F1;CRTAM;NGF;PASK;SLC22A2;VDR;EPB41L4B;RAB27A;FGF6;PIWIL2;HSPA1A;SLC38A2;EPHB2;PLD1;SPRY2;NWD1;MYOM1;NOS1AP;HMGA2;SPHK2;PLA2R1;ERP29;NAT10;ATF4
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.664424544137374,-0.9447448181217778,0.5932203389830508,0.9889064323784372,1.0,3/5,28.27%,SLC7A8;SLC6A9;SLC6A17
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.6378255971392139,-0.9446876189782871,0.6727272727272727,0.9885800196912577,1.0,1/7,14.33%,TRERF1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.5685828863811125,-0.9445616507366115,0.59375,0.9883541326812052,1.0,5/11,15.80%,SOX9;CEACAM1;CEBPB;CAV1;MAFF
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.4237548807854387,-0.944544513678622,0.5342465753424658,0.987888152513754,1.0,11/88,8.86%,P2RY12;TSHR;GABRG2;MEF2C;SOX9;GLRA2;RYR3;AQP1;GABRB2;XBP1;HCN1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.5186118394720626,-0.9445424144751086,0.5573770491803278,0.9873826202206852,1.0,6/19,27.17%,SOX9;VCL;ARHGAP12;TIMELESS;ACTG1;PRKX
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.6282559779045892,-0.9441177272546983,0.631578947368421,0.9879079469887019,1.0,2/6,23.35%,DAPK1;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.5974748008311547,-0.9437986056958827,0.6060606060606061,0.9875479686307056,1.0,4/8,37.56%,DYRK2;FHL2;CHP1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.5974748008311547,-0.9437986056958827,0.6060606060606061,0.9875479686307056,1.0,4/8,37.56%,DYRK2;FHL2;CHP1;PRNP
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.46405847800371375,0.9434086802476425,0.4117647058823529,1.0,1.0,21/35,28.95%,FARSB;TARS1;DARS1;HARS1;IARS1;MARS1;VARS1;HARS2;CARS1;FARSA;RARS2;KARS1;RARS1;AARS1;EPRS1;FARS2;SARS1;LARS2;WARS2;IARS2;GATC
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.45670004567563394,0.9433787529055335,0.47058823529411764,1.0,1.0,5/18,19.66%,INTS14;EXOSC8;INTS8;EXOSC7;EXOSC5
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.39565662605291685,0.9432240632974614,0.5925925925925926,1.0,1.0,21/61,21.05%,B4GALNT2;MOGS;SLC39A8;ST3GAL1;DAD1;OST4;GFPT2;UGGT1;LMAN1;DPM3;ALG1;TMEM165;ALG12;GFPT1;ALG5;DPAGT1;RPN2;ALG3;B4GALT1;PMM1;DPM2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.4619279159964728,0.9432042422449541,0.5666666666666667,1.0,1.0,3/13,14.65%,STAC3;CHRNB4;TSPOAP1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.6620365707412156,-0.9426826251874605,0.639344262295082,0.9896654503456308,1.0,2/5,2.06%,CD59;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5105735821186835,-0.9424766696292721,0.4827586206896552,0.98905976865044,1.0,4/14,35.52%,DMTN;ITGB1BP1;CORO1C;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5105735821186835,-0.9424766696292721,0.4827586206896552,0.98905976865044,1.0,4/14,35.52%,DMTN;ITGB1BP1;CORO1C;PHLDB2
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.5910931714270824,-0.9410720603760618,0.6166666666666667,0.9920806859278245,1.0,4/10,12.71%,CENPE;CENPF;CENPA;NUF2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3867706504530195,-0.9408123082473806,0.6071428571428571,0.9921930456768073,1.0,19/142,18.55%,RGS7;DOCK8;ARHGAP42;APC2;GRTP1;RGS1;THY1;SIPA1L1;USP6;TBC1D10A;NGEF;ARHGAP25;CAV2;CX3CL1;RASGRP1;EZH2;RIC1;NTRK3;TBC1D8B
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.4283290685797982,-0.940783293707516,0.589041095890411,0.9917274877771948,1.0,15/67,19.20%,GCNT1;ALG10B;B3GALNT1;ST3GAL5;CHST9;CSGALNACT1;ST8SIA3;ALG1L2;BMPR1B;CHST8;B3GALT1;CHST10;B3GALT2;B3GNT9;PMM2
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3677381995928911,0.9406922899284041,0.5,1.0,1.0,13/71,20.47%,PSME2;UBC;CDC26;PSMD13;ANAPC15;UBB;PSME4;PSMF1;ANAPC1;PSMD11;CDC23;PSMD4;RB1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.37857704693365707,-0.9405671922339737,0.5657894736842105,0.9917751931961621,1.0,29/184,16.56%,TLR2;MCM2;PLSCR1;MX1;PAK5;CIDEB;IRF1;FAP;BCL2L14;TGFBR2;NLRP3;RFK;SCN2A;DDIT4;KREMEN1;IFNA2;PDE1B;DAPK1;APAF1;TCHP;ATCAY;DAPK3;NOTCH2;EFNA5;PPP1R15A;NGFR;BBC3;SIAH1;NFKBIA
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.5881644842438867,-0.9404695581623875,0.5283018867924528,0.9914745342828423,1.0,2/5,14.05%,TOX;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.39751182281987396,-0.9403377442699729,0.5373134328358209,0.9912537582481233,1.0,31/108,19.19%,ROR1;TWF2;STMN2;RIT2;EPHA3;PLPPR5;CARMIL2;ROBO2;CAMK1D;FES;TENM3;GRIP1;TOX;ATP1B2;CARMIL1;LYN;CAMK1;SCN1B;DLG4;LRRC7;PLXNA2;NGFR;PTK7;CAMK2B;PLXNA4;CX3CL1;PLXNC1;NTRK3;NDRG4;PLXND1;SERPINI1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.6029725478528496,-0.9402539946920202,0.56,0.9904899480481286,1.0,2/5,23.24%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.6029725478528496,-0.9402539946920202,0.56,0.9904899480481286,1.0,2/5,23.24%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.5310732919931445,-0.9402012307877344,0.5522388059701493,0.9901260105349461,1.0,4/19,16.47%,FABP3;SLC25A20;ABCD2;PRKAB2
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-0.5534463260633956,-0.9398423318004435,0.6415094339622641,0.9905267759180069,1.0,2/8,7.01%,CITED2;LMO3
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.588864940585113,0.9395838054475099,0.5641025641025641,1.0,1.0,3/5,15.35%,CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.588864940585113,0.9395838054475099,0.5641025641025641,1.0,1.0,3/5,15.35%,CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.5394601519296338,-0.939563813390274,0.6229508196721312,0.9906493349513749,1.0,8/15,22.48%,LRRK2;CX3CR1;VEGFA;DISC1;CX3CL1;TAFA1;FZD3;PTN
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.4546496237105318,-0.9395572724646305,0.5909090909090909,0.9901569643222534,1.0,14/40,26.34%,KLF9;GLRA2;ADCY7;ADCY8;GNG2;BRCA1;GRAMD1C;CDH1;ADCY2;ADCY1;MLC1;GLRA1;MAP4K1;TNFSF4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.5166640154888789,-0.9395211408306864,0.6231884057971014,0.9897344755033757,1.0,2/14,11.83%,ZWILCH;CENPA
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.44922205511538627,-0.9391177159476066,0.5789473684210527,0.9901395742055796,1.0,10/39,24.49%,STAT5A;XBP1;CAV1;EIF2B4;STAT1;STAT3;STAT4;EIF2B2;ZBED3;ZFP36L1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.4669701152364482,-0.9389818963294578,0.5588235294117647,0.9899105955192957,1.0,3/30,1.31%,ITGB4;DMKN;IL13RA1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.468263075536633,0.938515387739522,0.6,1.0,1.0,1/13,0.17%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.468263075536633,0.938515387739522,0.6,1.0,1.0,1/13,0.17%,CRTAM
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.6008297978359137,0.9381601175034534,0.6304347826086957,1.0,1.0,1/6,2.79%,HMGB1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.4659371698296726,-0.9380397354668905,0.5892857142857143,0.9916758803097074,1.0,2/24,7.92%,MET;ARHGAP28
prerank,PanglaoDB_Augmented_2021__B Cells,0.39097148615029964,0.9377504927235994,0.5714285714285714,1.0,1.0,6/91,3.21%,CD38;CXCR4;CD72;EAF2;EVI2B;ITGAL
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.47393789842449796,0.937736986627602,0.6111111111111112,1.0,1.0,4/20,6.69%,WNK4;CASQ2;ACTN2;PXK
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.41656534256428934,-0.9375845337380219,0.6290322580645161,0.9922623479699473,1.0,26/94,23.88%,ISG15;CLU;SLF1;RPA3;LGALS3;RHOC;VEGFA;NRG1;SKAP1;HRK;TGFB1;WARS1;SYK;PSMC3;ABCA1;RPA2;ESR1;TIRAP;RBX1;LCP1;MPP7;PSMC5;FERMT1;RPA1;IL5;XPA
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.434022144265544,0.9374583023164568,0.6,1.0,1.0,4/27,4.86%,CD38;EPHB2;TNFSF13B;IKZF3
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.4615960921090463,-0.9373934525509902,0.5915492957746479,0.9922797819603223,1.0,5/27,9.59%,TRPM1;ATP2B3;JPH4;JPH3;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.5409766962222792,0.937354203875721,0.5833333333333334,1.0,1.0,2/8,9.25%,ALK;PLIN5
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.5595528705801991,-0.937278499627065,0.5245901639344263,0.9920501786347478,1.0,3/13,16.54%,DGKD;TNK2;PIK3CB
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.44659006352093494,0.9372597205253541,0.5348837209302325,1.0,1.0,4/25,9.19%,GPC4;GPC2;SDC2;FUCA1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.6168428557600478,-0.9368833403257858,0.5964912280701754,0.9926207446134057,1.0,1/6,14.10%,RNF213
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.33240708160290244,-0.9368644102119594,0.6666666666666666,0.9921493691869868,1.0,91/852,14.49%,PARP14;FSTL1;PTPRM;ASB4;IGFBP3;SPARCL1;FBXL16;CHRM3;ISG15;PARP9;TGFB2;PTPRC;PAK5;LAMC1;IGFBP4;TIMP1;ALG10B;ASB18;GMFG;GLRX;TGFBR2;PRSS23;PRKAR1B;PIM1;MAP3K21;MACROD1;PSMB8;FBXW9;B3GALNT1;MAP3K5;DCLK1;PEAK3;BMX;PTPRG;FBXO41;LRRK2;RAB11A;PIGH;ST3GAL5;TSSK3;MEPE;LAMB1;FUCA2;FBXL13;CPE;HIF3A;HUNK;OGFOD1;FBXL18;STK17B;USP6;FBXO17;PAK3;PRKG1;RAB3A;COQ8B;ST8SIA3;AFP;LYN;PTPRB;CST3;CAMK1;SCG3;DAPK1;UST;FBXO7;PTPRR;ALG1L2;CHRDL1;FBXO10;BMPR1B;ASB14;PP2D1;GPC3;PTPRT;SCG2;PRKD2;FBXL5;CP;STK17A;CCNF;CHGB;B3GALT1;RAB1B;MYLK3;PTPRZ1;ATG10;GRK6;DAPK3;FCGR3A;CDKL4
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.5590009480025416,-0.9366515329472572,0.6181818181818182,0.992132295324505,1.0,2/11,13.60%,VEGFA;PRKD2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.4023615524419581,-0.9366394598569455,0.5223880597014925,0.9916567182864343,1.0,20/105,10.97%,FRY;NPY;PTPRM;CFAP126;STMN2;GPRIN3;L1CAM;GPM6A;CSF1R;RAB11A;LGI1;LAMB1;STX3;SH3GL2;MANF;CYFIP1;CDK5R1;ATP1B2;CARMIL1;LYN
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.5014379384902528,-0.9366355454846521,0.5753424657534246,0.9911569861984644,1.0,2/13,11.76%,CHKB;ETNPPL
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.530664109664499,-0.9365764731169687,0.6031746031746031,0.9908153725020487,1.0,5/15,18.89%,CAV3;CAV1;NEDD4L;KCNH2;SLC43A1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.4926289921570325,0.9365219447108177,0.48484848484848486,1.0,1.0,3/16,10.28%,VDR;CUBN;VKORC1L1
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.5291336588039515,0.936475009902301,0.5,1.0,1.0,2/5,32.36%,FABP5;SLC27A1
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.6202121290021592,-0.9363818657243597,0.5818181818181818,0.9907940887395716,1.0,3/6,21.52%,SLC25A22;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.66509476183696,-0.9361811736405097,0.6481481481481481,0.9908023484527441,1.0,3/5,24.27%,UBASH3B;DDR2;COL4A6
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.489804136753709,-0.936154306523835,0.5522388059701493,0.9903630791800577,1.0,5/18,16.36%,C5;SULF1;TGFB1;BRCA1;CXCL17
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.40317187819344286,0.9361485304721704,0.5666666666666667,1.0,1.0,14/64,17.29%,ACADS;ABHD2;CROT;ACAA2;ACADVL;LPIN3;ECHS1;PEX2;ECI1;ACAT2;PECR;ACOX1;ACAD10;HSD17B10
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.5881425368068681,-0.9360307254168561,0.5789473684210527,0.9901405296115704,1.0,4/5,28.27%,SLC6A7;SLC1A4;SLC6A15;SLC6A17
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.40007082438121183,-0.9359249550845945,0.5714285714285714,0.9898936417741883,1.0,5/66,4.94%,LPL;PPARG;PLSCR1;CLU;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.42296598702117855,-0.9355108162822204,0.6271186440677966,0.990280436551197,1.0,14/75,13.54%,CLDN5;DACT1;KDM4D;PPARG;PARP9;DTX3L;MET;LRRK2;B2M;ADD2;CAV1;NMD3;LRP1;FLOT1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.6530680031766081,-0.9353588690240193,0.6545454545454545,0.9900975299704132,1.0,1/5,2.24%,PLSCR1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.48968717583970595,-0.935051745705557,0.6056338028169014,0.9903219529456004,1.0,3/20,12.33%,PLSCR1;ABHD12B;PLA2G12A
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.42843901865307743,-0.9343217889502043,0.6438356164383562,0.9915218195024313,1.0,9/63,8.94%,LPL;TLR2;IL6R;EOLA1;NCKAP1L;NLRP12;C1QTNF4;XBP1;IL16
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3938556995243752,0.9338598173410803,0.5666666666666667,1.0,1.0,10/76,11.91%,CRYAB;HSPA1A;RAE1;NUP42;FKBP4;NUP210;BAG2;HSPA1B;MLST8;TPR
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.5088461216191873,-0.9337946578818159,0.5396825396825397,0.9922990383063693,1.0,5/18,15.07%,TGFB2;TGFB3;CAV1;ABCB4;TGFB1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4883027185230862,0.9337394744473168,0.5142857142857142,1.0,1.0,4/12,18.53%,ALG1;ALG12;DPAGT1;ALG3
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.4516357753126753,-0.9335683822447128,0.618421052631579,0.9923309887328161,1.0,11/55,18.66%,TGFB2;TTN;FRMD4A;BMP6;TGFB3;MYH10;TGFB1;TMED10;DNM1L;TENM1;KIF20B
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.48803692150547406,0.933505867172269,0.5151515151515151,1.0,1.0,4/16,14.29%,EPHB4;SLIT2;GREM1;MIA3
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.42952926683681536,0.9334339196844945,0.5,1.0,1.0,3/25,8.31%,CHST7;DSEL;DSE
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.49270947920699404,0.9332853035831892,0.5263157894736842,1.0,1.0,4/14,16.53%,SEC23B;MIA3;SEC31A;SEC24B
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.43984347731203427,-0.9327064689616515,0.5373134328358209,0.9938804909191649,1.0,3/51,5.72%,CTSO;FAP;DENND3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4731811674314862,-0.9326919460951386,0.5862068965517241,0.9934272070198907,1.0,3/31,12.87%,TP73;DDIT4;ZNF385B
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.6165257693634528,-0.9324251950107301,0.6612903225806451,0.9936150348572601,1.0,2/5,18.12%,AGT;NTRK3
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.5194952118514262,-0.9322882675919697,0.5333333333333333,0.9933969674972541,1.0,2/14,2.74%,SHMT2;COX7A1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.41647247863331976,-0.9321646168663492,0.5074626865671642,0.9931791201850381,1.0,8/56,11.88%,TIMP4;WDR6;TIMP1;HGF;MET;NELL1;CST3;HTR2B
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.6341414590655761,-0.9320464083737043,0.6779661016949152,0.9929761418546182,1.0,2/5,24.18%,PRKCQ;IL12RB1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.48507231214446855,-0.9319946763317215,0.5652173913043478,0.9925537398913898,1.0,5/23,16.10%,TRPC6;LGALS3;CAV1;CACNB2;GRM6
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4834424787638243,-0.9319268077464149,0.5441176470588235,0.9921756670429005,1.0,6/30,11.88%,NYAP1;EDN1;MYO16;HTR2A;CD160;HTR2B
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5890373145221329,-0.9316700432802241,0.6296296296296297,0.9922855462025977,1.0,2/7,20.46%,PRPS1;CTPS2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.4282264360154903,-0.9307814064843953,0.5774647887323944,0.9938914052452048,1.0,20/64,14.51%,TLR2;FGL2;C1QB;GPIHBP1;ITGAM;AOAH;LAPTM5;CD53;CSF1R;P2RY13;C3AR1;PTAFR;IGSF6;TNFRSF1B;C1QC;LY86;WDFY4;TYMP;FCGR3A;SPI1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.5087455248891891,0.9307728235507853,0.5,1.0,1.0,2/14,11.92%,ERI1;TENT4B
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.4311081913298612,-0.9306071319757301,0.547945205479452,0.9938444449732413,1.0,7/55,8.79%,SPDYA;DBF4;CCND1;CRLF3;CDKN3;E2F3;E2F1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.3617438670191367,-0.9304098260871191,0.5897435897435898,0.9938072686386309,1.0,24/283,8.80%,CD44;ANGPT1;FSTL1;KANK2;FIGNL1;BIRC3;BCL2L2;NCKAP1L;APIP;PIM1;SOX9;CITED2;AVEN;HGF;MET;LAPTM5;IL7;PRAME;AQP1;GATA1;RNF144B;XBP1;TEK;TCIM
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.37473773302194774,0.9299194433776437,0.5925925925925926,1.0,1.0,19/65,26.19%,CDKL1;TBC1D12;USP6NL;TBC1D19;UBQLN2;TRAPPC12;STX18;NPM1;ALMS1;C10ORF90;STIL;TBC1D22A;C9ORF72;TBC1D22B;TBC1D16;VPS11;GSN;ODAD3;NPRL2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.5978129733936953,-0.9299171318665458,0.5932203389830508,0.9944562232978295,1.0,3/6,9.84%,RAB11A;GRIP1;GRIP2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5005229400777113,-0.9297999954875863,0.6428571428571429,0.9942339652395481,1.0,7/21,17.04%,PTPRC;RYR3;HTR2C;HTR2A;HTR2B;ITPR3;TRPM2
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.5278011439009908,0.9297923162087727,0.631578947368421,1.0,1.0,2/12,5.60%,NOC2L;SPHK2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.5859274267987737,-0.9297728815918949,0.6440677966101694,0.9937931841250239,1.0,1/7,10.71%,GLI3
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),-0.6124609302416788,-0.929742747477162,0.6333333333333333,0.9933771382786167,1.0,1/8,3.30%,ITGAM
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.5089033016281391,-0.9296954318268538,0.5714285714285714,0.9930197835439448,1.0,6/19,15.07%,HEY1;SOX9;SGMS2;CEBPB;DDR2;TGFB1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.5517283048510623,0.9296413051902092,0.5,1.0,1.0,2/6,18.14%,CAND2;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.48133058457307015,0.9295241632992766,0.5897435897435898,1.0,1.0,8/22,24.32%,PPP1R10;EIF4EBP1;EIF4E;CDC25B;PRKCA;APP;HSF1;LGMN
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),-0.6213617537880236,-0.929397017688739,0.6,0.9932986239873299,1.0,3/5,11.88%,HTR2C;HTR2A;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.4607153546530658,-0.9292372944011772,0.5972222222222222,0.9931308667854031,1.0,8/41,8.48%,DOCK8;PTPRC;NCKAP1L;HLA-A;IL7;HLA-DPB1;THY1;XBP1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.5820639706227144,-0.9289888216102828,0.6415094339622641,0.9932348135285131,1.0,5/10,30.12%,NOS1;CACNA1C;AKAP5;CACNA1D;ISCU
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6249051134534536,-0.9288550178164785,0.6296296296296297,0.9930478704723119,1.0,1/5,11.55%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4709265264329843,-0.9287942603100743,0.6103896103896104,0.9926867302829397,1.0,3/29,7.81%,TGFB2;B2M;ARG2
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6381418815112326,-0.9285933228610481,0.5555555555555556,0.9926454956928019,1.0,3/5,23.16%,SREBF1;ATP5IF1;HAX1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5531210129297129,-0.9284540086609825,0.5555555555555556,0.99249784072776,1.0,1/8,0.57%,LPL
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.511064617653087,0.9283510256856166,0.4857142857142857,1.0,1.0,8/12,29.77%,STAR;TSPOAP1;HSD17B10;FDX1;FDXR;AKR1D1;AKR1C3;STARD3
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.6081764319163563,-0.9282812146485142,0.6363636363636364,0.9924760886653134,1.0,1/6,10.86%,NDP
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.5152937704667142,0.9282408571427857,0.5263157894736842,1.0,1.0,5/9,27.02%,EXOSC8;EXOSC7;EXOSC5;DXO;EXOSC9
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.40477535420827176,-0.9279450582041177,0.5657894736842105,0.992710577876797,1.0,11/139,6.54%,KANK2;IGFBP3;BIRC3;CLU;TP53I3;CIDEB;TP73;BCL2L14;SOX9;ACTN1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.4382899159680836,-0.9277061945059565,0.6142857142857143,0.992727396717734,1.0,1/49,0.99%,IRGM
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.47646186997354883,-0.9276453132254333,0.5873015873015873,0.9924061331559406,1.0,13/33,26.61%,CENPK;CENPA;MIS18BP1;HIRA;CENPL;CENPQ;OIP5;ITGB3BP;CENPI;CENPP;MIS18A;HAT1;CENPH
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.38539163798391735,-0.9270829789651792,0.6666666666666666,0.9930795727869682,1.0,28/183,17.72%,ROR1;TLR2;PPARG;CLU;TRIM5;EDN1;TRIM22;NLRP3;CAMK1D;CARD11;CX3CR1;TERF2IP;AR;NOD1;ADCY8;TRIM25;VEGFA;CAV1;TRIM32;FLOT1;PRKD2;DDR2;AGT;CD200;NFKBIA;PRKCQ;CX3CL1;CLOCK
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.4676814114659258,-0.9270766806071584,0.5538461538461539,0.9925944142209814,1.0,3/28,9.69%,TWF2;CARMIL2;CYFIP1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.428213690804525,0.9267254399178542,0.4444444444444444,1.0,1.0,9/64,11.35%,MAPRE2;KIF3B;TPX2;NUMA1;ZNF207;FLNA;KIFC2;BCCIP;HAUS5
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5033815423706606,-0.9267214048771496,0.6285714285714286,0.9929391733693058,1.0,3/19,9.65%,HOPX;CLU;TMEM35A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.5100519194953816,-0.9254930839181205,0.53125,0.9954380815604128,1.0,4/16,11.55%,NOS1;CACNB1;UBASH3B;CAV3
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.5095052933809048,-0.9253514322958583,0.5230769230769231,0.9952463409336731,1.0,6/18,19.22%,ID2;LRRK2;TOX;PTPRZ1;TAFA1;SHCBP1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.46186845100689133,-0.9249209754392848,0.5671641791044776,0.9958733579417453,1.0,8/27,22.74%,WWTR1;E2F1;RUNX1T1;ZFPM1;TGFB1;GPS2;BBS12;WNT5A
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.48238539762123545,-0.9248255504031418,0.5423728813559322,0.9956094009747908,1.0,3/15,18.52%,PIGH;PIGC;PIGB
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.5650871249687384,-0.924758994103461,0.5614035087719298,0.9952831721565701,1.0,2/10,12.18%,LMOD1;TMOD1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.5323877336161488,0.9246726548949931,0.5714285714285714,1.0,1.0,3/12,19.54%,IDH2;IREB2;ASS1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.5081550316610097,0.9245331556341733,0.6585365853658537,1.0,1.0,2/9,3.95%,EVI2B;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.5224060569907387,0.9244021995965996,0.5,1.0,1.0,3/13,13.74%,TNKS2;PKIB;MAP2K7
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.3669081385548336,0.9243664257043533,0.6666666666666666,1.0,1.0,4/73,4.56%,CXCR4;LEPR;IL4R;IGF1R
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.32741894924102427,0.9242814142197778,0.5416666666666666,1.0,1.0,26/112,23.00%,PSME2;UBC;HSPA1A;EXOSC8;PSMD13;CSDC2;SAMD4A;DCP1A;PRR5L;UBB;ANP32A;PSME4;PNPT1;PSMF1;EXOSC7;PSMD11;MAPKAPK2;DIS3;PSMD4;EXOSC5;PRKCA;YTHDF1;AKT1;PSMB4;PSMB5;NUP214
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.5556677224585116,-0.9242333517667488,0.5507246376811594,0.9961255936144463,1.0,2/8,16.78%,GNPTAB;ITPK1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5459271846497445,-0.9242045641474016,0.6545454545454545,0.9956985160572971,1.0,3/9,24.76%,ADH4;ADH5;ACSS2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.5485377827857464,0.9241182247426712,0.5384615384615384,1.0,1.0,1/9,0.89%,NUPR1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.41164771480413287,-0.9240048984794809,0.5774647887323944,0.9956945400440802,1.0,24/71,24.60%,PDGFD;EDN1;LRRK2;DIRAS1;CBLC;LYN;CAV3;VEGFA;HTR2B;EGFR;AGT;TGFB1;PIK3CB;PTPRJ;RASGRP1;EZH2;TENM1;IL34;PDGFRB;FLT1;RGS2;PRKCD;UCHL1;STK38
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.56155179321381,-0.9236717414969892,0.5573770491803278,0.9955330511308574,1.0,3/7,19.57%,TYRP1;CDH3;OPN3
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.56155179321381,-0.9236717414969892,0.5573770491803278,0.9955330511308574,1.0,3/7,19.57%,TYRP1;CDH3;OPN3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.33562805335395635,-0.9236646231401158,0.7640449438202247,0.9950543569481659,1.0,112/686,20.49%,GRHL1;FOSL2;TLR2;NR4A3;HEY1;PPARG;TNFRSF1A;IL26;TGFB2;PLSCR1;ELK3;GLIS2;IRF1;TP73;PLAG1;MLIP;MEF2C;EDN1;CITED4;CASZ1;SOX9;NOS1;MACC1;PLAC8;FOS;BCL11B;CITED2;NLRP3;HGF;MET;CRLF3;GATA1;BMP6;ETV1;WWTR1;AR;E2F3;XBP1;E2F1;MRTFB;RARB;RFX5;CDH13;BTBD18;CEBPB;GLI3;CAMK1;GLIS3;HJV;VEGFA;NR2F1;TGFB3;BMPR1B;EGFR;LDB2;PAX6;PRKD2;MOSPD1;SKAP1;PID1;TRERF1;SPI1;POU2F2;ZFPM1;NLRC5;STAT1;TGFB1;TOX2;ESRRA;NR1D1;UHRF1;NGFR;FHOD1;MAFF;BRCA1;IRF4;LHX4;RFXANK;NFKBIA;POU5F1;PFKM;PPP3CA;CIITA;PSMC3;CX3CL1;PTPRN;NFYB;LILRB1;CLOCK;MAP2K5;HNF4G;SREBF1;EPAS1;RNF111;STAT3;ZNF593;NR2F2;MICAL2;CKAP2;ONECUT2;PLXND1;ESR1;TAF6L;KAT2B;ERG;KAT6B;PER1;KLF6;HLF;RREB1;BCL9;USF2
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.430693496268893,-0.9236507336394526,0.6142857142857143,0.994595311305112,1.0,8/52,11.42%,LPL;TLR2;TNFRSF1A;NLRP12;NINJ1;IL16;IFI35;NMI
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.45755935059658037,-0.923588559139751,0.5737704918032787,0.9942852494421078,1.0,4/26,18.21%,GLRA2;XBP1;VEGFA;NEURL1
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.5785806331445292,0.9235044047259013,0.5918367346938775,1.0,1.0,1/6,2.93%,MYOF
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5479644089236032,-0.9234772861568832,0.6190476190476191,0.9940473278388016,1.0,3/10,6.44%,CLDN5;CLDN16;CLDN20
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.4356093589775999,-0.923422273110709,0.5522388059701493,0.993689978013828,1.0,16/64,17.70%,IRGM;MEF2C;VIM;NLRP3;CX3CR1;XBP1;LDOC1;AXL;LYN;TNFRSF1B;ZFP36;TGFB1;NR1D1;LY96;GIT1;LILRB1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.5039493031467455,-0.9229670789376073,0.5873015873015873,0.9943137366927576,1.0,2/19,10.00%,AXL;HLA-DRB1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.5046176422959556,-0.9227974168773672,0.6212121212121212,0.9943008985721985,1.0,9/18,20.44%,NTN4;NTNG1;MYH11;LAMB1;TGFB1;NTNG2;LAMB4;LAMB2;GAS6
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.42677270186981003,-0.9226679201824788,0.5882352941176471,0.9941924841277151,1.0,11/62,21.18%,DND1;PPARG;WTIP;NUP43;ZFP36;TGFB1;POU5F1;STAT3;NUP88;POLR2J;NUP50
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.537333583364971,0.9222606250249008,0.575,1.0,1.0,3/12,19.48%,NCSTN;ADAM19;CLN3
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.5368397829477994,0.9220675175699029,0.5952380952380952,1.0,1.0,4/8,24.80%,PCM1;CEP120;DOCK7;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.585903289903339,-0.9220389181039089,0.6666666666666666,0.9951590223470951,1.0,1/8,2.11%,HLA-E
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.5195179104377148,-0.9219282249068622,0.639344262295082,0.9948879506445463,1.0,1/14,1.52%,SHMT2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4099533713364845,0.9218780982775571,0.6129032258064516,1.0,1.0,16/51,22.73%,LSM7;EXOSC8;SAMD4A;DCP1A;DCP1B;CNOT9;PATL1;EXOSC7;DIS3;DCPS;PDE12;EXOSC5;PAN2;POLR2D;CNOT2;TUT4
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.43865045291476645,-0.9218140523750432,0.5606060606060606,0.9946505528214377,1.0,10/42,15.41%,KIAA1614;LRRK2;FES;LYN;MAP2;TRIM46;ADGRE2;PARD6A;EFNA5;NR1D1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5317830135393826,-0.9217138033442903,0.5606060606060606,0.9943895387266632,1.0,2/10,8.59%,DOCK8;LRCH1
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.5518781471415111,0.9217137713006855,0.5952380952380952,1.0,1.0,2/8,4.72%,FOLH1B;AGBL2
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.6468429294503844,-0.9217068102366003,0.640625,0.9939094682156463,1.0,2/6,17.33%,CX3CR1;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.3925927915300678,0.9215619054015214,0.6,1.0,1.0,16/41,25.52%,HSPA1A;SLC38A2;RIOK1;RIOK2;NFKB1;PNPT1;RELA;DDX5;RBM22;MYCN;SIRT7;UTP15;LIN28B;ERN1;MAP2K2;DXO
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6072341077060714,-0.921552748417065,0.7258064516129032,0.993696729104657,1.0,3/6,26.10%,CAV1;KCNE1;ANK3
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.5370630359264815,-0.921326244493087,0.6,0.993731874932356,1.0,4/15,16.87%,EDN1;NMUR2;NFATC2;PPP3CA
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.48946644297405245,-0.9212954068028871,0.609375,0.9933052029931234,1.0,6/19,21.35%,PPARG;CAV1;LRP1;NFKBIA;GPS2;RXRA
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4622156332669435,-0.9210569242327165,0.5714285714285714,0.9934784977307973,1.0,8/26,13.95%,PCSK2;PCSK1;DCX;CHGA;PAK3;PAX6;SLC2A2;SYT13
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4109686101054178,-0.9205583870794217,0.5285714285714286,0.9940701480519578,1.0,16/64,13.66%,RIMS1;CACNG2;SYT1;GRIK2;LGI1;SLC8A3;GRIN2B;CACNG3;ADCY8;SLC24A1;CLSTN3;RIMS2;CACNG8;DLG4;FLOT1;GRIN2D
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.35871138596521646,-0.9205123380025209,0.6986301369863014,0.9936581993522807,1.0,16/203,14.09%,EPN1;CR1;RIMS1;MX1;SYT1;BAIAP2L2;SH3GL2;AMPH;NEMP1;SAR1A;CAV3;EGFR;DNM1;KIAA0319;TGFA;COX18
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.3805282429290451,0.9205058404955304,0.5,1.0,1.0,9/84,9.50%,PASK;TRMT10C;PIWIL2;PLD1;NAT10;EIF3E;EIF3D;SAMD4A;FASTKD3
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.6188358675399078,-0.9203895383398686,0.6071428571428571,0.9934414585426178,1.0,3/5,15.76%,FUCA2;CAV1;ITGAV
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.5223877538883099,-0.920322938171523,0.5454545454545454,0.9931062058869422,1.0,3/10,13.80%,ALDH1A2;CYP3A5;ALDH8A1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.563242137244104,-0.9202986122755638,0.59375,0.9926905888651271,1.0,3/12,22.39%,WTIP;CIT;SHANK2
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.597596025289296,-0.9201333111336111,0.6415094339622641,0.9926027374721265,1.0,1/7,1.19%,NR4A3
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.5108851791311358,-0.9197696600314016,0.6166666666666667,0.9928801061773425,1.0,3/15,12.32%,TGFB2;GLI3;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.4228208244104569,-0.9191694898269845,0.6176470588235294,0.9937970600979509,1.0,11/44,17.18%,CLDN5;THY1;TEK;CLSTN3;VEGFA;CAV1;EPHB1;FLOT1;AGT;PTPRJ;NRXN1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.45832300565239725,-0.9190795372761337,0.5882352941176471,0.9935382513309897,1.0,3/25,11.76%,CHKB;PLAAT4;ETNPPL
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.577463737706772,-0.9186640554869754,0.582089552238806,0.9939378668240256,1.0,5/7,34.08%,SREBF1;ATP5IF1;HAX1;MAPT;PINK1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.4166907117209792,-0.9183978717271626,0.6268656716417911,0.9940389297008346,1.0,7/64,14.07%,F8;CD59;SAR1A;GRIA1;RAB1B;TGFA;MCFD2
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.5998995071753683,-0.918329999803371,0.6129032258064516,0.9936621216280882,1.0,3/5,26.59%,XBP1;SLC2A5;GCKR
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.46996215189483426,-0.9182954811340731,0.6323529411764706,0.9933045939644474,1.0,6/26,22.08%,MEF2C;TGFBR2;CCDC39;MICAL2;NDRG4;MESP1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.5508796763951567,-0.9181000394400928,0.6119402985074627,0.9932687697191903,1.0,1/7,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4372831147966561,-0.9179609274608684,0.6052631578947368,0.9930204231345862,1.0,7/36,13.17%,CAMK1D;KNDC1;ZDHHC15;HECW1;PACSIN1;NEDD4L;KIAA0319
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.5188609363941652,-0.917960430739775,0.6818181818181818,0.9925362591057542,1.0,2/15,8.41%,SNAP25;STX3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.5523090850760862,0.9178320212361539,0.575,1.0,1.0,1/8,1.31%,CD274
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.554499212294868,-0.9177872563892844,0.6346153846153846,0.9924206405112568,1.0,1/9,17.60%,VCL
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.5269002408241219,0.9177050515855086,0.58,1.0,1.0,3/8,18.97%,VAMP4;STXBP6;SNCA
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.4303561237973841,-0.9176718553685225,0.6301369863013698,0.9921494869816131,1.0,9/53,18.60%,TGFB2;RFTN1;LGI1;PLCB1;TRIM32;EGFR;HPN;NCBP1;CXCL16
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.506458591883308,0.9174193261446207,0.675,1.0,1.0,1/8,5.20%,MST1
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.5990547580653878,0.917306857987812,0.6410256410256411,1.0,1.0,3/5,26.65%,VKORC1L1;CBR1;CYP4F11
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.5309514606813143,-0.9172948659440268,0.6530612244897959,0.992449027377752,1.0,6/12,17.41%,ANGPT1;BMP6;VEGFA;TJP3;TGFB1;TRPV4
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.5255348692118702,0.9168360504874503,0.5952380952380952,1.0,1.0,2/5,9.02%,ANXA2;AKT2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.39583199283396453,-0.9166610703893332,0.6811594202898551,0.9933938206120986,1.0,22/104,14.34%,TRPC4;TRPC6;EDN1;ATP2B3;ATP2B2;TPCN2;HTR2C;SLC8A3;SLC24A5;TRPC7;SLC8A1;ADCY8;SLC24A1;HTR2A;PLN;CALB2;CAV3;CAV1;HTR2B;CAV2;CDH23;HCRTR2
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.6184388190888024,-0.9162877891532553,0.7241379310344828,0.9937631100680437,1.0,1/6,4.85%,CITED2
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.6096133711256152,-0.9161585018929274,0.7049180327868853,0.993543612816593,1.0,2/5,24.49%,ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.5215102892781172,0.9152388740564348,0.5348837209302325,1.0,1.0,3/7,29.37%,CCDC88C;GSN;PIK3CA
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.5204400630593116,-0.9151727328205457,0.5238095238095238,0.9953710620931517,1.0,2/7,15.76%,LRP1;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3929636237894575,0.9151172517764858,0.5714285714285714,1.0,1.0,15/56,16.02%,ESPL1;PPP1R10;DMRT1;EPC1;UXT;RYBP;RNF2;ZFYVE19;MGA;KIF25;CBX5;RBBP4;TFDP1;E2F6;PHC1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.4217269529724373,0.9143763401381453,0.5641025641025641,1.0,1.0,3/22,6.84%,SLC22A6;ABCC2;SLC26A7
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.3973626814548724,0.9136588138841943,0.5128205128205128,1.0,1.0,12/49,17.29%,ACADS;CROT;ACAA2;ACADVL;ECHS1;PEX2;ECI1;ACAT2;ACOX1;IVD;ACAD10;HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.49227447953783715,0.9132986661968017,0.5526315789473685,1.0,1.0,3/13,8.62%,WNK4;DRD4;ATP1B1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.4762413141145159,-0.9131924651600797,0.6621621621621622,0.999242475459845,1.0,8/28,13.60%,TESPA1;LGALS3;LAPTM5;CEACAM1;CARD11;THY1;CD160;PRKD2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.5623482089848095,-0.9127288388923893,0.6046511627906976,0.9998291352858543,1.0,2/9,21.12%,DNM1L;VPS35
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.40780354139380176,-0.9126509475161313,0.5757575757575758,0.9995413448019095,1.0,5/73,5.04%,P2RY12;TWF2;PLPPR5;CARMIL2;GPM6A
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.3841022879725568,0.9126429970066081,0.6206896551724138,1.0,1.0,11/65,16.51%,NUPR1;RAE1;NUP42;FBP1;NUP210;TPR;PRKAA2;HDAC4;NUP37;ZBTB7A;PFKFB3
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.59101688736982,-0.9126372029980454,0.6481481481481481,0.9990894732273105,1.0,2/6,15.57%,SMOX;SAT1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.4823060463820622,0.9125626747205381,0.5,1.0,1.0,3/12,25.42%,PJVK;PIK3R4;TRAPPC8
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.4875754060980969,0.9120421326219044,0.5348837209302325,1.0,1.0,5/11,14.42%,DUSP1;SLIT2;GREM1;MIA3;BMP5
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.48648476767394333,-0.9120182149429217,0.6166666666666667,1.0,1.0,5/22,16.47%,KIF16B;MVB12A;TPP1;TGFB1;SIAH1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.5679845045402541,-0.9116547829912415,0.5806451612903226,1.0,1.0,2/8,5.34%,NOS1;DDAH1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.5275607514048473,0.9115848847519621,0.64,1.0,1.0,4/10,11.09%,SERPINF2;NLRP7;SERPINE1;GAS1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.5601128573762,0.9113563453570331,0.6585365853658537,1.0,1.0,1/7,6.44%,PLA2G4C
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.4995143045708616,0.9112762387565566,0.6153846153846154,1.0,1.0,1/9,6.14%,CHMP5
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.4995143045708616,0.9112762387565566,0.6153846153846154,1.0,1.0,1/9,6.14%,CHMP5
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.4604534470940742,-0.9111550478744547,0.6190476190476191,1.0,1.0,7/28,16.36%,SEMA3E;SEMA3D;MAP2;KIAA0319;TRIM46;SEMA4B;SEMA4G
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.38573317814355534,-0.9109641005246429,0.6533333333333333,1.0,1.0,18/147,13.96%,ANGPT1;P2RY12;IL26;KITLG;FGF22;PIK3AP1;F3;HGF;MET;CX3CR1;CHI3L1;TEK;AXL;NRG4;EGFR;FGF7;NRG1;TGFA
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.555495638454951,-0.9105737014173426,0.6,1.0,1.0,1/10,1.80%,RDH13
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.6033739538501436,-0.9104021458350672,0.6071428571428571,1.0,1.0,3/6,26.79%,LRRK2;RBX1;MTA1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5044100991825761,0.9102214926005692,0.5897435897435898,1.0,1.0,4/8,18.10%,ACTN2;ATP1B1;AKAP9;LRRC38
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.44433727181157023,0.910217606778791,0.5625,1.0,1.0,9/24,21.90%,ZNF335;DPY30;BEND3;ASH2L;KMT2B;WDR5B;MEN1;KMT2D;TET3
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.49688743003878677,0.9099910634586866,0.5945945945945946,1.0,1.0,3/16,12.87%,ZNF335;PIH1D1;DNMT1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.37549198072904594,0.909919354912734,0.5294117647058824,1.0,1.0,4/61,6.28%,BACE2;LEPR;IGF1R;LRRC8A
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.6373640941948395,-0.9098599652158995,0.65,1.0,1.0,1/6,5.11%,ALOX12
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3329078825798731,-0.9097610065127515,0.7529411764705882,1.0,1.0,95/538,21.37%,ZNF366;KANK2;ZIM2;DACT1;NR4A3;HEY1;PPARG;PARP9;ZNF550;CRYM;GLIS2;MLIP;MEF2C;EDN1;ID2;ZNF343;SOX9;ZNF239;CITED2;ZEB1;ZBTB32;CCND1;EFNA1;GATA1;BMP6;ZNF608;ZNF20;AR;BHLHE40;E2F1;RARB;CEBPB;ZNF764;GLI3;GTF2IRD1;H1-0;ETS2;DNAJB1;ZNF391;GLIS3;HJV;VEGFA;NR2F1;CAV1;NEDD4L;ZNF217;EDNRB;LDB2;PAX6;MOSPD1;ORC2;CBX7;PCGF2;SPI1;ZFP36;ZFPM1;ZNF248;STAT1;NR1D1;ID3;UHRF1;MYT1L;ETV6;ZFP69;TGIF1;POU5F1;PRDM1;CIITA;MAD2L2;TENM2;CBX8;EZH2;MAP2K5;POU6F1;MACROH2A2;ZNF10;STAT3;ZNF140;NR2F2;ZNF136;ESR1;ZNF705G;BCL6;ZNF566;PER1;RREB1;AASS;ZNF749;GPS2;IL33;BCL11A;MDFI;RXRA;KLF8;NR1I3
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.513034173839607,-0.90947227910008,0.6415094339622641,1.0,1.0,4/12,20.73%,DYNC2H1;DYNC2I2;WDR35;IFT122
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.4969098890111081,0.9093293251727282,0.5277777777777778,1.0,1.0,2/15,6.12%,ISYNA1;IP6K2
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.5937470089697594,-0.9092478215239015,0.6,1.0,1.0,3/5,34.43%,CCBE1;PROX1;BMPR2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.4449322702097138,-0.9092459639181109,0.6233766233766234,1.0,1.0,11/47,13.52%,FMO5;SLC22A9;PDZK1;TSHR;SLC5A9;SLC23A1;TPO;SMLR1;ABCG5;CYP3A5;SLC2A2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4753162503030419,-0.908844253124704,0.6521739130434783,1.0,1.0,4/23,18.35%,EPHA4;EFNA1;OPHN1;PRKCG
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3766569101895819,0.9087446187316389,0.6341463414634146,1.0,1.0,7/61,9.02%,SH2B2;GAB1;IGF1R;ATP6V0A4;ATP6V1G2;ATP6V1G1;AKT2
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.5512574710681591,0.9082700709224509,0.6052631578947368,1.0,1.0,4/8,20.55%,RAB39A;RAB7B;CLN3;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.5278670226340026,-0.9082514815313116,0.6451612903225806,1.0,1.0,3/10,19.99%,CSF1R;CXCL17;IL34
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.3964923249351485,-0.9082153646543287,0.5970149253731343,1.0,1.0,12/75,14.10%,SHMT2;GLRA3;CARD11;NINJ1;POLQ;KCNC2;HLA-DRB1;ADCY8;PRMT8;AQP11;NOL3;RNF213
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.3780971469134771,-0.908165213336936,0.671875,1.0,1.0,17/139,17.05%,ERCC6L;CENPK;CENPE;SPC25;CENPF;RAB11A;DYNC1LI1;NUP43;ZWILCH;DSN1;CENPA;NUF2;CENPL;CENPQ;KIF2C;PLK2;MAD2L1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.4403833812533251,-0.9078713559296465,0.5737704918032787,1.0,1.0,8/51,16.47%,DENND3;CEACAM1;FBXO17;PRPF19;TPP1;NR1D1;ADAMTS9;SIAH1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.45652125948446864,-0.9077264311525546,0.6461538461538462,1.0,1.0,3/28,6.31%,IL26;PTPRC;CRLF3
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.3799467684344069,-0.907711748094473,0.7051282051282052,1.0,1.0,32/169,13.38%,ITGB4;GJC3;SPARCL1;SHISA6;TCEAL6;HTR5A;C1QL2;ASTN1;SYNPR;TCEAL5;BRINP2;ATP2B2;CDH22;CADM3;GRM5;HPCA;SNCB;PHF24;SLC25A19;MPPED1;RGS7BP;ATP1B2;ADCY8;ST8SIA3;LRRTM3;OPCML;EPHB1;OPALIN;RAPGEF4;AQP4;PHYHIP;PTPRT
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.4799236154463808,-0.9076677116681693,0.647887323943662,1.0,1.0,10/25,24.15%,CENPK;CENPA;MIS18BP1;CENPL;CENPQ;OIP5;ITGB3BP;CENPI;CENPP;MIS18A
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.4799236154463808,-0.9076677116681693,0.647887323943662,1.0,1.0,10/25,24.15%,CENPK;CENPA;MIS18BP1;CENPL;CENPQ;OIP5;ITGB3BP;CENPI;CENPP;MIS18A
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.3780312132537062,0.9076503534555084,0.52,1.0,1.0,19/107,10.82%,SLC22A2;SLC38A1;TXNIP;ABCC2;ABCC1;SLC25A29;SLC52A1;SLC38A2;SLC7A11;ARRDC4;SLC52A2;ARRDC5;ARRDC3;CEP290;CUBN;SCAMP2;SLC6A13;CMTM6;SLC38A3
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.5148657524226432,0.9073866677923057,0.64,1.0,1.0,1/11,0.35%,SPIRE2
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),-0.603151672968987,-0.9072804544331168,0.631578947368421,1.0,1.0,1/5,14.32%,GDPD1
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),-0.603151672968987,-0.9072804544331168,0.631578947368421,1.0,1.0,1/5,14.32%,GDPD1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.39451549231728084,-0.9071839179162814,0.6027397260273972,0.9999714373048211,1.0,31/114,25.70%,LAMP5;GBP2;ISG15;LRRK2;RAB11A;SCG3;TRAM1L1;MTCH2;SNX10;PPP1R15A;TRAM2;TULP3;FSIP2;RPA2;SEC61G;WDR35;ATP6V1D;IFT122;VPS35;ALDH3A2;CEP68;ARL1;CNTLN;FAM149B1;RPA1;XPA;EHD1;OBSCN;PAQR3;CALR;CSNK1D
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.467605689344322,-0.9070607378152356,0.6027397260273972,0.9997520153616423,1.0,6/21,13.52%,SLC23A1;TCN2;AMN;SLC35F3;CBLIF;SLC2A2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.6249487446987904,-0.9070464676516848,0.6949152542372882,0.9993054557749714,1.0,5/6,34.93%,STAT3;PIK3R1;PXN;GHR;PTK2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.4126721130739455,-0.9069703545141157,0.5466666666666666,0.9990077249300594,1.0,7/35,11.53%,PLPPR5;ALOX12;PLPPR3;DGKD;SGPP2;DGKB;CYP3A5
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.5839790423719319,-0.9068239043292231,0.7096774193548387,0.9987705381790788,1.0,1/9,5.57%,PDXDC1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.567007302858083,0.9066601791548075,0.6226415094339622,1.0,1.0,1/5,7.71%,PHF1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.5123755424907672,-0.9064135764748604,0.6612903225806451,0.9992146431463119,1.0,2/13,10.19%,CIDEB;TBC1D10A
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.4728428254107915,-0.9063236228955088,0.5942028985507246,0.9989822151809419,1.0,4/25,9.09%,TGFB2;MEF2C;SOX9;SGMS2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4228881460457381,-0.9061652673160563,0.6056338028169014,0.9988703546902354,1.0,10/56,16.54%,BAIAP2;NCKAP1L;VAV3;AXL;CYFIP1;SULF1;VEGFA;PRKD2;ITGAV;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5203420204410727,-0.9061062229277682,0.582089552238806,0.998555037172417,1.0,1/9,1.95%,IL12A
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.4816319885801516,0.9055647430234378,0.5625,1.0,1.0,6/18,15.95%,TTLL9;TTLL1;VKORC1L1;TTLL11;AGTPBP1;TTLL3
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5684843771198144,-0.9055593120319442,0.6885245901639344,0.9992481058522197,1.0,2/7,16.12%,LOXL3;MTHFD1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.6347008777938663,-0.9053440305113919,0.7076923076923077,0.9992240973108629,1.0,3/5,34.91%,SETMAR;SETD3;SETD5
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.5935845934268962,-0.9053185120382041,0.6440677966101694,0.9987935665651307,1.0,2/6,13.96%,PRPS1;PRPSAP1
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.6054025619288537,0.9050387632478397,0.625,1.0,1.0,2/6,3.99%,F2;EPHB2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.5206771224294204,-0.9047796102926108,0.6521739130434783,0.9994993828657462,1.0,6/11,24.23%,LAPTM5;TNFRSF1B;SCIMP;LILRB1;WNT5A;TRIL
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.4594734331793786,0.9046249272159366,0.5454545454545454,1.0,1.0,5/18,16.50%,SMYD1;HDAC1;HDAC9;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5426856432628251,-0.9045207781974627,0.5789473684210527,0.9995675974212068,1.0,2/8,15.07%,EGFR;TGFB1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.5359845249229658,-0.9042723188877558,0.7,0.999543482420868,1.0,3/11,16.23%,HLA-E;IFNA2;IRF4
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.5313082967157772,-0.9041000966776074,0.5970149253731343,0.9994778911068003,1.0,1/9,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.40677896552649057,0.9040217708580598,0.5757575757575758,1.0,1.0,10/84,5.28%,GJC1;TNNC2;CRYAB;MYH4;MYOF;CASQ2;MYH3;TPM2;ACTN2;MYOM1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.43841668507214815,-0.9040201447636993,0.65625,0.9992003557532518,1.0,10/58,15.07%,HEY1;HOPX;SOX9;RPS6KA6;PRAME;THY1;CST3;KIAA0319;SPI1;TGFB1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.39961215086736,0.9039589229071094,0.5142857142857142,1.0,1.0,14/46,23.72%,RAE1;NUP42;NUP210;TPR;PNPT1;NOS2;NUP37;ZBTB7A;NOA1;NDC1;SEH1L;PGAM1;NUP214;KHK
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.5697091604229694,0.9039235036030987,0.65,1.0,1.0,3/7,9.81%,FGFR1;PLIN5;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5153215613825967,-0.9036630718606509,0.6507936507936508,0.9994574551571143,1.0,5/18,20.88%,PARP9;DTX3L;STAT1;LILRB1;PQBP1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3465732002409662,0.9035827533168033,0.5555555555555556,1.0,1.0,5/83,2.79%,CXCR4;TBXA2R;JPH1;CCR3;HMGB1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.5617701769208067,-0.9033785943708755,0.6545454545454545,0.9995577586393035,1.0,1/8,8.98%,OGFOD1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.46660075607382845,-0.9033513724299495,0.6515151515151515,0.9991379108381951,1.0,6/29,15.46%,RHBDF2;IL12A;CHGA;KCNB1;OPRM1;CD200
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.45583547300806454,-0.9030416842336183,0.5857142857142857,0.9993762731803002,1.0,4/35,17.70%,ISG15;TRIM25;NLRC5;LILRB1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.40776875263334134,-0.9028714873862277,0.6527777777777778,0.9992189902463909,1.0,8/68,15.19%,CLDN5;TGFB2;TGFBR2;FOS;FURIN;TGFB3;TGFB1;PARD6A
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.5216768098497422,-0.9027144328825335,0.6,0.9990021123506091,1.0,2/9,16.86%,CDK5R1;GRIN3A
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.40717136924424513,0.9026840647052008,0.5952380952380952,1.0,1.0,4/32,8.00%,ATP6V0A4;TF;ATP6V1G2;ATP6V1G1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.4785978369515255,0.9026759445243555,0.6176470588235294,1.0,1.0,5/14,21.83%,RPL7L1;URB1;FTSJ3;NIFK;RPL7
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.5204430311178377,0.9026374948195639,0.6808510638297872,1.0,1.0,1/7,1.35%,DPEP1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.5204430311178377,0.9026374948195639,0.6808510638297872,1.0,1.0,1/7,1.35%,DPEP1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.5733370510308684,-0.9026195752092929,0.6119402985074627,0.9987119437095624,1.0,1/5,2.94%,PDE10A
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.4384665378454259,-0.9023552917727793,0.5967741935483871,0.9987434450149714,1.0,6/37,11.94%,FBLN1;PTPRC;RPS6KA6;LMO3;LYN;PTPRR
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.34268884212493017,-0.9023544647949606,0.7368421052631579,0.9982701068893719,1.0,71/363,16.03%,GFRA3;PPP1R17;WNT8B;DACT1;NAGLU;CHRM3;ZIC4;PCDHB12;GLIS2;ALDH1A2;NRCAM;CNTFR;MEF2C;FGF12;L1CAM;NMUR2;KALRN;APC2;ROBO2;GPM6A;MET;NPTX1;DCLK1;RPS6KA6;ADGRV1;SCN2A;DCX;PCDHB11;NRGN;LGI1;GFRA2;WWTR1;PCDHB4;BTD;NELL1;EMX1;PRPS1;SH3GL2;NINJ1;GRIK1;ASIC2;AXL;NAV3;ACTL6B;NDP;TPP1;TAGLN3;VEGFA;PCDHB9;EPHB1;DLG4;APAF1;EDNRB;SRRM4;LDB2;CHST8;NRG1;NRSN2;PAX6;CHRM1;OPHN1;PTPRZ1;CNTN4;NOTCH2;TGFB1;NRSN1;EFNA5;MYT1L;PCDHB13;NHEJ1;LY6H
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.5486294797580132,-0.9023291047364255,0.6557377049180327,0.9978889572927934,1.0,3/10,19.57%,TYRP1;CDH3;OPN3
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.5108604885249307,-0.9022547312877913,0.5846153846153846,0.9975586017865913,1.0,2/11,9.69%,FCHSD2;CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.38507294173860784,0.901704828911736,0.5277777777777778,1.0,1.0,2/23,7.26%,ENPP1;NCK1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.374743389243454,-0.9016607938945033,0.6197183098591549,0.9984017205160579,1.0,21/111,22.50%,MX1;ITGAM;SFTPD;TPCN2;AMN;FCHSD2;CAV1;LRP1;DNM1;CAV2;SCARB1;RAMP1;SYK;LILRB1;MSR1;CXCL16;FNBP1L;HYOU1;HPR;MRC1;COLEC12
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.49773747987983563,-0.9016470697784673,0.6323529411764706,0.9979615031260217,1.0,4/16,17.01%,LZTFL1;PID1;TGFB1;MRAP
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.5308683538435964,-0.90142815025079,0.6376811594202898,0.9979657999114295,1.0,1/9,2.06%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4853338276011966,0.9012337458818475,0.6470588235294118,1.0,1.0,4/10,19.46%,ERRFI1;VPS25;SOCS4;CBLB
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5065855433522397,0.9009687836326349,0.5957446808510638,1.0,1.0,1/8,0.70%,DHFR
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.49346214514570763,-0.9008300768853315,0.6935483870967742,0.9988304116809789,1.0,4/19,12.42%,NOSTRIN;DDAH1;CAV1;EGFR
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.3904063252869432,0.9007872144262835,0.5882352941176471,1.0,1.0,12/43,20.00%,HDAC10;PRDM5;HDAC1;ZNF541;HDAC9;ELK4;HDAC4;MIER3;HDAC3;TBL1X;SIRT1;SUDS3
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.6296478263494512,-0.900693362291373,0.6666666666666666,0.9986970738585009,1.0,2/5,22.74%,NLRC5;WNT5A
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.490232120523139,0.9003428497753293,0.6190476190476191,1.0,1.0,7/20,16.90%,NAT10;TFB1M;MTERF4;DKC1;TFB2M;FTSJ3;METTL5
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.37610794235052064,0.9002034831340616,0.6666666666666666,1.0,1.0,13/96,10.24%,CXCR4;JPH1;EPB41L4B;ONECUT1;SOWAHA;DUSP15;FAM222A;EFNA2;ATP1B1;MYH14;C2ORF72;FGFR3;CD276
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.431560021670396,-0.9001262998848177,0.6764705882352942,0.9993822220071417,1.0,5/41,8.62%,MGST1;TXNRD2;GLRX;FES;IPCEF1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.6178839614620341,-0.8999671627699699,0.6481481481481481,0.9992761677419417,1.0,2/5,28.52%,IL12RB1;IL1R1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.43375884818565486,-0.8997844405380362,0.6190476190476191,0.999151943404491,1.0,8/34,18.31%,NCKAP1L;GATA1;LYN;SPI1;ZFP36;ZFPM1;STAT1;STAT3
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.4562444541546281,-0.8996592682890122,0.6086956521739131,0.9989365286569329,1.0,2/24,4.99%,KDM4D;KDM3A
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.5160563772966396,-0.8996229772289607,0.6190476190476191,0.9985387879020569,1.0,3/12,36.26%,UBA5;RB1CC1;ULK1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.4155622078363637,-0.8995104286732809,0.6233766233766234,0.9982600098332738,1.0,6/33,16.76%,TRPC4;TRPC6;COX17;TRPC7;CP;SLC11A2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.5894020016191376,-0.8993721028965309,0.7045454545454546,0.9980726728495424,1.0,2/7,18.31%,MAP2K5;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4997353679007858,-0.8991120855192996,0.6153846153846154,0.9982090438277809,1.0,2/14,6.91%,ISG15;SAMHD1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.5778070411443883,0.8989861454998814,0.6666666666666666,1.0,1.0,1/6,6.38%,BAK1
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.40431882360506305,0.898986069315361,0.6060606060606061,1.0,1.0,10/26,15.71%,IL4R;KCNN4;GPA33;FBP1;SLC26A3;WNT3;DLL1;LGALS4;LGR4;ATG16L1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.47419318972049684,-0.8989557748016308,0.5573770491803278,0.9980492348932154,1.0,11/25,15.70%,PKP2;FGF12;GJA1;SCN4B;SCN1B;CAV3;NEDD4L;ATP1A1;CACNA1G;KCNH2;CACNA1C
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.5458086302665335,-0.8989083264798183,0.5531914893617021,0.9976756087714683,1.0,4/6,37.99%,POU5F1;LEO1;PAF1;RTF1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.48623470895931675,-0.8988336662024814,0.5970149253731343,0.9973341863199391,1.0,5/20,14.83%,LOXL3;CHI3L1;VEGFA;FGF7;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.47183649204648,0.8988292738319612,0.5641025641025641,1.0,1.0,3/9,5.86%,ERRFI1;TESK1;ENPP1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.6108809574191139,-0.8988069166983494,0.6964285714285714,0.9969294094902719,1.0,2/6,15.26%,TEKT3;RSPH9
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.5005920636173296,-0.8987998951998482,0.6226415094339622,0.9964750057751482,1.0,2/17,8.59%,LRRK2;LRCH1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.5633660566377416,-0.8987521755311092,0.6981132075471698,0.9960937317898417,1.0,2/6,13.60%,VEGFA;PRKD2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.5626578234776862,-0.8987308835758961,0.6774193548387096,0.9956810227154127,1.0,3/7,16.13%,ZEB1;CEACAM1;BTG1
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.5706012667373876,-0.8986136513984753,0.6610169491525424,0.9954502883410181,1.0,3/5,23.32%,PTPN11;WNT5A;DNAJC19
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.5202929981407911,0.8985858339482677,0.5714285714285714,1.0,1.0,2/8,24.42%,GTF2H5;CCNH
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.4986212257248692,-0.8983629166290754,0.676923076923077,0.9954965617265631,1.0,7/20,17.04%,PTPRC;RYR3;HTR2C;HTR2A;HTR2B;ITPR3;TRPM2
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.5344432848149338,-0.8982530510426303,0.6388888888888888,0.9952117046096064,1.0,3/10,15.42%,CENPE;NUF2;KIF2C
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.36497244026975345,0.8980765563402725,0.5714285714285714,1.0,1.0,6/59,6.97%,GABRE;GABRR1;LRRC8A;SLC12A9;SLC26A7;CLIC5
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.42654185230648234,-0.8976363902734963,0.5606060606060606,0.995938043936538,1.0,5/41,16.82%,ISG20;DENND3;FBXO17;ADAMTS9;NCBP1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.3569374961686961,0.8973943416529812,0.5588235294117647,1.0,1.0,19/91,16.47%,PM20D1;DHFR;MTHFD2L;GLYAT;ST3GAL1;PDZD11;ATF4;MTRR;PLPP2;NLN;MTHFD2;ACOT6;ACOT12;MTHFD1L;PLAAT5;MME;THEM4;ACBD6;MTHFS
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.6097747564720036,0.8971804767127216,0.6818181818181818,1.0,1.0,1/5,2.29%,OAS3
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.4906715362418282,-0.8971318045874166,0.6984126984126984,0.9966093291391075,1.0,6/22,13.07%,MEF2C;CDON;BOC;OLFM2;CAMK1;NRG1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.5883075296668661,-0.8970810362602353,0.6785714285714286,0.9962700023396586,1.0,1/7,14.10%,RNF213
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.4831932542384956,-0.8970514448566491,0.5964912280701754,0.9958540345123291,1.0,4/17,22.72%,CLU;BBC3;DNM1L;FZD9
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.40075060803890156,-0.8970095139927342,0.6285714285714286,0.9954746541892328,1.0,17/75,24.36%,CENPE;HLA-DMA;HLA-DPB1;SH3GL2;DYNC1LI1;HLA-DRB1;AP1S2;KIF2C;KIF3C;ACTR10;KIF5A;HLA-DPA1;ARF1;CTSS;KIF3A;CANX;DYNLL2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.4905705597834664,0.8969879446657457,0.6923076923076923,1.0,1.0,2/11,3.25%,KCNJ2;CASQ2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.4158879521815654,-0.8969590266265776,0.6438356164383562,0.9951182419127386,1.0,4/51,7.83%,LPL;PLPPR5;PLPPR3;PLAAT4
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.4316707960419408,-0.8968874983438322,0.5972222222222222,0.9947531211832571,1.0,2/28,3.07%,PPARG;FABP3
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.4197040122290727,-0.896729545964952,0.65625,0.9946142666753058,1.0,2/40,2.83%,ATAD5;TSPYL2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.5593327771357731,-0.8966927155547111,0.6666666666666666,0.9942406888030283,1.0,4/10,22.74%,IL7;AXL;GAS6;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5707719063110779,-0.8965761175370661,0.6515151515151515,0.9939532308835857,1.0,1/7,9.55%,AXL
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.5429904238066301,0.8964203585441549,0.5813953488372093,1.0,1.0,2/7,17.28%,DDX3X;DHX9
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.5681524742832307,-0.8963568189855242,0.6984126984126984,0.9939818943507375,1.0,3/6,19.81%,CAV1;FLOT1;TIRAP
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3759310276234533,-0.896190362080914,0.6753246753246753,0.993771496292742,1.0,39/129,15.29%,CLDN5;PTPRM;ROBO4;TGFB2;MMP24;CDH9;ITGAM;CLDN16;CDH12;TGFBR2;L1CAM;EMB;SELL;ROBO2;CDH22;CADM3;LRRC4;NTNG1;CEACAM1;CLDN20;PCDHB11;CDH10;PALLD;PCDHB4;TENM3;CDH18;CDH13;VSTM2L;GPC6;PCDHB9;CLDN4;CDH3;LRFN5;SLITRK3;PTPRT;CDH23;CNTN4;MYOT;UNC5D
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.5910356528895986,-0.8961702068356824,0.6610169491525424,0.9933629425165849,1.0,1/7,3.72%,BCAT2
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.4776890297595543,0.8960723901376919,0.6,1.0,1.0,1/10,1.95%,NT5E
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.49525525098132583,0.8960156094797627,0.5897435897435898,1.0,1.0,2/10,3.55%,MGLL;AWAT2
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.5937173923836421,-0.8958001488164952,0.6607142857142857,0.9935991117573727,1.0,2/5,21.02%,GJA1;RNF207
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.4869012843934192,-0.8952340948418736,0.6666666666666666,0.9942809372952086,1.0,1/18,2.24%,PLSCR1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.4705272833126111,0.8950998097271011,0.5641025641025641,1.0,1.0,2/10,5.73%,SSC5D;PGLYRP2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.39566571083897156,0.8950936916967687,0.7027027027027027,1.0,1.0,2/45,1.54%,SPIRE2;MSRB1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.4786242913937462,0.8950356677546045,0.6216216216216216,1.0,1.0,3/14,11.19%,COX19;SLC31A2;COMMD1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.42219250093773447,0.8949774106959668,0.5666666666666667,1.0,1.0,10/46,7.95%,CD38;CXCR4;ZAP70;EVI2B;ITGAL;IL2RA;CD247;GPR174;GNLY;P2RY10
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.4995754789485879,0.89494150313424,0.6052631578947368,1.0,1.0,1/15,0.46%,TBXA2R
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.5476777011553291,0.894830772085371,0.5833333333333334,1.0,1.0,2/5,15.10%,CYP7B1;HSD3B7
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.47844039042920244,0.8947013382641643,0.5434782608695652,1.0,1.0,5/14,25.35%,NAA50;POGZ;RB1;NIPBL;BOD1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4371241317957246,0.894560047470037,0.6875,1.0,1.0,8/24,24.23%,UBE2A;CDC26;ANAPC1;UBE2D4;CDC23;UBE2E2;UBE2L3;ANAPC2
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.5993709178943226,0.8942462080296382,0.660377358490566,1.0,1.0,1/6,7.39%,TNIP1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.530647156447018,-0.8942078714289532,0.6451612903225806,0.9958714730910165,1.0,1/10,5.14%,EPHA4
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.5503425581483425,0.8941477873241258,0.6097560975609756,1.0,1.0,1/6,2.94%,MTCL1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.502139736667316,0.8941135958556289,0.6052631578947368,1.0,1.0,1/8,6.88%,OXSR1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.6089198867703082,0.8939708790887114,0.6923076923076923,1.0,1.0,2/5,22.14%,DKC1;CCT2
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.6089198867703082,0.8939708790887114,0.6923076923076923,1.0,1.0,2/5,22.14%,DKC1;CCT2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.5450950564628968,-0.8936341554693061,0.6515151515151515,0.9965471094198214,1.0,4/10,12.76%,SLC8A1;ATP1B2;NEDD4L;ATP1A1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.5015847018506352,-0.8935219215321486,0.6617647058823529,0.9962866334954055,1.0,3/15,18.50%,MX1;DNM1;DNM1L
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.5553813859712565,-0.8929122889603814,0.6885245901639344,0.9971008082156366,1.0,3/7,9.84%,RAB11A;GRIP1;GRIP2
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.6335553893380198,-0.8928634978737817,0.6851851851851852,0.9967324767380135,1.0,1/6,8.65%,TTLL4
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5228883943531994,-0.8928483672732342,0.640625,0.9963105917714515,1.0,4/12,20.39%,PTPRC;CALM3;PPP1R15A;PDGFRB
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.4904728221629947,-0.8927275897006002,0.65,0.996127024624774,1.0,4/13,17.52%,MET;DACT2;CNMD;COL15A1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.39514992730018406,0.8927185457483241,0.5625,1.0,1.0,4/32,11.09%,CRYAB;NUMA1;ATPSCKMT;GAS1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3801999206812276,-0.8927057337318335,0.6666666666666666,0.9957102983178376,1.0,20/88,26.12%,IHO1;DBF4;SOX9;RAB11A;CALM3;CAV2;DAPK3;PLK2;GIT1;BORA;KIF20B;TTL;PIN1;AURKA;KLHL9;NUDT16;RAB11FIP4;UVRAG;FBXO43;INSM1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.386183146626503,-0.8925113847513927,0.6891891891891891,0.9956841550792855,1.0,12/97,17.38%,LPL;PPARG;ALOX12;AOAH;XBP1;GGT5;ACSM3;ACSL5;LIPI;ACOT11;ABCD2;OXSM
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.5958605270139403,-0.8924822384125155,0.6129032258064516,0.9952904343970193,1.0,1/6,15.19%,PARD6A
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.5901108631491527,0.8924434380196472,0.5588235294117647,1.0,1.0,3/6,13.67%,CDK6;DLL1;HES5
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.6045395105572113,0.8923377130062143,0.6666666666666666,1.0,1.0,1/5,21.88%,AKT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.6045395105572113,0.8923377130062143,0.6666666666666666,1.0,1.0,1/5,21.88%,AKT1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.4868903650954511,0.8923269123601004,0.5405405405405406,1.0,1.0,3/12,8.62%,KCND3;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.39353917146510026,-0.892288799315882,0.6515151515151515,0.9952510670280283,1.0,6/87,4.73%,CLDN5;TGFB2;MEF2C;TGFBR2;SOX9;FOS
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.37848262638358804,0.8922883425732154,0.4482758620689655,1.0,1.0,6/63,3.79%,ADAM33;ADAMTS2;CRYAB;REN;SOD3;SEMA5A
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.5851639755114377,-0.8920544753505895,0.6551724137931034,0.9952744392754556,1.0,4/7,24.27%,UBASH3B;DDR2;ITGA11;COL4A6
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5262608269450566,-0.8920480383504727,0.6290322580645161,0.9948366867964229,1.0,3/8,19.09%,LRP1;PTPRJ;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.45198024631453737,-0.8920226393539812,0.5657894736842105,0.9944396108394737,1.0,7/29,11.17%,TIMP4;TIMP1;EPHA4;LRRK2;EFNA1;TM4SF20;CST3
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.41387128244254867,0.8918935633119727,0.5675675675675675,1.0,1.0,6/33,10.82%,SLC38A1;ABCC1;SLC38A2;SLC7A11;SLC38A7;SLC38A3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.5080752826005815,0.8917004443506237,0.6486486486486487,1.0,1.0,2/9,14.95%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4805580978556411,0.8915150183934702,0.5333333333333333,1.0,1.0,7/14,22.47%,PIH1D1;SMARCA4;NCL;MARS1;NOL11;MTOR;SIRT7
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.40570155072914355,-0.8912977133724457,0.6197183098591549,0.9954830768774254,1.0,11/64,17.59%,CERS6;ST3GAL5;SGPP2;SGMS2;ST8SIA3;PNPLA1;B4GALT6;PRKD2;CERS5;ST6GALNAC5;DEGS2
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4625175623273263,0.8911795790554968,0.5555555555555556,1.0,1.0,2/18,4.58%,SLC22A2;SLC47A1
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),0.5811968648574444,0.8899645724000956,0.7297297297297297,1.0,1.0,2/5,7.97%,PINX1;NOL8
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.4735070503281862,0.8899304647164905,0.5945945945945946,1.0,1.0,2/15,7.47%,B4GALNT2;B3GALT4
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.43482620078747314,-0.8898435266774759,0.6,0.9980768529202759,1.0,6/26,16.92%,MEF2C;SOX9;SULF1;BMPR1B;TGFB1;WNT5B
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5283285268559315,-0.8895655932738105,0.5849056603773585,0.9981748311506777,1.0,4/12,15.24%,IL6R;CAMK1D;LYN;ZNF580
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.5059341114704637,0.8891940924536643,0.625,1.0,1.0,3/11,12.71%,PEX5L;PEX6;PEX2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.5510881573671877,-0.8891674030458184,0.6551724137931034,0.998630031372587,1.0,2/8,23.35%,MAP3K12;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.3885531593255507,-0.8890750808869079,0.6666666666666666,0.9983481948514491,1.0,10/78,12.60%,PPARG;TNFRSF1A;NLRP12;NLRP3;EPHA4;AOAH;FNDC4;TEK;NMI;LRFN5
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.5457086177803097,0.8890472091335119,0.6363636363636364,1.0,1.0,3/13,6.44%,HMGB1;DICER1;EXOG
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.5401486151298474,0.889003452678667,0.6086956521739131,1.0,1.0,2/6,7.12%,HMGB1;TMEM98
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.56902020283225,-0.8889075557648377,0.6956521739130435,0.9982941947864163,1.0,3/7,27.63%,CCDC39;ODAD4;OFD1
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5969167407341611,0.8888601251237266,0.7142857142857143,1.0,1.0,2/5,9.25%,HDAC9;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.38714677071642045,-0.8885122772811236,0.6857142857142857,0.9986862677488784,1.0,3/64,3.07%,TLR2;ISG15;IRF1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.3558557773515753,0.8884218381069902,0.68,1.0,1.0,3/56,2.86%,ORC1;PSME2;UBC
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.37728869648248275,0.8883766545359754,0.5588235294117647,1.0,1.0,9/60,13.50%,TXNIP;EVI2B;OOEP;FSD1;DLL1;PLK4;AHCTF1;MLLT3;BECN1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.4519691619045212,0.8883217934608661,0.5609756097560976,1.0,1.0,3/17,5.55%,DUSP1;LAMB3;HMGA2
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.44477123051763423,-0.8882714220443899,0.6379310344827587,0.9988149471081932,1.0,2/25,10.08%,IRGM;NOD1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5896203605195656,-0.8882627609707493,0.7037037037037037,0.9983597553080631,1.0,2/7,25.44%,PLA2G12A;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5057779456121776,0.8881658721369007,0.6857142857142857,1.0,1.0,3/10,10.10%,HSPA1A;SACS;HSPA1B
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.40132291558886324,0.8881411693493174,0.6129032258064516,1.0,1.0,9/48,17.19%,PRELID2;ABCC1;MTTP;PRELID1;PITPNM1;ATP11C;ABCA3;NPC2;PLTP
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.5285061388325553,0.8880071005082689,0.5833333333333334,1.0,1.0,6/9,30.91%,FBP1;DGKQ;SIRT7;SDHAF3;SELENOS;USP7
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.3686669232746772,-0.8878392881422329,0.6753246753246753,0.9987156244513835,1.0,20/136,13.14%,GGH;HLA-F;OLFM1;IRF1;CCK;FOS;NPTX2;SLC6A12;TUBA4A;KLHDC3;RFC4;FURIN;ABCB1;LYN;DNAJB1;SLC6A8;DGAT1;DLG4;GRINA;TST
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5097198610956291,-0.8876367288100222,0.6612903225806451,0.99871055192217,1.0,3/13,7.95%,LPAR6;HTR2C;C3AR1
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.4441837984346674,-0.8875309278318231,0.640625,0.9984162350879905,1.0,7/31,22.20%,NLRP12;STAT1;NR1D1;RHOH;ESR1;PER1;TLE1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.42588528832794065,0.8875233881125052,0.5476190476190477,1.0,1.0,2/23,11.30%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.46510433560124975,-0.8875141548416098,0.5797101449275363,0.9980020942607826,1.0,7/25,19.22%,PLPPR5;GPM6A;TGFB3;TENM2;NEURL1;TENM1;FNBP1L
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.4564554841170685,-0.8874198488304095,0.6785714285714286,0.9977706155383056,1.0,6/27,11.84%,ZNF366;CITED4;CITED2;AR;TRIM25;CAV1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.4435175407253434,0.8872850687180648,0.6,1.0,1.0,1/9,2.17%,PLXNA1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.6049105725112129,-0.8872628255077392,0.6666666666666666,0.9975971194261903,1.0,1/5,8.42%,SH3GL2
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.3653840471100597,0.8872467357081895,0.6060606060606061,1.0,1.0,13/74,14.89%,ZNF335;SPHK2;MYO1C;PHF1;EPC1;POLR2K;KDM1B;DNMT3A;DNMT1;KAT2A;RBBP4;POLR2L;HDAC4
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.4174272212464908,-0.8872134568290779,0.6515151515151515,0.9972283424487067,1.0,9/45,20.23%,NR4A3;MEF2C;GATA1;ZFPM1;MOV10;PRKCQ;KAT2B;RBBP5;SETD1A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.48399371246988176,-0.8871948186964136,0.6666666666666666,0.9968199456019544,1.0,2/17,10.89%,DACT1;AMER1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.6004784510096876,-0.8869925227273598,0.6610169491525424,0.9968113203784826,1.0,5/6,31.58%,FERMT3;CX3CL1;ITGB1BP1;FN1;COL16A1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.43885554495392587,-0.8869858650498283,0.6571428571428571,0.9963680030060127,1.0,3/32,11.29%,NEFL;RAB27B;AP3B2
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.4263675929301666,0.8868937952077096,0.575,1.0,1.0,2/18,10.59%,CCNT1;VIRMA
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.5943866079076909,-0.8867175830905907,0.75,0.9964349652391702,1.0,3/6,29.53%,AGT;APOE;LAMTOR1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.39231434676781507,-0.8865241971561807,0.6428571428571429,0.9964220963958393,1.0,13/85,12.42%,TWF2;TGFB2;RIMS1;SYT4;SYT1;L1CAM;EDN1;LGI1;GOLGA4;RIMS2;NEDD4L;TRIM32;EGFR
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.5267595549555069,0.8865150534087861,0.673469387755102,1.0,1.0,4/10,15.13%,PLA2R1;SERPINE1;ATR;MME
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.5202809500996364,-0.8864279255514067,0.6363636363636364,0.9961700394485301,1.0,1/9,4.18%,EDN1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.4757015282974464,0.8863924284088989,0.6060606060606061,1.0,1.0,4/12,21.88%,AKT2;SLC45A3;SIRT1;AKT1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.3799032604579841,-0.8863868135846269,0.6666666666666666,0.9958252333653987,1.0,15/127,15.78%,ARIH2;PDZK1;TP73;ITGAM;NMT1;CEMIP;TOMM7;E2F1;SAR1A;KCNB1;CAMK1;YWHAH;GTSE1;TGFB1;BBC3
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5471787808069936,-0.8863547441731652,0.7241379310344828,0.9954453378347177,1.0,3/11,17.79%,PRAME;DHRS3;EZH2
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.532855692296485,-0.8862985999038396,0.6551724137931034,0.9951144485218271,1.0,4/10,25.81%,CSPG5;VCAN;CSPG4;HEXB
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.3866472089133235,0.8858629827964691,0.6153846153846154,1.0,1.0,11/99,5.30%,CXCR4;TXLNB;CRYAB;ADPRHL1;CASQ2;ASB5;PTH1R;ACTN2;MTTP;MYOM1;SMYD1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.39376263369461006,0.8855677466551215,0.5769230769230769,1.0,1.0,11/65,6.50%,GUCA1C;PDE6A;MGLL;KCTD8;KLK6;RGS11;DYNLT1;CNGB1;PLCE1;GUCA1B;PDE6B
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.4686715292376662,-0.8852160683337904,0.6417910447761194,0.9968221898207318,1.0,4/24,6.11%,COL4A1;MEF2C;MET;CSF1R
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.4415752053043783,-0.8851577192087209,0.5373134328358209,0.9964777155833149,1.0,5/24,20.16%,ID2;BHLHE40;CLOCK;PPP1CA;PER1
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.5809432180578495,-0.8851365240743432,0.7068965517241379,0.9960672931100817,1.0,3/7,5.11%,NOX4;DUOX1;ALOX12
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.37488716955863244,-0.8848926602664458,0.684931506849315,0.9961297021669381,1.0,22/118,15.02%,LURAP1L;CLU;KITLG;PPP1R3C;MAOB;PLSCR4;SERPING1;SOX9;NTN4;AQP1;GATA1;AR;LMOD1;ANKRD7;MEIG1;CST3;MATN2;EGFR;LRP1;NOTCH2;AGT;TIMP3
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.41341216146932414,-0.8848875393422729,0.6470588235294118,0.9956756776901071,1.0,3/45,6.13%,KDM4D;FIGNL1;RAD9A
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.5108689451284512,-0.8848529379469,0.6923076923076923,0.9953058847358459,1.0,1/11,8.48%,XBP1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.5095099051905113,0.8848194694071534,0.6304347826086957,1.0,1.0,1/6,20.54%,CALM1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.42119344135777087,0.8847854009686063,0.5357142857142857,1.0,1.0,8/34,15.49%,MFHAS1;PPP1R16A;PTBP1;PTPA;SYMPK;ENSA;CAMTA1;PPP1R8
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.31633891776971884,-0.8847353495904172,0.8522727272727273,0.9950157987777456,1.0,103/744,18.31%,MDFIC;ZNF366;KANK2;ZIM2;DACT1;NR4A3;HEY1;MAEL;PPARG;BASP1;PARP9;ZNF550;MIDEAS;CRYM;ELK3;GLIS2;IRF1;MLIP;MEF2C;LOXL3;PRICKLE1;CENPF;EDN1;ID2;ZNF343;SOX9;ZNF239;CITED2;DKK3;ZEB1;ZBTB32;CCND1;PRAME;EFNA1;GATA1;BMP6;ZNF608;ZNF20;AR;BHLHE40;E2F1;ZNF540;PLCB1;IFNA2;PBXIP1;RARB;CDK5R1;CEBPB;ZNF764;GLI3;GTF2IRD1;H1-0;ETS2;DNAJB1;ZNF391;RUNX1T1;IKZF1;GLIS3;HJV;VEGFA;NR2F1;CAV1;NEDD4L;L3MBTL4;ZNF217;EDNRB;LDB2;NRG1;PAX6;MOSPD1;ORC2;CBX7;PCGF2;TRERF1;SPI1;ZFP36;ZFPM1;ZNF248;STAT1;TGFB1;NR1D1;ID3;UHRF1;MYT1L;ETV6;ZFP69;ATP8B1;BRCA1;TGIF1;POU5F1;PRDM1;CIITA;MAD2L2;TENM2;CBX8;CLOCK;EZH2;MAP2K5;CREB3L1;POU6F1;MACROH2A2;ZNF10;STAT3
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.5376764098225983,-0.8845983654340364,0.6507936507936508,0.9948758301598304,1.0,2/8,16.51%,ZWILCH;PLK2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.40066401378179256,-0.8841178330268874,0.6666666666666666,0.9954496707940468,1.0,18/68,15.07%,DPEP2;PPARG;ITGAM;GMFG;ALOX12;AOAH;GATA1;FLI1;MRTFB;VEGFA;ADGRE3;TNFRSF1B;FERMT3;LRP1;MPL;FCGR3A;SPI1;TGFB1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.5650477916732666,-0.883453889091096,0.6440677966101694,0.9962739856201642,1.0,2/5,10.97%,CHGA;PLN
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3417501341616012,-0.8832969825564779,0.7341772151898734,0.996116030210117,1.0,25/347,8.80%,CD44;ANGPT1;FSTL1;FIGNL1;BIRC3;BCL2L2;NCKAP1L;MEF2C;APIP;PIM1;SOX9;CITED2;ALOX12;AVEN;HGF;IL7;PRAME;AQP1;CX3CR1;GATA1;RNF144B;CRLF1;XBP1;TEK;TCIM
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.5323409008992834,-0.8832304364720411,0.6140350877192983,0.9957954390845187,1.0,3/8,22.68%,CAV1;PTPRT;SOCS3
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.42662839180767503,-0.8830791562532205,0.6527777777777778,0.9955850751695886,1.0,6/44,15.07%,TGFB2;BMP6;HJV;TGFB3;BMPR1B;TGFB1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.47470474684091085,-0.8830690682906006,0.6811594202898551,0.9951595254271393,1.0,1/21,3.21%,DPY19L2
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.5471406387418717,-0.8829288049928877,0.6065573770491803,0.9949540343828592,1.0,4/8,36.59%,OXSM;MCEE;MMUT;PCCB
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.6082935947909565,-0.8829151645084465,0.6875,0.9940739381717816,1.0,2/5,16.91%,THY1;CRB2
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.6082935947909565,-0.8829151645084465,0.6875,0.9940739381717816,1.0,2/5,16.91%,THY1;CRB2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.38636040587286935,0.8828920827457473,0.5555555555555556,1.0,1.0,2/22,7.26%,ENPP1;NCK1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.4263952148500864,0.8826067805456764,0.6153846153846154,1.0,1.0,5/37,4.22%,F2;BYSL;TESK1;MFHAS1;PYHIN1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5172926224402188,0.8825492416180848,0.6052631578947368,1.0,1.0,1/7,3.52%,RNF6
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3509966463134294,-0.8824345675180978,0.7733333333333333,0.9946677394554801,1.0,48/220,17.70%,LPL;TLR2;IL26;IL12A;ISG15;HLA-E;PTPRC;IL6R;IRF1;C1QTNF4;C5;F3;NLRP3;LAPTM5;RFTN1;CSF1R;HLA-A;CARD11;IL7;CHI3L1;HLA-DPB1;XBP1;POLR3H;IL16;PLCB1;IL12RB2;NOD1;SULF1;CEBPB;HTR2B;FLOT1;PRKD2;POU2F2;ZFPM1;SCIMP;AGT;TGFB1;ZNF580;CD200;BRCA1;SCAMP5;IRF4;SYK;CXCL17;PRKCQ;TMED10;RASGRP1;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3321129705030377,-0.8822289647547802,0.8148148148148148,0.9946338775786584,1.0,51/426,12.30%,ANGPT1;KANK2;TLR2;FBLN1;IGFBP3;SFRP4;HOPX;CR1;TP53I11;TGFB2;PLSCR1;CLU;WDR6;TSPYL2;ALDH1A2;FABP3;IRF1;NOX4;TEX15;SSTR1;ADGRG1;NOS1;P3H2;CCN5;DDAH1;ACTN1;MYO16;CRLF3;PRAME;DACT2;TMIGD3;GJA1;ARHGDIG;AR;CDKN3;LDOC1;LRPAP1;PDE3B;RERG;IFI35;CDH13;BTBD18;INCA1;BRINP1;LYN;WFDC1;NMI;TGFB3;HTR2B;TNFRSF1B;AQP11
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.5996655325954052,0.8819727907359927,0.6530612244897959,1.0,1.0,2/5,26.07%,OTUD7A;ZRANB1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.5586598762266686,0.8818942821466331,0.5909090909090909,1.0,1.0,4/5,42.44%,CTR9;CDK9;RNF20;KDM1A
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.5634270466530746,-0.8817806706403086,0.6363636363636364,0.9951216836101215,1.0,2/5,3.25%,MAOB;DUOX1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.43956932428605017,-0.8817764434867202,0.6027397260273972,0.9946757838281375,1.0,13/36,23.20%,RND2;NCKAP1L;RHOC;FHOD3;RAC3;PPP2R3C;FHOD1;TRPV4;RHOH;FMNL3;LCP1;FMNL1;RHOF
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.4552087241714448,0.881736953681179,0.5384615384615384,1.0,1.0,3/16,14.11%,MORC3;HNRNPU;TAF3
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.33031832665175614,0.8811934924717361,0.7666666666666667,1.0,1.0,48/151,24.44%,POP5;RCL1;BYSL;DCAF13;MDN1;EXOSC8;PIH1D1;NOL8;RRP12;PELP1;DKC1;ESF1;RRP1B;RPL18A;NOLC1;TRIR;MPHOSPH10;RRP36;UTP3;WDR74;KRR1;RPL23A;NIFK;NOL11;EXOSC7;UTP6;RPL3;RPL11;DIS3;DDX10;WDR36;RPL13;EXOSC5;RPL8;RPL21;RPL5;NOP56;POP4;RPL32;RPL7;RPS16;UTP15;WDR18;RPS6;RPS2;RPL41;RPL29;C1D
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.5254955599527534,0.8809256091653761,0.6666666666666666,1.0,1.0,1/8,6.39%,ATF4
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.39917368593645064,-0.8805990300780515,0.6301369863013698,0.9967660417037709,1.0,13/61,23.89%,ASB4;DTX3L;RNFT1;SH3RF3;RNF213;UHRF1;BRCA1;TRIM17;OBI1;TRIM13;RNF4;UBE2B;RNF208
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.37675313581436487,-0.8804069384576317,0.7027027027027027,0.9967137822155372,1.0,18/116,8.94%,CARTPT;SRGN;TLR2;GBP2;IL12A;GCNT1;TGFB2;HLA-E;PTPRC;IFNGR2;TIMP1;NLRP3;HLA-A;IL7;B2M;HLA-DMA;THY1;IL16
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.45279505853333735,-0.8803662000518434,0.6567164179104478,0.9963158988910417,1.0,5/24,16.38%,P3H2;FKBP5;OGFOD1;NKTR;FKBP1B
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.5583274626420341,-0.8801614104044299,0.7368421052631579,0.9963163732089942,1.0,2/7,17.39%,CAV1;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.5209828964804775,-0.8800945951598427,0.5967741935483871,0.9960108328414257,1.0,4/10,19.66%,MDM1;CCNF;BRCA1;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.453805990037794,-0.8800061238724658,0.6935483870967742,0.9953044898612925,1.0,2/19,8.92%,PRXL2C;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.453805990037794,-0.8800061238724658,0.6935483870967742,0.9953044898612925,1.0,2/19,8.92%,PRXL2C;PFKFB2
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.4782539479540525,-0.8798232311907037,0.6285714285714286,0.9951526191485242,1.0,4/17,16.07%,AOAH;SAMHD1;FBXO17;ADAMTS9
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.48926642913419993,-0.879541142293726,0.6349206349206349,0.995380531731589,1.0,4/10,20.62%,COX17;STEAP4;SLC11A2;STEAP2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.4582630866856789,-0.8793371368345523,0.6296296296296297,0.9953421700281097,1.0,5/23,18.90%,PTPRM;PTPRG;PTPRR;ADAMTS9;NR2F2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.380397054765803,0.8792354322023767,0.5862068965517241,1.0,1.0,3/36,4.72%,CD38;EPHB2;TNFSF13B
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5299654806162752,-0.8791491831860085,0.671875,0.9948123327444439,1.0,6/11,39.90%,ZFP36;RBM4;TRIM71;NOTCH4;TNRC6A;AGO4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.5299654806162752,-0.8791491831860085,0.671875,0.9948123327444439,1.0,6/11,39.90%,ZFP36;RBM4;TRIM71;NOTCH4;TNRC6A;AGO4
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.3360467056698473,-0.8791123934021571,0.7894736842105263,0.9944432300206096,1.0,29/332,13.81%,FSTL1;IGFBP3;SPARCL1;CHRM3;RPL31;LAMC1;IGFBP4;TIMP1;PAPPA;PRSS23;DENND3;SFTPD;PIGH;MEPE;LAMB1;FUCA2;CPE;RPL38;USP6;FURIN;AFP;CST3;SCG3;CHRDL1;GPC3;ATP23;SCG2;CP;CHGB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.41594012377301015,-0.8790356158508598,0.6571428571428571,0.9941528301668783,1.0,6/42,8.94%,LPL;TLR2;IL6R;C1QTNF4;XBP1;IL16
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.5334487978007204,-0.8785507441113461,0.6206896551724138,0.9947722560990616,1.0,1/8,6.40%,CARD11
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.40013636285906445,-0.8784041867381759,0.6833333333333333,0.9946037701741468,1.0,11/86,9.47%,PKP2;CLDN5;CDH9;NRCAM;CDH12;CDH22;GPM6A;PCDHB11;CDH10;PCDHB4;CDH18
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.396862327239568,-0.8783985802224689,0.7619047619047619,0.9941788990726442,1.0,18/59,22.74%,SYT4;SYT1;MEF2C;ADGRV1;RYR3;HPCA;ADCY8;SYT12;SYT13;DMTN;TRPM2;CPNE8;KCNH1;ADD1;ADCY1;SYT7;SYT17;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.5105009510213054,0.8783304223703896,0.6486486486486487,1.0,1.0,8/16,24.88%,PTP4A3;DKC1;CEP120;CORO2B;CCT8;CCT2;CCT3;CCT6A
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.4792035331690404,-0.8782464629731088,0.6875,0.994145560570113,1.0,2/18,6.32%,ACADL;CEACAM1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.4012867545308293,-0.8782240587521166,0.6231884057971014,0.9937560296548877,1.0,8/60,17.04%,TWF2;GAP43;TBC1D10A;CAV1;DMTN;ATP8B1;ABITRAM;TRPM2
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.4292526415497525,-0.8779833753200251,0.6571428571428571,0.9938054129862172,1.0,9/36,16.91%,TIMP4;TIMP1;SERPING1;CST3;LRP1;AGT;TIMP3;SERPINI2;CRB2
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.39124159206104536,-0.8779669898569739,0.7083333333333334,0.9934120434533265,1.0,25/86,16.37%,HLA-F;TGFB2;HLA-E;BIRC3;PLSCR1;IRF1;SELL;SFTPD;HLA-A;ADCY7;PIANP;SAMHD1;B2M;ERAP1;NCR3LG1;HLA-DRB1;CD160;LYN;FGL1;FCGR3A;CD200;DENND1B;IRF4;SYK;HLA-C
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.38126500196329527,-0.8779398493297315,0.7012987012987013,0.9930537330882094,1.0,10/82,8.60%,FOSL2;RHBDF2;IL13RA1;TNFRSF1A;CEBPD;GBP3;LGALS3;DTX3L;ANXA11;BHLHE40
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.42913150500620745,0.877926557510162,0.5517241379310345,1.0,1.0,4/33,5.75%,JPH1;F2;CASQ2;CLIC2
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.3481954305835175,0.8778463886997794,0.6129032258064516,1.0,1.0,13/70,9.88%,RS1;KCNJ14;PDE6A;OPRD1;MSANTD1;CNGB1;CRX;DRD4;PDE6B;SLC2A11;RGR;CATSPER2;ZNF385C
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.5309601044470649,-0.8777801820704061,0.6666666666666666,0.9930123003302577,1.0,2/9,14.07%,HNMT;SLC22A3
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.4468715028036523,-0.8777577786188159,0.6349206349206349,0.992602476258223,1.0,6/29,17.72%,RAD9A;E2F1;PRPF19;STK33;DONSON;CLOCK
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.57596650959223,-0.8777276667963565,0.6481481481481481,0.9917795972460889,1.0,2/5,24.83%,GLYCTK;ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.57596650959223,-0.8777276667963565,0.6481481481481481,0.9917795972460889,1.0,2/5,24.83%,GLYCTK;ALDOB
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.3495452222047062,-0.8774015721156025,0.7808219178082192,0.9919379255415351,1.0,22/260,5.38%,ANGPT1;CLDN5;TLR2;SFRP4;VSIR;HEY1;RIMS1;OLFM1;TTN;PLSCR1;ACTA2;CLU;MUSK;FGF22;MEF2C;ID2;SOX9;VSTM2A;CITED2;F3;DTX3L;LAPTM5
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.5106951310170286,0.8773351679598328,0.5641025641025641,1.0,1.0,2/11,1.86%,DHFR;MTHFD2L
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.4085504808541395,0.877082413929939,0.631578947368421,1.0,1.0,7/31,20.07%,CPSF4;PCF11;CSTF2;SYMPK;MED18;SNRPB;CSTF1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.4984362263587252,-0.8770302248203542,0.6290322580645161,0.9922691805395882,1.0,5/16,19.99%,LGALS3;CSF1R;LYN;CXCL17;IL34
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.3924986971169661,-0.8770220472465134,0.6944444444444444,0.9918346549256138,1.0,16/80,13.39%,ANGPT1;CHST1;CEMIP;PRELP;XYLT2;OGN;HS3ST1;CHST9;CHST2;CSGALNACT1;GPC5;GPC6;CHST15;UST;GPC3;B4GALT6
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5006483990930108,0.8770172739543661,0.6486486486486487,1.0,1.0,2/13,2.21%,TCOF1;KBTBD8
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.4281203824471063,-0.8769655943941761,0.6153846153846154,0.9914696827482636,1.0,5/27,17.98%,CCND1;PLCB1;EGFR;EZH2;FAM83D
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.4946761436697621,-0.876946433242404,0.5660377358490566,0.9910618271662274,1.0,3/10,11.62%,ADGRV1;DGKD;VEGFA
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.5501760806463722,0.876746870443655,0.6666666666666666,1.0,1.0,4/9,20.55%,RAB39A;RAB7B;CLN3;RAB7A
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.41970669015403894,-0.8767463975677897,0.6212121212121212,0.990956664399069,1.0,12/38,14.51%,DPEP2;PTPRC;ITGAM;AOAH;CD53;PTAFR;IGSF6;ADGRE3;TNFRSF1B;LY86;FCGR3A;SPI1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.40298946641280214,-0.876730335946131,0.6428571428571429,0.9905321329667478,1.0,7/72,7.94%,ARIH2;CLU;PRICKLE1;RNF217;RNFT1;LRRK2;RNF144B
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.42926878137456514,0.8762619000601375,0.65,1.0,1.0,5/25,12.16%,AGER;EPHB2;ABL1;CHRNA7;RELN
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.47996731455179575,-0.8761874217477782,0.6716417910447762,0.9912040244760351,1.0,2/14,12.42%,ATAD5;EGFR
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.5406335570744923,0.876126743241916,0.6111111111111112,1.0,1.0,1/9,1.71%,CYB5A
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5824812419619683,-0.8758717606525787,0.6949152542372882,0.9914224299484814,1.0,1/8,3.94%,GLRX
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.457317676686667,-0.8757633556215692,0.6323529411764706,0.9912138228705805,1.0,5/27,11.36%,MEF2C;ID2;CDON;BOC;CAMK1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.5085765946297292,-0.8756634780293044,0.6507936507936508,0.9910097108436725,1.0,3/11,29.19%,CAV2;APOE;NUCKS1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.42543553334607276,-0.8756213507030035,0.6615384615384615,0.9906722492152789,1.0,3/20,12.27%,NUDT11;NUDT4;NT5C1A
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5806718761792703,-0.8756071041612088,0.7916666666666666,0.9902791156316713,1.0,2/8,6.00%,NR4A3;CCND1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.48023958652798504,-0.8753590404812431,0.6865671641791045,0.9903123907788646,1.0,4/21,8.25%,IL12A;NCKAP1L;HLA-DPB1;THY1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.40221357897619425,0.8752737705457209,0.6388888888888888,1.0,1.0,6/55,4.23%,AGER;SERPINF2;HMGB1;SH3RF2;MFHAS1;DUSP15
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.3977223363991143,-0.8752565959472537,0.6716417910447762,0.9901176453494914,1.0,19/64,17.47%,CNTFR;WIPF3;PPP1R1A;PTCHD1;CMYA5;SPTB;HIF3A;ATP1B2;ANO5;CKMT2;LRRC2;CACNB2;NT5C1A;SYNPO2L;MYLK3;ADCYAP1R1;SLC35F1;PDE11A;FGF13
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.516599968394627,0.8751434657570885,0.6052631578947368,1.0,1.0,3/7,10.95%,MGLL;AWAT2;PNPLA3
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.41017908026593164,-0.8751138593109327,0.6233766233766234,0.9899445719085671,1.0,8/38,16.36%,DUOX1;TMC4;AQP1;CLCA4;CBLC;CP;PPL;CXCL17
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.5012601675605173,-0.8746245731539732,0.6451612903225806,0.9904894011631415,1.0,2/11,9.55%,IFITM3;AXL
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.398180118774732,-0.8743939172748714,0.6857142857142857,0.9904838600392831,1.0,18/72,24.07%,SPDYA;CCND1;CCNJL;CDKN3;CDK5R1;INCA1;EGFR;CDK5R2;CCNF;SERTAD1;CDKN1A;NR2F2;MYOCD;CCNI2;CDKN2D;CCNB2;TFAP4;MNAT1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4519795078536633,0.8740472683554579,0.5675675675675675,1.0,1.0,3/20,5.75%,CASQ2;DRD4;CLIC2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.34226137752126506,0.8740039902223389,0.7692307692307693,1.0,1.0,14/111,5.91%,NGF;PTPRU;ZAP70;LCK;SHC4;FGFR1;ALK;EPHB4;EPHB2;RAPGEF1;IGF1R;FRK;CNKSR1;GUCA1B
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.5626695037797581,0.8738588284494176,0.6153846153846154,1.0,1.0,2/6,8.31%,DSEL;DSE
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.5786419973574767,-0.8735005221258267,0.6949152542372882,0.9918180788688784,1.0,3/6,13.19%,PDZK1;SLC22A4;SLC25A20
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.5351405710137629,0.8730740411267517,0.5882352941176471,1.0,1.0,1/7,3.91%,ASAP1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.4719064384585596,-0.8729241883446364,0.5806451612903226,0.9921276050829487,1.0,1/11,3.90%,IMPA2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.4719064384585596,-0.8729241883446364,0.5806451612903226,0.9921276050829487,1.0,1/11,3.90%,IMPA2
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.516991942990395,-0.8727935690264529,0.6666666666666666,0.9919240827150678,1.0,4/11,14.22%,CPS1;NOX4;TST;CBS
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.5419181729985496,-0.8726806260944242,0.6923076923076923,0.991686448670043,1.0,2/7,17.74%,ADGRV1;PDZD7
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.3700756454765106,0.8724598671710246,0.6428571428571429,1.0,1.0,8/37,8.62%,WNK4;KCNN3;KCNJ2;KCNN4;ACTN2;NOS1AP;FLNA;ATP1B1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.4017730128463258,-0.872418194061092,0.7096774193548387,0.991851776048955,1.0,5/63,11.83%,H2BC11;NAP1L2;SOX9;H1-0;LIN54
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.47561696348512095,-0.8722228293728439,0.671875,0.9917856918454959,1.0,4/14,21.45%,LRRK2;PPP1R15A;BCAP31;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.48121432991034996,-0.872064018599465,0.6716417910447762,0.9916426117051428,1.0,6/16,29.54%,PID1;TGFB1;MRAP;RHOQ;MRAP2;CLTC
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.3917958489648377,-0.8720485816315638,0.6714285714285714,0.9912300869065782,1.0,9/74,7.81%,LPL;TLR2;VSIR;HLA-E;PTPRC;CLU;C1QTNF4;CX3CR1;ARG2
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.43763861285376854,-0.8713720696353736,0.676923076923077,0.9920411532570074,1.0,5/21,12.03%,PIM1;KCNJ4;KCNJ6;KCNJ3;NEDD4L
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.49729549979256704,-0.87136328857921,0.6666666666666666,0.9916245416339925,1.0,6/14,23.10%,CACNG2;CACNG3;CACNG8;NRXN1;TSHZ3;CACNG5
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.4790789295282338,0.8713179308291221,0.6756756756756757,1.0,1.0,9/24,19.18%,VASH1;RSL1D1;HMGA2;CGAS;CDK6;PNPT1;YBX1;ZKSCAN3;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4797713379357288,-0.8712582045865719,0.6031746031746031,0.9914005935888232,1.0,9/15,20.44%,NCKAP1L;IL7;XBP1;AXL;CD27;PPP2R3C;SYK;RHOH;GAS6
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.510738494080907,-0.8712282480757846,0.6865671641791045,0.9910444310610321,1.0,2/13,15.63%,ENOX2;CYB561
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.46356527022321947,0.8709800296163704,0.6875,1.0,1.0,2/17,3.97%,RAB27A;TESK1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.38188037587075185,-0.8709753798135017,0.676056338028169,0.9911027215188407,1.0,21/89,14.30%,SOX9;FIGN;DDAH1;TUSC3;PTPRG;CTXN1;GPR161;TENM3;BOC;ADGRL2;GLI3;GTF2IRD1;GPC6;NR2F1;MEX3A;TRAM1L1;DZIP1;FHOD3;PCGF2;ADAMTS15;FAT1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4976457025842336,0.870876557996563,0.675,1.0,1.0,2/11,8.94%,CPSF4;CSTF2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.5073983673836654,-0.8708342697746216,0.7142857142857143,0.9908707643654296,1.0,1/13,1.53%,IHO1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.5456987152957902,0.8708097106673537,0.6444444444444445,1.0,1.0,2/5,19.78%,RYK;NR4A2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.5449056437254605,0.8707887304584192,0.7352941176470589,1.0,1.0,2/7,4.97%,CASQ2;ACTN2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.38998062385456517,-0.870749765633165,0.6285714285714286,0.9905878230398598,1.0,17/77,24.36%,CENPE;HLA-DMA;HLA-DPB1;SH3GL2;DYNC1LI1;HLA-DRB1;AP1S2;KIF2C;KIF3C;ACTR10;KIF5A;HLA-DPA1;ARF1;CTSS;KIF3A;CANX;DYNLL2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.5639858605661621,0.8707373614527355,0.7142857142857143,1.0,1.0,3/8,16.95%,EOGT;GALNT1;GALNT11
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.3835453890883722,0.8706902787133755,0.6097560975609756,1.0,1.0,13/44,18.59%,MTERF3;MDN1;MRPS7;MRPS2;NLE1;RPSA;BRIX1;DDX3X;NPM1;RPL23A;RPL3;MRPL22;RPL11
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.5461220314113068,0.870162653468759,0.5652173913043478,1.0,1.0,1/5,18.41%,CTDP1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4744874866909858,-0.8699823349802333,0.6140350877192983,0.99177188954743,1.0,4/23,5.72%,MMRN2;PPARG;MEF2C;ANGPT2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.48345895256517485,-0.8697186889275323,0.6153846153846154,0.9919107343726543,1.0,2/12,15.87%,GNB3;MCM7
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.5069962283974789,0.8695446342691868,0.6829268292682927,1.0,1.0,5/8,30.97%,UBB;PTTG1IP;PRKN;ARMC10;RPS7
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.48157368101382525,0.8694796612782788,0.6410256410256411,1.0,1.0,3/9,20.32%,MYLIP;AP2S1;AP2B1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.48157368101382525,0.8694796612782788,0.6410256410256411,1.0,1.0,3/9,20.32%,MYLIP;AP2S1;AP2B1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.5013014959346913,-0.8686026847422555,0.6949152542372882,0.9936597678653799,1.0,5/15,19.99%,C5;CSF1R;SLAMF8;CXCL17;IL34
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.4383227665408399,-0.8685442681670893,0.6575342465753424,0.9933505485139739,1.0,6/30,20.54%,NDUFC1;NDUFB9;NDUFB6;NDUFA8;NDUFAF1;NDUFS5
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.49309476202685654,0.8680990647887794,0.6341463414634146,1.0,1.0,5/11,29.50%,GBF1;PLK5;PDCD10;PLK3;VCPIP1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.4953673136807587,-0.8679639329498393,0.65625,0.9940375837332474,1.0,1/16,5.30%,MET
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.5134362493558227,-0.8679133705696764,0.6666666666666666,0.9937157067045823,1.0,5/10,27.13%,IL33;WNT5A;CD226;LBP;TNIP2
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.5248280271033313,-0.8679132558810572,0.6440677966101694,0.9932792922528015,1.0,2/7,27.12%,TOM1L1;NME6
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.36438475350697164,0.8677772104632377,0.7241379310344828,1.0,1.0,17/66,22.43%,CAVIN1;CPSF4;PCF11;CSTF2;POLR2K;SYMPK;MED18;POLR2L;UBTF;GTF2H5;ERCC2;TAF1C;SMN1;SNRPB;CSTF1;POLR2E;POLR3K
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.5787259020944765,0.8675469301386074,0.66,1.0,1.0,1/5,6.57%,FBP1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.4076984078875503,0.8671511241786467,0.7241379310344828,1.0,1.0,11/49,12.83%,HSPA1A;SH3RF2;GNL3L;SPRY2;PINX1;ABL1;BAG2;HSPA1B;PRR7;LIMK1;NXN
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.4030472145355834,0.8669001015308907,0.575,1.0,1.0,5/23,12.16%,EPHB2;NLGN3;HDAC1;GREM1;RELN
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.3780377428646144,0.8666228971176213,0.6129032258064516,1.0,1.0,9/32,24.52%,OTUD3;MAGI2;PHLPP1;THEM4;SIRT1;AKT1;PKHD1;CIB1;PHLDA3
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.39398952154535016,-0.8664934890986391,0.7258064516129032,0.9956019854349647,1.0,22/79,15.92%,FMO5;FGL2;RASSF4;C1QB;CHL1;ADAM28;GSAP;CSF1R;LRRK2;ANKUB1;ALDH1L1;HLA-DPB1;SLC8A1;DDO;APOBEC4;L3MBTL4;HNMT;C1QC;CP;OMG;SMIM14;ERICH3
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.4547996867921456,0.8664530039684819,0.5625,1.0,1.0,5/18,6.18%,STAC3;CACNB4;NOS1AP;DRD4;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.3983644240240007,-0.866191842559482,0.6909090909090909,0.9957642163869508,1.0,2/38,2.28%,DACT1;CLU
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.4306863756595949,-0.86617939780772,0.6825396825396826,0.995340218702692,1.0,9/42,17.67%,HEY1;B2M;CX3CR1;BHLHE40;TRIM32;PAX6;OPRM1;CX3CL1;PRUNE1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.37574184224969026,-0.8660887922580616,0.7142857142857143,0.9950821532617331,1.0,14/97,8.91%,ITGB4;FBLN1;IGFBP3;SEMA3E;HOPX;LRIG3;F3;NTN4;MET;KIAA1217;WWTR1;PALLD;CRLF1;SLC44A3
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.31438007637253074,0.8660807320508529,0.7916666666666666,1.0,1.0,33/233,16.63%,USP27X;PSME2;RNF128;UBC;USP31;OTUD3;USP36;DESI2;ACTR5;BRCC3;TNIP1;YY1;KEAP1;INO80D;PSMD13;KDM1B;USP37;USP18;USP40;UBB;USP9Y;PSME4;KAT2A;MAP3K7;BECN1;TADA3;UIMC1;SNX3;TRAF3;PSMF1;USP24;OTUB1;STAMBP
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.3981117987728063,-0.8659579167872471,0.6557377049180327,0.9948794766382216,1.0,7/41,16.20%,ESYT3;B3GALNT1;ST3GAL5;ST8SIA3;B4GALT6;SMPD3;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.4843315468372088,-0.8659098543817321,0.671875,0.9945285278129364,1.0,1/13,1.15%,IGFBP3
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.33075332939535435,0.8657080569815517,0.7142857142857143,1.0,1.0,62/393,15.32%,POU3F1;TEAD2;CD38;HIVEP3;MYRFL;WBP2NL;AFAP1L2;KDM8;RNF6;RUNX1;PYHIN1;MSANTD1;FANK1;JMJD6;HMGA2;CAND2;PAX3;PAX8;ATOH8;ATF4;HDAC1;SNAI1;GLI2;BRPF1;SMARCD3;EPC1;ACVR1;CEP290;CDKN1C;RBM23;TRIM16;PBX4;RYBP;RPS6KA1;CHUK;PSRC1;WNT4;SMARCA4;ESRRG;SP100;CNBP;KDM5A;NFKB1;KAT2A;LBHD1;MLLT3;PRMT2;BCL10;ZMIZ1;HES5;TADA3;MAP2K7;NFIB;HNF4A;NR5A2;KMT2B;RELA;HDAC4;ZNF281;TRIM44;HAS3;ZNF496
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.5494897678732467,-0.86556846288142,0.7068965517241379,0.9948731748840832,1.0,2/8,10.97%,PTPRC;LYN
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.33234828414098583,0.8654539488121296,0.64,1.0,1.0,20/140,9.19%,NGF;CXCR4;ETV5;MMP11;CFH;CA2;PTCD2;KCNN4;EPHB2;CROT;SPRY2;ALDH1A3;ANKH;ZNF639;YRDC;HSD11B1;HDAC9;DNMBP;AKT2;FUCA1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.43050634141356137,-0.8654459348597393,0.6811594202898551,0.9946878066500467,1.0,6/33,15.45%,CLDN5;CLDN16;CLDN20;CLDN4;PARD6A;PATJ
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.58386032555104,-0.8653806921803462,0.7258064516129032,0.9943882324973651,1.0,2/5,17.10%,XBP1;CIITA
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.535220173917403,0.8653752532572069,0.6363636363636364,1.0,1.0,1/5,3.96%,ABHD2
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.500284588450712,-0.8651835689109547,0.6140350877192983,0.9942836844740596,1.0,3/11,27.27%,RASA1;NOVA1;IGF2BP1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5469107986670434,-0.8650064448278899,0.6470588235294118,0.9941622992280021,1.0,3/6,19.81%,NINJ1;IFI35;TIRAP
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.49132705300652935,-0.8649959370433776,0.6363636363636364,0.9937364381671124,1.0,2/15,10.78%,KIF16B;DOP1B
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.4682806033949996,-0.8649670464275052,0.6301369863013698,0.9933363197763865,1.0,4/18,15.46%,ADGRG1;LPAR6;SYNPO2L;PRAG1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.3501683007249056,-0.8643809680719222,0.7702702702702703,0.9939551638930171,1.0,16/148,12.35%,VIL1;BASP1;SOX9;ZDHHC15;GJA1;AR;XBP1;GRIP1;PLCB1;TMEM79;CEBPB;CAMK1;VEGFA;PACSIN1;BMPR1B;DLG4
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.46091603236946554,0.8643409065916157,0.6,1.0,1.0,3/14,9.51%,SCRIB;ANXA2;OPTN
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.4282421571105285,-0.8640189323086978,0.6865671641791045,0.9942016885307267,1.0,2/31,4.09%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.5210453739216367,0.8636606427918921,0.6571428571428571,1.0,1.0,4/6,18.97%,NOSIP;GLA;NFKB1;SNCA
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.41551826332432046,-0.8631172734839173,0.7230769230769231,0.9955586272363207,1.0,14/32,30.18%,ENO4;PFKFB2;LDHA;PGK1;PFKM;GPI;GAPDHS;PFKL;ALDOB;ENOSF1;NEU1;TPI1;PGAM2;MANBA
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.4839577536441,-0.8629847326638966,0.6818181818181818,0.9953610242008359,1.0,5/13,19.97%,CEBPB;VEGFA;EIF2B4;NR2F2;EIF2B2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.5017361473276647,-0.8628569590712007,0.7121212121212122,0.9951129624381022,1.0,1/10,5.53%,DKK3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.41023422133841797,-0.8627521658216347,0.6721311475409836,0.9948904211963089,1.0,7/38,10.43%,BAIAP2;NCKAP1L;CARMIL2;BAIAP2L2;FCHSD2;LMOD1;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.37562236372377533,-0.8625084583211687,0.6666666666666666,0.9948872833870863,1.0,24/71,25.70%,FBLN1;PTPRC;RPS6KA6;LMO3;CBLC;LYN;CAV3;CAV1;PTPRR;AGT;TIMP3;PIK3CB;PTPRJ;SEMA6A;PRDM15;PIN1;DUSP26;RGS2;ITGB1BP1;PRKCD;UCHL1;STK38;PAQR3;PSCA
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.49012107274705086,-0.8624711387970452,0.6461538461538462,0.9945133395370304,1.0,5/12,20.92%,SCN4B;SCN1B;CAV3;KCNH2;KCNE1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.44578453659325346,0.8623592091488498,0.5882352941176471,1.0,1.0,2/16,1.95%,TXNIP;NT5E
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.5079344771155647,0.8621842733790082,0.6538461538461539,1.0,1.0,2/8,6.89%,GAB1;MYO1C
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.4822134381194467,-0.8617723291059093,0.6363636363636364,0.9953569610178579,1.0,3/13,7.20%,CLU;ITGAM;CX3CR1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.35736151227032187,-0.8617715938751961,0.7428571428571429,0.9949241971217633,1.0,16/137,8.25%,ROR1;FSTL1;PROM1;FBLN1;ARHGAP42;CD59;LRIG3;KITLG;LAMC1;COL4A1;ANO6;PTPRG;GJA1;LAMB1;TENM3;THY1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.5436636369379583,0.8617059453426427,0.6341463414634146,1.0,1.0,2/6,31.95%,BTRC;NLGN1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.555211119516954,-0.861683731650014,0.6612903225806451,0.9946601390687004,1.0,3/6,17.38%,OLAH;ABHD3;OXSM
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.34567500041423,0.8615389986229705,0.6129032258064516,1.0,1.0,24/102,20.00%,EYA4;HDAC10;PRDM5;UBE2A;CARM1;USP36;HDAC1;ZNF541;HDAC9;UBE2N;KAT2A;PRMT2;HDAC4;NAA50;MIER3;ENY2;PHC1;CPA4;PADI2;TBL1X;MRGBP;SIRT1;EHMT1;SUDS3
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5439311382524444,-0.8614508061305927,0.6666666666666666,0.9947117914947979,1.0,2/6,20.12%,SENP7;USPL1
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.559515118645036,-0.8611172904815196,0.7301587301587301,0.9949105596330293,1.0,1/6,5.53%,DKK3
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.3871888221319538,0.8610371586595479,0.6571428571428571,1.0,1.0,6/62,8.07%,SPIRE2;CEP55;ESPL1;TRIM36;SEPTIN10;RAB35
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.3970925526935337,0.860761595332481,0.6382978723404256,1.0,1.0,7/35,9.93%,ZDHHC16;FREM2;ADAMTS18;MEIS1;PAX8;ABCB5;PBX4
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.514590303781586,0.8605725929066655,0.5789473684210527,1.0,1.0,3/7,22.15%,BAG2;ADAM8;NLRC4
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.44684922673385696,-0.8602695137777719,0.6825396825396826,0.9960757906669262,1.0,2/19,11.40%,KIF16B;HOOK1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.37133792175585245,-0.8599310253717038,0.6944444444444444,0.996395621825502,1.0,13/81,22.21%,CLVS2;KIF16B;SH3GL2;GOLGB1;SORCS1;DOP1B;AP1S2;RP2;MYO1B;CCDC93;STEAP2;ARF1;VPS13A
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),-0.525040098707306,-0.8598901350468666,0.7169811320754716,0.9960769097026339,1.0,1/7,5.51%,LRRC4
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.4456110360907624,-0.8597030353756198,0.6805555555555556,0.9960271009224118,1.0,10/27,24.15%,CENPK;CENPA;MIS18BP1;CENPL;CENPQ;OIP5;ITGB3BP;CENPI;CENPP;MIS18A
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.4431524202194845,-0.8596805471355311,0.6857142857142857,0.9956333060298244,1.0,5/23,18.31%,WTIP;EGFR;ZFP36;TGFB1;STAT3
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4154068818978788,-0.8595634805451433,0.6956521739130435,0.995428567020276,1.0,6/36,15.45%,CLDN5;CLDN16;CLDN20;CLDN4;PARD6A;PATJ
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.560059886330499,0.8593667896816546,0.7317073170731707,1.0,1.0,3/5,7.08%,SLC52A1;ENPP1;SLC52A2
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.560059886330499,0.8593667896816546,0.7317073170731707,1.0,1.0,3/5,7.08%,SLC52A1;ENPP1;SLC52A2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.5402795084427979,0.8590867411377338,0.6666666666666666,1.0,1.0,3/5,21.21%,HS6ST1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.4329238905631734,-0.8589533849276831,0.6818181818181818,0.9957361161417406,1.0,2/28,4.09%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.4329238905631734,-0.8589533849276831,0.6818181818181818,0.9957361161417406,1.0,2/28,4.09%,TGFB2;PRICKLE1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.4380725823426701,-0.8577926331515441,0.6666666666666666,0.9976508378208926,1.0,6/23,10.97%,VSIR;CR1;EPHA4;EFNA1;GRIN2B;LYN
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.4770474280395693,0.8575714150931514,0.6888888888888889,1.0,1.0,2/7,19.35%,BMP5;PHACTR4
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.5504005528303605,0.8573845197589223,0.6744186046511628,1.0,1.0,1/7,5.05%,RIPPLY2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.415111435875527,0.8573449589980368,0.6410256410256411,1.0,1.0,9/35,20.94%,RAE1;NUP42;NUP210;TPR;NUP37;YBX1;NDC1;RAN;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.45950260885351324,-0.8571959431965772,0.6363636363636364,0.9982954217709837,1.0,7/26,17.47%,THY1;MAP2;KIAA0319;TRIM46;NGFR;OMG;FGF13
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.5093648440969177,-0.8571906768660933,0.6451612903225806,0.9978681908909728,1.0,3/11,16.76%,B2M;BMP6;SLC11A2
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.41587547147932674,-0.8571776415640762,0.6111111111111112,0.9974706086587974,1.0,10/29,15.24%,P2RY12;IL6R;F3;MET;STX3;CDH13;VEGFA;PRKD2;TGFB1;ZNF580
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.34625536135334173,0.8569746502060411,0.7352941176470589,1.0,1.0,43/123,26.56%,DICER1;MDN1;EIF5;CRNKL1;SRPK3;MRPS7;SNRPC;GEMIN6;LUC7L;SNUPN;NLE1;STRAP;RPSA;BRIX1;COIL;SF3A2;RPL23A;GEMIN5;DHX9;RPL3;NAF1;RPL11;SMN1;CELF1;RBM5;WDR77;SNRPB;EIF2S2;TGS1;SRSF9;RPL5;POLR2D;PRPF18;ABT1;LUC7L3;KHDC4;EIF4B;PUF60;PRMT5;PWP2;RSL24D1;RPL10;SF1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.5440812376389492,0.8568211180185125,0.6666666666666666,1.0,1.0,3/5,36.93%,ZFAND1;KIF5B;VCP
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.47843291423688894,0.8568146195377374,0.6111111111111112,1.0,1.0,2/14,7.47%,B4GALNT2;B3GALT4
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.5404214612287213,-0.8567568560971197,0.7076923076923077,0.997926291068802,1.0,1/6,17.91%,ADH4
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.3372490556726803,0.8566980339982808,0.7272727272727273,1.0,1.0,22/195,9.36%,CFAP61;FBF1;KIF3B;TMEM138;TTC29;ASAP1;PTPDC1;CFAP43;CNGB1;FHDC1;EHD2;FAM161B;PCM1;FLNA;CILK1;EXOC7;GBF1;MKS1;CFAP70;TCTN3;CEP290;CEP164
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.3008508333432383,0.8566674476410906,0.9166666666666666,1.0,1.0,34/244,14.08%,ORC1;CHRNA4;POLD3;NT5E;PRIM1;HMGB1;UBC;ENDOV;UBE2A;MGMT;CTC1;PARP3;POLE4;PURA;RAD52;DCLRE1B;TOP3B;UBB;ZBTB1;DMC1;POLG;ADPRS;SP100;HELLS;LTO1;CNBP;UBE2N;DNMT1;PSME4;POLH;NABP1;THAP9;POLI;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.5042360086358685,0.8565082915018012,0.6666666666666666,1.0,1.0,1/7,6.88%,OXSR1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.5042360086358685,0.8565082915018012,0.6666666666666666,1.0,1.0,1/7,6.88%,OXSR1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5253565370207378,-0.8558866728909952,0.6779661016949152,0.9991839831451409,1.0,2/7,15.80%,TMEM79;MAFF
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.5333342388818594,-0.8558095121706801,0.7454545454545455,0.9988782501769025,1.0,1/9,2.04%,ISG15
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.4834842863583996,-0.8557823200093901,0.6666666666666666,0.9984934449028641,1.0,2/12,11.48%,TUSC3;NIPAL2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.350342068788069,-0.8555189384140183,0.7313432835820896,0.9986766051928044,1.0,6/129,10.51%,CARTPT;MAP3K5;LRRK2;XBP1;ATP6V1C2;CEBPB
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.5359168449269547,0.8553308350779891,0.6976744186046512,1.0,1.0,1/6,5.45%,PLEKHA3
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.4413676536771316,-0.8551862105614156,0.6756756756756757,0.9988387477543054,1.0,2/19,6.11%,PTPRC;CSF1R
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.47034237247047994,0.8548424125979055,0.6444444444444445,1.0,1.0,3/8,17.25%,FBP1;GFPT2;GFPT1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.5003822960838427,-0.8548211899864429,0.6935483870967742,0.9990549630399278,1.0,3/10,14.82%,MFNG;GPR183;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.5877038307082898,-0.8541120288801515,0.7543859649122807,1.0,1.0,1/5,11.39%,CALM3
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3719755432737349,0.8540314859534758,0.5384615384615384,1.0,1.0,7/97,3.26%,CXCR4;TBXA2R;F2;WBP2NL;CCR3;HMGB1;SLC35G1
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.5048624377112125,-0.8539256784640151,0.7142857142857143,0.9999326609987915,1.0,1/9,9.95%,ACSS3
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.459333016316591,0.8539093332090011,0.696969696969697,1.0,1.0,3/12,17.18%,PARP3;TNKS2;PARP6
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.398171192513471,-0.8538289182715789,0.6885245901639344,0.999677504132932,1.0,8/41,22.63%,KDM4D;GRM5;LYN;ATG10;WARS1;KAT2B;PIN1;CADM4
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.4443340503047165,0.8538199468379553,0.6129032258064516,1.0,1.0,9/30,24.56%,PIH1D1;DGKQ;RNF152;SESN1;CASTOR2;SEH1L;C9ORF72;GPR137B;KPTN
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.5254360118399666,0.8538135766448495,0.5581395348837209,1.0,1.0,1/9,0.80%,CRYAB
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.5305252640655092,-0.8537342568022359,0.7419354838709677,0.9994350556978588,1.0,2/7,17.10%,XBP1;CIITA
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.4983803031967951,-0.8534606728625106,0.7166666666666667,0.9995132297959364,1.0,7/10,34.70%,ATP23;PMPCB;PMPCA;STOML2;IMMP1L;MIPEP;AFG3L2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.32576773144627014,-0.8534574480730116,0.8690476190476191,0.9990963639310225,1.0,41/447,14.10%,ASB4;H2BC11;ARIH2;FBXL16;ENC1;ISG15;TRIM5;KLHL7;DTX1;TRIM22;UBOX5;RNF217;DTX3L;PSMB8;FBXW9;THOP1;RNFT1;HLA-A;FBXO41;SH3RF3;PRAME;UBE2QL1;RNF144B;FBXL13;HIF3A;FBXL18;HECW1;FBXO17;PRPF19;TRIM25;CBLC;MAGEF1;FBXO7;NEDD4L;UNKL;FBXO10;TRIM32;UVSSA;FBXL5;CCNF;RNF213
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.5321396282943837,-0.8533034964702357,0.7592592592592593,0.9989999950474322,1.0,5/8,29.74%,ABCA1;APOM;BMP1;APOE;ABCA7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.5082630557486418,-0.853292234657393,0.6666666666666666,0.9986003307396776,1.0,3/7,21.10%,LYN;LILRB1;IL33
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.379227927363773,-0.8529378853057673,0.7702702702702703,0.9989155114691689,1.0,11/97,15.19%,CLDN5;TGFB2;TGFBR2;FOS;BMP6;FURIN;HJV;TGFB3;BMPR1B;TGFB1;PARD6A
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.46456161839775245,0.8524368995951219,0.6585365853658537,1.0,1.0,3/13,8.64%,CRHBP;CASQ2;TRPV1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.41098993162538694,-0.8523965012062993,0.6857142857142857,0.9995459967487836,1.0,10/40,17.99%,VIL1;SYNPO2;RHOC;CARMIL1;TGFB3;SYNPO2L;FHOD1;SYNPO;CX3CL1;TPM1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5539426753240242,-0.8518780662543542,0.75,1.0,1.0,1/6,3.09%,ALG10B
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.37087897173010076,-0.8518423438206715,0.7123287671232876,0.9997474171386863,1.0,10/83,15.07%,PPARG;IGSF1;ASPN;TGFBR2;VWC2L;CAV1;BMPR1B;BMPER;WFIKKN1;TGFB1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5024005144443224,0.8518388820183935,0.5714285714285714,1.0,1.0,3/11,19.55%,ARPC5;WHAMM;JMY
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.46495476109619993,0.8515646649588391,0.6,1.0,1.0,5/17,20.80%,TESK1;CDKN1C;DYNLL1;SIRT1;CDKN2C
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.46765890556788514,0.8512133175990285,0.6052631578947368,1.0,1.0,2/9,3.84%,MALT1;NFKBIZ
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.573772896642387,-0.8510205159770211,0.7719298245614035,1.0,1.0,3/6,19.66%,MDM1;BRCA1;KAT2B
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.44650540023850704,0.8509267123955232,0.6,1.0,1.0,4/14,13.95%,WNT9A;MEGF8;DSCAML1;HOXD3
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.39059423026954804,-0.8508032914595001,0.684931506849315,1.0,1.0,17/61,14.67%,HEY1;NRCAM;MEF2C;DTX1;ID2;BRINP2;CASZ1;ZEB1;ZFHX2;LRRK2;CDK5R1;NREP;BRINP1;YWHAH;TRIM32;CNTN4;BRINP3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.38391501984184334,-0.8507982115892112,0.7333333333333333,1.0,1.0,17/61,19.14%,ANGPT1;FBLN1;PTPRC;SPINT2;DACT2;ARHGDIG;PDE3B;CDH13;RASA1;TGFB1;PLXNA2;DMTN;PLXNA4;CX3CL1;PLXNC1;CDH1;PLXND1
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.34537950456720096,0.8506962267087391,0.7083333333333334,1.0,1.0,7/96,3.99%,CXCR4;DSCAM;EPB41L4B;PLXNA1;DUSP1;SEMA5A;EPHB2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.37066145816514684,0.8506888067183421,0.7419354838709677,1.0,1.0,4/53,3.39%,CRTAM;CD274;HMGB1;SCRIB
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.5154649736087152,-0.8504474852409069,0.631578947368421,1.0,1.0,1/6,13.49%,NOL3
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.4330611819779558,0.8502287974997584,0.6060606060606061,1.0,1.0,4/28,11.60%,HSPA1A;SLC38A2;PRDX6;NCL
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.331945351790119,-0.8502056377208193,0.7922077922077922,1.0,1.0,31/283,16.47%,ARIH2;FBXL16;TRIM5;TRIM22;UBOX5;RNF217;DTX3L;PSMB8;FBXW9;THOP1;FBXO41;PRAME;UBE2QL1;RNF144B;FBXL13;FBXL18;HECW1;FBXO17;PRPF19;FBXO7;NEDD4L;UNKL;FBXO10;TRIM32;FBXL5;CCNF;RNF213;ANAPC13;BRCA1;TRIM69;SIAH1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.4320646074268062,-0.8499762278799395,0.7183098591549296,1.0,1.0,11/33,24.15%,CENPK;CENPA;MIS18BP1;CENPL;CENPQ;OIP5;ITGB3BP;CENPI;CENPP;ANP32E;MIS18A
prerank,MSigDB_Hallmark_2020__Coagulation,-0.37313785575216907,-0.8499753000072722,0.7538461538461538,1.0,1.0,18/86,17.09%,F8;CTSO;CLU;TIMP1;PRSS23;SERPING1;F3;A2M;FURIN;PROS1;LRP1;PREP;TIMP3;MAFF;GNG12;HPN;CPB2;VWF
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.5565050823212323,-0.8499715139118262,0.78125,0.9997806283375968,1.0,4/8,38.50%,WASHC1;DAB2IP;PPP2R5A;RUBCN
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.3972615430195768,-0.8499258677101916,0.6911764705882353,0.9994365748506889,1.0,9/53,17.33%,PLEKHA2;UTRN;ECM2;CDH13;CARMIL1;RAC3;SKAP1;DMTN;CX3CL1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5270533282210318,0.8499208455139241,0.6842105263157895,1.0,1.0,3/7,27.85%,LIG4;SIRT1;ERCC6
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.4688194053030963,0.8497475907376821,0.7,1.0,1.0,4/9,21.40%,YBX1;HNRNPA2B1;RTRAF;RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.49872242419503443,-0.849025921776057,0.6885245901639344,1.0,1.0,1/9,11.87%,FBXO7
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3408886501131744,0.8487147848295791,0.7692307692307693,1.0,1.0,4/84,4.56%,CXCR4;LEPR;IL4R;IGF1R
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.4430142000618813,-0.8485957008144266,0.7096774193548387,1.0,1.0,6/24,13.95%,SYT4;SYT1;CHGA;KCNB1;SYT12;SYT13
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.49683592668660387,0.8485529689866623,0.525,1.0,1.0,3/7,10.10%,HSPA1A;CPNE1;HSPA1B
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.3796025344024862,-0.8483681124784637,0.6956521739130435,1.0,1.0,11/94,12.32%,ABCC4;AKAP12;GUCY1A1;INPP4B;FKBP5;ACTN1;CCND1;B2M;H1-0;STEAP4;BMPR1B
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3014497716469086,0.8482133668822255,0.8260869565217391,1.0,1.0,42/346,14.05%,TEAD2;ONECUT1;MLF1;ZNF676;CDK11A;SLC39A8;APBB3;RNF6;HDAC10;ZNF460;CARM1;CRX;HMGA2;ACTR5;ATF4;SOX12;SPIN2B;ZNF117;SBNO1;RALY;ABL1;PHF1;ZNF212;MLX;PTP4A3;TAF5;THAP1;RYBP;SOX13;ACVR1B;CCAR1;ASCC2;ESRRG;ZNF74;DAXX;CNBP;NKX6-2;CELSR2;ZMIZ1;ZNF488;PATZ1;PRRX2
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.4096496682304836,0.8480257356850542,0.6486486486486487,1.0,1.0,6/25,18.30%,RSL1D1;RPL7L1;URB1;FTSJ3;NIFK;NSA2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.41017161754998765,-0.8479137036282159,0.7246376811594203,1.0,1.0,6/46,4.25%,LPL;TLR2;HLA-E;PTPRC;CLU;C1QTNF4
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.5229167278164502,-0.8477812145588717,0.6785714285714286,1.0,1.0,2/9,12.68%,ROBO2;GPC3
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.38459732385737244,-0.8476927055762395,0.6896551724137931,1.0,1.0,5/46,11.83%,H2BC11;NAP1L2;SOX9;H1-0;LIN54
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.45391922766550596,0.8476530043612434,0.5869565217391305,1.0,1.0,1/16,1.35%,DPEP1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4482994942075243,-0.8476328432237352,0.7058823529411765,1.0,1.0,5/21,23.61%,FAR2;DGAT1;ACSL5;ACSBG2;ELOVL2
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.3923433848593544,-0.847486916257194,0.6486486486486487,1.0,1.0,8/54,17.99%,FOS;MAP3K5;AQP1;ROMO1;EGFR;ZNF580;TRPM2;TPM1
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.42216525262420657,0.8472489053108837,0.7419354838709677,1.0,1.0,3/16,9.50%,SMIM20;COX19;FASTKD3
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.46666772205384177,-0.8472170783483886,0.7313432835820896,1.0,1.0,3/18,5.11%,NOX4;DUOX1;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.35994820800448357,-0.8471713377243141,0.6363636363636364,1.0,1.0,18/96,19.58%,MT1M;TGFB2;TSPYL2;CRLF3;GJA1;RERG;WFDC1;TCHP;NOTCH2;TGFB1;CDKN1A;BTG1;PTPRJ;MT1E;GNG4;OSGIN2;OSGIN1;BCL6
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.41529701660168444,0.8470857463243626,0.696969696969697,1.0,1.0,3/22,6.59%,DSCAM;SEMA5A;MEGF8
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.496436802337567,-0.8470513924210318,0.7352941176470589,1.0,1.0,5/12,17.18%,MPP4;ZDHHC15;DLG4;PCLO;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.4043587153683963,-0.8468954013861252,0.7301587301587301,1.0,1.0,1/58,0.58%,MDFIC
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5595154207821491,-0.8468329575405598,0.8125,0.9998567002333381,1.0,3/10,18.31%,STAT5A;LYN;STAT3
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3610726601098668,-0.8468296865838865,0.7428571428571429,0.99943660115196,1.0,13/77,16.60%,FBLN1;IGFBP3;LRRK2;TERF2IP;WWTR1;SH3GL2;LYN;PID1;PTPN13;TGFB1;CDKN1A;WARS1;GIT1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.5171787804228622,0.8468004768661347,0.6756756756756757,1.0,1.0,2/10,1.31%,AGER;CD274
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.43040557084512243,0.8467231895711533,0.6470588235294118,1.0,1.0,3/12,14.31%,PLXNA1;NRP2;PLXNB1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.4205156116693963,-0.8466693304190964,0.6875,0.9992673558827642,1.0,12/35,20.62%,VIL1;ID2;HSD11B2;CHGA;FLI1;SLC44A3;CBLC;OVOL2;TRPV4;HNF4G;CDH1;GPX2
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.3871591348352027,-0.8466401097652408,0.7910447761194029,0.9988848057760976,1.0,11/62,8.94%,DPEP2;HOPX;SLA;PTPRC;ITGAM;GMFG;SELL;AOAH;CD53;STYK1;IL16
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.4544349617847574,-0.8465850060802008,0.6470588235294118,0.9985682284435932,1.0,8/23,23.38%,GLIS2;GPR161;GLI3;GPC3;TULP3;IFT122;MGRN1;RFX4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.40450385774706443,-0.8464519957855562,0.7464788732394366,0.9983913634275376,1.0,6/48,4.25%,LPL;TLR2;HLA-E;PTPRC;CLU;C1QTNF4
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3887994290143535,0.8462392339903972,0.8064516129032258,1.0,1.0,15/42,22.29%,TESK1;CRK;FLNA;ABL1;PTPRD;IL1RAPL1;MYADM;CUL7;CASS4;CDC42;ARHGEF7;RAC1;CUX1;FERMT2;CIB1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.37244777293041126,-0.8461716452079452,0.7536231884057971,0.9985016175096298,1.0,9/106,8.60%,SFRP4;GLIS2;NLRP12;ID2;PIM1;NFKBIE;NLRP3;TMIGD3;BHLHE40
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.41361409395509086,0.8459340051184792,0.76,1.0,1.0,5/28,11.91%,PCM1;IFI27;CEP290;PRR5L;TPR
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4030211417953591,0.8458285409327421,0.6923076923076923,1.0,1.0,8/33,20.94%,RAE1;NUP42;NUP210;TPR;NUP37;NDC1;RAN;SEH1L
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.4030211417953591,0.8458285409327421,0.6923076923076923,1.0,1.0,8/33,20.94%,RAE1;NUP42;NUP210;TPR;NUP37;NDC1;RAN;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.5650286504516198,0.8457990697014937,0.6666666666666666,1.0,1.0,1/6,2.63%,SERPINF2
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.41226306036718185,-0.8457700966937426,0.7666666666666667,0.9988289631107202,1.0,2/31,1.17%,ITGB4;DMKN
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.5132668263208678,-0.8455139892211135,0.7,0.9988979778687418,1.0,1/8,9.95%,ACSS3
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.44305115511488297,-0.8454382825266402,0.7014925373134329,0.9985738755399238,1.0,6/18,19.38%,NCKAP1L;CYFIP1;NEFH;RAC3;RHOJ;RHOH
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.5489467479739808,-0.8451262756199832,0.7142857142857143,0.9987534408155049,1.0,1/5,12.69%,LRP1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.5413753905930427,0.8444079901708916,0.675,1.0,1.0,2/5,21.30%,GREM1;LDLRAD4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.45688662696880317,0.8443493731539301,0.6976744186046512,1.0,1.0,4/9,23.38%,NOC2L;SNCA;SIRT1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4683176584017815,0.8443275377314917,0.7222222222222222,1.0,1.0,2/13,8.07%,NCK1;ATF6B
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.4458528552846044,-0.844134120687994,0.6896551724137931,1.0,1.0,5/24,6.68%,CHRM3;ANO6;KCNJ4;KCNJ6;KCNJ3
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.42639147804348654,-0.8441144051377946,0.6825396825396826,0.9997622951466578,1.0,1/22,0.92%,TLR2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3648010091517939,-0.8438717540997607,0.7671232876712328,0.9997694585381912,1.0,19/121,12.32%,HEY1;HOPX;CEBPD;EPHA3;ID2;CASZ1;APC2;LGALS3;ST7;ZFHX2;PRAME;FES;AR;CDK5R1;NREP;CEBPB;CAMK1;YWHAH;BMPR1B
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.43304391441527157,0.8438541878195623,0.7307692307692307,1.0,1.0,4/24,7.65%,VCPKMT;KMT5A;SMYD1;ATPSCKMT
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.4545360365502791,-0.8436878770774262,0.6666666666666666,0.999682644237078,1.0,3/18,10.85%,GNPTAB;MAN1A1;ST8SIA3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.4992672374809869,0.8433509221822019,0.6666666666666666,1.0,1.0,1/7,4.09%,NOC2L
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.4137906775149223,0.8432726280505948,0.6944444444444444,1.0,1.0,4/22,10.38%,PRR5;EIF4EBP1;PRR5L;MLST8
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.5376373081575412,-0.8432190075764237,0.7076923076923077,1.0,1.0,1/6,14.51%,SPI1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.5423789539395338,-0.8430966563480733,0.6666666666666666,0.999807241588425,1.0,1/6,17.49%,MOCS3
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.5037793695253314,0.8428861299939937,0.6470588235294118,1.0,1.0,2/7,7.23%,CD274;PRELID1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.33749294199049873,0.8428775755975125,0.75,1.0,1.0,10/62,13.41%,NUPR1;DUSP1;SCRIB;HECA;CDKN1C;CDK6;GAS1;IPO5;LATS2;TRIM35
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.47217626608537433,0.8426120375858462,0.65,1.0,1.0,3/20,6.44%,HMGB1;DICER1;EXOG
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.32063598619214284,-0.8420295986810018,0.8648648648648649,1.0,1.0,54/271,24.51%,ANGPT1;SEPTIN12;GPIHBP1;MYO7A;RPGR;LAPTM5;LRRK2;GRTP1;ZDHHC15;GJA1;CPE;STX3;SEPTIN6;USP6;SAR1A;TBC1D10A;PRPF19;HPS6;PACSIN1;YWHAH;EGFR;FGF7;RAB1B;COX18;NGFR;SEPTIN3;NAPG;TMED10;VCL;RIC1;TBC1D8B;USP4;AMOT;RAB6B;TBC1D9;STX19;WLS;VPS35;ARF1;ARF5;CEP68;SEPTIN2;WNT5A;ARL1;CNTLN;STX17;HEY2;PICK1;REEP1;ABCA12;WDR11;TBC1D2;EHD1;RAB6C
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.37277202256565717,-0.8417600014999774,0.7631578947368421,1.0,1.0,10/65,17.33%,CLU;BCL2L2;LGALS3;HGF;CX3CR1;AR;NOL3;SCG2;ITGAV;CX3CL1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.4296345483422886,0.8415483244521034,0.6904761904761905,1.0,1.0,4/19,18.69%,TPX2;TUBG1;AKAP9;SLAIN2
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.4137389491983963,-0.8415455863289244,0.6764705882352942,1.0,1.0,1/34,1.24%,HEY1
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),-0.597461744697641,-0.8415197137149198,0.7288135593220338,1.0,1.0,2/5,29.69%,METRNL;UCP1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.44148437571154503,0.8414716754303783,0.7647058823529411,1.0,1.0,8/27,18.40%,B4GALNT2;DAD1;OST4;UGGT1;LMAN1;DPM3;ALG5;RPN2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.39752961486761035,0.8412325941797174,0.65,1.0,1.0,3/30,10.25%,DPEP1;OPLAH;HAGH
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.4037687743949912,0.8409875548608561,0.7837837837837838,1.0,1.0,9/37,20.94%,RAE1;NUP42;NUP210;TPR;NUP37;NPM1;NDC1;RAN;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4491399100813144,0.8408920144026695,0.6888888888888889,1.0,1.0,3/11,13.10%,SPRY2;SPRY3;SHISA2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.41822582821249954,0.8406440918208568,0.65,1.0,1.0,3/22,6.02%,NDC80;DYNLT1;NUMA1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.49694969446101167,0.8405205753279305,0.6666666666666666,1.0,1.0,2/10,2.21%,TCOF1;KBTBD8
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.4135580092954392,-0.8403956328935908,0.7391304347826086,1.0,1.0,4/30,12.03%,KNDC1;HECW1;NEDD4L;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.3994982221156916,0.8402342343186519,0.6521739130434783,1.0,1.0,3/34,2.79%,AGER;CD274;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.5716995244056822,-0.8401704642356557,0.7333333333333333,1.0,1.0,3/5,38.57%,HSPA5;DNAJB9;BFAR
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.4332706765264678,0.8400868675596004,0.6857142857142857,1.0,1.0,8/28,18.40%,B4GALNT2;DAD1;OST4;UGGT1;LMAN1;DPM3;ALG5;RPN2
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.35078351292497423,-0.8399298511182932,0.7746478873239436,1.0,1.0,21/124,13.01%,BAIAP2;NYAP1;CCK;NRCAM;NCKAP1L;GPM6A;MYO16;DCLK1;SLITRK5;NTNG1;SLITRK4;LRRK2;FLRT1;PAK3;RAB3A;NEFH;PACSIN1;EPHB1;DLG4;MAP2;SLITRK3
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.29470966880401356,0.8399271601600532,0.8636363636363636,1.0,1.0,28/137,19.90%,PSME2;RIDA;UBC;HSPA1A;EXOSC8;PSMD13;CSDC2;SAMD4A;FASTKD3;DCP1A;UBB;FASTKD1;ANP32A;PSME4;HNRNPU;PSMF1;NPM1;YBX1;EXOSC7;AXIN2;PSMD11;MAPKAPK2;DIS3;CELF1;PSMD4;PDE12;EXOSC5;TENT5D
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.4219562845324775,0.8399036831814432,0.7352941176470589,1.0,1.0,3/21,8.15%,PDE3A;CGAS;PEX5L
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4526990072828464,-0.8398224107673208,0.7333333333333333,1.0,1.0,5/20,31.81%,PSMC3;ESR1;PSMC5;DHX36;MED14
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.5308300837788025,0.8397567624647165,0.7391304347826086,1.0,1.0,3/5,34.13%,NAPB;STX1B;UNC13B
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.42175992097286763,0.8395065228661154,0.6153846153846154,1.0,1.0,5/20,12.66%,MOGAT1;PLCE1;DGKH;DGKQ;DAGLA
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.32595109123671484,0.8393941074807693,0.8,1.0,1.0,24/142,13.53%,CD38;ZAP70;LCK;PSME2;SH2B2;MALT1;NFKBIZ;CD247;PDE4B;NCK1;MOG;PSMD13;PTPN22;CD276;BTN2A1;CHUK;TNFRSF21;ICOSLG;UBE2N;NFKB1;PSME4;MAP3K7;BCL10;NFAM1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.35169450402578556,-0.8392227587099331,0.7945205479452054,1.0,1.0,20/110,14.06%,FSTL1;LRIG3;KITLG;LAMC1;COL4A1;SOX9;NTN4;MET;DDAH1;KIAA1217;WWTR1;LAMB1;PALLD;BOC;LMOD1;CAV1;TRIM32;EGFR;NFATC2;ADAMTS15
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.39776779223609227,-0.8391749267760584,0.7121212121212122,1.0,1.0,9/44,12.03%,TWF2;RIMS1;SYT4;SYT1;L1CAM;PLCB1;GOLGA4;RIMS2;NEDD4L
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.4271214253949122,-0.8390504804525214,0.6923076923076923,1.0,1.0,1/20,0.84%,PPP1R17
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.5035819196564622,-0.8390311330033476,0.6557377049180327,1.0,1.0,3/9,27.89%,REP15;EHD3;NSG1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.5426966759977313,-0.8385373211337727,0.711864406779661,1.0,1.0,1/7,7.50%,TOMM7
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.3635205253027361,-0.8385099414761239,0.7692307692307693,1.0,1.0,16/83,16.09%,CIDEB;TP73;BCL2L2;MAP3K5;SCN2A;E2F1;TMEM117;CEBPB;TNFRSF1B;APAF1;ZNF385B;PPP1R15A;CDKN1A;MLLT11;BBC3;BRCA1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.5025396792573728,0.838235137171445,0.6341463414634146,1.0,1.0,3/8,14.63%,NRP2;ASCL1;UNC5C
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.39628106264617335,-0.8382312597276175,0.7586206896551724,1.0,1.0,8/40,21.86%,KIF16B;FLOT1;STK17A;PID1;GNB3;VPS35;ARF1;PDK2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.33360850539288195,0.83820937454364,0.6785714285714286,1.0,1.0,16/140,9.48%,PASK;PTH;PIWIL2;PLD1;PTH1R;NOS1AP;NAT10;CTC1;GLI2;EPM2AIP1;EIF3E;ZEB2;AKT2;EIF3D;PLIN5;SAMD4A
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.4010041582083866,0.8381858395603153,0.6551724137931034,1.0,1.0,1/28,0.89%,NUPR1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.430217735398056,-0.8379275770621573,0.7096774193548387,1.0,1.0,4/22,16.47%,ACADL;CEACAM1;BRCA1;PRKAB2
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.35627745734691646,0.8378360815948083,0.75,1.0,1.0,10/62,9.02%,DHFR;CYB5A;MTHFD2L;ABCC1;SLC52A1;ENPP1;PDZD11;SLC52A2;MTRR;CUBN
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.5066615852918004,-0.8377534432088133,0.7241379310344828,1.0,1.0,4/12,9.70%,EPHA3;NRCAM;EPHA4;CDK5R1
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),0.5096029690839932,0.8377484815476806,0.6666666666666666,1.0,1.0,2/6,2.74%,GPAT2;PIWIL2
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.36342750024434733,-0.8377207103799261,0.654320987654321,1.0,1.0,9/71,8.00%,ABCC4;MGST1;SLC22A9;CYB5R2;SLC23A1;SLCO4A1;AQP1;SLC4A10;SLC25A19
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.5409124667336483,-0.8376691733763885,0.6779661016949152,1.0,1.0,2/7,28.21%,RAD50;NBN
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.41737710797352623,0.8376379352010377,0.6216216216216216,1.0,1.0,1/14,0.36%,DSCAM
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.4918960712216019,0.8375338976891649,0.7368421052631579,1.0,1.0,2/11,6.03%,COX19;SLC31A2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.41959080126414094,0.8374887513423224,0.5675675675675675,1.0,1.0,3/16,11.89%,USP36;RIOK1;RIOK2
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.513365441111229,0.8374799625394217,0.7272727272727273,1.0,1.0,1/7,1.47%,HDC
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.46559884391757717,-0.8374508705564616,0.7878787878787878,1.0,1.0,3/28,10.71%,CC2D2A;PTCHD1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3502484035959603,0.8373363832538983,0.7333333333333333,1.0,1.0,9/53,10.97%,UBC;HSPA1A;SPRY2;SPRED1;SPRED2;ADAMTSL2;FAM89B;UBB;ZNF451
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.4207343633529703,-0.8369453658773437,0.7096774193548387,1.0,1.0,2/32,5.63%,DMKN;RFTN1
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.52617564329833,-0.8369094403410385,0.6825396825396826,1.0,1.0,1/5,3.30%,ITGAM
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.5347420134235998,0.8369090724039061,0.6511627906976745,1.0,1.0,3/5,12.81%,DCP1A;PNRC2;DCP1B
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.4675294605887216,0.8367894450335085,0.6666666666666666,1.0,1.0,2/12,8.94%,CPSF4;CSTF2
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.4545824262987218,-0.8361887352333064,0.7076923076923077,1.0,1.0,3/17,16.47%,SLC25A20;ABCD2;PRKAB2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.3780740921513262,-0.8361845700557354,0.7761194029850746,1.0,1.0,8/65,13.72%,TWF2;STMN2;CLU;APC2;NAV3;CAV3;MAP2;PLEKHH2
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.4731221859911974,-0.8360265617770205,0.6984126984126984,1.0,1.0,4/15,14.65%,P2RY12;GAP43;NREP;RTN4RL2
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.37986508415385467,0.8359265552852437,0.6842105263157895,1.0,1.0,10/22,30.84%,PHF1;FAM47E;DNMT1;SIRT1;SMAD4;JARID2;DNMT3B;AUTS2;KMT2A;PAXIP1
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.573438050074183,-0.8358290517239394,0.8163265306122449,1.0,1.0,2/5,9.89%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.517611210751862,0.8358250049028403,0.7380952380952381,1.0,1.0,4/7,37.74%,ZFAND1;KIF5B;VCP;DHX8
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.2737320585174159,0.8358116054656453,1.0,1.0,1.0,122/905,14.45%,POU3F1;TEAD2;CD38;PTH;VDR;ETV5;SSBP3;ONECUT1;HIVEP3;MYRFL;WBP2NL;EAF2;AFAP1L2;SERPINF2;KDM8;HMGB1;UBC;RASL11A;NRIP1;RNF6;RUNX1;PYHIN1;MSANTD1;FANK1;CRX;JMJD6;ZNF335;HMGA2;CAND2;MAML2;ZNF639;MEIS1;PAX3;PAX8;ATOH8;ATF4;SOX12;HDAC1;SNAI1;CCNT1;GLI2;BRPF1;DMRT1;NCK1;MEOX2;TNIP1;TCF20;ABL1;YY1;ZNF24;AKIRIN1;SMARCD3;TFEC;MED21;ATF6B;EPC1;ELL;SPAG8;GABPB2;E4F1;ACVR1;LPIN3;CREB3L3;HELZ2;ZEB2;MLX;CEP290;SERPINE1;E2F4;PELP1;KDM1B;CDKN1C;DHX33;ELK4;RBM23;TRIM16;PBX4;RYBP;RPS6KA1;ITGA6;CHUK;ST18;GREM1;PSRC1;WNT4;UBB;DPF3;ZNF451;MLXIP;RRP1B;SMARCA4;ESRRG;DLL1;CRTC1;SP100;CNBP;KDM5A;NFKB1;ZC3H8;KAT2A;LBHD1;NHLH2;MLLT3;PRMT2;BCL10;VEZF1;PRDM4;CCDC62;HNRNPU;ZMIZ1;HES5;TADA3;MAP2K7;CDCA4;NFIB;HOXD3;HNF4A;ATF3;ASCL1;BMP5;NR5A2;KMT2B
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.45575869559348253,-0.8357735755657851,0.7605633802816901,1.0,1.0,4/20,13.03%,SHMT2;MPV17L2;MTG1;TSFM
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.3716554617515089,0.8356780442037558,0.7317073170731707,1.0,1.0,2/31,2.83%,PTH;FGFR1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.5509702211792605,-0.8355290847448401,0.6896551724137931,1.0,1.0,1/5,8.48%,XBP1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.49560477493507815,-0.8354743055523834,0.6730769230769231,1.0,1.0,3/10,12.39%,ADGRV1;GABBR2;EDNRB
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.49560477493507815,-0.8354743055523834,0.6730769230769231,1.0,1.0,3/10,12.39%,ADGRV1;GABBR2;EDNRB
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.5331795614306036,-0.835456591308622,0.6551724137931034,1.0,1.0,1/6,14.51%,SPI1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.273639365583242,0.8354035163144459,1.0,1.0,1.0,84/791,12.02%,POU3F1;TEAD2;NGF;PTH;SLC22A2;VDR;EPB41L4B;ONECUT1;RAB27A;FGF6;MLF1;ABCC2;ZNF676;CDK11A;DICER1;NKAPL;SLC39A8;HSPA1A;APBB3;RNF6;HDAC10;OPRD1;NFKBIZ;SLC38A2;RUNX1;EPHB2;PRDM5;SPRY2;NWD1;ZNF460;CARM1;CRX;CIAO3;MYOM1;NOS1AP;USP36;ZNF335;HMGA2;ERP29;TRIM60;ATOH8;ACTR5;ATF4;SOX12;HDAC1;MEGF8;UBAP2;SPIN2B;ZNF117;SBNO1;ABL1;YY1;PHF1;CPSF4;MOG;PTBP1;ZNF212;ATP1B1;CPNE1;MLX;PTP4A3;TAF5;THAP1;PTPN22;WNT3;RYBP;HSPA1B;SOX13;CD276;CDK6;BTN2A1;ACVR1B;WNT4;ZNF451;RRP1B;MAPK8;CCAR1;ADAM19;ASCC2;ICOSLG;MYADM;ESRRG;ZNF74;DGKQ
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.4213709135546833,0.8350321934357331,0.5806451612903226,1.0,1.0,7/25,7.95%,ZAP70;IL2RA;PYHIN1;CD247;GPR174;GNLY;P2RY10
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3919288625248947,0.8350239637154199,0.7857142857142857,1.0,1.0,8/49,10.48%,HSPA1A;SH3RF2;GNL3L;SPRY2;PINX1;BAG2;HSPA1B;PRR7
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.4338775724681085,0.8349142387265501,0.6666666666666666,1.0,1.0,5/17,22.72%,HMGA2;KAT2A;LOXL2;ZNF706;CNOT2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.38902265971871375,-0.8347118689063858,0.6779661016949152,1.0,1.0,6/42,11.94%,ITGB4;ALOX12;MET;DACT2;TMEM79;CLDN4
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.39753567814087093,-0.8345496817292894,0.7910447761194029,1.0,1.0,8/53,15.76%,BCL2L14;LGALS3;AR;CAV1;NOL3;SCG2;AGT;ITGAV
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.46061630575926704,-0.8344132835525695,0.7068965517241379,1.0,1.0,2/10,10.73%,DGKD;DGKB
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.46698097933199156,0.8343723952113553,0.7692307692307693,1.0,1.0,2/14,6.90%,AIFM2;COQ2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4267197814489692,0.8341835836419702,0.6153846153846154,1.0,1.0,2/23,10.80%,UBC;UBB
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.32666328930614663,0.8340196529085632,0.7777777777777778,1.0,1.0,22/150,13.62%,PSME2;CDK10;AFAP1L2;CDK11A;SCRIB;PIM3;HECA;CDC26;GBF1;EIF4EBP1;PSMD13;THAP1;CDKN1C;ANAPC15;MAEA;GAS1;TMEM8B;PSME4;CKS1B;TRIM35;HNRNPU;EIF4E
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.49899781767447987,-0.8337661492018096,0.6896551724137931,1.0,1.0,1/12,2.15%,MCTP1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5047320622069076,-0.8336729149665895,0.7424242424242424,1.0,1.0,3/12,8.74%,NOS1;ARG2;MTARC2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.4153788418956227,-0.8334102733238287,0.5882352941176471,1.0,1.0,4/23,20.16%,ID2;BHLHE40;PPP1CA;PER1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.49532454548242927,0.8330471168192407,0.7027027027027027,1.0,1.0,3/9,26.74%,GALNT1;POGLUT1;GALNT2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.4999902669536531,-0.8329192348866158,0.7619047619047619,1.0,1.0,2/15,3.86%,PPARG;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.5268542722243857,-0.8327593259236984,0.7358490566037735,1.0,1.0,3/8,15.65%,TERF2IP;TOP2A;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4875295511523955,-0.8327150000230525,0.6984126984126984,1.0,1.0,1/13,14.64%,ZFP36
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.5078836671105011,-0.8325048825149419,0.7627118644067796,1.0,1.0,3/8,29.05%,DDX11;TIMELESS;FMR1
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.33915087162537205,-0.8324918139027734,0.7671232876712328,1.0,1.0,26/162,17.60%,ITGB4;CLDN5;ADAMTS5;BAIAP2;PTPRC;CADM3;ACTN1;CNTN1;MPZL1;SGCE;DHX16;THY1;CALB2;CLDN4;YWHAH;CDH3;EGFR;RASA1;MYH10;FYB1;KCNH2;SYK;PIK3CB;VWF;CX3CL1;VCL
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.4523487114900385,0.8324021141636593,0.5789473684210527,1.0,1.0,2/11,3.91%,CRHBP;SLC38A2
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.49697502334398913,0.8323557816632113,0.7297297297297297,1.0,1.0,1/8,3.96%,THAP4
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.3942976047762911,0.832218877050223,0.7317073170731707,1.0,1.0,11/39,16.86%,SRFBP1;LTV1;NOM1;MRPS7;RIOK1;RIOK2;RRP36;RPSA;NPM1;METTL17;NOL11
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.4965815801785728,-0.8321258739846102,0.7096774193548387,1.0,1.0,5/13,19.66%,TGFB2;CD200;ITGAV;LILRB1;LTBP1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4375462249278748,-0.8320998994526113,0.7794117647058824,1.0,1.0,6/29,15.79%,B2M;THY1;YWHAH;PAX6;NGFR;OMG
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.3874280953589033,0.8317447114776563,0.7741935483870968,1.0,1.0,3/35,3.18%,CHRNA4;SCN11A;KCNJ2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.3884200569282565,0.8315911303277799,0.7674418604651163,1.0,1.0,6/29,9.93%,ZDHHC16;FREM2;ADAMTS18;MEIS1;ABCB5;PBX4
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.37905536818534974,0.8313686549638567,0.6296296296296297,1.0,1.0,8/36,9.89%,PIWIL4;PIWIL2;DICER1;TDRD12;HENMT1;MOV10L1;PLD6;PRKRA
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.4225992713040747,0.8312470414574706,0.6428571428571429,1.0,1.0,6/23,12.08%,PPP1R36;SH3RF2;PPP1R1B;PTPA;PPP1R26;STYXL1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.4617645520378473,-0.8311418494066187,0.7142857142857143,1.0,1.0,4/16,16.63%,THY1;TEK;VEGFA;PTPRJ
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.5356027960197701,0.8307804000971383,0.7291666666666666,1.0,1.0,1/5,1.07%,LHFPL2
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.4635344699566656,0.8307550106910377,0.6792452830188679,1.0,1.0,5/11,28.39%,DKC1;TENT4B;EXOSC5;LARP7;FBL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.44664942390858153,0.8307197162137322,0.6944444444444444,1.0,1.0,2/16,2.79%,CD274;HMGB1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.5093484949902642,0.8305287917477023,0.6888888888888889,1.0,1.0,2/8,6.23%,DAO;THNSL2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.5486983807243511,-0.830430885323567,0.75,1.0,1.0,2/5,35.52%,DAG1;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.5486983807243511,-0.830430885323567,0.75,1.0,1.0,2/5,35.52%,DAG1;PHLDB2
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5136360369517495,-0.8302562845260785,0.75,1.0,1.0,3/9,12.26%,IL12A;LGALS3;TNFRSF1B
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.4240325574775302,-0.83020873606971,0.7384615384615385,1.0,1.0,3/26,11.30%,CHKB;SLC44A3;ABHD3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.42051064938204663,0.8301382665728166,0.7073170731707317,1.0,1.0,2/16,12.71%,MORC3;PEX2
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.3128586935974604,-0.8300852787523132,0.9,1.0,1.0,38/356,16.65%,TTC8;CC2D2A;ABCC4;IRGM;ATG16L2;CENPE;SMIM22;CDS1;CENPF;RPGR;DYNC2H1;RAB11A;CYS1;TEKT3;LZTFL1;TTC39C;MVB12A;SEPTIN6;OGFOD1;LMOD1;GOLGA8B;GOLGA8O;CENPA;TMOD1;DZIP1;SPAG16;TXNDC15;RAB1B;SNX10;ABLIM1;PATL2;TP53INP1;CFAP44;RP2;DYNC2I2;DISC1;KASH5;SYNPO
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.5302750750850062,-0.829979611464213,0.7538461538461538,1.0,1.0,2/8,9.75%,TESPA1;TOX
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.4639818046478771,0.8297219440861577,0.6521739130434783,1.0,1.0,1/9,0.70%,DHFR
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.4296971022153932,-0.8293073613029359,0.7142857142857143,1.0,1.0,1/19,1.00%,MT1M
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.4411953737963762,-0.8292519456314443,0.7213114754098361,1.0,1.0,7/28,20.04%,OSTN;MAP2;KIAA0319;TRIM46;CDKN1A;FGF13;SLC6A4
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.45945993072302166,-0.8292180875605822,0.703125,1.0,1.0,2/18,14.99%,CAV1;AGT
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.3589998655423249,0.8291471603495136,0.7878787878787878,1.0,1.0,8/39,16.97%,RIDA;HSPA1A;HSPA1B;ZC3H12D;NUDT16L1;PNPT1;PPP1R8;EXOSC7
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.5007760823029637,0.8285767123712169,0.6046511627906976,1.0,1.0,3/7,29.59%,NPM1;RAN;TSC1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.43731044398785346,-0.8285632476894017,0.7090909090909091,1.0,1.0,5/21,21.55%,STMN2;KIF2C;TRPV4;FGF13;PIN1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.5639194828280605,-0.8284417836735639,0.7758620689655172,1.0,1.0,2/6,15.99%,LOXL3;DMTN
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.45658830264371875,-0.8275776490924274,0.6451612903225806,1.0,1.0,3/16,7.12%,NLRP3;HLA-A;B2M
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.41573206074540947,-0.8274815866265977,0.765625,1.0,1.0,4/27,18.14%,FABP3;HSD17B13;SCARB1;SREBF1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3395162556071021,0.8270608485134006,0.7727272727272727,1.0,1.0,18/82,19.54%,PSME2;UBC;PSMD13;CHUK;ST18;UBB;PELI2;UBE2N;NFKB1;PSME4;MAP3K7;RELA;PSMF1;IRAK2;PSMD11;TAB3;PSMD4;BTRC
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.5012869347756752,0.8269708423448269,0.7777777777777778,1.0,1.0,1/9,1.57%,SPX
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.4392549004287173,0.8267919001477136,0.6571428571428571,1.0,1.0,5/11,14.88%,WNT9A;GDF5;GREM1;ADAMTS12;CHADL
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.3431923548330978,-0.8267496814143751,0.8695652173913043,1.0,1.0,6/111,5.35%,H2BC11;MCM2;NAP1L2;SOX9;RPA3;PSMB8
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3850699862337465,0.8265826477138211,0.6666666666666666,1.0,1.0,12/63,12.46%,KIF3B;NDC80;ESPL1;TPX2;ZNF207;FLNA;KIFC2;BCCIP;TUBG1;SGO2;NSL1;KIF25
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.48128889631709376,0.826547408671561,0.6363636363636364,1.0,1.0,4/10,24.56%,RNF152;SESN1;CASTOR2;KPTN
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.3412423762640026,-0.8260143953519339,0.7945205479452054,1.0,1.0,38/146,29.55%,TGFBR2;HIPK4;RPS6KA6;CAMK1D;LRRK2;CDK5R1;CAMK1;PRKD2;MAP3K12;PLK2;PRKCQ;PRKCG;CDK5;VRK3;GAS6;AURKA;HIPK3;PRKCZ;STK38L;DYRK2;PRKCD;CDC7;MASTL;STK38;CSNK1D;CSNK1E;TLK1;MAP4K1;AKT3;RPS6KA3;CSNK1G1;PRKX;MAPKAPK3;MKNK1;CAMK2D;BRSK1;DYRK1B;TBK1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3586255914624557,-0.8255406478699738,0.88,1.0,1.0,19/146,15.07%,PARP14;CLDN5;PARP9;TGFB2;OLFM1;MEF2C;ID2;CITED2;SH3GL2;RIN3;LRPAP1;IFNA2;VEGFA;DLG4;RBL2;OVOL2;SPI1;NOTCH2;TGFB1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.34379503741682016,0.8254944858386525,0.6666666666666666,1.0,1.0,10/98,11.91%,TEAD2;CD247;MDN1;KNTC1;DARS1;LLGL1;TCAP;MATN1;WASF3;TPR
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.45657447638326687,-0.8254792988879134,0.7575757575757576,1.0,1.0,2/26,5.82%,EDN1;MAP3K5
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.47389739035522727,-0.8254213903271872,0.7166666666666667,1.0,1.0,5/12,15.10%,NOS1;CAV3;CAV1;NEDD4L;KCNH2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.45286292470720585,-0.8253155621470771,0.6724137931034483,1.0,1.0,1/12,3.90%,IMPA2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.41901734606133867,0.8251332818705042,0.696969696969697,1.0,1.0,2/18,11.62%,SPHK2;ARV1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.4784635948908592,0.8249762035145556,0.6571428571428571,1.0,1.0,2/15,4.33%,SOAT2;ABCA8
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.5254668970642655,-0.8249140949865464,0.6590909090909091,1.0,1.0,1/5,3.77%,SLF1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.5097634472475123,0.8245965678245114,0.7631578947368421,1.0,1.0,3/7,14.92%,MTRR;MSRA;SMS
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5156798545750587,-0.8242549882640645,0.746268656716418,1.0,1.0,3/10,13.54%,CD53;CAMK1;FLOT1
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.554134440166595,-0.8241711669649953,0.7333333333333333,1.0,1.0,3/5,16.07%,PDZK1;ABCB1;ATP8B1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.34193918067447454,0.8240807580165741,0.7857142857142857,1.0,1.0,4/88,4.72%,TNFRSF8;PSME2;EDARADD;TNFSF13B
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.3625390978102514,0.8239595095040394,0.7586206896551724,1.0,1.0,6/30,6.60%,KCNN3;KCNJ2;KCNN4;ACTN2;NOS1AP;FLNA
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.41615899365534104,0.8238878136411656,0.75,1.0,1.0,5/16,10.95%,SQLE;AUP1;PLA2G4C;PLIN5;PNPLA3
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.49112529827865536,-0.8238862415778518,0.6615384615384615,1.0,1.0,1/8,5.06%,NLRP3
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4102516235227261,-0.8237462887801038,0.8235294117647058,1.0,1.0,10/44,24.86%,GLIS2;GLI3;GPC3;TXNDC15;TULP3;IFT122;MGRN1;WDR11;TUBD1;ZIC1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.5148394677973206,-0.8235495741108054,0.7846153846153846,1.0,1.0,3/13,18.31%,STAT5A;LYN;STAT3
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.36869362707205994,-0.8234895629244149,0.7391304347826086,1.0,1.0,19/59,19.14%,NRCAM;GABRG2;GABRA1;GPM6A;LRRC4;PCDHB11;PCDHB4;GABRB2;GABRA2;LRRTM3;PCDHB9;CBLN4;GABRB3;PCDHB13;NRXN1;FGF13;CDK5;CDH1;PLXND1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.47760545281372546,0.8234541833660206,0.6382978723404256,1.0,1.0,1/7,5.63%,SPRED1
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.4382724391591428,0.8233072054730981,0.6285714285714286,1.0,1.0,5/12,14.88%,WNT9A;GDF5;GREM1;ADAMTS12;CHADL
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.5213559002106918,-0.8223702461619078,0.6842105263157895,1.0,1.0,1/5,4.62%,SOX9
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.36409324401791104,-0.822330654556326,0.6891891891891891,1.0,1.0,10/43,19.47%,ISG15;RPA3;RFC3;RFC4;TRIM25;WRN;FAAP20;RPA2;DTL;SYCP1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5562076960893518,-0.822292358404709,0.7846153846153846,1.0,1.0,3/6,15.07%,PPARG;STAT1;TGFB1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5562076960893518,-0.822292358404709,0.7846153846153846,1.0,1.0,3/6,15.07%,PPARG;STAT1;TGFB1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.4640747888096318,-0.822185093163706,0.7719298245614035,1.0,1.0,5/18,25.11%,MEF2C;CAV1;MYL6B;ZBTB18;SVIL
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.5054795185365548,-0.8221095592993071,0.7627118644067796,1.0,1.0,2/8,14.73%,EFNA1;ZFPM1
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.45546781067772013,0.8221083831011877,0.725,1.0,1.0,4/9,27.10%,ABHD17A;ABHD10;LYPLAL1;LYPLA1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),-0.5387675482928266,-0.8220222538610479,0.7647058823529411,1.0,1.0,1/5,10.96%,ABCG5
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.37682354235734067,0.8218848794406258,0.6923076923076923,1.0,1.0,5/31,8.51%,TRMT10C;TRMT1;METTL2A;NSUN2;TRMT13
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4177497181611304,0.8212103573643024,0.6363636363636364,1.0,1.0,6/20,14.42%,SPRY2;USF3;SPRED1;SPRED2;ADIPOR1;BMP5
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.4817102148570735,-0.8210458378994772,0.6666666666666666,1.0,1.0,5/16,19.22%,MYO7A;MYO5C;MYO1H;MYO1B;FNBP1L
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.4941862508568,0.820493262254469,0.7368421052631579,1.0,1.0,1/9,1.35%,DPEP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.4375140313698187,-0.820236439052234,0.7384615384615385,1.0,1.0,4/20,9.04%,TLR2;LAPTM5;IL16;PLCB1
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.44638116394943267,-0.8201488457694766,0.7671232876712328,1.0,1.0,4/19,5.35%,MAEL;TDRD1;TEX15;EXD1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4251006970454051,-0.8195788549373743,0.7432432432432432,1.0,1.0,3/19,6.40%,PTPRC;TESPA1;CARD11
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.4715877721239923,-0.8191799336758008,0.7464788732394366,1.0,1.0,4/14,12.76%,SLC8A1;ATP1B2;NEDD4L;ATP1A1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.37560011771625534,-0.8190621410644527,0.7183098591549296,1.0,1.0,10/42,16.56%,EDN1;GRM5;CYFIP1;EIF2B4;EDNRB;AGT;TGFB1;RBM3;UHRF1;NFKBIA
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.4283576335990037,0.8185779623594832,0.6571428571428571,1.0,1.0,5/25,8.73%,CMPK1;AK6;AK8;DUT;DCTD
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.5030691892540174,-0.8185218606615522,0.7586206896551724,1.0,1.0,2/11,15.70%,NOS1;CACNA1C
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.4798426699644659,0.8182514871946989,0.74,1.0,1.0,2/9,10.61%,HMGB1;TOP3B
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.4448141917787175,-0.8181823241750316,0.7538461538461538,1.0,1.0,2/18,8.25%,ACTN1;THY1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.32670057183891105,-0.818058210717794,0.9154929577464789,1.0,1.0,26/203,18.59%,IRGM;DEPP1;TRIM5;WDR6;CAPN1;TRIM22;HGF;MET;LRRK2;TPCN2;CDK5R1;ATP6V1C2;DAPK1;HTR2B;DRAM1;DAPK3;EEF1A2;TP53INP1;SNX32;PRKAB2;PLK2;PIK3CB;SREBF1;STAT3;DNM1L;CDK5
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.38487263197176014,-0.8177777356771632,0.8,1.0,1.0,7/44,11.95%,SYT1;CADPS2;STXBP5L;RAB3C;RAB27B;RAB3A;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.5135202410683988,0.817679087345999,0.7368421052631579,1.0,1.0,2/6,12.87%,PIH1D1;DNMT1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.3893665792859657,-0.8172632605315929,0.711864406779661,1.0,1.0,7/34,19.22%,SYT4;MYO7A;MYO5C;CCDC186;MYO1H;MYO1B;FNBP1L
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.5376955410752287,-0.8172182555373173,0.7692307692307693,1.0,1.0,3/8,25.68%,ENTPD3;ENTPD1;ENTPD2
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.37051787357384935,0.8167143012397203,0.8333333333333334,1.0,1.0,10/56,11.80%,TRMT10C;METTL2A;HENMT1;NSUN2;TFB1M;MTERF4;METTL8;TRMT13;VIRMA;TFB2M
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.42572004347887177,-0.8166451221647953,0.6875,1.0,1.0,7/29,25.32%,MAP3K5;AQP1;ZNF580;TRPM2;PRKCD;IMPACT;PPIF
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.404212505879491,-0.8166309248219953,0.75,1.0,1.0,10/29,21.10%,SMIM22;PTGR1;SLC44A3;LGALS2;CBLC;CLDN4;ATP8B1;TMEM184A;GPX2;IL33
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.5408752763927593,-0.8164857650244091,0.7894736842105263,1.0,1.0,1/6,16.04%,NNMT
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.3307170593116886,-0.8164512723571085,0.8933333333333333,1.0,1.0,29/239,15.99%,TTC8;CC2D2A;ABCC4;P2RY12;RPGR;ANO6;DYNC2H1;RAB11A;CYS1;TEKT3;LZTFL1;TTC39C;SEPTIN6;CYFIP1;CDH13;FGD5;CARMIL1;DZIP1;ABLIM2;SPAG16;TXNDC15;OPHN1;SNX10;ABLIM1;CFAP44;RP2;DYNC2I2;DISC1;DMTN
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.5142271611469389,-0.8164210037112839,0.8214285714285714,1.0,1.0,1/9,1.36%,ARIH2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.42338937466204385,-0.8163987714184306,0.7222222222222222,1.0,1.0,2/25,6.91%,ISG15;SAMHD1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.3085926108883863,-0.8163931713747926,0.9156626506024096,1.0,1.0,40/562,8.80%,CD44;ANGPT1;FSTL1;IGFBP3;SFRP4;FIGNL1;OLFM1;BIRC3;CLU;TP53I3;CIDEB;TP73;BCL2L2;NCKAP1L;BCL2L14;MEF2C;APIP;VAV3;PIM1;KALRN;SOX9;CITED2;AVEN;HGF;ANO6;ACTN1;MAP3K5;IL7;PRAME;AQP1;GATA1;KCNMA1;TOP2A;RNF144B;TFPT;XBP1;PNMA2;TEK;E2F1;TCIM
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4175102336694344,0.8163660195279847,0.6388888888888888,1.0,1.0,2/14,6.44%,MBOAT1;PLA2G4C
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.3305276417923828,-0.8162004175369406,0.8676470588235294,1.0,1.0,25/166,17.47%,ITGB4;RHBDF2;BAIAP2;TSPYL2;VWA5A;FOS;PROCR;RAD9A;TCN2;DDIT4;NINJ1;CDK5R1;CDH13;APAF1;DRAM1;TGFA;TGFB1;PPP1R15A;SAT1;CDKN1A;ABAT;BTG1;PLK2;DEF6;FGF13
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.5054975585615735,0.8161190569423331,0.696969696969697,1.0,1.0,2/9,2.63%,F2;SERPINF2
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.41303799984745115,-0.8160929252123335,0.703125,1.0,1.0,6/28,17.98%,ID2;E2F1;TCIM;CDKN1A;EZH2;FAM83D
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.3698668019838134,0.8156519127370844,0.5813953488372093,1.0,1.0,2/33,0.70%,LOC400499;DHFR
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.5423010951059659,-0.8155636770934263,0.75,1.0,1.0,2/5,41.34%,RABL3;SVIP
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.4546239692966819,0.8155427266049623,0.7894736842105263,1.0,1.0,2/12,6.69%,VCPKMT;PXK
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.45671767789563156,0.815406724615799,0.6585365853658537,1.0,1.0,6/17,16.95%,UBE2A;RNF168;RYBP;RNF2;RNF8;PCGF1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3706280631024489,0.8151678382252009,0.7096774193548387,1.0,1.0,14/34,33.11%,QRICH2;RYBP;RPL11;EIF3H;PDCL3;RPL5;TLK2;HIPK2;FHIT;UBXN1;USP7;RPS7;CSNK2A2;TAF1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.40805084640359734,0.8150826579302296,0.8205128205128205,1.0,1.0,5/21,7.77%,CHRNA4;NLGN3;DRD4;GRID2;GRIN2A
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.418804612254187,0.8148609654418721,0.6511627906976745,1.0,1.0,4/23,11.89%,DUSP1;ESPL1;ANAPC15;RIOK2
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.37984602050948246,-0.8147792374184043,0.7846153846153846,1.0,1.0,11/50,20.49%,PPARG;SLC4A10;PNPLA1;NEDD4L;ABCB4;AQP11;AQP4;RBP1;PNPLA2;ACOX2;USF2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.49366228910197507,-0.8144653774564146,0.7368421052631579,1.0,1.0,2/8,11.62%,MANF;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.4384387051893149,-0.8142557763967151,0.7,1.0,1.0,3/17,16.09%,SLC18A2;ABCD2;BRCA1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.37830633770838773,-0.814160312432483,0.7719298245614035,1.0,1.0,9/60,16.54%,BAIAP2;NCKAP1L;VAV3;WIPF3;CYFIP1;LYN;FCGR3A;SYK;PIK3CB
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.37830633770838773,-0.814160312432483,0.7719298245614035,1.0,1.0,9/60,16.54%,BAIAP2;NCKAP1L;VAV3;WIPF3;CYFIP1;LYN;FCGR3A;SYK;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.32612403952731844,0.8138737069385305,0.8888888888888888,1.0,1.0,13/102,9.48%,PASK;PTH;PIWIL2;PLD1;NOX1;NAT10;CTC1;GLI2;EPM2AIP1;EIF3E;AKT2;EIF3D;SAMD4A
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.35276519273572016,0.813518043300057,0.7586206896551724,1.0,1.0,6/52,6.65%,ETV5;AGER;EGFL6;LAMB3;FBP1;IFI27
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.4009679029456836,-0.8133265361469014,0.7619047619047619,1.0,1.0,2/22,8.92%,PRXL2C;PFKFB2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.4130055832422813,-0.8133241836910738,0.7377049180327869,1.0,1.0,7/27,21.77%,PPARG;CAV1;LRP1;NFKBIA;GPS2;RXRA;TTC39B
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.36374551224442664,0.8131121833056443,0.8181818181818182,1.0,1.0,4/34,9.42%,B4GALNT2;NEU4;B3GALT4;GLA
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.4453467963830583,-0.8131016148664417,0.7164179104477612,1.0,1.0,4/19,16.38%,NCKAP1L;LGALS3;PPP1R15A;FKBP1B
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.378782608882293,-0.8130858195415545,0.7368421052631579,1.0,1.0,10/52,24.10%,CERS6;SGPP2;SGMS2;PRKD2;CERS5;DEGS2;CERS3;ALDH3A2;ELOVL2;B3GNT5
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.382672533969025,-0.8128264075672802,0.75,1.0,1.0,6/34,17.01%,PDGFD;NLRP12;CALM3;VEGFA;RAD50;TOM1L1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.5587799275252551,-0.8127123448686933,0.7407407407407407,1.0,1.0,1/5,5.40%,SLC6A12
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.5563054678468693,-0.8126871704615272,0.7894736842105263,1.0,1.0,4/6,16.59%,AQP1;SLC14A1;AQP11;SLC14A2
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.30807242599848905,0.8125311315969461,0.8,1.0,1.0,11/115,8.92%,SQLE;SC5D;PSME2;HMGCS1;CARM1;NQO1;SMARCD3;HMGCR;PSMD13;HELZ2;PMVK
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.3580038182953218,-0.8124261689733683,0.7727272727272727,1.0,1.0,21/88,20.59%,MCM2;KDM4D;RMI1;RPA3;SAMHD1;POLQ;FANCM;RECQL4;XRCC2;WRN;RAD54L;RAD50;MCM7;MEIOB;BRCA1;LIG3;RPA2;AP5S1;RAD54B;MRE11;MMS22L
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.44495995947888306,0.8123747163763232,0.8,1.0,1.0,5/14,10.69%,DUSP1;HMGB1;SLIT2;SERPINE1;GREM1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.39143338364017777,-0.8117530289228794,0.8095238095238095,1.0,1.0,8/46,15.68%,CCND1;CCNJL;CDKN3;CDK5R1;CDK5R2;CCNF;SERTAD1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.4163127159279212,0.8114518108112098,0.7058823529411765,1.0,1.0,4/11,19.18%,NOC2L;ZNF451;SNCA;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.383385964800988,-0.8114282699991598,0.7647058823529411,1.0,1.0,7/44,11.67%,CIDEB;NLRP3;MAP3K5;GRIN2B;NOD1;TBC1D10A;DAPK1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.37475189737209197,-0.8113969253813055,0.7397260273972602,1.0,1.0,10/41,13.52%,PKP2;MET;EFNA1;SMLR1;SLC44A3;CBLC;AFP;CLDN4;FGL1;SLC2A2
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.4920340518863689,-0.8111920068012936,0.7049180327868853,1.0,1.0,2/8,33.19%,ADAM9;FER1L5
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.44623728403785934,0.8110501733224049,0.5833333333333334,1.0,1.0,6/7,32.45%,PTGIS;CBR1;HPGDS;AKR1C3;TBXAS1;PTGES3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.40825762706266544,-0.8109931904259239,0.7424242424242424,1.0,1.0,8/29,22.95%,CYREN;POLQ;RADX;MAGEF1;KLHL15;MAD2L2;FANCB;SHLD2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.2973825925789814,0.8109604304842849,1.0,1.0,1.0,34/225,16.63%,USP27X;PSME2;RNF128;UBC;USP31;OTUD3;USP36;DESI2;ACTR5;BRCC3;TNIP1;YY1;KEAP1;INO80D;PSMD13;KDM1B;USP37;USP18;USP40;UBB;USP9Y;PSME4;KAT2A;MAP3K7;BECN1;TADA3;UIMC1;SNX3;TRAF3;PSMF1;ENY2;USP24;OTUB1;STAMBP
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.4235204237696808,-0.8105146023642334,0.7903225806451613,1.0,1.0,4/21,13.22%,METTL21A;EEF2KMT;PRMT8;EEF1AKMT2
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.3871204200821188,0.8101903390844774,0.7241379310344828,1.0,1.0,12/51,23.00%,RAE1;NUP42;NUP210;POLR2K;TPR;POLR2L;NUP37;NDC1;SEH1L;POLR2E;POLR2D;NUP214
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.3871204200821188,0.8101903390844774,0.7241379310344828,1.0,1.0,12/51,23.00%,RAE1;NUP42;NUP210;POLR2K;TPR;POLR2L;NUP37;NDC1;SEH1L;POLR2E;POLR2D;NUP214
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.45845951936411833,-0.8100906584329948,0.7666666666666667,1.0,1.0,4/16,10.18%,RIT2;LRRK2;BST1;CDH13
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.38482865479705597,0.8100455302805913,0.717948717948718,1.0,1.0,6/23,15.53%,DICER1;TMEM98;TNFRSF21;NKX6-2;HES5;ITGAX
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.45205633002520373,0.8099752685416839,0.6388888888888888,1.0,1.0,3/11,8.62%,KCND3;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.548085207558564,-0.8098004876950932,0.7321428571428571,1.0,1.0,2/5,25.08%,CPSF3;LSM11
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.5015955407904189,-0.8097012355267873,0.7894736842105263,1.0,1.0,3/9,29.05%,DDX11;TIMELESS;FMR1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.4010366887403553,-0.8095245158599627,0.71875,1.0,1.0,6/32,17.72%,RAD9A;E2F1;PRPF19;SETMAR;DONSON;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3708675696896108,0.8094964163158515,0.8,1.0,1.0,5/42,5.51%,CD38;CD274;EPHB2;TNFSF13B;ZNF335
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.49011177684717605,0.8092874232052758,0.7631578947368421,1.0,1.0,3/8,17.66%,THAP4;QDPR;KYAT1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.3889014961499276,-0.8092832531303696,0.7878787878787878,1.0,1.0,10/47,22.95%,TERF2IP;POLQ;RADX;H1-0;MAGEF1;KLHL15;MAD2L2;POLR2J;FANCB;SHLD2
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),-0.5531445852088014,-0.8092558291506733,0.7704918032786885,1.0,1.0,1/5,1.28%,H2BC11
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5159268841022588,-0.8089720665506348,0.7213114754098361,1.0,1.0,2/8,32.65%,ZNF593;LAMTOR5
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.29905940017895266,0.8088709096994812,0.9310344827586207,1.0,1.0,15/76,16.50%,SQLE;SC5D;HMGCS1;CARM1;SMARCD3;HMGCR;HELZ2;PMVK;IDI1;ADIPOR1;HNF4A;NPC2;DISP3;MID1IP1;HDAC3
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.4788000044401237,-0.8088356722643538,0.711864406779661,1.0,1.0,1/9,8.48%,XBP1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.4042325407668669,-0.8087062102278527,0.7719298245614035,1.0,1.0,5/24,22.92%,PIGH;PIGC;MPPE1;PIGB;PGAP3
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.4282396068564539,0.8085373770851182,0.6944444444444444,1.0,1.0,4/12,21.88%,AKT2;PLIN5;TYSND1;AKT1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.4225526755157521,-0.8082696214857218,0.8382352941176471,1.0,1.0,11/28,25.28%,TTN;LMOD1;TMOD1;SYNPO2L;FHOD3;MYLK3;TPM1;PDGFRB;MYH6;OBSCN;MYOM2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.39521994973695446,-0.8082315258974833,0.7333333333333333,1.0,1.0,9/49,21.59%,CIDEB;FBXO7;HRK;MLLT11;BBC3;DNM1L;ZDHHC6;VPS35;AURKA
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.41418637767980865,0.8079792985209341,0.6585365853658537,1.0,1.0,5/18,7.73%,EPHB2;SPRY2;SLIT2;FBP1;SPRY3
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.48549982446926615,0.8079220661067117,0.7021276595744681,1.0,1.0,1/8,8.00%,ATP6V1G1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.47041179895908414,0.8078967059678918,0.7,1.0,1.0,2/12,8.31%,DSEL;DSE
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.40735828890221243,-0.8077122711805443,0.7704918032786885,1.0,1.0,8/32,25.68%,ISG20;ENTPD3;NCBP1;NUDT18;ENTPD1;NUDT1;NUDT16;ENTPD2
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.4452734327811394,0.8076517167863226,0.7058823529411765,1.0,1.0,6/17,14.21%,DHFR;MTHFD2L;MTRR;PM20D2;MTHFD2;MTHFD1L
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.2913868266079277,0.807587816274063,0.967741935483871,1.0,1.0,34/265,14.08%,CHRNA4;RFWD3;POLD3;FAAP100;UBC;ENDOV;UBE2A;MGMT;HMGA2;RNF168;ACTR5;H2AX;PARP3;BRCC3;ABL1;TENT4A;RAD52;DCLRE1B;UBB;ZBTB1;COMMD1;MAPK8;ASCC2;ADPRS;HERC2;UBE2N;RNF8;PSME4;GTF2H2C;POLH;NABP1;POLI;UIMC1;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.45688273426335635,0.807542996087066,0.6521739130434783,1.0,1.0,3/5,30.25%,DHX9;KHDRBS1;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.45688273426335635,0.807542996087066,0.6521739130434783,1.0,1.0,3/5,30.25%,DHX9;KHDRBS1;CPSF6
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.3425098239628925,0.8072177499017498,0.7435897435897436,1.0,1.0,5/45,9.19%,GPC4;GPC2;SDC2;HS6ST1;FUCA1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.39085559736490094,0.8069212852323057,0.725,1.0,1.0,4/24,17.85%,UBC;UBB;GTF2H5;ERCC2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.2855624591182376,-0.8061387789658591,0.9893617021276596,1.0,1.0,254/1642,20.27%,ZNF215;ZNF366;GRHL1;FOSL2;KANK2;TLR2;ZIM2;DACT1;NR4A3;HEY1;ZSCAN1;PPARG;HOPX;TNFRSF1A;ZIC4;IL26;PARP9;CEBPD;ZNF550;PLSCR1;ZIK1;MIDEAS;CRYM;KLF9;ZNF549;ELK3;GLIS2;IRF1;TP73;ZSCAN31;PLAG1;MLIP;MEF2C;CCNQ;ZNF789;ZNF814;EDN1;CITED4;ID2;ZNF343;CASZ1;ZNF154;SOX9;NOS1;MACC1;PLAC8;FOS;ZNF239;BCL11B;CITED2;KDM3A;NLRP3;HGF;MET;ZEB1;STAT5A;DUXB;ZBTB32;KLF3;CCND1;CSF1R;PURG;ZNF394;CRLF3;CPHXL;ZBTB22;ZFHX2;ALX3;EFNA1;GATA1;BMP6;ETV1;ZNF235;ZNF608;WWTR1;ZNF584;ZNF20;AR;EMX1;HIF3A;E2F3;FLI1;XBP1;BHLHE40;ZNF433;E2F1;ZSCAN22;ZNF540;SP110;MRTFB;RARB;RFX5;PCGF3;ZKSCAN7;TOX;SOX21;CDH13;IKZF2;CEBPB;ZNF764;MED12L;PROX2;GLI3;ACTL6B;GTF2IRD1;H1-0;ETS2;DNAJB1;ZNF391;ZFP30;IKZF1;CAMK1;GLIS3;ZNF850;HJV;ZNF367;VEGFA;ZNF654;NR2F1;TGFB3;CAV1;ZNF652;NEDD4L;ZNF571;ZNF217;BMPR1B;ZNF233;EDNRB;ZNF442;EGFR;LDB2;ZNF530;EBF1;PAX6;NFATC2;PRKD2;MOSPD1;ZNF671;HIRA;OVOL2;ORC2;TGFA;CBX7;PCGF2;SKAP1;PID1;MYT1;TRERF1;MED29;ZNF763;SPI1;POU2F2;ZNF490;ZFP36;ZNF572;ZNF213;ZFPM1;NR3C2;ZNF248;NLRC5;ZNF740;STAT1;TGFB1;TOX2;ZNF157;ZNF580;ESRRA;NR1D1;ID3;UHRF1;MYT1L;ETV6;FHOD1;CDKN1A;ZFP69;MAFF;ZSCAN29;ATXN7L3;BRCA1;IRF4;LHX4;ZNF790;RFXANK;TGIF1;MAF;NFKBIA;MOV10;POU5F1;PRDM1;PFKM;ARID3A;PPP3CA;CIITA;ZKSCAN8;EBF2;MAD2L2;ZNF420;PSMC3;TENM2;CX3CL1;ZNF768;PTPRN;ZNF546;CBX8;NFYB;LILRB1;CLOCK;EZH2;ZNF543;NFE2L3;MAP2K5;HNF4G;CREB3L1;POU6F1;MACROH2A2;SREBF1;EPAS1;ZNF33B;RNF111;ZNF10;STAT3;ZSCAN5A;ZNF776;ZNF765;ZNF593;TSHZ2;ZNF597;ZNF140;NR2F2;ZBTB12;CKAP2;ONECUT2;ZSCAN32;ZNF136;STAT4;ESR1;TAF6L;ZNF705G;BCL6;ZNF566;ZFP3;KAT2B;TSHZ3;ERG;MECOM;KAT6B;IFRD1;PER1;KLF6;ZNF726;HLF;RREB1;AASS;ZNF578
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.4358823094472503,-0.8061043475001473,0.7611940298507462,1.0,1.0,6/20,18.90%,NDST3;B3GALNT1;CSGALNACT1;B3GALT1;B3GALT2;B3GNT9
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.4743402097867876,-0.8058948751195865,0.7321428571428571,1.0,1.0,5/13,22.03%,TGFB2;CELF4;BRCA1;CAMSAP3;SCEL
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.4867383935234919,-0.8058795626586582,0.7457627118644068,1.0,1.0,1/8,4.93%,ROBO2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.38985384881866125,-0.8057190580613003,0.8059701492537313,1.0,1.0,7/35,21.12%,GSAP;FURIN;NEDD4L;TMEM9;MAP2K5;FAM83D;VPS35
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.39162842259980557,-0.8057144588710095,0.7384615384615385,1.0,1.0,4/29,16.09%,NOS1;CAMK1;SPI1;BRCA1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.42720530766818376,-0.8057087788534979,0.7288135593220338,1.0,1.0,2/13,11.84%,PRKAR1B;PKIA
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.42739865359969986,0.8056976156299163,0.7142857142857143,1.0,1.0,7/15,19.48%,RUNX1;NLRP7;BAG2;GAS1;ADAM8;TMEM59;CLN3
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3662205782007491,0.8055559398679647,0.7647058823529411,1.0,1.0,10/41,23.00%,RAE1;NUP42;NUP210;TPR;NUP37;ZBTB7A;NDC1;SEH1L;PGAM1;NUP214
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.43977027381876505,-0.8055531536465349,0.7301587301587301,1.0,1.0,2/17,6.24%,NCKAP1L;CAMK1D
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.5116194101757022,0.8052924839793941,0.7272727272727273,1.0,1.0,1/6,1.47%,HDC
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.5116194101757022,0.8052924839793941,0.7272727272727273,1.0,1.0,1/6,1.47%,HDC
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.44136544826172946,-0.8048926203312099,0.6833333333333333,1.0,1.0,4/17,14.66%,CRYM;DDO;SDS;SLC25A21
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.5704207190578088,-0.8047449226581255,0.8305084745762712,1.0,1.0,1/5,7.97%,LZTFL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.4096740081093122,-0.8046848502295922,0.7419354838709677,1.0,1.0,3/29,5.06%,LPL;NLRP12;NLRP3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.5083848132118309,-0.8042394514559937,0.7966101694915254,1.0,1.0,2/9,18.16%,COPS9;EPAS1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.35610482596184817,-0.8041170566029818,0.7631578947368421,1.0,1.0,13/98,18.03%,RGS7;DOCK8;RHOC;RGS1;THY1;CALM3;CAV2;WRN;CD200;CX3CL1;RASGRP1;EZH2;RIC1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.46027331686295286,-0.8040997323809561,0.7272727272727273,1.0,1.0,2/15,8.59%,DOCK8;LRCH1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.47766999995233955,0.8029642540623522,0.717948717948718,1.0,1.0,1/12,0.80%,CRYAB
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.4963434541624882,-0.8028849888899685,0.7714285714285715,1.0,1.0,3/9,18.21%,CAMK2B;NRXN1;NEURL1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.46088190654423616,-0.8028221426273622,0.746031746031746,1.0,1.0,5/15,14.45%,CHRM3;NMUR2;KCNB2;CAV1;DAPK3
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.42265078817554974,-0.8027451867512468,0.78125,1.0,1.0,7/27,16.09%,EDN1;RIN3;LRPAP1;DLG4;EDNRB;ITGAV;BRCA1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.524954005901859,0.8026156892440798,0.6571428571428571,1.0,1.0,1/5,3.15%,SLC25A29
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.4809173868113148,0.8025671783154374,0.7021276595744681,1.0,1.0,1/6,9.79%,CHRNA7
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.34045733142361234,-0.8025619608289748,0.855072463768116,1.0,1.0,8/92,6.54%,TWF2;TGFBR2;NLRP12;NOS1;ROBO2;SLC1A1;CSF1R;LRRK2
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.43576111702502673,-0.8025132570648582,0.7833333333333333,1.0,1.0,2/19,16.58%,WTIP;MOV10
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.3601213322487285,0.8023402628681225,0.7567567567567568,1.0,1.0,5/36,7.77%,SLC38A1;SLC25A29;SLC38A2;SLC7A11;SLC38A7
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.3659815039441717,0.802086620058172,0.7777777777777778,1.0,1.0,8/38,13.71%,TAF12;BRPF1;TAF5;TRIM16;KAT2A;JADE3;MAP3K7;TADA3
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.5154488627372817,-0.8020279974808819,0.8333333333333334,1.0,1.0,1/8,1.19%,NR4A3
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4995773088411778,-0.8019198486856748,0.7352941176470589,1.0,1.0,1/10,10.15%,SAR1A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.37418664260721257,0.8016193527281571,0.7142857142857143,1.0,1.0,3/26,4.22%,NUPR1;OSBPL7;PYHIN1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.3958745046971556,-0.8014560116074125,0.7575757575757576,1.0,1.0,1/36,1.02%,DND1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.48089815292094434,-0.8013940997413407,0.6721311475409836,1.0,1.0,2/8,29.05%,MACROH2A1;FMR1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3429032752644676,-0.8013737730132492,0.875,1.0,1.0,6/86,6.98%,CENPK;TTN;CENPE;SMC4;RAB11A;NCAPH
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.49586976203240635,-0.8012793097960514,0.75,1.0,1.0,5/12,26.41%,FGD5;FGD1;SPEF1;FGD6;ARHGEF4
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3205058775711961,0.8012359115639984,0.8666666666666667,1.0,1.0,10/74,15.20%,PSME2;UBC;HSPA1A;ATF4;PSMD13;UBB;ELOC;PSME4;ATF3;PSMF1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.37185614631708575,0.8010575579388162,0.7352941176470589,1.0,1.0,4/27,14.75%,GAB1;SPRY2;GAS1;RELA
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.4853153737615053,-0.8008823279567341,0.7538461538461538,1.0,1.0,2/10,9.08%,CEACAM1;PDE3B
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.49431225610208784,-0.8008468589758224,0.8333333333333334,1.0,1.0,2/8,13.98%,PCGF3;PCGF2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.46018303307525177,-0.8007603822652941,0.711864406779661,1.0,1.0,5/13,35.78%,KIF20B;SEMA6A;SEMA3A;DAB2IP;ZNF609
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.332786087887585,0.8005632891109182,0.825,1.0,1.0,7/44,14.65%,ATP6V0A4;TF;ATP6V1G2;ATP6V1G1;MELTF;TTYH1;IREB2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5097663584655617,0.800555243477613,0.8205128205128205,1.0,1.0,5/8,11.88%,CD274;HMGB1;RUNX1;TARM1;TWSG1
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.40318072563379515,-0.8004387468625964,0.7301587301587301,1.0,1.0,4/20,16.86%,TGFBR2;GRIN2B;TGFB1;GRIN3A
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.5102114340753453,0.8002079531435855,0.6578947368421053,1.0,1.0,4/6,30.01%,ABCA3;ROCK2;SELENOS;LDLR
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.38673169090972304,0.8001945136298844,0.7142857142857143,1.0,1.0,4/37,6.99%,SPIRE2;OOEP;MGMT;PPP4R2
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.4985565734168793,-0.7998828283163206,0.7586206896551724,1.0,1.0,1/7,10.00%,HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.4985565734168793,-0.7998828283163206,0.7586206896551724,1.0,1.0,1/7,10.00%,HLA-DRB1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.3780579778170571,0.7998080152737307,0.6538461538461539,1.0,1.0,6/27,11.53%,HMGA2;ZNF639;HDAC1;CCNT1;RRP1B;SMARCA4
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.4205009913378986,-0.7997874891556755,0.711864406779661,1.0,1.0,2/20,6.54%,NR4A3;LRRK2
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.36488908824128125,0.7997470079107847,0.7647058823529411,1.0,1.0,7/48,12.85%,RFWD3;FAAP100;UBC;RNF168;DCLRE1B;UBB;RNF8
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.5339243858034242,-0.7996318075926229,0.7377049180327869,1.0,1.0,3/6,26.34%,RHOJ;WAS;RHOU
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.48410056061512546,0.7995648017813108,0.7435897435897436,1.0,1.0,1/6,2.87%,ALK
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.43645339001369227,-0.7994665629099944,0.696969696969697,1.0,1.0,5/22,16.12%,CPS1;NOX4;TST;CBS;MTHFD1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.48075248837010465,0.799336878826553,0.74,1.0,1.0,3/9,18.30%,OPLAH;HAGH;GGCT
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.39574682894006,0.7990606333815988,0.7435897435897436,1.0,1.0,3/16,13.38%,STAC3;ATP1B1;P2RY6
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4272635307058931,0.7988872538309814,0.7045454545454546,1.0,1.0,1/14,3.00%,OOEP
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.4537724661926251,0.7988091573312237,0.65625,1.0,1.0,3/10,8.62%,KCND3;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.474324821046655,-0.7987456827793432,0.7704918032786885,1.0,1.0,5/12,27.68%,PCGF3;BRCA1;RLIM;LRIF1;METTL3
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.36853169434388106,-0.7985958784794536,0.75,1.0,1.0,6/43,14.92%,IL26;TGFB2;EPHB1;EGFR;MAPK8IP1;SCIMP
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.46409795121395686,-0.7984548181874497,0.7049180327868853,1.0,1.0,5/14,12.76%,KCNMA1;SLC8A1;ATP1B2;NEDD4L;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.4511516837732409,0.7982202446813805,0.6410256410256411,1.0,1.0,2/6,17.00%,ENPP1;PEA15
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.3488559696937048,-0.798151038607932,0.8333333333333334,1.0,1.0,18/98,24.12%,CERS6;ESYT3;PDXDC1;B3GALNT1;SGPP2;SGMS2;PRKD2;SMPD3;CERS5;DEGS2;CERS3;ALDH3A2;CERKL;PPP2R1A;ELOVL2;AGK;CPTP;ABCA12
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.49921288418339743,-0.797963132984754,0.7333333333333333,1.0,1.0,2/8,6.32%,NLRP12;CEACAM1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.38787504848235355,0.7976784587292421,0.6923076923076923,1.0,1.0,5/29,9.10%,ATP6V0A4;RAB32;ATP6V1G2;ATP6V1G1;RAB39A
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.33085081508452313,-0.7976607216000688,0.8947368421052632,1.0,1.0,17/154,18.04%,F8;CD59;ANK1;SPTB;GOLGB1;DYNC1LI1;SAR1A;GRIA1;PROS1;RAB1B;TGFA;MCFD2;STEEP1;TMED10;BCAP31;ACTR10;MPPE1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.43560402107177754,0.7976547781199606,0.7380952380952381,1.0,1.0,2/11,14.51%,NASP;RBBP4
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.3851808565299288,0.7975301174952198,0.7368421052631579,1.0,1.0,1/19,0.86%,AGER
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.3511527471723735,0.797420628893725,0.775,1.0,1.0,10/31,24.42%,CAVIN1;POLR2K;POLR2L;UBTF;GTF2H5;ERCC2;TAF1C;POLR2E;RRN3;CCNH
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.4438527802441668,0.7973175451424169,0.7804878048780488,1.0,1.0,8/17,31.07%,MRPS7;RPSA;ABT1;PWP2;RPS28;RPS5;PRKDC;MRPS11
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.4527518530109582,-0.7970121145199331,0.7096774193548387,1.0,1.0,4/12,12.76%,CHGA;SLC8A1;PLN;ATP1A1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.4232012132340394,-0.7965075325571057,0.8059701492537313,1.0,1.0,1/21,1.00%,MT1M
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.42180643139417734,0.7964730228224871,0.6363636363636364,1.0,1.0,2/13,5.45%,DAO;DRD4
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.38850645544666706,-0.7962987181781669,0.7761194029850746,1.0,1.0,10/48,19.74%,IFNGR2;ID2;WWTR1;FURIN;TGFB1;PPP1R15A;ID3;TGIF1;CDH1;PPP1CA
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.3689934102820381,0.796143247595961,0.6944444444444444,1.0,1.0,6/21,14.88%,WNT9A;GDF5;GREM1;TRPS1;ADAMTS12;CHADL
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.5550506519355578,-0.7960656006896679,0.8,1.0,1.0,1/5,6.69%,EFNA1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.34196095464473886,-0.7955305906632809,0.7671232876712328,1.0,1.0,17/100,16.09%,PROM1;SPARCL1;MAOB;KALRN;SYBU;SORBS2;MYO5C;HOOK1;ABLIM2;AQP4;PTPRT;CP;SYT13;MAPK4;ABLIM1;PATJ;ABAT
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.5112245685946415,-0.7954610708163637,0.8181818181818182,1.0,1.0,3/7,15.27%,KNDC1;OPHN1;CEND1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.4005313864792332,-0.795345373480142,0.7666666666666667,1.0,1.0,2/25,4.92%,TP73;RPA3
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3980605990343108,0.7952567950692918,0.6486486486486487,1.0,1.0,9/29,28.44%,DKC1;GREM1;PKIB;MAP2K7;NAF1;CCT2;ACD;MAP3K4;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.43676657287153614,-0.7950881084770939,0.7818181818181819,1.0,1.0,2/15,8.48%,RNFT1;XBP1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.3737855560916773,0.7949784833596673,0.7714285714285715,1.0,1.0,8/35,14.35%,TNFRSF8;BAK1;CRADD;MAP3K1;MAPK8;NFKB1;BCL10;CNN2
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.38182968558671615,-0.7949399089768462,0.8194444444444444,1.0,1.0,10/42,21.31%,SEMA3E;PDXDC1;SEMA3D;HTR2B;GPC3;SEMA4B;SEMA4G;AMOT;SEMA6B;SEMA6A
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.301011391757173,0.794803927544794,0.8148148148148148,1.0,1.0,72/192,28.20%,MRPL32;EEF1D;EEF1A1;FARSB;TARS1;TNIP1;RPS3A;DARS1;RPS15A;MRPL3;MRPS7;RWDD1;MRPS2;RPL18A;PTCD3;HARS1;MRPS5;MRPL52;MRPL24;RPS23;MRPL47;IARS1;MARS1;RPSA;VARS1;HARS2;MRPL13;RPL23A;MRPL43;CARS1;RPL3;MRPS16;RPL11;NOA1;RPS3;FARSA;RPL13;RPS8;RARS2;RPL8;RPL21;KARS1;RPL5;RPL32;RPL7;RPS16;MRPL57;RPS18;ETF1;MRPS18C;RPS6;RPS2;RPL41;RPL29;RARS1;EIF4EBP2;MRPL28;AARS1;RPL14;RSL24D1;EPRS1;RPL10;MRPL42;IGHMBP2;RPS28;FARS2;RPL15;SARS1;LARS2;WARS2;RPL10A;MRPL9
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.37078181740053984,0.7946897324813678,0.782608695652174,1.0,1.0,2/20,6.25%,CHMP5;NAT10
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.3737449114549773,0.7944896983067796,0.75,1.0,1.0,6/29,16.46%,HMGCS1;GLYAT;ACOT6;ACOT12;THEM4;ACBD6
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.44104036846706246,0.7944316662814641,0.6666666666666666,1.0,1.0,4/22,14.23%,BPIFB1;MFHAS1;RAB7B;LGR4
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.4643970102150799,0.7941589088081852,0.6551724137931034,1.0,1.0,3/11,9.00%,SPHK2;KDSR;PLPP2
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.4146186556972813,-0.7938516492213711,0.7391304347826086,1.0,1.0,5/25,8.74%,CPS1;NOS1;ASAH2B;ARG2;MTARC2
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.5449363772430889,-0.7936922834965312,0.7540983606557377,1.0,1.0,1/6,5.60%,STAT5A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.42640986726181157,-0.7936096832736961,0.7272727272727273,1.0,1.0,8/21,12.24%,NOS1;HPCA;JPH4;CACNB1;JPH3;PLN;CAV3;CACNB2
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.38034830062882624,-0.7934017272988221,0.76,1.0,1.0,6/50,17.99%,TXNRD2;FOS;ROMO1;EGFR;PTPRN;TPM1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.3610730502100741,0.7933328567114386,0.6944444444444444,1.0,1.0,4/25,12.96%,B3GNT6;TNIP1;GK5;GAL3ST2
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.3940821205432169,0.7931239886949357,0.75,1.0,1.0,6/26,13.58%,PINX1;ABL1;CDKN1C;LIMK1;PRDX3;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.5200640653933517,-0.7928224963371512,0.7586206896551724,1.0,1.0,1/6,1.22%,VSIR
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.3658202427154619,0.7927438561254859,0.7368421052631579,1.0,1.0,10/41,23.00%,RAE1;NUP42;NUP210;TPR;NUP37;ZBTB7A;NDC1;SEH1L;PGAM1;NUP214
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5018401024626429,-0.7926633819424811,0.8166666666666667,1.0,1.0,2/9,19.27%,OPHN1;CAMSAP3
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.3170431483614069,0.7925105233971025,0.9,1.0,1.0,21/90,12.21%,DNAH6;SPATA16;COX7B2;MLF1;SPATA3;PIWIL2;SOHLH1;DYNLT1;SPATA33;TSKS;MDN1;DMRT1;MYO1D;MOV10L1;GCNA;LDHC;PHF13;CCDC30;DMC1;NR6A1;GALNTL5
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.2991818379366649,0.7923340156081539,0.8387096774193549,1.0,1.0,23/121,14.72%,CXCR4;CTNNA2;NES;ZNF335;MEIS1;GRIN2A;POMK;PITPNM1;MDGA1;PBX4;DSCAML1;KLHL17;RELN;PBX3;CDH2;EPHA7;AFF2;NKX2-2;HES5;CNTNAP2;NFIB;JHY;UTP3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4275669248848697,0.7922474497948465,0.6923076923076923,1.0,1.0,3/11,19.85%,UQCRFS1;UQCRHL;CYC1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.43228428173782796,-0.792095272437702,0.8064516129032258,1.0,1.0,4/17,17.18%,RIMS1;RIMS2;DLG4;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.3974214680276774,-0.791938983945588,0.7575757575757576,1.0,1.0,9/31,15.10%,PDZK1;NOS1;KCNJ4;KCNJ6;KCNJ3;KCNMA1;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.3878107610034156,0.7918518425526646,0.8,1.0,1.0,1/19,1.24%,CHST7
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.4577304001429358,0.7916244856626691,0.717948717948718,1.0,1.0,1/9,2.92%,DICER1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.3769310110583879,0.7916108581297556,0.6666666666666666,1.0,1.0,6/28,18.69%,TPX2;ZNF207;MAP7D3;TUBG1;AKAP9;SLAIN2
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.36492024368462844,-0.7914907377768614,0.828125,1.0,1.0,6/51,14.11%,KCND2;SCN2A;AQP1;SLC8A3;VEGFA;PGK1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2957900007712234,0.7914578178766624,0.9545454545454546,1.0,1.0,40/383,12.37%,TEAD2;TCOF1;ONECUT1;MLF1;ZNF676;CDK11A;SLC39A8;APBB3;RNF6;HDAC10;ZNF460;CARM1;CRX;PDGFA;HMGA2;ACTR5;ATF4;SOX12;SPIN2B;ZNF117;SBNO1;ABL1;PHF1;ZNF212;RBBP6;MLX;PTP4A3;TAF5;THAP1;USP37;RYBP;SOX13;ACVR1B;NOLC1;CCAR1;ASCC2;ESRRG;ZNF74;DAXX;CNBP
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.35863412681357887,-0.7914129208551209,0.8115942028985508,1.0,1.0,14/64,15.98%,ACTA2;LRIG3;COL4A1;F3;NTN4;MYH11;WWTR1;PALLD;CAV1;CDH3;EGFR;CAV2;NGFR;GNG12
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.42996415494851065,-0.7911812879422602,0.7903225806451613,1.0,1.0,2/26,7.81%,VSIR;ARG2
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.5180178006383427,-0.7908125616420204,0.7903225806451613,1.0,1.0,2/7,11.84%,LIN7A;CAV1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.41693557086489313,0.7907756207266295,0.6666666666666666,1.0,1.0,1/10,1.50%,B3GNT6
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.41693557086489313,0.7907756207266295,0.6666666666666666,1.0,1.0,1/10,1.50%,B3GNT6
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.33785716619633066,-0.7906224808958636,0.8591549295774648,1.0,1.0,20/100,19.58%,TGFB2;TSPYL2;OSTN;CRLF3;GJA1;RERG;WFDC1;TCHP;MAP2;KIAA0319;TRIM46;TGFB1;CDKN1A;BTG1;PTPRJ;FGF13;GNG4;OSGIN2;OSGIN1;BCL6
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.4759388064061537,0.7904554092570453,0.7631578947368421,1.0,1.0,2/8,9.81%,FGFR1;FGFR3
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.36655136237615277,0.7902362402705582,0.8666666666666667,1.0,1.0,4/27,9.70%,CRHBP;RAPGEF1;HCN2;SLC26A3
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.5091280048987219,0.7899761712495571,0.8055555555555556,1.0,1.0,1/5,21.64%,C9ORF72
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.27925794575305707,0.789948760715745,0.9473684210526315,1.0,1.0,59/188,26.68%,U2AF1;LSM7;RSL1D1;EIF3B;DUT;HPRT1;CSTF2;EIF3D;HDGF;ERH;NOLC1;YWHAQ;CNBP;EIF4G2;PRDX3;HNRNPU;EIF4E;ACP1;IARS1;TFDP1;NPM1;EXOSC7;HNRNPA2B1;GLO1;RPS3;AP3S1;CYC1;SF3A1;RAN;EIF2S2;UBA2;G3BP1;EIF2S1;CCNA2;HNRNPC;KARS1;CAD;FAM120A;NOP56;HNRNPR;UBE2L3;CCT2;ETF1;CCT3;SRM;RPS6;RPS2;DEK;STARD7;PPM1G;MCM6;GOT2;SRSF7;CDK4;TARDBP;VDAC3;RPL14;EPRS1;PSMB3
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.3687001216399593,-0.7897106968163887,0.8181818181818182,1.0,1.0,17/56,17.65%,KCNJ4;KCNJ6;SLC5A2;KCNJ3;SLC8A3;SLC8A1;ATP1B2;SLC9C1;SLC24A1;SLC9C2;ABCC9;ATP1A1;KCNH2;TRPV3;TRPM2;TRPV4;KCNJ13
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.3695438361660425,0.7894812858260115,0.65625,1.0,1.0,7/37,14.62%,MLF1;PAX8;EPC1;POLR2K;THAP1;HOXD3;POLR2L
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.5158550599610245,-0.7894062004645938,0.8363636363636363,1.0,1.0,2/7,14.82%,MFNG;NOTCH2
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.45160222402605255,-0.7893906937857447,0.859375,1.0,1.0,6/12,22.50%,CAV1;FLOT1;IFIT1;PQBP1;RALB;COLEC12
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.33830565835223964,0.7885684074667523,0.8529411764705882,1.0,1.0,8/54,7.36%,HMGB1;EYA4;PPP1R10;RNF168;H2AX;TMEM161A;PARP3;BRCC3
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.38858752202341906,0.7881103801001975,0.7209302325581395,1.0,1.0,4/31,11.87%,TMEM11;BAK1;SAMM50;CHCHD6
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.33805112206066057,-0.787647533920124,0.8513513513513513,1.0,1.0,18/125,17.33%,YBX3;TNFRSF1A;GBP2;BIRC3;GBP3;PSMB8;CHI3L1;TNFRSF1B;ADAMTS7;PID1;CD27;ZFP36;STAT1;NR1D1;BRCA1;NFKBIA;PSMC3;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.3646881272752647,-0.7874934199215242,0.7887323943661971,1.0,1.0,6/56,12.42%,TGFB2;SPDYA;CITED2;CCND1;TRIM32;EGFR
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.4812159714082963,0.7874685703100701,0.75,1.0,1.0,2/5,9.11%,EIF3E;EIF3D
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.4256731459985533,0.787218526666354,0.75,1.0,1.0,2/20,12.71%,GDAP1;PEX2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3639771156300798,-0.7866661758417591,0.7948717948717948,1.0,1.0,10/50,20.54%,DMAC1;NDUFC1;NDUFAF5;NDUFB9;NDUFB6;NDUFA8;NDUFAF1;ECSIT;TIMM21;NDUFS5
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.3639771156300798,-0.7866661758417591,0.7948717948717948,1.0,1.0,10/50,20.54%,DMAC1;NDUFC1;NDUFAF5;NDUFB9;NDUFB6;NDUFA8;NDUFAF1;ECSIT;TIMM21;NDUFS5
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.35637685863615715,-0.7864869160403937,0.9014084507042254,1.0,1.0,17/66,13.42%,DPEP2;PTPRC;ADAM28;NCKAP1L;CLCA3P;GMFG;SELL;LAPTM5;CD53;ZBTB32;IL7;CR2;IL16;IKZF1;ARHGAP25;LY86;WDFY4
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.31440240106110723,0.7859299250133897,0.8666666666666667,1.0,1.0,14/155,10.10%,USP27X;CRYAB;HSPA1A;PYHIN1;OTUD3;MORC3;USP36;ZSWIM7;ZNF207;FLNA;ATP1B1;BAG2;PRKRA;HSPA1B
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4537717007400414,0.7856974660369269,0.725,1.0,1.0,5/9,32.90%,RELA;RHOA;NFAT5;ETS1;MDK
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.4851609400234348,0.7849648167579812,0.813953488372093,1.0,1.0,3/5,21.70%,PLEKHA7;TJP1;FERMT2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.45459002501371254,-0.7848671077908798,0.7575757575757576,1.0,1.0,2/11,13.60%,MET;PRKD2
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.38546014752273206,-0.7847912121872934,0.8088235294117647,1.0,1.0,2/31,5.30%,TGFB2;MET
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2946855153679727,-0.7846707947783148,0.9466666666666667,1.0,1.0,30/363,12.25%,MDFIC;HEY1;MAEL;PPARG;BASP1;MIDEAS;ELK3;GLIS2;IRF1;LOXL3;PRICKLE1;CENPF;ID2;SOX9;CITED2;DKK3;ZEB1;PRAME;BHLHE40;E2F1;ZNF540;PLCB1;IFNA2;PBXIP1;CDK5R1;GLI3;RUNX1T1;IKZF1;L3MBTL4;ZNF217
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.4029150623147085,-0.784280843397747,0.7971014492753623,1.0,1.0,3/21,8.41%,RPA3;RFC3;RFC4
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4761839367088101,-0.784136933719534,0.8181818181818182,1.0,1.0,5/14,27.80%,HLA-DRB1;STAT3;BTN3A3;CD70;SLA2
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.41680741011418454,-0.7841053157774186,0.7538461538461538,1.0,1.0,2/24,5.26%,PARP9;DTX3L
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.5003529892822024,-0.7837475167533017,0.7586206896551724,1.0,1.0,3/5,17.52%,MET;CNMD;COL15A1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.4237951633511381,-0.7837175265433671,0.6896551724137931,1.0,1.0,3/18,9.70%,TGFB2;ITGAM;CDK5R1
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4091851977901789,-0.7835315584794259,0.7833333333333333,1.0,1.0,12/22,33.94%,HLA-DRB1;ADCY8;EFNA5;NR1D1;ABCA12;EPHA5;STX4;CFTR;CDK16;BAIAP3;GPLD1;KLF7
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.2964980817798193,-0.7834465346921209,0.9761904761904762,1.0,1.0,51/420,16.51%,TLR2;IGFBP3;TGFB2;PAK5;EPHA3;MUSK;GMFG;TGFBR2;PRKAR1B;PIM1;MAP3K21;HIPK4;EPHA4;MAP3K5;DCLK1;PEAK3;BMX;RPS6KA6;CSF1R;CAMK1D;LRRK2;TSSK3;FES;TEK;HUNK;STK17B;CDK5R1;PAK3;PRKG1;COQ8B;LYN;CAMK1;DAPK1;STK33;BMPR1B;EPHB1;EGFR;PRKD2;STK17A;DDR2;MYLK3;GRK6;DAPK3;CDKL4;TGFB1;PRAG1;CAMK2B;SYK;GLYCTK;MAP3K12;PLK2
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.51683754863115,-0.7826017475558371,0.7358490566037735,1.0,1.0,2/6,12.46%,TNFRSF1B;NMD3
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.4856291836923648,0.7825499465257774,0.7894736842105263,1.0,1.0,2/6,14.75%,NFKB1;RELA
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.33328748155093574,0.782537202079946,0.8181818181818182,1.0,1.0,14/76,19.32%,GDAP1;MYO1C;ZDHHC12;MICALL1;ZDHHC14;RTP5;PEX2;SRPRA;ICMT;ZDHHC3;SSR2;ZDHHC7;RABGEF1;SEC61A1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.45659567923915845,-0.782445310009946,0.75,1.0,1.0,3/11,22.95%,TGFB1;MAD2L2;SHLD2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.4077349412717561,0.782306948423878,0.75,1.0,1.0,10/24,28.39%,CARM1;SMYD1;PRMT2;EHMT1;SIRT7;NTMT1;SMYD3;PRMT5;EHMT2;FBL
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.5234441183001166,-0.7819914193768382,0.7868852459016393,1.0,1.0,1/5,6.92%,MYH11
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.3530189863974465,0.7819828416212995,0.7692307692307693,1.0,1.0,5/25,12.85%,FAM9B;TDRD5;PLD6;GALNTL5;RNF8
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.3973273309020444,-0.7819593758637222,0.8382352941176471,1.0,1.0,1/23,2.17%,BIRC3
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3973273309020444,-0.7819593758637222,0.8382352941176471,1.0,1.0,1/23,2.17%,BIRC3
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.45549675234756504,-0.7819295281683599,0.746268656716418,1.0,1.0,1/13,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.5182825781701109,-0.7816735629989644,0.7636363636363637,1.0,1.0,1/5,18.55%,CEP135
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.4505566887042126,0.7816159486614614,0.7272727272727273,1.0,1.0,2/8,17.00%,ENPP1;PEA15
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3637255643504084,0.7812301024045271,0.775,1.0,1.0,6/38,11.21%,PPP1R36;ECM1;SH3RF2;PPP1R26;PLIN5;RRP1B
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.45207152938879547,0.7810649768003533,0.8125,1.0,1.0,1/9,0.94%,F2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.37369584581712334,-0.7809492671119727,0.765625,1.0,1.0,1/49,0.20%,TRPM1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.43308707022666637,0.7809205808056037,0.7352941176470589,1.0,1.0,2/12,3.79%,FGFR1;SEMA5A
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.37774038895317785,-0.7806641522628422,0.78125,1.0,1.0,5/27,22.92%,PIGH;PIGC;MPPE1;PIGB;PGAP3
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.31848778525769283,0.7806021727396953,0.8387096774193549,1.0,1.0,9/49,14.69%,RIDA;ENPEP;NPL;USE1;ADO;LTA4H;BCKDK;CYP2D6;CLN6
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.4589586841255414,0.7806001437720655,0.7321428571428571,1.0,1.0,2/6,27.48%,SNCA;PRKN
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.3656365596911899,0.7804879435914853,0.6666666666666666,1.0,1.0,3/47,6.08%,PASK;CRHBP;PAX8
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.29609697320933037,0.7804586425010908,1.0,1.0,1.0,63/161,28.55%,ERI1;EXOSC8;EIF3E;RPS3A;RPS15A;HELZ2;RBM8A;SAMD4A;DCP1A;RPL18A;TENT4B;PNRC2;DCP1B;CNOT9;RPS23;RPSA;DHX34;PATL1;SMG9;RPL23A;EXOSC7;DDX5;SMG5;RPL3;RPL11;RPS3;MAGOH;DCPS;PDE12;RPL13;EXOSC5;RPS8;PAN2;RPL8;RPL21;RPL5;PPP2R2A;RPL32;RPL7;RPS16;POLR2D;RPS18;CNOT2;TUT4;ETF1;RPS6;RPS2;RPL41;RPL29;RC3H1;DXO;NBDY;RPL14;RPL10;EXOSC9;RPS28;CNOT6;SMG1;RPL15;RPL10A;CASC3;LSM1;RPS13
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.46084697983586936,-0.7804151804707526,0.7241379310344828,1.0,1.0,4/14,20.39%,MEF2C;CALM3;PPP1R15A;PDGFRB
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.278995861259577,0.7803950450822741,1.0,1.0,1.0,70/320,21.95%,U2AF1;MLF1;M1AP;RAE1;MRPL32;NUP42;PRPF4;PAX8;EEF1A1;FARSB;TNIP1;NUP210;CPSF4;RPS3A;DARS1;EPC1;RPS15A;MRPL3;MRPS7;RBM8A;POLR2K;SYMPK;THAP1;DKC1;RPL18A;TPR;MPHOSPH10;HARS1;MRPS5;HNRNPU;EIF4E;SARNP;HOXD3;MRPL52;MRPL24;RPS23;NXF1;POLR2L;RPSA;TSPAN17;NUP37;HARS2;MRPL13;RPL23A;HNRNPH1;MRPL43;HNRNPA2B1;SMG5;RBM15B;THOC2;RPL3;MRPS16;RPL11;RPS3;MAGOH;NDC1;RPL13;RBM5;ALYREF;NR4A2;RPS8;SEH1L;RPL8;RPL21;SRSF9;RPL5;POLR2E;RPL32;RPL7;RPS16
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.39791742408672526,-0.7803566820006469,0.8,1.0,1.0,8/30,19.81%,TLR2;LAPTM5;IL16;PLCB1;SCIMP;SYK;LILRB1;TIRAP
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.38017094384244376,-0.780273307921058,0.8125,1.0,1.0,4/30,11.63%,CENPK;SMC4;TOP2A;DSN1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.47331173270969334,0.7797848613061962,0.7894736842105263,1.0,1.0,2/11,8.31%,DSEL;DSE
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.467289620273296,-0.7796400583426921,0.7741935483870968,1.0,1.0,1/9,3.38%,CHST1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.3822501351177562,0.7795725892529115,0.6818181818181818,1.0,1.0,1/18,2.27%,VASH1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.4470692255912362,-0.7794864400285458,0.7868852459016393,1.0,1.0,3/10,11.84%,SLC8A1;CALM3;CAV1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.4438761276131966,-0.7794171625724042,0.7424242424242424,1.0,1.0,4/13,16.20%,ST3GAL5;ST8SIA3;B4GALT6;ST6GALNAC5
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.44031191282053295,0.7791819247237034,0.7631578947368421,1.0,1.0,2/12,12.40%,MYOF;AHNAK2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.3942006826079255,-0.7791173501890662,0.8181818181818182,1.0,1.0,4/21,15.88%,BTBD18;SLC25A31;SYCP3;MEIOB
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.48000810232360874,0.7790757302585749,0.6888888888888889,1.0,1.0,3/6,17.62%,LLGL2;SLC3A2;SLC7A5
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.38103747355504947,0.779064651115886,0.8,1.0,1.0,5/45,7.86%,DHFR;MTHFD2L;AADAT;IDH2;MTRR
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.3534573961875168,0.7789374996901639,0.8421052631578947,1.0,1.0,19/65,22.17%,NT5E;ENPP1;PTBP1;POLR2K;POLG;HNRNPU;POLR2L;WDR74;HNRNPH1;HNRNPA2B1;EXD2;PDE12;RAN;WTAP;HNRNPC;HNRNPM;POLR2E;HNRNPR;POLR2D
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.3856160640382228,0.7787662894068462,0.8636363636363636,1.0,1.0,1/21,0.46%,PTH
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.38824099892914155,0.7787136621116056,0.71875,1.0,1.0,3/25,3.19%,LOC400499;CRHBP;NRIP1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3062843109418113,-0.7786920396441583,0.9390243902439024,1.0,1.0,11/261,4.85%,PARP14;CLDN5;SRGN;ENC1;PARP9;TGFB2;OLFM1;MEF2C;NLRP12;ID2;CITED2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.3402124103496692,-0.7782471447246005,0.8285714285714286,1.0,1.0,5/62,8.41%,IHO1;ISG20;RPA3;RFC3;RFC4
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.4506663823053512,0.7781207706979575,0.6956521739130435,1.0,1.0,5/11,15.99%,PAX8;GLI2;WNT4;HOXD3;SALL1
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.5099970936741228,-0.7780938384055504,0.7868852459016393,1.0,1.0,1/6,4.18%,EDN1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.42188361920976575,-0.7779424817842276,0.7868852459016393,1.0,1.0,5/16,15.46%,CAMK1D;ADCY8;VEGFA;PRKD2;CD200
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.432877468949624,0.7779081875605914,0.6875,1.0,1.0,1/14,1.24%,CHST7
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.3749914348328837,-0.7779018939871751,0.8656716417910447,1.0,1.0,11/44,17.62%,GRHL1;CDS1;CCND1;IGSF3;CLDN4;KLRG2;CDH3;OVOL2;GNG12;TOM1L1;MYO1B
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.3586530613241189,0.7773210473703481,0.8285714285714286,1.0,1.0,3/32,6.91%,CYB5A;EMC4;UBE2J2
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.44985923609704365,0.7768476436681904,0.7142857142857143,1.0,1.0,3/8,6.44%,SQLE;AUP1;PLA2G4C
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.49797903681546224,0.7764007447915536,0.8095238095238095,1.0,1.0,1/5,0.36%,DSCAM
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.4884457228778194,-0.7763449490661006,0.8367346938775511,1.0,1.0,2/7,28.11%,SKAP1;SASH3
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.37391747657194746,0.7762038471777764,0.7666666666666667,1.0,1.0,4/18,16.75%,FGFR1;FGFR3;ABL2;KIT
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.4556645303246762,-0.7760884785484184,0.7288135593220338,1.0,1.0,8/15,35.93%,ATP5F1E;ATP5MC1;DMAC2L;STOML2;ATP5ME;ATP5PD;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.49265591148737087,0.7760488605742665,0.7368421052631579,1.0,1.0,1/6,7.63%,GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.49265591148737087,0.7760488605742665,0.7368421052631579,1.0,1.0,1/6,7.63%,GBF1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.49265591148737087,0.7760488605742665,0.7368421052631579,1.0,1.0,1/6,7.63%,GBF1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.48591513376227025,-0.7760432917096249,0.7894736842105263,1.0,1.0,1/7,14.10%,RNF213
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.40371297973677256,-0.7759811372198157,0.7580645161290323,1.0,1.0,1/18,1.20%,SFRP4
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.3959857737125219,0.7756470638407091,0.7027027027027027,1.0,1.0,3/12,9.91%,VDR;NUMA1;TRIM16
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.33556987442055153,-0.7753645422284534,0.8513513513513513,1.0,1.0,8/75,12.73%,ARHGAP42;APC2;GRTP1;SIPA1L1;USP6;TBC1D10A;NGEF;ARHGAP25
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.43197628721078674,-0.7752486470708296,0.7096774193548387,1.0,1.0,2/18,1.52%,GGH;SHMT2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.40314198117003064,0.7750691647947804,0.6976744186046512,1.0,1.0,6/10,32.89%,HNRNPA2B1;PUS10;SMAD1;SMAD2;MRPL44;DGCR8
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.39847389644975983,0.7750660064902829,0.7368421052631579,1.0,1.0,5/19,15.76%,USP36;BRCC3;KAT2A;UIMC1;ENY2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.49727122978415744,-0.7748784433882985,0.75,1.0,1.0,1/6,20.96%,FZD3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.477042890888024,0.7747588337215469,0.7333333333333333,1.0,1.0,2/6,14.95%,ZDHHC12;NLGN2
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.37370352571189325,0.7744617454282678,0.9032258064516129,1.0,1.0,14/32,28.44%,HSPA1A;TRPV1;HSPA1B;TPR;DAXX;ZFAND1;SUMO1;POLR2D;HSF1;IER5;HIKESHI;HMOX1;CLPB;HSP90AA1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.46043858243537805,-0.774210692912236,0.7887323943661971,1.0,1.0,2/12,18.18%,PATL2;EDC3
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.442534317078547,0.7742043560400617,0.717391304347826,1.0,1.0,1/9,3.61%,OR9Q1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3007994198645688,0.7741585971536863,0.8461538461538461,1.0,1.0,12/107,9.02%,TRARG1;SH2B2;GAB1;IGF1R;ATP6V0A4;ENPP1;ATP6V1G2;HDAC9;ATP6V1G1;LPIN3;SLC25A33;AKT2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.4005989549040354,0.773983768123159,0.76,1.0,1.0,2/13,3.75%,LCK;KCNN4
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.5083782097453218,-0.773739497225447,0.8064516129032258,1.0,1.0,2/8,13.54%,CD53;FLOT1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.5208489403308166,-0.7734967464714922,0.71875,1.0,1.0,2/5,23.35%,SYK;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.4203442306698839,0.7734631654252048,0.6756756756756757,1.0,1.0,7/13,24.83%,EIF3E;EIF4EBP1;TPR;PAIP2B;PAIP2;LARP1;EIF4EBP2
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.47918848133424996,0.7732919917012966,0.7547169811320755,1.0,1.0,1/5,15.77%,DDX3X
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.38085427532944494,0.7731228285467419,0.7777777777777778,1.0,1.0,5/22,19.92%,CCNT1;ELL;ALYREF;HMGN1;CCNK
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.4616295786572056,-0.7731037554859118,0.7457627118644068,1.0,1.0,8/14,35.93%,ATP5F1E;ATP5MC1;DMAC2L;STOML2;ATP5ME;ATP5PD;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.4609939585680554,-0.7730897645798258,0.7547169811320755,1.0,1.0,1/10,0.43%,MMRN2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.3635192743048333,0.7728750463878755,0.7567567567567568,1.0,1.0,1/19,0.94%,F2
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.4595686578053141,-0.7725364411239863,0.75,1.0,1.0,4/9,16.34%,FES;LYN;ADGRE2;SYK
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3075979535946813,0.7725113103540463,0.8636363636363636,1.0,1.0,12/118,13.23%,TUBA1A;KDM8;NES;PCM1;CEP290;CEP164;OPTN;TUBG1;HAUS5;ENSA;PLK4;USH1C
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.3667267294598118,-0.7724306228196096,0.8769230769230769,1.0,1.0,10/46,23.88%,MCM2;RECQL4;WRN;RAD50;MCM7;RBX1;MRE11;DDX11;RPA1;XPA
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.43395232154270147,-0.772290913824112,0.8253968253968254,1.0,1.0,5/14,26.34%,MAD2L2;C17ORF99;SHLD2;CD226;TNFSF4
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.38246960230761495,-0.772220583953513,0.8285714285714286,1.0,1.0,4/30,9.94%,LRRK2;RAB11A;FES;USP6
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.33778147201426834,0.772051193252772,0.8387096774193549,1.0,1.0,14/83,16.51%,DHFR;RIDA;EIF4E2;PUS7;EIF3E;EIF4EBP1;SAMD4A;NCL;TPR;CNOT9;CPEB2;DDX3X;MRPL13;YBX1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.4893758382146269,0.7717222204440091,0.825,1.0,1.0,2/5,37.34%,LDLRAP1;FGF1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.4293260467178299,-0.7716634424391028,0.7666666666666667,1.0,1.0,4/16,11.84%,PSMB8;FURIN;CST3;CAV1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.5106097733103141,-0.7712489887628883,0.7678571428571429,1.0,1.0,3/5,31.66%,TRPV4;SLC12A5;MYLK
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4480850009309818,0.7711779904138928,0.7948717948717948,1.0,1.0,4/11,14.09%,ATF4;ATF6B;CREB3L3;ATF3
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.3331814170580808,-0.7711344746519705,0.875,1.0,1.0,8/92,6.32%,ITGB4;PROM1;FMO5;CKAP2L;MUC16;DKK3;TMC4;CEACAM1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.4752639270877864,0.7709349504763395,0.6938775510204082,1.0,1.0,2/5,19.32%,SEC61A2;SEC61A1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.3725235444363425,-0.7708274805326303,0.8208955223880597,1.0,1.0,5/30,16.36%,SEMA3E;SEMA3D;HTR2B;SEMA4B;SEMA4G
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.435644199673937,-0.7707922219065065,0.7647058823529411,1.0,1.0,1/13,4.18%,EDN1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.321323050615091,-0.770435411696228,0.8732394366197183,1.0,1.0,38/155,29.55%,TGFBR2;HIPK4;RPS6KA6;CAMK1D;LRRK2;CDK5R1;CAMK1;PRKD2;MAP3K12;PLK2;PRKCQ;PRKCG;CDK5;VRK3;GAS6;AURKA;HIPK3;PRKCZ;STK38L;DYRK2;PRKCD;CDC7;MASTL;STK38;CSNK1D;CSNK1E;TLK1;MAP4K1;AKT3;RPS6KA3;CSNK1G1;PRKX;MAPKAPK3;MKNK1;CAMK2D;BRSK1;DYRK1B;TBK1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.40145582500727484,0.7699976536833272,0.7647058823529411,1.0,1.0,2/16,3.19%,CRHBP;NRIP1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.3676832193358417,-0.7694023594777827,0.8769230769230769,1.0,1.0,11/38,20.96%,BRINP2;BRINP1;ZWILCH;BRINP3;TGFB1;BTG1;PLK2;TOM1L1;MAD2L1;BCL6;FZD3
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.4966790564659323,0.7686520641639047,0.7352941176470589,1.0,1.0,2/6,16.61%,SPHK2;GAB2
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.5057147308415608,-0.7685976400486638,0.8166666666666667,1.0,1.0,2/5,42.25%,PEX7;DHRS7B
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.5057147308415608,-0.7685976400486638,0.8166666666666667,1.0,1.0,2/5,42.25%,PEX7;DHRS7B
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.3074081498145987,0.7685921044861835,0.7916666666666666,1.0,1.0,12/119,13.23%,TUBA1A;KDM8;NES;PCM1;CEP290;CEP164;OPTN;TUBG1;HAUS5;ENSA;PLK4;USH1C
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.4866059608957173,0.76842572007662,0.7045454545454546,1.0,1.0,1/6,6.60%,DPY30
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.3853654563577541,0.7680920703995906,0.8,1.0,1.0,1/16,0.94%,F2
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.37745152624523365,0.7676292446399019,0.7105263157894737,1.0,1.0,4/21,17.29%,OSBPL7;CYP7B1;HSD3B7;HSD17B10
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.3350554014533823,-0.7674568072746033,0.8472222222222222,1.0,1.0,24/92,20.48%,TRPC6;TRPM3;ANO6;SLC1A1;SLC5A12;CNGB3;PKD1L3;SLC8A3;SLC24A5;SLC8A1;SLC24A1;SLC26A4;AQP11;SLC25A22;PLP2;SLC26A8;SLC17A6;SLC17A7;SLC1A6;SLC24A4;SLC15A4;SLC1A2;SLC9A7;SLC26A9
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.4565456349566026,-0.7673889226080907,0.8181818181818182,1.0,1.0,2/13,17.41%,RIMS2;PTPRN
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.4051720889959637,-0.7673150516123123,0.8125,1.0,1.0,4/17,17.97%,CENPF;MAD2L1;MAD2L2;TEX14
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.3791323745056162,-0.7671654450932008,0.7142857142857143,1.0,1.0,6/32,15.06%,TGFB2;CENPF;SULF1;VEGFA;AGT;STAT1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.5112439595705366,-0.7671125071119588,0.8214285714285714,1.0,1.0,1/7,0.91%,ABCC4
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.36353867852177313,0.7668381302053192,0.813953488372093,1.0,1.0,5/33,16.39%,PIK3C2G;IP6K2;EFR3B;SOCS7;SOCS4
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4271339228738107,-0.7667094147856527,0.75,1.0,1.0,7/15,17.39%,PTPRC;GRM5;DMTN;FKBP1B;PTPRJ;TRPM2;BCAP31
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.4558921232731428,0.7664859411033305,0.7692307692307693,1.0,1.0,1/11,2.06%,CTNNA2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4257547785172255,-0.7662301446121762,0.7627118644067796,1.0,1.0,1/14,1.95%,IL12A
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.3827260366730846,0.7662297195630314,0.8055555555555556,1.0,1.0,2/16,8.26%,LLGL2;LLGL1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.43401395523468833,0.7660634327006735,0.7352941176470589,1.0,1.0,2/10,14.95%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.41221249278798844,-0.7659715894191195,0.6865671641791045,1.0,1.0,5/22,13.58%,ANGPT1;ANO6;TEK;CD160;SCG2
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.46227889742568584,-0.7657266936811883,0.7796610169491526,1.0,1.0,4/10,14.57%,NRCAM;EPHA4;CDK5R1;CNTN4
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.3635247857798827,-0.7654474125997032,0.835820895522388,1.0,1.0,4/44,7.20%,LPL;NLRP12;NLRP3;CX3CR1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.469158558292756,-0.7653334191876575,0.7758620689655172,1.0,1.0,1/7,3.90%,IMPA2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.4399396700547197,-0.7653220634581942,0.7547169811320755,1.0,1.0,4/17,15.70%,ADGRV1;GABBR2;EDNRB;CACNA1C
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3417958440511625,-0.7651954117231184,0.9047619047619048,1.0,1.0,15/82,12.42%,FSTL1;TTN;PPP1R3C;MUSK;COL4A1;CAPN1;ANGPT2;WWTR1;LAMB1;PALLD;LMOD1;SYNC;PRKG1;CAV1;EGFR
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.32248973973421996,0.7648303399267544,0.9615384615384616,1.0,1.0,9/27,22.03%,CHMP5;NAT10;NPM1;CEP120;ALMS1;C10ORF90;SIRT1;STIL;PKHD1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.38478673026185595,0.7646172719006714,0.8333333333333334,1.0,1.0,4/13,14.50%,ODAD2;ZMYND10;DNAI1;DNAH8
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.40112801341168824,0.7645965605738917,0.8,1.0,1.0,4/10,20.92%,PLEKHA7;THBS4;KIT;JUP
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.3339233782158512,-0.7643757685043974,0.9382716049382716,1.0,1.0,13/89,13.54%,SRGN;IL26;ISG15;PTPRC;EOLA1;NLRP12;SFTPD;HLA-DRB1;LYN;HTR2B;TNFRSF1B;TRIM32;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.3784906567717532,-0.7641346689646301,0.84375,1.0,1.0,3/32,7.92%,NCKAP1L;GATA1;FES
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.3571092938652099,0.7639331318376866,0.8529411764705882,1.0,1.0,7/29,18.08%,CAVIN1;POLR2K;POLR2L;UBTF;GTF2H5;ERCC2;TAF1C
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.42387552272244666,-0.763803927667427,0.75,1.0,1.0,1/19,6.97%,ME3
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.4370907676567197,0.763800249759594,0.7777777777777778,1.0,1.0,1/8,0.86%,AGER
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.4693958817287936,-0.7637334087083554,0.7333333333333333,1.0,1.0,3/8,17.85%,SLC7A7;SLC3A1;SLC15A4
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.4169759322145994,-0.763605797207984,0.8142857142857143,1.0,1.0,7/15,30.28%,PRPS1;PRPSAP1;MTHFD1;NMNAT2;NMNAT3;PRPS2;PPAT
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.49167380353947654,-0.7633130232324847,0.78125,1.0,1.0,1/6,1.78%,MPV17L2
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.42901391838574876,0.7633117787685967,0.7209302325581395,1.0,1.0,2/7,11.66%,DYNLT1;STAU1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.34512261531249244,0.7631693457980189,0.8571428571428571,1.0,1.0,11/50,20.94%,RAE1;NUP42;NUP210;KIAA1586;ZNF451;TPR;NUP37;NDC1;SUMO1;UBA2;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.40324608461416755,0.763146705355176,0.7567567567567568,1.0,1.0,7/15,32.76%,PIH1D1;SEH1L;GPR137B;SIK3;TELO2;RRAGB;CLEC16A
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.3217370745514184,-0.7630485045245248,0.8840579710144928,1.0,1.0,19/96,22.68%,IRGM;CLU;SLF1;LGALS3;RHOC;SAR1A;VEGFA;NRG1;HRK;TGFB1;WARS1;SYK;ABCA1;TIRAP;HSPA5;PTPN11;MPP7;RALB;PRKCZ
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.43046313023960825,0.7628050045242125,0.813953488372093,1.0,1.0,2/9,10.60%,ACVR1;ACVR1B
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.5110256325697753,-0.7626174655518233,0.7666666666666667,1.0,1.0,2/5,14.94%,FANCM;RAD54L
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.36766657124424795,-0.7623056078946822,0.765625,1.0,1.0,6/36,14.94%,ANO6;SLC4A10;BEST1;ANO5;SLC26A4;SLC26A8
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.30858580667630925,0.7622798736040062,0.9333333333333333,1.0,1.0,11/82,13.54%,DHFR;F2;RIDA;EIF4E2;PUS7;DNAJC1;SAMD4A;NCL;KNG1;NFKB1;CNOT9
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.41728560356472255,-0.762268372401649,0.8059701492537313,1.0,1.0,3/21,11.26%,XBP1;ADCY8;KCNB1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.45586339885932237,-0.7622121681677038,0.7903225806451613,1.0,1.0,1/9,3.78%,KCNS1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.3723269385926921,0.7617050262258726,0.8275862068965517,1.0,1.0,3/19,3.99%,CRHBP;ERRFI1;EPHB2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.5031877524794539,-0.7614713454149927,0.7966101694915254,1.0,1.0,3/5,20.59%,PRPS1;CTPS2;DCK
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.36090494950229324,-0.7613479805823856,0.8656716417910447,1.0,1.0,4/38,5.26%,KDM4D;PARP9;SLF1;DTX3L
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.4515144570322933,-0.7611277256387469,0.8181818181818182,1.0,1.0,5/11,11.88%,IRAG1;AQP1;HTR2C;KCNC2;HTR2B
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.37028776693177184,0.761002714750706,0.8125,1.0,1.0,5/37,9.06%,GPAT2;MBOAT1;IP6K2;AGPAT5;GK5
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.351213343472217,-0.7608011300843958,0.8169014084507042,1.0,1.0,15/61,14.43%,GPHB5;TSHR;ADGRG1;ADCY7;ADGRG2;RXFP1;GPR161;PTGER3;ADGRL2;ADCY8;ADGRE3;GNAL;CNR2;ADGRE2;GNG2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.5073586917475272,0.7607667486430798,0.8604651162790697,1.0,1.0,2/5,22.32%,PRKCA;PKN1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.4977173234859741,-0.7606928110494626,0.75,1.0,1.0,3/7,20.39%,LGALS3;GRM6;PDGFRB
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.37812270100736994,-0.760510315827394,0.9,1.0,1.0,8/44,20.09%,ARHGAP4;ADGRG1;ARHGDIG;CDH13;NGFR;RHOJ;CDC42EP3;ARHGEF3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.3947464986297077,-0.7604485074716982,0.7741935483870968,1.0,1.0,7/21,22.74%,AQP1;E2F1;DDR2;AGT;CDKN1A;GAS6;WNT5A
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.4989815132836599,-0.7601480217932355,0.7666666666666667,1.0,1.0,2/5,17.70%,LYN;LILRB1
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.42226994695516007,0.7598668646694587,0.6486486486486487,1.0,1.0,3/11,22.44%,ATIC;LHPP;PFAS
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.4029467225581481,-0.7598015401195232,0.7575757575757576,1.0,1.0,11/21,18.18%,SCN2A;SCN9A;SLC8A1;SCN4B;SCN1B;YWHAH;CACNA1G;KCNH2;CACNA1C;SCN3A;SCN1A
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.40894383761448105,0.7595554796292271,0.7441860465116279,1.0,1.0,2/15,13.00%,KANSL2;JADE3
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.40894383761448105,0.7595554796292271,0.7441860465116279,1.0,1.0,2/15,13.00%,KANSL2;JADE3
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.295573094216593,0.7592434354750315,1.0,1.0,1.0,11/76,15.20%,PSME2;RUNX1;PUS7;NSUN2;ABL1;PSMD13;ITCH;PSME4;HNRNPU;HES5;PSMF1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.4003748290790343,0.7592296875429964,0.7948717948717948,1.0,1.0,4/10,22.59%,RIOK1;RIOK2;SIRT7;UTP15
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.3613823068367702,-0.7592096360975349,0.8356164383561644,1.0,1.0,7/38,22.12%,PLPPR5;PLPPR3;SGPP2;PLPPR1;PLPP6;PLPPR4;TPTE2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.45588137468447854,-0.7583621742788826,0.8095238095238095,1.0,1.0,4/9,19.21%,CHI3L1;PTPRT;PID1;SELPLG
prerank,MSigDB_Hallmark_2020__Apical Surface,0.3307873306553323,0.7583261932315569,0.9375,1.0,1.0,7/33,11.13%,AFAP1L2;EPHB4;ATP6V0A4;MDGA1;CROCC;GAS1;TMEM8B
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.3437335624672491,0.7580474760649433,0.8648648648648649,1.0,1.0,4/30,11.30%,HSPA1A;DNAJB4;HSPA1B;UGGT1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.33935206012923846,-0.7580407451367712,0.873015873015873,1.0,1.0,9/42,13.01%,TLR2;MUSK;MEF2C;ROBO2;CLSTN3;GPC6;EPHB1;LRFN5;SLITRK3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4433882149714209,-0.7580061383600435,0.8166666666666667,1.0,1.0,2/13,12.37%,CLU;TRIM32
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.4443508693179032,0.7577381628696315,0.7428571428571429,1.0,1.0,3/11,10.97%,SPHK2;PIH1D1;ZNF451
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4442316790738572,-0.7577182043603421,0.8620689655172413,1.0,1.0,6/15,15.70%,SLC8A1;SCN4B;SCN1B;CACNB2;CACNA1G;CACNA1C
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.2896121023204742,0.7571659752175032,0.8888888888888888,1.0,1.0,5/116,2.86%,ORC1;POLD3;PSME2;PRIM1;UBC
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.44524231708227757,0.7571286526216324,0.8695652173913043,1.0,1.0,4/8,12.11%,SPRY2;SPRED1;SPRED2;DLL1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.3944595796831466,0.7567464559655118,0.7804878048780488,1.0,1.0,4/13,11.39%,LEPR;RUNX1;SUCO;THBS4
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.49482662511513154,-0.7566928290413095,0.7636363636363637,1.0,1.0,3/7,27.68%,APOBEC2;NUDT16;METTL3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.5028154820709323,-0.7565177401649062,0.7843137254901961,1.0,1.0,2/5,11.62%,ADGRV1;VEGFA
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.3934454368020503,0.7563307516692493,0.7441860465116279,1.0,1.0,4/15,14.95%,NLGN3;PTPRD;IL1RAPL1;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.4698395790573927,-0.7561927532907723,0.7377049180327869,1.0,1.0,1/7,8.16%,NELL1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.47172149851715117,0.7561394580479469,0.8333333333333334,1.0,1.0,1/5,6.60%,FLNA
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.33378191904062626,-0.7555997719280134,0.8904109589041096,1.0,1.0,3/74,5.35%,DACT1;PRICKLE1;PSMB8
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.4472381828448138,0.7555266510682784,0.7959183673469388,1.0,1.0,3/10,18.30%,OPLAH;HAGH;GGCT
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.33947437247667517,-0.75545399683411,0.8676470588235294,1.0,1.0,12/74,14.92%,IL26;TGFB2;ANKRD6;MAP3K5;SH3RF3;PLCB1;GADD45B;VEGFA;SPI1;CD27;MAPK8IP1;SCIMP
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.35390392035908125,0.755405209928474,0.8888888888888888,1.0,1.0,5/33,4.22%,AGER;MALT1;HMGB1;STMP1;PYHIN1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.35101235053259006,-0.754946100820837,0.921875,1.0,1.0,7/46,17.72%,RAD9A;E2F1;PRPF19;STK33;DONSON;MAD2L2;CLOCK
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.4742271396702836,-0.7549359918699817,0.78,1.0,1.0,5/10,33.99%,NCBP1;LEO1;DHX36;NCBP2;PAF1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.3897581825238159,-0.7548770801843121,0.8382352941176471,1.0,1.0,15/27,20.79%,CACNG2;CACNA1E;SCN2A;SCN9A;CACNA1B;SCN1B;CAV1;YWHAH;CACNA1G;KCNH2;SCN3A;SCN1A;CACNA1A;ATP5IF1;SCN3B
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.5065001137983093,-0.7548304300075269,0.7931034482758621,1.0,1.0,3/5,31.94%,TMEM9;ALDOB;VMA21
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.3447440746702634,-0.7548013903480937,0.9315068493150684,1.0,1.0,8/52,11.97%,DMKN;CR1;PLSCR1;PLSCR4;ANO6;RAB3A;CAV3;PACSIN1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.34760452308716633,-0.7544324085005983,0.8769230769230769,1.0,1.0,11/37,17.91%,LPL;GPIHBP1;RDH12;GPC5;GPC6;GPC3;LRP1;RBP1;DHRS3;PLB1;ADH4
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.4224023448738039,0.754352073495018,0.7435897435897436,1.0,1.0,1/12,0.89%,NUPR1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.29598263982926126,-0.7541602719585049,0.9577464788732394,1.0,1.0,40/274,19.88%,TTC8;CC2D2A;ABCC4;ARL13A;RPGR;TUBA4A;DCX;DYNC2H1;RAB11A;CYS1;TEKT3;RSPH6A;LZTFL1;TTC39C;SEPTIN6;CEP70;BBOF1;DZIP1;SPAG16;TXNDC15;SNX10;ABLIM1;CCDC39;RSPH9;CFAP44;RP2;DYNC2I2;DISC1;KIF3C;SSX2IP;CFAP74;TTC36;CEP135;FNBP1L;DNAH5;CFAP46;CEP126;CEP152;WDR35;ATP6V1D
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.49749782972177775,-0.7539940222785706,0.8181818181818182,1.0,1.0,1/9,0.91%,ABCC4
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.3957786910834805,-0.7536959503506054,0.7727272727272727,1.0,1.0,6/24,17.33%,CLU;ITGAM;IFI35;NMI;SYK;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.45958084294663437,-0.7535072927140369,0.8032786885245902,1.0,1.0,5/11,20.96%,CX3CR1;VEGFA;DISC1;CX3CL1;FZD3
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.4277056469102891,0.7533524927687211,0.8292682926829268,1.0,1.0,2/11,22.47%,CTDP1;SIRT7
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.2947451432138209,-0.7532711709178808,0.9411764705882353,1.0,1.0,24/180,18.65%,MCM2;CENPE;SPC25;CDCA3;RPA3;RFC3;SMC4;TOP2A;CDKN3;PRPS1;CKS2;NAA38;ORC2;KIF2C;RAD50;CDKN1A;DIAPH3;MCM7;BRCA1;DONSON;MAD2L1;EZH2;CIT;RPA2
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.4973894673695928,-0.7531583985080456,0.7741935483870968,1.0,1.0,1/7,4.30%,ATP2B3
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.41516335483942735,0.7531117534488235,0.7073170731707317,1.0,1.0,2/11,4.10%,LCK;MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.4015955282628126,-0.7527204368537139,0.7534246575342466,1.0,1.0,7/26,10.80%,HLA-F;IL12A;HLA-E;ITGAM;HLA-A;HLA-DRB1;CD160
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.48641904648182727,-0.7525649391024962,0.7288135593220338,1.0,1.0,2/6,15.19%,CSF1R;PARD6A
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.3127898112487042,0.7524788651798198,0.8,1.0,1.0,4/38,6.56%,PSME2;LMNB1;ANXA2;RALA
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.4070968172600509,-0.7524742267012654,0.84375,1.0,1.0,4/16,17.97%,CENPF;MAD2L1;MAD2L2;TEX14
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.4070968172600509,-0.7524742267012654,0.84375,1.0,1.0,4/16,17.97%,CENPF;MAD2L1;MAD2L2;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.4070968172600509,-0.7524742267012654,0.84375,1.0,1.0,4/16,17.97%,CENPF;MAD2L1;MAD2L2;TEX14
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.40532718178167126,-0.7523707863256017,0.7457627118644068,1.0,1.0,3/16,14.17%,CSF1R;GPR183;SNX10
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.36989044796001447,-0.7523678493892774,0.8387096774193549,1.0,1.0,2/29,5.25%,SHMT2;STAMBPL1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.49823392686170054,0.7522918978242653,0.8157894736842105,1.0,1.0,1/5,14.41%,PRKAA2
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.3684130218532656,-0.7521947347705419,0.8382352941176471,1.0,1.0,4/42,6.86%,GCNT1;MUC16;GALNT12;GALNT8
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.3731691250849989,-0.7518967126133812,0.84375,1.0,1.0,4/25,18.31%,NCKAP1L;GATA1;STAT1;STAT3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3582278570532977,-0.7518287325412558,0.8636363636363636,1.0,1.0,6/43,12.26%,CIDEB;TP73;BCL2L2;DDIT4;E2F1;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.3404883590698483,0.7517168839430668,0.7105263157894737,1.0,1.0,5/44,9.25%,F2;DCXR;SPHK2;SLC25A33;PLIN5
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.4778502370789154,-0.7515596773133475,0.8,1.0,1.0,1/8,7.83%,PLAAT4
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.4456596443947748,-0.7514928117874488,0.7313432835820896,1.0,1.0,2/11,6.11%,ID2;CSF1R
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3013621364091919,-0.7514575603262222,0.9240506329113924,1.0,1.0,39/215,19.47%,PKP2;VIL1;BAIAP2;RIMS1;LAMC1;NCKAP1L;SOX9;BAIAP2L2;DCX;RSPH6A;LIN7A;ADD2;CYFIP1;STAG3;LRRTM3;NEFH;DLG4;SYCE2;SPAG16;RAC3;SYCP2;OPHN1;PCLO;TGFB1;RSPH9;DMTN;SPAG17;RHOJ;NAPG;MYO1B;TAPBP;CFAP74;NDUFAF1;DNM1L;NEDD9;SHROOM2;RHOH;CFAP46;SYCP1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.5091365111858401,-0.7510980320473958,0.859375,1.0,1.0,2/7,13.54%,CD53;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.4105045233069458,-0.7509155873430389,0.8548387096774194,1.0,1.0,3/13,22.38%,PLCB1;TENM4;ZBED3
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.312781088248844,0.7508725071675112,0.8064516129032258,1.0,1.0,9/60,11.07%,ENPP6;PRDX6;PLA2G4C;PIGF;CPNE1;HDHD5;LCAT;PNPLA3;DGKH
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.3161719741412326,-0.750852608973051,0.948051948051948,1.0,1.0,13/98,17.24%,NR4A3;VAV3;FOS;PSMB8;CARD11;LYN;NFATC2;LAT2;SYK;PIK3CB;PPP3CA;PRKCQ;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.42637680713743753,-0.7507251481895175,0.8225806451612904,1.0,1.0,2/16,6.31%,IL26;CRLF3
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.40133717604091246,0.7507084154857104,0.7941176470588235,1.0,1.0,2/15,10.63%,INTS14;INTS8
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.44707002813844265,-0.7506186774463427,0.8507462686567164,1.0,1.0,3/12,12.34%,EPHA4;EPHB6;EPHB1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.3569050148752584,0.7505626095368506,0.8611111111111112,1.0,1.0,4/47,11.49%,DCXR;ATF4;FBP1;PGM1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.31071410279560785,-0.7503472855048979,0.8918918918918919,1.0,1.0,21/105,16.44%,FSTL1;ADAMTS5;OLFML2B;FAP;COL4A1;DKK3;COL11A1;GJA1;BOC;THY1;LMOD1;SULF1;GADD45B;GLI3;VEGFA;LRP1;DDR2;TIMP3;STAT1;RHOJ;COL10A1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.47709012565684117,0.7503026685748038,0.782608695652174,1.0,1.0,2/5,35.00%,NAA20;NAA25
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.37560610161173286,0.750191259573255,0.7777777777777778,1.0,1.0,4/16,9.89%,BPIFB1;MFHAS1;RAB7B;PTPN22
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.45052769069150744,-0.7499531833120979,0.8260869565217391,1.0,1.0,3/10,18.21%,CAMK2B;NRXN1;NEURL1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.41751348166751623,0.749919794354953,0.868421052631579,1.0,1.0,3/13,12.16%,EPHB2;CHRNA7;RELN
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.4285254752993286,0.7498109282761269,0.7941176470588235,1.0,1.0,1/11,4.19%,KMT5A
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.4583788208408419,0.7496645324153159,0.7307692307692307,1.0,1.0,1/6,7.71%,PHF1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.4303617917259722,-0.7496620057289562,0.782608695652174,1.0,1.0,3/16,22.39%,WTIP;CIT;SHANK2
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.4426610734337686,0.7491590151237786,0.7391304347826086,1.0,1.0,4/6,28.14%,PDCD7;SOX30;CALCR;AKR1C3
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.3561817896947832,0.7490522150746041,0.813953488372093,1.0,1.0,13/33,22.58%,TRARG1;GGA2;RAB26;OPTN;VAMP4;GGA3;MACF1;BLZF1;RAB7A;GCC2;GGA1;GOLGA7;AFDN
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.45654651663045165,-0.7490449662406184,0.8208955223880597,1.0,1.0,2/8,5.34%,PLCB3;DDAH1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.5068104280523862,-0.7485396312036443,0.8823529411764706,1.0,1.0,1/5,17.83%,MAP2K5
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.41041102614027336,0.7484674895698815,0.7222222222222222,1.0,1.0,5/11,26.57%,IFI27;TPR;SIRT7;NUP214;KHDRBS1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3864620964137002,0.7480065507459549,0.7872340425531915,1.0,1.0,4/15,12.02%,SPRY2;SPRED1;SPRED2;DGKQ
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.30631550638770555,0.747994887836661,0.9523809523809523,1.0,1.0,6/60,9.02%,RAB27A;CYBA;ANXA2;NUMA1;BAK1;AKT2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.39864418304907834,-0.7478237814084875,0.8615384615384616,1.0,1.0,5/22,13.33%,KCNS1;ATP1B2;CAV3;NEDD4L;NETO1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.35876392095629267,0.7474605506777094,0.8333333333333334,1.0,1.0,5/36,5.81%,TCOF1;KBTBD8;SEMA5A;NRTN;RADIL
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.46276240541209274,-0.7472217590910415,0.7575757575757576,1.0,1.0,2/8,7.81%,B2M;ARG2
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.4715711942376163,0.7470941436826624,0.7333333333333333,1.0,1.0,1/5,6.39%,ATF4
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.3637159070260399,0.7470392431433579,0.8529411764705882,1.0,1.0,4/27,8.83%,MGLL;CASQ2;CRK;GRK5
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.4160776441951592,0.7469487933447824,0.775,1.0,1.0,1/12,3.39%,SCRIB
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.2831490464798184,0.7468899794750093,0.9,1.0,1.0,21/126,13.12%,ZAP70;LCK;PSME2;MALT1;NFKBIZ;CD247;PDE4B;NCK1;MOG;PSMD13;PTPN22;CD276;BTN2A1;CHUK;TNFRSF21;ICOSLG;UBE2N;NFKB1;PSME4;MAP3K7;BCL10
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.3791069244134061,0.7468147168472374,0.8,1.0,1.0,4/14,16.75%,FGFR1;ABL1;ABL2;KIT
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.4407556516011288,-0.7466522628968978,0.8709677419354839,1.0,1.0,3/10,19.38%,EPHA4;CHN1;RHOH
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.3078490142642854,-0.7465600589344672,0.972972972972973,1.0,1.0,21/138,19.13%,YBX3;PTPRC;TRIM5;TP73;EOLA1;TRIM22;KIF16B;NELL1;SLC8A1;NFKBID;FLOT1;RASA1;GNB3;RFXANK;POU5F1;PRDM1;TRIM17;TAPBP;KDM6A;ALPK2;CDH1
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.39338551574651764,0.7465525720466896,0.85,1.0,1.0,5/11,27.01%,HACD1;TECR;HACD3;ELOVL1;ELOVL6
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.43299974574026245,-0.7464164781219392,0.8166666666666667,1.0,1.0,1/12,1.53%,IHO1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.42993431869296095,-0.7463754272411837,0.7936507936507936,1.0,1.0,1/11,3.65%,ACADL
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.37507880883110245,0.7463317847891412,0.8205128205128205,1.0,1.0,2/18,8.52%,PIH1D1;FAM47E
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.4487378874005854,0.7460332694259367,0.6666666666666666,1.0,1.0,1/5,7.26%,NCK1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.48979246709137814,0.746010357831927,0.8,1.0,1.0,4/5,27.48%,DUSP12;MIDN;BAD;PRKN
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.3825661157061504,-0.7457993341957136,0.8181818181818182,1.0,1.0,4/25,7.70%,HOPX;CENPF;ADGRG1;TOP2A
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.4691321190939388,-0.7457685647304346,0.8421052631578947,1.0,1.0,3/8,24.42%,PEX1;LONP2;ZFAND6
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.48042141669848204,-0.7455626134532695,0.8253968253968254,1.0,1.0,1/7,13.59%,NFATC2
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.4582184043625769,0.7454332698638548,0.7435897435897436,1.0,1.0,1/6,7.67%,PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.47980601411115453,0.7454089298845941,0.7441860465116279,1.0,1.0,3/5,28.49%,ERLIN2;SOD1;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.47980601411115453,0.7454089298845941,0.7441860465116279,1.0,1.0,3/5,28.49%,ERLIN2;SOD1;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.47980601411115453,0.7454089298845941,0.7441860465116279,1.0,1.0,3/5,28.49%,ERLIN2;SOD1;ERLIN1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.38084240616876897,-0.7453892519743859,0.8088235294117647,1.0,1.0,2/30,7.20%,BCL2L14;CX3CR1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.4779068329663481,-0.7452956155105277,0.8,1.0,1.0,2/5,9.59%,RYR3;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.4779068329663481,-0.7452956155105277,0.8,1.0,1.0,2/5,9.59%,RYR3;SLC8A1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.3617233231017387,-0.7449580384398505,0.8225806451612904,1.0,1.0,3/33,4.97%,GLRA3;GPIHBP1;GLRA2
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.47344713586237736,0.7448093688925691,0.8292682926829268,1.0,1.0,1/6,5.84%,PLA2R1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.43226191411338255,-0.7446513379141367,0.8181818181818182,1.0,1.0,2/10,13.92%,TJP3;RAB1B
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.48087113475050214,-0.7445842735320576,0.7543859649122807,1.0,1.0,1/6,7.20%,CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.408815363459967,-0.7445325262878719,0.9253731343283582,1.0,1.0,3/15,15.07%,CARMIL2;DDR2;TGFB1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.41784527079743744,0.7440915693199097,0.8055555555555556,1.0,1.0,1/10,0.36%,DSCAM
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.35021101293801477,0.7439802961959041,0.7727272727272727,1.0,1.0,15/72,15.06%,DHFR;ORC1;KLF11;NASP;EIF4EBP1;ACVR1;USP37;CDK6;ACVR1B;CDK18;CDK15;LATS2;EIF4E;BCAT1;TFDP1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.3788427464305566,0.7439708235329955,0.8214285714285714,1.0,1.0,6/17,15.09%,KCNJ2;SLC12A9;ATP12A;ATP1B1;SLC12A4;SLC12A2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.4073161102663109,-0.7434965019496503,0.8412698412698413,1.0,1.0,5/19,18.59%,SCN2A;NGFR;SIAH1;CIT;CDK5
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.30161525717132687,-0.7433372756363985,0.9736842105263158,1.0,1.0,28/171,19.58%,TGFB2;PAK5;TSPYL2;CRLF3;CEACAM1;LGI1;GJA1;NRG3;RERG;WFDC1;TRIM32;EGFR;TCHP;AGT;TGFB1;CDKN1A;BTG1;HPN;OGFR;PTPRJ;NCBP1;PRKCQ;MAD2L2;GNG4;OSGIN2;CXCL16;OSGIN1;BCL6
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.4361132973666032,0.7432863286014294,0.813953488372093,1.0,1.0,2/9,20.28%,HDAC4;UBA2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.3722165629697881,0.7428725774095256,0.8421052631578947,1.0,1.0,3/18,7.22%,SYNE2;MYO1C;MYO1D
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.29578671991466254,0.7427719180301381,0.9117647058823529,1.0,1.0,5/59,6.60%,F2;TESK1;PYHIN1;PINX1;FLNA
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.34488694516599033,0.7427550575295033,0.7407407407407407,1.0,1.0,3/43,4.10%,EVI2B;RUNX1;MFHAS1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.40575104555207253,-0.7423841461452587,0.7761194029850746,1.0,1.0,3/22,8.41%,RPA3;RFC3;RFC4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.43503617728348165,0.7421166659676683,0.782608695652174,1.0,1.0,2/9,5.01%,ACADS;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.44235317260465135,-0.7420714281831963,0.8301886792452831,1.0,1.0,6/14,16.33%,SYT4;RAB3A;KCNB1;CACNA1G;SCAMP5;RAB15
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.42224879176569813,0.7420405001051162,0.8297872340425532,1.0,1.0,1/11,6.39%,ATF4
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.37891472186803216,0.7419800997558217,0.8285714285714286,1.0,1.0,5/20,10.29%,LEPR;ACADVL;COX10;LYRM7;GFPT2
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4066764542522354,0.7413927222336545,0.7948717948717948,1.0,1.0,8/13,20.21%,YAE1;ISCA2;CIAO2B;LTO1;NFU1;GLRX3;ISCA1;CIAO1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.4342185096506669,-0.7412795065212379,0.8793103448275862,1.0,1.0,1/10,4.00%,TGFBR2
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.4898334685160699,-0.7412003787590759,0.8333333333333334,1.0,1.0,2/6,8.31%,MACROD1;PRPS1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.3767229222984946,-0.7411513659478965,0.8333333333333334,1.0,1.0,4/27,13.07%,NRG4;PTPRR;EGFR;NRG1
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.45130909590244744,-0.7410587007652872,0.7333333333333333,1.0,1.0,2/6,19.58%,PTGER3;OSMR
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.4003163051172897,-0.7408600255651023,0.855072463768116,1.0,1.0,1/29,1.07%,DACT1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.49508771584758116,-0.7406862298930498,0.8571428571428571,1.0,1.0,3/6,14.82%,CDH3;FGF7;NOTCH2
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.4757209122357073,0.7406336634559485,0.7317073170731707,1.0,1.0,1/5,5.07%,CIAO3
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.3126538229939603,0.7405733119662662,0.9285714285714286,1.0,1.0,9/69,9.79%,CCR3;ECM1;SEMA5A;GAB1;RUNX1;HMGA2;PTGIS;SERPINE1;CHRNA7
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.40052488049750934,0.7405329681693786,0.75,1.0,1.0,3/15,13.58%,SLIT2;PDCD7;HNRNPU
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.37063629089312233,0.7403550031882862,0.8387096774193549,1.0,1.0,1/10,1.47%,HDC
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.45345878050916333,-0.7399780872167593,0.8333333333333334,1.0,1.0,1/8,19.96%,RBX1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3117859684229096,0.7397716922053943,0.9285714285714286,1.0,1.0,8/89,9.48%,PASK;PIWIL2;PLD1;NAT10;BAK1;EIF3E;EIF3D;SAMD4A
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.45656323791472797,0.7397539808701731,0.7380952380952381,1.0,1.0,4/8,28.77%,GMNN;WDR18;METTL4;BLM
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.3765621410458962,0.7397399325135442,0.7714285714285715,1.0,1.0,2/14,9.17%,CRHBP;BMP8A
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.4781321682463712,-0.7397389837541327,0.8305084745762712,1.0,1.0,3/9,21.13%,ADCY8;ADCY2;ADCY1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.4781321682463712,-0.7397389837541327,0.8305084745762712,1.0,1.0,3/9,21.13%,ADCY8;ADCY2;ADCY1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.35665925022675643,-0.7396633940828412,0.8787878787878788,1.0,1.0,8/44,12.64%,FOSL2;HOPX;LGALS3;BHLHE40;TMEM40;SMAGP;CLDN4;ERVFRD-1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.44710975591636015,0.7394276471575413,0.8205128205128205,1.0,1.0,1/7,3.99%,EPHB2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3894930877552538,-0.7392225930070678,0.8225806451612904,1.0,1.0,1/22,0.43%,MMRN2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3269810917122872,-0.7391944822414686,0.8701298701298701,1.0,1.0,4/63,7.35%,KITLG;TP73;PSMB8;GATA1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.3094730508778124,0.7391217294504506,0.7857142857142857,1.0,1.0,4/40,6.56%,PSME2;LMNB1;ANXA2;RALA
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",-0.5198454023868979,-0.7389424991048754,0.8333333333333334,1.0,1.0,1/5,1.22%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.3848386162690739,-0.7389410900127727,0.7796610169491526,1.0,1.0,4/17,17.70%,B2M;CAV3;PAX6;LILRB1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.3676740004170571,0.7382221481679212,0.7659574468085106,1.0,1.0,6/28,16.24%,GRPEL2;TIMM23;GRPEL1;PEX6;PEX2;TOMM40L
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.3929101979709013,0.7375273292649098,0.868421052631579,1.0,1.0,5/12,27.01%,HACD1;TECR;HACD3;ELOVL1;ELOVL6
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.3806658376471233,0.7375058203638849,0.8484848484848485,1.0,1.0,6/24,16.46%,GLYAT;CROT;ACOT6;ACOT12;THEM4;ACBD6
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.3806658376471233,0.7375058203638849,0.8484848484848485,1.0,1.0,6/24,16.46%,GLYAT;CROT;ACOT6;ACOT12;THEM4;ACBD6
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.3246056526617708,0.7373685991543386,0.918918918918919,1.0,1.0,9/43,10.40%,SSC5D;AFAP1L2;HMGB1;HSPA1A;TLR1;SERPINE1;PTPN22;HSPA1B;IL17D
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.34633099716693827,-0.7368414164103056,0.8307692307692308,1.0,1.0,3/33,8.41%,RPA3;RFC3;RFC4
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.32857705099296164,-0.7364954978307138,0.9117647058823529,1.0,1.0,2/53,2.74%,SHMT2;COX7A1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.35335188462202605,-0.7364676599131956,0.890625,1.0,1.0,2/32,8.48%,GLRA2;XBP1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4065256474560907,0.7362497768906888,0.8085106382978723,1.0,1.0,1/9,2.46%,PYCR1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.43062437376718343,0.7362067313955409,0.7560975609756098,1.0,1.0,1/10,3.25%,CASQ2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.41896639930695595,-0.7360792542426793,0.8181818181818182,1.0,1.0,7/14,28.03%,ENTPD3;NUDT18;ENTPD1;NUDT1;NUDT16;ENTPD2;NUDT15
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5014533699662745,-0.7357866727990702,0.8490566037735849,1.0,1.0,1/5,4.18%,EDN1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.2579246108930557,-0.7357191753304573,1.0,1.0,1.0,244/1673,19.75%,ZNF215;MDFIC;ZNF100;ZNF366;GRHL1;FOSL2;ZIM2;NR4A3;HEY1;ZSCAN1;MAEL;PPARG;HOPX;ZIC4;BASP1;PARP9;CEBPD;ZNF550;ZIK1;MIDEAS;ACTA2;KLF9;IGSF1;ZNF549;ELK3;GLIS2;IRF1;TP73;ZSCAN31;PLAG1;MEF2C;CCNQ;LOXL3;ZNF789;PRICKLE1;CENPF;ZNF814;ID2;ZNF343;TRIM22;CASZ1;ZNF154;SOX9;NOS1;FOS;ZNF239;BCL11B;CITED2;KDM3A;DTX3L;DKK3;ZEB1;STAT5A;DUXB;ZBTB32;MAP3K5;KLF3;ZNF486;PURG;ZNF394;CRLF3;CPHXL;ZBTB22;WTIP;ZFHX2;ALX3;PRAME;TERF2IP;ELAVL2;GATA1;ETV1;ZNF235;ZNF608;WWTR1;ZNF584;ZNF20;AR;EMX1;HIF3A;E2F3;FLI1;DNAJC2;BHLHE40;ZNF433;E2F1;TCIM;ZSCAN22;ZNF540;PLCB1;SP110;IFNA2;PBXIP1;RFX5;PCGF3;ZNF730;TASP1;CDK5R1;ZKSCAN7;TOX;HLA-DRB1;SOX21;IKZF2;SNAI3;CEBPB;ZNF764;MED12L;PROX2;GLI3;ACTL6B;GTF2IRD1;NAT14;NDP;ETS2;ZNF391;RUNX1T1;ZFP30;IKZF1;GLIS3;ZNF850;ZNF367;VEGFA;ZNF654;NR2F1;TGFB3;LIN54;ZNF652;YWHAH;ZNF571;L3MBTL4;ZNF217;ZNF233;ZNF442;EGFR;SPIN2A;ZNF530;FGF7;EBF1;TSFM;NRG1;IFNK;PAX6;IL31RA;NFATC2;ZNF671;HIRA;OVOL2;TGFA;SKAP1;MYT1;TRERF1;MED29;DAPK3;ZNF763;SPI1;POU2F2;ZNF490;ZNF572;ZNF213;TP53INP1;NR3C2;ZNF248;ZNF736;AGT;ZNF740;STAT1;TGFB1;TOX2;KCNH2;ZNF157;ZNF580;ESRRA;NR1D1;ID3;MYT1L;ETV6;CDKN1A;MLLT11;ZFP69;MAFF;ZSCAN29;ATXN7L3;TULP3;ATP8B1;BRCA1;BTG1;IRF4;LHX4;ZNF790;MAP3K12;RFXANK;TGIF1;MAF;ZNF714;POU5F1;PRDM1;ARID3A;PRKCQ;CIITA;ZKSCAN8;EBF2;MAD2L2;ZNF420;ZNF768;TYMS;ZNF546;NFYB;CLOCK;EZH2;ZNF543;NFE2L3;HNF4G;CREB3L1;POU6F1;SREBF1;EPAS1;ZNF33B;RNF111;ZNF10;STAT3;ZSCAN5A;ZNF776;CDK5;ZNF765;TENM1;TSHZ2;ZNF597;ZNF140;NR2F2;ZBTB12;ONECUT2;ZSCAN32;CDH1;ZNF136;RHOH;STAT4;ESR1;TAF6L;ZNF705G;SAP30L;BCL6;ZNF566;ZFP3;TSHZ3;ERG
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.35477012448856743,-0.7353231671715112,0.8148148148148148,1.0,1.0,7/32,20.34%,SLF1;TERF2IP;TPP1;CENPA;RPA2;ESR1;IFFO1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.43529552586108866,0.7351543379596011,0.75,1.0,1.0,2/6,12.87%,HELLS;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.4396390894396244,0.7350910463802119,0.8571428571428571,1.0,1.0,1/7,0.86%,AGER
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.4023361072804608,-0.7350517449657009,0.7761194029850746,1.0,1.0,1/17,1.22%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.3779967751130203,-0.7346037118441922,0.859375,1.0,1.0,7/31,19.13%,SPINT2;BMP6;VEGFA;TGFB1;MAD2L2;MAP2K5;CDH1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.3786872687974169,-0.7344206921593328,0.8082191780821918,1.0,1.0,7/25,20.79%,TTN;SLC8A1;SCN4B;SCN1B;KCNH2;TPM1;SCN3B
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.432912589226063,0.7341497963982913,0.8888888888888888,1.0,1.0,1/9,0.86%,AGER
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.39198638792942586,-0.7339375474038343,0.7857142857142857,1.0,1.0,2/14,19.44%,AR;ESR1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.4387982082472024,0.7338503671685523,0.8888888888888888,1.0,1.0,2/7,9.42%,PTGIS;GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.4387982082472024,0.7338503671685523,0.8888888888888888,1.0,1.0,2/7,9.42%,PTGIS;GLA
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4491039378286881,-0.7337800517645405,0.864406779661017,1.0,1.0,2/11,16.25%,HGF;HPN
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.41732147793724056,0.7336899461227627,0.8571428571428571,1.0,1.0,4/19,11.54%,HMGB1;DICER1;EXOG;BLCAP
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.39544723533978193,-0.7336569382961821,0.8666666666666667,1.0,1.0,5/27,11.55%,MET;FES;NAV3;CDK5R1;CAV3
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.3351668226637677,0.7335767678024854,0.8604651162790697,1.0,1.0,4/27,5.90%,F2;EPHB2;AJAP1;CRK
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.32652210273235,0.7332823099262585,0.7878787878787878,1.0,1.0,13/51,17.29%,ACADS;CROT;ACAA2;ACADVL;ECHS1;PEX2;ADIPOR1;ECI1;ACAT2;PECR;ACOX1;ACAD10;HSD17B10
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.3658367525655244,-0.733119183208621,0.9074074074074074,1.0,1.0,1/31,0.99%,IRGM
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.4005863535680743,-0.7330815646430723,0.7868852459016393,1.0,1.0,3/12,18.50%,LRRK2;ATCAY;DNM1L
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.32995222808497454,-0.732381813448236,0.9545454545454546,1.0,1.0,16/53,21.05%,PTPRC;BLNK;CR2;IFNA2;AXL;TOX;IKZF1;IFNA6;IFNK;NHEJ1;PTPRJ;RHOH;JAG2;KLF6;TPD52;GPS2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.302631180801311,-0.7321896033937578,0.9493670886075949,1.0,1.0,12/107,17.33%,GBP2;GBP3;SOX9;PSMB8;PLCB1;NOD1;ADAMTS7;MYLK3;NR1D1;NFKBIA;PSMC3;CX3CL1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.3957621801634619,-0.7317213567604104,0.8421052631578947,1.0,1.0,2/14,15.55%,LRRK2;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.3503578200167831,0.7315032758587547,0.875,1.0,1.0,8/25,20.92%,FLNA;TPR;IPO5;HDAC3;DMAP1;RBM22;RAN;JUP
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.3874938914712335,-0.7309575725905253,0.8333333333333334,1.0,1.0,3/22,6.50%,MEF2C;EPHA4;SLITRK4
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.3985734168450022,0.7309301168906549,0.8444444444444444,1.0,1.0,4/11,17.47%,SEPHS2;SEPHS1;PSPH;PSAT1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.4362083381369755,-0.7308722967225066,0.8035714285714286,1.0,1.0,1/7,6.54%,LRRK2
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.39057989275635974,-0.7308336114716483,0.8153846153846154,1.0,1.0,2/18,4.73%,TEX15;FOS
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.39057989275635974,-0.7308336114716483,0.8153846153846154,1.0,1.0,2/18,4.73%,TEX15;FOS
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.4656381767053834,-0.7304807853597594,0.8363636363636363,1.0,1.0,2/5,17.39%,LRRK2;BCAP31
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.42429822106130055,0.7304204006255863,0.7391304347826086,1.0,1.0,2/11,28.94%,BTRC;SKP1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.4183005444979011,-0.7300514933577023,0.7966101694915254,1.0,1.0,3/12,12.39%,ADGRV1;GABBR2;EDNRB
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.3523437590216809,0.7297318576156914,0.8222222222222222,1.0,1.0,4/18,13.67%,NES;ALDH1A3;CEP290;HES5
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.3223732924365743,-0.7290672981700052,0.9365079365079365,1.0,1.0,7/71,7.77%,TNFRSF1A;CLU;VIM;GSAP;EPHA4;EFNA1;PRR16
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.3148221843751908,0.7290355768277956,0.9,1.0,1.0,12/53,12.62%,TRIM67;OOEP;TESK1;RSL1D1;MMD2;CEP290;STX10;STX6;DLG1;MAPK8;TPR;PPM1F
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.3726330515687145,-0.7285367251848095,0.9,1.0,1.0,1/19,9.88%,NEMP1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.41612239409574936,0.7282637112279191,0.7631578947368421,1.0,1.0,6/12,24.80%,PCM1;CEP19;BICD2;NIN;NINL;HOOK3
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.41692694090581306,-0.727951247284582,0.8909090909090909,1.0,1.0,1/10,10.97%,LYN
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.44079683326686475,0.7273796011938991,0.7586206896551724,1.0,1.0,1/12,1.24%,CHST7
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.3677671337668206,0.7270663319048317,0.8823529411764706,1.0,1.0,6/27,18.48%,PPP1R10;TNKS2;PKIB;MAP2K7;HNRNPA2B1;NAF1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.34325488505611035,-0.7269192170661424,0.953125,1.0,1.0,9/39,13.96%,CEBPD;RDH12;LGALS3;CEBPB;CBLC;CLDN4;CNR2;TJP3;TGFA
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.24921943797635288,0.7266090066355342,1.0,1.0,1.0,34/278,15.02%,PTH;ORC1;B3GNT6;POLD3;MLF1;MRPL32;EEF1D;PAX8;EEF1A1;FARSB;DUT;TNIP1;RPS3A;DARS1;EPC1;RPS15A;MRPL3;KIN;MRPS7;POLR2K;THAP1;RPL18A;HARS1;MRPS5;GAL3ST2;EIF4G2;HOXD3;MRPL52;MRPL24;RPS23;POLR2L;ATR;RPSA;RAD1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4552280021256212,-0.7265268156561221,0.8571428571428571,1.0,1.0,3/11,9.78%,GLRX;NOS1;ATP1B2
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.4328901396181083,0.7264610891602802,0.8292682926829268,1.0,1.0,1/6,6.18%,PDE4B
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.39716292929339797,-0.7262054675520407,0.7605633802816901,1.0,1.0,1/12,5.32%,SYN3
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.35169933312370893,0.7260714955934244,0.8181818181818182,1.0,1.0,1/16,1.75%,POLD3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2654545340340558,0.7259783010163408,1.0,1.0,1.0,58/431,14.97%,CD38;PASK;VDR;DHFR;CRYAB;MTERF3;RIDA;SCML2;KDM8;HDAC10;SAP18;PRDM5;HMX1;SCMH1;KMT5A;EIF4E2;PUS7;HMGA2;ZNF639;ENPP1;ATOH8;HDAC1;ZNF541;TLE2;ZNF24;HDAC9;EPC1;ZNF425;MLX;ID1;SAMD4A;SAMD1;CDKN1C;SOX13;WNT4;DPF3;SMARCA4;NCL;DAXX;YWHAQ;PPM1F;CBX5;ZC3H8;NKX6-2;PRMT2;CCDC85B;CNOT9;UIMC1;HNF4A;PATZ1;ZMYND11;ZNF12;ASCL1;DPF2;RELA;HDAC4;ATR;ZNF281
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.3539746418589368,0.7258866016520574,0.7878787878787878,1.0,1.0,7/17,30.41%,LPIN3;ACOX1;NUDT19;CYP4F11;PPARD;FAAH;LPIN1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.2927751608956859,0.7258600291315811,1.0,1.0,1.0,9/64,15.20%,PSME2;MALT1;DICER1;PSMD13;CHUK;PSME4;MAP3K7;RELA;PSMF1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.350983169106536,0.7258510820594077,0.8181818181818182,1.0,1.0,6/17,25.29%,DPM3;CRPPA;DPM2;TMTC2;TMTC3;TMTC1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.46962125825874335,-0.7257514821753469,0.875,1.0,1.0,3/7,24.42%,PEX1;LONP2;ZFAND6
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.4152111371156927,0.7257062401888387,0.8947368421052632,1.0,1.0,2/8,14.92%,PIH1D1;IWS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.3819575178615402,0.7253501242932247,0.6976744186046512,1.0,1.0,3/17,8.62%,CASQ2;CLIC2;ATP1B1
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.46547458520770957,-0.7252268039879752,0.7735849056603774,1.0,1.0,1/5,4.85%,CITED2
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.4407511652379914,-0.7251980133501191,0.851063829787234,1.0,1.0,1/9,6.54%,LRRK2
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),0.4561508414567539,0.7250232985453604,0.7837837837837838,1.0,1.0,2/5,13.63%,PRELID1;ABCA3
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.3612222850221354,-0.724892816590041,0.8955223880597015,1.0,1.0,4/40,7.28%,CLDN5;CLDN16;CLDN20;RHOC
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.46784367098907453,0.7246004324086034,0.7551020408163265,1.0,1.0,1/5,4.39%,ST3GAL1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.3187268985681342,0.7245742604766848,0.8,1.0,1.0,5/27,14.51%,PHF1;EPC1;DNMT3A;DNMT1;RBBP4
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.40888189372391615,-0.7244283023852608,0.8939393939393939,1.0,1.0,3/15,16.51%,ZWILCH;SETMAR;PLK2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3303196325475215,0.7241734205155637,0.8387096774193549,1.0,1.0,10/57,20.09%,OAS3;USP36;PTBP1;RRP1B;AHNAK2;AFF2;RBM12B;HNRNPH1;CELF1;FASTK
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.43176843617474125,0.7241428054727886,0.8333333333333334,1.0,1.0,3/7,32.38%,PRKAA2;FNTA;TPPP
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.38256820600352326,-0.7240322768961407,0.835820895522388,1.0,1.0,2/27,8.80%,RAB11A;MVB12A
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.40681650304980455,-0.7238256679417918,0.859375,1.0,1.0,2/18,6.31%,IL26;CRLF3
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.4208059120671891,-0.7237484122740311,0.8450704225352113,1.0,1.0,3/12,13.39%,EPHB6;EPHB1;B4GALT6
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3959799867797556,-0.7233741090835653,0.8275862068965517,1.0,1.0,2/12,15.55%,LRRK2;GTPBP1
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.39272194077794537,-0.7229586594857954,0.7931034482758621,1.0,1.0,5/16,26.78%,EIF2B4;B4GALT6;EIF2B2;MYRF;CNTNAP1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.4263517380248475,-0.722472439667624,0.8392857142857143,1.0,1.0,4/9,27.85%,XBP1;HSPA5;CALR;HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.4506409739702532,-0.7224389343965139,0.7941176470588235,1.0,1.0,2/9,7.81%,B2M;ARG2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.4529793368258136,-0.7219583675071497,0.8148148148148148,1.0,1.0,1/5,18.00%,NOP9
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.4529793368258136,-0.7219583675071497,0.8148148148148148,1.0,1.0,1/5,18.00%,NOP9
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.4529793368258136,-0.7219583675071497,0.8148148148148148,1.0,1.0,1/5,18.00%,NOP9
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.39228925194498937,-0.7216457745800907,0.873015873015873,1.0,1.0,4/21,14.69%,MPP4;DLG4;TJP3;PCLO
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.30249340526925,0.7216203166296514,0.967741935483871,1.0,1.0,6/47,15.20%,PSME2;NQO1;PSMD13;BCKDK;PSME4;PSMF1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.38534087553593666,0.7213788239571618,0.7380952380952381,1.0,1.0,2/9,19.18%,KAT2A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.35365044787096384,0.7212668437362466,0.875,1.0,1.0,8/24,20.92%,FLNA;TPR;IPO5;HDAC3;DMAP1;RBM22;RAN;JUP
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.4585621824440402,-0.7210696335663399,0.8666666666666667,1.0,1.0,3/7,14.14%,FES;LYN;ADGRE2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.3727129969419079,0.7207700221109663,0.875,1.0,1.0,4/24,10.22%,MAPRE2;FKBP4;ABL1;SKA3
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.45651808891668927,-0.720673881837283,0.8727272727272727,1.0,1.0,2/10,11.39%,SYT1;CALM3
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.39245733518377063,0.7206037147426632,0.85,1.0,1.0,6/13,24.93%,BAG2;MELTF;ADAM8;PLGRKT;NLRC4;GSN
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.38057829784587305,0.7203586158527541,0.7941176470588235,1.0,1.0,4/22,9.10%,ATP6V0A4;ATP6V1G2;ATP6V1G1;RAB39A
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.4053108274737115,-0.720350118760632,0.8253968253968254,1.0,1.0,2/15,3.25%,MAOB;DUOX1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.38003149658235863,-0.7203017490536285,0.819672131147541,1.0,1.0,2/17,13.89%,LRRK2;ATCAY
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.4639349312779016,-0.7202458226363506,0.8253968253968254,1.0,1.0,2/6,21.44%,SLC25A19;ABCC5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.4074231290743516,0.7201447243218188,0.8857142857142857,1.0,1.0,1/17,0.32%,ICAM1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.4084381202730215,-0.7199222150919036,0.8333333333333334,1.0,1.0,6/13,25.25%,PAK3;EPHB1;DLG4;EPHB3;CTNND2;SHANK1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.3846638049725856,0.719745645107509,0.7878787878787878,1.0,1.0,3/26,2.79%,AGER;CD274;HMGB1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.3360487977860029,-0.7196463510220698,0.9,1.0,1.0,7/44,18.65%,RPA3;RFC3;RFC4;POLQ;WRN;LIG3;RPA2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.46071412775995274,0.7196426489226786,0.7714285714285715,1.0,1.0,2/5,22.42%,TRIP11;TBC1D23
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.3446426100424862,-0.7193434966175216,0.8461538461538461,1.0,1.0,3/26,9.30%,VAMP5;AMN;GOLGA4
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.4549549388573142,-0.7192368894886813,0.8208955223880597,1.0,1.0,1/8,11.62%,VEGFA
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.2816895902594102,0.7189040746963359,1.0,1.0,1.0,31/115,20.26%,B3GNT6;MOGS;SLC39A8;ST3GAL1;EOGT;DAD1;B3GALT4;POMK;GFPT2;GALNTL5;GALNT1;B3GALT9;DPM3;ALG1;TRAK1;TMEM165;ALG12;GFPT1;GALNT18;POGLUT1;PLOD3;ALG5;DPAGT1;RPN2;ALG3;ST8SIA1;B3GNT3;ST8SIA5;B4GALT1;POFUT1;ST3GAL4
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.3517988050081963,-0.7186103157084054,0.9344262295081968,1.0,1.0,3/30,4.92%,MCM2;DBF4;RPA3
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.3000712081130041,-0.7182250217083432,0.9315068493150684,1.0,1.0,17/167,17.15%,SRGN;CR1;DYNC2H1;LRRK2;GOLGA8B;GOLGB1;GOLGA8O;DOP1B;HOOK1;CAV3;DNM1;CAV2;SNX10;PI4K2A;ATP8B1;ATP8B4;TMED10
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.3533007139521686,0.7182157265103716,0.8636363636363636,1.0,1.0,4/26,12.00%,PRPF39;SF3A3;SNRPC;LUC7L
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.4233471087109045,-0.7181972324493291,0.8032786885245902,1.0,1.0,1/12,2.26%,CRYM
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.4233471087109045,-0.7181972324493291,0.8032786885245902,1.0,1.0,1/12,2.26%,CRYM
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.41176089162670887,0.7181221349692161,0.8157894736842105,1.0,1.0,4/8,28.49%,ARHGEF10L;ERLIN2;INSIG2;ERLIN1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.41176089162670887,0.7181221349692161,0.8157894736842105,1.0,1.0,4/8,28.49%,ARHGEF10L;ERLIN2;INSIG2;ERLIN1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.3412913754442146,-0.7178984900840453,0.8985507246376812,1.0,1.0,5/41,15.37%,PARP9;GRM5;CYFIP1;EIF2B4;RBM3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.3564654858094499,-0.7174622034622858,0.9206349206349206,1.0,1.0,9/33,19.81%,TLR2;F3;CHI3L1;NOD1;PRKD2;ZNF580;SYK;STAT3;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.32671162287013644,0.7170968671569429,0.8823529411764706,1.0,1.0,5/37,9.89%,DUSP1;SPRY2;SPRY3;DUSP7;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),0.4625208425623437,0.7163813456180559,0.7916666666666666,1.0,1.0,2/5,1.57%,TBXA2R;SPX
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.39330220033619623,-0.7161606058122664,0.8307692307692308,1.0,1.0,7/21,20.79%,TTN;SLC8A1;SCN4B;SCN1B;KCNH2;TPM1;SCN3B
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.40714661994763546,0.716028094893628,0.7435897435897436,1.0,1.0,1/7,9.09%,TRNAU1AP
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.40714661994763546,0.716028094893628,0.7435897435897436,1.0,1.0,1/7,9.09%,TRNAU1AP
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.34677774474741424,-0.7158653486910268,0.8767123287671232,1.0,1.0,5/42,10.38%,ISG15;RPA3;RFC3;RFC4;TRIM25
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.47477554564758384,-0.7156079421101004,0.8571428571428571,1.0,1.0,1/5,14.64%,GNB3
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.3879572333630698,0.7154679867312396,0.7692307692307693,1.0,1.0,8/18,27.88%,PTPRD;IL1RAPL1;RELN;CUL7;CUX1;OBSL1;SS18L1;CAPRIN1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.32046760756706827,-0.7153603009507884,0.927536231884058,1.0,1.0,3/66,6.13%,KDM4D;FIGNL1;RAD9A
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3579533893411236,0.7143133334416899,0.9,1.0,1.0,11/29,22.29%,TESK1;CRK;FLNA;ABL1;MYADM;CASS4;CDC42;ARHGEF7;RAC1;FERMT2;CIB1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.47662793244646895,-0.714300925528351,0.8333333333333334,1.0,1.0,2/6,28.24%,TGFB1;EID2
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.37262660571140344,0.7141146630684595,0.7708333333333334,1.0,1.0,2/14,9.42%,NEU4;GLA
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.30808533501223545,-0.7139345996336846,0.9411764705882353,1.0,1.0,12/116,12.42%,SFRP4;LRIG3;PPP1R3C;CITED4;FKBP5;DDAH1;KIAA1217;FNDC4;CPE;ADGRL2;GPC6;EGFR
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.39427597706230655,0.7137881733494008,0.8181818181818182,1.0,1.0,5/16,20.27%,GRPEL2;TIMM23;GRPEL1;TOMM40L;TIMM17A
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.27907332070870994,0.7135442649860806,0.96875,1.0,1.0,37/111,26.87%,BET1;FHDC1;USP6NL;GBF1;OPTN;STX6;TMED5;VAMP4;LMAN1;TRAPPC12;SEC22B;TRIP11;ZFP69B;CUL7;BLZF1;GOLGA8M;NSFL1C;CDC42;ARHGEF7;SEC23IP;COG2;GCC2;FAM174B;ARFGEF1;PLK5;VTI1A;UBXN2A;UBXN2B;GOLGA8H;OBSL1;PDCD10;TRAPPC8;TJAP1;PRMT5;DYM;SPTBN5;TMED3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.4120214613200017,-0.7134873182590293,0.8333333333333334,1.0,1.0,1/14,0.26%,ANGPT1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.314547514613369,0.7133795745785805,0.90625,1.0,1.0,6/27,12.48%,PTBP1;PTPA;SYMPK;ITGA1;MAGI2;CAMTA1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.382780314530936,-0.7132271722443833,0.875,1.0,1.0,4/20,13.95%,SYT4;SYT1;SYT12;SYT13
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.4631502468173499,-0.7132143438740003,0.8305084745762712,1.0,1.0,1/7,1.28%,H2BC11
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.4164069290260989,0.7130601470021436,0.8461538461538461,1.0,1.0,3/10,12.79%,MST1;WNT4;BCKDK
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.28668174806897145,0.713045785082392,0.9523809523809523,1.0,1.0,15/139,11.89%,PASK;MYO3A;FGFR1;ALK;EPHB4;IGF1R;PIM3;STK16;OXSR1;ABL1;GRK5;FGFR3;ACVR1B;TNK1;RIOK2
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.32310589931412215,-0.7127647919731033,0.9411764705882353,1.0,1.0,6/63,14.09%,RFTN1;RAB11A;ZDHHC15;AQP11;EGFR;COX18
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.39458764610338226,0.7126165999198819,0.7647058823529411,1.0,1.0,3/8,22.28%,CDC42EP5;CDC42;CDC42EP1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.39458764610338226,0.7126165999198819,0.7647058823529411,1.0,1.0,3/8,22.28%,CDC42EP5;CDC42;CDC42EP1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.4368817593369258,0.7123645503914778,0.782608695652174,1.0,1.0,5/9,35.49%,ERLEC1;UBE2G2;YOD1;DERL3;OS9
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.3021471458052904,0.7121829830522323,0.9310344827586207,1.0,1.0,8/71,10.27%,LCK;SLC39A8;COX19;HMOX2;SLC31A2;TF;ATP6V1G1;CYBRD1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.41994156364171653,-0.7120159611664175,0.8360655737704918,1.0,1.0,3/11,19.44%,AR;NR3C2;ESR1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.32678424540204076,0.711932851163674,0.8709677419354839,1.0,1.0,5/46,6.61%,MSRB1;PRSS57;TOR2A;GFI1B;NOSIP
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3768486968491823,-0.7118707312745965,0.8714285714285714,1.0,1.0,3/17,9.69%,GMFG;FCHSD2;CYFIP1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.294380078832375,-0.7116636437928295,0.9850746268656716,1.0,1.0,24/132,22.12%,PTPRM;PTPRC;HDHD2;PLPPR5;PTPRG;PLPPR3;SGPP2;PTPRB;PTPRR;PP2D1;PTPRT;PTPRZ1;PTPN13;PTPRJ;PPP3CA;PLPPR1;PTPN5;PLPP6;PPEF1;PPP1CA;ALPL;PLPPR4;DUSP26;TPTE2
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.44422286786860093,0.7116251493090834,0.75,1.0,1.0,1/6,3.06%,DPH1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.44422286786860093,0.7116251493090834,0.75,1.0,1.0,1/6,3.06%,DPH1
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.4502489404456289,-0.7115002854481295,0.8076923076923077,1.0,1.0,1/5,17.24%,PSMC3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.3089038509876111,0.7114242599036411,0.9285714285714286,1.0,1.0,9/54,12.16%,ZAP70;LCK;FGFR1;EPHB2;IGF1R;ABL1;FGFR3;PRLR;RELN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.4189121338912134,0.7112426985776089,0.8,1.0,1.0,8/8,58.13%,VDAC2;BNIP3L;STPG1;RHOT2;BLOC1S2;ATF2;BNIP3;RHOT1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.38133039316144013,0.7105372082367207,0.8125,1.0,1.0,1/10,3.66%,HDAC10
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.4171266209239356,0.7101596327716743,0.7441860465116279,1.0,1.0,2/7,7.41%,ATF4;ABL1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.4171266209239356,0.7101596327716743,0.7441860465116279,1.0,1.0,2/7,7.41%,ATF4;ABL1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.38950165783573415,0.7100113787138518,0.8717948717948718,1.0,1.0,1/11,2.66%,MALT1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.29868751603013277,0.7099804361419597,0.9705882352941176,1.0,1.0,7/86,4.56%,AGER;SERPINF2;HMGB1;SH3RF2;MFHAS1;DUSP15;IGF1R
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.3230015875572053,-0.7099213728995946,0.9047619047619048,1.0,1.0,14/80,22.10%,CLU;GPIHBP1;PRICKLE1;NUP62CL;E2F3;ABCD2;SYK;STAT3;NUP88;SNX33;HEATR3;NUP50;ALDH3A2;SPRN
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.3906251571548505,0.7098095795516884,0.8333333333333334,1.0,1.0,9/16,24.22%,PDZD11;PLEKHA7;TPR;AHCTF1;NDC1;RTN4;P2RX7;AFDN;BAD
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.39771617196451037,-0.7096344505488937,0.8484848484848485,1.0,1.0,4/14,10.76%,SLC1A1;SLC23A1;BEST1;ABCB1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.3494437987988883,0.7096313522576085,0.7804878048780488,1.0,1.0,7/40,12.71%,GRPEL2;SEC61A2;TIMM23;AKT2;GRPEL1;PEX6;PEX2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.3051784217928666,0.7095639455454004,0.9615384615384616,1.0,1.0,4/47,3.99%,ZAP70;LCK;FGFR1;EPHB2
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.3966523933345683,-0.7094919768868918,0.828125,1.0,1.0,3/14,14.33%,AR;ATP1A1;TRERF1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.3809550264216592,0.7093248379128394,0.84375,1.0,1.0,6/14,14.46%,F2;EPHB2;SERPINE1;TFPI;KNG1;GP1BA
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.4772827692238164,-0.709063759346255,0.8166666666666667,1.0,1.0,2/5,30.68%,BAG3;MAPT
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3323590841199131,0.7088129555397465,0.8857142857142857,1.0,1.0,2/24,2.86%,POLD3;UBC
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.3515044707036353,0.7087557227678084,0.8,1.0,1.0,4/23,9.79%,EPHB2;IGF1R;MTMR2;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.323827004102783,-0.7087406844104683,0.9264705882352942,1.0,1.0,5/52,16.95%,RFC3;HGF;RFC4;PRKD2;PRKCQ
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.36256281904068993,0.7085699056154331,0.9047619047619048,1.0,1.0,7/28,21.52%,RNF128;GGA3;LAMTOR4;ZFYVE16;RTN4;RAB7A;GCC2
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.38633515418023123,0.7084782291537853,0.8333333333333334,1.0,1.0,5/18,15.09%,ATP6V0A4;SLC12A9;SCNN1B;SLC12A4;SLC12A2
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.43727776123455253,-0.7084221325819292,0.8571428571428571,1.0,1.0,5/10,27.68%,BRCA1;MACROH2A2;MACROH2A1;LRIF1;METTL3
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.38644244419434226,0.7083811027466089,0.8333333333333334,1.0,1.0,1/14,4.26%,CROT
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.3239139656219817,-0.7082736593947694,0.961038961038961,1.0,1.0,20/72,20.25%,SHMT2;CRYM;BCAT2;NOS1;DDAH1;ACMSD;DDO;SDS;AMDHD1;FTCD;HNMT;CBS;SLC25A21;ABAT;KYNU;GAD1;KMO;MCCC1;ALDH5A1;AASS
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.4434771259935403,-0.707663182272588,0.8305084745762712,1.0,1.0,2/7,16.12%,CBS;MTHFD1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.2727909314961259,0.7076055742115173,0.967741935483871,1.0,1.0,26/115,22.17%,DICER1;M1AP;PRPF4;PTBP1;POLR2K;DKC1;FASTKD1;MPHOSPH10;HNRNPU;PNPT1;POLR2L;WDR74;PPP1R8;DDX3X;HNRNPH1;EXOSC7;DHX9;PAPOLG;HNRNPA2B1;RBM5;WTAP;HNRNPC;HNRNPM;POLR2E;HNRNPR;POLR2D
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.38462394286141005,0.7073346943086446,0.868421052631579,1.0,1.0,1/13,0.98%,TRMT10C
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.28195305484764954,-0.7071731676372325,1.0,1.0,1.0,21/230,14.07%,F8;VIL1;TNFRSF1A;CD59;RIMS1;LAMC1;NCKAP1L;SOX9;ANO6;LRRK2;LIN7A;ADD2;ADCY8;AMER1;GRIA1;DLG4;FERMT3;NOL3;RAB1B;TGFA;MCFD2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.3224023322919422,0.7070314062064713,0.9354838709677419,1.0,1.0,4/28,15.25%,SLC27A6;HACD1;PEX2;ACOX1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.44448410042797337,0.7069859572154279,0.8125,1.0,1.0,3/8,28.33%,ERN1;MAP2K2;DYRK1A
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.3223472739967445,0.7068971634500675,0.9210526315789473,1.0,1.0,5/37,14.75%,RAB27A;WASHC4;RILP;WASHC5;SNX3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3109248084234868,-0.7063656923811429,1.0,1.0,1.0,7/81,13.75%,FBXL16;PSMB8;FBXL13;FBXL18;FBXO17;FBXL5;CCNF
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.4104571371230365,-0.7057772752384418,0.7910447761194029,1.0,1.0,3/10,27.59%,TYMP;DCK;PUDP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.4104571371230365,-0.7057772752384418,0.7910447761194029,1.0,1.0,3/10,27.59%,TYMP;DCK;PUDP
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.4065471558238627,0.7049242048693793,0.851063829787234,1.0,1.0,1/8,2.46%,PYCR1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3631871951955498,0.7048537703953965,0.9411764705882353,1.0,1.0,4/16,18.53%,ALG1;ALG12;DPAGT1;ALG3
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.44496641391907565,-0.704608309565417,0.8928571428571429,1.0,1.0,1/8,16.05%,ABCD2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.44923528697783704,-0.7045678548498425,0.859375,1.0,1.0,2/7,14.14%,FERMT3;SKAP1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.31575203252087963,0.7045195786079633,0.8333333333333334,1.0,1.0,12/57,16.25%,NOC2L;ACTR5;BAK1;ATF4;TMEM161A;YY1;SDE2;CASP9;ZBTB1;ATR;MME;NPM1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.3782208865444352,-0.7044108775643666,0.8235294117647058,1.0,1.0,3/23,15.68%,ID2;SPI1;CDKN1A
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.2834159947314281,0.704307182007762,1.0,1.0,1.0,12/76,14.02%,DMAC2;SMIM20;COX19;NDUFV3;LYRM7;SLC25A33;FASTKD3;SAMM50;UQCRFS1;NDUFAF7;SDHAF1;FOXRED1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.29923639802989993,0.7042665175306257,0.9696969696969697,1.0,1.0,3/74,2.86%,GPC4;WNT9A;UBC
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.31772485045667315,0.7042335338736884,0.9333333333333333,1.0,1.0,6/59,9.69%,RFWD3;CARM1;CRADD;SDE2;E2F4;PIDD1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.42400623950151,0.7042163982855031,0.7692307692307693,1.0,1.0,3/8,16.48%,DPH1;CPEB2;DPH3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.35890161594206155,0.7040406053284431,0.9354838709677419,1.0,1.0,1/20,0.94%,F2
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.37230495248302714,-0.703932364631703,0.8888888888888888,1.0,1.0,2/21,4.73%,TEX15;FOS
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.4358885115651937,0.703619117189748,0.825,1.0,1.0,2/5,33.22%,EPHX2;ACAA1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.32978138237617177,-0.7033460779079893,0.9264705882352942,1.0,1.0,9/38,22.74%,AQP1;E2F1;TRIM32;DDR2;AGT;CDKN1A;GAS6;PARP10;WNT5A
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.37584336066861507,-0.70301640307839,0.8615384615384616,1.0,1.0,3/15,17.11%,TGFBR2;TGFB1;GRAMD1C
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.36233643890624345,-0.7028418729736491,0.9393939393939394,1.0,1.0,3/27,16.47%,CEACAM1;HSD17B13;PRKAB2
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.4143092812564506,0.7022182191180276,0.8378378378378378,1.0,1.0,2/8,11.15%,HMGCR;IDI1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.30369495115808814,0.7022047134058902,0.9285714285714286,1.0,1.0,3/36,7.65%,KIF3B;PCM1;DYNLRB1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.40536501675634706,0.7021801020825414,0.7631578947368421,1.0,1.0,2/15,11.92%,TENT4A;TENT4B
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.33496435291696036,0.7020435486558716,0.8055555555555556,1.0,1.0,3/19,13.74%,TNKS2;PKIB;MAP2K7
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.3420411737780366,0.7018270303124979,0.975,1.0,1.0,3/13,17.28%,CHUK;DDX3X;DHX9
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.45379602620766657,-0.7017305709765844,0.8571428571428571,1.0,1.0,2/6,16.77%,ATP6AP2;TMEM9
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.41109921410110056,-0.7017168917574107,0.8548387096774194,1.0,1.0,3/7,28.67%,GLYCTK;ALDOB;TPI1
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.42950021926306226,0.7016748297908906,0.8863636363636364,1.0,1.0,2/6,17.85%,CAT;ERCC2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.48408355720278684,-0.7013915480841212,0.8301886792452831,1.0,1.0,1/6,6.18%,RYR3
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.30399929373285733,-0.7013590162595218,0.9722222222222222,1.0,1.0,10/76,21.55%,ISG15;IRF1;POLR3H;TRIM25;TRIM32;NLRC5;TIRAP;MRE11;PQBP1;PIN1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.4430198418261637,-0.7012001160581595,0.8823529411764706,1.0,1.0,2/9,16.47%,SLC25A20;PRKAB2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.33626073180591537,0.6998322682670026,0.8611111111111112,1.0,1.0,2/25,6.91%,CYB5A;UBE2J2
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.33064598068225526,-0.6998145173710497,0.9142857142857143,1.0,1.0,11/54,23.35%,TGFBR2;HIPK4;LRRK2;CDK5R1;PRKD2;MAP3K12;CIT;CDK5;HIPK3;DYRK2;PRKCD
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.3981937675189565,0.6997495320776379,0.7692307692307693,1.0,1.0,4/12,22.70%,NAA50;NAA40;NAA11;NAA20
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.3837963329997688,0.6997233827122483,0.8571428571428571,1.0,1.0,4/10,21.41%,KLRD1;JAG1;CD55;BTN3A2
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.4388340625115406,-0.6997082017230665,0.8653846153846154,1.0,1.0,1/5,17.49%,MOCS3
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.3935943228629829,0.6980355787878568,0.8409090909090909,1.0,1.0,1/12,3.39%,SCRIB
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.3868457145436179,-0.6979532429773182,0.828125,1.0,1.0,4/15,24.95%,TGFB1;GAS6;ZFP36L1;TYRO3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.32619831620300316,-0.6979351616195663,0.9577464788732394,1.0,1.0,10/53,22.60%,FIGNL1;FIGN;RAB11A;HOOK1;TRPV4;CAMSAP3;CEP126;TUBGCP2;LIMK2;VPS4B
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.3074401045506921,-0.697794032987333,0.9491525423728814,1.0,1.0,15/103,10.98%,SLC2A12;DNALI1;SOX9;CADPS2;DDAH1;AQP1;KIAA1217;FNDC4;SLC4A10;HTR2C;PCDHB4;CPE;SLC44A3;ADGRL2;GPC6
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4005129893383167,0.6976294496551193,0.8378378378378378,1.0,1.0,2/9,6.18%,NOS1AP;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.4079448166003177,-0.6975530899730297,0.8507462686567164,1.0,1.0,2/14,12.23%,LAPTM5;FGL1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.4403880159614601,-0.6974060593635444,0.8269230769230769,1.0,1.0,4/6,17.41%,NR4A3;SGPP2;NR1D1;PTPRN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.42689734058018525,0.6973797136446418,0.825,1.0,1.0,5/10,15.39%,ACTN2;TAX1BP3;COMMD1;GOPC;GPM6B
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.2676172680773683,0.6968306708668428,1.0,1.0,1.0,12/92,11.91%,VCPKMT;RAE1;HDAC10;NUP42;RNF113A;ATPSCKMT;NUP210;HDAC9;P3H3;KIAA1586;ZNF451;TPR
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.4008431559708665,-0.6966262878739998,0.8888888888888888,1.0,1.0,3/16,5.39%,IL12A;LGALS3;ANO6
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3642144377586355,-0.6965626273787333,0.8115942028985508,1.0,1.0,2/20,11.62%,XBP1;VEGFA
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.305119618539074,0.6964898471942851,0.9375,1.0,1.0,7/61,9.56%,TRMT1;METTL2A;ANKRD16;PUS7;NSUN2;TRMT13;PUS1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.3394182495849756,-0.695961415788801,0.8813559322033898,1.0,1.0,10/39,21.59%,EDN1;CAV2;TGFA;DAPK3;TOM1L1;BORA;KIF20B;PDGFRB;PIN1;AURKA
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.43317339080877915,0.6956746762238981,0.8809523809523809,1.0,1.0,1/5,11.65%,MAPK8
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.252645876451096,0.6956656056540784,1.0,1.0,1.0,36/308,14.08%,BCL2A1;CHRNA4;ZDHHC16;RFWD3;MACROD2;ENDOV;UBE2A;MGMT;CGAS;RNF168;BAK1;H2AX;PARP3;ABL1;YY1;PHF1;RBBP6;SMC6;KIN;PIDD1;CASP9;RAD52;SLF2;ASH2L;ZBTB1;CHCHD6;ADPRS;HERC2;CBX5;RNF8;PSME4;POLH;NABP1;POLI;CDKN2AIP;KMT5B
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.4333494083467503,-0.6956108750752374,0.8,1.0,1.0,3/7,26.78%,B4GALT6;MYRF;CNTNAP1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.4036561504967997,-0.6955824457845532,0.8208955223880597,1.0,1.0,4/10,20.59%,SLC25A19;TYMP;CTPS2;DCK
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.37441984060391786,-0.6955067879167182,0.875,1.0,1.0,5/22,20.39%,HGF;PRKD2;CDKN1A;TOM1L1;PDGFRB
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.32405613352054646,-0.6952881844104793,0.9523809523809523,1.0,1.0,4/38,13.92%,GRHL1;HLA-DRB1;FGF7;OVOL2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.4394087709214204,0.6951728780758405,0.8333333333333334,1.0,1.0,4/6,32.79%,ZBTB7A;LIG4;ERCC6;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.42404319193922835,-0.6951052680453055,0.890625,1.0,1.0,2/9,15.46%,LRCH1;CD200
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.4740659948718664,-0.6950530050829351,0.8070175438596491,1.0,1.0,3/5,44.95%,PISD;BNIP3;YME1L1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.4077234949132956,0.6950324952387217,0.85,1.0,1.0,2/7,18.44%,GLI2;MEN1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.35490818934426677,0.6949690192800664,0.8181818181818182,1.0,1.0,5/19,25.59%,PTBP1;CAMTA1;CIB1;AKAP6;PLCG2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.36172542800798485,0.6947822756869473,0.8157894736842105,1.0,1.0,5/19,22.46%,AUP1;UGGT1;TOR1A;DNAJC18;RNF126
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.2857834866821153,0.694089096117014,0.918918918918919,1.0,1.0,4/49,7.39%,B3GNT6;NEU4;GANC;TNIP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.2849649182077726,-0.6939518960925085,1.0,1.0,1.0,36/160,24.88%,PDE10A;BCL2L2;NLRP12;NLRP3;WTIP;DDIT4;DGKD;PDE3B;IFI35;LYN;NMI;CAV3;CAV1;ARHGAP25;SPI1;STAT1;NR1D1;TNFAIP8L1;PDE11A;PIK3CB;PTPRJ;CIT;RHOH;ESR1;PER1;MGRN1;PRDM15;TLE1;SHANK2;UBE2B;ARHGAP12;PHLPP2;ITPR1;PDE2A;TBC1D7;CDC34
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.3289600537214907,0.6935492740014366,0.868421052631579,1.0,1.0,1/23,0.94%,F2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.3554618910961832,0.6934331149144178,0.8709677419354839,1.0,1.0,10/36,20.24%,SNRPC;GEMIN6;SNUPN;STRAP;COIL;GEMIN5;SMN1;WDR77;SNRPB;TGS1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.3614189034866174,0.6933366253229855,0.8333333333333334,1.0,1.0,3/25,12.71%,GDAP1;PEX6;PEX2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.41739747362757174,-0.6933309204415168,0.890625,1.0,1.0,4/10,25.25%,TPP1;NRXN1;UBA5;SHANK1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.34964936286548803,0.6928395426883942,0.8648648648648649,1.0,1.0,7/20,15.92%,CCR3;GNLY;VEZF1;BECN1;LGALS3BP;RELA;RAB23
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.39930388144345197,-0.6928013119928565,0.8461538461538461,1.0,1.0,2/18,15.65%,TERF2IP;SETMAR
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.39723177780353225,0.6924657606227834,0.8857142857142857,1.0,1.0,4/11,22.61%,VAPB;STX18;RTN4;BNIP1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.2912370383072479,0.6923334980546627,0.9333333333333333,1.0,1.0,3/44,8.32%,PSME2;NQO1;PSMD13
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.4062075410346434,-0.6923230757169261,0.8688524590163934,1.0,1.0,4/12,30.02%,LIG3;DONSON;TIMELESS;ZRANB3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.46769154192028567,0.6922882170006049,0.8,1.0,1.0,1/5,10.69%,GREM1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.42790364785502655,-0.692085329872794,0.8448275862068966,1.0,1.0,2/10,23.63%,ROMO1;AGK
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.45933705271525116,-0.6920114482482612,0.8518518518518519,1.0,1.0,2/6,22.77%,SPI1;TNFRSF10B
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.43767223964068547,-0.6919867868151178,0.9016393442622951,1.0,1.0,4/8,29.09%,STEAP4;SLC1A2;DISP1;MLKL
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.43767223964068547,-0.6919867868151178,0.9016393442622951,1.0,1.0,4/8,29.09%,STEAP4;SLC1A2;DISP1;MLKL
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.27286839214459807,0.6916191382043235,1.0,1.0,1.0,10/55,19.31%,PSME2;PINX1;PSMD13;ZFYVE19;PSME4;NABP1;PSMF1;FBXL7;PSMD11;PSMD4
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.3832185758693213,0.6910837376930106,0.7428571428571429,1.0,1.0,3/14,3.95%,F2;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.31890270669384,0.6910360152987691,0.8620689655172413,1.0,1.0,5/30,12.38%,PPP1R1B;PTPA;ITGA1;STYXL1;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.44601694840475004,0.6910308022061271,0.8048780487804879,1.0,1.0,1/6,6.08%,PAX8
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.31664662169820035,-0.6909686394669958,0.9444444444444444,1.0,1.0,9/60,18.68%,TGFBR2;HIPK4;LRRK2;CDK5R1;PRKD2;MAP3K12;CIT;CDK5;GALNTL6
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.38003598586160897,-0.6909182325945358,0.8805970149253731,1.0,1.0,2/17,9.01%,ASAH2B;SGPP2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.37333301881761216,-0.6908606716002532,0.8767123287671232,1.0,1.0,2/27,5.26%,CLU;HGF
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.33583453038313127,-0.690834065015375,0.9393939393939394,1.0,1.0,9/38,18.35%,CLU;EDN1;EDNRB;EGFR;AZIN1;ITGAV;MAD2L1;MAD2L2;PRKCG
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.3619017317561718,0.6907976160236474,0.90625,1.0,1.0,4/23,12.59%,UBC;UBB;UGGT1;AMFR
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.3614925759865443,-0.6906838034581305,0.9,1.0,1.0,10/21,33.09%,CAMK1;CAMK2B;NEURL1;SHANK1;LRP8;DHX36;FMR1;APOE;DBNL;CUX2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.37294455883600747,0.6904955217804001,0.8484848484848485,1.0,1.0,1/7,9.02%,AKT2
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.40213597430778264,-0.690492812895074,0.8769230769230769,1.0,1.0,5/16,17.99%,TTN;SYNPO2L;FHOD3;MYLK3;TPM1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.28512505265958726,0.690455598347123,0.9565217391304348,1.0,1.0,7/59,12.88%,PSME2;RUNX1;PUS7;ABL1;PSMD13;ITCH;PSME4
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.292409474804131,0.6898227079199032,1.0,1.0,1.0,11/88,13.20%,TUBA1A;FBF1;PCM1;MKS1;TCTN3;CEP290;CEP164;TUBG1;HAUS5;PLK4;TMEM216
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.4493617297152513,0.6898069496864708,0.8571428571428571,1.0,1.0,1/6,4.09%,NOC2L
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.44093372980827666,-0.6896137102419657,0.92,1.0,1.0,2/8,22.68%,IFNA2;PRKCZ
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.36649259766044634,0.689472447310113,0.8787878787878788,1.0,1.0,1/13,1.95%,NT5E
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.40719960039237346,0.6891288051235436,0.75,1.0,1.0,2/5,13.22%,YY1;POLH
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.3998084044932616,-0.6890843051732088,0.8305084745762712,1.0,1.0,3/9,26.45%,ATP8B1;SHROOM2;MAL
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.2935341115182504,-0.6890630641324187,0.9583333333333334,1.0,1.0,19/104,23.64%,SFRP4;PRICKLE1;PLCB3;PSMB8;PLCB1;FZD8;GNG2;PARD6A;DAAM1;MOV10;PPP3CA;PSMC3;PRICKLE2;FZD3;PSME1;FZD9;WNT5A;PSMC5;PSMA3
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.37866613695444473,0.6890205491335949,0.775,1.0,1.0,2/16,10.34%,MEIS1;CDK6
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4008968531691951,-0.6889891502457783,0.9047619047619048,1.0,1.0,4/14,12.03%,HECW1;PLN;CAV3;NEDD4L
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3262565585420884,-0.6884660554374973,0.9384615384615385,1.0,1.0,9/42,22.98%,FBLN1;CARMIL1;RAC3;EFNA5;DMTN;NEDD9;RREB1;CSPG5;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.39217923618638184,0.6883244509474918,0.8461538461538461,1.0,1.0,2/9,4.97%,CASQ2;ACTN2
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.43605201159586304,-0.6877643286594001,0.8275862068965517,1.0,1.0,3/8,30.02%,DONSON;TIMELESS;ZRANB3
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.331500369146044,0.6876790961926746,0.8857142857142857,1.0,1.0,4/22,12.48%,PTBP1;PTPA;SYMPK;CAMTA1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.28201702237795323,0.6876085159270487,1.0,1.0,1.0,9/79,9.79%,CCR3;ECM1;SEMA5A;GAB1;RUNX1;HMGA2;PTGIS;SERPINE1;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.3334118103529764,0.6873035680624969,0.9285714285714286,1.0,1.0,10/36,15.96%,EPHB2;NLGN3;ZNF335;GRID2;PTPRD;IL1RAPL1;SLITRK2;NLGN2;MME;FAIM
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.3064317634873935,-0.6870330625557421,0.9552238805970149,1.0,1.0,15/52,21.05%,PTPRC;MEF2C;BLNK;CR2;IFNA2;GPR183;IFNA6;IFNK;LAT2;NHEJ1;PTPRJ;RASGRP1;KLF6;TPD52;GPS2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.36510860006589874,-0.6869808705443162,0.9365079365079365,1.0,1.0,3/23,10.00%,ID2;FES;HLA-DRB1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.31969320926578776,-0.6865951583013198,0.9411764705882353,1.0,1.0,5/44,10.38%,ISG15;RPA3;RFC3;RFC4;TRIM25
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.40914099503659984,0.6863429295364071,0.8125,1.0,1.0,2/7,15.77%,PTPN22;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.4653152820362669,-0.6863333458324777,0.8484848484848485,1.0,1.0,1/5,7.12%,B2M
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.32506510024606117,0.6860459399404794,0.9393939393939394,1.0,1.0,8/44,14.29%,EPB41L4B;MYOF;PDGFA;DST;CORO1B;AHNAK2;MACF1;MIA3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.3949382625601081,0.6860172358731055,0.75,1.0,1.0,2/7,11.91%,NDC80;TPR
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.3949382625601081,0.6860172358731055,0.75,1.0,1.0,2/7,11.91%,NDC80;TPR
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3336631507877122,-0.6858271350715752,0.8923076923076924,1.0,1.0,11/47,20.82%,RAB3C;OLFM2;RAB3A;RIMS2;SCG2;RAB15;TVP23A;PTPRN;ABCA1;NAGPA;WLS
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.3732424724931531,0.6857078297907263,0.85,1.0,1.0,2/19,13.00%,KANSL2;JADE3
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.39960728130389883,0.6855363000187403,0.7894736842105263,1.0,1.0,3/8,25.04%,YY1;PTPRS;SIRPA
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.405153088541907,0.6855190519307934,0.8431372549019608,1.0,1.0,1/6,24.89%,NSUN5
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.32925517291018724,-0.6854991475310914,0.8783783783783784,1.0,1.0,11/61,15.61%,PARP9;PDZK1;DTX3L;WWTR1;STX3;TMEM35A;GTSE1;TGFB1;PARD6A;CENPQ;NGFR
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.3759721150415144,0.6854578167860905,0.8055555555555556,1.0,1.0,1/18,5.85%,COX10
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.44566312779784256,0.6852146839582596,0.8222222222222222,1.0,1.0,1/5,17.82%,SLC35B3
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.44566312779784256,0.6852146839582596,0.8222222222222222,1.0,1.0,1/5,17.82%,SLC35B3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3699848255872824,0.685067304503958,0.9142857142857143,1.0,1.0,6/17,21.86%,ERRFI1;VPS25;SOCS4;CBLB;APP;FBXW7
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.3751791452126207,0.6848815226945101,0.8571428571428571,1.0,1.0,1/13,4.73%,RASGRF1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.4360499089793425,0.6847900309423233,0.8085106382978723,1.0,1.0,1/5,19.18%,SIRT1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.4176351609774671,-0.6845885448558223,0.8181818181818182,1.0,1.0,2/9,18.82%,BTD;MCCC1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.30598822840808404,0.6845726688142799,0.9722222222222222,1.0,1.0,6/46,13.71%,KANSL2;EPC1;TRIM16;BEND3;JADE3;TADA3
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.4129117607255377,-0.6843825030659038,0.8813559322033898,1.0,1.0,1/9,1.52%,SHMT2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.34173235178014577,0.6842752495552141,0.925,1.0,1.0,3/12,16.50%,HDAC1;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.2591380884805009,-0.684218953572298,1.0,1.0,1.0,43/348,16.54%,IGFBP3;TGFB2;PAK5;GMFG;TGFBR2;PRKAR1B;PIM1;MAP3K21;GNPTAB;MAP3K5;DCLK1;PEAK3;BMX;LRRK2;TSSK3;HUNK;DGKD;STK17B;PAK3;PRKG1;DGKB;COQ8B;LYN;CAMK1;DAPK1;HTR2B;TNK2;BMPR1B;PRKD2;STK17A;MYLK3;PGK1;GRK6;DAPK3;CDKL4;TGFB1;PRAG1;CAMK2B;SYK;GLYCTK;MAP3K12;PLK2;PIK3CB
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.2687946163425894,0.6842116967987673,1.0,1.0,1.0,30/167,19.54%,TUBA1A;PSME2;UBC;CDC26;TPX2;PCM1;KNTC1;PSMD13;CEP290;CEP164;ANAPC15;TUBG1;UBB;HAUS5;RIOK2;ANLN;PLK4;PSME4;PSMF1;ANAPC1;TUBB4A;HMMR;AKAP9;ALMS1;ERCC2;PSMD11;CDC23;DYNLL1;PSMD4;BTRC
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.40194432437380506,0.6841731448515729,0.8421052631578947,1.0,1.0,4/7,19.17%,DCP1A;DCP1B;PATL1;DCPS
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.30736487884830577,0.6836165723301156,0.8918918918918919,1.0,1.0,6/35,12.62%,SERPINF2;TESK1;ABL1;ARHGEF10L;LIMK1;PPM1F
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.3455972319313767,0.6833118817516752,0.9285714285714286,1.0,1.0,4/22,12.22%,IFI27;ANP32B;TPR;SP100
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.466609346337868,-0.6832342876336648,0.8545454545454545,1.0,1.0,1/5,8.48%,XBP1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.29576220623452826,0.6832090765903426,0.8974358974358975,1.0,1.0,14/36,21.40%,EPC1;UXT;RYBP;RNF2;MGA;CBX5;RBBP4;TFDP1;E2F6;PHC1;EHMT1;BMI1;YAF2;RAD51
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.289410101543602,0.6830569761940647,0.96875,1.0,1.0,7/46,12.33%,POLD3;CTC1;PARP3;SMC6;DCLRE1B;SP100;LTO1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.4037799658500891,0.6823388457560798,0.7619047619047619,1.0,1.0,4/8,20.55%,IL1RAPL1;STXBP6;SNCA;RAB7A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.3753093511699165,-0.682201495877711,0.9016393442622951,1.0,1.0,4/14,15.10%,SCN4B;SCN1B;CAV3;KCNH2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.37951943138534283,0.681801530250195,0.9230769230769231,1.0,1.0,1/12,3.39%,SCRIB
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.30936215245655235,0.6814046866262516,0.9615384615384616,1.0,1.0,4/30,11.12%,SEMA5A;NLGN3;CPNE1;NRP2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.42490556368685617,0.6812450323272151,0.7368421052631579,1.0,1.0,3/5,35.68%,TMEM39A;CLEC16A;PHF23
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.3001594256113505,0.6812395576692322,0.9230769230769231,1.0,1.0,8/35,15.57%,UBC;UBB;MAP4K2;MAPK8;UBE2N;MAP3K7;MAP2K7;IRAK2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.348097252537682,0.6808894926846605,0.825,1.0,1.0,2/18,5.75%,CASQ2;CLIC2
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.41768902606715885,0.6797761729267682,0.8604651162790697,1.0,1.0,5/10,35.49%,ERLEC1;UBE2G2;YOD1;DERL3;OS9
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.44388749538227457,-0.6796481337581936,0.8,1.0,1.0,1/5,18.59%,CDK5
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.3922138597785064,0.6795785147812156,0.8611111111111112,1.0,1.0,3/7,28.23%,CDC42;PDCD10;ARHGAP21
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.35668284756582114,-0.6791892946734341,0.873015873015873,1.0,1.0,3/21,15.07%,KIF16B;MVB12A;TGFB1
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.42285151373250734,-0.6787388499105815,0.8307692307692308,1.0,1.0,2/7,26.34%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.43823437392218356,-0.6778778182096928,0.8666666666666667,1.0,1.0,3/5,37.99%,LEO1;PAF1;RTF1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.35035110762046595,0.6776044360175871,0.8947368421052632,1.0,1.0,4/24,17.29%,OSBPL7;CYP7B1;HSD3B7;HSD17B10
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.3048040891348986,0.6772325288290735,0.9705882352941176,1.0,1.0,3/33,13.50%,ATG9A;CTSK;BECN1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.42957312994593655,0.676754762270515,0.8235294117647058,1.0,1.0,1/6,9.79%,CHRNA7
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.3201547337666071,-0.676750102862304,0.9344262295081968,1.0,1.0,3/54,9.79%,LGALS8;VIM;DYNC1LI1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.344950940236194,0.6767300139747078,0.9393939393939394,1.0,1.0,5/9,30.49%,LATS2;WWC2;SOD1;LATS1;DUSP6
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.2936745711314661,-0.6764768430426277,0.9863013698630136,1.0,1.0,18/88,21.35%,PEX11A;SLC23A1;BMP6;AR;ALDH8A1;ACSL5;NR3C2;PEX1;RBP1;ABCD2;DIO2;PFKM;ABCA1;RETSAT;GCLM;GSTK1;CYP46A1;RXRA
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.38171800573281167,-0.6764134746315045,0.9508196721311475,1.0,1.0,5/17,26.80%,SLC25A19;SCARB1;SLC15A4;CPTP;LBP
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.4163314542550754,0.6761500065954498,0.8235294117647058,1.0,1.0,2/5,19.18%,PIH1D1;SIRT1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.44866558912963933,-0.6761362520709588,0.9272727272727272,1.0,1.0,2/9,16.87%,NFATC2;PPP3CA
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.44866558912963933,-0.6761362520709588,0.9272727272727272,1.0,1.0,2/9,16.87%,NFATC2;PPP3CA
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.2949200926292079,-0.6760000380923585,0.9259259259259259,1.0,1.0,4/69,9.08%,PPARG;CEACAM1;XBP1;PDE3B
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.4277069539349844,0.6759169901834898,0.8085106382978723,1.0,1.0,1/5,2.06%,CTNNA2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.29361682238707015,0.6756945748229319,0.9459459459459459,1.0,1.0,14/38,21.40%,EPC1;UXT;RYBP;RNF2;MGA;CBX5;RBBP4;TFDP1;E2F6;PHC1;EHMT1;BMI1;YAF2;RAD51
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.4459712276642593,-0.675655388926153,0.8392857142857143,1.0,1.0,2/5,26.34%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.44155100542269277,-0.6752074404904409,0.8269230769230769,1.0,1.0,1/6,13.56%,CAV2
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.4278479520211146,-0.6750000343366408,0.8166666666666667,1.0,1.0,1/9,1.52%,SHMT2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.3360060990685962,0.6749296406063524,0.9090909090909091,1.0,1.0,6/42,11.11%,GDAP1;GRPEL2;RALA;TIMM23;GRPEL1;AIP
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.40635009522246646,0.6747447771125777,0.8666666666666667,1.0,1.0,2/10,4.43%,AADAT;AFMID
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.34180546655393207,-0.6746570885410419,0.9859154929577465,1.0,1.0,1/33,1.07%,DACT1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.29449434155558313,0.674451374049888,0.9655172413793104,1.0,1.0,23/80,23.73%,SNX1;GBF1;WASHC2A;STX10;RAB7B;STX6;LMAN1;SNX3;VPS26B;VPS54;SGSM2;VPS29;TRAPPC10;RAB7A;VPS26A;GCC2;GGA1;RAB9A;TBC1D23;RNF126;VTI1A;TMEM87A;SPAG9
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.346784659516151,-0.674297939594241,0.9242424242424242,1.0,1.0,4/24,15.07%,P2RY12;TEK;EEF1A2;TGFB1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.44286205950479496,0.6742890239921748,0.8636363636363636,1.0,1.0,1/5,14.83%,NPHP4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.4282604654455149,0.6742789029102488,0.8604651162790697,1.0,1.0,3/5,21.08%,MYADM;MBP;WNK1
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.4282604654455149,0.6742789029102488,0.8604651162790697,1.0,1.0,3/5,21.08%,MYADM;MBP;WNK1
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.4459837521803349,-0.6742555114321394,0.9137931034482759,1.0,1.0,5/7,31.42%,MTHFD1;KYNU;HAAO;GLUD1;GOT1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2864879669780341,0.6740837160707078,0.96875,1.0,1.0,27/79,27.05%,SAP18;JMJD6;PRDX6;PTBP1;RBM8A;RBM23;NCL;HNRNPU;ZBTB7A;DDX5;RBM15B;MAGOH;CELF1;RBM5;WTAP;SRSF9;RBFOX1;DAZAP1;TRA2A;NSRP1;SF3B4;LARP7;PUF60;SRSF7;SF1;KHDRBS1;MBNL1
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.4148524015665381,-0.673980027471974,0.873015873015873,1.0,1.0,1/7,5.53%,DKK3
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.4016749777227104,0.673968192630123,0.8085106382978723,1.0,1.0,5/8,35.42%,BECN1;PRKN;SQSTM1;ATG13;PHB2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3285718721257561,0.6739019421138654,0.9210526315789473,1.0,1.0,4/27,9.89%,CD274;DICER1;CHRNA7;PTPN22
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.32739142777968655,-0.6738906488418582,0.9838709677419355,1.0,1.0,5/38,15.47%,TLR2;SFTPD;NOD1;ALPK1;LY96
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.2837476189520438,0.6737320916151432,0.9032258064516129,1.0,1.0,2/32,7.26%,ENPP1;NCK1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.43592946750119393,-0.6736921834329377,0.9180327868852459,1.0,1.0,2/6,8.62%,AQP1;IPCEF1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.38652782774919675,-0.6736814563666634,0.8387096774193549,1.0,1.0,1/12,8.16%,NELL1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.25515529441885476,0.6732448414842853,1.0,1.0,1.0,54/357,16.77%,CFAP61;TMEM11;AUP1;TTC29;PTCD2;CEP55;STRIP1;RAB32;PLCE1;FAM161B;NUMA1;CHMP5;TFB1M;VAPB;ATAD3B;USP6NL;MSTO1;ZNF135;FMNL2;GBF1;SLC25A33;PLIN5;OPTN;SYNE3;CENPT;PNPLA3;WASF3;DST;TMED5;TFB2M;KIF25;LMAN1;TRAPPC12;PEX6;PEX2;PRDX3;TRIP11;ABCA3;AGTPBP1;POLG2;MIA3;CNN2;SH3KBP1;NIPSNAP2;SEC31A;CLUH;ZFP69B;MTX2;FGD4;CUL7;MICAL1;BLZF1;BRWD1;PYROXD2
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.3575737802701821,0.6729409749299631,0.9024390243902439,1.0,1.0,2/10,13.63%,MTMR2;ABCA3
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.35698151352651786,-0.6728936299671886,0.847457627118644,1.0,1.0,3/24,15.70%,TGFB2;GLI3;CACNA1C
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.33477396705727763,0.6727264929391971,0.782608695652174,1.0,1.0,1/25,0.86%,AGER
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.3759009667187694,-0.6726519308039182,0.9047619047619048,1.0,1.0,4/16,13.07%,VEGFA;TGFB3;CAV1;NRG1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.37083605187404856,0.6725637890580431,0.8108108108108109,1.0,1.0,1/11,4.56%,IGF1R
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.3827753416004617,0.6725408073024344,0.8775510204081632,1.0,1.0,3/6,14.42%,SLIT2;CD200R1;BMP5
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.4274161855737879,-0.6719746141348611,0.8076923076923077,1.0,1.0,1/6,12.39%,EDNRB
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.43396945999834025,0.6719604888197752,0.8095238095238095,1.0,1.0,2/5,6.08%,EPHB2;PAX8
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.4394563902429915,-0.6716801580327865,0.8181818181818182,1.0,1.0,1/6,16.56%,NFKBIA
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.38744906621276687,-0.6716723626837379,0.8805970149253731,1.0,1.0,2/11,21.89%,HSPA5;KDELR3
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.4263238716996123,0.6715535402330155,0.85,1.0,1.0,2/7,14.26%,NRP2;ASCL1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.29435746004412716,0.6712929933345009,1.0,1.0,1.0,4/52,8.41%,RFWD3;HMGA2;BRCC3;SDE2
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.41054740485202634,-0.6710867706039243,0.7843137254901961,1.0,1.0,5/9,35.47%,ADH4;CYP46A1;APOE;CYP27A1;SNX17
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.35052836951166777,-0.6710399306920141,0.9090909090909091,1.0,1.0,8/25,23.44%,XYLT2;CHST9;CSGALNACT1;CHST15;B3GAT2;CSPG5;VCAN;CSPG4
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.29156738379818836,0.670806666328661,0.967741935483871,1.0,1.0,6/59,9.30%,EPB41L4B;MYH3;ACTN2;FHDC1;MYH14;TCAP
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.261781319412184,0.6706876538623986,1.0,1.0,1.0,16/124,12.87%,ERAS;PLD1;RAPGEF1;PLCE1;RASGRP2;CNKSR1;RALA;TAX1BP3;RRAS2;EPS8L2;G3BP2;CDC42EP5;SHC3;LIMK1;RAP2B;DNMT1
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.38244846874605043,-0.6705712445821992,0.875,1.0,1.0,4/16,12.84%,TCN2;AMN;CBLIF;MMACHC
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.38244846874605043,-0.6705712445821992,0.875,1.0,1.0,4/16,12.84%,TCN2;AMN;CBLIF;MMACHC
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.437047250282818,-0.6701733928799397,0.8620689655172413,1.0,1.0,1/5,29.19%,NUCKS1
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.4226759767928176,0.6700985905483086,0.8571428571428571,1.0,1.0,2/5,20.82%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2793455121897426,0.669933270953739,1.0,1.0,1.0,18/84,19.65%,PSME2;MALT1;MUC4;PSMD13;CHUK;KLRD1;NFKB1;PSME4;MAP3K7;BCL10;RELA;PSMF1;PSMD11;TAB3;CLEC4C;PSMD4;BTRC;RAF1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2793455121897426,0.669933270953739,1.0,1.0,1.0,18/84,19.65%,PSME2;MALT1;MUC4;PSMD13;CHUK;KLRD1;NFKB1;PSME4;MAP3K7;BCL10;RELA;PSMF1;PSMD11;TAB3;CLEC4C;PSMD4;BTRC;RAF1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.2793455121897426,0.669933270953739,1.0,1.0,1.0,18/84,19.65%,PSME2;MALT1;MUC4;PSMD13;CHUK;KLRD1;NFKB1;PSME4;MAP3K7;BCL10;RELA;PSMF1;PSMD11;TAB3;CLEC4C;PSMD4;BTRC;RAF1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.3025634507009617,-0.6698513982686843,0.9857142857142858,1.0,1.0,10/78,12.69%,CLU;CIDEB;CCN5;LRRK2;SNCB;LRPAP1;HTR2B;TNFRSF1B;EPHB1;LRP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.3582511457926335,-0.6696909686895602,0.8709677419354839,1.0,1.0,4/19,16.23%,PTPRC;CARD11;PRKD2;IRF4
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.4101405605789633,-0.6693756486371456,0.9076923076923077,1.0,1.0,1/8,4.18%,EDN1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.30597178246883405,0.6692807815856724,0.9523809523809523,1.0,1.0,4/16,21.37%,CHUK;DDX3X;DHX9;PTPRS
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.30808453437120514,0.669250534970222,0.8888888888888888,1.0,1.0,14/67,18.62%,TAF12;BRPF1;EPC1;TAF5;TRIM16;BEND3;KAT2A;JADE3;MAP3K7;TADA3;NAA50;CPA4;DMAP1;MRGBP
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.4490100845411228,-0.6690947501370603,0.8245614035087719,1.0,1.0,1/5,16.32%,LIG3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.42444532463598383,-0.6686450071703977,0.890625,1.0,1.0,1/7,9.08%,PDE3B
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3001107707165348,-0.6685748394978923,0.9142857142857143,1.0,1.0,15/74,18.89%,ABCC4;SLC6A12;SLC7A7;SLC23A1;CEACAM1;SLC16A8;SLC51A;SLC7A8;SLC26A8;SLC25A48;SLC3A1;ATP8B1;SLCO2B1;SLC10A6;SLC43A1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.26661592145563884,-0.668295531159771,1.0,1.0,1.0,29/187,25.15%,ENC1;TRIM9;PSMB8;PRAME;SIAH3;HECW1;PRPF19;NEDD4L;NR1D1;ANKRD9;SIAH1;PSMC3;CLOCK;RNF139;RBX1;RNF5;TRIM13;KCTD2;PSME1;RNF4;UBE2B;PSMC5;PSMA3;WWP1;UCHL1;PSMB2;CDC34;DNAJB12;ARMC8
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.3316682047457454,0.6676273203653659,0.9696969696969697,1.0,1.0,3/25,10.10%,HSPA1A;DNAJB4;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.39751732603964174,-0.6676267558676078,0.8421052631578947,1.0,1.0,2/12,12.95%,VEGFA;BMPER
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.3761697931355841,-0.6675201459518076,0.9365079365079365,1.0,1.0,6/15,22.50%,CAV1;FLOT1;IFIT1;PQBP1;RALB;COLEC12
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.3809614346948695,-0.667152762126251,0.8620689655172413,1.0,1.0,1/6,8.00%,FUCA2
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.3809614346948695,-0.667152762126251,0.8620689655172413,1.0,1.0,1/6,8.00%,FUCA2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.42492392054272,0.6664098632166525,0.8666666666666667,1.0,1.0,1/6,2.36%,STAC3
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.36991712312365166,-0.6663419505929847,0.9552238805970149,1.0,1.0,2/16,9.98%,GRIN2B;KCNC2
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.41658255072852635,-0.6663017429035271,0.819672131147541,1.0,1.0,3/7,25.89%,TST;MPST;TXN2
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.3797088833248506,0.665275476770107,0.8888888888888888,1.0,1.0,3/15,16.47%,AADAT;OAT;MTHFS
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3556830371557318,-0.6652323750587212,0.9420289855072463,1.0,1.0,6/15,27.04%,EMC3;EMC10;CAMLG;EMC1;GET3;EMC9
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.3681068373043258,0.6649168753392387,0.9166666666666666,1.0,1.0,5/12,23.67%,ARV1;STAR;NPC2;NPC1;RELCH
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3876364189255491,-0.6648222561157116,0.890625,1.0,1.0,3/15,16.82%,CELF4;RBM3;NCBP1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.4366766769778906,-0.6643236709710418,0.8524590163934426,1.0,1.0,1/5,11.62%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3475362652655275,-0.664249819054752,0.84375,1.0,1.0,5/18,13.54%,TLR2;NINJ1;IFI35;CAV1;FLOT1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.3474475726746602,-0.663962217720629,0.8805970149253731,1.0,1.0,1/21,7.20%,TERF2IP
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.26123241897549193,0.6638702592797016,1.0,1.0,1.0,17/175,9.30%,JPT1;SLC38A1;SQLE;LMNB1;NDC80;ESPL1;KMT5A;NASP;MEIS1;TPX2;NUMA1;H2AX;CCNT1;ABL1;TENT4A;PURA;E2F4
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.41360666864774137,-0.6636601279748067,0.8545454545454545,1.0,1.0,2/6,31.12%,FAM111A;SPRTN
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.4601170258539783,-0.6632072915002716,0.9016393442622951,1.0,1.0,2/5,26.10%,KCNE1;ANK3
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.3982780728403449,0.6631024781439477,0.8222222222222222,1.0,1.0,2/7,11.91%,PYHIN1;TPR
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.3158583343078146,0.6631021807908356,0.875,1.0,1.0,7/30,15.39%,MFHAS1;ACTN2;TAX1BP3;COMMD1;LATS2;GOPC;GPM6B
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.38592001615134247,-0.6625862195938974,0.9384615384615385,1.0,1.0,2/14,8.48%,LRRK2;XBP1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.3645210082213904,0.6625482416464519,0.7954545454545454,1.0,1.0,3/12,20.03%,H6PD;DGKQ;RAN
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.38214604420320686,0.6623304101296265,0.8292682926829268,1.0,1.0,1/8,6.65%,IFI27
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.3827586548061519,-0.6615899813153017,0.8769230769230769,1.0,1.0,3/10,14.27%,MACROD1;NT5C1A;TYMP
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.3055325947600674,-0.6614826460287924,0.9855072463768116,1.0,1.0,8/53,20.54%,COX6C;NDUFC1;NDUFB9;NDUFB6;NDUFA8;NDUFAF1;COX4I1;NDUFS5
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.3592463289065524,0.6614249857396368,0.8787878787878788,1.0,1.0,2/20,14.48%,COX10;RSAD1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.36126246502537007,-0.6610509033259171,0.9,1.0,1.0,2/18,5.84%,CITED2;MMP21
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.2959369418368086,-0.6609176739837747,0.9710144927536232,1.0,1.0,14/79,17.05%,ERCC6L;ATAD5;FANCI;CENPF;RFC3;ZGRF1;RFC4;PRMT8;TRIM32;CCNF;DEPDC1B;LIG3;POU5F1;MAD2L1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.302901593295502,0.6607434374474669,0.9655172413793104,1.0,1.0,7/56,9.81%,FGF6;FGFR1;SPRED1;PTBP1;SPRED2;POLR2K;FGFR3
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.3922664211114508,-0.6599529241445224,0.9122807017543859,1.0,1.0,3/8,17.04%,RYR3;SLC8A1;TRPM2
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.36217670553825076,0.6599299714031799,0.8780487804878049,1.0,1.0,2/7,26.98%,MSH3;SSBP1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.3246286064863268,-0.6588347658887193,0.9104477611940298,1.0,1.0,5/26,23.69%,TERF2IP;NOP10;RAD50;MRE11;RPA1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3521930960138742,-0.6587928461919746,0.8709677419354839,1.0,1.0,5/24,15.78%,MAP3K5;TMEM117;CEBPB;PPP1R15A;BBC3
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.37051343552007343,-0.658535821680829,0.8852459016393442,1.0,1.0,4/18,16.32%,RFC3;RFC4;MCM7;LIG3
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.346342119619034,-0.6584703055722031,0.9692307692307692,1.0,1.0,1/29,4.64%,NOS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.36683063907529817,-0.6581987517992306,0.9393939393939394,1.0,1.0,6/13,38.09%,TMEM33;REEP1;REEP2;ATL1;RAB18;ATL2
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.31962663429353555,0.6581843600939307,0.90625,1.0,1.0,7/19,21.64%,RPS23;DDX3X;PRRC2C;G3BP1;EIF2S1;YTHDF1;C9ORF72
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.28419361529891607,0.6581355597310806,1.0,1.0,1.0,6/40,12.33%,POLD3;CTC1;PARP3;DCLRE1B;SP100;LTO1
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.3367768448265965,0.6581007406923294,0.9,1.0,1.0,1/15,3.59%,NEU4
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),-0.41146150172206297,-0.6579788188892839,0.8596491228070176,1.0,1.0,3/6,22.08%,NRG1;RBM24;MESP1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.392615343548628,-0.6578065022612103,0.8714285714285714,1.0,1.0,3/12,8.68%,SOX9;MYO3B;TTC39C
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3398886812666582,0.6575970662623308,0.9318181818181818,1.0,1.0,5/21,22.73%,SAMD4A;CNOT9;PAN2;CNOT2;TUT4
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.3230570361554943,-0.6574796424873932,0.8783783783783784,1.0,1.0,7/30,17.40%,SLC22A9;SLC26A4;SLC22A3;SLC26A8;SLC17A6;SLC17A7;SLCO2B1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.32546501426164315,-0.6573078260242824,0.9508196721311475,1.0,1.0,4/34,11.84%,ACADL;ACMSD;CEACAM1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.4086267063069803,0.6572515799319737,0.851063829787234,1.0,1.0,2/6,16.25%,PPM1F;NPM1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.32571310761967237,-0.6570972775560552,0.9411764705882353,1.0,1.0,7/39,24.34%,LRRK2;PID1;SREBF1;DNM1L;VPS35;HAX1;PDE2A
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.40896335610877105,-0.6568769513974974,0.8703703703703703,1.0,1.0,1/7,11.62%,VEGFA
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.38038026037006034,-0.6564325974387434,0.8947368421052632,1.0,1.0,3/12,17.38%,OLAH;ABHD3;OXSM
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.2783953735770853,0.6560967995264734,1.0,1.0,1.0,6/56,14.31%,ZDHHC16;PIGF;ZDHHC12;ZDHHC14;ZDHHC3;DPM3
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.3709257270162529,-0.6560053410548213,0.8484848484848485,1.0,1.0,1/19,3.72%,BCAT2
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.3709257270162529,-0.6560053410548213,0.8484848484848485,1.0,1.0,1/19,3.72%,BCAT2
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3130762505056711,0.6557076881601736,0.9375,1.0,1.0,2/35,2.72%,KBTBD8;ZNF598
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.368960532996276,-0.6553658086203326,0.9285714285714286,1.0,1.0,1/16,1.44%,PPARG
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.36736158572032956,0.6552099392974842,0.9024390243902439,1.0,1.0,2/10,14.26%,NRP2;ASCL1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.32454667564663126,-0.6547383963693513,0.9411764705882353,1.0,1.0,11/29,25.89%,PRELP;OGN;GGT5;TST;OMD;CSPG5;VCAN;CSPG4;MPST;HEXB;TXN2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.27527896344198755,0.6545894013331236,1.0,1.0,1.0,30/118,20.47%,HDAC10;HMGA2;HDAC1;SNAI1;PIH1D1;PHF1;SMARCD3;FAM47E;ZBTB1;SMARCA4;DAXX;KDM5A;KAT2A;KDM5B;RBBP4;HDAC4;KDM5D;ZBTB7A;NPM1;HDAC3;BRWD1;HP1BP3;PADI2;LOXL2;NUDT5;SIRT1;EHMT1;TCF7L1;HMGN1;RB1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.29716449215556257,0.6540820082719946,0.9285714285714286,1.0,1.0,4/58,3.79%,ECM1;HMGB1;FGFR1;SEMA5A
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.31591739113792483,0.6531540366676555,0.9285714285714286,1.0,1.0,8/30,24.42%,POLR2K;POLR2L;CMTR2;GTF2H5;ERCC2;POLR2E;POLR2D;CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.31591739113792483,0.6531540366676555,0.9285714285714286,1.0,1.0,8/30,24.42%,POLR2K;POLR2L;CMTR2;GTF2H5;ERCC2;POLR2E;POLR2D;CCNH
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.32013671385967857,-0.6530430294379868,0.9393939393939394,1.0,1.0,6/32,25.66%,AQP11;OPHN1;PRKCG;CAMLG;SDCBP;GIPC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3573380169262049,0.6524069816612174,0.8809523809523809,1.0,1.0,2/14,5.75%,CASQ2;CLIC2
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.33958701085063125,0.6521571154684719,0.9333333333333333,1.0,1.0,6/15,24.88%,DKC1;NAF1;CCT8;CCT2;CCT3;CCT6A
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.32287717034407387,0.6521130756902238,0.9655172413793104,1.0,1.0,6/27,9.33%,KCNJ14;KCNJ2;SLC12A9;ATP12A;ATP1B1;HCN2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.34237099985317,-0.6520880960100754,0.9264705882352942,1.0,1.0,4/22,14.99%,DGKD;DOK1;TGFA;AGT
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.32651859818195694,-0.6518265162672874,0.9032258064516129,1.0,1.0,6/30,22.72%,CLU;BBC3;IFIT2;DNM1L;VPS35;FZD9
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),0.42778447807047004,0.6517448059563424,0.9166666666666666,1.0,1.0,4/5,14.42%,CDK6;DLL1;CDH2;BMP5
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.3026113901187479,0.651594752460014,0.9705882352941176,1.0,1.0,3/41,13.99%,RIDA;PRR5L;PNPT1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.28023677554702164,0.6515528074414625,1.0,1.0,1.0,30/110,23.36%,LTBP2;GDAP1;SRPRB;MYO1C;TIMM23;AP4B1;ZDHHC12;AIP;MICALL1;ZDHHC14;RTP5;PEX6;SRPRA;ICMT;ZDHHC3;KIF13B;TRAK1;ZDHHC7;RPL11;RABGEF1;SEC61A1;AP4E1;TIMM9;TIMM17A;TIMM22;GOLGA7;ZDHHC20;AKAP6;TRAK2;KATNB1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3642224300261004,-0.6513319900677337,0.9166666666666666,1.0,1.0,3/14,20.88%,CELF4;RSRC1;PQBP1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.3865184179486821,-0.6511350447451794,0.8813559322033898,1.0,1.0,1/10,7.70%,TOP2A
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.277519140382593,0.6509083331160987,0.9705882352941176,1.0,1.0,10/56,15.57%,UBC;CHUK;UBB;MAP4K2;MAPK8;UBE2N;NFKB1;MAP3K7;MAP2K7;IRAK2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.2654739170758299,0.6508519744740605,1.0,1.0,1.0,29/178,16.05%,FEM1A;SPSB2;RNF128;UBC;RNF6;UBE2A;CDC26;RNF168;ZNRF3;KEAP1;PSMD13;RBBP6;ANAPC15;KLHL8;UBB;FBXL14;ELOC;ITCH;UBQLN2;AMFR;RNF8;UBE3B;MYLIP;RNF19B;PSMF1;ANAPC1;FBXO8;KCTD6;RNF144A
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3726092877329313,-0.6505240298171413,0.9482758620689655,1.0,1.0,2/12,15.07%,LYN;TGFB1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.30076204473842477,-0.6499927957213194,0.96875,1.0,1.0,17/70,20.59%,KDM4D;RMI1;RPA3;SAMHD1;POLQ;RECQL4;XRCC2;WRN;RAD50;MEIOB;BRCA1;LIG3;RPA2;AP5S1;RAD54B;MRE11;MMS22L
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.3081570231860742,-0.6488917193332395,0.9344262295081968,1.0,1.0,1/35,3.52%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.3485960592507441,-0.6487365449004785,0.9076923076923077,1.0,1.0,1/21,3.02%,ENO4
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.3795302695299092,0.6487359095134873,0.8695652173913043,1.0,1.0,4/10,25.18%,COPS6;TOR1A;COPS2;GPS1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.2952714009140799,0.6486282449757714,0.9375,1.0,1.0,8/43,11.23%,SLC38A1;SLC25A29;SLC38A2;LLGL2;SLC6A13;SLC38A3;SLC66A1;SLC16A13
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.2743879676076862,0.6485078713729915,1.0,1.0,1.0,12/79,16.51%,DHFR;RIDA;EIF4E2;PUS7;SAMD4A;CHRNA7;NCL;GGA3;CNOT9;DDX3X;MRPL13;YBX1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.2947710206516064,-0.6483861973539756,0.9722222222222222,1.0,1.0,6/59,14.45%,DEPP1;LRRK2;TPCN2;DAPK1;DRAM1;DAPK3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2941583094889471,-0.648200754529692,0.9402985074626866,1.0,1.0,4/49,12.42%,CCND1;RAB11A;PLCB1;EGFR
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.27214564650668066,-0.6477775214472419,1.0,1.0,1.0,26/149,20.59%,KDM4D;PARP9;RMI1;RPA3;DTX3L;SAMHD1;CYREN;POLQ;PRPF19;RECQL4;ATP23;XRCC2;WRN;RAD50;SETMAR;MEIOB;NHEJ1;BRCA1;LIG3;MAD2L2;RPA2;AP5S1;RAD54B;IFFO1;MRE11;MMS22L
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.3591001859192781,0.6476409450842794,0.9,1.0,1.0,1/13,5.72%,DESI2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.376237692209674,0.6474138145429522,0.8181818181818182,1.0,1.0,3/12,23.13%,BRCC3;LIG4;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.4328561145297477,-0.6473996811739653,0.9375,1.0,1.0,2/5,22.59%,GPS2;PARP10
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.29125062322327766,-0.6473334567569891,0.9855072463768116,1.0,1.0,5/71,10.38%,SEL1L2;RNF175;MAN1A1;FBXO17;TRIM25
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.3454882711091927,0.6470731600712599,0.9166666666666666,1.0,1.0,4/29,4.88%,PYCR1;SLC39A8;AADAT;RIMKLA
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.309368670998691,0.6469795873995572,0.8823529411764706,1.0,1.0,4/21,14.45%,MAPRE2;ABL1;PPM1F;MAP4K4
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.3023128856448996,-0.6469758820243804,0.987012987012987,1.0,1.0,14/61,19.76%,CDS1;MUC16;CHST9;KCNMA1;MYO5C;DNAH9;MROH9;APOBEC4;DNAH7;SPAG17;CXCL17;VWA3B;DNAH5;SLC9A7
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2873727928072816,-0.6465896634447711,1.0,1.0,1.0,19/66,24.60%,PRKAR1B;SLC8A3;SLC8A1;INCA1;CBLC;LYN;CAV3;PKIA;AGT;PIK3CB;PTPRJ;NR2F2;MYOCD;RGS2;PRKCD;MACROH2A1;TFAP4;UCHL1;STK38
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3614257529829688,-0.6463803458296511,0.9411764705882353,1.0,1.0,4/17,29.63%,NOL3;NME5;HIF1A;NONO
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.31424653494307786,0.6463221218711626,0.9459459459459459,1.0,1.0,2/34,2.86%,POLD3;UBC
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.41996291784911133,-0.646141555617105,0.9193548387096774,1.0,1.0,2/8,13.50%,LRTOMT;SNCAIP
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.36042220571254974,-0.6459176708118916,0.8857142857142857,1.0,1.0,3/13,21.27%,NFKBIE;NFKBIA;MDFI
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.3814332336677023,-0.6457584515757301,0.9016393442622951,1.0,1.0,2/14,11.19%,TERF2IP;TPP1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.4046201449247586,-0.6453485945902734,0.8166666666666667,1.0,1.0,2/6,11.55%,SLC8A3;CAV3
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.4053597899261792,0.6450745990018188,0.8723404255319149,1.0,1.0,1/5,7.41%,ABL1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.3020439617632619,0.6446235401594922,0.9736842105263158,1.0,1.0,9/44,21.52%,TMEM11;SAMM50;CHCHD6;MTX2;ATP5F1C;TIMM9;MAIP1;MTX3;TIMM22
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.39190834833087734,0.644577430902763,0.8292682926829268,1.0,1.0,1/5,6.39%,ATF4
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),0.37459685042082597,0.6444743220565038,0.8809523809523809,1.0,1.0,2/8,13.63%,PRELID1;ABCA3
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.40029984578961364,-0.6444217592585435,0.8484848484848485,1.0,1.0,1/5,26.82%,SLC6A9
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.39651279057504624,-0.6444198721577931,0.85,1.0,1.0,2/10,22.05%,CRB2;TENM4
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.3316988723581,0.6440023473766815,0.8518518518518519,1.0,1.0,2/13,9.15%,SLC2A11;SLC2A14
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.42855502454390826,-0.6436821982691986,0.9122807017543859,1.0,1.0,1/5,22.21%,VPS13A
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.40651243982461704,-0.6436305036728588,0.9180327868852459,1.0,1.0,4/8,22.08%,CITED2;NDRG4;IFT122;MESP1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.37549828395784035,-0.6434880722350795,0.8852459016393442,1.0,1.0,3/13,13.54%,RFTN1;CAV3;FLOT1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.3247642224502677,-0.6433285366308683,0.9375,1.0,1.0,5/25,23.69%,TERF2IP;NOP10;RAD50;MRE11;RPA1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.35939629254192207,-0.6431654593880669,0.9310344827586207,1.0,1.0,3/15,17.16%,DTX3L;MAD2L1;MAD2L2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.43809001783545726,-0.6431241866977713,0.9622641509433962,1.0,1.0,2/5,21.40%,LRPAP1;MYOCD
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.3584554740421817,-0.642965843377094,0.90625,1.0,1.0,3/14,12.07%,H2BC11;CXCL14;ROMO1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.3910829071769977,0.6420740250909122,0.8461538461538461,1.0,1.0,2/9,8.64%,NOX1;TRPV1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.28958688138309635,-0.6420071883645978,0.9696969696969697,1.0,1.0,4/52,6.54%,WDR6;HGF;MET;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.34640049736634726,0.6419737626052052,0.8611111111111112,1.0,1.0,4/17,13.41%,APLP1;ADA;KLK14;GRK2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2976976918149379,-0.6417484922838046,1.0,1.0,1.0,8/54,20.54%,COX6C;NDUFC1;NDUFB9;NDUFB6;NDUFA8;NDUFAF1;COX4I1;NDUFS5
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.3543290913351686,-0.641563327391619,0.8983050847457628,1.0,1.0,7/23,21.52%,SLC1A1;SLC25A22;SLC7A8;SLC1A6;SLC1A2;SLC1A4;SLC25A12
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.4040111246516327,-0.641535840526852,0.9508196721311475,1.0,1.0,2/6,13.32%,BMP6;PAX6
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.3408653761832314,0.6412746167494688,0.918918918918919,1.0,1.0,2/9,11.94%,GGTA1;LTA4H
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.36210663834868007,0.6412260054628366,0.9333333333333333,1.0,1.0,1/8,6.22%,EEF1A1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.3539179977104086,0.6410552322770212,0.9166666666666666,1.0,1.0,1/16,1.05%,SCN11A
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.37571695978720565,0.6410200437399247,0.95,1.0,1.0,4/11,20.12%,H6PD;RPIA;TKT;PGLS
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.3827386083684027,0.6400730074712814,0.9333333333333333,1.0,1.0,5/10,24.80%,PCM1;CEP19;NIN;NINL;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.35655472612340483,-0.6399704160334784,0.8970588235294118,1.0,1.0,2/14,11.26%,CHGA;KCNB1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.2630935581616941,-0.639538064092708,0.9855072463768116,1.0,1.0,13/102,15.87%,KDM4D;NCKAP1L;GRM5;AR;IFNA2;NUP43;LYN;SLAMF8;EGFR;LDB2;NLRC5;CDKN1A;MCM7
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.38464000389800823,-0.6391192255650517,0.8636363636363636,1.0,1.0,1/9,14.78%,IFIT1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.3437483891179087,0.638675346301461,0.9,1.0,1.0,5/17,11.34%,LLGL2;STRIP1;FMNL2;LLGL1;DLG1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.28078116630529165,0.6380567305694876,0.9615384615384616,1.0,1.0,18/68,25.40%,USP6NL;ZEB2;PJVK;LMAN1;PDE4DIP;STX18;CAPN2;PLXNB1;TJP1;AKAP9;CLN3;ARMH3;SAR1B;SIRT7;STOX1;PREB;VPS11;PDCD10
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.33099531509463204,-0.6379617368950866,0.9701492537313433,1.0,1.0,2/26,6.00%,DTX1;CCND1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),0.35070167742689956,0.6377720844531051,0.9032258064516129,1.0,1.0,1/9,2.18%,GSDMB
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.2934310877895343,0.6377030475408523,0.9,1.0,1.0,7/41,14.79%,F2;BAK1;DNAJC1;KNG1;ITCH;CLN6;TRAF3
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.33703754797021135,-0.6376884354623952,0.9692307692307692,1.0,1.0,5/30,15.10%,CLDN16;SLC8A1;CAV1;SLC7A8;KCNH2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.31394686279778267,0.6375893231450827,0.9166666666666666,1.0,1.0,2/36,2.86%,POLD3;UBC
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.2914263937880146,-0.6370375211380482,1.0,1.0,1.0,4/68,9.94%,CHRM3;PIGH;CPE;USP6
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.404060001936592,0.6368901424177867,0.88,1.0,1.0,2/5,28.39%,SIRT7;FBL
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.3660367350416962,-0.636771294526227,0.8867924528301887,1.0,1.0,2/12,14.94%,SLC26A4;SLC26A8
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.3624168436910491,0.6366295255945482,0.8157894736842105,1.0,1.0,1/9,7.20%,DMRT1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.3081068494477934,0.6366227968249077,0.8947368421052632,1.0,1.0,1/15,4.56%,IGF1R
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.36570052354613714,-0.6365850166773749,0.9122807017543859,1.0,1.0,1/11,10.19%,BTBD18
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.29190849669615127,-0.6364789281538783,0.9571428571428572,1.0,1.0,5/82,7.85%,GCNT1;MUC16;GALNT12;GALNT8;SLC35C1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.2476859142022546,0.6358171865103539,1.0,1.0,1.0,19/81,18.51%,NOC2L;UBE2A;BAK1;ATF4;CAT;TMEM161A;YY1;SDE2;CASP9;ZBTB1;MAPK8;POLH;MAP2K7;RELA;ATR;NPM1;ERCC2;MEN1;PRIMPOL
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.440966796720767,-0.6356896860276516,0.8461538461538461,1.0,1.0,3/5,42.54%,FMR1;RPS6KA4;MAPK3
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.35107669706257233,-0.6355437886249592,0.9019607843137255,1.0,1.0,2/9,26.77%,SREBF1;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.294889630932777,-0.6348811841766023,1.0,1.0,1.0,8/59,17.83%,NLRP12;NLRP3;TMIGD3;SPI1;NLRC5;CD200;NFKBIA;MAP2K5
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.3421553267018786,0.6346064567342921,0.9285714285714286,1.0,1.0,5/17,20.54%,RNF168;RYBP;RNF2;PCGF1;BMI1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.29122441322442094,-0.63451513434306,0.9142857142857143,1.0,1.0,8/42,22.90%,TBC1D10A;FURIN;TNFRSF1B;TRIM32;SNX33;ATP5IF1;WDR48;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.3749759903304467,-0.6344378950496551,0.9016393442622951,1.0,1.0,2/9,12.69%,ABCB4;LRP1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.2945136132384475,-0.634402300974973,0.9855072463768116,1.0,1.0,4/53,12.37%,ARIH2;DTX3L;NEDD4L;TRIM32
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.387494810934353,0.6342597830415818,0.8958333333333334,1.0,1.0,4/8,33.18%,CDC42;CCNB1;SIRT2;RACGAP1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.40574762496266426,-0.6341766092987792,0.8620689655172413,1.0,1.0,3/6,39.09%,CNTNAP1;PARD3;LGI4
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.40574762496266426,-0.6341766092987792,0.8620689655172413,1.0,1.0,3/6,39.09%,CNTNAP1;PARD3;LGI4
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.34624585280458064,0.6340395841047264,0.9487179487179487,1.0,1.0,3/11,12.96%,EHD2;MICALL1;WHAMM
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.41701412605458144,-0.6339056116483373,0.9649122807017544,1.0,1.0,2/6,22.59%,GPS2;PARP10
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.3502331049389549,0.6337198855680352,0.9487179487179487,1.0,1.0,3/11,11.34%,SEMA5A;THAP1;DLG1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.2806852745481218,0.6335882963836846,0.9655172413793104,1.0,1.0,4/43,6.14%,NDC80;CEP55;PINX1;CHMP5
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.3046016395286306,0.6334639207944442,0.9411764705882353,1.0,1.0,5/29,11.49%,DCXR;GALT;FBP1;FUCA1;PGM1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3208722313445107,0.6332476601549913,0.9487179487179487,1.0,1.0,4/22,14.09%,ATF4;ATF6B;CREB3L3;ATF3
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.3411950119412221,0.6331082305608168,0.8775510204081632,1.0,1.0,2/9,14.95%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.3459198658748075,-0.6326707935874816,0.9253731343283582,1.0,1.0,1/19,4.64%,NOS1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.3540600199935156,-0.6321463121806483,0.9137931034482759,1.0,1.0,4/10,33.76%,NRG1;KCNQ1;SCIN;GPLD1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.3721007935837644,0.632046282274014,0.8809523809523809,1.0,1.0,1/6,7.86%,MTRR
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.35503667654846227,0.6318365264373023,0.8536585365853658,1.0,1.0,3/8,18.71%,RNF168;RNF8;LIG4
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3406262265103617,-0.6314572324719923,0.9193548387096774,1.0,1.0,1/17,4.85%,CITED2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3406262265103617,-0.6314572324719923,0.9193548387096774,1.0,1.0,1/17,4.85%,CITED2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.3142743797519447,0.6312936184589953,1.0,1.0,1.0,1/22,1.68%,WNK4
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.32043808859938805,-0.6309329665251148,0.9365079365079365,1.0,1.0,6/47,16.76%,B2M;BMP6;HJV;FBXL5;CP;SLC11A2
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.2680253070337173,0.6301287915333593,1.0,1.0,1.0,15/52,24.46%,SPHK2;MYO1C;POLR2K;KAT2A;ZMIZ1;CDCA4;POLR2L;PADI2;TAF1C;PHF2;POLR2E;ARID1B;SMARCA5;MYBBP1A;DEK
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.41678449265026696,-0.6299880930170096,0.9019607843137255,1.0,1.0,2/7,16.32%,TOP2A;LIG3
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.25351644603243706,-0.6298025891742433,1.0,1.0,1.0,25/168,20.12%,ANK1;NUDT4;KLF3;GATA1;ALDH1L1;SPTB;ADD2;SLC22A4;H1-0;SMOX;SLC6A8;IGSF3;FBXO7;TYR;FTCD;MOSPD1;DAAM1;DMTN;SLC11A2;BLVRB;GYPE;CA1;KAT2B;GCLM;ADD1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.3944086561187763,0.6296918290146444,0.9444444444444444,1.0,1.0,4/6,14.42%,CDK6;DLL1;CDH2;BMP5
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.4137118780297218,-0.6291397724568247,0.8727272727272727,1.0,1.0,3/5,34.08%,HIF1A;NONO;PINK1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.38169012401303776,0.6289179387599895,0.967741935483871,1.0,1.0,3/9,8.62%,KCNJ2;ATP12A;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.36857469419323885,-0.6288820448008976,0.8620689655172413,1.0,1.0,3/11,12.35%,RIN3;LRPAP1;DLG4
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.31129061024436805,0.6288039240718072,0.875,1.0,1.0,2/19,5.95%,HMGB1;XKR8
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.3562940135303031,-0.6284277119434825,0.9402985074626866,1.0,1.0,3/16,26.93%,TXNDC15;TUBD1;RAB34
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.38252451394467346,0.627430695767719,0.825,1.0,1.0,3/5,28.72%,CLN3;LETM1;SLC25A23
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.31281022329919744,-0.6273918393859117,0.9411764705882353,1.0,1.0,9/32,23.74%,CADPS2;RAB27B;RAB3A;SMPD3;RAB15;CADPS;SDC4;VPS4B;SDCBP
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.35728997429525977,0.626217611410244,0.9607843137254902,1.0,1.0,1/13,6.38%,BAK1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.2984925859720135,-0.6260729659815748,0.9852941176470589,1.0,1.0,4/47,11.19%,TSPYL2;KLHDC3;XBP1;TPP1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.2467311276670956,-0.6251955831731001,1.0,1.0,1.0,34/341,18.47%,H2BC11;ARIH2;ENC1;ISG15;TRIM5;KLHL7;DTX1;TRIM22;DTX3L;HLA-A;HIF3A;HECW1;NUP43;RNF212B;CBLC;MAGEF1;FBXO7;NEDD4L;FBXO10;TRIM32;UVSSA;FBXL5;CCNF;RNF213;ATG10;UHRF1;BRCA1;TRIM69;ANKRD9;MOCS3;TRIM17;EPAS1;RNF111;NUP88
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.37052600297673177,-0.6249837104148434,0.9032258064516129,1.0,1.0,1/10,6.53%,SULT4A1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.3147772035119061,-0.624100265373887,0.9402985074626866,1.0,1.0,4/28,13.72%,B2M;HJV;FBXL5;CP
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.3440270353008975,0.6238272237575464,0.926829268292683,1.0,1.0,3/9,16.50%,HDAC1;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.40965642864051344,-0.623562622534845,0.8983050847457628,1.0,1.0,1/7,8.80%,TCIM
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.3256210208348188,0.6231968833536484,1.0,1.0,1.0,4/29,9.10%,ATP6V0A4;ATP6V1G2;ATP6V1G1;RAB39A
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.3950134945811034,-0.6229844264283714,0.9354838709677419,1.0,1.0,1/11,3.91%,LOXL3
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.35566418449224285,-0.6227758917902936,0.9117647058823529,1.0,1.0,2/16,6.75%,EPHA4;SIGLEC10
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.400027709581028,-0.6227464765978045,0.9230769230769231,1.0,1.0,1/7,13.56%,CAV2
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.33295642087985977,-0.622054295807821,0.9375,1.0,1.0,2/20,4.62%,PDE7A;SOX9
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.3470391535278351,-0.6220375497060917,0.9423076923076923,1.0,1.0,3/11,16.58%,NTNG1;NTNG2;MOV10
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.2865466654218404,0.6217326092761878,0.972972972972973,1.0,1.0,3/36,13.50%,ATG9A;CTSK;BECN1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.3133800662768706,0.6215564928928573,0.9512195121951219,1.0,1.0,3/12,17.52%,AKT2;PLIN5;DAGLB
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.35662804554229843,-0.6215415608027428,0.95,1.0,1.0,3/11,12.76%,SLC8A1;PLN;ATP1A1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.3003857294472108,0.621334746719157,1.0,1.0,1.0,8/25,18.81%,ODAD2;DNAI4;ZMYND10;DNAI1;DNAH8;DNAI3;CFAP73;CFAP100
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2730460089995852,-0.621133852988553,0.9859154929577465,1.0,1.0,8/78,15.07%,ASPN;TGFBR2;CITED2;DKK3;NREP;CAV1;WFIKKN1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.3253585300160348,-0.6209114226805084,0.8923076923076924,1.0,1.0,7/20,22.72%,CX3CR1;TOX;VEGFA;DISC1;CX3CL1;FZD3;FZD9
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.4028338276475799,0.6207681036463196,0.8974358974358975,1.0,1.0,2/6,21.64%,ARHGAP35;C9ORF72
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.3322852285521613,0.6206388043678067,0.967741935483871,1.0,1.0,6/33,14.72%,CTNNA2;EPHB2;SDC2;CHRNA7;CELSR2;BTBD3
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.33185214038069033,0.6203413511028943,0.8947368421052632,1.0,1.0,5/10,19.17%,DCP1A;PNRC2;DCP1B;PATL1;DCPS
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.32727024530504584,-0.619374743716574,0.96875,1.0,1.0,4/19,22.98%,DDR2;TGFB1;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.31526936715931275,0.6191676814303869,0.9354838709677419,1.0,1.0,3/27,12.71%,GDAP1;PEX6;PEX2
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.3682743622670454,0.6189720551036741,0.9318181818181818,1.0,1.0,2/8,13.57%,UGT8;GALC
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.3371963724717763,-0.6186609015603576,0.9508196721311475,1.0,1.0,4/15,21.59%,EDN1;TGFA;PDGFRB;AURKA
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.3912737619385277,0.6186360224850438,0.8043478260869565,1.0,1.0,3/5,23.38%,PIH1D1;SIRT1;TAF7
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.40505969213451953,0.6179661332551857,0.8536585365853658,1.0,1.0,1/5,10.40%,IL17D
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.40505969213451953,0.6179661332551857,0.8536585365853658,1.0,1.0,1/5,10.40%,IL17D
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3650496027591055,-0.6177992159784174,0.9107142857142857,1.0,1.0,3/9,27.32%,PTPN11;PRKCZ;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3650496027591055,-0.6177992159784174,0.9107142857142857,1.0,1.0,3/9,27.32%,PTPN11;PRKCZ;SORBS1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.40012740488829457,-0.6173317250868837,0.9152542372881356,1.0,1.0,2/6,26.34%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.34813171029586387,-0.6170093766753988,0.9516129032258065,1.0,1.0,2/16,18.59%,AR;CDK5
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.3099218003385955,0.6166143900481527,0.8888888888888888,1.0,1.0,5/11,30.41%,CNEP1R1;PRKCA;NEK9;CCNB1;LPIN1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.406236055332441,0.6164904091868253,0.8636363636363636,1.0,1.0,5/5,59.39%,ROCK2;ROCK1;TMBIM1;IL18;IL23A
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.3900334288973847,-0.6164808442154729,0.9047619047619048,1.0,1.0,2/7,31.66%,PROX1;MYLK
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.3829031332659123,-0.6163143321826173,0.8852459016393442,1.0,1.0,4/7,21.73%,SLC22A4;SLC22A3;SLC25A48;SLC22A1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.33182100390561975,-0.6162754036192436,0.9841269841269841,1.0,1.0,4/25,21.59%,LRRK2;DNM1L;VPS35;AURKA
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.33007651659066467,-0.6154895958820161,1.0,1.0,1.0,8/16,29.54%,LRFN5;IL31RA;CD200;IL33;WNT5A;LBP;TNIP2;CD74
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.3879565045588589,-0.6150255145934191,0.8955223880597015,1.0,1.0,2/6,28.10%,ELOVL2;ELOVL4
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.3879565045588589,-0.6150255145934191,0.8955223880597015,1.0,1.0,2/6,28.10%,ELOVL2;ELOVL4
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.3879565045588589,-0.6150255145934191,0.8955223880597015,1.0,1.0,2/6,28.10%,ELOVL2;ELOVL4
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.3879565045588589,-0.6150255145934191,0.8955223880597015,1.0,1.0,2/6,28.10%,ELOVL2;ELOVL4
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.29918386909175637,-0.6148316359643047,0.9855072463768116,1.0,1.0,8/39,25.32%,MAP3K5;AQP1;ZNF580;TRPM2;ADAM9;PRKCD;IMPACT;PPIF
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.3714085879997549,-0.6146073207261535,1.0,1.0,1.0,1/9,8.05%,AR
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.39900758749192344,-0.6138503450719448,0.9215686274509803,1.0,1.0,1/5,16.32%,LIG3
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.32839556947489246,-0.6137014553406448,0.9206349206349206,1.0,1.0,3/20,16.82%,CELF4;RBM3;NCBP1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.32218368393031427,-0.6133687406234856,0.9365079365079365,1.0,1.0,2/23,6.69%,EPHA4;EFNA1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.3243793106259852,-0.6132802366351696,0.9565217391304348,1.0,1.0,6/19,25.32%,FKBP5;NKTR;FKBP1B;PIN1;PPIH;PPIF
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.31570282101561825,-0.6130589903556359,0.9090909090909091,1.0,1.0,4/23,21.59%,EDN1;TGFA;PDGFRB;AURKA
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.38005177807632196,-0.6129728347531538,0.9206349206349206,1.0,1.0,1/7,9.54%,PCGF3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.2978561990419881,0.6129663310418645,0.9444444444444444,1.0,1.0,8/29,22.83%,NCSTN;ABL1;MAPK8;ABL2;MID1IP1;PHACTR4;CIB1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.367758558936238,-0.6127827299043787,0.9152542372881356,1.0,1.0,3/9,11.80%,C5;RIN3;SLAMF8
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.23843577435043703,0.6123295820978788,1.0,1.0,1.0,43/283,16.71%,TRARG1;NUTF2;LTBP2;TBC1D12;NUP42;PPP1R10;EVI5L;SGSM1;RAB32;ERP29;RANBP17;MYO1C;SNX1;USP6NL;AP4B1;GGA2;FAM53A;AKT2;STX10;VPS25;STX6;AP3D1;TMED5;TPR;HERC2;LMAN1;IPO5;GGA3;SRPRA;RAB24;STXBP3;UNC93B1;VPS26B;SEC31A;KIF13B;SNX27;SGSM2;NXT2;RAB23;TRAK1;NPM1;VPS29;ARFIP2
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3056566959882303,0.6122503518722544,0.9761904761904762,1.0,1.0,3/15,13.10%,SPRY2;SPRY3;SHISA2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.3414009451233766,-0.6121804471462389,0.896551724137931,1.0,1.0,2/16,11.80%,LAPTM5;SLAMF8
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.3900436220388632,-0.6121328600770009,0.9523809523809523,1.0,1.0,2/8,12.76%,ATP1B2;ATP1A1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.42120507180858113,-0.6119035236633144,0.921875,1.0,1.0,1/5,31.32%,MCM3AP
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.31015085140463716,-0.6116131909028375,0.9411764705882353,1.0,1.0,3/23,16.47%,CX3CR1;TNFRSF1B;PRKAB2
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.3528796667305475,0.6115776974132686,0.9210526315789473,1.0,1.0,6/11,31.37%,CDC42;ARCN1;HOOK3;PDCD10;ARHGAP21;TBCCD1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.30796627512688973,-0.6115677541744517,0.9838709677419355,1.0,1.0,7/31,22.74%,PLCB3;PLCB1;GNG2;MOV10;PPP3CA;FZD3;WNT5A
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.30268990035678545,-0.6114186945847607,0.9824561403508771,1.0,1.0,6/35,18.31%,CLU;ABCG5;CAV1;SCARB1;MSR1;ABCA1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.31771086875730603,-0.6107066280764246,1.0,1.0,1.0,5/32,15.99%,DUOX1;AQP1;HCN1;STAT1;DMTN
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.34555295003997233,0.6097422145441319,0.9285714285714286,1.0,1.0,4/9,22.70%,ZSWIM4;ZSWIM8;YTHDF1;ZSWIM5
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.33599579700764337,-0.609585732269464,0.8955223880597015,1.0,1.0,6/17,22.01%,RFC3;RFC4;RAD50;MCM7;MRE11;GINS1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.3649689793089348,0.6095557978817406,0.8947368421052632,1.0,1.0,2/6,17.66%,QDPR;KYAT1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.32708584535944074,0.6095218865923663,0.9444444444444444,1.0,1.0,2/13,14.41%,ATF4;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.34162221746850263,-0.6090815454741021,0.984375,1.0,1.0,3/15,19.66%,STAT1;PLXND1;KAT2B
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.2951345593305636,-0.6090219951267961,1.0,1.0,1.0,9/42,19.11%,RHOC;SEPTIN6;CENPA;RASA1;MYH10;TTC19;CIT;CKAP2;SNX33
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.32022371590810444,-0.6088949808512366,0.9508196721311475,1.0,1.0,4/18,15.76%,RIN3;LRPAP1;DLG4;ITGAV
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.37131543125611677,-0.6085942700028405,0.8852459016393442,1.0,1.0,3/8,34.08%,LANCL1;FYN;PINK1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.3783632883673141,-0.6085801835964335,0.9076923076923077,1.0,1.0,2/8,23.65%,RREB1;FERMT1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.2902839824046935,0.6085477952662982,0.9696969696969697,1.0,1.0,2/24,10.38%,PRR5;MLST8
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.36744229783713855,0.6084727011683271,0.8918918918918919,1.0,1.0,2/10,3.95%,HMGB1;RUNX1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.3349403252642525,-0.6082575306470397,0.9661016949152542,1.0,1.0,3/14,17.29%,OR2M4;GNAL;SLC24A4
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.39940359405299025,0.6080286275829561,0.9148936170212766,1.0,1.0,1/6,4.39%,ST3GAL1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.32828140376157816,-0.6076282057998295,0.9864864864864865,1.0,1.0,5/14,23.77%,MDM1;BRCA1;PLK2;KAT2B;CEP76
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.38789272565071364,-0.6075528805997273,0.9333333333333333,1.0,1.0,3/10,23.53%,MAPK8IP1;HIPK3;ZNF675
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.378767926145901,0.6073671763103329,0.851063829787234,1.0,1.0,1/5,20.03%,RAN
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.3744753520676196,0.6063364375077335,0.9090909090909091,1.0,1.0,2/7,9.23%,HMGB1;SERPINE1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.2602349230781212,-0.6059216226834471,0.984375,1.0,1.0,11/67,23.93%,RPS6KA6;E2F1;RBL2;GTSE1;CDKN1A;PLK2;ARID3A;AURKA;ZNF385A;PLAGL1;TFAP4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.2484237894250578,0.6059076258973617,1.0,1.0,1.0,33/105,24.37%,EIF3E;RPS3A;RPS15A;HELZ2;RBM8A;DCP1A;RPL18A;PNRC2;RPS23;RPSA;DHX34;SMG9;RPL23A;SMG5;RPL3;RPL11;RPS3;MAGOH;RPL13;RPS8;RPL8;RPL21;RPL5;PPP2R2A;RPL32;RPL7;RPS16;RPS18;ETF1;RPS6;RPS2;RPL41;RPL29
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.37481541358968035,-0.6055234552650489,0.9242424242424242,1.0,1.0,1/8,6.61%,RAB11A
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.3824398609144031,-0.6051678917161278,0.9365079365079365,1.0,1.0,2/10,14.83%,DNAH7;CCDC39
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.34521361092842473,-0.6048868951934501,0.9253731343283582,1.0,1.0,1/12,4.47%,NFKBIE
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.3886872116565728,0.6046666337135838,0.9038461538461539,1.0,1.0,3/7,20.03%,LTV1;NPM1;RAN
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.23527825083818962,-0.6044391059585177,1.0,1.0,1.0,55/303,24.98%,PPARG;CLU;GPIHBP1;CENPF;RPGR;LAPTM5;GRTP1;VAMP5;RAB3C;AMN;STX3;OLFM2;GOLGA4;ATP6V1C2;USP6;SAR1A;TBC1D10A;RAB3A;YWHAH;LRP1;SCG2;RAB1B;NGFR;RAMP1;SCAMP5;RAB15;TVP23A;NAPG;TMED10;RIC1;ABCA1;TBC1D8B;SNX33;RAB6B;TBC1D9;ATP6V1D;STX19;WLS;VPS35;ARF1;ARF5;REP15;KIF3A;CHMP1A;ARL1;STX17;PICK1;CANX;ABCA12;WDR11;TBC1D2;EHD1;RAB6C;ATP6V0D2;SCG5
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22820568520205128,0.6044059362653857,1.0,1.0,1.0,13/132,12.88%,TUBA1A;PSME2;PINX1;TPX2;PCM1;PSMD13;CEP290;CEP164;DBF4B;TUBG1;HAUS5;PLK4;PSME4
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.4069162443459694,-0.6043359717215259,0.9180327868852459,1.0,1.0,1/6,7.12%,B2M
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.32141406880165413,-0.6041444947967498,0.9705882352941176,1.0,1.0,9/25,29.99%,SLC4A10;SLC9C1;SLC9C2;SLC9A7;SLC4A4;SLC9A5;SLC9B1;SLC4A9;SLC9A9
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.4099567455136177,-0.6037884970177655,0.9298245614035088,1.0,1.0,3/5,36.63%,RABGGTB;RABGGTA;CHM
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.29878508138500043,0.6031831479345285,0.96875,1.0,1.0,1/29,1.18%,TCOF1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.259728365725696,-0.6029978330731817,0.9852941176470589,1.0,1.0,13/70,24.07%,RPA3;RFC3;RFC4;PRPF19;UVSSA;LIG3;RPA2;RBX1;POLR2J;COPS7A;RPA1;XPA;MNAT1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.4045382224703995,-0.602966822032647,0.896551724137931,1.0,1.0,1/6,18.55%,CEP135
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.30538564854282546,-0.6027789883391161,0.96875,1.0,1.0,7/34,18.31%,RAB3C;OLFM2;RAB3A;SCG2;RAB15;TVP23A;ABCA1
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.37449799196787137,0.6027164525492109,0.95,1.0,1.0,5/5,62.56%,ADCYAP1;CHD7;DRD2;GHRL;SELENOT
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.32664408165963005,0.6021990247171991,0.9333333333333333,1.0,1.0,3/14,11.20%,SMC6;RAD52;DMC1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.342542641899173,-0.6019597832758695,0.9333333333333333,1.0,1.0,4/9,26.96%,SLC26A4;SLC9A7;PDK2;CLCN3
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.3722376946147584,-0.6016120540463125,0.9,1.0,1.0,1/8,7.12%,B2M
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.25890187122844793,-0.6015746627085263,1.0,1.0,1.0,21/105,20.87%,NYAP1;SOX9;DDAH1;FNDC4;CPE;NR2F1;NGEF;EGFR;DZIP1;PHYHIP;FAT1;GPR37L1;MAPK8IP1;SMIM10L2B;ANTXR1;NDRG4;SHROOM2;TMEM59L;KIAA1549L;LARP6;FARP1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.27106287787982764,-0.6015459000019523,1.0,1.0,1.0,5/53,12.33%,CHKB;PLAAT4;SLC44A3;ABHD3;PLA2G12A
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.3329447817616669,-0.6013828130218982,0.9142857142857143,1.0,1.0,3/18,20.23%,EEF1AKMT2;SETMAR;SETD1A
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.37370727633806095,-0.6012464652997769,0.9565217391304348,1.0,1.0,5/9,23.58%,ACMSD;KYNU;KMO;HAAO;TDO2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.37370727633806095,-0.6012464652997769,0.9565217391304348,1.0,1.0,5/9,23.58%,ACMSD;KYNU;KMO;HAAO;TDO2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.34877781178064327,0.6011800965857651,0.9333333333333333,1.0,1.0,3/9,23.12%,SLC45A3;MID1IP1;NR1H3
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.3093797088761636,-0.6009471992270078,0.9714285714285714,1.0,1.0,4/30,12.16%,LRRK2;SLC4A10;SLC9C1;SLC9C2
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.29205748471150755,-0.6009043094682027,0.9733333333333334,1.0,1.0,14/54,21.95%,SLC1A1;SLC23A1;SLC25A19;SLC6A8;SLC25A22;SLC25A41;SLC7A8;SLC25A21;SLC1A6;SLC1A2;ABCC5;SLC25A12;SLC35A2;SLC25A42
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.3469136643226576,-0.6005360671546357,0.958904109589041,1.0,1.0,6/13,23.83%,ACMSD;KYNU;KMO;HAAO;TDO2;FAH
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.29937933124088223,0.6002632995566612,0.9714285714285714,1.0,1.0,4/30,10.62%,PINX1;CTC1;DCLRE1B;DKC1
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.37104412738045217,0.6002433410650172,0.8085106382978723,1.0,1.0,4/6,22.26%,GRK5;GRK2;TACR3;TAC1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.34589806809347434,0.5986908510283128,0.9166666666666666,1.0,1.0,2/14,8.31%,DSEL;DSE
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.29112503046091165,-0.5980877757708153,0.9696969696969697,1.0,1.0,1/35,2.48%,EPHA3
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.3126371445355123,-0.5980804311889693,0.9642857142857143,1.0,1.0,3/24,15.85%,DTX3L;UHRF1;ATXN7L3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.2843520559720414,0.597686279726533,0.9487179487179487,1.0,1.0,6/48,11.11%,GDAP1;GRPEL2;TIMM23;SAMM50;GRPEL1;AIP
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.35423014928574914,-0.5968491559089194,0.9354838709677419,1.0,1.0,3/12,28.27%,ZWILCH;MTBP;SPDL1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.38453608063832073,-0.5966045524047324,0.9322033898305084,1.0,1.0,3/6,34.71%,FANCB;RAD21L1;XRCC1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.24963585075728842,0.5965408703905387,1.0,1.0,1.0,11/123,9.89%,PTPRU;DUSP1;EYA4;PPM1M;PPP4R2;MTMR2;NCK1;PPP2R2C;DUSP7;PTPRD;PTPN22
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.344482081620189,-0.5963319919210557,0.9230769230769231,1.0,1.0,4/12,23.97%,BMX;EGFR;ITK;TEC
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.3108868828701628,-0.5961622137901643,0.9666666666666667,1.0,1.0,2/26,9.79%,VIM;DYNC1LI1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.393181223713496,-0.5960965095321755,0.953125,1.0,1.0,1/6,4.00%,TGFBR2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.3749328789101729,0.5956875937549252,0.8837209302325582,1.0,1.0,2/6,17.76%,NDUFV3;NDUFV1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.2811473656465333,0.5953995628372561,1.0,1.0,1.0,5/34,13.43%,HMGB1;HDAC10;RAD52;DMC1;THAP9
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.3083189198236901,0.59521732733103,0.875,1.0,1.0,10/10,69.19%,BAD;BAX;VDAC2;BNIP3L;BCL2L11;RHOT2;BLOC1S2;BNIP3;RHOT1;MOAP1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.30780856863335193,-0.5951747594999733,0.9863013698630136,1.0,1.0,6/29,19.27%,ANK1;LIN7A;LRRC7;OPHN1;CRB2;CAMSAP3
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.32300196855016966,-0.5942650572933894,1.0,1.0,1.0,4/18,20.36%,RAD50;SETMAR;BRCA1;MRE11
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.2567994771538714,-0.5936877254653272,1.0,1.0,1.0,17/106,25.60%,LAPTM5;KIF16B;DENND2A;CCDC91;TBC1D10A;DOP1B;HOOK1;SNX32;RIC1;RAB6B;HEATR5B;VPS35;VPS13A;ARL1;RAB6C;WASHC1;EHD3
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.38758483893429385,0.5932358184049897,0.8235294117647058,1.0,1.0,1/6,2.06%,CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.38758483893429385,0.5932358184049897,0.8235294117647058,1.0,1.0,1/6,2.06%,CTNNA2
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.24788317294115939,0.5929759616382483,1.0,1.0,1.0,26/155,17.29%,TMEM11;AIFM2;PTCD2;GDAP1;RAB32;TFB1M;ATAD3B;MSTO1;TIMM23;SLC25A33;PLD6;MYH14;SAMM50;AIP;TFB2M;PRDX3;PNPT1;AGTPBP1;POLG2;NIPSNAP2;CLUH;MTX2;TRAK1;PYROXD2;IMMP2L;HSD17B10
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.3457711144941441,-0.5925676468121707,0.9482758620689655,1.0,1.0,1/11,7.16%,ASAH2B
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.3457711144941441,-0.5925676468121707,0.9482758620689655,1.0,1.0,1/11,7.16%,ASAH2B
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.33346258182407384,-0.5924099032535424,0.9642857142857143,1.0,1.0,2/18,11.84%,SLC8A1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.33043596631911265,-0.5921472196718585,0.9666666666666667,1.0,1.0,4/14,25.58%,TGFB1;ESR1;KAT2B;NUDT16
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.3896405682218739,0.5920909207224689,0.9230769230769231,1.0,1.0,4/6,28.06%,DKC1;RPUSD2;TSR3;RPUSD1
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.3162739857624949,0.591977289486438,0.926829268292683,1.0,1.0,1/22,3.60%,MAP10
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.2609318455401408,-0.5916755085129738,1.0,1.0,1.0,9/96,17.57%,ARHGAP18;RIT2;ARHGAP31;RERG;TNK2;KSR2;CDKN1A;PLK2;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3099935215627213,-0.5911337982638663,0.9830508474576272,1.0,1.0,5/20,23.93%,INCA1;CDKN1A;NR2F2;MYOCD;TFAP4
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.28672694797945975,0.5908156288029361,0.9743589743589743,1.0,1.0,17/17,71.35%,MITF;MED4;PAXIP1;SRF;BCLAF1;SETX;MED13;JUN;MED1;HNF1A;MED12;MED24;MED30;SUB1;MED16;MED14;DHX36
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.3409009903055297,-0.5899178151394391,0.953125,1.0,1.0,1/15,11.17%,INTS12
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3552124453530688,0.5896140602241668,0.9166666666666666,1.0,1.0,3/8,20.54%,DRD4;GPR35;CALM1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.21219695706529274,0.5893528329291243,1.0,1.0,1.0,33/180,20.69%,CYB5A;ACAA2;ACADVL;IDH2;COX10;MPC1;MTRR;ATP6V1G1;ATP1B1;MRPL15;GRPEL1;UQCRFS1;ECHS1;COX5B;OAT;PRDX3;ECI1;ECH1;LRPPRC;MTX2;ATP5F1C;HSD17B10;FDX1;NDUFV1;MRPS30;TIMM9;ISCA1;CYC1;TIMM17A;OGDH;FH;HADHB;SURF1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.30528907033990127,-0.5890513752254186,0.9836065573770492,1.0,1.0,3/20,15.85%,DTX3L;UHRF1;ATXN7L3
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3247395216256922,-0.5883512745772476,0.9682539682539683,1.0,1.0,1/15,6.53%,SULT4A1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.3052520942297364,0.5881706725975145,1.0,1.0,1.0,3/21,11.03%,LAMB3;HMGA2;ITGA7
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.39667325017307364,-0.5880737339586319,0.9333333333333333,1.0,1.0,1/5,17.41%,TRPV4
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.3265085819287584,-0.5880500326834536,0.9705882352941176,1.0,1.0,3/16,20.36%,TERF2IP;RAD50;MRE11
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.335899074780989,0.5880491865042633,0.9428571428571428,1.0,1.0,3/8,20.82%,DEF8;ADAM8;PRKCA
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.22525345130611646,0.587908809934077,1.0,1.0,1.0,17/72,22.49%,PSME2;PSMD13;RYK;PFN1;CELSR3;MAGI2;PSME4;CELSR2;PSMF1;PSMD11;AP2S1;CDC42;PSMD4;AP2B1;RAC1;PSMB4;PSMB5
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.3661266193416141,-0.5877712901224177,0.9242424242424242,1.0,1.0,3/5,20.92%,KCNJ3;KCNH2;KCNE1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.256640239073289,-0.5877538739087628,1.0,1.0,1.0,5/84,10.38%,SEL1L2;RNF175;MAN1A1;FBXO17;TRIM25
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.39997026727959206,-0.5874895964289566,0.9166666666666666,1.0,1.0,2/5,11.22%,DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.24120969808212062,0.5871945064508749,1.0,1.0,1.0,18/91,16.92%,HMGA2;ACTR5;HDAC1;PIH1D1;SMARCD3;ZBTB1;SMARCA4;GATAD2B;DAXX;KDM5A;KAT2A;KDM5B;RBBP4;HDAC4;KDM5D;ZBTB7A;NPM1;CHD4
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.3727669549622447,-0.5871004348596622,0.95,1.0,1.0,4/5,31.73%,PMPCB;PMPCA;IMMP1L;MIPEP
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.28092563188893316,0.5870788078171765,0.96875,1.0,1.0,6/36,15.30%,VCPKMT;CARM1;ATPSCKMT;PRMT2;ICMT;FAM98A
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.36145451924120225,-0.5868753810701814,0.9838709677419355,1.0,1.0,3/10,16.12%,PRPS1;PRPSAP1;MTHFD1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.2952237428806225,-0.5866161692586188,1.0,1.0,1.0,6/28,19.46%,CITED2;MMP21;CCDC39;ENKUR;DNAH5;ODAD4
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.27378293584782226,0.5855321006754806,0.9166666666666666,1.0,1.0,4/19,21.04%,GFPT2;GFPT1;NANS;PMM1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.3816382562042037,-0.5851026932570197,0.921875,1.0,1.0,2/6,27.68%,NUDT16;METTL3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.23875386808849686,0.5850540856133539,1.0,1.0,1.0,3/50,8.32%,PSME2;PINX1;PSMD13
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.38419107581033163,-0.584829194535092,0.9056603773584906,1.0,1.0,1/5,6.61%,RAB11A
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.29536508449749865,0.5843368029279913,0.96875,1.0,1.0,2/19,7.42%,NT5E;HPRT1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.3513444391410575,0.5840004810960352,0.9607843137254902,1.0,1.0,1/6,7.67%,PIH1D1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.3421961951132661,0.5832396697850694,0.926829268292683,1.0,1.0,1/7,7.91%,HMGCR
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3122092114934343,-0.5832332458482449,0.9444444444444444,1.0,1.0,4/24,14.82%,LRRK2;FBXO7;NOL3;GPR37L1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.3582262129757863,0.5830562478051234,0.9787234042553191,1.0,1.0,2/7,12.58%,HMGA2;NUDT16L1
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.3526213199852816,-0.5828623484632972,0.9508196721311475,1.0,1.0,2/6,18.47%,NMD3;NUP88
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.36618845936479893,0.5816420771913673,0.975,1.0,1.0,1/7,6.59%,SNAI1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),-0.38566003002415994,-0.5812701969357037,0.9423076923076923,1.0,1.0,2/6,17.77%,B3GALT1;B3GALT2
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),-0.38566003002415994,-0.5812701969357037,0.9423076923076923,1.0,1.0,2/6,17.77%,B3GALT1;B3GALT2
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.3909313363430442,0.5809773813719725,0.9487179487179487,1.0,1.0,3/5,31.56%,JAK3;RC3H1;SMAD7
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2310992652787496,0.580443757306729,1.0,1.0,1.0,6/65,12.88%,PSME2;UBC;PSMD13;UBB;ELOC;PSME4
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.28493955957536343,-0.579729569596642,0.9710144927536232,1.0,1.0,8/23,23.48%,MUSK;THY1;DLG4;LRRC7;NRXN1;PTN;ITGB1BP1;PICK1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.30558531712442416,-0.5796896341298106,0.9310344827586207,1.0,1.0,3/19,15.99%,DDIT4;CAV1;DMTN
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.32448104132083105,0.577728381487195,0.9090909090909091,1.0,1.0,1/7,7.67%,PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.25529535379565493,-0.5776434124982319,1.0,1.0,1.0,16/71,25.66%,PLSCR1;EDN1;DBF4;DYNC1LI1;TGFA;MAD2L1;CIT;KIF20B;PDGFRB;AURKA;DDX11;CDC7;SVIL;GEN1;NUDT16;GIPC1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.27080777857874216,-0.5772834058580388,1.0,1.0,1.0,12/40,27.47%,ALOX12;PTGR1;AWAT1;FAAH2;SCD;GPX4;ACOT8;ELOVL2;PLA2G4A;EPHX1;FADS2;GPX1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.3160077172761976,-0.5772182535133339,0.9846153846153847,1.0,1.0,2/19,8.48%,LRRK2;XBP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2961200573451417,-0.5770743810222658,0.9850746268656716,1.0,1.0,6/29,16.63%,UBASH3B;PTPRB;PTPRT;PTPRZ1;PTPN13;PTPRJ
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.3311330876350101,-0.5770595578018495,0.9565217391304348,1.0,1.0,4/14,25.07%,PKD1L3;GPR68;IMPACT;HVCN1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.32237725817208995,-0.5768774830373846,0.9672131147540983,1.0,1.0,4/14,23.58%,CAMK1;GTSE1;GAS6;BAG3
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),-0.3741527102433041,-0.5762338795283799,0.9795918367346939,1.0,1.0,2/7,17.77%,B3GALT1;B3GALT2
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.3623490723271445,-0.575942762395699,0.9166666666666666,1.0,1.0,2/7,26.72%,ABCD2;SLC27A2
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.339143665121458,-0.5758274387084567,0.9137931034482759,1.0,1.0,2/10,13.99%,SGMS2;SMPD3
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.36449938202209153,0.575767900958651,0.8837209302325582,1.0,1.0,2/6,17.52%,PLIN5;DAGLB
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.298509251492948,-0.5754787197145438,0.9692307692307692,1.0,1.0,6/21,22.11%,ABCB1;ABCB4;ATP8B1;ATP8B4;ABCA1;ATP9A
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.27300062380816564,0.5747697298979214,1.0,1.0,1.0,5/37,12.86%,UBC;NCSTN;GGA2;UBB;GGA3
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.288770954674616,-0.5747163114365237,0.984375,1.0,1.0,3/28,13.72%,TWF2;CAV3;PLEKHH2
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.22519850657476384,0.574295872019247,1.0,1.0,1.0,19/142,15.02%,TTC5;PRR5;NOC2L;KMT5A;TPX2;PPP1R13L;TAF13;HDAC1;TAF12;BRPF1;TAF5;MLST8;CCNG1;DAXX;TAF3;PRKAA2;RBBP4;ATR;RAD1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.29269161765991025,-0.5741335516175053,0.9344262295081968,1.0,1.0,6/21,23.59%,KREMEN1;GLI3;BMPR1B;KAT2B;IFT122;RSPO2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.3796487526424867,-0.5741122120650148,0.9090909090909091,1.0,1.0,2/5,26.04%,KDM6A;KDM6B
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.2367016958072884,0.5737470807319541,1.0,1.0,1.0,9/53,20.18%,PSME2;NQO1;PSMD13;PSME4;PSMF1;PSMD11;SIRT1;PSMD4;PANK2
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.37327816854373613,0.5737310750782171,0.9285714285714286,1.0,1.0,1/5,6.57%,FBP1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.30368712830198935,-0.573458610395956,0.95,1.0,1.0,4/18,23.16%,FBXO7;SREBF1;DNM1L;HAX1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.3623704802377081,-0.5732145217298141,0.9375,1.0,1.0,3/8,30.26%,NFATC2;HEY2;FGF9
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.3900262368443115,-0.5730270450639928,0.8888888888888888,1.0,1.0,1/5,12.38%,APAF1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.2288906953164904,0.57283722160264,1.0,1.0,1.0,26/88,24.37%,SRP9;RPS3A;RPS15A;RPL18A;SRPRA;RPS23;RPSA;SSR2;RPL23A;RPL3;RPL11;RPS3;SEC61A1;RPL13;RPS8;RPL8;RPL21;RPL5;RPL32;RPL7;RPS16;RPS18;RPS6;RPS2;RPL41;RPL29
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.36716221016247286,0.5727449208207398,1.0,1.0,1.0,1/8,9.76%,RAB7B
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.37271537655052056,-0.5721445569964776,0.9661016949152542,1.0,1.0,1/7,17.72%,CLOCK
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.3298601484784719,0.5721250706263357,0.9534883720930233,1.0,1.0,2/6,14.95%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.28178154766497066,0.5718982199745113,0.9333333333333333,1.0,1.0,4/17,22.36%,ATP6V0A4;CLN6;CLN3;ATP6V0E1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.33171561765937574,0.5715313470726422,0.9459459459459459,1.0,1.0,2/12,12.51%,COX10;COX5B
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.3557256139066871,0.5713829559370417,0.95,1.0,1.0,1/7,7.32%,SEC61A2
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.3664820746304145,-0.5712577173078156,0.9795918367346939,1.0,1.0,2/7,26.50%,LIG3;TOP3A
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.27774970046392516,0.5712162787093479,1.0,1.0,1.0,9/36,19.27%,MTCL1;NUMA1;ZNF207;NAV1;PSRC1;JHY;TTLL3;NCKAP5;RSPH4A
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.3206155993734278,0.5711841051023175,1.0,1.0,1.0,4/12,20.76%,FARSB;KRT10;FARSA;PKD1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.313943920662758,0.5705950081702916,0.9761904761904762,1.0,1.0,1/13,6.33%,SELP
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.3791655843955736,-0.5705388809221336,0.95,1.0,1.0,2/8,16.34%,STAT5A;SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.3791655843955736,-0.5705388809221336,0.95,1.0,1.0,2/8,16.34%,STAT5A;SYK
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.24541716936669217,0.5704734631994165,1.0,1.0,1.0,24/91,22.95%,BET1;GBF1;TMX1;GLA;ERGIC3;DST;VAMP4;LMAN1;SEC22B;GALC;SEC31A;TSPAN8;STX7;SGMS1;STX12;AP2S1;AP3S1;ARCN1;AP2B1;COG2;RAB9A;ARFIP1;SOD1;ARFGEF1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.354100528170468,-0.5703961467113701,0.9661016949152542,1.0,1.0,2/14,18.16%,NRG1;EPAS1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.344572570803323,0.5702606705533909,0.9767441860465116,1.0,1.0,3/6,32.72%,SEC14L1;NPLOC4;UFD1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.22179802188611442,-0.5701247905364264,1.0,1.0,1.0,35/316,20.91%,ARIH2;TRIM9;RNF217;DTX3L;PSMB8;PRAME;RNF150;SIAH3;RNF144B;XBP1;MVB12A;HECW1;UBL7;TRIM25;CBLC;FBXO7;NEDD4L;FBXO10;KLHL15;TRIM32;RNF213;UHRF1;ANKRD9;SIAH1;TOM1L1;MAD2L1;PSMC3;CLOCK;RNF111;RNF215;DTL;RBX1;RNF5;TRIM13;KCTD2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.34465930832189934,-0.5700512077589229,0.9523809523809523,1.0,1.0,3/10,17.05%,XYLT2;CSGALNACT1;B3GAT2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.23478925454185315,-0.5695926139240012,1.0,1.0,1.0,6/105,8.45%,KCND2;PSMB8;SCN2A;AQP1;HIF3A;SLC8A3
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.361229975656425,-0.5695259844672437,0.9682539682539683,1.0,1.0,1/8,7.20%,CX3CR1
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),-0.400444399139972,-0.5687976702603939,0.9649122807017544,1.0,1.0,1/5,10.41%,DDO
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.2364131102240489,0.5685074671253597,1.0,1.0,1.0,25/85,24.37%,SRP9;SEC61A2;RPS3A;RPS15A;RPL18A;RPS23;RPSA;RPL23A;RPL3;RPL11;RPS3;SEC61A1;RPL13;RPS8;RPL8;RPL21;RPL5;RPL32;RPL7;RPS16;RPS18;RPS6;RPS2;RPL41;RPL29
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.25096801496045645,-0.5682318773617615,1.0,1.0,1.0,14/75,24.51%,CENPE;RAB1B;KIF2C;KIF3C;TMED10;TAPBP;KIF5A;RAB6B;ARF5;KDELR3;ATP9A;KIF3A;PICK1;RAB6C
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.24735188875384434,-0.567932363824889,1.0,1.0,1.0,11/58,20.36%,CYREN;POLQ;PRPF19;ATP23;RAD50;SETMAR;NHEJ1;BRCA1;LIG3;IFFO1;MRE11
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.2520853012544957,0.5673739931855285,0.972972972972973,1.0,1.0,11/41,22.35%,FLNA;ANP32B;TPR;IPO5;HDAC3;DHX9;DMAP1;RBM22;RAN;JUP;RAPGEF3
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.34762583467247826,0.5662811540738949,0.9111111111111111,1.0,1.0,4/8,21.45%,FUCA1;GLA;ABHD10;NAGA
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.31309524345255274,0.565674508507645,1.0,1.0,1.0,4/13,17.98%,FAM47E;ZMIZ1;CDCA4;PADI2
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.3351079507796152,-0.565502187535603,0.9322033898305084,1.0,1.0,1/9,11.84%,CAV1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.3594377510040161,0.5654837860785981,0.9629629629629629,1.0,1.0,5/5,64.07%,ATP8A1;ATP8A2;SCARB2;ATP11B;TMEM30A
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.2784623800550784,0.5653983552222289,0.9743589743589743,1.0,1.0,4/14,25.34%,CYRIB;ARFGEF1;GSN;ROCK2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.26895639600750765,0.5647908603258378,0.9736842105263158,1.0,1.0,2/19,10.87%,SMDT1;MCUR1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.34853090745196935,-0.5647286215582666,0.9215686274509803,1.0,1.0,2/10,11.06%,CITED2;DNAJB1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.3166100640787124,-0.564697274686903,0.9333333333333333,1.0,1.0,1/14,12.33%,PLA2G12A
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.3659648629599761,-0.5645029075883673,0.9836065573770492,1.0,1.0,3/10,23.94%,PKD1L3;CTSS;IMPACT
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.2656731170111913,0.5638735868569941,0.96875,1.0,1.0,2/26,11.92%,ERI1;TENT4B
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.21231269831987729,0.5636053391299533,1.0,1.0,1.0,21/294,12.88%,FEM1A;SPSB2;PSME2;UBC;DMAC2;AUP1;UBXN4;UBE2A;CDC26;IFI27;UBE2J2;PSMD13;ANAPC15;TMEM129;UBB;MAEA;FBXL14;ITCH;UBQLN2;AMFR;PSME4
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.35326958988380286,-0.5635059865593993,0.9375,1.0,1.0,1/5,13.14%,TST
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),-0.36374623699347386,-0.5627160529761414,0.9508196721311475,1.0,1.0,2/5,22.69%,FGF13;LHX6
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.28778105325666004,0.5622797810676117,0.9473684210526315,1.0,1.0,9/27,24.06%,VAPB;STAU1;NR5A2;DDX3X;FKBP6;RAD23A;PDE12;HACD3;LARP1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.31807558527197666,-0.5620286346771521,0.9846153846153847,1.0,1.0,3/13,27.59%,TYMP;DCK;PUDP
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.2375954865022441,-0.5618598319718873,1.0,1.0,1.0,14/98,19.76%,VAV3;FOS;PSMB8;CARD11;LYN;NFATC2;LAT2;SYK;PIK3CB;PPP3CA;PRKCQ;PSMC3;ITK;PLCG1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.29391481896794336,0.5613866290625346,0.9024390243902439,1.0,1.0,5/13,30.41%,CNEP1R1;PRKCA;NEK9;CCNB1;LPIN1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.3263029588001057,0.5609110089325919,0.9743589743589743,1.0,1.0,7/11,31.60%,ZMIZ1;CDCA4;PADI2;ARID1B;ARID1A;CHEK1;ELOF1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.24530546190057106,-0.5604779400623143,1.0,1.0,1.0,21/96,25.02%,MAP3K5;TTC23L;TMEM117;CEBPB;FLOT1;ATG10;PPP1R15A;RASGRF2;BBC3;SCAMP5;BCAP31;CREB3L1;RNF139;RNF5;TMEM33;HYOU1;HSPA5;TNFRSF10B;UBA5;ITPR1;DNAJB12
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.29097941321145415,-0.5603339057170748,0.9838709677419355,1.0,1.0,3/21,12.42%,CCND1;PLCB1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.33847043339486865,0.5601148287277115,0.875,1.0,1.0,2/5,28.09%,PRKN;STX1B
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.2841959577588484,0.5598393425662956,1.0,1.0,1.0,3/18,14.75%,NCSTN;NFKB1;RELA
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.31527605577405715,-0.5595253021461709,0.9516129032258065,1.0,1.0,2/11,19.38%,XKR4;RHOH
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.2767495687132325,0.5595116406520619,1.0,1.0,1.0,1/26,3.00%,OOEP
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.3116995628023728,-0.5591796537351655,0.9523809523809523,1.0,1.0,2/12,16.58%,GTPBP1;MOV10
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.38787007484609204,-0.5586660152501982,0.967741935483871,1.0,1.0,1/6,17.41%,PTPRN
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.3033530484511981,-0.5585221398562359,0.967741935483871,1.0,1.0,3/13,18.14%,SCARB1;PNPLA2;SREBF1
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.3334296827314231,-0.557081741179182,0.9230769230769231,1.0,1.0,5/11,34.91%,NNMT;MYOCD;PARG;HPF1;SETD5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.31698937254704707,-0.5569362144362122,0.9705882352941176,1.0,1.0,2/15,25.81%,NOL3;NME5
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.33466223742267953,-0.5566000318165031,1.0,1.0,1.0,2/12,16.11%,VEGFA;RHOJ
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.29700329272522197,0.5554254203889349,0.9555555555555556,1.0,1.0,3/16,16.18%,BAK1;THEM4;ALKBH7
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.3532299453308043,0.5550384766972838,0.972972972972973,1.0,1.0,7/7,64.69%,TMEM39A;CLEC16A;PHF23;HDAC6;UBQLN4;RUBCN;IRAK3
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.33327141229489665,0.5548710890749945,0.975609756097561,1.0,1.0,1/11,6.12%,IP6K2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.35023107538060827,-0.5546243063268455,0.9516129032258065,1.0,1.0,1/7,13.60%,PRKD2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.2949473194790802,-0.5543202806626002,0.9857142857142858,1.0,1.0,2/20,14.09%,ROMO1;COX18
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.3088583026917875,0.552779720784509,0.9333333333333333,1.0,1.0,4/15,15.33%,ABCA8;LCAT;ARV1;NPC2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.3111004680519876,0.5516760845217591,0.972972972972973,1.0,1.0,1/13,4.54%,PPP1R10
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.32468405591242455,-0.551106060580534,0.9692307692307692,1.0,1.0,2/11,24.49%,ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.28285505013724477,-0.549153828001045,0.9705882352941176,1.0,1.0,6/24,25.70%,ZDHHC15;TMED10;VPS13A;ARL1;PAQR3;CSNK1D
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.21845875860605932,0.5490761949212442,1.0,1.0,1.0,39/186,20.90%,TUBA1A;KDM8;NES;NASP;PCM1;CCNB3;EIF4EBP1;ACVR1;CEP290;CEP164;OPTN;USP37;CDK6;ACVR1B;TUBG1;CCNG1;HAUS5;ENSA;PLK4;LATS2;USH1C;EIF4E;BCAT1;ANAPC1;TUBB4A;AKAP9;ALMS1;CUL2;FBXL7;CTDP1;CDC23;DYNLL1;PPP1R12B;BTRC;PPP6C;RB1;CDC25B;CDKN2C;CCNA2
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.34569101018989873,-0.5490414694563549,0.9354838709677419,1.0,1.0,2/6,29.14%,LHFPL4;APOE
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.22655579274326518,-0.5489474999525344,1.0,1.0,1.0,16/98,24.12%,RPA3;RFC3;RFC4;PRPF19;UVSSA;LIG3;RNF111;RPA2;USP45;RBX1;POLR2J;COPS7A;RPA1;XPA;MNAT1;MMS19
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.2572883583722552,-0.5488107659711287,1.0,1.0,1.0,8/47,19.33%,SIPA1L1;THSD7A;FGF7;PTK7;DMTN;TRPV4;ANTXR1;NEDD9
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3177264480114428,-0.5485188783539298,0.9836065573770492,1.0,1.0,3/10,19.82%,EMC3;EMC10;EMC1
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.30991173241963005,-0.5484667459429999,0.9666666666666667,1.0,1.0,2/13,21.52%,SLC25A22;SLC25A12
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.21566907928669812,0.5483121905532019,1.0,1.0,1.0,41/142,24.94%,MRPL32;EEF1A1;FARSB;TNIP1;RPS3A;DARS1;RPS15A;MRPL3;MRPS7;RPL18A;GGTA1;HARS1;MRPS5;MRPL52;MRPL24;RPS23;RPSA;HARS2;MRPL13;RPL23A;MRPL43;RPL3;MRPS16;RPL11;RPS3;RPL13;RPS8;RPL8;RPL21;RPL5;RPL32;RPL7;RPS16;RPS18;MRPS18C;RPS6;RPS2;RPL41;RPL29;EIF4EBP2;CARNS1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.34806378318678266,-0.5474063783836963,0.9811320754716981,1.0,1.0,1/6,8.20%,ELAVL4
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.28698818668549286,0.5474008636078014,1.0,1.0,1.0,2/12,13.58%,MLLT3;HNRNPU
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.30440503605218805,-0.5472619260593727,0.9666666666666667,1.0,1.0,2/17,14.17%,GOLGB1;SNX10
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.2887516255838502,-0.5468790760358643,1.0,1.0,1.0,3/20,14.99%,DGKD;DOK1;AGT
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.29108163137850196,0.5466625562380653,0.95,1.0,1.0,2/13,14.08%,PARP3;KMT5B
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.29941228924370183,-0.54655242419917,1.0,1.0,1.0,3/17,19.10%,MAN1A1;SRP54;SEC61G
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3173827714850955,-0.5465222764786433,0.984375,1.0,1.0,1/11,8.48%,XBP1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.30123729030939206,0.5459829467513216,0.9767441860465116,1.0,1.0,1/10,7.67%,PIH1D1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.239015100331066,-0.5455856853269442,1.0,1.0,1.0,2/46,5.68%,ESYT3;B3GALNT1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.34502814540647375,0.5455101913782013,1.0,1.0,1.0,2/5,23.23%,CNTNAP2;CNTN2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.26689991728196133,0.5454791051492279,0.9714285714285714,1.0,1.0,16/44,24.09%,LLGL1;GGA2;RAB26;OPTN;COMMD1;VAMP4;GGA3;MACF1;GOPC;BLZF1;STXBP6;GCC2;GGA1;GOLGA7;SPTBN1;CCDC22
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.22132672569631756,-0.5454144772824883,1.0,1.0,1.0,26/189,21.91%,CENPE;ARHGAP4;CENPF;TUBA4A;SMC4;SORBS2;TOP2A;PALLD;RASA1;OPHN1;MYH10;NOTCH2;KIF2C;ARHGAP10;KIF3C;SYNPO;DOCK2;VCL;KIF20B;NEDD9;SHROOM2;ARHGEF3;FARP1;ABR;AURKA;TUBGCP2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.2820075871713159,-0.5452132272821082,1.0,1.0,1.0,4/30,12.03%,STX3;TMEM35A;CAV3;NEDD4L
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.27150111951412587,0.5445794098889764,1.0,1.0,1.0,6/22,22.72%,ZDHHC12;ZDHHC14;ZDHHC3;ZDHHC7;GOLGA7;ZDHHC20
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.27150111951412587,0.5445794098889764,1.0,1.0,1.0,6/22,22.72%,ZDHHC12;ZDHHC14;ZDHHC3;ZDHHC7;GOLGA7;ZDHHC20
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.29837362959188707,-0.5438967395956851,1.0,1.0,1.0,3/19,16.91%,SULF1;BMPR1B;CRB2
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.3433769832188345,0.5435719425944551,0.9130434782608695,1.0,1.0,3/6,28.22%,SALL1;SHANK3;ZSWIM6
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.31442165234925,0.5434881912065912,0.9354838709677419,1.0,1.0,1/10,2.87%,ALK
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.29365251940252257,-0.5431430837406195,0.9836065573770492,1.0,1.0,2/13,17.49%,TRMT9B;MOCS3
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.34989959839357443,0.542295346472361,0.9534883720930233,1.0,1.0,5/5,65.02%,CRYZ;ACAA1;GSTM3;GSTO1;GSTM4
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.3295587661069896,0.5421775599558215,0.9714285714285714,1.0,1.0,6/6,67.06%,STX1B;NLGN1;GPER1;DTNBP1;BAIAP3;SLC4A8
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.32908958150792816,-0.5407265555371416,0.967741935483871,1.0,1.0,3/9,32.54%,PARD6A;CEP72;CEP250
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.3167011079442372,-0.5405066051812895,0.9661016949152542,1.0,1.0,2/14,15.52%,TERF2IP;RAD50
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.21593609545336567,0.5399463499375101,1.0,1.0,1.0,21/104,17.62%,SRPRB;BANF1;ATF4;H2AX;TARS1;EIF4EBP1;DCP1A;SDAD1;DKC1;NOLC1;MTHFD2;CKS1B;NABP1;SRPRA;EIF4E;ATF3;IARS1;SEC31A;NPM1;PSAT1;SLC7A5
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.23469500888685801,0.53974931913145,1.0,1.0,1.0,7/68,12.78%,NUTF2;PPP1R10;RANBP17;FAM53A;RGPD4;TPR;IPO5
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.3322183041403131,0.5383487490276063,0.8709677419354839,1.0,1.0,1/5,9.02%,AKT2
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.23505002250858842,0.5381753030015762,1.0,1.0,1.0,19/67,24.56%,ATF4;ATP6V1G2;ATP6V1G1;MLST8;MAPK8;LAMTOR4;RNF152;WDR59;DAPL1;SESN1;CASTOR2;EIF2S1;SEH1L;SLC38A9;MTOR;ATP6V0E1;MIOS;LARP1;KPTN
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.2965299469213538,-0.5378622357495938,0.9491525423728814,1.0,1.0,3/16,16.20%,ST3GAL5;ST8SIA3;ST6GALNAC5
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.29891213389121346,0.537820401034703,1.0,1.0,1.0,8/8,70.12%,VPS8;VPS11;ANKFY1;TGFBRAP1;VPS39;VPS41;SAMD9;VPS4A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.3429466527368321,0.5377275659679343,0.9069767441860465,1.0,1.0,3/7,12.81%,DCP1A;PNRC2;DCP1B
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.3491141526748527,-0.5371076897143865,0.9818181818181818,1.0,1.0,1/5,8.20%,ELAVL4
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.35552695524844935,-0.5366762012683947,0.9508196721311475,1.0,1.0,2/5,38.90%,SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.35552695524844935,-0.5366762012683947,0.9508196721311475,1.0,1.0,2/5,38.90%,SLC25A30;SLC25A14
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.2615902624461775,0.5364360236404161,1.0,1.0,1.0,6/34,18.18%,ATF4;TBL2;BECN1;PRKAA2;PIK3R4;SESN1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.30295727969919334,0.5360576656599453,1.0,1.0,1.0,1/9,12.14%,ITCH
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.2716934422022498,0.5360259537598309,0.975609756097561,1.0,1.0,1/13,5.86%,ENPP1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.28934842994032844,0.5359778540457999,0.9583333333333334,1.0,1.0,4/14,20.16%,BCKDK;ADIPOR1;SIRT1;FOXK1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2826630886252981,-0.5351958268801439,0.9701492537313433,1.0,1.0,4/21,24.55%,MVB12A;VPS4B;CHMP1A;TMEM50A
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.25758443440557943,-0.5350976379602426,1.0,1.0,1.0,7/42,22.44%,CELF4;CELF2;PRPF19;NOL3;NCBP1;SRSF5;GCFC2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.3243269142750928,0.5346132426137247,0.9142857142857143,1.0,1.0,1/5,16.57%,CEP120
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.26055486882734863,0.5343116658584994,1.0,1.0,1.0,2/30,9.89%,DICER1;PRKRA
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.31760273244062875,-0.5341985981014891,0.9661016949152542,1.0,1.0,2/9,19.23%,SLAMF8;ECSIT
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.3502882949271393,-0.5336457845116115,0.9661016949152542,1.0,1.0,1/6,15.07%,TGFB1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.3404730031236056,0.5320749682853856,0.9215686274509803,1.0,1.0,5/5,65.96%,FTO;ALKBH3;TDG;ALKBH1;ALKBH2
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.23228842634649655,-0.5316526078096396,1.0,1.0,1.0,4/89,8.39%,GBP2;PRICKLE1;NUP62CL;E2F3
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.34922450254136506,-0.5314321650974715,1.0,1.0,1.0,1/5,17.47%,FGF13
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.2554281971542452,0.5312707152716707,1.0,1.0,1.0,8/33,25.05%,ATF4;FBP1;PGM1;CRTC2;SLC25A1;PGAM1;SLC37A4;GOT2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.32624313743295175,-0.5307008548908629,0.96,1.0,1.0,4/10,32.16%,WRN;NBN;XRCC3;SLX4
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.32624313743295175,-0.5307008548908629,0.96,1.0,1.0,4/10,32.16%,WRN;NBN;XRCC3;SLX4
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.32624313743295175,-0.5307008548908629,0.96,1.0,1.0,4/10,32.16%,WRN;NBN;XRCC3;SLX4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.3188107143018588,0.5301501519586552,0.9230769230769231,1.0,1.0,1/7,8.30%,G3BP2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.23256809723591193,0.5300883344023067,1.0,1.0,1.0,16/66,22.36%,ATF4;ATP6V1G2;ATP6V1G1;MLST8;MAPK8;LAMTOR4;RNF152;WDR59;DAPL1;SESN1;CASTOR2;EIF2S1;SEH1L;SLC38A9;MTOR;ATP6V0E1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.32012281958898015,0.5299272590290203,0.9722222222222222,1.0,1.0,2/6,22.03%,DLG1;PKHD1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.3429310017742391,0.5292210938901781,0.918918918918919,1.0,1.0,3/5,26.33%,MACIR;RAC1;FGF2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.31532056978090595,-0.5290655078743403,0.9803921568627451,1.0,1.0,1/9,8.48%,XBP1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.32029073008859554,-0.5289935337078369,0.9710144927536232,1.0,1.0,5/9,33.09%,CAMK2B;LRP8;DHX36;DBNL;CUX2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.2953705183325277,0.5282908495879148,0.9393939393939394,1.0,1.0,6/16,21.88%,SPHK2;PLPP2;GCH1;NAAA;CALM1;AKT1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.23837301152733514,-0.5282549780229526,1.0,1.0,1.0,6/62,12.48%,MET;RHOC;ARHGAP28;CARMIL1;TGFB3;SYNPO2L
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.3169520834495457,0.5282410914384061,1.0,1.0,1.0,6/6,68.32%,IGBP1;QARS1;PPIA;GSTP1;FOXO1;FOXM1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.350719625125516,-0.5274008634038524,0.9824561403508771,1.0,1.0,7/7,64.95%,RB1CC1;ULK1;ATG2B;ATG7;ULK2;ATG2A;ATG13
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.350719625125516,-0.5274008634038524,0.9824561403508771,1.0,1.0,7/7,64.95%,RB1CC1;ULK1;ATG2B;ATG7;ULK2;ATG2A;ATG13
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.26721359333607575,0.5260879380111252,0.9777777777777777,1.0,1.0,1/19,6.56%,RALA
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.3172403208637586,0.5258408899273749,1.0,1.0,1.0,2/9,16.33%,ATPSCKMT;MID1IP1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.2316525499099525,0.5254823051367445,1.0,1.0,1.0,8/67,12.78%,NUTF2;PPP1R10;RANBP17;FAM53A;GEMIN6;TPR;SNUPN;IPO5
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.33272129358580116,-0.5251591222299364,1.0,1.0,1.0,1/5,15.68%,CDKN1A
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.28268145422242485,0.5250253481964133,0.9230769230769231,1.0,1.0,2/10,12.02%,PNPLA3;DGKQ
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.2590719087557797,0.5237658167411462,0.96875,1.0,1.0,5/25,18.62%,ATAT1;KAT2A;NAA50;CPA4;MRGBP
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.3210188778426966,-0.5237640713783427,0.9038461538461539,1.0,1.0,2/8,19.33%,DMTN;NEDD9
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.28079697820744565,0.5223141612538785,0.9565217391304348,1.0,1.0,1/11,7.32%,SEC61A2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.31963034787245864,-0.5213002443287237,0.967741935483871,1.0,1.0,2/7,22.98%,GCLM;ITGB1BP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.31963034787245864,-0.5213002443287237,0.967741935483871,1.0,1.0,2/7,22.98%,GCLM;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.3272160325943775,-0.5210187421653066,0.9661016949152542,1.0,1.0,3/10,25.83%,PID1;ZDHHC6;VAT1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.2833333189250585,-0.5208992136082902,1.0,1.0,1.0,1/20,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.2833333189250585,-0.5208992136082902,1.0,1.0,1.0,1/20,7.20%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.23156242046556264,-0.5203348756585768,1.0,1.0,1.0,17/76,26.22%,ATAD5;CENPF;TUBA4A;CEP70;KCNH5;GTSE1;CEP135;CEP152;AURKA;CEP41;PPP2R1A;CEP76;MACROH2A1;NEDD1;CSNK1D;CSNK1E;CEP72
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3306015960684784,-0.5182728804440172,0.9666666666666667,1.0,1.0,2/6,24.18%,PRKCQ;IL12RB1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.24568615078392708,0.5181805289228117,0.9655172413793104,1.0,1.0,2/19,10.87%,SMDT1;MCUR1
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.26966856377636406,0.5181590466386011,1.0,1.0,1.0,11/11,73.05%,SLC37A4;XPR1;SLC20A2;SLC37A3;SLC25A10;SLC20A1;SLC25A11;SLC25A3;SLC25A14;SLC37A1;SLC25A30
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.26966856377636406,0.5181590466386011,1.0,1.0,1.0,11/11,73.05%,SLC37A4;XPR1;SLC20A2;SLC37A3;SLC25A10;SLC20A1;SLC25A11;SLC25A3;SLC25A14;SLC37A1;SLC25A30
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.3348509494486436,-0.5180981327040123,0.9272727272727272,1.0,1.0,1/5,20.46%,CTPS2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.2374847197452523,-0.5180650232089331,1.0,1.0,1.0,10/64,21.34%,TGFBR2;RFTN1;NUP62CL;TST;FLOT1;ZFP36;NCBP1;EIF4A3;SIDT1;SRSF5
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.30374577121935803,0.5175811315008393,0.9574468085106383,1.0,1.0,4/12,20.03%,LTV1;SDAD1;NPM1;RAN
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.32834089620038376,-0.5168721683019618,1.0,1.0,1.0,3/8,21.45%,PPP1R15A;TMEM33;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.2890869400310754,0.5160750140962206,0.9523809523809523,1.0,1.0,2/12,12.87%,PHF1;DNMT1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.33885357660775073,-0.5148037844843792,0.9807692307692307,1.0,1.0,2/7,13.60%,VEGFA;PRKD2
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.2815117011898644,0.5139901526944687,1.0,1.0,1.0,7/14,30.01%,STAR;NPC2;NPC1;RELCH;LDLRAP1;SERAC1;LDLR
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.3314926372155288,0.5136308675473158,0.95,1.0,1.0,5/5,66.86%,HIPK2;SERBP1;ETS1;HABP4;PML
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.2707019909697521,-0.512747689864331,0.9491525423728814,1.0,1.0,6/22,28.66%,TERF2IP;RAD50;MRE11;GNL3;NBN;DHX36
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.27314850135201646,0.5126049565763481,1.0,1.0,1.0,4/20,21.39%,BAG2;RPL11;BTRC;RPL5
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.33061252732463703,-0.5121289235567191,0.9333333333333333,1.0,1.0,2/7,32.43%,FMR1;SYT11
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.3087905980264566,-0.5120867972384634,0.984375,1.0,1.0,1/11,8.79%,POLR1E
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.28275714801645097,0.512053010182744,1.0,1.0,1.0,2/10,15.99%,HDAC1;SALL1
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.3564250557144314,-0.5111822673001775,0.9622641509433962,1.0,1.0,2/5,13.67%,AGBL4;AGBL3
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2987812568296006,0.5110976427284581,0.9761904761904762,1.0,1.0,2/18,16.90%,BAK1;THADA
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.2968148272695758,0.5109961356511692,0.9772727272727273,1.0,1.0,1/7,13.41%,GRK2
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.3309544606291433,-0.5105911801807903,1.0,1.0,1.0,2/6,29.88%,CX3CL1;FYN
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.28580041036227266,0.5105368245956075,0.9736842105263158,1.0,1.0,4/9,27.32%,DNMT1;SIRT1;JARID2;DNMT3B
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.29664137469314883,-0.5102774349838389,1.0,1.0,1.0,9/9,70.36%,DLAT;ACAT1;ACSS1;MLYCD;DIP2A;PDHA1;ACLY;PPCS;PDHB
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.3298678317942148,-0.509837483534363,1.0,1.0,1.0,2/5,23.35%,DDX11;PRKCD
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.24198955805982875,0.5091533222152078,1.0,1.0,1.0,3/28,13.83%,HMGA2;BRCC3;UIMC1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.2315538709851549,-0.5085806601104569,1.0,1.0,1.0,19/62,30.52%,RAB11A;CALM3;DCDC1;PLK2;GIT1;CIT;KIF20B;PIN1;AURKA;KLHL9;SVIL;GIPC1;RAB11FIP4;UVRAG;CUL3;VPS4A;CENPV;KIF14;ECT2
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.27931046839805546,-0.5081507177340459,1.0,1.0,1.0,8/18,32.89%,PLA2G12A;PLB1;PLA2G4A;LPCAT3;LPCAT2;MBOAT2;PNPLA8;MBOAT7
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.30623744699843786,-0.5080819531778186,0.9827586206896551,1.0,1.0,9/9,69.40%,RABGGTB;RABGGTA;CHM;PTAR1;FNTB;PGGT1B;AIPL1;RCE1;FNTA
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.2892393081930744,-0.506986435324551,1.0,1.0,1.0,2/13,17.49%,TRMT9B;MOCS3
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.3136378955807987,-0.5069614145349298,0.9523809523809523,1.0,1.0,1/7,14.92%,SCIMP
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.30779856252291965,-0.5053970502629911,0.9393939393939394,1.0,1.0,4/8,25.89%,TST;CBS;MPST;TXN2
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.22432758355601612,0.5047247737433509,1.0,1.0,1.0,13/51,26.13%,BANF1;AHCTF1;NUP37;NSFL1C;NDC1;SUMO1;RAN;SEH1L;PPP2R2A;UBXN2A;UBXN2B;CC2D1B;NUP85
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.3251338688085677,0.5045914033514001,0.925,1.0,1.0,5/5,67.50%,VAMP8;VAMP7;VAMP3;SNX4;SNX6
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.32387638972191,-0.5034034904914857,0.9629629629629629,1.0,1.0,3/7,28.66%,WRN;DDX11;DHX36
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.30685410358049126,-0.5027371699765529,1.0,1.0,1.0,1/11,11.29%,AP3B2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.30685410358049126,-0.5027371699765529,1.0,1.0,1.0,1/11,11.29%,AP3B2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.25852852938538406,-0.5004799082939602,1.0,1.0,1.0,2/20,18.65%,AR;TENM1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.32144513540259834,-0.5002606267603412,0.9833333333333333,1.0,1.0,2/7,32.36%,PLA2G4A;PNPLA8
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.31494155758534503,0.4995866370004475,0.9714285714285714,1.0,1.0,1/8,6.44%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.2140331652375311,0.49891692618957467,1.0,1.0,1.0,13/84,19.54%,PSME2;CDC26;PSMD13;ANAPC15;DBF4B;PSME4;PSMF1;ANAPC1;ERCC2;PSMD11;CDC23;PSMD4;BTRC
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.23423272442880283,0.4984173868619094,1.0,1.0,1.0,32/32,76.62%,GBF1;ZFAND1;PLK5;PLK3;KIF5B;ATG2A;VCP;DDRGK1;MRRF;MTIF2;GOLGA2;UFM1;UFL1;GFM2;EIF2D;TEX264;ULK2;RETREG1;UFC1;DENR;STX5;KLC1;CDK1;ATG2B;DYRK3;ULK1;MCTS1;RB1CC1;VRK1;MTIF3;KIF9;UBA5
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.2911483404826596,0.4977695907104788,0.9696969696969697,1.0,1.0,2/7,19.77%,THOC2;ALYREF
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.2911483404826596,0.4977695907104788,0.9696969696969697,1.0,1.0,2/7,19.77%,THOC2;ALYREF
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.34636603850743763,-0.4976008769641982,0.9672131147540983,1.0,1.0,2/5,30.02%,SLC6A4;WWC3
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.2850990899057162,-0.4974912857969097,0.9838709677419355,1.0,1.0,1/11,16.04%,NNMT
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.2706934378082594,0.4971853039446004,0.975,1.0,1.0,1/7,10.87%,MCUR1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.2959527250013119,0.49607337750102193,0.9318181818181818,1.0,1.0,2/5,19.58%,IVD;HMGCL
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.2288026762319147,-0.4960653183280943,1.0,1.0,1.0,9/51,23.35%,E2F1;RBL2;GTSE1;CDKN1A;PLK2;ARID3A;AURKA;ZNF385A;PLAGL1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.2649857495506524,0.49579984808163285,0.9722222222222222,1.0,1.0,1/22,2.79%,HMGB1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.24365780759750946,0.4952233577357106,1.0,1.0,1.0,6/16,27.01%,HACD1;ACSL4;ACSF3;TECR;ELOVL1;ELOVL6
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.25520245778151285,-0.4949828365657665,1.0,1.0,1.0,7/29,32.82%,LIX1;STX17;UVRAG;ATG14;TSG101;LAMP2;TECPR1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.3453628663345517,-0.49466787507442483,0.9833333333333333,1.0,1.0,1/6,22.60%,VPS4B
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.25354410410292805,0.494039295718971,0.9722222222222222,1.0,1.0,1/27,3.60%,MAP10
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.24778116732009936,0.4932202740514065,1.0,1.0,1.0,10/37,23.94%,PDGFA;KDM1B;UBE2N;POLH;SMG5;ALYREF;YLPM1;SIRT7;WDR18;STOX1
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.3239827511167421,-0.49317865014871126,0.9824561403508771,1.0,1.0,3/7,30.68%,KAT2B;HAT1;MAPT
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.25672896899365355,-0.4931315020080797,1.0,1.0,1.0,6/26,24.07%,RPA3;RPA2;RBX1;RPA1;XPA;MNAT1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.281789769975051,-0.49283917325288373,0.9830508474576272,1.0,1.0,2/10,18.14%,SCARB1;SREBF1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.3037942522051963,-0.4924999098539757,1.0,1.0,1.0,2/9,17.16%,MAD2L1;MAD2L2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.25943979699612024,-0.4921157276709736,1.0,1.0,1.0,5/44,16.76%,BMP6;HJV;FBXL5;CP;SLC11A2
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.33578212802587604,-0.4915156410872334,1.0,1.0,1.0,3/5,28.17%,TAPBP;CALR;STX4
prerank,GO_Biological_Process_2021__regulation of dendritic cell cytokine production (GO:0002730),-0.3219196943355883,-0.488605149359037,0.9836065573770492,1.0,1.0,1/5,14.92%,SCIMP
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.27921410380310974,0.48856725904802467,1.0,1.0,1.0,2/9,18.48%,PIH1D1;NAF1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.24979823988873037,-0.48840131874255616,1.0,1.0,1.0,2/29,10.31%,HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.29403691046875635,0.4859760645928596,0.9743589743589743,1.0,1.0,5/7,33.64%,KMT2B;KMT2D;KMT2C;KMT2A;SETD4
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.30924274267248525,0.48408867729265287,0.9722222222222222,1.0,1.0,4/6,34.53%,DPAGT1;DOLPP1;NUS1;DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.30924274267248525,0.48408867729265287,0.9722222222222222,1.0,1.0,4/6,34.53%,DPAGT1;DOLPP1;NUS1;DOLK
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.25701540829212294,-0.4810896773163455,1.0,1.0,1.0,6/22,35.32%,NMI;TYRO3;RNF26;C1QBP;ILRUN;IRAK3
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.22528816642690097,-0.4800962972198638,1.0,1.0,1.0,11/64,22.38%,LRRK2;DOP1B;TRAM1L1;CAV2;STEEP1;TRAM2;DNM1L;SEC61G;TMEM33;ALDH3A2;ZBED3
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.30679979918558586,0.4794243465065381,0.9210526315789473,1.0,1.0,6/6,69.33%,APP;HSPA8;DCTN1;SPG11;APBA1;MAPT
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.2844460893972789,0.47900889252193607,0.9523809523809523,1.0,1.0,2/8,17.19%,LCAT;PLTP
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2512067028403935,-0.47897221525131906,1.0,1.0,1.0,4/22,25.30%,MVB12A;TOM1L1;VPS4B;VPS37A
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.29804205946337925,-0.4781688670099143,0.9838709677419355,1.0,1.0,6/6,70.21%,SLC6A9;LDB1;PRMT1;SLC25A37;ABCB10;EIF2AK1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.27083171513980653,0.47577909873704927,1.0,1.0,1.0,1/15,6.05%,PCM1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.2407013843625584,0.47524660300347027,0.972972972972973,1.0,1.0,2/11,13.99%,MYH14;PNPT1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.2964046509400462,-0.4740955044389647,0.92,1.0,1.0,4/8,35.47%,CYP46A1;APOE;CYP27A1;SNX17
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.2964046509400462,-0.4740955044389647,0.92,1.0,1.0,4/8,35.47%,CYP46A1;APOE;CYP27A1;SNX17
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.31448014279339565,0.47387643433797977,0.95,1.0,1.0,5/5,68.56%,VPS13D;VDAC1;TSC2;SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.25229462746379766,0.4727840160386053,0.975,1.0,1.0,5/11,29.79%,CHRNA7;PICALM;ROCK2;RANBP9;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.26411515286766374,0.47237071948814596,0.9166666666666666,1.0,1.0,9/9,73.60%,SEC14L1;NPLOC4;UFD1;TKFC;GPATCH3;DHX58;RIOK3;C1QBP;TSPAN6
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.3040582735411368,-0.46965765253849034,0.9629629629629629,1.0,1.0,2/6,28.82%,EXOSC10;EXOSC4
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.2989988849354357,-0.46896122738240925,1.0,1.0,1.0,1/6,14.65%,NOP10
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.31568891701057455,-0.46800905217619204,1.0,1.0,1.0,4/7,38.23%,LILRB1;C1QBP;IRAK3;CCR7
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.25426455487984,-0.4678906233422982,0.9830508474576272,1.0,1.0,8/22,30.68%,MAP2;PRUNE1;CAMSAP3;AKAP13;GPX1;MAPRE3;APOE;MAPT
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.26068855082378123,0.46777807890539574,0.975,1.0,1.0,5/11,21.88%,QDPR;MTHFD1L;GCH1;CALM1;AKT1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.24575992178194006,-0.4668206995254724,1.0,1.0,1.0,3/28,24.51%,NAPG;RAB6B;RAB6C
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.28622295901256456,-0.46599893299236744,0.9848484848484849,1.0,1.0,2/8,22.98%,PLAT;ITGB1BP1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.28049994114687815,0.46509804233639224,0.9722222222222222,1.0,1.0,4/8,23.13%,KIT;COBL;PKD1;NIPBL
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2256590457819636,-0.4644463078156152,1.0,1.0,1.0,7/47,21.22%,CELF4;CELF2;SRRM4;KHDRBS3;RBFOX3;RBM24;KHDRBS2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.25386111807944106,-0.4643324208907771,1.0,1.0,1.0,4/18,23.93%,INCA1;NR2F2;MYOCD;TFAP4
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.2885600325164307,-0.46430009837805974,0.95,1.0,1.0,1/6,19.22%,FNBP1L
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated immunity (GO:0002705),-0.3066470562578685,-0.46408826114394275,1.0,1.0,1.0,1/5,14.92%,SCIMP
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.2264071635887388,-0.46294608535666054,1.0,1.0,1.0,4/28,24.55%,DDIT4;TNFAIP8L1;SESN3;TBC1D7
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.3121125982468139,-0.46236907869368915,1.0,1.0,1.0,2/5,23.81%,NEB;WAS
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.3189878768054535,-0.4620812098182436,0.9836065573770492,1.0,1.0,3/5,38.26%,ANK3;CLIP3;SERINC1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.2807485118157885,-0.46155627075902517,1.0,1.0,1.0,2/7,21.05%,GARS1;DARS2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.1976553271718175,0.4607049682967533,1.0,1.0,1.0,2/107,3.66%,MTERF3;HDAC10
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.3014948869995947,0.46025252124814386,1.0,1.0,1.0,2/6,20.57%,KMT2B;KMT2D
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.19846044403561847,-0.4600510344425703,1.0,1.0,1.0,9/97,21.32%,RPL31;MAN1A1;RPL38;RPL37A;SRP54;SEC61G;RPS27;RPS29;RPL34
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.2044099149713132,-0.4597541995625619,1.0,1.0,1.0,7/87,21.32%,RPL31;RPL38;GSPT2;RPL37A;RPS27;RPS29;RPL34
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.26981650811343266,-0.4591789439179698,1.0,1.0,1.0,2/13,24.80%,BCAP31;EDEM1
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.27719330456501645,-0.45791970171950486,1.0,1.0,1.0,2/10,18.63%,RAD50;TPRKB
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.28820838911200375,0.45722474668009955,0.975609756097561,1.0,1.0,5/5,71.19%,EXOSC5;EXOSC6;APOBEC3H;CDADC1;EXOSC4
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.23123194104429678,0.45714750732181103,1.0,1.0,1.0,4/17,20.12%,H6PD;RPIA;TKT;PGLS
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.26935959564736317,0.4554215192749926,1.0,1.0,1.0,2/8,17.66%,QDPR;KYAT1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.22752178575498247,0.45536189710360864,1.0,1.0,1.0,6/18,24.88%,DKC1;NAF1;CCT8;CCT2;CCT3;CCT6A
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.195270965101662,-0.4551946899448975,1.0,1.0,1.0,10/103,21.12%,CAPN1;LRRK2;CDK5R1;ATP6V1C2;SNX32;PRKAB2;CDK5;ATP6V1D;TRIM13;VPS35
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.27897762333775267,-0.45457917281765675,0.984375,1.0,1.0,3/7,32.34%,ZCCHC17;FMR1;SLIRP
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.2525106003124302,0.454227027825517,0.96875,1.0,1.0,9/9,74.76%,CLN3;LGMN;CHRNB2;MAP1A;DRD2;SLC6A1;ADCY3;BRSK1;SHANK1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.28040045956424,-0.45315652815435054,0.984375,1.0,1.0,3/7,23.48%,ARF1;WNT5A;PICK1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.20896414105282965,-0.4525213776867919,1.0,1.0,1.0,9/51,25.32%,TOMM7;SLC25A31;FBXO7;COX18;BCAP31;TMEM14A;DNAJC19;TIMM17B;PPIF
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.2407103999261898,-0.452194769287371,1.0,1.0,1.0,10/25,35.93%,ATP5F1E;MICOS13;ATP5MC1;DMAC2L;ATP5ME;APOOL;ATP5PD;ATP5PB;AFG3L2;ATP5F1A
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.291834002677376,0.4519876451148611,1.0,1.0,1.0,5/5,70.82%,NIPBL;XRCC6;ATM;XRCC5;NUCKS1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.1972664597020917,0.44979006438456764,1.0,1.0,1.0,8/48,21.46%,BANF1;AHCTF1;NUP37;NDC1;SUMO1;RAN;SEH1L;PPP2R2A
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.1972664597020917,0.44979006438456764,1.0,1.0,1.0,8/48,21.46%,BANF1;AHCTF1;NUP37;NDC1;SUMO1;RAN;SEH1L;PPP2R2A
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.27828573864945166,-0.4484137212055144,0.9523809523809523,1.0,1.0,1/7,21.89%,KDELR3
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.23245427120941753,-0.4470072034346374,1.0,1.0,1.0,2/13,18.14%,SCARB1;SREBF1
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.2916976800769412,0.4463580096330713,1.0,1.0,1.0,1/6,11.01%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.2886178688686728,0.4441719814453539,1.0,1.0,1.0,1/7,10.40%,IL17D
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.288185831741002,0.4429441603000371,1.0,1.0,1.0,2/6,20.96%,SLC38A3;SLC36A4
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2207404367827312,-0.44214153498789643,0.9848484848484849,1.0,1.0,4/26,23.61%,ACSL5;SCD;ACSBG2;ELOVL2
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.25738982095027,-0.441087031070746,1.0,1.0,1.0,3/10,29.66%,IMPACT;SESN3;RRAGD
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.2585341617108115,-0.4400042301873656,1.0,1.0,1.0,5/12,33.07%,TYMP;TOP3A;AKT3;SLC25A4;MPV17
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.2904997135767613,0.4395932742384927,0.9767441860465116,1.0,1.0,2/5,31.33%,RAC1;PIP5K1A
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.27362904006812205,0.43940698160798036,0.9375,1.0,1.0,1/5,13.50%,BECN1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.2893248424399898,-0.4387557555149118,0.9838709677419355,1.0,1.0,1/5,17.18%,NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.2893248424399898,-0.4387557555149118,0.9838709677419355,1.0,1.0,1/5,17.18%,NRXN1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.24585492286783017,0.4368371555767736,1.0,1.0,1.0,6/12,30.84%,DNMT1;SMAD4;DNMT3B;AUTS2;KMT2A;PAXIP1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.2582840566774516,0.43561022817769035,1.0,1.0,1.0,7/7,74.18%,ADCK1;PRKN;MUL1;HUWE1;TFRC;BNIP3;VAT1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.2401545964149338,0.4350542841120899,1.0,1.0,1.0,5/12,25.34%,ASAP3;ALMS1;CDC42;RAC1;ROCK2
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.24124232227669262,0.43487341420954484,1.0,1.0,1.0,1/8,13.58%,HNRNPU
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.2515990203756185,-0.43140173414562627,1.0,1.0,1.0,1/12,12.39%,EDNRB
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.2505786753609986,0.43089457244535534,1.0,1.0,1.0,3/7,25.67%,PADI2;SPTY2D1;TLK2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.28329543272962937,-0.4303785712616068,1.0,1.0,1.0,1/7,21.40%,MYOCD
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.20247416981553462,0.42941980747426917,1.0,1.0,1.0,3/36,11.49%,ATF4;FBP1;PGM1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.2471262658169769,-0.42907042656277306,0.9836065573770492,1.0,1.0,5/12,28.29%,DDO;GAD1;ACOT8;GLUD1;QPRT
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.2517638720674528,0.4275901163992238,1.0,1.0,1.0,2/9,19.18%,PRKAA2;SIRT1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.24147743123361032,0.42728854305051184,1.0,1.0,1.0,10/10,75.87%,SESN1;MTOR;UBR1;KLHL22;UBR2;SESN2;LARS1;RPTOR;RRAGD;SESN3
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.24147743123361032,0.42728854305051184,1.0,1.0,1.0,10/10,75.87%,SESN1;MTOR;UBR1;KLHL22;UBR2;SESN2;LARS1;RPTOR;RRAGD;SESN3
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.24630788143002444,-0.42642170046085787,0.9846153846153847,1.0,1.0,3/13,22.02%,PID1;DNM1L;CSPG5
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.24125638294646953,-0.4258390486645471,1.0,1.0,1.0,3/14,23.48%,ABCD2;ARF1;PICK1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.28404083226418236,0.42429570736042393,1.0,1.0,1.0,6/6,71.61%,FBXW7;PRKN;MCL1;PARK7;NONO;HIF1A
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.23562008676581048,0.4222981776489315,1.0,1.0,1.0,1/11,7.42%,HPRT1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.22513344486374184,-0.41977011574611084,1.0,1.0,1.0,1/15,19.79%,SCD
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.2506922347921151,0.4177186153953413,1.0,1.0,1.0,3/7,25.95%,PECR;SLC25A17;PHYH
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.20703741956788774,-0.4167480231341116,1.0,1.0,1.0,4/27,25.66%,USP14;CAMLG;SDCBP;GIPC1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.23684292260674994,-0.41600687429961,1.0,1.0,1.0,3/12,26.43%,ACOT8;ELOVL2;FADS2
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.25118153145354905,-0.4157839675281841,1.0,1.0,1.0,2/8,32.08%,PDK2;PDK3
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.25118153145354905,-0.4157839675281841,1.0,1.0,1.0,2/8,32.08%,PDK2;PDK3
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.293711684506299,-0.41499880832835845,1.0,1.0,1.0,2/5,25.44%,LCLAT1;PLA2G4A
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),0.29402577118313167,0.41498634094535075,1.0,0.9999886205064261,1.0,6/6,70.61%,CELSR1;BRSK2;VANGL2;NPHP1;FUZ;BRSK1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.2526739062923654,0.4139926943184352,1.0,0.99960079989426,1.0,2/6,20.82%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.23202495152834862,-0.41325954859778397,1.0,1.0,1.0,2/13,18.99%,COQ8B;PDSS1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.23202495152834862,-0.41325954859778397,1.0,1.0,1.0,2/13,18.99%,COQ8B;PDSS1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.25697333960699237,-0.41125333070442127,0.9824561403508771,1.0,1.0,2/10,18.93%,NOP10;RPUSD3
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.2500179779263255,-0.41057581391135434,1.0,1.0,1.0,4/9,35.93%,ATP5MC1;ATP5PD;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),-0.2701092577845368,-0.41055105682869913,1.0,0.9998175471842098,1.0,2/7,29.05%,RBM24;FMR1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.25849658241893025,0.4003010361371672,1.0,1.0,1.0,1/6,18.97%,SNCA
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.21535221679082095,-0.39961313649520874,1.0,1.0,1.0,7/17,32.62%,RRP15;WDR12;EXOSC10;RPF1;EXOSC4;LAS1L;MAK16
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),-0.2580284850337447,-0.39277141742287774,1.0,1.0,1.0,1/5,15.41%,NR1D1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.240356230717873,-0.39209489176160633,1.0,0.9998036361710066,1.0,2/9,24.92%,CX3CL1;C1QA
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.1996503686760316,-0.39134378580507856,1.0,0.9995165547560874,1.0,7/25,32.64%,FCHSD2;FNBP1L;CANX;CLTC;GAK;ITSN2;AP2A2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.20127225043245373,0.3799218170183899,1.0,1.0,1.0,12/12,79.89%,AFF2;HIPK2;SERBP1;ETS1;ZPR1;SRPK2;DYRK3;HABP4;USP50;PML;WRAP53;USPL1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.19267693681625364,-0.3788464367527822,1.0,0.9996122995353109,1.0,17/17,80.76%,SREBF1;LPCAT3;APOE;KPNB1;MBTPS2;SEC14L2;PRKAA1;MBTPS1;SREBF2;SCAP;ABCG1;FGF1;ABCA2;ERLIN1;SOD1;RAN;ERLIN2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.18934527635155268,0.3784028521317053,1.0,1.0,1.0,15/26,35.28%,GREM1;DDX5;JMY;PPP1R13B;BOK;MYBBP1A;MDM4;FHIT;USP10;PAXIP1;TP53BP2;TP53;IFI16;NDRG1;ACER2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.23761441919962895,-0.36907410990557366,1.0,0.9995648999853993,1.0,3/9,32.36%,LCLAT1;PLA2G4A;PNPLA8
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.2317304473948454,0.36130320081277073,1.0,1.0,1.0,7/7,76.84%,CALM1;SNAP29;VAMP8;VMP1;ATP2A2;ATG14;STX17
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.19274553571428588,0.34321381294635145,1.0,1.0,1.0,13/13,80.74%,CDC42;APP;DYNC1I2;BORCS5;ARHGAP21;DYNC1I1;SPG11;COPG1;APBA1;COPG2;CLIP3;BAG3;CAMSAP3
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.20316858194800846,0.328010621337956,1.0,0.9999848980619179,1.0,7/7,79.69%,CAPN10;GSN;RYR2;HIPK1;BMPR2;DAB2IP;COL4A3
